data_5fim_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5fim _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.467 HD11 ' N ' ' A' ' 4' ' ' PHE . 3.1 tm? . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.061 0.458 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.467 ' N ' HD11 ' A' ' 3' ' ' LEU . 96.7 m-85 -126.09 136.35 52.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.223 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -108.44 147.25 31.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.447 0.641 . . . . 0.0 112.275 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 53.7 m-85 -130.47 -169.17 2.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.751 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.413 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 40.5 t -86.61 -13.38 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.536 0.207 . . . . 0.0 111.115 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.657 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 63.7 tttm 73.85 -68.71 0.21 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.083 0.553 . . . . 0.0 111.784 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.02 -26.24 65.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.905 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.493 ' CB ' ' HA3' ' A' ' 141' ' ' GLY . . . -100.28 125.53 46.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.153 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.11 -169.43 40.32 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -60.49 129.89 43.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -74.81 73.39 2.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.029 0.919 . . . . 0.0 109.717 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 14' ' ' LEU . 12.1 tp . . . . . 0 N--CA 1.436 -1.142 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.552 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.535 ' O ' HG21 ' A' ' 31' ' ' VAL . 95.8 mt-30 -63.88 -45.99 86.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.586 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.1 78.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.184 0.516 . . . . 0.0 110.727 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.09 -45.47 94.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.537 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' O ' HD22 ' A' ' 14' ' ' LEU . 68.5 mmtt -61.11 -35.21 76.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.852 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 97.4 t -62.74 -48.94 85.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -55.35 -48.56 74.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.569 172.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 66.1 mt-10 -55.71 -50.27 70.76 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -53.23 -43.95 67.7 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.698 0.624 . . . . 0.0 111.505 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 98.5 mt -62.76 -42.95 99.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.502 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -75.1 -25.39 58.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.989 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 13.2 mmmm -65.84 -51.99 54.25 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.222 0.534 . . . . 0.0 110.385 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 130' ' ' PRO . 2.4 p -73.3 -28.97 62.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.375 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.07 30.54 7.81 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.973 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.61 126.05 85.93 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.52 145.71 71.57 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.894 1.729 . . . . 0.0 112.107 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.29 21.45 11.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.804 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.11 -22.39 63.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.6 2.99 56.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.684 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -99.26 3.05 46.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.453 . . . . 0.0 110.155 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.12 172.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.025 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -137.3 131.73 32.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.627 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 mm -98.14 141.45 16.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.952 0.406 . . . . 0.0 111.21 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 49.2 tt0 -139.67 119.8 13.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.686 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.434 HD12 HG22 ' A' ' 31' ' ' VAL . 43.5 mm -96.57 108.16 20.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.289 0.566 . . . . 0.0 110.833 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.56 72.48 2.04 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 68.08 -82.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.867 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.7 1.81 24.64 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.132 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -110.08 110.48 21.39 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.522 -0.399 . . . . 0.0 111.084 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.24 92.14 7.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.792 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 84' ' ' ASP . 43.3 m -75.78 122.62 24.33 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.905 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.4 t -112.01 113.61 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.115 0.483 . . . . 0.0 110.28 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -100.91 162.96 12.53 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.224 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.75 167.05 32.18 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.495 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -155.15 142.27 19.3 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.959 0.409 . . . . 0.0 110.319 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.11 7.83 86.41 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.384 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.44 169.23 18.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.381 0.61 . . . . 0.0 112.165 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.1 m -115.32 147.69 40.15 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 170.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.578 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 39.8 tt0 -51.93 -45.8 64.44 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -173.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.3 -50.35 62.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.945 0.403 . . . . 0.0 110.184 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.08 -43.06 96.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.066 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.471 ' O ' HD11 ' A' ' 71' ' ' LEU . 27.5 ttpp -59.13 -47.34 85.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 0.0 111.098 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 4.1 mm-40 -66.19 -15.88 63.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.091 0.472 . . . . 0.0 110.736 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -39.04 53.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.701 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.3 mm -65.31 -57.04 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.471 0.653 . . . . 0.0 109.915 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 67' ' ' LYS . 11.0 mp -42.44 -49.68 5.23 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.871 -177.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.5 HG23 ' HG2' ' A' ' 145' ' ' ARG . 57.5 t -69.85 -49.56 56.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.235 0.54 . . . . 0.0 111.199 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HA ' ' SD ' ' A' ' 131' ' ' MET . . . -64.02 -29.68 70.81 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.956 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.2 m -87.6 -29.08 5.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.988 0.423 . . . . 0.0 111.043 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -73.63 -33.46 58.13 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.443 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -80.01 54.26 1.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.773 0.32 . . . . 0.0 111.138 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -122.76 142.48 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 120.927 0.394 . . . . 0.0 110.551 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 t -70.83 103.26 2.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.504 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.61 -18.11 5.46 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.285 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.657 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 45.9 mm -94.34 117.17 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.455 0.645 . . . . 0.0 111.045 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.58 -30.47 13.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.881 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 p -153.17 160.23 42.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.261 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.94 125.89 70.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.432 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.515 ' HB3' HG21 ' A' ' 56' ' ' THR . 6.4 t70 -97.98 96.84 8.44 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.45 104.98 5.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.117 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -115.94 19.45 15.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.111 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.9 114.91 20.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.997 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -83.19 122.33 28.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.1 p -99.43 130.72 45.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.155 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.47 -21.84 35.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.905 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -140.17 131.69 14.36 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.105 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.53 156.96 36.44 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.499 2.133 . . . . 0.0 111.066 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -150.64 -160.41 1.16 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.512 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.7 m -67.04 131.78 46.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 110.723 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.41 159.53 17.97 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.0 m -138.66 143.26 39.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.101 0.477 . . . . 0.0 110.814 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 6.5 tt0 -81.33 137.05 35.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.488 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 98' ' ' PHE . 79.8 m-85 -99.1 80.29 2.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.532 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.66 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 84.9 t80 -73.91 144.86 45.16 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.541 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.419 ' OG1' HG23 ' A' ' 143' ' ' VAL . 12.9 m -120.74 117.94 28.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.604 HG11 ' O ' ' A' ' 142' ' ' GLN . 0.6 OUTLIER -68.18 131.38 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -84.0 -61.14 1.89 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.92 -170.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.8 t -163.15 -68.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.19 53.43 4.79 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.515 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.8 m-20 -113.1 112.65 24.19 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.129 0.49 . . . . 0.0 111.05 -172.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.475 ' O ' HG21 ' A' ' 110' ' ' ILE . 25.1 m -108.81 146.59 33.39 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.548 ' O ' HG13 ' A' ' 110' ' ' ILE . 25.4 tp -52.61 -45.89 66.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -168.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.581 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 38.9 m -67.19 -41.56 85.67 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.096 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.37 -37.77 88.66 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.4 pp -76.96 -22.36 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 109.992 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -67.98 -49.38 62.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.05 171.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.581 ' HG3' ' O ' ' A' ' 108' ' ' SER . 22.2 mttt -55.26 -30.31 59.84 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 121.295 0.569 . . . . 0.0 110.155 172.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.62 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 4.5 tp60 -68.24 -56.82 7.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.617 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.465 HG21 ' N ' ' A' ' 115' ' ' TYR . 33.8 m -86.32 -42.91 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.158 -172.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.473 ' HB3' HD13 ' A' ' 120' ' ' LEU . 17.6 m-85 -90.82 -26.18 19.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.747 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.14 -9.73 76.86 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.626 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.517 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 26.2 t30 -126.12 129.35 48.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.554 ' CB ' ' HG2' ' A' ' 112' ' ' LYS . . . -72.9 -28.95 62.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.631 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.82 -19.19 65.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.551 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.517 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 54.6 mt -82.99 13.93 3.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.122 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.648 ' HD2' ' CD1' ' A' ' 121' ' ' TYR . 42.6 p90 -61.2 -32.62 72.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.424 0.63 . . . . 0.0 110.333 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.488 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 11.7 p30 -69.57 -30.04 67.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.458 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -61.94 -46.55 88.84 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.285 0.564 . . . . 0.0 109.656 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.5 mt -64.52 -44.94 96.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.451 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.529 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 26.2 t80 -51.8 -59.44 4.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.207 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 45.4 mt-10 -59.22 -41.37 88.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.361 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -59.51 -31.62 69.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.377 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.478 ' OD1' ' HA ' ' A' ' 144' ' ' LEU . 43.0 m-80 -90.11 -1.63 57.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 132' ' ' LEU . 29.5 mtpp -81.84 155.19 70.63 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.683 0.277 . . . . 0.0 110.362 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.448 ' HB2' ' O ' ' A' ' 38' ' ' THR . 1.9 Cg_endo -87.58 24.56 18.33 Favored 'Cis proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.819 -1.326 . . . . 0.0 113.461 0.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.467 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.1 OUTLIER -76.35 -37.13 57.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.222 0.534 . . . . 0.0 110.044 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 129' ' ' LYS . 13.4 tp -98.0 117.13 31.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.891 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -81.24 -51.29 8.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.783 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.4 m -138.29 154.61 73.94 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.527 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.24 -54.4 5.51 Favored 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 123.415 2.743 . . . . 0.0 112.963 -175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.98 5.76 24.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.541 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -83.82 -0.94 53.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.628 0.251 . . . . 0.0 111.185 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.9 pt -65.76 168.36 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -158.49 153.48 21.43 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.07 112.85 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.043 2.496 . . . . 0.0 112.389 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 96.77 35.91 5.22 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.615 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.604 ' O ' HG11 ' A' ' 101' ' ' VAL . 7.2 tp60 -108.78 121.43 45.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.988 0.394 . . . . 0.0 110.152 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.454 HG22 ' CD2' ' A' ' 6' ' ' PHE . 41.2 t -83.62 129.46 37.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.237 0.542 . . . . 0.0 110.645 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.478 ' HA ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -118.98 130.83 55.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.229 -177.14 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.5 ' HG2' HG23 ' A' ' 72' ' ' VAL . 55.3 mtp180 -69.52 119.26 13.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.334 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 27.6 mm -106.93 95.58 12.87 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 35.0 Cg_exo -61.49 149.88 87.71 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.656 2.237 . . . . 0.0 111.737 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.286 175.737 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 121.76 0.791 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 1.656 ' HD2' ' CD1' ' A' ' 4' ' ' PHE . 97.7 m-85 -101.44 127.11 48.25 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.358 175.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -87.43 134.08 33.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.697 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 50.7 m-85 -117.76 -158.15 0.7 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 88.5 t -89.36 -79.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.015 173.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.6 tmtp? 165.82 -71.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.017 0.823 . . . . 0.0 109.235 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.03 -25.95 34.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.355 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.79 124.06 23.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.963 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.21 -178.02 28.84 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -71.5 130.0 40.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 117.017 0.408 . . . . 0.0 109.911 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -77.64 92.93 4.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.356 0.598 . . . . 0.0 111.554 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.556 174.556 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 24.2 t70 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 121.005 0.431 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.581 ' O ' HG21 ' A' ' 31' ' ' VAL . 20.7 mt-30 -61.55 -38.98 89.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.291 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.2 -42.89 96.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.101 0.477 . . . . 0.0 110.483 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 27.1 ttpp -62.04 -42.84 99.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.041 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 28.0 mmtp -60.44 -40.11 89.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.97 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 27' ' ' GLN . 95.3 t -58.29 -49.06 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.359 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -55.16 -46.61 75.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.922 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 46.6 mt-10 -57.28 -44.15 83.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.732 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -57.81 -44.74 86.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.979 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 91.3 mt -64.96 -40.79 95.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.964 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -72.5 -34.01 67.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.273 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -72.1 -33.19 67.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.42 -25.35 46.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.109 0.48 . . . . 0.0 110.854 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.35 26.91 12.71 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.082 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.0 mm -65.09 122.15 78.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -75.45 151.21 37.29 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.978 1.785 . . . . 0.0 111.745 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 63.78 6.72 2.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.949 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.24 -22.92 61.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.018 0.437 . . . . 0.0 111.001 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -77.32 -19.67 56.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.383 176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -77.47 -21.81 52.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.986 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.5 m -101.34 173.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.338 0.59 . . . . 0.0 111.88 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -131.19 140.56 49.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.991 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.3 mm -102.99 138.68 26.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.957 0.408 . . . . 0.0 111.118 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -137.29 122.53 19.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.699 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.404 HG22 ' NE2' ' A' ' 27' ' ' GLN . 17.4 mm -92.93 122.37 44.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.979 0.419 . . . . 0.0 110.597 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.7 70.41 0.71 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.98 -82.34 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.325 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 -5.86 23.34 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.989 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 106.3 17.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.941 0.401 . . . . 0.0 111.017 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 80' ' ' ILE . . . -83.09 111.18 18.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.45 HG21 ' HB3' ' A' ' 84' ' ' ASP . 32.6 m -93.31 132.49 37.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.858 0.361 . . . . 0.0 111.32 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.99 123.56 65.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.0 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -122.75 158.04 31.02 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.385 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.22 177.7 28.75 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -160.16 145.18 14.89 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.053 0.426 . . . . 0.0 110.433 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 90' ' ' ALA . . . 100.26 11.7 41.34 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.942 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 mp -96.12 165.67 12.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.172 0.51 . . . . 0.0 111.574 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.0 m -85.57 143.02 28.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.871 174.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -63.92 -28.18 69.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.466 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.46 -29.59 59.67 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.904 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.38 -39.98 31.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.744 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -62.68 -31.97 72.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.679 -176.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.575 ' O ' HG22 ' A' ' 72' ' ' VAL . 6.5 mm-40 -65.29 -42.59 92.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.148 0.499 . . . . 0.0 110.118 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.46 -43.9 96.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.668 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.52 -53.65 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.583 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 94.9 mt -44.65 -48.35 10.54 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.798 0.686 . . . . 0.0 111.917 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 68' ' ' GLU . 54.8 t -62.91 -52.11 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.141 0.496 . . . . 0.0 111.053 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.9 70.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.692 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.402 HG11 HG12 ' A' ' 31' ' ' VAL . 52.7 t -75.04 -43.38 45.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.697 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -71.8 -28.79 68.33 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.329 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -77.79 45.29 0.5 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.062 0.458 . . . . 0.0 111.919 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.3 mt -117.89 140.33 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.356 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.9 t -65.96 103.28 0.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.529 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.14 -19.71 4.08 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.443 HG22 ' HA2' ' A' ' 75' ' ' GLY . 34.8 mm -97.13 133.24 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.301 0.572 . . . . 0.0 110.546 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 8' ' ' LYS . . . -113.45 -14.21 12.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.479 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 p -165.26 150.77 9.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.777 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 4' ' ' PHE . 15.0 p -120.3 134.23 64.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.835 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.45 ' HB3' HG21 ' A' ' 56' ' ' THR . 22.7 t0 -101.71 125.53 48.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.0 101.36 13.91 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.847 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -119.11 12.96 12.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.205 0.526 . . . . 0.0 110.217 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 p -86.77 128.28 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.432 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -89.18 147.35 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.841 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.4 p -108.01 142.09 38.68 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.83 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.421 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . . . -95.2 -33.17 12.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.321 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 p -126.87 134.77 26.46 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.087 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.72 119.05 5.29 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.579 2.186 . . . . 0.0 111.102 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -130.48 -160.91 1.08 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.658 -175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 m -76.47 116.87 17.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.101 0.477 . . . . 0.0 111.764 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.38 162.69 24.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.732 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 m -128.02 150.17 50.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.49 0.662 . . . . 0.0 112.308 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.6 tt0 -91.16 139.33 30.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.144 172.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -106.35 82.27 1.72 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.95 0.405 . . . . 0.0 110.838 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.64 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 75.6 t80 -84.71 141.32 30.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.062 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.2 m -107.44 118.8 37.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.694 0.283 . . . . 0.0 110.77 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.493 HG21 ' H ' ' A' ' 142' ' ' GLN . 1.0 OUTLIER -72.56 134.05 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.4 mmtp -100.99 -166.03 1.27 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.397 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.8 t -72.77 122.64 21.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.948 0.404 . . . . 0.0 109.959 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.67 7.18 69.23 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.91 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 102' ' ' LYS . 5.8 m-20 -82.6 118.84 23.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.211 0.529 . . . . 0.0 110.518 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.571 ' O ' HG21 ' A' ' 110' ' ' ILE . 7.1 m -100.74 149.43 23.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.81 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.513 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 24.4 tp -58.66 -35.21 72.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.571 0.623 . . . . 0.0 110.29 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.435 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 9.1 p -69.22 -40.33 78.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.401 0.62 . . . . 0.0 110.567 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.566 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -68.18 -38.92 82.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.152 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.595 ' HA ' ' CG ' ' A' ' 113' ' ' GLN . 1.5 pp -79.34 -23.79 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.7 p -74.57 -34.96 63.02 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 5.7 tmmm? -58.34 -30.53 66.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.768 170.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.595 ' CG ' ' HA ' ' A' ' 110' ' ' ILE . 11.0 mm100 -68.32 -72.22 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.126 0.965 . . . . 0.0 110.774 175.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 110' ' ' ILE . 29.2 m -73.32 -36.87 50.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 113.65 -1.613 . . . . 0.0 112.631 -166.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.53 ' HH ' ' HG2' ' A' ' 147' ' ' PRO . 22.8 m-85 -97.46 -22.86 16.34 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.482 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.21 11.31 76.08 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.436 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -151.94 124.19 8.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.66 0.267 . . . . 0.0 110.791 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 108' ' ' SER . . . -73.58 -19.54 60.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.951 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -68.15 -24.64 65.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 51.6 mt -85.83 20.46 2.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.757 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 17.3 p90 -68.95 -28.42 66.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.121 0.486 . . . . 0.0 110.217 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.509 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 27.1 p-10 -70.63 -31.48 68.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.448 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 29.4 mmmt -54.81 -49.19 71.58 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.428 0.632 . . . . 0.0 110.158 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mt -66.72 -47.51 82.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.315 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.537 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 44.7 t80 -49.32 -54.02 19.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.561 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 34.8 mt-10 -61.96 -36.62 81.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.244 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.37 -31.02 65.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.459 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 131' ' ' MET . 8.1 m120 -76.09 -27.95 57.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.969 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.561 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 29.5 mtpp -61.24 151.72 75.01 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.087 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -88.73 17.03 41.65 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.672 -1.803 . . . . 0.0 112.779 0.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.448 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -69.37 -37.56 77.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.417 177.176 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.74 117.01 29.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.66 -37.39 24.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.574 -174.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.428 ' HB2' ' HG3' ' A' ' 137' ' ' LYS . 19.3 m -152.0 144.55 16.85 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.151 0.501 . . . . 0.0 109.879 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.41 -20.37 66.18 Favored 'Trans proline' 0 C--N 1.332 -0.32 0 C-N-CA 123.487 2.791 . . . . 0.0 112.545 -171.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -98.73 -4.65 33.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.909 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 134' ' ' SER . 27.3 mtpp -90.15 9.28 28.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.928 0.394 . . . . 0.0 111.284 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 14.0 pt -58.89 169.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.569 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -157.21 143.87 13.29 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.069 -175.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.6 112.73 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.281 2.654 . . . . 0.0 112.559 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 107.56 27.01 5.4 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.894 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.493 ' H ' HG21 ' A' ' 101' ' ' VAL . 48.1 tt0 -103.21 116.61 32.79 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.989 -175.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.657 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 25.7 t -80.63 130.88 35.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.7 mt -118.25 145.58 44.92 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.795 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.443 ' HB2' HG23 ' A' ' 72' ' ' VAL . 37.3 ttt180 -74.93 98.38 3.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.826 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 19.7 mm -87.51 106.55 11.8 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.53 ' HG2' ' HH ' ' A' ' 115' ' ' TYR . 34.7 Cg_endo -67.65 156.04 67.65 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.718 1.612 . . . . 0.0 111.748 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.805 177.523 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 83' ' ' VAL . 41.3 tp . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 1.657 ' HE1' ' CE2' ' A' ' 4' ' ' PHE . 78.1 m-85 -124.72 138.9 54.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.901 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -98.19 140.99 31.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.618 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.625 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 86.7 m-85 -127.27 -171.69 2.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.037 0.446 . . . . 0.0 111.899 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.569 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 4.5 p -78.16 -26.44 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.176 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.537 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 25.1 tptp 78.95 -55.05 0.45 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.472 0.709 . . . . 0.0 112.295 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.08 7.23 43.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.569 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -125.21 157.62 36.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 121.243 -0.183 . . . . 0.0 110.561 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.6 -148.29 16.88 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.089 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.465 ' HG2' ' ND1' ' A' ' 34' ' ' HIS . 8.9 tp10 -82.39 129.87 34.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.007 0.404 . . . . 0.0 110.277 177.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -95.84 93.16 6.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.775 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 C--N 1.324 -0.54 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.233 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 24.3 t70 . . . . . 0 CA--C 1.522 -0.121 0 CA-C-O 121.117 0.484 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.457 ' O ' HG21 ' A' ' 31' ' ' VAL . 90.9 mt-30 -63.17 -36.46 83.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.379 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.06 86.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -63.68 -39.91 95.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.556 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -62.42 -32.94 73.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.157 177.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 84.6 t -68.48 -44.99 82.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.377 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -52.87 -52.26 58.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.311 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.32 -41.32 88.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.702 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.465 ' ND1' ' HG2' ' A' ' 12' ' ' GLU . 31.9 t60 -54.52 -48.67 71.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.805 0.336 . . . . 0.0 110.797 174.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 77.4 mt -66.92 -42.8 84.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.985 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -75.99 -27.11 57.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.725 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.55 -34.36 47.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.495 0.188 . . . . 0.0 111.159 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 130' ' ' PRO . 2.0 p -73.44 -44.55 57.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.675 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.2 32.86 1.58 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.529 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.429 HD11 ' HD2' ' A' ' 130' ' ' PRO . 35.8 mm -73.08 126.69 90.22 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 5.7 Cg_exo -73.54 145.09 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.374 2.049 . . . . 0.0 112.763 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 63.56 15.8 9.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.12 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.36 -23.8 63.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.239 0.542 . . . . 0.0 110.457 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.13 -20.51 62.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.801 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -92.03 -26.24 18.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.952 0.406 . . . . 0.0 110.984 -174.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 70' ' ' ILE . 33.6 m -90.26 163.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -128.41 131.61 48.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.705 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.7 mp -105.79 128.89 59.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.08 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -117.15 132.74 56.59 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.2 mm -105.04 108.82 25.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.379 0.609 . . . . 0.0 111.331 -175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 52' ' ' ASP . . . -99.05 69.26 1.74 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.096 176.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 3.5 m-20 70.2 -80.04 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.132 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.75 -8.21 12.41 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.702 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 84' ' ' ASP . 82.4 tttt -102.26 112.97 25.87 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.049 0.452 . . . . 0.0 110.688 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -94.54 121.39 36.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.139 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.0 m -99.93 118.24 35.94 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.26 122.76 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.89 155.16 33.24 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.859 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.4 174.74 36.75 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 p-10 -153.02 142.31 21.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.975 0.417 . . . . 0.0 110.649 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.89 17.42 61.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.238 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mp -93.34 178.41 5.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.103 0.477 . . . . 0.0 111.201 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.8 m -126.82 149.55 49.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.99 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.478 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 15.7 mm100 -57.53 -26.59 61.6 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.988 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.82 -36.6 72.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.722 0.296 . . . . 0.0 111.785 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.85 -34.45 10.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.498 . . . . 0.0 110.396 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 82.3 tttt -61.0 -41.26 96.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.469 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.469 ' O ' ' HD2' ' A' ' 145' ' ' ARG . 7.1 mm-40 -78.25 8.92 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.086 0.469 . . . . 0.0 110.822 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -98.72 -46.44 5.68 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.518 ' O ' HG13 ' A' ' 74' ' ' VAL . 20.7 mt -67.34 -55.34 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.352 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 tp -65.33 -16.85 64.02 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.099 -170.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 63.9 t -90.6 -52.63 10.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.327 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.32 -18.98 65.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.954 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 70' ' ' ILE . 7.6 p -82.05 -42.74 19.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.875 0.369 . . . . 0.0 110.693 175.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.625 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -67.71 -35.92 86.54 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.135 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -85.3 38.23 0.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.546 0.689 . . . . 0.0 111.262 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.2 mt -102.29 144.13 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.116 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -70.47 99.26 1.58 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.428 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.97 -18.27 3.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.986 -175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 41.0 mm -98.53 120.5 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.376 0.608 . . . . 0.0 110.991 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.537 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -98.55 -24.91 14.93 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.738 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.7 m -159.52 160.21 34.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.917 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.563 HG11 ' HB2' ' A' ' 4' ' ' PHE . 4.3 p -131.31 138.4 53.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.891 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HB2' ' CE ' ' A' ' 54' ' ' LYS . 31.3 t70 -111.36 120.53 42.51 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -88.54 121.46 30.95 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.107 0.479 . . . . 0.0 110.942 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -135.26 32.16 3.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.592 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.74 110.61 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.087 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 53.5 mttm -74.76 130.09 38.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.966 0.412 . . . . 0.0 110.144 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 p -105.29 124.6 49.82 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.767 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.97 -18.17 44.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.96 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.6 p -109.27 144.88 30.66 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.72 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.36 42.73 1.28 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.985 2.457 . . . . 0.0 111.988 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.85 156.59 32.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.899 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 m -74.07 129.13 37.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.182 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.74 164.17 23.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.397 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.9 m -120.16 148.16 43.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.189 0.518 . . . . 0.0 111.471 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -78.67 148.91 32.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.426 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.662 ' HE1' ' CE2' ' A' ' 98' ' ' PHE . 22.9 m-85 -116.54 116.22 27.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.875 0.369 . . . . 0.0 110.531 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.671 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 94.4 t80 -110.57 130.26 55.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.9 m -94.08 118.54 31.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.587 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 2.0 m -72.63 130.3 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 140' ' ' PRO . 73.3 mmtt -98.72 -60.43 1.54 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -169.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.4 t -164.0 122.76 1.92 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.745 0.307 . . . . 0.0 110.189 -174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.62 11.06 72.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.827 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.587 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 2.0 m-20 -73.16 121.33 20.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.265 0.555 . . . . 0.0 110.431 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.574 ' O ' HG21 ' A' ' 110' ' ' ILE . 46.3 p -114.63 157.7 22.73 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 135' ' ' PRO . 26.0 tp -58.05 -40.55 81.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.583 0.629 . . . . 0.0 111.455 -170.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 13.3 m -76.54 -20.12 57.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.067 0.46 . . . . 0.0 111.05 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.8 -39.55 26.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.049 -0.407 . . . . 0.0 110.43 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.1 pp -80.25 -24.5 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.958 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.0 p -70.21 -45.12 67.24 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -61.41 -24.28 66.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.579 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.73 HE21 ' HH ' ' A' ' 99' ' ' TYR . 1.6 tp-100 -72.12 -57.75 4.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.977 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.535 HG21 ' N ' ' A' ' 115' ' ' TYR . 32.6 m -84.0 -48.43 17.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.043 -172.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.535 ' N ' HG21 ' A' ' 114' ' ' VAL . 56.2 m-85 -82.23 -41.23 20.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.056 0.455 . . . . 0.0 110.647 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.96 -14.73 34.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.997 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -123.0 123.12 40.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.815 0.341 . . . . 0.0 110.297 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 108' ' ' SER . . . -67.32 -27.59 67.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.675 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -74.58 -3.55 31.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 0.0 111.282 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 115' ' ' TYR . 68.4 mt -91.11 19.49 5.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.232 0.539 . . . . 0.0 110.682 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -63.09 -35.77 81.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.499 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -67.4 -27.64 67.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.723 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -60.08 -43.74 95.28 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.355 0.597 . . . . 0.0 109.921 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.0 mt -72.21 -43.35 65.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.296 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.405 ' CE1' ' HA ' ' A' ' 134' ' ' SER . 61.1 t80 -55.54 -53.01 61.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.249 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.448 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 19.2 mt-10 -68.11 -24.01 64.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.349 0.595 . . . . 0.0 111.399 -177.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -79.38 -25.76 42.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.85 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.608 ' HB3' ' HE3' ' A' ' 131' ' ' MET . 24.1 m-80 -99.13 18.68 16.83 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.028 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.448 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 30.5 mmmt -79.76 140.83 55.0 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.209 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.429 ' HD2' HD11 ' A' ' 40' ' ' ILE . 19.6 Cg_endo -100.22 13.24 23.51 Favored 'Cis proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.84 -0.9 . . . . 0.0 112.078 -6.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.608 ' HE3' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -65.51 -25.93 67.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.712 -178.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.433 HD13 ' N ' ' A' ' 133' ' ' LYS . 9.0 tp -100.63 122.7 43.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 170.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.504 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 9.6 mptt -81.05 -44.71 17.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.738 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.405 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 57.2 p -157.72 163.11 25.79 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.882 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.423 ' HA ' HD23 ' A' ' 107' ' ' LEU . 51.8 Cg_exo -54.5 -28.13 53.32 Favored 'Trans proline' 0 C--N 1.328 -0.526 0 C-N-CA 123.096 2.531 . . . . 0.0 112.316 175.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.11 -20.25 19.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.48 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -73.48 -6.93 49.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -173.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.612 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 21.1 pt -65.82 166.56 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.182 0.515 . . . . 0.0 111.086 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 142' ' ' GLN . 12.4 p90 -165.58 148.99 7.02 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.923 -177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 102' ' ' LYS . 50.5 Cg_exo -42.71 118.32 1.13 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.915 3.077 . . . . 0.0 113.313 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 106.66 12.32 24.85 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.799 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.612 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 14.0 mt-30 -99.86 120.77 40.3 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.968 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 23.2 t -86.53 127.73 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.173 170.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.3 mt -117.72 143.28 46.35 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.754 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 68' ' ' GLU . 42.2 ttt180 -70.37 118.93 13.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.691 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.3 mm -111.16 90.19 11.13 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.766 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.54 176.67 9.77 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.32 2.013 . . . . 0.0 111.801 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 C--N 1.322 -0.593 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.542 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 83' ' ' VAL . 47.9 tp . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 121.582 0.706 . . . . 0.0 111.981 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 1.669 ' HE1' ' CE2' ' A' ' 4' ' ' PHE . 83.4 m-85 -123.61 147.16 47.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.982 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -114.9 138.55 50.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.988 0.423 . . . . 0.0 111.165 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.534 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 37.8 m-85 -130.27 171.03 13.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.339 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.67 119.29 35.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.941 0.4 . . . . 0.0 110.009 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 81' ' ' ALA . 5.0 tmtp? -52.2 -40.34 61.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.232 -171.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.31 -17.07 35.52 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.277 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.07 164.65 15.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.927 0.394 . . . . 0.0 111.535 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.52 -170.92 14.29 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.061 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.97 125.47 26.06 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -77.27 59.94 1.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.219 1.009 . . . . 0.0 109.062 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 30' ' ' LYS . 17.3 tp . . . . . 0 N--CA 1.437 -1.091 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.428 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 12.8 t70 . . . . . 0 CA--C 1.523 -0.059 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.564 ' NE2' HG22 ' A' ' 50' ' ' ILE . 24.8 mt-30 -57.65 -44.17 85.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.159 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.48 -44.87 73.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.966 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 52.5 tttm -66.35 -43.87 84.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.807 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -55.44 -42.61 74.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.339 178.063 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.641 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 43.2 t -66.16 -44.41 91.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.597 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.491 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 8.6 mm-40 -57.77 -46.58 84.34 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.548 0.213 . . . . 0.0 111.01 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.628 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.2 mt-10 -58.44 -46.33 86.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -55.78 -44.01 77.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.351 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 83.8 mt -64.16 -38.45 91.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 110.557 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -78.27 -22.83 47.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.197 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 32.5 mmmt -75.52 -48.07 24.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.903 0.382 . . . . 0.0 110.344 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 p -64.24 -38.71 92.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.505 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.32 32.69 3.63 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.585 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.503 HD11 ' HD2' ' A' ' 130' ' ' PRO . 29.9 mm -72.6 120.36 80.21 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -81.09 150.58 17.92 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 122.099 1.866 . . . . 0.0 111.876 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 65.57 11.9 7.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.259 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.42 -25.64 33.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.189 0.518 . . . . 0.0 110.045 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.03 -12.05 59.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.881 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -76.97 -25.23 52.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.841 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.14 168.11 3.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.397 0.618 . . . . 0.0 111.822 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -121.93 146.62 46.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.415 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.491 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 21.0 mm -105.63 137.07 37.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.878 0.37 . . . . 0.0 110.692 -177.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.407 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 98.6 mt-30 -134.04 145.68 49.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.564 HG22 ' NE2' ' A' ' 27' ' ' GLN . 26.0 mm -126.09 128.12 71.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.114 0.483 . . . . 0.0 111.754 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -119.22 89.2 3.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.046 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 63.85 -92.65 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.735 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.26 10.5 13.18 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.605 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 82' ' ' SER . 21.7 ttmm -104.18 112.84 26.01 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.088 0.471 . . . . 0.0 110.381 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -92.06 121.75 33.92 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.982 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 23.7 m -100.22 116.7 32.83 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.9 t -92.78 133.9 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.779 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -142.06 160.64 39.81 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.009 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.43 172.29 31.71 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.55 146.08 41.44 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.99 0.395 . . . . 0.0 110.22 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.63 10.74 78.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.229 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.86 168.7 19.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.122 0.487 . . . . 0.0 111.896 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.3 p -111.18 154.06 24.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.87 0.74 8.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.13 -51.46 4.62 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.72 90.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.746 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.423 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 19.8 ptmt -58.79 -34.63 71.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.671 0.272 . . . . 0.0 111.544 -174.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.524 ' O ' HG21 ' A' ' 72' ' ' VAL . 6.4 mm-40 -65.96 -29.45 69.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.215 0.531 . . . . 0.0 110.083 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -72.73 -40.8 65.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.599 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.41 ' O ' HG13 ' A' ' 74' ' ' VAL . 2.4 mp -63.11 -47.21 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 96.4 mt -53.73 -32.74 53.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.008 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 68' ' ' GLU . 47.0 t -72.15 -58.32 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.393 0.616 . . . . 0.0 110.975 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.38 -28.32 69.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.451 -173.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 31' ' ' VAL . 7.2 p -79.98 -26.14 12.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.337 0.589 . . . . 0.0 110.661 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.534 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -83.99 -34.16 18.94 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.543 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.57 60.95 2.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.018 0.437 . . . . 0.0 111.006 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.461 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 7.9 mm -126.22 128.81 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -65.11 113.4 3.92 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.28 -13.76 11.08 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.397 -171.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.461 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 37.4 mm -100.61 138.86 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.064 0.459 . . . . 0.0 110.133 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.55 ' CB ' ' HG2' ' A' ' 8' ' ' LYS . . . -125.55 -17.04 5.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.5 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 9.2 p -155.87 158.57 38.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.081 0.467 . . . . 0.0 111.321 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 56.0 t -133.23 130.5 57.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.949 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -104.05 124.58 49.3 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -95.23 101.41 13.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.302 -174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -119.11 11.84 12.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.121 0.486 . . . . 0.0 110.596 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.43 135.52 26.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.228 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -99.77 141.85 32.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.631 -173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.5 p -109.17 137.44 47.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.194 0.521 . . . . 0.0 111.445 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.62 -35.79 9.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.393 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 24.2 p -112.43 147.05 36.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.293 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 3.0 Cg_endo -80.43 143.09 15.18 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.417 2.744 . . . . 0.0 111.843 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -161.06 166.68 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.209 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.7 m -73.39 131.43 41.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.502 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.8 173.31 8.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.7 m -123.8 151.76 42.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.442 0.639 . . . . 0.0 111.297 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 17.9 tt0 -89.81 143.36 26.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.132 173.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -105.77 102.06 11.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.247 0.546 . . . . 0.0 111.067 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 93.3 t80 -102.14 135.99 42.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.219 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.0 m -105.46 122.29 45.7 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.49 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 1.2 m -67.37 126.74 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 140' ' ' PRO . 34.5 mmtp -87.18 -66.06 0.95 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -170.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.2 t -175.12 122.63 0.22 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.88 15.12 81.6 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -172.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.49 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -86.42 118.12 25.64 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.547 -0.827 . . . . 0.0 109.885 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.603 ' O ' HG21 ' A' ' 110' ' ' ILE . 22.7 p -109.03 157.8 18.34 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -55.29 -45.54 76.23 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.579 -174.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.4 m -61.09 -42.45 98.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.709 0.29 . . . . 0.0 110.82 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.36 87.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.341 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.603 HG21 ' O ' ' A' ' 106' ' ' THR . 1.2 pp -76.27 -26.52 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.74 0.305 . . . . 0.0 110.442 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.53 ' OG ' ' HA ' ' A' ' 121' ' ' TYR . 42.5 m -68.37 -46.45 70.05 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-O 121.204 0.526 . . . . 0.0 109.793 169.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -56.38 -30.61 62.93 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.326 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.902 HE21 ' HH ' ' A' ' 99' ' ' TYR . 1.6 tp-100 -68.52 -63.3 1.09 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.4 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' ' 115' ' ' TYR . 23.5 m -80.0 -40.98 20.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.111 -170.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.435 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 15.7 m-85 -91.27 -49.74 6.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.446 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.95 5.74 32.91 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.418 ' HB3' ' CD1' ' A' ' 120' ' ' LEU . 58.6 t-20 -135.17 113.91 11.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.52 -15.59 62.31 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -85.48 -2.87 58.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.04 0.448 . . . . 0.0 110.743 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . 63.4 mt -89.51 18.65 5.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.061 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.53 ' HA ' ' OG ' ' A' ' 111' ' ' SER . 47.5 p90 -68.94 -26.14 64.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.084 -174.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -68.93 -36.47 78.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.439 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 120' ' ' LEU . 31.6 mtmt -54.26 -52.76 60.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.328 0.585 . . . . 0.0 110.697 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.6 mt -68.75 -39.44 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.747 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.521 ' HA ' ' CD2' ' A' ' 132' ' ' LEU . 5.5 t80 -59.55 -52.91 63.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.745 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.438 ' HA ' ' HG3' ' A' ' 129' ' ' LYS . 2.2 mm-40 -60.99 -39.66 90.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.131 0.491 . . . . 0.0 111.507 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -63.85 -28.04 69.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.386 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.537 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 38.9 m-80 -98.99 6.69 46.57 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.438 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 20.9 mtmm -78.7 156.2 77.89 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 122.101 -0.374 . . . . 0.0 110.709 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.503 ' HD2' HD11 ' A' ' 40' ' ' ILE . 1.3 Cg_endo -87.73 14.62 46.83 Favored 'Cis proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.994 -1.253 . . . . 0.0 112.478 -3.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.537 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.0 tmm? -64.71 -39.23 93.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.521 ' CD2' ' HA ' ' A' ' 125' ' ' PHE . 35.0 tp -97.33 117.83 32.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.409 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 10.6 mptt -87.51 -33.9 18.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.899 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.456 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 15.1 p -161.8 155.0 17.56 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.137 0.494 . . . . 0.0 109.751 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 134' ' ' SER . 12.2 Cg_endo -60.75 -8.14 8.79 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 123.679 2.919 . . . . 0.0 113.117 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -113.72 -14.8 12.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.238 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -87.47 20.16 3.0 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.476 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 8.3 pt -79.06 172.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -154.12 142.05 13.99 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.428 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 102' ' ' LYS . 80.4 Cg_exo -51.07 114.27 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.261 2.641 . . . . 0.0 112.851 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.34 13.91 11.33 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.892 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.478 ' H ' HG23 ' A' ' 101' ' ' VAL . 41.5 tt0 -98.47 120.58 39.14 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.661 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.65 133.18 29.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.281 0.562 . . . . 0.0 109.999 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.1 mt -126.2 136.03 52.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.605 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.463 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 2.2 ptm180 -74.49 123.64 25.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.222 0.534 . . . . 0.0 110.026 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 37.0 mm -100.34 102.9 20.13 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.784 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 46.4 Cg_exo -56.77 145.37 83.45 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.377 2.052 . . . . 0.0 111.253 176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.618 -178.426 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 23.9 tp . . . . . 0 N--CA 1.451 -0.375 0 CA-C-O 121.166 0.507 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 82' ' ' SER . 82.8 m-85 -113.03 139.22 48.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.921 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -99.52 155.87 17.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.579 0.228 . . . . 0.0 110.909 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 1.652 ' HD2' ' CD1' ' A' ' 6' ' ' PHE . 94.2 m-85 -134.29 -158.73 0.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.977 0.418 . . . . 0.0 111.429 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.605 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 6.3 p -82.3 -23.14 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.462 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.556 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 18.5 tptm 75.82 -61.39 0.47 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.472 0.709 . . . . 0.0 111.891 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.44 -37.94 35.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -81.53 152.6 27.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.737 0.303 . . . . 0.0 110.622 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.25 -178.26 19.4 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.055 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.63 134.52 47.64 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -83.72 89.97 7.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.62 0.724 . . . . 0.0 112.287 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.408 HD21 HD13 ' A' ' 77' ' ' ILE . 6.4 mp . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.672 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.649 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 2.9 m-20 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -62.42 -31.83 72.58 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.929 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 48' ' ' ILE . . . -69.77 -35.0 74.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.313 0.578 . . . . 0.0 110.086 174.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -69.28 -38.99 78.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.642 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 75.3 mmtt -53.06 -43.4 66.67 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.556 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 51.7 t -69.73 -36.14 68.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.78 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -59.61 -43.52 93.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.0 mt-10 -57.7 -51.14 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.05 -47.11 53.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.347 177.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 91.6 mt -66.83 -41.95 86.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.192 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -72.13 -32.07 66.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.121 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 14.3 mmmm -72.34 -38.6 68.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 0.0 111.225 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.406 ' OG1' HG12 ' A' ' 40' ' ' ILE . 2.9 p -74.49 -31.42 62.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.156 0.503 . . . . 0.0 110.91 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.1 30.1 8.07 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.6 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.481 HD12 ' HD2' ' A' ' 130' ' ' PRO . 46.0 mm -59.3 129.01 86.34 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 122.264 0.226 . . . . 0.0 110.504 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -61.46 129.02 26.55 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.541 2.161 . . . . 0.0 112.637 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.16 22.75 10.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.53 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . . . -70.59 -20.04 62.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.207 0.527 . . . . 0.0 110.69 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -78.02 -15.78 58.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.244 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -87.53 -24.58 24.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.9 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.16 162.94 2.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.276 0.56 . . . . 0.0 111.73 -174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -126.92 150.49 49.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.328 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 56' ' ' THR . 60.6 mt -128.43 142.66 43.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.799 0.333 . . . . 0.0 111.549 -173.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -130.4 128.67 41.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.454 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 40.0 mm -106.1 119.66 55.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.028 0.442 . . . . 0.0 111.45 -175.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.75 79.27 1.2 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.182 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 69.38 -74.49 0.08 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.34 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.65 42.99 1.3 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 84' ' ' ASP . 49.4 tttm -141.98 114.25 8.24 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.453 ' O ' HG21 ' A' ' 83' ' ' VAL . . . -99.4 96.81 7.96 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.118 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 84' ' ' ASP . 21.1 m -84.83 112.83 20.89 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.414 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -101.2 131.15 49.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.273 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -130.71 160.57 33.91 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.389 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.59 142.24 3.65 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -122.98 150.72 42.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.947 0.403 . . . . 0.0 110.397 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.28 12.28 54.74 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.051 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.23 175.55 10.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.403 . . . . 0.0 111.768 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.7 p -127.05 144.98 50.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 172.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -46.74 -45.31 19.58 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 9.6 tp10 -61.14 -47.5 85.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.466 -174.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.33 -39.3 65.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.408 0.623 . . . . 0.0 110.315 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -52.34 -47.75 65.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.872 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -76.89 -20.2 56.53 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.548 -174.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 35.3 mmtm -62.26 -38.82 90.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mt -70.7 -58.51 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.421 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 mp -43.67 -48.25 7.8 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.35 -28.86 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.928 0.394 . . . . 0.0 111.439 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.86 -26.22 22.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -82.43 -23.71 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 110.835 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.68 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -81.4 -29.81 39.04 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.929 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -81.1 53.8 2.09 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.163 0.506 . . . . 0.0 111.232 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.508 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 26.1 mm -117.77 134.76 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -68.73 99.5 1.03 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.96 -14.71 5.7 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.299 -172.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 21.9 mm -98.4 122.67 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.314 0.578 . . . . 0.0 111.315 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.556 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -102.62 -14.73 16.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.705 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 25.8 p -160.26 158.31 29.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 112.413 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 55' ' ' ALA . 7.5 p -126.74 133.02 69.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.231 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.495 ' HB3' HG21 ' A' ' 56' ' ' THR . 10.7 t70 -107.6 95.48 5.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.39 107.57 5.76 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.375 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -115.13 22.21 13.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.218 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -83.26 131.32 34.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.962 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -105.29 129.01 53.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.405 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 p -97.45 136.44 37.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.485 0.66 . . . . 0.0 112.153 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.65 -44.16 10.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.937 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.7 p -114.43 137.73 22.75 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.588 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.59 152.91 29.99 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.61 2.207 . . . . 0.0 111.719 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -157.14 -174.1 4.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.419 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.0 m -64.3 132.55 50.53 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.368 0.418 . . . . 0.0 111.109 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.22 169.19 8.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.648 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.5 p -143.65 155.34 44.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.543 0.687 . . . . 0.0 112.105 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.4 tt0 -86.23 141.58 29.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.48 173.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.641 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 99.2 m-85 -101.59 101.73 12.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.963 0.411 . . . . 0.0 110.853 -176.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 93.6 t80 -107.07 141.16 38.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.547 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.6 m -104.19 122.41 45.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.183 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.445 HG21 ' H ' ' A' ' 142' ' ' GLN . 2.8 m -67.22 140.03 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.46 -162.19 0.93 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.112 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.2 t -56.62 -31.4 64.27 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 123.123 0.264 . . . . 0.0 111.219 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.28 49.23 2.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.155 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -64.92 109.24 2.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.44 1.114 . . . . 0.0 112.117 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.414 ' O ' HG22 ' A' ' 110' ' ' ILE . 86.4 m -151.39 129.24 11.66 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.616 170.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 15.2 mt -51.03 -48.74 61.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.878 0.763 . . . . 0.0 111.333 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 p -58.48 -37.61 75.88 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.297 0.373 . . . . 0.0 111.152 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.68 -50.63 49.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -74.17 -23.81 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.575 -176.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.6 t -69.78 -46.29 66.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . 61.7 tttm -60.88 -28.04 68.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.619 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.813 HE21 ' HH ' ' A' ' 99' ' ' TYR . 2.6 tp-100 -66.2 -64.18 0.91 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.21 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.462 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.8 m -78.23 -44.67 27.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.558 -170.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.462 ' N ' HG21 ' A' ' 114' ' ' VAL . 63.8 m-85 -81.61 -46.37 14.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.67 0.747 . . . . 0.0 110.343 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.94 -6.28 32.68 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.567 -170.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -127.98 131.34 49.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.221 -0.489 . . . . 0.0 110.161 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 112' ' ' LYS . . . -84.77 0.97 48.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.991 0.424 . . . . 0.0 110.717 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -93.68 0.09 56.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.739 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.76 21.18 17.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.377 0.608 . . . . 0.0 110.875 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.408 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 44.0 p90 -61.51 -32.33 72.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.479 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -79.27 -22.37 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.824 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -60.48 -48.75 80.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.373 0.606 . . . . 0.0 110.13 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.412 ' CG1' ' HE2' ' A' ' 115' ' ' TYR . 50.1 mt -63.83 -49.9 79.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.094 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -46.3 -53.34 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.806 0.691 . . . . 0.0 111.083 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.525 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 7.7 mm-40 -65.24 -29.36 70.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.621 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -77.2 -19.1 57.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.043 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.487 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 5.3 m120 -95.05 -2.1 50.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.511 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.525 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 6.5 mmmm -68.6 145.88 97.34 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.481 ' HD2' HD12 ' A' ' 40' ' ' ILE . 66.6 Cg_endo -96.36 22.97 25.96 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 124.059 -1.226 . . . . 0.0 112.027 -7.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.487 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 1.7 tmm? -70.81 -35.81 72.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.529 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.9 tp -90.33 119.31 30.53 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -77.96 -45.65 23.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.616 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -154.66 157.32 32.09 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.39 -51.89 9.84 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 C-N-CA 123.29 2.66 . . . . 0.0 112.83 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.06 6.49 18.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.407 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -98.93 15.22 26.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.639 0.257 . . . . 0.0 111.332 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.508 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 9.6 pt -78.0 175.55 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -159.63 144.25 11.17 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -52.3 112.31 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.277 2.651 . . . . 0.0 112.312 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 117.61 0.16 18.03 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.167 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.508 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 39.5 tt0 -88.28 122.78 32.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.965 0.412 . . . . 0.0 110.354 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 37.6 t -83.33 133.6 28.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.999 173.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 70.2 mt -124.02 151.04 44.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.284 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.441 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 58.0 mtp180 -80.07 122.82 27.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.229 177.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 25.4 mm -109.23 97.29 25.12 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.228 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.02 148.77 35.64 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.084 1.856 . . . . 0.0 111.312 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.532 -178.369 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.7 tp . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.451 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 86.7 m-85 -105.52 118.02 35.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.803 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -89.83 150.0 22.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.071 0.463 . . . . 0.0 111.351 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 1.658 ' HE1' ' CE2' ' A' ' 6' ' ' PHE . 74.8 m-85 -132.08 -156.72 0.77 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.928 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.605 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 5.7 p -88.6 -22.01 6.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.038 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.616 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 23.8 tptm 75.99 -57.84 0.56 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.549 0.739 . . . . 0.0 111.513 -175.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.58 -53.49 11.76 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.029 0.442 . . . . 0.0 111.726 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -73.31 146.24 45.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.126 -175.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.75 -167.73 29.29 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -72.03 124.79 25.69 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -73.01 83.13 1.25 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.445 HD22 ' O ' ' A' ' 30' ' ' LYS . 20.1 tp . . . . . 0 N--CA 1.436 -1.164 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.87 -170.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.092 0.472 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.584 ' O ' HG21 ' A' ' 31' ' ' VAL . 54.9 mt-30 -64.74 -32.87 74.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.301 173.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.01 85.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.119 0.485 . . . . 0.0 110.416 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -64.18 -44.09 93.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.52 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -52.93 -44.74 67.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.689 175.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 27' ' ' GLN . 82.1 t -58.59 -48.92 84.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.303 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -63.92 -40.79 97.28 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.282 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 40.7 mt-10 -58.86 -46.29 88.09 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 65.7 t60 -52.7 -44.9 66.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.866 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 99.0 mt -66.08 -39.75 90.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.248 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -74.17 -39.35 63.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.228 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 62.2 mtpt -64.43 -44.54 90.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.016 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.7 p -66.05 -51.05 61.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.166 0.508 . . . . 0.0 110.037 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.71 30.54 1.98 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.928 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.4 mm -67.19 120.69 74.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.57 142.64 84.99 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.369 2.046 . . . . 0.0 112.961 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 58.54 25.47 13.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.473 -1.239 . . . . 0.0 112.645 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.51 -15.9 63.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.406 0.622 . . . . 0.0 110.14 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -86.61 -8.0 57.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.684 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -97.41 -8.81 28.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.738 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.84 172.1 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.317 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.69 131.19 25.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.458 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 56' ' ' THR . 4.1 mp -108.04 141.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.793 0.33 . . . . 0.0 110.794 -176.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -134.54 123.91 24.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.756 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mm -87.16 120.79 37.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.442 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -127.73 81.5 2.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.756 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 49.75 64.59 1.7 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.776 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.26 -26.53 14.88 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.54 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 30.8 mttp -90.06 114.16 26.01 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.152 0.501 . . . . 0.0 111.468 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.586 ' O ' HG21 ' A' ' 83' ' ' VAL . . . -89.49 94.68 9.97 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.221 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 21.1 m -77.55 125.9 30.05 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG21 HG13 ' A' ' 48' ' ' ILE . 42.8 t -119.01 109.68 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.127 0.489 . . . . 0.0 111.18 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.7 m -102.67 166.63 10.4 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.911 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 88' ' ' LYS . . . 168.44 170.5 33.21 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.475 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -155.89 138.71 15.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.065 0.46 . . . . 0.0 110.151 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.53 3.55 64.62 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.91 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.59 -177.14 2.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.333 0.587 . . . . 0.0 111.994 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.7 p -132.04 157.8 43.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.105 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.479 ' CD ' ' HA ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER -47.91 -41.77 25.44 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 123.165 0.291 . . . . 0.0 111.05 176.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.447 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 49.9 mm-40 -55.92 -64.87 0.72 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.515 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.78 95.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.169 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.65 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 49.1 tttm -50.09 -63.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.891 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.638 ' O ' HG22 ' A' ' 72' ' ' VAL . 5.6 mm-40 -64.67 -35.01 79.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.158 0.504 . . . . 0.0 110.489 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -62.24 -45.35 93.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.81 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.8 mt -62.2 -51.91 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.997 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 78.6 mt -47.44 -42.23 21.95 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.889 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 68' ' ' GLU . 62.0 t -67.25 -51.85 48.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.401 0.62 . . . . 0.0 110.739 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.22 72.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.222 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.3 m -81.37 -32.68 12.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.875 0.369 . . . . 0.0 110.788 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.648 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -70.66 -26.2 74.46 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.676 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -85.14 47.21 1.37 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.766 0.317 . . . . 0.0 111.341 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.8 mt -120.45 141.19 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 120.846 0.355 . . . . 0.0 110.478 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -66.26 105.3 1.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.216 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.89 -2.75 9.96 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.774 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.1 mm -106.24 117.79 52.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.579 0.704 . . . . 0.0 111.126 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -91.98 -27.51 17.8 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.229 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.457 ' OG ' ' HG2' ' A' ' 54' ' ' LYS . 5.5 p -164.48 161.06 21.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.184 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.586 HG21 ' O ' ' A' ' 55' ' ' ALA . 4.3 p -119.77 124.1 72.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.611 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -94.68 103.08 15.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.24 119.06 19.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.866 -174.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -127.22 28.64 5.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.854 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.48 123.81 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.209 0.528 . . . . 0.0 111.351 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 59' ' ' GLY . 13.9 tptm -90.23 124.66 35.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.265 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 p -100.02 135.06 42.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.199 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.12 -23.93 12.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.58 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 67.4 p -123.58 138.75 30.77 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.52 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 2.1 Cg_endo -80.96 158.88 20.92 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.181 2.588 . . . . 0.0 112.788 -176.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . . . -161.84 -176.84 5.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.168 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.3 m -82.42 125.02 30.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.479 ' HA ' ' CD ' ' A' ' 64' ' ' GLN . . . -73.24 145.48 46.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -123.96 172.09 9.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.388 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -106.66 153.88 21.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.784 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -111.63 116.98 31.69 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.667 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 88.3 t80 -123.52 142.43 51.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.588 0.232 . . . . 0.0 110.4 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 2.5 m -104.1 124.28 48.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.361 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.426 HG21 ' H ' ' A' ' 142' ' ' GLN . 2.8 m -68.09 134.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -98.36 -177.19 3.62 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.143 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 p -61.9 116.21 4.68 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.15 25.75 5.99 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -169.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.554 ' OD2' HG13 ' A' ' 138' ' ' ILE . 10.4 p-10 -53.94 118.91 4.37 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.218 1.009 . . . . 0.0 111.768 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.431 ' O ' HG21 ' A' ' 110' ' ' ILE . 92.6 m -144.35 127.37 16.49 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 125' ' ' PHE . 22.9 tp -63.15 -31.09 72.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.255 -170.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 p -75.71 -26.95 57.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.371 0.605 . . . . 0.0 110.152 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.419 ' CB ' ' HB ' ' A' ' 106' ' ' THR . . . -75.77 -44.22 42.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.851 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.604 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.3 pp -78.35 -24.28 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.394 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.2 p -72.7 -45.33 59.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.95 0.405 . . . . 0.0 109.993 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HZ2' ' HB3' ' A' ' 112' ' ' LYS . 6.5 ttpm? -64.26 -18.48 64.6 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.277 0.561 . . . . 0.0 110.231 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.604 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 5.4 tp-100 -72.66 -60.98 1.97 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.859 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.515 HG21 ' N ' ' A' ' 115' ' ' TYR . 30.8 m -78.01 -48.52 23.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.072 -172.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.515 ' N ' HG21 ' A' ' 114' ' ' VAL . 83.4 m-85 -84.12 -36.21 23.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.327 0.584 . . . . 0.0 110.822 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 -2.54 56.74 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.096 -173.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.409 HD22 ' HB3' ' A' ' 119' ' ' ASN . 33.0 t30 -134.67 125.27 26.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.577 -0.311 . . . . 0.0 110.399 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.429 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -74.66 -22.78 58.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.56 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.409 ' HB3' HD22 ' A' ' 117' ' ' ASN . 7.9 t30 -63.78 -21.42 66.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.898 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.449 HD13 ' HB3' ' A' ' 115' ' ' TYR . 63.3 mt -85.83 15.8 4.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.498 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.432 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 35.2 p90 -62.0 -35.84 79.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.284 0.564 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.72 -33.07 75.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.676 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -57.0 -49.26 76.32 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.442 0.639 . . . . 0.0 109.67 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.497 HG23 ' OD1' ' A' ' 128' ' ' ASN . 27.7 mt -67.73 -43.98 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.896 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.601 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 43.2 t80 -53.54 -56.33 18.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.854 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.481 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 19.2 mt-10 -65.42 -25.81 67.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.559 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.39 -34.9 31.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.061 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.497 ' OD1' HG23 ' A' ' 124' ' ' ILE . 7.8 m120 -74.6 -30.54 61.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 7.2 mtpm? -57.25 148.41 52.73 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.559 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -87.78 8.74 64.56 Favored 'Cis proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.291 -1.545 . . . . 0.0 113.256 1.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.471 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -62.97 -39.98 96.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.108 0.48 . . . . 0.0 109.826 175.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.14 125.99 37.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -95.98 -36.64 10.98 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.442 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 19.7 m -150.79 153.2 33.31 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.063 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.5 -54.12 5.99 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 C-N-CA 123.318 2.679 . . . . 0.0 113.054 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -84.52 7.36 20.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.55 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.442 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 37.1 mmtm -92.13 4.59 52.84 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.751 0.31 . . . . 0.0 111.802 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.554 HG13 ' OD2' ' A' ' 105' ' ' ASP . 11.6 pt -67.71 173.72 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.517 171.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -158.59 141.93 10.87 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.604 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.75 117.11 3.02 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.374 2.716 . . . . 0.0 112.858 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' ' 7' ' ' VAL . . . 113.12 4.03 24.23 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.03 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.426 ' H ' HG21 ' A' ' 101' ' ' VAL . 34.3 tt0 -93.0 116.38 29.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.348 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 37.1 t -79.71 134.66 27.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.7 mt -123.51 143.43 50.19 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.091 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.542 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 34.8 ttt180 -74.64 109.79 8.4 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.96 105.61 14.3 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.701 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 32.0 Cg_exo -59.12 164.44 10.33 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.722 2.281 . . . . 0.0 111.907 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--N 1.321 -0.667 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.525 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.6 tp . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 121.356 0.598 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.648 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 56.5 m-85 -106.76 131.56 53.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.608 -176.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.33 136.77 41.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.453 0.644 . . . . 0.0 112.252 -171.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.583 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 31.4 m-85 -123.03 -166.0 1.39 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.48 176.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.6 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 57.2 t -81.25 -81.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.98 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtt? 160.68 -74.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.91 -30.56 69.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.098 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.17 126.24 30.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.885 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.434 ' HA2' ' HH ' ' A' ' 139' ' ' TYR . . . 154.93 -178.26 31.73 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.02 125.83 25.32 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -74.67 69.24 1.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.975 0.893 . . . . 0.0 109.16 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 30' ' ' LYS . 19.4 tp . . . . . 0 N--CA 1.439 -0.999 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.214 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.509 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 2.1 m-20 . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.626 0.25 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.568 ' HB2' HG13 ' A' ' 50' ' ' ILE . 6.6 mm100 -75.88 -41.22 52.77 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -176.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.11 62.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.76 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 24.7 ttmm -67.1 -49.13 66.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.14 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 14.0 mptt -58.28 -41.51 84.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.673 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 27' ' ' GLN . 93.9 t -60.71 -43.46 95.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.731 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -58.13 -47.04 84.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.699 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 39.8 mt-10 -58.22 -47.17 84.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.065 176.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -51.67 -49.9 61.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.094 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 98.2 mt -63.58 -38.72 92.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.333 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -79.85 -33.14 40.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.549 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -71.65 -30.56 65.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.662 0.268 . . . . 0.0 110.908 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 p -80.18 -40.42 27.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.039 0.447 . . . . 0.0 110.547 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.07 26.81 5.35 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.248 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.434 HD11 ' HD2' ' A' ' 130' ' ' PRO . 35.9 mm -61.71 132.25 93.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 110.467 -0.198 . . . . 0.0 110.467 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -65.31 130.97 26.79 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.429 2.086 . . . . 0.0 112.819 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 59.44 29.56 19.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.819 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.87 -26.52 68.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.777 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -75.32 -26.06 58.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.733 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -74.07 -22.03 59.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.684 -174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.5 m -100.76 162.39 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.563 0.697 . . . . 0.0 111.816 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -128.83 129.76 46.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.878 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.74 133.73 46.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.963 0.411 . . . . 0.0 110.914 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -119.69 122.06 40.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.52 173.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.568 HG13 ' HB2' ' A' ' 27' ' ' GLN . 30.5 mm -97.59 108.36 21.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.212 0.529 . . . . 0.0 110.868 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.21 66.2 0.65 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.798 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 55.94 77.82 0.22 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.653 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.07 -18.24 32.84 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.219 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 82' ' ' SER . 28.0 ttpp -108.37 116.5 32.08 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.153 -0.616 . . . . 0.0 110.702 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.27 101.34 13.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.933 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.449 HG21 ' HB3' ' A' ' 84' ' ' ASP . 14.4 m -85.18 124.95 32.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.237 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.95 110.77 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 120.982 0.42 . . . . 0.0 111.436 -175.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -97.92 157.49 16.07 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.889 177.121 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 87' ' ' VAL . . . 163.1 165.98 21.13 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.432 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -148.37 143.01 26.54 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.916 0.389 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 90' ' ' ALA . . . 83.68 37.75 11.49 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.964 176.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.62 165.51 12.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.802 0.334 . . . . 0.0 110.961 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -93.57 160.65 14.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.998 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 7.6 tp60 -53.54 -58.0 8.71 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.222 0.326 . . . . 0.0 111.76 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG2' HH12 ' A' ' 145' ' ' ARG . 27.1 mt-10 -58.24 -46.78 85.32 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.23 76.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.113 0.482 . . . . 0.0 110.09 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.427 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 68.3 tttt -57.4 -46.33 83.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.528 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.64 ' O ' HG21 ' A' ' 72' ' ' VAL . 75.5 mt-10 -60.71 -47.53 85.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.653 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -55.8 -40.05 72.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.755 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 58.6 mt -63.03 -57.84 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.339 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 98.6 mt -48.03 -45.53 32.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.099 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.64 HG21 ' O ' ' A' ' 68' ' ' GLU . 30.9 t -68.64 -49.17 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.156 0.503 . . . . 0.0 110.593 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.41 74.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.486 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.14 -33.48 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.842 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.583 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -70.88 -35.4 65.55 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.247 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.05 38.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.801 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.5 mt -110.42 139.99 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.7 t -65.6 120.21 12.52 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.54 -22.93 11.49 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.411 HG22 ' HA2' ' A' ' 75' ' ' GLY . 45.8 mm -97.37 136.95 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.398 0.618 . . . . 0.0 110.196 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.476 ' HB3' ' HG2' ' A' ' 8' ' ' LYS . . . -126.45 -9.51 6.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.739 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 1.8 p -160.06 150.56 18.71 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.648 ' CG1' ' HB2' ' A' ' 4' ' ' PHE . 7.2 p -122.97 132.74 70.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.416 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.449 ' HB3' HG21 ' A' ' 56' ' ' THR . 9.9 t0 -111.29 110.99 21.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -78.24 123.21 26.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.993 -173.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 77.7 mm-40 -131.25 8.32 4.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.846 174.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 1.7 p -96.11 126.58 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.265 0.555 . . . . 0.0 111.17 -176.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.51 149.26 25.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.932 -176.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.2 p -104.37 121.29 43.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.926 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.429 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . . . -84.99 -41.87 15.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.027 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 p -117.19 127.36 26.75 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.799 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.82 153.08 13.12 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.77 2.313 . . . . 0.0 112.822 -175.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . . . -148.68 -161.14 1.28 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.506 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.4 m -76.04 127.81 33.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.929 0.395 . . . . 0.0 110.305 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.85 128.11 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.898 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.9 m -103.65 153.32 20.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.348 0.594 . . . . 0.0 111.84 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.465 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 8.6 tt0 -87.05 155.66 20.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.324 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -116.2 98.69 6.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.242 0.544 . . . . 0.0 110.517 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.668 ' HD2' ' CD1' ' A' ' 99' ' ' TYR . 78.8 t80 -101.49 136.33 41.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.553 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.421 ' OG1' HG23 ' A' ' 143' ' ' VAL . 5.4 m -102.09 126.93 49.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.557 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 142' ' ' GLN . 3.3 m -73.56 141.52 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -91.83 -165.56 1.38 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.931 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.3 m -62.38 -31.46 72.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.814 0.34 . . . . 0.0 111.091 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -96.37 44.8 1.95 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.651 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.447 ' OD2' HG13 ' A' ' 138' ' ' ILE . 7.8 p-10 -56.37 120.81 8.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 122.007 0.908 . . . . 0.0 112.137 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.478 ' O ' HG21 ' A' ' 110' ' ' ILE . 53.4 m -143.71 126.11 15.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 168.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 40.6 tp -61.1 -28.1 68.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.714 0.293 . . . . 0.0 110.765 -174.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.44 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 9.6 m -76.24 -29.87 57.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.302 0.572 . . . . 0.0 110.274 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.0 -44.86 45.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.802 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.1 pp -76.5 -21.58 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.976 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.2 p -77.05 -43.92 32.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.89 -23.28 63.33 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.317 0.58 . . . . 0.0 110.156 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -70.02 -61.93 1.58 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.142 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.414 HG21 ' N ' ' A' ' 115' ' ' TYR . 31.6 m -82.86 -39.51 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.376 -169.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.414 ' N ' HG21 ' A' ' 114' ' ' VAL . 40.9 m-85 -91.38 -36.17 13.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.62 -3.91 53.62 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.264 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -131.76 129.21 40.28 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 108' ' ' SER . . . -81.46 -13.7 57.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.495 -176.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.27 -18.14 55.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.381 0.61 . . . . 0.0 110.183 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -84.39 21.06 1.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.211 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.457 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 41.9 p90 -65.74 -33.41 75.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.566 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.564 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 7.9 p30 -68.11 -28.47 67.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.946 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -59.74 -49.69 76.76 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.337 0.589 . . . . 0.0 110.163 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.1 mt -65.82 -44.82 92.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.868 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.429 ' HB2' HD22 ' A' ' 107' ' ' LEU . 50.8 t80 -48.98 -56.73 8.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.171 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 29.5 mt-10 -68.43 -21.19 64.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.944 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.88 -23.39 36.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.063 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.494 ' OD1' HD23 ' A' ' 144' ' ' LEU . 7.6 m120 -88.3 -3.26 58.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.936 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.536 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 28.0 mmmt -72.07 148.52 91.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.434 ' HD2' HD11 ' A' ' 40' ' ' ILE . 72.1 Cg_endo -95.98 31.9 11.79 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.636 -1.401 . . . . 0.0 112.409 -2.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.462 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -84.87 -33.84 22.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.072 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.01 120.98 33.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.451 0.643 . . . . 0.0 110.578 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -67.24 -62.5 1.39 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.066 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.5 m -145.66 161.05 42.35 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.345 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.24 -41.49 65.56 Favored 'Trans proline' 0 C--N 1.332 -0.303 0 C-N-CA 123.216 2.611 . . . . 0.0 112.426 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.7 19.91 7.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -107.03 11.73 29.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.874 0.368 . . . . 0.0 111.335 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.447 HG13 ' OD2' ' A' ' 105' ' ' ASP . 15.0 pt -73.88 172.95 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.11 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.434 ' HH ' ' HA2' ' A' ' 11' ' ' GLY . 35.4 p90 -166.46 149.62 6.42 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.44 110.91 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.092 2.528 . . . . 0.0 112.515 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.88 4.68 26.01 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.522 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.444 ' H ' HG23 ' A' ' 101' ' ' VAL . 7.4 tp60 -82.37 112.27 19.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.713 0.292 . . . . 0.0 110.377 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.463 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 26.8 t -82.97 134.15 27.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.494 HD23 ' OD1' ' A' ' 128' ' ' ASN . 77.7 mt -121.29 144.0 48.86 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.068 0.461 . . . . 0.0 111.112 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.479 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 27.4 ttp85 -75.01 108.03 7.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.266 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 30.9 mm -99.02 103.04 17.38 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.57 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 20.9 Cg_exo -63.78 146.99 92.55 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.126 1.884 . . . . 0.0 111.382 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--N 1.321 -0.656 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.676 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 CA--C 1.509 -0.607 0 CA-C-O 121.627 0.727 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' A' ' 4' ' ' PHE . 87.0 m-85 -111.97 125.58 54.22 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.447 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -93.12 136.44 33.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.433 0.635 . . . . 0.0 111.839 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.518 ' CE2' ' HB ' ' A' ' 143' ' ' VAL . 32.7 m-85 -126.1 -167.47 1.71 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.858 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.5 t -116.0 113.81 44.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 19.2 ptmt -59.85 -29.03 68.01 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -171.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.97 -10.09 58.96 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.04 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.13 122.18 46.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.124 0.488 . . . . 0.0 111.222 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.647 ' HA2' ' HH ' ' A' ' 139' ' ' TYR . . . 157.76 179.18 32.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.972 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.17 132.91 48.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -86.53 80.36 8.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.188 0.518 . . . . 0.0 111.801 -173.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' ' 34' ' ' HIS . 7.1 mp . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.244 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.2 p-10 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.63 0.252 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.563 ' O ' HG21 ' A' ' 31' ' ' VAL . 53.2 mt-30 -61.95 -45.77 92.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.348 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.62 71.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.805 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -70.52 -36.21 73.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.185 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 30.1 mmmt -62.7 -43.28 99.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.338 174.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 27' ' ' GLN . 72.6 t -62.59 -39.5 84.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.815 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -57.31 -43.9 83.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.592 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.35 -48.94 78.96 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.9 0.381 . . . . 0.0 110.579 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' HB2' HD23 ' A' ' 14' ' ' LEU . 58.5 t60 -52.51 -43.17 64.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.369 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.21 -39.71 65.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.471 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -82.19 -31.26 30.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.777 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -75.05 -23.45 58.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.608 0.242 . . . . 0.0 111.376 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 p -86.06 -39.08 17.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.232 0.539 . . . . 0.0 110.439 174.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.61 33.81 3.75 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.96 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.28 124.72 88.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.99 144.87 65.76 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.845 1.696 . . . . 0.0 112.379 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.471 ' HB3' HD21 ' A' ' 62' ' ' LEU . 12.0 m-20 65.9 3.41 2.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.419 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.55 -16.23 61.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.401 0.62 . . . . 0.0 110.518 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.66 -18.31 59.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.018 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -103.25 -0.6 30.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.531 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.428 HG13 HD12 ' A' ' 70' ' ' ILE . 30.7 m -103.02 171.13 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.181 0.515 . . . . 0.0 111.593 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -134.73 125.11 26.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.866 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.0 135.73 37.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.278 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 48.2 tt0 -127.7 125.33 39.83 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mm -97.26 134.86 33.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.893 0.378 . . . . 0.0 110.595 -177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.39 50.96 2.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.375 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 54' ' ' LYS . 27.3 t70 63.1 93.23 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.788 0.68 . . . . 0.0 111.483 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 78.41 -23.47 2.84 Favored Glycine 0 CA--C 1.517 0.176 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.585 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.509 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 0.8 OUTLIER -109.68 115.14 29.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -101.48 120.17 39.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.315 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.509 ' OG1' ' HE3' ' A' ' 54' ' ' LYS . 49.2 m -90.72 132.86 35.56 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.309 -0.244 . . . . 0.0 110.528 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.99 119.96 61.82 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.347 0.594 . . . . 0.0 110.396 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -117.62 162.24 18.34 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.226 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.85 156.87 8.21 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -138.54 144.83 40.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.912 0.387 . . . . 0.0 110.509 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.36 22.69 39.82 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.48 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' A' ' 42' ' ' ASP . 8.6 mt -100.08 -166.85 1.38 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.238 0.542 . . . . 0.0 109.952 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.4 p -125.73 168.26 14.03 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.923 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.659 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -63.22 -43.34 98.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.843 0.354 . . . . 0.0 110.522 -178.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.461 ' H ' ' HB1' ' A' ' 93' ' ' ALA . 42.7 tt0 -64.46 -42.82 95.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.622 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.42 -46.95 83.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.454 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 12.9 ptmm? -59.62 -37.34 78.35 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.915 -175.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.565 ' O ' HG21 ' A' ' 72' ' ' VAL . 85.9 mt-10 -64.75 -48.17 75.55 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.719 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 28.6 mtpp -54.22 -41.01 68.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.676 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.428 HD12 HG13 ' A' ' 46' ' ' VAL . 29.7 mt -71.38 -53.93 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.691 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 96.3 mt -48.95 -47.31 43.97 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.656 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 68' ' ' GLU . 70.0 t -65.37 -45.78 92.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.389 0.614 . . . . 0.0 110.647 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -61.72 -39.24 90.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.358 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 m -78.18 -31.21 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.718 0.294 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -69.6 -36.79 76.81 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.301 175.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -80.24 50.02 1.2 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.321 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.04 143.34 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 120.946 0.403 . . . . 0.0 110.387 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -67.66 115.11 6.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 111.29 -13.17 28.42 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.131 -172.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 50.6 mm -105.96 132.89 51.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.896 0.379 . . . . 0.0 110.684 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.513 ' HB3' ' HB3' ' A' ' 8' ' ' LYS . . . -131.29 -5.49 3.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.421 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 2.7 p -156.2 154.34 30.63 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.193 0.52 . . . . 0.0 111.317 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 4' ' ' PHE . 7.6 p -134.4 134.6 54.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.034 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.71 113.68 27.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -83.09 111.06 18.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.474 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -123.47 29.02 6.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.483 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.412 ' CG1' HD11 ' A' ' 62' ' ' LEU . 77.4 t -82.45 139.9 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.508 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -105.14 137.71 42.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.047 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.4 p -108.89 130.27 55.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.419 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.31 -29.46 13.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.104 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.7 p -127.27 140.29 37.51 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.707 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.04 153.47 25.08 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.754 2.303 . . . . 0.0 111.774 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.461 ' HB1' ' H ' ' A' ' 65' ' ' GLU . . . -159.58 -172.77 3.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.99 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.2 m -61.78 149.2 40.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.348 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.89 138.53 51.08 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.732 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.5 m -120.18 149.41 42.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.217 0.532 . . . . 0.0 111.709 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 8.8 tt0 -84.16 153.01 23.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.019 173.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.591 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 91.7 m-85 -110.67 96.17 6.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 0.0 111.167 -176.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.61 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 86.7 t80 -95.3 136.07 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.861 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.438 ' OG1' HG23 ' A' ' 143' ' ' VAL . 18.4 m -106.83 124.0 48.97 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.545 HG11 ' O ' ' A' ' 142' ' ' GLN . 0.8 OUTLIER -67.45 134.05 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.451 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 72.0 mmtt -86.67 -72.39 0.51 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.376 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 t -175.08 115.5 0.16 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -175.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.01 -3.81 85.71 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -171.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 1.0 OUTLIER -63.71 113.94 3.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.2 -1.0 . . . . 0.0 110.829 178.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.529 ' O ' HG21 ' A' ' 110' ' ' ILE . 40.0 p -104.97 158.28 16.65 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.664 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -57.37 -45.91 83.94 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.356 -172.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 17.2 m -65.47 -35.16 80.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.75 0.309 . . . . 0.0 110.588 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.98 77.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.106 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.5 pp -75.6 -29.68 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 120.833 0.349 . . . . 0.0 110.495 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.2 t -65.16 -45.69 83.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.232 0.539 . . . . 0.0 109.627 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -62.88 -30.33 71.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.455 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.5 OUTLIER -64.41 -62.86 1.34 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.229 176.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.456 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.2 m -77.21 -46.23 28.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.262 -170.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.747 ' HH ' ' HD2' ' A' ' 123' ' ' LYS . 15.8 m-85 -88.14 -50.46 6.36 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 120.5 -19.88 9.02 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -111.23 128.32 55.89 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 108' ' ' SER . . . -81.56 -8.59 59.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.981 0.42 . . . . 0.0 110.247 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -80.25 -12.3 59.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.395 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.462 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 55.7 mt -87.16 11.53 13.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.459 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.404 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 51.0 p90 -58.05 -30.78 66.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.196 0.522 . . . . 0.0 110.51 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 26.9 p-10 -76.27 -32.71 58.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.171 -176.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.747 ' HD2' ' HH ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -71.81 -24.31 61.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mt -83.99 -41.97 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.65 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.56 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 40.9 t80 -53.66 -59.76 4.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.359 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 30.2 mt-10 -60.6 -36.11 77.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.152 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.73 -32.34 73.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.045 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.512 ' O ' ' HB3' ' A' ' 131' ' ' MET . 40.8 m-80 -90.01 -8.15 52.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.939 0.399 . . . . 0.0 110.866 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 132' ' ' LEU . 30.4 mtpp -74.11 156.67 87.56 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.531 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HA ' ' HB3' ' A' ' 129' ' ' LYS . 88.9 Cg_endo -84.28 14.82 35.48 Favored 'Cis proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.383 -1.507 . . . . 0.0 113.365 -0.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.512 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 4.2 tmm? -67.31 -38.5 85.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.175 0.512 . . . . 0.0 109.75 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.625 ' O ' ' HG2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -90.9 111.69 23.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.485 ' HZ2' ' HB3' ' A' ' 133' ' ' LYS . 8.0 mtpm? -74.29 -60.34 2.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.335 -174.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 16.3 m -137.96 155.62 74.55 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.09 -23.64 73.45 Favored 'Trans proline' 0 CA--C 1.522 -0.097 0 C-N-CA 123.655 2.903 . . . . 0.0 113.134 -171.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -99.67 4.87 45.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.952 0.406 . . . . 0.0 110.668 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 134' ' ' SER . 27.3 mmmt -90.62 -0.77 57.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.756 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.4 pt -64.56 166.13 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.046 0.451 . . . . 0.0 110.833 174.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.647 ' HH ' ' HA2' ' A' ' 11' ' ' GLY . 5.2 p90 -155.24 144.65 15.25 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.917 -174.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -54.29 116.39 3.03 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.332 2.688 . . . . 0.0 112.71 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.46 14.52 14.22 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.202 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.545 ' O ' HG11 ' A' ' 101' ' ' VAL . 65.0 tt0 -99.78 130.83 46.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.899 0.381 . . . . 0.0 110.322 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.518 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 42.5 t -85.63 130.57 36.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.269 0.557 . . . . 0.0 109.957 174.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.0 mt -118.81 134.76 54.93 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.733 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.5 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 51.8 mtp180 -65.87 120.34 12.88 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.325 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 35.2 mm -111.46 82.65 3.74 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 31.9 Cg_exo -62.79 170.17 7.62 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.825 2.35 . . . . 0.0 112.215 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.64 174.283 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.1 tp . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 1.649 ' HE1' ' CE2' ' A' ' 4' ' ' PHE . 77.1 m-85 -121.39 133.62 55.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.329 -175.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.71 146.88 24.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.756 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.494 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 77.2 m-85 -128.23 -157.95 0.85 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.073 -176.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.505 HG23 ' HB1' ' A' ' 10' ' ' ALA . 22.8 m -83.73 -26.76 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 24.4 tptp 72.51 -53.37 0.7 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.248 0.619 . . . . 0.0 111.479 -174.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.39 -49.34 8.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.857 0.36 . . . . 0.0 111.831 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.505 ' HB1' HG23 ' A' ' 7' ' ' VAL . . . -76.21 -169.18 1.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.45 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.36 -160.02 19.2 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -76.82 127.1 32.12 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -74.64 63.42 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.017 0.913 . . . . 0.0 109.019 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.49 HD22 ' O ' ' A' ' 30' ' ' LYS . 11.8 tp . . . . . 0 N--CA 1.436 -1.153 0 CA-C-N 113.793 -1.548 . . . . 0.0 110.491 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 20.4 t70 . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 121.065 0.46 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -61.57 -45.12 95.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.973 174.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.71 84.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.603 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 51.6 tttp -60.67 -43.42 97.68 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.48 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 43.5 mmtt -62.66 -38.77 91.64 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.373 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 73.5 t -66.09 -42.92 92.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.267 176.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -55.44 -51.54 66.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 38.6 mt-10 -56.85 -46.92 81.42 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.255 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -52.59 -48.15 66.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.044 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 88.6 mt -65.81 -41.9 91.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.927 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -69.03 -41.77 77.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.347 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 99.3 mttt -65.17 -42.81 93.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.512 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 p -72.43 -40.64 66.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 111.141 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.01 32.67 2.99 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.234 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.407 HD11 ' HD2' ' A' ' 130' ' ' PRO . 26.2 mm -71.71 126.09 91.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.67 148.35 77.65 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.089 1.86 . . . . 0.0 112.604 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 61.78 16.44 7.9 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.737 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.32 70.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.125 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.49 -23.39 63.62 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.338 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -88.91 -27.92 20.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.322 -171.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.4 m -88.01 164.11 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.222 0.534 . . . . 0.0 111.833 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -128.32 135.06 49.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.973 173.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 48' ' ' ILE . 4.3 mp -108.79 131.01 60.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.815 0.34 . . . . 0.0 110.287 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -118.75 124.84 48.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.078 0.466 . . . . 0.0 110.539 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.0 mm -105.19 136.75 37.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.782 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.06 54.88 1.56 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.205 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 54' ' ' LYS . 5.0 m-20 62.7 88.57 0.09 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.98 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.4 -34.93 2.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.978 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 52' ' ' ASP . 22.6 tptm -84.1 119.95 25.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.983 0.421 . . . . 0.0 110.388 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -121.6 105.89 10.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.233 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.0 m -93.6 122.01 35.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.204 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.67 130.72 47.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.165 0.507 . . . . 0.0 109.989 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.55 136.78 54.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.135 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.78 168.22 40.77 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.6 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.446 ' HB3' ' HE3' ' A' ' 88' ' ' LYS . 3.5 p30 -157.17 142.57 17.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.991 0.424 . . . . 0.0 110.453 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.56 24.92 64.11 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.091 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD11 HG13 ' A' ' 87' ' ' VAL . 11.5 mt -99.41 -162.43 0.95 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.339 0.59 . . . . 0.0 109.916 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.2 p -120.73 155.59 33.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.968 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.413 ' NE2' ' HA ' ' A' ' 95' ' ' ALA . 59.8 tt0 -60.77 -35.29 76.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.893 0.378 . . . . 0.0 110.14 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -60.81 -44.27 97.09 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.538 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.55 -41.85 59.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -54.8 -57.07 13.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.753 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.505 ' O ' HG22 ' A' ' 72' ' ' VAL . 5.9 mm-40 -67.11 -15.77 63.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.043 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HB2' ' NZ ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -75.9 -48.32 21.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.269 0.557 . . . . 0.0 109.524 176.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.57 ' O ' HG13 ' A' ' 74' ' ' VAL . 47.6 mt -65.05 -52.35 54.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.817 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.6 mp -40.78 -46.49 2.69 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.83 0.706 . . . . 0.0 112.653 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 68' ' ' GLU . 98.9 t -71.81 -48.52 50.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.196 0.522 . . . . 0.0 110.872 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.413 ' HA ' ' SD ' ' A' ' 131' ' ' MET . . . -60.6 -32.11 71.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.182 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 70' ' ' ILE . 11.9 p -88.59 -28.28 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.276 0.56 . . . . 0.0 110.851 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -70.37 -35.25 69.02 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.02 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -83.42 58.86 4.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.795 0.331 . . . . 0.0 110.807 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.494 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 41.8 mm -123.78 132.75 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -63.81 95.42 0.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.53 -17.73 3.96 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.9 -173.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 35.3 mm -102.61 127.81 55.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.194 0.521 . . . . 0.0 111.471 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.51 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -111.48 -30.89 7.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.562 -174.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 p -150.69 150.6 31.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.313 0.577 . . . . 0.0 111.448 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 85.4 t -124.25 126.52 72.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.878 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -103.24 112.58 25.51 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -84.35 110.63 18.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.344 0.592 . . . . 0.0 111.427 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -119.22 33.04 5.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.461 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 HD11 ' A' ' 62' ' ' LEU . 77.6 t -95.73 123.64 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.22 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.446 ' HE3' ' HB3' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -89.71 123.18 33.5 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 174.185 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.4 p -102.82 126.46 49.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.82 0.343 . . . . 0.0 111.259 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.0 -27.81 23.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.424 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.8 p -121.04 129.46 25.28 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.998 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.53 164.5 16.46 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.815 2.343 . . . . 0.0 112.418 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.59 -155.04 0.58 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.7 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.6 m -86.62 122.77 31.0 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.413 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -62.92 142.66 58.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.607 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.9 m -127.57 143.27 51.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.116 0.484 . . . . 0.0 111.803 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.545 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 5.8 tt0 -91.85 153.4 19.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 171.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.647 ' HD1' ' CD2' ' A' ' 98' ' ' PHE . 31.1 m-85 -107.17 86.84 2.38 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.028 0.442 . . . . 0.0 110.264 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.622 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 82.1 t80 -84.63 131.77 34.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.707 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.473 ' OG1' HG21 ' A' ' 143' ' ' VAL . 20.0 m -103.31 120.43 40.75 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.973 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 142' ' ' GLN . 0.9 OUTLIER -68.44 129.86 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -78.62 -64.1 1.25 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.302 -169.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.9 t -159.18 -72.91 0.08 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.674 0.273 . . . . 0.0 110.505 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.35 51.6 4.58 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.509 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.1 m-20 -108.72 111.96 24.01 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.039 -0.58 . . . . 0.0 110.983 -171.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.504 ' O ' HG21 ' A' ' 110' ' ' ILE . 8.1 m -104.03 150.37 24.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 21.3 tp -57.87 -43.1 85.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.623 0.647 . . . . 0.0 110.944 -173.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.2 p -61.03 -39.98 91.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.22 0.533 . . . . 0.0 111.095 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.24 -40.87 74.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.354 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.7 pp -79.02 -23.84 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.2 p -71.22 -39.16 71.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.971 0.415 . . . . 0.0 110.03 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' A' ' 112' ' ' LYS . 8.3 tmtm? -64.03 -29.93 71.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.594 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -65.16 -52.75 53.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.318 177.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.473 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.7 m -87.78 -44.0 15.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.175 -171.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.473 ' N ' HG21 ' A' ' 114' ' ' VAL . 64.8 m-85 -89.56 -53.07 4.69 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.891 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.48 -22.86 7.71 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.061 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -116.51 124.33 49.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.356 -0.422 . . . . 0.0 109.903 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.91 -19.28 60.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.555 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -67.68 -11.39 58.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.187 0.517 . . . . 0.0 110.485 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 115' ' ' TYR . 39.1 mt -89.11 14.43 10.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.176 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.41 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 27.9 p90 -64.74 -28.91 69.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.049 0.452 . . . . 0.0 109.814 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.597 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 32.1 p30 -69.46 -29.6 67.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.878 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -58.69 -49.62 76.92 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.51 0.671 . . . . 0.0 110.078 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.78 -39.82 78.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.295 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.425 ' CE2' ' HD2' ' A' ' 129' ' ' LYS . 45.5 t80 -54.58 -55.76 26.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.758 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 35.1 mt-10 -63.51 -40.13 96.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.942 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.494 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -60.06 -28.47 67.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.115 -177.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.464 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 47.1 m-80 -99.93 0.01 40.36 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 120.619 0.247 . . . . 0.0 110.871 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 25.8 mtpp -79.36 150.75 74.27 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-O 120.644 0.259 . . . . 0.0 110.779 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.407 ' HD2' HD11 ' A' ' 40' ' ' ILE . 9.5 Cg_endo -90.5 25.1 21.4 Favored 'Cis proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.662 -1.391 . . . . 0.0 112.843 -0.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.464 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 1.0 OUTLIER -74.95 -34.7 62.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.372 . . . . 0.0 110.276 176.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.442 HD22 HE21 ' A' ' 142' ' ' GLN . 0.1 OUTLIER -93.03 117.76 30.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.98 -43.37 24.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.892 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.3 m -151.45 149.85 25.34 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.255 0.55 . . . . 0.0 110.762 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.97 -18.08 61.19 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 123.713 2.942 . . . . 0.0 112.875 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.12 -16.31 22.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.498 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -78.62 -1.2 33.05 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.8 pt -65.7 168.14 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.912 0.387 . . . . 0.0 110.063 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -163.9 154.96 13.86 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.343 -172.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -45.2 113.31 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.164 2.576 . . . . 0.0 112.662 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.29 34.65 5.77 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.339 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.573 ' O ' HG11 ' A' ' 101' ' ' VAL . 7.2 tp60 -107.08 116.6 32.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.835 0.318 . . . . 0.0 110.164 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.473 HG21 ' OG1' ' A' ' 100' ' ' THR . 46.7 t -80.5 132.08 32.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.066 0.46 . . . . 0.0 110.004 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -125.63 134.42 51.9 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.073 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 47.2 mtp180 -62.68 118.76 8.09 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.064 171.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 39.7 mm -106.24 93.27 7.79 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 173.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 38.5 Cg_exo -59.85 139.14 86.78 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.222 1.948 . . . . 0.0 111.184 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 C--N 1.32 -0.678 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.014 176.171 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 121.268 0.556 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -93.6 138.81 31.47 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.26 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 5' ' ' ASN . 0.9 OUTLIER -97.57 138.31 35.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.018 0.437 . . . . 0.0 111.01 -177.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.404 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 59.5 m-85 -127.25 -179.12 4.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.496 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.583 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 23.7 m -81.26 -9.94 12.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -171.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 53.4 tptt 74.35 -54.95 0.67 Allowed 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.528 0.518 . . . . 0.0 112.141 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.62 -46.53 15.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.097 0.475 . . . . 0.0 111.963 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.583 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -81.29 126.93 32.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.183 -173.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.442 ' HA2' ' HH ' ' A' ' 139' ' ' TYR . . . 159.96 -173.1 36.59 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.371 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.04 129.59 41.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.35 54.98 1.8 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.992 0.901 . . . . 0.0 108.88 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 30' ' ' LYS . 14.7 tp . . . . . 0 C--N 1.315 -0.896 0 CA-C-N 113.8 -1.545 . . . . 0.0 111.312 -172.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.544 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 19.0 t70 . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.488 ' O ' HG21 ' A' ' 31' ' ' VAL . 51.5 mt-30 -59.92 -48.35 82.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.375 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.43 -34.7 72.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.765 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 38.6 ttpt -68.11 -39.99 82.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.985 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 74.6 mmtt -56.96 -44.96 83.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.063 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.6 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 47.5 t -59.96 -45.16 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.49 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -55.56 -47.64 76.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.868 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 38.2 mt-10 -58.91 -48.88 79.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.359 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -53.04 -39.37 63.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.456 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 85.7 mt -70.76 -40.91 72.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.013 0.435 . . . . 0.0 111.201 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -78.07 -31.01 50.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.175 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -67.92 -38.2 82.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.943 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 p -75.66 -36.42 60.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 110.789 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.92 35.29 4.32 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.167 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.8 mm -77.11 124.69 87.26 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.69 146.46 66.87 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.229 1.953 . . . . 0.0 112.396 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 64.34 -0.9 0.81 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.907 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.77 -9.89 59.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.341 0.591 . . . . 0.0 110.432 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -87.7 -9.53 53.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.276 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -91.72 -35.54 14.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.089 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.8 m -69.68 166.12 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.373 -175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -130.23 128.99 42.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.802 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 48' ' ' ILE . 3.6 mp -103.87 140.91 20.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.8 0.333 . . . . 0.0 110.869 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 38.5 tt0 -123.14 135.78 54.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 173.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.3 mm -104.35 111.72 35.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.079 0.466 . . . . 0.0 110.306 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.25 93.89 4.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.473 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.6 t70 64.18 -83.62 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.368 -171.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.77 13.96 4.73 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.637 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 38.0 mtmm -95.82 117.23 30.16 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.662 0.267 . . . . 0.0 110.475 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.458 ' O ' HG11 ' A' ' 83' ' ' VAL . . . -92.1 80.59 5.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.823 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 89.3 m -66.68 119.65 12.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.959 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 57' ' ' VAL . 7.3 p -106.89 109.97 30.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.441 0.638 . . . . 0.0 111.193 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.4 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.9 OUTLIER -100.68 154.41 18.62 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.028 178.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.93 160.23 17.72 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -151.75 146.08 25.47 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.241 0.543 . . . . 0.0 110.721 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.94 31.13 58.34 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.529 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.3 mt -98.83 -169.99 1.86 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.837 0.827 . . . . 0.0 110.851 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 m -108.96 128.78 55.24 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.718 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 9.4 tt0 -61.49 -31.51 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.946 -172.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HG3' ' NH2' ' A' ' 145' ' ' ARG . 42.2 tt0 -65.63 -39.53 91.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.069 0.461 . . . . 0.0 110.151 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.55 ' O ' HG13 ' A' ' 70' ' ' ILE . . . -72.92 -39.34 66.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.918 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.485 ' HE3' ' OD1' ' A' ' 85' ' ' ASP . 73.3 tttt -52.12 -53.68 39.77 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.593 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.585 ' O ' HG22 ' A' ' 72' ' ' VAL . 7.7 mm-40 -52.95 -35.25 58.51 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 28.7 ttpt -79.25 -32.55 43.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.505 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 66' ' ' ALA . 45.3 mt -61.89 -52.17 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 67' ' ' LYS . 9.8 mp -45.01 -43.84 9.53 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.646 173.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 68' ' ' GLU . 66.5 t -67.3 -51.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.465 0.65 . . . . 0.0 110.885 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.89 79.95 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.6 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.5 m -80.63 -25.94 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.029 0.442 . . . . 0.0 111.087 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -77.86 -28.87 55.95 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.832 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -83.39 42.61 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 111.404 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.2 mt -114.53 138.26 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-O 121.14 0.495 . . . . 0.0 110.488 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 t -71.49 111.91 7.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.182 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.09 -14.61 8.35 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -172.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.6 mm -98.74 121.83 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 110.902 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -104.14 -20.51 13.79 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.73 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.637 ' OG ' ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -158.83 153.85 25.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.465 -177.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 55' ' ' ALA . 68.1 t -127.84 124.27 62.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.789 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.8 105.85 18.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.485 ' OD1' ' HE3' ' A' ' 67' ' ' LYS . 3.3 t70 -72.84 116.54 13.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.224 0.535 . . . . 0.0 111.54 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.4 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 75.9 mt-30 -121.32 25.74 9.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.119 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.0 t -89.55 125.57 42.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.655 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -95.53 142.89 27.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.269 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.0 p -115.72 143.55 45.21 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.942 0.401 . . . . 0.0 111.548 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.91 -8.34 31.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.581 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.5 p -135.32 133.68 20.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.234 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.35 69.15 6.64 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.97 2.446 . . . . 0.0 111.283 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.44 -168.06 1.85 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.731 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.0 m -56.51 129.38 40.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.35 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.16 138.95 31.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.6 m -126.5 157.3 39.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.369 0.605 . . . . 0.0 112.02 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.522 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.9 tt0 -96.38 149.15 22.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.577 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -109.78 93.99 4.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.942 0.401 . . . . 0.0 110.603 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.63 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 83.2 t80 -98.2 139.18 34.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.272 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.6 m -104.54 123.44 47.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.345 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.9 m -70.92 134.87 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.4 mmtp -98.92 -165.61 1.26 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.481 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.401 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 13.9 m -65.1 122.87 18.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.633 0.254 . . . . 0.0 110.481 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.09 8.85 83.3 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.312 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 13.1 m-20 -88.31 105.18 17.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.367 0.603 . . . . 0.0 111.009 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.453 ' O ' HG21 ' A' ' 110' ' ' ILE . 5.8 m -102.69 161.09 14.01 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 138' ' ' ILE . 19.7 tp -56.39 -41.66 76.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.412 0.551 . . . . 0.0 111.699 -170.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 9.8 m -63.14 -41.57 99.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.955 0.407 . . . . 0.0 110.571 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.88 81.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.004 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -75.11 -24.52 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 120.917 0.389 . . . . 0.0 110.481 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.7 t -67.44 -44.14 79.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 170.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.79 -24.27 66.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.431 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 2.1 tp-100 -71.87 -59.87 2.53 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.924 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.8 m -82.83 -35.82 12.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.236 -170.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.474 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 19.0 m-30 -103.68 -23.89 13.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.05 -175.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.44 -6.31 82.34 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.909 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.447 HD22 ' HB3' ' A' ' 119' ' ' ASN . 41.0 t30 -133.94 124.0 25.62 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 108' ' ' SER . . . -76.18 -15.2 60.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.712 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.447 ' HB3' HD22 ' A' ' 117' ' ' ASN . 22.9 t-20 -68.68 -23.43 64.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.139 0.495 . . . . 0.0 110.596 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.449 HD13 ' HB3' ' A' ' 115' ' ' TYR . 67.1 mt -85.06 14.22 5.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.572 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.427 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 24.2 p90 -62.3 -31.61 72.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.189 0.519 . . . . 0.0 110.257 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.582 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 26.3 p-10 -68.89 -29.64 67.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.507 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -58.17 -47.47 83.29 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.543 0.687 . . . . 0.0 109.772 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.9 mt -71.8 -41.02 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.304 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.442 ' HB2' HD22 ' A' ' 107' ' ' LEU . 83.5 t80 -53.72 -51.76 62.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 40.2 mt-10 -62.74 -23.22 67.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.941 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.505 ' O ' ' HD3' ' A' ' 69' ' ' LYS . . . -86.87 -31.87 20.53 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.632 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.563 ' O ' ' HB3' ' A' ' 131' ' ' MET . 10.5 m120 -76.67 -42.07 43.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 58.5 pttt -64.47 153.72 85.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.949 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.1 Cg_endo -86.27 21.55 22.36 Favored 'Cis proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.225 -1.573 . . . . 0.0 112.892 0.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.563 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.2 tmm? -73.23 -26.73 61.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.465 HD13 ' H ' ' A' ' 133' ' ' LYS . 18.8 tp -111.72 133.75 53.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.078 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.465 ' H ' HD13 ' A' ' 132' ' ' LEU . 29.7 mtpp -81.67 -45.18 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.063 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.484 ' OG ' ' HG2' ' A' ' 137' ' ' LYS . 79.0 p -154.02 160.94 30.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.79 -17.75 52.05 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.528 2.819 . . . . 0.0 111.929 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -100.43 -12.98 18.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.511 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.484 ' HG2' ' OG ' ' A' ' 134' ' ' SER . 56.4 mmtt -81.49 -8.03 59.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.654 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 9.3 pt -68.43 168.9 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.098 0.475 . . . . 0.0 110.978 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.48 ' CE1' ' HG3' ' A' ' 142' ' ' GLN . 15.4 p90 -155.98 147.79 17.18 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.177 -174.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.401 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 88.7 Cg_exo -48.48 103.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.597 2.865 . . . . 0.0 113.037 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.19 8.81 5.86 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.601 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.654 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 1.7 mt-30 -94.37 121.97 36.45 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 117.341 0.571 . . . . 0.0 111.224 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.9 t -80.61 135.31 25.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.303 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.2 mt -126.36 145.31 50.5 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.063 0.459 . . . . 0.0 110.748 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.411 ' NH2' ' HG3' ' A' ' 65' ' ' GLU . 28.5 ttt180 -72.48 110.37 6.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.906 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 41.5 mm -94.7 112.38 57.72 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.497 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 32.4 Cg_exo -59.69 166.68 7.81 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.985 2.457 . . . . 0.0 113.109 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.922 176.942 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.501 HD11 ' N ' ' A' ' 4' ' ' PHE . 1.7 tm? . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.291 0.567 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.501 ' N ' HD11 ' A' ' 3' ' ' LEU . 86.5 m-85 -125.52 132.22 52.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.194 175.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -97.61 140.9 31.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.006 0.431 . . . . 0.0 110.997 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -127.75 -164.4 1.36 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.151 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.3 -10.81 8.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.794 0.331 . . . . 0.0 111.128 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 84.8 tttt 72.67 -67.19 0.27 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 176.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.31 -24.78 63.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.289 0.566 . . . . 0.0 110.504 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.26 119.98 31.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.711 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.01 -173.55 41.58 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.842 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -77.31 136.18 38.46 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 19.3 mtpt -77.97 86.05 4.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.45 0.643 . . . . 0.0 111.781 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 34' ' ' HIS . 8.9 mp . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.005 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 121.138 0.494 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -66.56 -33.78 76.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.154 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.23 72.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.763 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 17.4 tppt? -65.18 -43.29 92.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.589 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' N ' ' HD2' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -66.87 -32.06 73.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.046 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 75.3 t -63.59 -46.18 95.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.311 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.433 ' NE2' HD13 ' A' ' 35' ' ' LEU . 16.5 mm-40 -57.85 -41.42 82.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.516 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 54.6 mt-10 -56.95 -48.47 78.26 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.765 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.482 ' HB2' HD12 ' A' ' 14' ' ' LEU . 57.7 t60 -57.97 -37.02 73.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.428 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 64.4 mt -73.18 -40.65 64.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.008 0.433 . . . . 0.0 110.429 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -65.05 -48.0 75.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.419 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -58.03 -49.88 75.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.754 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.401 ' OG1' HG12 ' A' ' 40' ' ' ILE . 16.7 p -68.28 -44.38 75.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.37 35.49 3.85 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.792 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.401 HG12 ' OG1' ' A' ' 38' ' ' THR . 35.6 mm -66.67 124.04 87.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -66.38 138.65 51.48 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.989 1.793 . . . . 0.0 112.333 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 63.33 9.33 3.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.351 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HB3' HD11 ' A' ' 35' ' ' LEU . . . -75.94 -14.38 60.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.27 0.557 . . . . 0.0 110.367 177.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -81.36 -16.32 52.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.13 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -75.19 -44.1 48.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.614 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.5 m -77.34 163.63 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.595 -172.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -118.8 139.28 51.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.877 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.9 mm -102.39 139.78 22.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.026 0.441 . . . . 0.0 111.316 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 49.9 tt0 -138.97 128.7 24.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.327 172.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mm -108.91 116.57 52.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.672 0.272 . . . . 0.0 110.912 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.48 100.06 7.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.832 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 t70 66.11 -80.96 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.8 0.688 . . . . 0.0 110.757 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.06 18.51 2.53 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 82' ' ' SER . 38.9 ttmt -107.78 114.74 28.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.294 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.68 111.87 23.62 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.155 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 18.5 m -86.65 130.64 34.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.917 177.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 57' ' ' VAL . 5.3 p -114.74 106.93 21.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.337 0.589 . . . . 0.0 110.897 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 m -104.55 155.88 18.44 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.996 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.22 179.72 39.25 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.325 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.13 150.52 13.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 0.0 110.6 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.54 23.97 48.46 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.504 -0.771 . . . . 0.0 113.163 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.46 175.35 5.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.76 0.314 . . . . 0.0 110.667 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 91' ' ' THR . 14.3 m -104.75 157.95 16.85 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 93' ' ' ALA . 7.8 tp60 -53.85 -41.91 67.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.891 0.377 . . . . 0.0 110.227 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.675 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 61.1 mm-40 -49.84 -62.39 1.59 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.061 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.02 -37.69 84.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.685 0.279 . . . . 0.0 110.966 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -55.55 -51.77 65.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.625 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.585 ' O ' HG22 ' A' ' 72' ' ' VAL . 56.1 mt-10 -65.09 -33.56 76.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.106 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 29.8 mtpp -60.01 -42.73 94.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.867 0.365 . . . . 0.0 110.095 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 74' ' ' VAL . 52.6 mt -62.45 -57.38 12.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.322 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mp -41.9 -43.25 3.0 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.828 0.705 . . . . 0.0 112.406 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 68' ' ' GLU . 86.2 t -69.08 -53.19 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.33 0.586 . . . . 0.0 111.017 177.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.424 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -64.07 -31.09 72.16 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.588 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 70' ' ' ILE . 11.7 p -84.62 -23.35 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.492 0.663 . . . . 0.0 110.532 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.23 -35.37 34.1 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.196 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -82.07 60.29 4.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.64 0.257 . . . . 0.0 111.145 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.612 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 32.7 mm -118.13 142.24 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 13' ' ' LYS . 72.3 p -65.91 91.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.966 0.412 . . . . 0.0 110.492 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.98 -17.72 5.67 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.914 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 28.1 mm -86.51 113.06 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.667 0.746 . . . . 0.0 110.868 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.99 -24.61 15.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.03 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 5.4 p -150.05 156.83 42.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.293 0.568 . . . . 0.0 111.514 -178.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.5 130.23 59.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.737 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -104.95 106.71 17.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -72.65 117.27 14.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.539 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -133.92 28.39 3.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.138 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.25 116.29 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.617 0.723 . . . . 0.0 110.712 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -82.37 144.46 30.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.766 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.9 p -112.17 127.43 55.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.19 0.519 . . . . 0.0 111.222 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.57 -27.75 23.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.23 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 63' ' ' SER . 16.3 p -119.93 132.24 24.13 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.332 176.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -91.3 168.09 3.46 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.793 2.329 . . . . 0.0 113.205 -175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . . . -158.51 -156.63 0.56 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.554 174.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.11 154.5 19.32 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.21 129.09 35.85 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.6 m -97.39 156.48 16.44 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.281 0.563 . . . . 0.0 111.006 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.9 tt0 -87.87 142.19 28.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.323 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.632 ' HE1' ' CE2' ' A' ' 98' ' ' PHE . 94.3 m-85 -106.76 90.55 3.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.442 . . . . 0.0 110.235 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.661 ' HD2' ' CD1' ' A' ' 99' ' ' TYR . 90.5 t80 -90.89 146.48 23.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.96 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.464 ' OG1' HG23 ' A' ' 143' ' ' VAL . 5.9 m -117.96 123.01 44.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.042 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.5 m -67.85 128.85 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -106.87 115.7 30.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.5 t 55.58 -90.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.822 173.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.5 19.32 53.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.427 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.531 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 2.2 m-20 -66.93 134.58 52.29 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.49 0.662 . . . . 0.0 111.253 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.619 ' O ' HG21 ' A' ' 110' ' ' ILE . 36.0 p -119.4 156.44 30.12 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.284 175.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 110' ' ' ILE . 20.9 tp -56.38 -40.86 75.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 118.185 0.448 . . . . 0.0 111.132 -171.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 4.6 m -63.77 -40.25 96.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.155 0.502 . . . . 0.0 110.378 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -73.83 -27.52 61.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.73 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.619 HG21 ' O ' ' A' ' 106' ' ' THR . 1.4 pp -85.34 -24.28 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.809 0.338 . . . . 0.0 110.958 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.3 p -76.3 -29.67 57.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 170.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 52.5 tptt -60.43 -26.33 66.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.842 170.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 16.2 mm-40 -75.69 -72.42 0.31 Allowed 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 122.282 1.039 . . . . 0.0 110.715 175.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.466 HG21 ' N ' ' A' ' 115' ' ' TYR . 28.8 m -70.41 -40.1 77.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 113.251 -1.795 . . . . 0.0 112.659 -167.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.466 ' N ' HG21 ' A' ' 114' ' ' VAL . 56.5 m-85 -96.97 -20.11 18.32 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.602 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 80.89 5.5 90.05 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.544 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.478 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 35.8 t30 -140.81 116.05 9.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.806 0.336 . . . . 0.0 110.318 -176.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.431 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -70.31 -11.11 60.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.553 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -81.76 -10.96 59.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.478 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 74.8 mt -96.11 22.68 7.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.76 -178.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.652 ' HE1' ' CE2' ' A' ' 121' ' ' TYR . 50.8 p90 -68.35 -29.13 67.79 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.041 -175.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.405 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 9.0 t30 -69.93 -30.51 67.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.084 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -53.83 -47.76 70.6 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.808 0.813 . . . . 0.0 109.484 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.535 HG23 ' OD1' ' A' ' 128' ' ' ASN . 55.7 mt -68.49 -46.71 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.491 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -53.96 -46.64 71.69 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.103 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.437 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 15.0 mt-10 -69.63 -24.67 63.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.96 0.41 . . . . 0.0 111.598 -176.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.49 29.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.951 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.535 ' OD1' HG23 ' A' ' 124' ' ' ILE . 8.3 m120 -74.82 -46.84 33.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.925 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 62.3 pttt -58.5 154.06 36.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.84 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.448 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.9 Cg_endo -80.86 15.18 20.15 Favored 'Cis proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.241 -1.566 . . . . 0.0 113.674 0.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.468 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.6 tmm? -70.03 -36.86 75.37 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.7 tp -94.45 115.88 28.14 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -73.81 -42.6 60.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.316 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.409 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 52.8 m -157.89 154.03 23.71 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 134' ' ' SER . 33.2 Cg_exo -61.72 -23.19 75.92 Favored 'Trans proline' 0 C--O 1.23 0.077 0 C-N-CA 123.76 2.974 . . . . 0.0 112.975 -173.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -105.38 7.16 33.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 110.689 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.409 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 30.9 mmtp -100.82 14.79 30.57 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.458 0.647 . . . . 0.0 110.692 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 106' ' ' THR . 17.6 pt -67.54 171.61 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.605 172.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -153.81 143.77 15.41 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.705 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.64 115.49 2.14 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.285 2.657 . . . . 0.0 112.898 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.01 26.0 7.68 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.357 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.529 ' H ' HG23 ' A' ' 101' ' ' VAL . 65.4 tt0 -100.21 121.62 41.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.871 0.367 . . . . 0.0 110.782 -175.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.464 HG23 ' OG1' ' A' ' 100' ' ' THR . 55.4 t -82.12 138.4 19.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.691 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.0 mt -132.52 146.38 51.88 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.441 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.675 ' NH2' ' HA ' ' A' ' 65' ' ' GLU . 32.7 ttt180 -75.65 113.4 13.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.746 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 36.4 mm -99.93 103.09 20.0 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.106 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 27.2 Cg_exo -61.96 160.55 29.22 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.33 2.02 . . . . 0.0 111.805 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.0 tp . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 120.913 0.387 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 1.65 ' HE1' ' CE2' ' A' ' 4' ' ' PHE . 81.3 m-85 -120.85 133.63 55.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.902 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -102.64 151.08 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.971 0.415 . . . . 0.0 110.813 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.628 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 90.8 m-85 -131.68 -179.88 5.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.945 -175.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.23 -17.81 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.867 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 81.2 tttt 72.93 -69.46 0.19 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.403 0.681 . . . . 0.0 111.7 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.26 -25.11 65.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.823 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.76 124.57 42.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.714 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.39 -163.26 36.78 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.71 134.4 38.11 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -78.06 90.49 4.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.327 0.584 . . . . 0.0 111.359 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.59 176.409 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 18.9 t70 . . . . . 0 CA--C 1.523 -0.077 0 CA-C-O 121.277 0.56 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.411 ' O ' HG21 ' A' ' 31' ' ' VAL . 17.6 mt-30 -69.09 -31.33 69.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.787 176.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 50' ' ' ILE . . . -62.89 -27.45 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.232 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.583 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 60.5 tttp -65.19 -42.76 93.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -64.04 -37.99 89.43 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.176 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.55 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 62.1 t -59.15 -51.68 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.893 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -54.58 -43.43 72.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.445 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 43.3 mt-10 -57.36 -56.74 17.93 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.105 0.478 . . . . 0.0 110.034 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -51.74 -42.76 62.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.283 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 99.2 mt -68.04 -42.76 80.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.645 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.51 -26.81 51.46 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.124 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -74.13 -32.43 63.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.688 0.28 . . . . 0.0 111.346 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' HG12 ' A' ' 40' ' ' ILE . 2.1 p -80.4 -30.64 37.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.905 0.383 . . . . 0.0 110.984 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.28 27.51 8.66 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.843 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.494 HD11 ' HD2' ' A' ' 130' ' ' PRO . 43.8 mm -58.41 129.75 84.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 122.402 0.281 . . . . 0.0 110.582 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -66.56 134.62 36.15 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.047 1.831 . . . . 0.0 111.981 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 62.96 21.69 13.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.804 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . . . -70.34 -20.53 62.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.089 0.471 . . . . 0.0 111.093 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -91.54 -9.59 43.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.322 0.582 . . . . 0.0 109.991 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.77 -14.31 30.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.203 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.4 m -97.87 177.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -142.09 133.16 26.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.063 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.04 132.98 58.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.003 0.43 . . . . 0.0 110.751 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -115.71 147.9 40.36 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 27' ' ' GLN . 23.0 mm -120.48 128.86 76.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.19 35.24 4.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.194 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.8 t70 66.88 98.26 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.671 0.607 . . . . 0.0 110.992 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 75.49 7.26 82.67 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.835 -176.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -146.5 138.69 24.95 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -120.11 148.26 43.84 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.693 175.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.2 m -117.65 119.79 36.05 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.1 t -99.54 111.76 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.459 0.647 . . . . 0.0 110.522 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -113.12 160.5 18.14 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.977 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.78 161.93 15.93 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -139.87 150.66 44.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.127 0.464 . . . . 0.0 111.008 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.92 35.45 84.57 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.93 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.424 HD13 ' CG1' ' A' ' 87' ' ' VAL . 15.2 mt -107.67 -166.25 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.677 0.751 . . . . 0.0 111.305 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.559 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 79.5 p -141.59 159.06 43.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.2 -1.363 . . . . 0.0 107.862 174.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 13.4 mt-30 -68.26 -18.92 64.67 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.413 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.42 -44.9 96.33 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.86 -38.33 15.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.964 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -58.76 -41.26 86.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 -178.592 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.16 35.04 0.63 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.319 1.057 . . . . 0.0 110.304 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 67' ' ' LYS . 47.3 mmtm -123.75 -50.06 1.85 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.597 -1.638 . . . . 0.0 107.152 167.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.5 mt -61.99 -51.94 66.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.775 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp -67.43 -19.26 65.35 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.829 0.824 . . . . 0.0 110.419 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.4 t -86.14 -56.25 5.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.15 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.67 -23.23 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.151 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.5 p -76.28 -39.13 34.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.866 0.365 . . . . 0.0 110.662 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.628 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -71.24 -27.89 70.98 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.865 175.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -83.06 44.69 0.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 111.064 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.4 mt -119.71 141.28 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.424 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.3 m -68.27 103.19 1.53 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.548 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.462 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 130.62 -20.14 4.94 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.458 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.637 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 50.1 mm -94.73 116.85 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.439 . . . . 0.0 110.93 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.415 ' HB1' ' HB2' ' A' ' 8' ' ' LYS . . . -107.78 -10.11 15.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.249 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 5.4 p -162.32 156.93 22.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.983 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 11.5 p -140.93 136.58 34.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.586 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.82 114.46 28.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.542 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.7 112.39 18.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.088 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -129.64 35.91 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.385 0.612 . . . . 0.0 110.503 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.424 ' CG1' HD13 ' A' ' 62' ' ' LEU . 93.4 t -89.09 131.98 35.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.392 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -94.99 97.6 10.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.748 175.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.7 p -81.74 121.52 26.5 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.88 -32.69 20.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.57 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.559 ' OG1' ' HB3' ' A' ' 63' ' ' SER . 17.5 p -106.67 130.22 23.25 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.593 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.21 148.81 34.99 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.93 2.42 . . . . 0.0 112.795 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.429 ' HB1' ' HB2' ' A' ' 64' ' ' GLN . . . -157.12 166.75 32.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.818 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.0 m -74.76 127.24 32.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.871 0.367 . . . . 0.0 110.943 -177.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.417 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -75.75 136.04 40.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.902 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.9 m -112.96 172.84 6.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.195 0.521 . . . . 0.0 111.694 -174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.441 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.0 tt0 -96.79 143.25 27.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.232 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.659 ' HD1' ' CD2' ' A' ' 98' ' ' PHE . 35.4 m-85 -103.6 87.53 2.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.154 0.502 . . . . 0.0 110.456 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.644 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 89.7 t80 -88.11 136.71 32.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.115 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.426 ' OG1' HG23 ' A' ' 143' ' ' VAL . 6.6 m -105.7 123.64 48.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.338 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 142' ' ' GLN . 1.2 m -72.16 135.06 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.277 0.561 . . . . 0.0 109.633 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.438 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 75.2 mmtt -86.92 -165.29 1.25 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.154 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.3 m -55.45 -55.21 34.37 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.862 -173.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.13 26.53 20.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.818 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 7.9 m-20 -82.11 111.51 18.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.149 0.499 . . . . 0.0 111.111 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.551 ' O ' HG21 ' A' ' 110' ' ' ILE . 22.7 p -101.06 164.42 11.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.217 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 125' ' ' PHE . 18.2 tp -63.37 -36.49 83.88 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.165 -174.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -67.16 -35.83 80.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.958 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.85 -41.73 67.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.037 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.635 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -78.34 -24.3 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.622 -176.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 p -73.28 -40.63 64.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.405 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 27.4 ttpp -61.86 -21.92 65.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.292 0.568 . . . . 0.0 110.145 171.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.885 HE21 ' HH ' ' A' ' 99' ' ' TYR . 1.1 tp-100 -75.44 -63.86 1.19 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.8 176.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.438 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.4 m -76.76 -43.0 33.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.192 -170.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.491 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 19.7 m-85 -92.96 -32.36 14.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.933 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 99.1 -4.62 58.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.192 -176.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.51 ' OD1' ' HG ' ' A' ' 120' ' ' LEU . 24.1 t-20 -126.59 121.99 33.78 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.495 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -77.12 -18.42 57.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -78.67 -14.45 59.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.146 0.498 . . . . 0.0 110.339 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.51 ' HG ' ' OD1' ' A' ' 117' ' ' ASN . 78.4 mt -84.62 14.99 4.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.582 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' A' ' 118' ' ' ALA . 38.8 p90 -63.08 -30.69 71.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.864 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.517 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 15.9 m120 -64.9 -32.76 74.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -61.12 -48.4 81.84 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.391 0.615 . . . . 0.0 110.187 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.06 -36.28 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.368 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.446 ' HB2' HD22 ' A' ' 107' ' ' LEU . 83.3 t80 -56.23 -53.82 52.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.406 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 26.6 mt-10 -70.72 -17.03 62.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.281 -175.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -84.86 -10.0 57.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.032 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.6 ' HB3' ' HE3' ' A' ' 131' ' ' MET . 29.6 m-80 -115.1 25.65 10.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.203 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 11.1 mmmm -86.31 150.21 51.31 Favored Pre-proline 0 C--N 1.326 -0.424 0 O-C-N 122.158 -0.339 . . . . 0.0 110.402 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.494 ' HD2' HD11 ' A' ' 40' ' ' ILE . 10.0 Cg_endo -95.87 15.99 37.75 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.441 -1.066 . . . . 0.0 111.969 -6.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.6 ' HE3' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -70.2 -14.71 62.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.222 178.349 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.67 124.21 49.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 168.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -99.43 -42.09 7.11 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.757 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.447 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 14.7 m -149.56 147.96 24.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.19 0.519 . . . . 0.0 109.786 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.63 -19.91 65.08 Favored 'Trans proline' 0 C--N 1.336 -0.129 0 C-N-CA 123.714 2.943 . . . . 0.0 112.851 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -96.88 -8.24 31.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.371 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 36.7 mmtm -91.44 9.13 33.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 106' ' ' THR . 10.3 pt -69.51 174.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.016 169.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -162.2 148.12 10.49 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.69 116.92 2.36 Favored 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.226 2.617 . . . . 0.0 112.136 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.99 14.32 23.11 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.1 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.495 ' O ' HG11 ' A' ' 101' ' ' VAL . 1.7 mm100 -86.5 108.71 18.66 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.16 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.426 HG23 ' OG1' ' A' ' 100' ' ' THR . 41.7 t -79.8 125.06 38.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 172.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.2 mt -118.96 140.17 50.45 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.81 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 35.6 ttt180 -74.74 111.54 10.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.544 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 33.3 mm -97.67 102.93 14.47 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.006 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 25.5 Cg_exo -63.13 145.76 93.9 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.55 2.167 . . . . 0.0 111.67 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.492 177.171 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.448 HD11 ' C ' ' A' ' 83' ' ' VAL . 19.4 tp . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 121.491 0.662 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 1.635 ' HE2' ' CE1' ' A' ' 4' ' ' PHE . 90.0 m-85 -93.88 140.71 29.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.039 174.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -92.19 124.89 36.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.846 0.355 . . . . 0.0 110.81 -176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.619 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 57.1 m-85 -110.41 -164.16 0.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.784 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 7.3 p -82.8 -28.26 8.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -173.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 22.2 tptm 76.44 -60.4 0.48 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.218 0.607 . . . . 0.0 111.33 -175.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.26 -42.62 36.38 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.522 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -84.22 179.05 7.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.034 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.2 -168.89 12.69 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' A' ' 14' ' ' LEU . 4.8 tp10 -60.19 122.87 15.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -77.68 64.75 3.03 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.257 1.027 . . . . 0.0 109.216 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.504 HD11 ' HG2' ' A' ' 12' ' ' GLU . 11.7 tp . . . . . 0 N--CA 1.438 -1.066 0 CA-C-N 113.571 -1.65 . . . . 0.0 110.383 -174.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -57.89 -45.49 86.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.379 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.78 78.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.115 0.483 . . . . 0.0 110.734 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -70.93 -45.21 64.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.562 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' C ' HD22 ' A' ' 14' ' ' LEU . 30.1 mmtp -58.77 -39.38 80.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.397 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 98.1 t -64.81 -36.28 77.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.735 0.302 . . . . 0.0 110.372 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.412 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 25.6 mm-40 -64.4 -46.98 80.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.906 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.71 -38.71 78.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.246 0.546 . . . . 0.0 109.922 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -60.32 -40.47 90.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.381 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 95.9 mt -71.13 -38.79 72.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.244 0.545 . . . . 0.0 110.888 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -76.72 -32.41 57.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.487 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -75.33 -23.82 57.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.082 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -83.77 -32.72 25.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.288 0.566 . . . . 0.0 110.541 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.07 35.69 4.71 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.753 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.5 mm -74.75 126.19 88.74 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -71.59 144.89 45.7 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.079 1.853 . . . . 0.0 112.596 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 59.37 23.84 12.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.418 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.89 -42.6 73.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 -177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.64 -0.52 34.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.924 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -88.92 -11.23 45.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.014 0.435 . . . . 0.0 110.242 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.26 157.26 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.288 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -106.44 130.33 54.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.854 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.412 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 34.4 mm -90.54 135.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.337 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 27.0 mt-30 -132.86 140.34 47.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.956 175.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mm -118.35 120.65 65.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.48 60.46 1.01 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.068 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 53.68 76.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.039 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 86.59 20.72 53.55 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.641 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 82' ' ' SER . 3.1 ttmp? -146.69 124.21 11.73 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 122.682 -0.305 . . . . 0.0 110.479 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.483 ' O ' HG11 ' A' ' 83' ' ' VAL . . . -104.79 91.53 3.88 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.783 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.436 HG21 ' HB3' ' A' ' 84' ' ' ASP . 58.7 m -80.41 109.42 14.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.151 0.501 . . . . 0.0 109.899 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 12.2 p -93.83 136.87 24.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.124 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.406 HG21 ' HB3' ' A' ' 86' ' ' GLN . 1.4 m -132.01 157.17 44.82 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.0 171.62 29.48 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -155.15 144.52 21.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.873 0.368 . . . . 0.0 110.803 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.25 18.19 31.97 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.165 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.36 178.24 4.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.993 0.425 . . . . 0.0 111.265 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -111.68 170.28 8.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.959 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.548 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 47.8 tp60 -57.47 -53.57 56.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.448 ' HG3' ' NH1' ' A' ' 145' ' ' ARG . 39.5 tt0 -57.33 -49.37 76.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.175 -174.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.01 -49.12 77.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.688 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 41.6 tttp -45.94 -52.81 10.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.45 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.592 ' O ' HG21 ' A' ' 72' ' ' VAL . 53.7 mt-10 -74.79 -28.55 60.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.937 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 65' ' ' GLU . 13.4 tptm -63.32 -42.74 99.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.407 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.06 -49.65 80.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 77.3 mt -48.41 -47.42 37.84 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.164 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.592 HG21 ' O ' ' A' ' 68' ' ' GLU . 39.7 t -66.2 -52.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.308 0.575 . . . . 0.0 111.1 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.31 -30.35 70.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.565 -172.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -83.43 -23.15 8.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.061 0.457 . . . . 0.0 111.234 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.619 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -78.01 -33.06 42.28 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.821 176.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -80.15 61.28 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.716 0.293 . . . . 0.0 110.812 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.552 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 23.3 mm -122.51 132.71 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 t -65.22 101.81 0.59 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 173.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.417 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 126.8 -17.37 6.4 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.645 -172.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.552 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 39.2 mm -102.14 121.11 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.292 0.568 . . . . 0.0 110.822 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -98.86 -33.97 10.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.704 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 25.4 m -147.24 160.34 42.6 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.483 HG11 ' O ' ' A' ' 55' ' ' ALA . 55.7 t -132.34 121.72 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.671 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.436 ' HB3' HG21 ' A' ' 56' ' ' THR . 10.5 t70 -97.58 106.53 18.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.267 0.556 . . . . 0.0 109.597 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.98 115.64 9.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.034 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 26.7 mt-30 -125.86 35.05 4.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.305 171.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.02 118.86 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.959 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -86.4 131.88 34.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.824 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.6 p -104.39 120.81 42.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.056 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.88 -25.14 43.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.73 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -127.94 127.37 23.9 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.884 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.25 155.92 10.99 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.078 2.519 . . . . 0.0 112.25 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 64' ' ' GLN . . . -160.27 -157.97 0.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.463 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -71.81 121.09 18.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.875 0.369 . . . . 0.0 111.231 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.35 146.46 27.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.697 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.8 m -123.22 157.97 31.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.66 0.743 . . . . 0.0 112.258 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -96.46 155.38 16.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.278 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.584 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 90.7 m-85 -113.52 96.08 5.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.873 0.368 . . . . 0.0 110.776 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.663 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 90.3 t80 -96.23 142.63 28.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.453 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.426 ' OG1' HG23 ' A' ' 143' ' ' VAL . 3.8 m -109.13 120.86 43.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.517 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.3 m -72.21 139.89 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.7 mmtp -109.76 -165.9 1.05 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.002 0.429 . . . . 0.0 111.257 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 m -67.55 114.69 6.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.63 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.85 13.13 57.08 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.973 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 11.5 m-20 -94.48 123.53 37.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.346 0.593 . . . . 0.0 110.837 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.537 ' O ' HG21 ' A' ' 110' ' ' ILE . 24.7 p -111.39 155.85 22.51 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.346 174.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 2.3 pt? -55.52 -36.59 66.89 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.409 -176.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.522 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 m -66.32 -44.78 82.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.683 0.278 . . . . 0.0 110.804 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.32 -42.33 96.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.039 0.447 . . . . 0.0 110.831 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.598 ' HB ' ' CE2' ' A' ' 99' ' ' TYR . 1.4 pp -76.17 -25.11 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.3 t -66.0 -45.06 82.94 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -58.95 -33.77 71.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.345 0.593 . . . . 0.0 109.678 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.859 HE21 ' HH ' ' A' ' 99' ' ' TYR . 1.1 tp-100 -65.75 -56.82 10.0 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.53 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -86.3 -47.85 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.442 -171.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.463 ' N ' HG21 ' A' ' 114' ' ' VAL . 54.2 m-85 -82.48 -37.99 24.55 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.183 0.516 . . . . 0.0 110.695 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 106.92 -14.06 41.15 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -129.33 128.36 42.97 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.516 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -72.39 -24.9 61.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.747 -175.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -74.07 -0.19 15.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 0.0 111.92 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.3 mt -96.13 15.68 20.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.149 0.499 . . . . 0.0 110.764 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 53.6 p90 -62.83 -27.46 69.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.137 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.554 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 4.6 p30 -67.0 -35.2 79.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.869 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -60.07 -31.67 70.23 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.425 0.631 . . . . 0.0 110.059 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.575 HG23 ' OD1' ' A' ' 128' ' ' ASN . 39.3 mt -79.17 -52.09 15.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.448 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.411 ' CE2' ' HD3' ' A' ' 129' ' ' LYS . 76.6 t80 -49.76 -48.83 50.05 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.085 0.469 . . . . 0.0 111.355 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 42.6 mt-10 -63.63 -25.9 68.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.402 ' O ' ' HE3' ' A' ' 69' ' ' LYS . . . -94.77 -10.22 32.22 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.761 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.757 ' O ' ' HG3' ' A' ' 131' ' ' MET . 8.9 m120 -94.54 -43.97 8.08 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 126' ' ' GLU . 40.6 pttt -60.03 147.36 80.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.416 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -90.56 11.5 58.48 Favored 'Cis proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.554 -1.436 . . . . 0.0 114.574 6.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.757 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -81.05 -7.57 59.59 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.481 0.658 . . . . 0.0 110.297 174.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.451 ' HB3' ' CB ' ' A' ' 128' ' ' ASN . 12.9 tp -132.84 112.06 11.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.827 166.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.07 -26.5 20.23 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 25.5 m -151.49 153.82 32.69 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.353 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -53.17 -48.55 21.46 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 C-N-CA 123.197 2.598 . . . . 0.0 112.397 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -82.27 6.91 15.3 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.893 -175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 134' ' ' SER . 37.8 mmtm -89.79 -4.62 57.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.577 0.227 . . . . 0.0 111.441 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.637 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 15.8 pt -63.02 171.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 174.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -163.11 147.94 9.25 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.099 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -51.11 104.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.213 2.609 . . . . 0.0 112.251 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.472 ' O ' HG13 ' A' ' 7' ' ' VAL . . . 112.08 35.19 1.85 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.218 -177.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.637 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 45.8 tt0 -117.13 121.96 42.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.881 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 48.6 t -80.16 136.05 24.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.963 174.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.0 mt -124.31 145.18 49.57 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.067 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.542 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 37.3 ttt180 -73.51 117.06 14.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.593 176.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.7 88.66 4.5 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.961 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 24.7 Cg_exo -63.83 166.47 15.98 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.361 2.041 . . . . 0.0 111.927 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--N 1.321 -0.653 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.704 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 1.659 ' HD2' ' CD1' ' A' ' 4' ' ' PHE . 82.1 m-85 -103.7 134.49 46.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.592 -176.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -96.06 132.57 41.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.732 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.487 ' CD2' HG22 ' A' ' 143' ' ' VAL . 50.2 m-85 -124.6 179.91 4.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.188 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.8 t -97.3 107.5 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 59.1 tttm -56.5 -51.74 67.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.337 -170.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.54 -12.81 61.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.026 0.441 . . . . 0.0 111.037 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 78' ' ' SER . . . -92.82 -164.06 1.13 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.528 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.94 -173.05 44.61 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.923 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.51 125.27 25.62 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -73.52 66.95 1.04 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.201 1.001 . . . . 0.0 109.541 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.438 HD22 ' O ' ' A' ' 30' ' ' LYS . 11.7 tp . . . . . 0 N--CA 1.439 -1.014 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.765 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 33.5 t70 . . . . . 0 C--O 1.23 0.063 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.568 ' O ' HG21 ' A' ' 31' ' ' VAL . 7.0 mm100 -60.37 -41.75 94.4 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.62 -43.2 65.25 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.926 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.3 tttm -64.2 -44.11 92.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.064 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.438 ' O ' HD22 ' A' ' 14' ' ' LEU . 73.2 mmtt -61.85 -40.92 97.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.112 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.568 HG21 ' O ' ' A' ' 27' ' ' GLN . 92.2 t -62.52 -45.1 99.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.355 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.53 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 7.8 mm-40 -55.96 -46.41 78.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.615 173.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 50.4 mt-10 -55.74 -47.39 77.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.349 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -54.78 -45.84 74.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.326 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 80.3 mt -68.0 -35.52 78.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.968 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -73.43 -34.49 65.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.897 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 98.7 mttt -69.11 -46.12 68.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.131 178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.8 p -64.29 -34.14 77.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.099 0.476 . . . . 0.0 110.764 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.53 34.39 4.45 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.503 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.424 ' HB ' ' CB ' ' A' ' 43' ' ' ALA . 7.8 mm -80.31 116.34 61.02 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.25 -49.08 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.958 2.439 . . . . 0.0 113.346 -171.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.44 -5.99 54.03 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.428 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.424 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -72.72 -17.89 61.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.326 0.584 . . . . 0.0 110.149 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.09 -14.62 59.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.891 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.52 -0.76 37.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.21 -172.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -117.3 162.57 15.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.148 0.499 . . . . 0.0 111.216 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.33 138.2 42.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.043 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.53 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 31.2 mm -100.37 130.26 49.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.631 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.477 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 98.4 mt-30 -129.98 136.27 49.24 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 172.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.25 119.37 59.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.022 0.439 . . . . 0.0 111.167 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 54' ' ' LYS . . . -100.46 59.53 0.98 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 172.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 70.15 -65.56 0.31 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.712 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 -17.62 6.49 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.246 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 40.7 ttmt -97.85 121.51 39.84 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.078 0.466 . . . . 0.0 110.718 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -100.38 114.62 28.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.078 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 47.3 m -92.9 123.81 36.43 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.836 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.02 125.16 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.813 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -131.59 143.34 50.27 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.479 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.9 174.56 36.93 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -146.56 149.64 33.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.874 0.337 . . . . 0.0 110.325 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.4 22.69 53.49 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.263 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 89' ' ' THR . 7.0 mp -99.07 176.18 5.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.847 0.356 . . . . 0.0 110.42 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.6 p -113.24 154.21 27.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.162 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.642 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 2.3 mm100 -51.27 -47.61 62.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.469 ' H ' ' HB1' ' A' ' 93' ' ' ALA . 7.4 tp10 -53.19 -48.6 67.94 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 111.051 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.19 -43.14 71.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.667 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.428 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 28.0 tttm -54.07 -45.22 71.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.735 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 6.1 mm-40 -60.72 -36.65 79.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.35 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -63.6 -40.09 96.06 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.6 mm -60.34 -54.6 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 88.8 mt -52.6 -39.47 61.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.824 -1.535 . . . . 0.0 112.224 -174.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 68' ' ' GLU . 42.9 t -76.74 -51.92 18.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.038 0.447 . . . . 0.0 110.878 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.53 72.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.716 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.487 HG22 HG12 ' A' ' 31' ' ' VAL . 9.1 p -80.47 -30.03 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.069 0.462 . . . . 0.0 110.849 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.33 -32.8 27.38 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.148 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.08 60.88 3.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 111.493 -178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.43 139.64 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.427 173.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 23.5 m -66.06 112.47 3.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.723 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.5 -28.09 5.59 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -173.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 46.0 mm -89.12 126.2 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.254 0.55 . . . . 0.0 110.475 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.94 -28.49 9.56 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.485 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.8 m -156.54 160.72 39.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.474 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 55.0 t -127.99 129.52 69.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.61 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -98.09 103.85 15.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.711 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -78.13 114.17 16.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.291 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -132.26 18.9 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.615 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.56 115.15 27.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.451 0.643 . . . . 0.0 110.825 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -73.68 133.49 43.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.197 -175.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 12.4 p -99.54 110.28 22.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.587 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.66 -21.58 38.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.655 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 34.0 p -128.58 143.95 50.31 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 6.2 Cg_exo -77.38 140.28 19.23 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.296 2.664 . . . . 0.0 111.857 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.469 ' HB1' ' H ' ' A' ' 65' ' ' GLU . . . -162.14 -166.63 1.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.974 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 7.7 m -58.77 132.99 55.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.85 129.74 55.4 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 168.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.6 m -114.32 147.59 38.87 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.09 0.471 . . . . 0.0 111.67 -171.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.479 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 5.0 tt0 -80.5 136.17 36.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.597 ' HE1' ' CE2' ' A' ' 98' ' ' PHE . 90.7 m-85 -99.6 100.39 11.39 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.084 0.469 . . . . 0.0 110.471 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.633 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 92.0 t80 -100.93 136.95 39.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.621 176.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.487 ' OG1' HG23 ' A' ' 143' ' ' VAL . 16.9 m -106.22 124.84 50.21 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.95 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.525 HG23 ' H ' ' A' ' 142' ' ' GLN . 1.5 m -67.88 126.33 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -75.81 -56.89 4.24 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.289 -167.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.434 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 10.7 t -167.23 -71.05 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.773 0.32 . . . . 0.0 110.373 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.15 45.45 3.51 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.483 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 2.2 m-20 -103.06 143.1 33.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.119 0.485 . . . . 0.0 110.448 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.58 ' O ' HG21 ' A' ' 110' ' ' ILE . 61.6 p -122.11 159.58 26.84 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.827 173.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.517 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 30.9 tp -61.45 -36.88 81.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 118.506 0.593 . . . . 0.0 110.221 -174.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 p -69.79 -33.02 71.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.189 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.4 -43.69 59.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.969 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.58 HG21 ' O ' ' A' ' 106' ' ' THR . 1.3 pp -74.82 -25.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.18 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.3 p -71.42 -43.06 67.47 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.182 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -65.82 -23.95 66.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 110.393 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.577 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.0 OUTLIER -66.28 -52.85 43.33 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.167 175.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.448 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.1 m -89.99 -40.87 13.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.259 -171.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.448 ' N ' HG21 ' A' ' 114' ' ' VAL . 55.5 m-85 -88.9 -38.49 14.5 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.96 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.56 -8.02 59.91 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -169.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -124.42 125.95 45.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.64 -0.78 . . . . 0.0 109.576 -174.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.33 -8.76 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.308 . . . . 0.0 111.622 -175.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -76.52 -20.27 57.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.352 0.596 . . . . 0.0 109.754 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 50.7 mt -84.25 18.55 2.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.342 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.517 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 34.8 p90 -66.61 -33.75 76.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.349 0.595 . . . . 0.0 109.454 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -68.4 -35.26 77.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.267 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 27.7 mmmt -52.27 -54.52 30.29 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.611 0.72 . . . . 0.0 110.189 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.2 mt -63.2 -36.93 77.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.588 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.49 ' CE1' ' HA ' ' A' ' 134' ' ' SER . 30.8 t80 -61.54 -56.35 20.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.746 0.308 . . . . 0.0 110.734 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.64 -37.31 83.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.159 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.83 -31.26 70.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.928 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.578 ' HB3' ' HE3' ' A' ' 131' ' ' MET . 33.7 m-80 -93.18 8.69 39.14 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.366 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 9.1 mtpm? -84.9 153.83 60.68 Favored Pre-proline 0 C--N 1.318 -0.794 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.882 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -91.87 11.81 55.65 Favored 'Cis proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.946 -1.689 . . . . 0.0 112.752 -0.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.578 ' HE3' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -69.28 -24.38 63.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.708 0.289 . . . . 0.0 111.476 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.4 tp -98.48 121.68 40.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -74.68 -54.38 7.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.654 -172.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.49 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 49.5 m -156.44 157.66 31.12 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.722 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.8 -56.53 3.01 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 124.002 3.135 . . . . 0.0 113.889 -175.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.6 3.9 26.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 137' ' ' LYS . 13.7 mmmm -91.92 7.82 40.27 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 120.886 0.374 . . . . 0.0 111.414 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 106' ' ' THR . 19.1 pt -66.59 169.16 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.354 171.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 1.638 ' HE2' ' CE1' ' A' ' 139' ' ' TYR . 34.9 p90 -163.75 148.1 8.6 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.434 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 63.6 Cg_exo -46.13 120.47 3.67 Favored 'Trans proline' 0 CA--C 1.519 -0.267 0 C-N-CA 123.183 2.589 . . . . 0.0 112.621 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.554 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 94.21 24.68 18.64 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.297 -176.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.525 ' H ' HG23 ' A' ' 101' ' ' VAL . 7.3 tp60 -97.79 111.56 23.81 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.487 HG22 ' CD2' ' A' ' 6' ' ' PHE . 46.1 t -77.66 135.86 25.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.2 mt -130.9 137.59 49.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.829 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.451 ' HG2' HG23 ' A' ' 72' ' ' VAL . 25.4 mtm180 -69.1 123.31 20.72 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.083 174.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 24.9 mm -103.87 95.02 7.05 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.16 148.13 49.54 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.311 2.008 . . . . 0.0 111.799 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.489 -179.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.1 tp . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -105.99 129.18 54.17 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.597 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -99.32 134.8 41.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.548 0.69 . . . . 0.0 112.002 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 33.0 m-85 -121.19 -166.16 1.32 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.672 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.584 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 94.6 t -78.09 -83.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.571 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.3 tmtp? 163.53 -77.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.969 0.793 . . . . 0.0 109.167 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.42 ' H ' ' HB3' ' A' ' 8' ' ' LYS . 22.5 t70 -76.4 -25.49 54.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.711 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.34 125.15 28.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.497 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.43 -172.35 32.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.737 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -69.62 131.07 44.07 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -78.55 66.25 4.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.199 0.999 . . . . 0.0 108.84 173.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.532 HD22 ' O ' ' A' ' 30' ' ' LYS . 16.1 tp . . . . . 0 N--CA 1.44 -0.96 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.902 -172.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.903 0.382 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -58.92 -38.36 78.78 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.884 174.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 48' ' ' ILE . . . -56.99 -45.93 82.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.707 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 60.0 tttp -67.34 -39.47 85.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.532 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -53.08 -47.64 68.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 110.554 175.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.558 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 86.9 t -65.62 -39.57 85.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.825 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.51 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -60.02 -44.2 94.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.274 -0.171 . . . . 0.0 110.558 174.011 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 66.5 mm-40 -54.86 -49.27 71.54 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.193 0.521 . . . . 0.0 110.315 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -55.04 -33.07 62.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.603 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 79.5 mt -81.87 -44.59 16.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.061 0.458 . . . . 0.0 110.989 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -69.14 -35.02 75.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.64 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -77.36 -31.54 54.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.568 0.223 . . . . 0.0 111.467 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -76.63 -39.28 52.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.676 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.92 28.64 4.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.222 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.5 mm -62.61 130.7 93.76 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.1 130.83 23.7 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.234 1.956 . . . . 0.0 112.679 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 62.63 12.08 5.27 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.253 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 35' ' ' LEU . . . -71.64 -17.41 62.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.381 0.61 . . . . 0.0 110.796 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.01 -22.08 39.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.491 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -84.61 -23.65 29.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.168 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.32 177.59 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.61 129.77 25.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.086 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 3.2 mp -96.57 131.01 44.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -126.12 118.35 25.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.0 110.426 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.7 mm -89.33 132.7 33.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.514 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.11 -81.42 0.61 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.375 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -152.42 101.81 2.7 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.66 13.23 50.53 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 82' ' ' SER . 34.7 mtmm -133.2 124.44 27.43 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 120.844 0.354 . . . . 0.0 111.113 -174.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.38 104.77 14.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.498 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 m -82.58 113.88 20.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.322 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG21 HG13 ' A' ' 48' ' ' ILE . 62.9 t -100.62 113.46 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-O 121.089 0.471 . . . . 0.0 110.711 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -110.26 158.66 18.16 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.075 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.6 157.65 8.29 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.23 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -137.08 151.47 48.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 90' ' ' ALA . . . 86.85 38.55 7.96 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.98 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.2 163.93 18.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 0.0 111.201 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 m -106.01 151.21 24.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.54 173.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.584 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 11.2 mm100 -49.15 -48.23 45.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.33 -41.56 80.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 70' ' ' ILE . . . -72.55 -42.31 64.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.259 0.552 . . . . 0.0 109.936 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.462 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 50.1 tttm -55.26 -51.66 65.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.48 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 4.9 mm-40 -67.89 -28.87 67.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.3 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -65.43 -37.25 86.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.148 0.499 . . . . 0.0 109.989 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 66' ' ' ALA . 43.6 mt -70.09 -55.52 14.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.14 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 78.5 mt -50.06 -44.18 51.55 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.405 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.17 -34.55 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.964 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.57 -27.14 34.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.658 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.7 m -84.82 -22.5 7.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.223 0.535 . . . . 0.0 110.768 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -79.89 -35.51 27.76 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.32 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -79.91 55.84 2.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.025 0.44 . . . . 0.0 111.187 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.409 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 11.2 mm -118.67 138.13 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 t -68.21 92.07 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.241 0.543 . . . . 0.0 109.95 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.1 -19.93 3.05 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.409 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 48.2 mm -97.16 131.59 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.254 0.55 . . . . 0.0 110.026 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.456 ' HB3' ' HG2' ' A' ' 8' ' ' LYS . . . -124.27 -3.37 7.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.755 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -164.78 147.2 8.38 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.225 -179.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.25 122.79 69.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.782 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.51 92.05 7.41 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.28 123.08 20.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.508 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -126.49 14.65 7.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.053 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -73.92 118.54 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.12 0.486 . . . . 0.0 109.776 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -89.14 4.94 46.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.267 -170.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 90' ' ' ALA . 32.0 p 44.95 -153.92 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.765 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.477 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . . . -173.29 -41.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -118.16 131.97 23.95 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.564 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.8 144.34 48.21 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.868 2.379 . . . . 0.0 112.434 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 64' ' ' GLN . . . -158.74 -178.46 7.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.222 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.2 m -66.72 126.21 28.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.142 0.496 . . . . 0.0 111.258 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.53 164.47 20.85 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.8 m -121.37 145.13 48.21 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.622 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.448 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.5 tt0 -84.77 140.96 30.86 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -110.19 102.95 11.59 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.027 0.441 . . . . 0.0 110.504 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.599 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 76.9 t80 -106.27 133.52 50.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.011 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.441 ' OG1' HG23 ' A' ' 143' ' ' VAL . 7.8 m -100.02 122.46 42.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.346 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.514 HG23 ' H ' ' A' ' 142' ' ' GLN . 1.7 m -71.21 136.3 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -84.44 -163.9 0.87 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.451 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 1.6 p -60.33 -64.51 0.93 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.97 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.87 46.67 2.48 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.194 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.501 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 7.4 m-20 -104.79 127.81 52.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.131 0.491 . . . . 0.0 110.92 -177.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.539 ' O ' HG21 ' A' ' 110' ' ' ILE . 40.6 m -114.93 153.06 31.23 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.929 177.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 29.1 tp -51.97 -49.98 62.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.785 0.266 . . . . 0.0 111.63 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.44 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 m -66.66 -27.09 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.214 0.531 . . . . 0.0 111.156 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -73.33 -40.64 64.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.811 0.339 . . . . 0.0 110.375 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.539 HG21 ' O ' ' A' ' 106' ' ' THR . 1.2 pp -79.71 -25.29 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.106 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.3 p -70.28 -38.67 75.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.032 0.444 . . . . 0.0 109.824 173.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.429 ' HD3' ' O ' ' A' ' 112' ' ' LYS . 5.6 tmtm? -58.71 -35.84 73.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.449 173.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 13.6 mm100 -59.72 -65.05 0.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 122.241 1.02 . . . . 0.0 111.267 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -81.97 -37.47 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 113.679 -1.6 . . . . 0.0 112.643 -165.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.493 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 55.5 m-85 -89.58 -45.25 9.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.292 0.568 . . . . 0.0 110.65 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.86 -14.72 26.58 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.474 ' HB3' ' HG ' ' A' ' 120' ' ' LEU . 56.7 t-20 -123.19 121.71 36.61 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.85 62.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.619 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.422 ' C ' ' H ' ' A' ' 121' ' ' TYR . 25.2 t-20 -65.64 -21.63 66.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.07 0.462 . . . . 0.0 110.765 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.495 HD11 ' HE2' ' A' ' 123' ' ' LYS . 42.2 mt -79.78 29.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.703 -176.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.457 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 50.1 p90 -72.17 -35.27 68.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.166 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -71.05 -31.82 68.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.948 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.495 ' HE2' HD11 ' A' ' 120' ' ' LEU . 22.0 mtmt -52.44 -44.78 65.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.365 0.602 . . . . 0.0 110.439 173.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.4 HG23 ' OD1' ' A' ' 128' ' ' ASN . 46.2 mt -70.1 -44.67 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.278 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -52.97 -47.81 67.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.655 0.264 . . . . 0.0 111.043 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -66.03 -29.98 70.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.402 . . . . 0.0 110.908 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.07 -25.11 40.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.364 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.511 ' O ' ' HB3' ' A' ' 131' ' ' MET . 7.0 m120 -84.75 -41.87 15.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.106 0.479 . . . . 0.0 109.715 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.477 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 18.6 pttp -64.62 155.99 79.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.595 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 92.7 Cg_endo -81.97 17.69 18.8 Favored 'Cis proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.436 -1.485 . . . . 0.0 113.448 2.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.511 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -74.49 -36.27 63.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.874 0.368 . . . . 0.0 110.32 174.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.1 tp -88.95 126.81 35.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.014 0.435 . . . . 0.0 109.867 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -88.09 -38.77 15.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.426 -173.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.1 m -153.56 153.09 28.58 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.36 -18.41 38.92 Favored 'Trans proline' 0 C--O 1.23 0.089 0 C-N-CA 123.54 2.827 . . . . 0.0 112.312 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -101.95 -5.67 24.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.807 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -86.28 10.19 15.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.469 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 106' ' ' THR . 9.0 pt -62.88 173.69 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.189 170.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.557 ' CE1' ' HG2' ' A' ' 142' ' ' GLN . 5.9 p90 -166.19 150.85 7.34 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -175.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.453 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 84.9 Cg_exo -49.57 102.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.258 2.639 . . . . 0.0 112.656 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.33 23.53 5.12 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.473 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.557 ' HG2' ' CE1' ' A' ' 139' ' ' TYR . 0.5 OUTLIER -91.33 109.78 21.07 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.441 HG23 ' OG1' ' A' ' 100' ' ' THR . 39.3 t -80.58 122.2 35.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.448 0.642 . . . . 0.0 110.052 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.428 HD23 ' OD1' ' A' ' 128' ' ' ASN . 75.6 mt -117.39 139.91 50.26 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.863 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.434 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 48.4 mtp180 -69.79 119.09 13.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.084 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 31.7 mm -105.32 98.49 16.73 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.493 ' HD2' ' OH ' ' A' ' 115' ' ' TYR . 47.9 Cg_exo -56.64 154.04 32.96 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.827 2.351 . . . . 0.0 111.706 175.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--N 1.32 -0.706 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.21 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.7 tp . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.047 0.451 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -100.73 125.2 47.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.044 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -103.3 140.59 37.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.828 0.346 . . . . 0.0 110.648 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.447 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 73.5 m-85 -126.24 -161.14 1.03 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.751 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.61 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 7.3 p -79.75 -25.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 16.9 tptm 79.06 -66.26 0.19 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.488 0.715 . . . . 0.0 112.003 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.97 -36.01 36.73 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.742 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.61 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -79.17 152.17 30.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.498 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.65 -172.24 24.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.112 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -62.89 128.77 37.43 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.54 65.62 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.038 0.923 . . . . 0.0 108.969 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 30' ' ' LYS . 11.2 tp . . . . . 0 N--CA 1.436 -1.129 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.161 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.977 0.418 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.43 ' OE1' HG22 ' A' ' 50' ' ' ILE . 98.9 mt-30 -65.04 -30.22 71.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.055 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.33 89.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.503 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 87.7 tttt -68.32 -36.84 79.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.177 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' O ' HD22 ' A' ' 14' ' ' LEU . 3.2 mptp? -58.63 -43.07 89.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.423 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.58 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 95.3 t -64.2 -44.61 97.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.218 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -52.25 -50.36 62.22 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.693 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 48.6 mt-10 -56.16 -51.66 67.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.181 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -53.72 -42.68 68.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.331 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 93.0 mt -70.13 -41.04 74.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.53 -39.48 67.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.189 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 74.6 mmtt -63.98 -36.86 85.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.152 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 p -78.74 -38.81 37.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.141 0.496 . . . . 0.0 110.868 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.41 31.95 4.43 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.998 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.2 mm -63.2 127.35 90.87 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -59.78 130.56 35.56 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.484 2.123 . . . . 0.0 112.729 -175.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.28 26.5 15.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.198 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.94 -17.15 64.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.192 0.52 . . . . 0.0 110.718 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -84.18 -16.25 44.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.639 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -86.04 -35.09 20.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.998 0.428 . . . . 0.0 110.363 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.2 m -83.73 166.25 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.554 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -134.33 131.05 37.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.542 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 mp -108.23 139.16 31.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.636 0.255 . . . . 0.0 110.652 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -123.89 140.8 52.63 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 172.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.43 HG22 ' OE1' ' A' ' 27' ' ' GLN . 11.1 mm -118.14 133.05 66.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.9 0.381 . . . . 0.0 111.107 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.28 91.86 2.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.894 174.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.4 t70 65.9 -75.82 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.829 0.705 . . . . 0.0 111.215 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.38 6.2 4.6 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -98.68 110.88 23.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.809 0.338 . . . . 0.0 110.235 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -103.51 106.44 16.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.028 176.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.5 m -92.72 115.97 28.59 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.638 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.91 120.46 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.083 0.468 . . . . 0.0 110.295 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.22 160.47 21.54 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.09 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.21 178.3 28.48 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 6.3 p-10 -167.51 155.12 8.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.908 0.385 . . . . 0.0 110.513 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.34 15.99 63.27 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.145 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -95.56 -167.69 1.65 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.658 0.742 . . . . 0.0 110.723 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -124.19 152.27 43.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.241 -1.345 . . . . 0.0 108.658 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.504 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 51.7 tt0 -58.18 -42.02 85.18 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -166.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.54 -48.83 71.53 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.611 0.243 . . . . 0.0 111.374 -176.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.84 75.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.216 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.533 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 49.7 tttp -49.35 -53.43 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.452 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.651 ' O ' HG21 ' A' ' 72' ' ' VAL . 54.1 mt-10 -62.03 -48.01 82.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -59.98 -38.48 82.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.495 ' O ' HG13 ' A' ' 74' ' ' VAL . 57.8 mt -62.02 -56.1 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.085 174.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 91.0 mt -49.16 -42.11 38.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.105 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.651 HG21 ' O ' ' A' ' 68' ' ' GLU . 40.9 t -72.7 -44.63 59.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.902 0.382 . . . . 0.0 110.957 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.12 -35.58 81.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 70' ' ' ILE . 11.3 p -79.15 -26.83 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.328 0.585 . . . . 0.0 110.423 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.447 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -77.02 -11.82 85.22 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.535 173.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.529 ' OD1' ' HG3' ' A' ' 142' ' ' GLN . 5.8 m-80 -97.64 39.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.725 -0.238 . . . . 0.0 110.714 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.472 ' HB ' HG12 ' A' ' 80' ' ' ILE . 10.8 mm -115.44 132.38 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.4 t -65.46 99.25 0.41 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.4 -15.66 3.9 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.025 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 43.2 mm -96.78 121.65 47.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.157 0.503 . . . . 0.0 111.069 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.577 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -96.75 -37.19 10.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.393 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 p -150.87 154.2 36.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.456 0.646 . . . . 0.0 111.612 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 53.0 t -117.71 122.77 70.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.587 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -91.78 93.37 8.83 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -71.78 112.51 7.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.157 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -128.06 14.77 6.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.544 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 p -93.62 129.7 43.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.189 0.519 . . . . 0.0 111.4 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -96.77 158.22 15.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.068 -177.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.5 p -124.58 136.45 53.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.431 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.98 -28.07 16.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.608 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 p -123.07 138.89 30.5 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.852 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.53 160.16 28.63 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.785 2.323 . . . . 0.0 111.664 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.06 -167.31 2.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.938 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 88.4 m -57.95 138.7 55.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.476 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -108.01 125.25 51.31 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.347 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.1 m -110.69 146.49 36.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.424 0.63 . . . . 0.0 111.286 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.437 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 15.8 tt0 -87.86 138.82 31.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.772 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.582 ' HD1' ' CD2' ' A' ' 98' ' ' PHE . 90.7 m-85 -98.13 94.09 6.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.12 0.486 . . . . 0.0 110.699 -175.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.667 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 92.1 t80 -95.74 136.3 36.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.044 177.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.483 ' OG1' HG23 ' A' ' 143' ' ' VAL . 7.5 m -106.66 122.9 47.27 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.54 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -67.82 128.55 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -82.13 -57.9 3.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.861 -167.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' A' ' 140' ' ' PRO . 12.0 p -156.98 -87.61 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.112 -176.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.97 49.83 2.93 Favored Glycine 0 C--N 1.329 0.19 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.54 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -97.46 120.05 37.12 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.937 -0.631 . . . . 0.0 110.941 -174.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.558 ' O ' HG21 ' A' ' 110' ' ' ILE . 58.7 p -112.61 163.3 14.68 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -63.07 -40.45 97.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 118.837 0.744 . . . . 0.0 110.573 -174.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 15.6 m -69.98 -23.07 63.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 110.43 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.82 -47.42 13.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.236 -0.29 . . . . 0.0 110.759 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.6 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.4 pp -72.46 -23.57 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.141 -177.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 p -73.93 -48.01 33.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.729 0.3 . . . . 0.0 110.237 173.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -61.16 -21.84 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.451 0.643 . . . . 0.0 110.208 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.734 HE21 ' HH ' ' A' ' 99' ' ' TYR . 6.4 tp60 -71.84 -58.43 3.47 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.161 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.418 HG21 ' N ' ' A' ' 115' ' ' TYR . 23.0 m -85.39 -39.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.045 -172.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.418 ' N ' HG21 ' A' ' 114' ' ' VAL . 46.2 m-85 -88.48 -57.21 3.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.548 0.689 . . . . 0.0 110.43 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.04 -23.81 6.46 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.644 -171.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -105.52 124.09 48.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.079 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 108' ' ' SER . . . -72.12 -21.03 61.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.206 0.526 . . . . 0.0 110.346 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.85 -22.53 65.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.114 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.8 mt -84.29 16.13 3.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.191 -0.458 . . . . 0.0 112.202 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.452 ' HD1' ' O ' ' A' ' 118' ' ' ALA . 40.0 p90 -64.46 -27.27 68.87 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -54.82 -55.04 34.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.24 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -50.27 -51.75 42.19 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.474 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.479 HG23 ' OD1' ' A' ' 128' ' ' ASN . 35.8 mt -62.98 -45.17 99.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.419 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.482 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 62.6 t80 -56.7 -49.48 74.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.985 0.422 . . . . 0.0 110.846 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.505 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 17.4 mt-10 -70.02 -23.62 63.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.981 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.71 -28.88 30.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.262 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.654 ' O ' ' HG3' ' A' ' 131' ' ' MET . 7.0 m120 -81.62 -10.83 59.32 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 28.8 mtpp -76.27 153.38 84.17 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.704 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -91.95 13.43 51.71 Favored 'Cis proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.762 -1.766 . . . . 0.0 112.814 -0.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.654 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -76.25 -13.95 60.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.672 0.273 . . . . 0.0 111.71 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.3 tp -99.07 125.8 44.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 171.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -73.61 -56.62 4.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.966 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.2 m -153.22 155.65 31.99 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.003 0.43 . . . . 0.0 109.988 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.23 -27.24 56.27 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.906 3.071 . . . . 0.0 113.447 -170.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -99.76 0.87 42.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.99 0.424 . . . . 0.0 110.231 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -96.17 12.45 30.79 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.139 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.422 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 15.5 pt -72.57 168.51 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 1.634 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 26.3 p90 -158.78 144.06 11.93 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.143 -171.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.447 ' HG3' ' O ' ' A' ' 103' ' ' SER . 87.3 Cg_exo -49.41 110.11 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.605 2.87 . . . . 0.0 112.387 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.35 3.19 10.57 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.185 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.529 ' HG3' ' OD1' ' A' ' 76' ' ' ASN . 46.0 tt0 -93.13 118.21 30.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.518 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.483 HG23 ' OG1' ' A' ' 100' ' ' THR . 50.3 t -80.15 134.18 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.459 170.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 76.5 mt -130.21 147.98 51.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.575 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -77.41 119.11 20.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.972 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 38.9 mm -103.85 102.37 30.77 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.02 143.18 90.4 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.113 1.875 . . . . 0.0 110.746 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.571 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.429 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 20.1 tp . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.006 0.431 . . . . 0.0 109.953 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -101.21 123.32 45.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.374 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -78.77 141.54 37.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.539 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 1.665 ' HE1' ' CE2' ' A' ' 6' ' ' PHE . 93.6 m-85 -134.54 175.18 9.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.565 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.477 HG22 ' HA2' ' A' ' 141' ' ' GLY . 22.6 t -78.03 -15.06 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.791 -167.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.565 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 26.6 tptp 74.34 -49.82 0.67 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.946 0.498 . . . . 0.0 112.027 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -91.01 -36.06 14.29 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.73 0.3 . . . . 0.0 111.567 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.07 155.51 20.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.083 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.37 -160.91 24.34 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -76.58 125.46 29.28 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -86.07 65.47 9.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.482 0.658 . . . . 0.0 111.081 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.6 mt . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.549 178.631 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.487 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 34.5 t70 . . . . . 0 CA--C 1.521 -0.152 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.436 ' HB2' HG13 ' A' ' 50' ' ' ILE . 22.7 mt-30 -59.03 -41.49 87.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.729 174.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.71 -43.15 85.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.852 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 61.1 tttp -63.51 -44.81 93.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.373 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 12.9 mptt -57.71 -42.16 83.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.576 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 95.7 t -68.65 -41.92 82.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.892 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.502 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 2.9 mm-40 -56.45 -48.67 76.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.071 174.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 53.7 mt-10 -60.28 -40.59 90.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.817 0.341 . . . . 0.0 110.441 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -56.52 -38.24 71.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.212 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 88.7 mt -72.96 -43.63 62.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.2 0.524 . . . . 0.0 110.864 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -72.49 -35.7 68.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.48 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -71.9 -27.07 62.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.563 0.22 . . . . 0.0 111.56 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 p -83.85 -39.36 20.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.182 0.515 . . . . 0.0 110.514 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.85 31.14 3.73 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.806 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 30.5 mm -66.44 127.31 93.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -64.28 139.4 65.65 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.055 1.836 . . . . 0.0 112.509 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 57.18 24.8 10.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.103 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . . . -72.17 -17.67 61.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.271 0.558 . . . . 0.0 110.175 176.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.93 -19.92 36.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.026 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -83.0 -24.71 32.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.759 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.11 179.66 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.506 -177.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 27.0 t-20 -144.87 138.38 26.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.46 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.502 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 14.9 mm -108.48 126.56 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 123.26 0.35 . . . . 0.0 110.836 -175.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -132.18 123.21 26.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.115 0.483 . . . . 0.0 110.39 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 27' ' ' GLN . 26.8 mm -98.4 112.4 30.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.396 -173.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.85 86.4 2.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.844 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 67.53 -76.58 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.422 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.45 -2.3 4.08 Favored Glycine 0 N--CA 1.454 -0.138 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.569 ' HG2' ' HB3' ' A' ' 82' ' ' SER . 38.3 mtmm -99.0 118.7 36.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.817 0.341 . . . . 0.0 110.682 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.65 106.75 18.74 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.947 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -82.99 113.14 20.36 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 120.766 0.317 . . . . 0.0 110.322 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 97.6 t -99.67 109.99 25.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.199 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 m -104.9 164.38 11.83 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.871 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.5 172.65 28.04 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -162.66 148.08 12.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.987 0.422 . . . . 0.0 110.056 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 90' ' ' ALA . . . 97.5 6.97 57.23 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.103 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 89' ' ' THR . 6.8 mp -95.81 169.86 9.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.057 0.456 . . . . 0.0 110.856 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -110.66 154.9 23.17 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.651 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 7.5 tp60 -50.36 -47.79 55.93 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -173.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.463 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 43.9 mt-10 -52.17 -40.31 61.27 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -176.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.05 -45.53 13.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 110.338 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.474 ' HE3' ' OD1' ' A' ' 85' ' ' ASP . 75.7 tttt -51.54 -59.52 4.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.133 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 26.1 pt-20 -67.29 -18.07 65.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -72.33 -35.19 68.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.467 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.5 -46.56 92.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 10.1 mp -46.13 -43.62 15.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.652 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.573 HG21 ' O ' ' A' ' 68' ' ' GLU . 39.9 t -63.13 -58.92 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.379 0.609 . . . . 0.0 111.117 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.3 64.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.347 -173.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.443 HG11 HG12 ' A' ' 31' ' ' VAL . 53.3 t -87.61 -29.19 5.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 0.0 110.712 177.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.55 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -75.98 -34.46 47.43 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.824 177.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -79.92 58.73 2.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.608 0.242 . . . . 0.0 110.849 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.548 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 29.7 mm -124.7 130.42 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.1 m -66.13 102.81 0.87 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.52 -17.86 5.51 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.481 -172.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.548 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 38.9 mm -100.46 126.23 54.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.195 0.522 . . . . 0.0 110.729 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.565 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -105.27 -17.18 14.55 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.297 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.569 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . 16.1 t -166.96 167.23 14.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.204 0.525 . . . . 0.0 110.763 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.23 125.38 47.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.809 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -98.42 90.81 4.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.474 ' OD1' ' HE3' ' A' ' 67' ' ' LYS . 2.9 t70 -66.75 124.2 22.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.153 -177.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -134.67 27.03 3.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.239 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -85.96 127.05 40.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.889 0.376 . . . . 0.0 110.267 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -91.95 127.78 37.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.18 0.514 . . . . 0.0 111.005 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.2 p -89.86 124.47 34.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.416 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.437 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . . . -79.77 -38.37 33.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.758 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.8 p -127.13 150.59 72.62 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.892 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.31 141.73 52.64 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.339 2.693 . . . . 0.0 112.063 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 64' ' ' GLN . . . -156.47 174.37 15.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.807 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.1 m -67.95 127.87 34.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.265 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.76 127.86 42.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.588 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 146' ' ' ILE . 14.1 m -106.03 171.55 7.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.124 0.488 . . . . 0.0 111.71 -175.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.552 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 13.7 tt0 -89.59 153.7 20.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.322 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.618 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 98.9 m-85 -111.78 91.5 3.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.648 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 76.3 t80 -98.79 118.68 36.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.34 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.8 m -85.59 121.03 27.7 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.057 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.559 HG11 ' O ' ' A' ' 142' ' ' GLN . 1.5 m -69.34 136.74 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -105.7 -166.16 1.18 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.985 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -62.02 116.84 5.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.108 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.39 18.23 64.82 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.658 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.516 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 9.3 m-20 -90.93 114.46 26.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.128 0.49 . . . . 0.0 110.833 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.546 ' O ' HG21 ' A' ' 110' ' ' ILE . 21.7 p -110.02 162.0 14.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.084 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.451 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 16.1 tp -62.02 -41.46 98.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 118.391 0.541 . . . . 0.0 111.356 -169.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.3 p -69.32 -27.33 65.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.213 0.53 . . . . 0.0 110.972 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.91 -41.78 50.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -78.89 -23.65 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.465 -176.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.3 p -71.11 -41.01 71.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 172.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.426 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 4.9 tmmm? -60.19 -29.87 68.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.986 171.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.9 OUTLIER -67.71 -63.52 1.04 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.018 177.335 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.481 HG21 ' N ' ' A' ' 115' ' ' TYR . 35.3 m -76.22 -46.3 33.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.406 -171.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.481 ' N ' HG21 ' A' ' 114' ' ' VAL . 59.6 m-85 -90.91 -30.94 16.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.193 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 92.47 -2.92 74.72 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -170.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -126.08 110.63 13.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.738 -0.731 . . . . 0.0 109.876 -173.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.44 -31.77 72.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.455 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -69.43 -14.75 63.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.627 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.5 mt -83.83 17.32 2.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.821 0.343 . . . . 0.0 111.318 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.451 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 31.3 p90 -66.58 -27.48 67.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.08 0.467 . . . . 0.0 110.106 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.517 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 25.7 p-10 -66.69 -33.69 76.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -57.25 -52.45 65.27 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.579 0.704 . . . . 0.0 109.495 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.9 mt -66.53 -40.21 85.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.251 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.566 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 20.4 t80 -54.27 -60.01 3.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.538 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 24.5 mt-10 -61.72 -34.5 75.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.689 -176.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.57 -31.29 70.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.835 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 131' ' ' MET . 36.4 m-80 -91.34 -18.78 23.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 28.4 mtpp -67.08 151.7 96.85 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.434 176.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -87.67 15.35 44.47 Favored 'Cis proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.987 -1.672 . . . . 0.0 113.474 1.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.476 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.3 OUTLIER -67.75 -33.18 74.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.024 0.44 . . . . 0.0 110.281 177.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.46 131.01 44.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -85.0 -49.56 8.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.598 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.463 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 46.5 p -154.08 161.45 29.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.973 0.416 . . . . 0.0 110.441 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.98 -15.29 48.35 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 123.631 2.887 . . . . 0.0 111.944 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -103.69 -16.34 15.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.206 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -81.74 -6.92 59.48 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 106' ' ' THR . 12.1 pt -65.6 168.53 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 0.0 110.709 172.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -165.06 148.29 7.2 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.476 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.78 115.13 0.62 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.51 2.807 . . . . 0.0 112.806 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 7' ' ' VAL . . . 109.51 6.89 28.67 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.445 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.559 ' O ' HG11 ' A' ' 101' ' ' VAL . 6.5 mm100 -87.7 110.08 20.17 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 41.5 t -77.63 119.63 26.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.403 0.62 . . . . 0.0 109.887 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.8 132.55 53.89 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.183 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.495 ' HB2' HG22 ' A' ' 72' ' ' VAL . 36.1 ttt180 -75.56 110.47 9.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.656 175.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 18.1 mm -94.08 108.63 36.86 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 34.8 Cg_exo -58.31 153.14 48.86 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.591 2.194 . . . . 0.0 111.938 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.602 176.973 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.5 tp . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.581 ' HB2' HG11 ' A' ' 83' ' ' VAL . 74.7 m-85 -99.47 125.29 45.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.362 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.32 144.64 28.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.946 -178.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 1.654 ' HE1' ' CE2' ' A' ' 6' ' ' PHE . 68.3 m-85 -130.07 -162.48 1.21 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.951 0.405 . . . . 0.0 111.658 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.561 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 5.9 p -73.32 -25.71 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.996 -176.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 49.9 tptt 78.17 -56.97 0.48 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.457 0.703 . . . . 0.0 111.575 -176.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.91 -47.99 14.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -73.71 151.79 40.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.889 0.376 . . . . 0.0 110.907 -176.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.83 173.94 14.29 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.437 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.18 125.49 24.23 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 122.485 0.314 . . . . 0.0 110.179 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 96.1 mttt -90.28 83.35 5.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.957 0.408 . . . . 0.0 110.892 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 34' ' ' HIS . 1.7 mm? . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 121.479 0.657 . . . . 0.0 109.392 175.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 CA--C 1.522 -0.115 0 CA-C-O 120.966 0.412 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.413 ' O ' HG21 ' A' ' 31' ' ' VAL . 28.1 mt-30 -67.3 -17.38 64.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 171.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . . . -59.92 -42.22 93.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.053 171.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -63.15 -42.36 99.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 3.6 mptp? -54.46 -36.87 64.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.264 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.546 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 96.0 t -69.36 -46.09 77.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.641 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.416 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 16.5 mm-40 -56.9 -42.04 79.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.97 174.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -57.62 -51.13 70.77 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.411 ' HB2' HD12 ' A' ' 14' ' ' LEU . 51.3 t60 -51.19 -42.45 60.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.624 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 86.2 mt -72.63 -41.61 65.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.543 -176.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -80.56 -26.43 37.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.82 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -69.74 -45.78 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.594 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.0 p -68.1 -40.16 82.65 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.836 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.55 31.22 4.06 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.879 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' HD2' ' A' ' 130' ' ' PRO . 30.8 mm -65.81 125.0 89.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.68 141.53 50.15 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.0 1.8 . . . . 0.0 112.545 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 55.68 20.27 3.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.538 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 35' ' ' LEU . . . -84.87 -17.26 38.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.988 0.423 . . . . 0.0 111.0 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -83.74 -16.71 43.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.731 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.58 -27.15 61.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.772 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 m -89.8 159.62 2.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.658 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -112.95 136.91 52.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.79 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.416 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 15.8 mm -106.07 143.61 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 123.375 0.422 . . . . 0.0 110.707 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 9.6 tt0 -144.98 126.68 15.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.5 mm -107.44 121.26 60.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.966 0.412 . . . . 0.0 111.553 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.47 76.74 1.07 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.56 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 69.1 -80.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.953 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.01 2.53 7.89 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -104.95 98.62 8.31 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -94.23 118.78 32.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.336 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 12.8 m -90.57 134.14 34.59 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.638 0.256 . . . . 0.0 110.319 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.5 t -120.7 109.77 26.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.087 0.47 . . . . 0.0 109.98 176.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.19 159.87 16.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.223 -177.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.62 172.57 39.14 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -155.98 139.33 15.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.052 0.453 . . . . 0.0 110.666 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.16 7.03 59.81 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.822 -0.626 . . . . 0.0 113.131 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 89' ' ' THR . 7.3 mp -92.94 168.6 11.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.023 0.44 . . . . 0.0 110.735 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 m -105.82 151.49 24.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.114 172.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.684 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 41.0 tt0 -56.55 -43.13 79.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.489 -173.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -54.18 -36.57 63.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.808 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.38 -38.97 29.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.355 176.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -55.91 -42.41 76.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.071 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 3.0 mm-40 -64.34 -23.69 67.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.659 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -66.42 -38.83 88.31 Favored 'General case' 0 N--CA 1.461 0.085 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.597 ' O ' HG13 ' A' ' 74' ' ' VAL . 4.0 mp -71.14 -55.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.203 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -48.7 -45.72 39.6 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.34 -30.49 43.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.963 0.411 . . . . 0.0 111.219 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -84.72 -30.64 24.59 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.284 -0.26 . . . . 0.0 111.555 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 70' ' ' ILE . 4.5 p -81.98 -39.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.018 0.437 . . . . 0.0 110.7 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.58 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -67.24 -26.01 73.49 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.656 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -88.39 48.19 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.299 . . . . 0.0 110.814 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.3 mt -121.21 142.93 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 121.225 0.536 . . . . 0.0 111.442 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.545 ' OG ' ' HA ' ' A' ' 13' ' ' LYS . 51.8 p -64.83 105.91 1.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.764 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.51 -11.86 10.35 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.685 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 35.8 mm -90.96 113.37 26.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.544 0.688 . . . . 0.0 111.105 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.552 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -92.82 -26.49 17.65 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.002 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 5.9 p -157.76 155.17 29.37 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.526 -177.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 4' ' ' PHE . 10.6 p -126.59 127.05 69.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.56 174.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.62 93.32 6.68 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -70.43 112.84 7.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.53 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -121.76 22.74 10.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.202 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.06 118.41 28.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.071 0.462 . . . . 0.0 110.523 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -80.05 123.58 27.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.356 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 5.1 p -92.53 111.38 22.94 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.234 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.58 -33.38 69.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.007 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 p -128.72 138.84 34.0 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.861 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.5 142.7 33.36 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.771 2.314 . . . . 0.0 111.724 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.25 174.18 10.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.967 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.8 m -61.65 137.03 58.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.935 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.63 143.2 27.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.646 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.1 m -110.69 137.35 48.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.08 0.467 . . . . 0.0 110.514 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 14.5 tt0 -86.67 147.23 25.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.242 177.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 1.659 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 98.4 m-85 -116.64 118.86 33.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.985 0.422 . . . . 0.0 111.24 -176.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.65 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 87.3 t80 -119.72 136.61 54.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.098 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.1 m -99.91 124.51 45.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.512 HG23 ' H ' ' A' ' 142' ' ' GLN . 2.4 m -71.4 136.42 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -93.31 -168.67 1.96 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.065 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 140' ' ' PRO . 27.4 m -56.51 -40.19 74.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.61 37.26 3.44 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.566 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.579 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 73.4 m-20 -99.36 128.57 45.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.411 0.624 . . . . 0.0 110.639 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.591 ' O ' HG21 ' A' ' 110' ' ' ILE . 1.5 p -114.48 153.82 29.29 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.205 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 27.6 tp -54.75 -43.33 72.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.307 0.503 . . . . 0.0 110.931 -172.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -62.39 -44.03 97.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.092 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.71 83.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.41 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.2 pp -73.73 -25.14 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.541 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.9 t -68.03 -46.82 70.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.131 0.491 . . . . 0.0 109.823 171.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 112' ' ' LYS . 12.6 tmtt? -60.61 -29.01 68.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.583 0.706 . . . . 0.0 109.194 175.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.616 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 6.4 tp60 -67.32 -62.27 1.5 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.43 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.471 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.5 m -79.6 -45.81 23.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.254 -172.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.471 ' N ' HG21 ' A' ' 114' ' ' VAL . 38.8 m-85 -81.42 -51.23 8.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.305 0.574 . . . . 0.0 110.509 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.51 -14.19 13.28 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.679 -174.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.452 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 17.7 t30 -123.34 126.93 47.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.154 -0.523 . . . . 0.0 109.829 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.01 -17.06 60.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.82 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -80.46 -13.24 59.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.061 0.458 . . . . 0.0 110.843 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.452 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 39.1 mt -82.47 14.14 3.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.448 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.443 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 53.6 p90 -60.07 -24.82 64.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.27 -178.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.475 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 51.0 m-80 -62.56 -38.9 91.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.09 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -55.57 -50.51 69.86 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.575 0.702 . . . . 0.0 109.805 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.97 -39.41 81.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.48 -177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -58.55 -53.95 52.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.512 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 21.5 mt-10 -66.04 -35.74 81.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.061 -176.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.425 ' HB1' ' HG3' ' A' ' 147' ' ' PRO . . . -64.14 -33.43 75.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.513 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.524 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 42.5 m-80 -95.72 -28.63 14.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.849 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 56.8 pttt -64.45 155.76 79.49 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 2.9 Cg_endo -82.0 10.63 36.33 Favored 'Cis proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.968 -1.263 . . . . 0.0 113.088 1.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.524 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.4 tmm? -66.31 -40.29 89.86 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.402 HD11 HE22 ' A' ' 142' ' ' GLN . 7.6 tp -86.24 113.38 22.2 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 171.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -76.9 -52.46 9.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.612 -170.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.485 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 24.0 m -142.38 155.74 64.23 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.011 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.72 -54.53 5.17 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.495 2.797 . . . . 0.0 113.258 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.07 9.78 29.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.219 0.533 . . . . 0.0 111.024 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.485 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 26.2 mmtp -92.27 13.09 20.28 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 106' ' ' THR . 18.3 pt -67.19 171.39 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 171.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -148.08 144.69 19.22 Favored Pre-proline 0 C--N 1.315 -0.898 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.64 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 103' ' ' SER . 81.5 Cg_exo -49.33 110.66 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.275 2.65 . . . . 0.0 112.47 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.515 ' O ' HG13 ' A' ' 7' ' ' VAL . . . 109.53 22.79 6.56 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.085 -176.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.512 ' H ' HG23 ' A' ' 101' ' ' VAL . 44.8 tt0 -105.56 118.63 37.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 117.613 0.706 . . . . 0.0 110.708 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 37.3 t -78.46 131.64 34.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.744 174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.7 mt -121.19 135.64 55.11 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.101 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -65.44 123.36 19.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.39 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 23.3 mm -106.24 97.86 17.44 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.425 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 39.5 Cg_endo -70.49 158.8 54.91 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.227 1.951 . . . . 0.0 111.871 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.492 -177.482 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.493 HD11 ' N ' ' A' ' 4' ' ' PHE . 2.6 tm? . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 1.661 ' HE1' ' CE2' ' A' ' 4' ' ' PHE . 98.4 m-85 -121.55 145.78 47.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.371 178.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.23 128.97 48.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 111.268 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.518 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 76.1 m-85 -124.77 -167.22 1.63 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.78 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.2 t -107.69 118.94 56.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.114 0.483 . . . . 0.0 110.262 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 22.5 tptm -60.7 -33.74 73.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.906 -172.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -90.23 -33.94 15.98 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.34 128.65 35.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.857 0.36 . . . . 0.0 111.426 -172.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' HA2' ' HH ' ' A' ' 139' ' ' TYR . . . 150.69 179.9 26.84 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.873 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.68 135.92 47.05 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -99.86 94.29 6.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.76 0.314 . . . . 0.0 110.525 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.419 ' CB ' ' HB3' ' A' ' 30' ' ' LYS . 1.8 mm? . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.852 0.358 . . . . 0.0 111.062 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.8 m-20 . . . . . 0 CA--C 1.516 -0.355 0 CA-C-O 120.285 0.088 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.42 ' O ' HG21 ' A' ' 31' ' ' VAL . 97.7 mt-30 -63.05 -46.95 85.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.638 0.256 . . . . 0.0 110.721 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 48' ' ' ILE . . . -57.15 -30.58 64.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.326 0.584 . . . . 0.0 111.197 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 35.6 ttpt -80.03 -50.67 10.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.339 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 72.7 mmtt -51.74 -39.66 58.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.412 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 41.4 t -58.46 -52.06 64.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.694 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.475 ' HB3' HD11 ' A' ' 48' ' ' ILE . 3.0 pt20 -78.28 -21.1 50.26 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.464 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 46.9 mt-10 -64.99 -39.0 92.82 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 172.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.518 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 63.6 t60 -55.97 -37.49 69.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.02 172.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.6 mt -70.53 -45.84 64.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.22 -41.7 94.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.05 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 97.3 mttt -59.48 -54.85 41.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.053 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 p -62.74 -44.18 96.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.085 0.469 . . . . 0.0 111.142 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.54 33.75 1.86 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.899 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.441 HD11 ' HD2' ' A' ' 130' ' ' PRO . 24.3 mm -69.53 129.15 91.75 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.83 143.19 49.74 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.614 2.209 . . . . 0.0 113.207 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 57.15 28.57 15.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.697 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.83 -20.6 62.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.24 0.543 . . . . 0.0 110.349 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -81.32 -15.99 53.75 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.425 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -86.81 -11.28 51.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.816 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.08 177.31 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.113 0.483 . . . . 0.0 111.292 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 42.0 t30 -141.4 128.51 20.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.065 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 32' ' ' GLN . 3.2 mp -104.53 129.25 57.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 123.39 0.431 . . . . 0.0 110.608 -174.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -128.7 128.03 43.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.273 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.4 mm -98.74 120.59 48.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.001 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.45 88.01 2.86 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.769 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 67.33 -74.88 0.06 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.803 0.69 . . . . 0.0 111.134 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.38 -1.0 4.01 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.403 ' HD3' ' HB2' ' A' ' 84' ' ' ASP . 38.7 ttmt -96.74 115.74 27.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.959 0.409 . . . . 0.0 110.731 -178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.82 100.74 12.26 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 38.1 m -83.35 128.5 34.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.382 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -120.79 117.33 52.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.008 0.432 . . . . 0.0 111.043 177.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.455 HG21 ' HB3' ' A' ' 86' ' ' GLN . 2.2 m -100.52 162.96 12.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.789 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.8 166.68 33.64 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.801 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -156.13 138.07 14.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.875 0.369 . . . . 0.0 110.066 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.96 8.21 63.56 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.802 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.471 ' HG ' ' CG1' ' A' ' 87' ' ' VAL . 4.5 mm? -78.68 171.79 14.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.0 112.265 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -128.05 146.41 50.69 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 170.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.577 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 9.8 mt-30 -59.65 -22.48 61.95 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.303 0.377 . . . . 0.0 112.008 -175.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.67 -34.55 72.98 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.259 0.349 . . . . 0.0 111.311 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.42 -36.52 7.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.027 0.441 . . . . 0.0 110.475 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 52.5 tttm -50.91 -46.53 60.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.049 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 145' ' ' ARG . 21.7 mt-10 -87.92 20.58 3.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.415 0.626 . . . . 0.0 110.923 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -113.91 -41.7 3.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.059 170.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 54.6 mt -59.22 -59.3 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.245 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.52 HD11 ' O ' ' A' ' 67' ' ' LYS . 9.3 mp -42.86 -41.99 3.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.458 176.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.85 -53.39 30.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.99 -24.06 65.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.39 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.2 t -79.0 -40.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.171 0.51 . . . . 0.0 110.481 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.518 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -72.27 -25.94 73.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.506 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.419 ' HB3' ' OH ' ' A' ' 139' ' ' TYR . 90.4 m-20 -86.45 39.95 0.86 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.099 0.476 . . . . 0.0 111.056 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.449 ' CD1' HG11 ' A' ' 31' ' ' VAL . 92.9 mt -114.26 135.31 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.715 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -67.92 123.81 21.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.31 -9.27 38.72 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.252 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.1 mm -105.01 137.81 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -124.04 -19.47 5.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.721 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 p -152.97 157.04 39.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.065 0.459 . . . . 0.0 111.297 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.3 t -133.04 126.11 52.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.84 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.403 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . 15.1 t70 -102.37 110.64 22.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -92.49 100.47 13.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 122.145 0.974 . . . . 0.0 111.77 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.455 ' HB3' HG21 ' A' ' 58' ' ' THR . 43.0 mt-30 -98.98 18.47 17.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.163 172.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.471 ' CG1' ' HG ' ' A' ' 62' ' ' LEU . 43.1 t -80.01 108.08 13.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.437 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -86.59 137.57 32.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.075 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.8 p -102.45 130.42 49.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.058 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.08 -16.18 30.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.6 p -129.27 142.53 45.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.85 124.42 7.44 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.668 2.245 . . . . 0.0 111.842 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.35 168.87 18.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.5 m -65.18 140.77 58.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.434 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.89 154.7 17.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.08 0.467 . . . . 0.0 111.759 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.9 m -118.94 146.96 44.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.981 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 7.6 tt0 -91.3 150.73 21.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.425 175.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -105.82 100.83 10.37 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.103 0.477 . . . . 0.0 110.85 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.601 ' HD2' ' CD1' ' A' ' 99' ' ' TYR . 80.0 t80 -101.66 144.24 30.63 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.917 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 143' ' ' VAL . 17.1 m -110.94 124.15 51.57 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.358 -0.137 . . . . 0.0 110.675 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 142' ' ' GLN . 1.7 m -66.09 129.5 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -80.84 -81.51 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.969 -171.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.3 m -162.26 123.49 2.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.12 28.88 71.01 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.26 130.43 43.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.892 -0.654 . . . . 0.0 109.95 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.527 ' O ' HG21 ' A' ' 110' ' ' ILE . 7.6 p -115.76 162.61 17.04 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.878 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.57 ' CD1' ' HA ' ' A' ' 135' ' ' PRO . 22.9 mt -57.83 -42.67 84.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.76 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.4 m -59.63 -38.69 82.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.942 0.401 . . . . 0.0 110.822 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.7 -44.65 69.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.264 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.626 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.5 pp -78.22 -22.15 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.483 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.4 p -77.8 -42.67 33.05 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.243 -0.286 . . . . 0.0 110.564 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -62.73 -26.27 68.6 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.506 0.67 . . . . 0.0 109.75 171.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.626 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 4.7 tp60 -64.33 -55.02 24.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.949 175.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.498 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.2 m -86.46 -51.25 13.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.349 -173.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.498 ' N ' HG21 ' A' ' 114' ' ' VAL . 21.6 m-85 -87.67 -31.01 19.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.249 -176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.31 -19.51 39.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.102 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -114.1 120.61 41.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.19 -20.13 63.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.872 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -81.77 -0.15 41.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.985 0.421 . . . . 0.0 111.004 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.8 mt -91.28 17.43 8.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 1.652 ' HD1' ' CD2' ' A' ' 121' ' ' TYR . 42.3 p90 -60.84 -30.91 70.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.362 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -69.8 -30.54 68.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.522 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -63.11 -44.12 96.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.257 0.551 . . . . 0.0 110.341 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.3 mt -75.46 -36.88 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.163 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -53.26 -60.81 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.801 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.486 ' CD ' ' HZ3' ' A' ' 129' ' ' LYS . 11.6 mm-40 -50.43 -43.62 55.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.943 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.555 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -63.84 -33.08 74.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.32 -174.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.496 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 42.2 m-80 -92.8 5.17 52.17 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.715 0.293 . . . . 0.0 111.506 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.486 ' HZ3' ' CD ' ' A' ' 126' ' ' GLU . 15.3 mtmm -82.63 156.27 68.14 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.441 ' HD2' HD11 ' A' ' 40' ' ' ILE . 96.6 Cg_endo -86.39 15.37 41.24 Favored 'Cis proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.72 -1.367 . . . . 0.0 113.424 -1.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.496 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.3 OUTLIER -66.12 -41.94 89.84 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.128 0.49 . . . . 0.0 110.069 175.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 tp -95.03 124.41 39.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.441 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -101.6 -33.27 9.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.862 -172.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 69.0 m -155.42 153.64 26.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.57 0.224 . . . . 0.0 111.179 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.57 ' HA ' ' CD1' ' A' ' 107' ' ' LEU . 81.9 Cg_exo -48.67 -56.95 2.67 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.627 2.885 . . . . 0.0 113.382 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.01 -7.78 53.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.864 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 137' ' ' LYS . 30.2 mmtp -81.51 -2.72 50.88 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' A' ' 106' ' ' THR . 12.3 pt -68.37 167.55 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.972 0.415 . . . . 0.0 110.438 174.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.47 ' HH ' ' HA2' ' A' ' 11' ' ' GLY . 10.5 p90 -141.46 141.67 23.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.428 -174.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.81 111.02 0.5 Allowed 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 123.176 2.584 . . . . 0.0 112.248 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.24 23.47 6.35 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.907 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.517 ' H ' HG23 ' A' ' 101' ' ' VAL . 47.3 tt0 -104.48 121.8 44.2 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.572 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.449 HG23 ' OG1' ' A' ' 100' ' ' THR . 42.7 t -80.93 133.75 28.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.965 174.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.1 mt -126.15 135.67 51.94 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.673 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.571 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 3.1 ptm180 -73.84 123.78 24.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.289 0.566 . . . . 0.0 110.011 176.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 26.3 mm -103.84 91.29 3.45 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.038 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 37.1 Cg_exo -60.88 144.28 99.53 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.501 2.134 . . . . 0.0 111.318 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 121.18 0.515 . . . . 0.0 110.328 -179.5 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.7 tp . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 1.655 ' HD2' ' CD1' ' A' ' 4' ' ' PHE . 74.1 m-85 -114.16 133.92 55.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.645 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -109.85 134.56 51.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.272 0.558 . . . . 0.0 110.827 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.487 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 67.3 m-85 -118.03 -157.96 0.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.644 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.533 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 7.7 p -85.17 -24.61 6.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 28.9 tptp 74.83 -52.43 0.68 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.319 0.647 . . . . 0.0 111.881 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -85.81 -44.07 12.77 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -78.8 172.33 13.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.761 -177.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.73 ' HA2' ' HH ' ' A' ' 139' ' ' TYR . . . 121.21 -173.72 15.65 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.32 121.29 15.4 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 57.6 mtmt -80.04 74.76 6.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.471 0.653 . . . . 0.0 111.601 -171.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.581 175.882 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.845 0.355 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -67.18 -21.85 65.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.579 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.77 82.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.225 176.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.3 tptt -65.28 -45.9 82.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.317 176.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -55.73 -46.86 77.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.793 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.419 HG11 ' CD1' ' A' ' 77' ' ' ILE . 72.0 t -60.39 -49.31 84.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.941 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.458 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 3.2 mm-40 -53.11 -41.97 65.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.613 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 44.8 mt-10 -56.28 -44.84 80.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.498 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -56.16 -46.87 79.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.728 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.414 HD13 ' N ' ' A' ' 35' ' ' LEU . 8.3 mp -67.66 -39.21 84.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.826 0.346 . . . . 0.0 111.823 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -77.08 -24.36 51.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.488 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -82.54 -24.33 34.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.562 0.22 . . . . 0.0 111.353 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -83.75 -35.9 24.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.859 0.362 . . . . 0.0 110.955 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.69 24.15 6.23 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.162 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.88 125.56 91.01 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -78.53 149.32 23.96 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.978 1.786 . . . . 0.0 111.955 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.56 8.2 4.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.42 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.81 -13.24 56.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.054 0.454 . . . . 0.0 110.951 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.77 -7.46 56.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.634 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -89.36 -12.32 40.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.403 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.05 157.56 4.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.839 -178.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 18.3 m120 -119.27 132.96 55.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.646 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.458 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 13.4 mm -95.26 140.97 15.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -174.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -137.53 127.41 25.62 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 34.5 mm -117.91 116.58 52.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.185 0.517 . . . . 0.0 111.711 -172.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.05 70.81 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.915 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 t70 72.87 -66.45 0.31 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.185 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.422 ' O ' ' HB1' ' A' ' 81' ' ' ALA . . . -135.12 31.49 2.69 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.894 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.558 ' CE ' ' HB2' ' A' ' 84' ' ' ASP . 87.2 tttt -140.25 129.42 23.68 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.503 -0.41 . . . . 0.0 110.718 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -108.63 107.68 18.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.41 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.431 HG21 ' HB3' ' A' ' 84' ' ' ASP . 36.5 m -95.21 114.05 25.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -104.71 127.6 59.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.82 0.343 . . . . 0.0 111.609 -177.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.35 158.08 16.71 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.123 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.41 156.72 10.11 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.29 137.49 27.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.144 0.497 . . . . 0.0 110.533 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.43 0.58 61.05 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.514 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.64 178.1 2.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.176 0.512 . . . . 0.0 111.982 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.444 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 53.6 p -127.02 144.34 51.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.564 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.588 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 48.8 tp60 -45.64 -54.86 7.1 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.532 0.52 . . . . 0.0 112.076 -175.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.91 -35.13 72.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.03 -42.6 19.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.936 0.398 . . . . 0.0 110.077 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.522 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 79.8 tttt -54.54 -40.45 68.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.27 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 79.0 mt-10 -63.46 -35.47 80.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.44 -43.87 93.05 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.26 -50.77 78.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.092 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 88.0 mt -53.97 -45.96 71.5 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.409 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 68' ' ' GLU . 46.5 t -72.0 -44.22 66.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.211 0.529 . . . . 0.0 110.83 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.45 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -62.9 -34.66 77.89 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.349 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 80' ' ' ILE . 22.5 m -82.18 -31.12 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.638 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.487 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -72.36 -32.8 62.06 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.766 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.25 41.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.941 0.4 . . . . 0.0 111.056 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.419 ' CD1' HG11 ' A' ' 31' ' ' VAL . 96.8 mt -115.54 134.75 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 121.061 0.458 . . . . 0.0 110.398 172.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 14.8 t -62.47 105.99 0.7 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.486 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.91 -15.42 5.65 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.565 -174.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 49.7 mm -100.85 120.57 50.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.128 0.49 . . . . 0.0 111.49 -177.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.536 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -98.96 -38.26 9.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.685 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.4 p -142.7 159.6 41.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.48 0.657 . . . . 0.0 111.85 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 69.0 t -131.07 127.53 61.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.628 177.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.558 ' HB2' ' CE ' ' A' ' 54' ' ' LYS . 5.6 t70 -106.39 107.75 18.92 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.76 110.04 15.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.115 0.96 . . . . 0.0 111.032 -173.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -107.98 17.51 22.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.531 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -92.4 116.24 33.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.843 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -85.59 139.17 31.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.307 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.6 p -105.48 131.11 53.29 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.99 0.424 . . . . 0.0 111.202 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.77 -40.02 6.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 63' ' ' SER . 17.8 p -96.28 141.0 22.5 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.586 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.6 130.49 18.4 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.805 2.337 . . . . 0.0 112.293 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 64' ' ' GLN . . . -148.54 160.86 42.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.9 m -82.36 133.71 35.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.379 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.6 141.42 29.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.677 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.8 m -108.96 170.99 7.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.65 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.6 tt0 -96.33 147.7 23.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.518 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -104.29 107.08 17.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.976 0.417 . . . . 0.0 110.039 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.659 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 91.3 t80 -108.31 129.96 55.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.353 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.433 ' OG1' HG23 ' A' ' 143' ' ' VAL . 17.7 m -98.07 123.44 42.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.95 175.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -69.03 130.14 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.307 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.437 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 45.5 mmtm -80.18 -73.37 0.36 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.313 -170.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 140' ' ' PRO . 18.4 t -150.39 -68.66 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.765 -176.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.35 36.67 2.58 Favored Glycine 0 C--N 1.329 0.189 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -96.4 115.84 28.08 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.152 -172.2 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.602 ' O ' HG21 ' A' ' 110' ' ' ILE . 27.6 p -110.2 159.2 17.59 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.446 HD11 ' HA ' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -57.41 -45.12 84.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.178 0.444 . . . . 0.0 110.783 -171.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 14.3 m -63.04 -40.19 96.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.56 82.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.331 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.602 HG21 ' O ' ' A' ' 106' ' ' THR . 1.3 pp -74.11 -27.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 120.805 0.336 . . . . 0.0 110.503 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -67.19 -43.52 81.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.057 0.456 . . . . 0.0 110.133 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.16 -28.2 69.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.369 0.604 . . . . 0.0 109.964 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.592 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.1 tp-100 -67.42 -54.49 19.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.078 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.495 HG21 ' N ' ' A' ' 115' ' ' TYR . 27.4 m -85.18 -50.49 14.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.207 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.495 ' N ' HG21 ' A' ' 114' ' ' VAL . 68.9 m-85 -85.81 -42.13 14.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.057 0.456 . . . . 0.0 111.146 -177.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.8 -14.88 31.83 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.449 ' HB3' ' HG ' ' A' ' 120' ' ' LEU . 55.3 t-20 -118.75 120.15 36.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 108' ' ' SER . . . -71.08 -22.24 62.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -174.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.08 -8.18 55.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.039 0.447 . . . . 0.0 111.106 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HG ' ' HB3' ' A' ' 117' ' ' ASN . 46.6 mt -86.4 10.8 13.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.648 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.425 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 51.0 p90 -59.14 -26.49 64.79 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.925 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -70.3 -31.54 68.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.112 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.421 ' HE2' HD11 ' A' ' 120' ' ' LEU . 33.6 mtmt -62.43 -45.29 93.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.717 0.77 . . . . 0.0 109.68 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.0 mt -66.62 -42.76 90.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.619 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -56.74 -53.78 53.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.367 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -65.45 -26.31 67.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 111.664 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.417 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -76.58 -25.83 54.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.708 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.527 ' O ' ' HB3' ' A' ' 131' ' ' MET . 39.2 m-80 -98.02 -30.59 12.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.272 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 19.4 pttp -66.14 156.91 83.22 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.483 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.4 Cg_endo -81.2 10.33 32.71 Favored 'Cis proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.494 -1.461 . . . . 0.0 113.4 2.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.527 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.6 tmm? -64.99 -37.96 89.39 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.466 HD11 HE22 ' A' ' 142' ' ' GLN . 7.8 tp -88.74 114.77 25.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.026 171.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -73.41 -46.65 47.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.684 -171.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' A' ' 135' ' ' PRO . 16.4 m -152.1 150.54 25.92 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 121.239 0.542 . . . . 0.0 109.928 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.446 ' HA ' HD11 ' A' ' 107' ' ' LEU . 28.0 Cg_endo -62.6 -20.78 71.79 Favored 'Trans proline' 0 C--N 1.334 -0.232 0 C-N-CA 123.784 2.99 . . . . 0.0 113.025 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -101.4 -0.45 35.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.564 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -98.35 16.18 22.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.464 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 19.0 pt -74.0 166.44 2.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 171.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.73 ' HH ' ' HA2' ' A' ' 11' ' ' GLY . 17.3 p90 -153.27 147.21 18.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.821 -173.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' A' ' 103' ' ' SER . 92.4 Cg_exo -47.53 113.68 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.573 2.849 . . . . 0.0 112.629 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 7' ' ' VAL . . . 104.57 30.63 4.86 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.315 -177.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.466 HE22 HD11 ' A' ' 132' ' ' LEU . 43.1 tt0 -114.02 124.9 53.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.629 0.714 . . . . 0.0 110.933 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.433 HG23 ' OG1' ' A' ' 100' ' ' THR . 45.1 t -82.69 134.73 26.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.757 173.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.4 mt -126.01 138.84 53.76 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.896 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.544 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 52.9 mtp180 -65.91 118.28 9.5 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.675 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 39.3 mm -105.96 90.16 4.24 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 24.5 Cg_exo -62.37 150.31 87.69 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.685 2.257 . . . . 0.0 111.443 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--N 1.321 -0.657 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.34 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 110.736 -0.098 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.48 -135.4 3.12 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.995 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.467 HD11 ' N ' ' A' ' 4' ' ' PHE . 3.1 tm? -96.2 136.93 36.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.061 0.458 . . . . 0.0 110.283 -175.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' N ' HD11 ' A' ' 3' ' ' LEU . 96.7 m-85 -126.09 136.35 52.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.223 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -108.44 147.25 31.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.447 0.641 . . . . 0.0 112.275 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 53.7 m-85 -130.47 -169.17 2.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.751 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.413 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 40.5 t -86.61 -13.38 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.536 0.207 . . . . 0.0 111.115 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.657 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 63.7 tttm 73.85 -68.71 0.21 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.083 0.553 . . . . 0.0 111.784 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.02 -26.24 65.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.905 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.493 ' CB ' ' HA3' ' A' ' 141' ' ' GLY . . . -100.28 125.53 46.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.153 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.11 -169.43 40.32 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -60.49 129.89 43.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -74.81 73.39 2.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.029 0.919 . . . . 0.0 109.717 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.52 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 12.1 tp -89.5 -45.25 9.55 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.552 -174.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.52 ' CZ3' HD21 ' A' ' 14' ' ' LEU . 18.0 p90 -143.71 -29.61 0.51 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.087 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 54.76 81.91 0.1 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.795 0.331 . . . . 0.0 110.46 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 67.1 4.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.151 0.501 . . . . 0.0 111.578 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.1 t -88.24 -68.14 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.28 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.7 p -94.62 -20.53 19.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.408 0.623 . . . . 0.0 109.763 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.84 118.59 4.17 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.758 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -125.49 -0.49 7.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.576 0.227 . . . . 0.0 111.061 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -164.67 147.83 8.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.912 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 5.3 t70 -79.9 169.99 17.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.156 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -59.34 -48.66 80.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.878 0.37 . . . . 0.0 111.185 -171.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.51 -30.6 70.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -71.3 -36.2 71.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.86 0.362 . . . . 0.0 110.099 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.535 ' O ' HG21 ' A' ' 31' ' ' VAL . 95.8 mt-30 -63.88 -45.99 86.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.586 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.1 78.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.184 0.516 . . . . 0.0 110.727 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.09 -45.47 94.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.537 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' O ' HD22 ' A' ' 14' ' ' LEU . 68.5 mmtt -61.11 -35.21 76.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.852 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 97.4 t -62.74 -48.94 85.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -55.35 -48.56 74.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.569 172.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 66.1 mt-10 -55.71 -50.27 70.76 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -53.23 -43.95 67.7 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.698 0.624 . . . . 0.0 111.505 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 98.5 mt -62.76 -42.95 99.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.502 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -75.1 -25.39 58.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.989 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 13.2 mmmm -65.84 -51.99 54.25 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.222 0.534 . . . . 0.0 110.385 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 130' ' ' PRO . 2.4 p -73.3 -28.97 62.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.375 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.07 30.54 7.81 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.973 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.61 126.05 85.93 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.52 145.71 71.57 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.894 1.729 . . . . 0.0 112.107 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.29 21.45 11.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.804 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.11 -22.39 63.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.6 2.99 56.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.684 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -99.26 3.05 46.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.453 . . . . 0.0 110.155 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.12 172.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.025 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -137.3 131.73 32.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.627 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 mm -98.14 141.45 16.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.952 0.406 . . . . 0.0 111.21 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 49.2 tt0 -139.67 119.8 13.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.686 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.434 HD12 HG22 ' A' ' 31' ' ' VAL . 43.5 mm -96.57 108.16 20.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.289 0.566 . . . . 0.0 110.833 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.56 72.48 2.04 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 68.08 -82.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.867 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.7 1.81 24.64 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.132 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -110.08 110.48 21.39 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.522 -0.399 . . . . 0.0 111.084 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.24 92.14 7.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.792 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 84' ' ' ASP . 43.3 m -75.78 122.62 24.33 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.905 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.4 t -112.01 113.61 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.115 0.483 . . . . 0.0 110.28 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -100.91 162.96 12.53 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.224 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.75 167.05 32.18 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.495 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -155.15 142.27 19.3 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.959 0.409 . . . . 0.0 110.319 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.11 7.83 86.41 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.384 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.44 169.23 18.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.381 0.61 . . . . 0.0 112.165 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.1 m -115.32 147.69 40.15 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 170.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.578 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 39.8 tt0 -51.93 -45.8 64.44 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -173.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.3 -50.35 62.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.945 0.403 . . . . 0.0 110.184 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.08 -43.06 96.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.066 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.471 ' O ' HD11 ' A' ' 71' ' ' LEU . 27.5 ttpp -59.13 -47.34 85.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 0.0 111.098 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 4.1 mm-40 -66.19 -15.88 63.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.091 0.472 . . . . 0.0 110.736 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -39.04 53.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.701 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.3 mm -65.31 -57.04 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.471 0.653 . . . . 0.0 109.915 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 67' ' ' LYS . 11.0 mp -42.44 -49.68 5.23 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.871 -177.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.5 HG23 ' HG2' ' A' ' 145' ' ' ARG . 57.5 t -69.85 -49.56 56.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.235 0.54 . . . . 0.0 111.199 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HA ' ' SD ' ' A' ' 131' ' ' MET . . . -64.02 -29.68 70.81 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.956 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.2 m -87.6 -29.08 5.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.988 0.423 . . . . 0.0 111.043 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -73.63 -33.46 58.13 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.443 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -80.01 54.26 1.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.773 0.32 . . . . 0.0 111.138 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -122.76 142.48 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 120.927 0.394 . . . . 0.0 110.551 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 t -70.83 103.26 2.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.504 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.61 -18.11 5.46 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.285 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.657 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 45.9 mm -94.34 117.17 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.455 0.645 . . . . 0.0 111.045 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.58 -30.47 13.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.881 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 p -153.17 160.23 42.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.261 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.94 125.89 70.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.432 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.515 ' HB3' HG21 ' A' ' 56' ' ' THR . 6.4 t70 -97.98 96.84 8.44 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.45 104.98 5.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.117 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -115.94 19.45 15.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.111 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.9 114.91 20.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.997 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -83.19 122.33 28.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.1 p -99.43 130.72 45.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.155 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.47 -21.84 35.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.905 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -140.17 131.69 14.36 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.105 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.53 156.96 36.44 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.499 2.133 . . . . 0.0 111.066 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -150.64 -160.41 1.16 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.512 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.7 m -67.04 131.78 46.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 110.723 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.41 159.53 17.97 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.0 m -138.66 143.26 39.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.101 0.477 . . . . 0.0 110.814 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 6.5 tt0 -81.33 137.05 35.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.488 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 98' ' ' PHE . 79.8 m-85 -99.1 80.29 2.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.532 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.66 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 84.9 t80 -73.91 144.86 45.16 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.541 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.419 ' OG1' HG23 ' A' ' 143' ' ' VAL . 12.9 m -120.74 117.94 28.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.604 HG11 ' O ' ' A' ' 142' ' ' GLN . 0.6 OUTLIER -68.18 131.38 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -84.0 -61.14 1.89 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.92 -170.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.8 t -163.15 -68.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.19 53.43 4.79 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.515 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.8 m-20 -113.1 112.65 24.19 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.129 0.49 . . . . 0.0 111.05 -172.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.475 ' O ' HG21 ' A' ' 110' ' ' ILE . 25.1 m -108.81 146.59 33.39 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.548 ' O ' HG13 ' A' ' 110' ' ' ILE . 25.4 tp -52.61 -45.89 66.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -168.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.581 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 38.9 m -67.19 -41.56 85.67 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.096 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.37 -37.77 88.66 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.4 pp -76.96 -22.36 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 109.992 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -67.98 -49.38 62.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.05 171.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.581 ' HG3' ' O ' ' A' ' 108' ' ' SER . 22.2 mttt -55.26 -30.31 59.84 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 121.295 0.569 . . . . 0.0 110.155 172.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.62 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 4.5 tp60 -68.24 -56.82 7.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.617 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.465 HG21 ' N ' ' A' ' 115' ' ' TYR . 33.8 m -86.32 -42.91 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.158 -172.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.473 ' HB3' HD13 ' A' ' 120' ' ' LEU . 17.6 m-85 -90.82 -26.18 19.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.747 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.14 -9.73 76.86 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.626 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.517 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 26.2 t30 -126.12 129.35 48.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.554 ' CB ' ' HG2' ' A' ' 112' ' ' LYS . . . -72.9 -28.95 62.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.631 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.82 -19.19 65.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.551 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.517 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 54.6 mt -82.99 13.93 3.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.122 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.648 ' HD2' ' CD1' ' A' ' 121' ' ' TYR . 42.6 p90 -61.2 -32.62 72.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.424 0.63 . . . . 0.0 110.333 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.488 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 11.7 p30 -69.57 -30.04 67.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.458 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -61.94 -46.55 88.84 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.285 0.564 . . . . 0.0 109.656 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.5 mt -64.52 -44.94 96.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.451 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.529 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 26.2 t80 -51.8 -59.44 4.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.207 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 45.4 mt-10 -59.22 -41.37 88.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.361 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -59.51 -31.62 69.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.377 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.478 ' OD1' ' HA ' ' A' ' 144' ' ' LEU . 43.0 m-80 -90.11 -1.63 57.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 132' ' ' LEU . 29.5 mtpp -81.84 155.19 70.63 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.683 0.277 . . . . 0.0 110.362 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.448 ' HB2' ' O ' ' A' ' 38' ' ' THR . 1.9 Cg_endo -87.58 24.56 18.33 Favored 'Cis proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.819 -1.326 . . . . 0.0 113.461 0.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.467 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.1 OUTLIER -76.35 -37.13 57.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.222 0.534 . . . . 0.0 110.044 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 129' ' ' LYS . 13.4 tp -98.0 117.13 31.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.891 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -81.24 -51.29 8.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.783 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.4 m -138.29 154.61 73.94 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.527 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.24 -54.4 5.51 Favored 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 123.415 2.743 . . . . 0.0 112.963 -175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.98 5.76 24.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.541 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -83.82 -0.94 53.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.628 0.251 . . . . 0.0 111.185 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.9 pt -65.76 168.36 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -158.49 153.48 21.43 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.07 112.85 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.043 2.496 . . . . 0.0 112.389 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 96.77 35.91 5.22 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.615 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.604 ' O ' HG11 ' A' ' 101' ' ' VAL . 7.2 tp60 -108.78 121.43 45.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.988 0.394 . . . . 0.0 110.152 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.454 HG22 ' CD2' ' A' ' 6' ' ' PHE . 41.2 t -83.62 129.46 37.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.237 0.542 . . . . 0.0 110.645 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.478 ' HA ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -118.98 130.83 55.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.229 -177.14 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.5 ' HG2' HG23 ' A' ' 72' ' ' VAL . 55.3 mtp180 -69.52 119.26 13.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.334 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 27.6 mm -106.93 95.58 12.87 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 35.0 Cg_exo -61.49 149.88 87.71 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.656 2.237 . . . . 0.0 111.737 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -58.55 132.23 53.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.286 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -73.46 67.5 1.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.152 0.501 . . . . 0.0 110.961 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.67 61.52 6.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 172.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -140.38 121.52 14.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.647 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -117.96 152.28 35.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.659 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 60.14 57.11 3.08 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.709 0.631 . . . . 0.0 111.032 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -111.81 122.97 49.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.258 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.523 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 5.7 t-80 -60.99 134.93 57.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.167 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' A' ' 155' ' ' HIS . 13.0 m-70 75.15 126.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.959 0.787 . . . . 0.0 110.65 -173.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 . . . . . 0 C--O 1.247 0.949 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.117 177.345 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.43 68.73 1.48 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.995 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.1 mt -73.51 134.01 43.76 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.76 0.791 . . . . 0.0 112.225 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 1.656 ' HD2' ' CD1' ' A' ' 4' ' ' PHE . 97.7 m-85 -101.44 127.11 48.25 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.358 175.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -87.43 134.08 33.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.697 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 50.7 m-85 -117.76 -158.15 0.7 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 88.5 t -89.36 -79.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.015 173.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.6 tmtp? 165.82 -71.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.017 0.823 . . . . 0.0 109.235 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.03 -25.95 34.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.355 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.79 124.06 23.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.963 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.21 -178.02 28.84 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -71.5 130.0 40.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 117.017 0.408 . . . . 0.0 109.911 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -77.64 92.93 4.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.356 0.598 . . . . 0.0 111.554 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.9 mp -91.98 -42.54 9.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.556 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.407 ' CB ' ' HG2' ' A' ' 21' ' ' GLN . 38.5 p90 -136.14 23.86 3.27 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.708 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 66.26 -6.46 0.48 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.22 29.27 17.4 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.815 0.446 . . . . 0.0 111.951 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.0 t -106.24 -71.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.006 0.431 . . . . 0.0 110.461 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 p -121.04 -39.79 2.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.92 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 145.93 -139.78 8.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.731 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.407 ' HG2' ' CB ' ' A' ' 15' ' ' TRP . 15.2 mm-40 -141.13 -91.54 0.15 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.408 0.146 . . . . 0.0 110.645 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -94.38 -35.12 12.51 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 4.3 t70 -169.15 -175.04 2.16 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -81.18 -39.21 25.84 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.702 0.287 . . . . 0.0 110.405 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -72.07 -21.54 61.5 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 24.2 t70 -64.34 -37.37 87.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.957 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.581 ' O ' HG21 ' A' ' 31' ' ' VAL . 20.7 mt-30 -61.55 -38.98 89.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.291 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.2 -42.89 96.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.101 0.477 . . . . 0.0 110.483 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 27.1 ttpp -62.04 -42.84 99.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.041 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 28.0 mmtp -60.44 -40.11 89.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.97 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 27' ' ' GLN . 95.3 t -58.29 -49.06 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.359 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -55.16 -46.61 75.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.922 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 46.6 mt-10 -57.28 -44.15 83.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.732 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -57.81 -44.74 86.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.979 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 91.3 mt -64.96 -40.79 95.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.964 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -72.5 -34.01 67.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.273 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -72.1 -33.19 67.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.42 -25.35 46.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.109 0.48 . . . . 0.0 110.854 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.35 26.91 12.71 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.082 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.0 mm -65.09 122.15 78.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -75.45 151.21 37.29 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.978 1.785 . . . . 0.0 111.745 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 63.78 6.72 2.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.949 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.24 -22.92 61.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.018 0.437 . . . . 0.0 111.001 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -77.32 -19.67 56.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.383 176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -77.47 -21.81 52.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.986 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.5 m -101.34 173.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.338 0.59 . . . . 0.0 111.88 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -131.19 140.56 49.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.991 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.3 mm -102.99 138.68 26.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.957 0.408 . . . . 0.0 111.118 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -137.29 122.53 19.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.699 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.404 HG22 ' NE2' ' A' ' 27' ' ' GLN . 17.4 mm -92.93 122.37 44.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.979 0.419 . . . . 0.0 110.597 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.7 70.41 0.71 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.98 -82.34 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.325 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 -5.86 23.34 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.989 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 106.3 17.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.941 0.401 . . . . 0.0 111.017 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 80' ' ' ILE . . . -83.09 111.18 18.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.45 HG21 ' HB3' ' A' ' 84' ' ' ASP . 32.6 m -93.31 132.49 37.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.858 0.361 . . . . 0.0 111.32 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.99 123.56 65.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.0 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -122.75 158.04 31.02 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.385 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.22 177.7 28.75 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -160.16 145.18 14.89 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.053 0.426 . . . . 0.0 110.433 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 90' ' ' ALA . . . 100.26 11.7 41.34 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.942 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 mp -96.12 165.67 12.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.172 0.51 . . . . 0.0 111.574 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.0 m -85.57 143.02 28.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.871 174.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -63.92 -28.18 69.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.466 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.46 -29.59 59.67 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.904 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.38 -39.98 31.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.744 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -62.68 -31.97 72.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.679 -176.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.575 ' O ' HG22 ' A' ' 72' ' ' VAL . 6.5 mm-40 -65.29 -42.59 92.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.148 0.499 . . . . 0.0 110.118 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.46 -43.9 96.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.668 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.5 mt -61.52 -53.65 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.583 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 94.9 mt -44.65 -48.35 10.54 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.798 0.686 . . . . 0.0 111.917 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 68' ' ' GLU . 54.8 t -62.91 -52.11 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.141 0.496 . . . . 0.0 111.053 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.9 70.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.692 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.402 HG11 HG12 ' A' ' 31' ' ' VAL . 52.7 t -75.04 -43.38 45.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.697 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -71.8 -28.79 68.33 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.329 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -77.79 45.29 0.5 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.062 0.458 . . . . 0.0 111.919 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.3 mt -117.89 140.33 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.356 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.9 t -65.96 103.28 0.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.529 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.14 -19.71 4.08 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.443 HG22 ' HA2' ' A' ' 75' ' ' GLY . 34.8 mm -97.13 133.24 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.301 0.572 . . . . 0.0 110.546 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 8' ' ' LYS . . . -113.45 -14.21 12.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.479 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 p -165.26 150.77 9.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.777 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 4' ' ' PHE . 15.0 p -120.3 134.23 64.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.835 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.45 ' HB3' HG21 ' A' ' 56' ' ' THR . 22.7 t0 -101.71 125.53 48.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.0 101.36 13.91 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.847 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -119.11 12.96 12.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.205 0.526 . . . . 0.0 110.217 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 p -86.77 128.28 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.432 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -89.18 147.35 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.841 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.4 p -108.01 142.09 38.68 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.83 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.421 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . . . -95.2 -33.17 12.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.321 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 p -126.87 134.77 26.46 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.087 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.72 119.05 5.29 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.579 2.186 . . . . 0.0 111.102 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -130.48 -160.91 1.08 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.658 -175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 m -76.47 116.87 17.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.101 0.477 . . . . 0.0 111.764 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.38 162.69 24.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.732 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 m -128.02 150.17 50.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.49 0.662 . . . . 0.0 112.308 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.6 tt0 -91.16 139.33 30.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.144 172.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -106.35 82.27 1.72 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.95 0.405 . . . . 0.0 110.838 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.64 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 75.6 t80 -84.71 141.32 30.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.062 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.2 m -107.44 118.8 37.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.694 0.283 . . . . 0.0 110.77 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.493 HG21 ' H ' ' A' ' 142' ' ' GLN . 1.0 OUTLIER -72.56 134.05 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.4 mmtp -100.99 -166.03 1.27 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.397 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.8 t -72.77 122.64 21.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.948 0.404 . . . . 0.0 109.959 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.67 7.18 69.23 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.91 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 102' ' ' LYS . 5.8 m-20 -82.6 118.84 23.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.211 0.529 . . . . 0.0 110.518 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.571 ' O ' HG21 ' A' ' 110' ' ' ILE . 7.1 m -100.74 149.43 23.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.81 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.513 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 24.4 tp -58.66 -35.21 72.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.571 0.623 . . . . 0.0 110.29 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.435 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 9.1 p -69.22 -40.33 78.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.401 0.62 . . . . 0.0 110.567 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.566 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -68.18 -38.92 82.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.152 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.595 ' HA ' ' CG ' ' A' ' 113' ' ' GLN . 1.5 pp -79.34 -23.79 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.7 p -74.57 -34.96 63.02 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 5.7 tmmm? -58.34 -30.53 66.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.768 170.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.595 ' CG ' ' HA ' ' A' ' 110' ' ' ILE . 11.0 mm100 -68.32 -72.22 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.126 0.965 . . . . 0.0 110.774 175.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 110' ' ' ILE . 29.2 m -73.32 -36.87 50.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 113.65 -1.613 . . . . 0.0 112.631 -166.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.53 ' HH ' ' HG2' ' A' ' 147' ' ' PRO . 22.8 m-85 -97.46 -22.86 16.34 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.482 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.21 11.31 76.08 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.436 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -151.94 124.19 8.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.66 0.267 . . . . 0.0 110.791 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 108' ' ' SER . . . -73.58 -19.54 60.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.951 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -68.15 -24.64 65.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 51.6 mt -85.83 20.46 2.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.757 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 17.3 p90 -68.95 -28.42 66.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.121 0.486 . . . . 0.0 110.217 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.509 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 27.1 p-10 -70.63 -31.48 68.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.448 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 29.4 mmmt -54.81 -49.19 71.58 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.428 0.632 . . . . 0.0 110.158 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mt -66.72 -47.51 82.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.315 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.537 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 44.7 t80 -49.32 -54.02 19.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.561 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 34.8 mt-10 -61.96 -36.62 81.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.244 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.37 -31.02 65.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.459 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 131' ' ' MET . 8.1 m120 -76.09 -27.95 57.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.969 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.561 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 29.5 mtpp -61.24 151.72 75.01 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.087 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -88.73 17.03 41.65 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.672 -1.803 . . . . 0.0 112.779 0.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.448 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -69.37 -37.56 77.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.417 177.176 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.74 117.01 29.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.66 -37.39 24.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.574 -174.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.428 ' HB2' ' HG3' ' A' ' 137' ' ' LYS . 19.3 m -152.0 144.55 16.85 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.151 0.501 . . . . 0.0 109.879 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.41 -20.37 66.18 Favored 'Trans proline' 0 C--N 1.332 -0.32 0 C-N-CA 123.487 2.791 . . . . 0.0 112.545 -171.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -98.73 -4.65 33.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.909 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 134' ' ' SER . 27.3 mtpp -90.15 9.28 28.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.928 0.394 . . . . 0.0 111.284 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 14.0 pt -58.89 169.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.569 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -157.21 143.87 13.29 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.069 -175.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.6 112.73 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.281 2.654 . . . . 0.0 112.559 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 107.56 27.01 5.4 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.894 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.493 ' H ' HG21 ' A' ' 101' ' ' VAL . 48.1 tt0 -103.21 116.61 32.79 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.989 -175.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.657 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 25.7 t -80.63 130.88 35.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.7 mt -118.25 145.58 44.92 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.795 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.443 ' HB2' HG23 ' A' ' 72' ' ' VAL . 37.3 ttt180 -74.93 98.38 3.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.826 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 19.7 mm -87.51 106.55 11.8 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.53 ' HG2' ' HH ' ' A' ' 115' ' ' TYR . 34.7 Cg_endo -67.65 156.04 67.65 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.718 1.612 . . . . 0.0 111.748 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.89 136.08 56.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.805 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -67.73 101.63 1.08 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.092 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 151' ' ' GLU . 44.0 tp -103.58 90.5 3.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 150' ' ' LEU . 34.4 tt0 71.11 147.58 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.93 0.769 . . . . 0.0 110.035 -172.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -134.78 123.57 23.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.407 0.622 . . . . 0.0 112.484 -175.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -82.45 78.88 9.04 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -78.02 41.34 0.36 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -169.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -136.5 114.47 11.36 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.277 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -113.97 -30.52 6.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.827 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 38.6 t60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.739 -178.197 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.589 ' HA ' ' O ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.685 0.279 . . . . 0.0 110.397 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.42 167.33 16.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.064 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 83' ' ' VAL . 41.3 tp -134.87 125.78 27.46 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 1.657 ' HE1' ' CE2' ' A' ' 4' ' ' PHE . 78.1 m-85 -124.72 138.9 54.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.901 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -98.19 140.99 31.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.618 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.625 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 86.7 m-85 -127.27 -171.69 2.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.037 0.446 . . . . 0.0 111.899 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.569 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 4.5 p -78.16 -26.44 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.176 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.537 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 25.1 tptp 78.95 -55.05 0.45 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.472 0.709 . . . . 0.0 112.295 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.08 7.23 43.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.569 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -125.21 157.62 36.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 121.243 -0.183 . . . . 0.0 110.561 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.6 -148.29 16.88 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.089 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.465 ' HG2' ' ND1' ' A' ' 34' ' ' HIS . 8.9 tp10 -82.39 129.87 34.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.007 0.404 . . . . 0.0 110.277 177.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -95.84 93.16 6.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.775 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.36 -51.32 6.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -105.97 2.34 27.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.218 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 63.09 104.93 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.117 0.885 . . . . 0.0 111.214 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HB3' ' C ' ' A' ' 78' ' ' SER . . . -73.02 79.97 1.2 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.386 0.612 . . . . 0.0 110.371 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.0 p -170.26 -35.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.514 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 p -103.59 -62.03 1.35 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.323 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.79 73.16 1.08 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -84.74 121.46 27.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.138 -0.531 . . . . 0.0 111.765 -171.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 38.3 m80 65.81 -170.65 0.19 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.134 174.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -67.69 163.98 20.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.459 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' HZ1' ' CG ' ' A' ' 52' ' ' ASP . 88.4 mttt -70.31 -30.14 67.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.651 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -67.78 -31.32 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.956 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 24.3 t70 -70.26 -35.88 74.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.734 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.457 ' O ' HG21 ' A' ' 31' ' ' VAL . 90.9 mt-30 -63.17 -36.46 83.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.379 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.06 86.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -63.68 -39.91 95.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.556 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -62.42 -32.94 73.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.157 177.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 84.6 t -68.48 -44.99 82.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.377 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -52.87 -52.26 58.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.311 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.32 -41.32 88.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.702 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.465 ' ND1' ' HG2' ' A' ' 12' ' ' GLU . 31.9 t60 -54.52 -48.67 71.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.805 0.336 . . . . 0.0 110.797 174.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 77.4 mt -66.92 -42.8 84.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.985 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -75.99 -27.11 57.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.725 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.55 -34.36 47.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.495 0.188 . . . . 0.0 111.159 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 130' ' ' PRO . 2.0 p -73.44 -44.55 57.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.675 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.2 32.86 1.58 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.529 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.429 HD11 ' HD2' ' A' ' 130' ' ' PRO . 35.8 mm -73.08 126.69 90.22 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 5.7 Cg_exo -73.54 145.09 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.374 2.049 . . . . 0.0 112.763 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 63.56 15.8 9.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.12 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.36 -23.8 63.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.239 0.542 . . . . 0.0 110.457 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.13 -20.51 62.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.801 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -92.03 -26.24 18.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.952 0.406 . . . . 0.0 110.984 -174.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 70' ' ' ILE . 33.6 m -90.26 163.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -128.41 131.61 48.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.705 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.7 mp -105.79 128.89 59.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.08 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -117.15 132.74 56.59 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.2 mm -105.04 108.82 25.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.379 0.609 . . . . 0.0 111.331 -175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 52' ' ' ASP . . . -99.05 69.26 1.74 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.096 176.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.417 ' CG ' ' HZ1' ' A' ' 24' ' ' LYS . 3.5 m-20 70.2 -80.04 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.132 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.75 -8.21 12.41 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.702 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 84' ' ' ASP . 82.4 tttt -102.26 112.97 25.87 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.049 0.452 . . . . 0.0 110.688 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -94.54 121.39 36.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.139 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.0 m -99.93 118.24 35.94 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.26 122.76 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.89 155.16 33.24 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.859 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.4 174.74 36.75 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 p-10 -153.02 142.31 21.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.975 0.417 . . . . 0.0 110.649 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.89 17.42 61.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.238 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mp -93.34 178.41 5.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.103 0.477 . . . . 0.0 111.201 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.8 m -126.82 149.55 49.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.99 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.478 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 15.7 mm100 -57.53 -26.59 61.6 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.988 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.82 -36.6 72.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.722 0.296 . . . . 0.0 111.785 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.85 -34.45 10.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.498 . . . . 0.0 110.396 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 82.3 tttt -61.0 -41.26 96.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.469 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.469 ' O ' ' HD2' ' A' ' 145' ' ' ARG . 7.1 mm-40 -78.25 8.92 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.086 0.469 . . . . 0.0 110.822 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -98.72 -46.44 5.68 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.518 ' O ' HG13 ' A' ' 74' ' ' VAL . 20.7 mt -67.34 -55.34 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.352 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 tp -65.33 -16.85 64.02 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.099 -170.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 63.9 t -90.6 -52.63 10.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.327 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.32 -18.98 65.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.954 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 70' ' ' ILE . 7.6 p -82.05 -42.74 19.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.875 0.369 . . . . 0.0 110.693 175.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.625 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -67.71 -35.92 86.54 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.135 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -85.3 38.23 0.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.546 0.689 . . . . 0.0 111.262 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.2 mt -102.29 144.13 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.116 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.42 ' C ' ' HB3' ' A' ' 17' ' ' ALA . 67.8 m -70.47 99.26 1.58 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.428 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.97 -18.27 3.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.986 -175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 41.0 mm -98.53 120.5 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.376 0.608 . . . . 0.0 110.991 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.537 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -98.55 -24.91 14.93 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.738 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.7 m -159.52 160.21 34.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.917 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.563 HG11 ' HB2' ' A' ' 4' ' ' PHE . 4.3 p -131.31 138.4 53.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.891 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HB2' ' CE ' ' A' ' 54' ' ' LYS . 31.3 t70 -111.36 120.53 42.51 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 1' ' ' MET . 7.1 t0 -88.54 121.46 30.95 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.107 0.479 . . . . 0.0 110.942 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -135.26 32.16 3.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.592 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.74 110.61 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.087 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 53.5 mttm -74.76 130.09 38.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.966 0.412 . . . . 0.0 110.144 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 p -105.29 124.6 49.82 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.767 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.97 -18.17 44.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.96 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.6 p -109.27 144.88 30.66 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.72 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.36 42.73 1.28 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.985 2.457 . . . . 0.0 111.988 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.85 156.59 32.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.899 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 m -74.07 129.13 37.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.182 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.74 164.17 23.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.397 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.9 m -120.16 148.16 43.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.189 0.518 . . . . 0.0 111.471 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -78.67 148.91 32.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.426 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.662 ' HE1' ' CE2' ' A' ' 98' ' ' PHE . 22.9 m-85 -116.54 116.22 27.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.875 0.369 . . . . 0.0 110.531 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.671 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 94.4 t80 -110.57 130.26 55.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.9 m -94.08 118.54 31.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.587 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 2.0 m -72.63 130.3 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 140' ' ' PRO . 73.3 mmtt -98.72 -60.43 1.54 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -169.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.4 t -164.0 122.76 1.92 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.745 0.307 . . . . 0.0 110.189 -174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.62 11.06 72.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.827 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.587 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 2.0 m-20 -73.16 121.33 20.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.265 0.555 . . . . 0.0 110.431 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.574 ' O ' HG21 ' A' ' 110' ' ' ILE . 46.3 p -114.63 157.7 22.73 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 135' ' ' PRO . 26.0 tp -58.05 -40.55 81.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.583 0.629 . . . . 0.0 111.455 -170.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 13.3 m -76.54 -20.12 57.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.067 0.46 . . . . 0.0 111.05 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.8 -39.55 26.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.049 -0.407 . . . . 0.0 110.43 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.1 pp -80.25 -24.5 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.958 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.0 p -70.21 -45.12 67.24 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -61.41 -24.28 66.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.579 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.73 HE21 ' HH ' ' A' ' 99' ' ' TYR . 1.6 tp-100 -72.12 -57.75 4.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.977 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.535 HG21 ' N ' ' A' ' 115' ' ' TYR . 32.6 m -84.0 -48.43 17.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.043 -172.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.535 ' N ' HG21 ' A' ' 114' ' ' VAL . 56.2 m-85 -82.23 -41.23 20.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.056 0.455 . . . . 0.0 110.647 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.96 -14.73 34.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.997 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -123.0 123.12 40.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.815 0.341 . . . . 0.0 110.297 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 108' ' ' SER . . . -67.32 -27.59 67.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.675 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -74.58 -3.55 31.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 0.0 111.282 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 115' ' ' TYR . 68.4 mt -91.11 19.49 5.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.232 0.539 . . . . 0.0 110.682 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -63.09 -35.77 81.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.499 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -67.4 -27.64 67.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.723 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -60.08 -43.74 95.28 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.355 0.597 . . . . 0.0 109.921 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.0 mt -72.21 -43.35 65.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.296 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.405 ' CE1' ' HA ' ' A' ' 134' ' ' SER . 61.1 t80 -55.54 -53.01 61.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.249 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.448 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 19.2 mt-10 -68.11 -24.01 64.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.349 0.595 . . . . 0.0 111.399 -177.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -79.38 -25.76 42.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.85 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.608 ' HB3' ' HE3' ' A' ' 131' ' ' MET . 24.1 m-80 -99.13 18.68 16.83 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.028 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.448 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 30.5 mmmt -79.76 140.83 55.0 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.209 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.429 ' HD2' HD11 ' A' ' 40' ' ' ILE . 19.6 Cg_endo -100.22 13.24 23.51 Favored 'Cis proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.84 -0.9 . . . . 0.0 112.078 -6.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.608 ' HE3' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -65.51 -25.93 67.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.712 -178.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.433 HD13 ' N ' ' A' ' 133' ' ' LYS . 9.0 tp -100.63 122.7 43.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 170.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.504 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 9.6 mptt -81.05 -44.71 17.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.738 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.405 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 57.2 p -157.72 163.11 25.79 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.882 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.423 ' HA ' HD23 ' A' ' 107' ' ' LEU . 51.8 Cg_exo -54.5 -28.13 53.32 Favored 'Trans proline' 0 C--N 1.328 -0.526 0 C-N-CA 123.096 2.531 . . . . 0.0 112.316 175.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.11 -20.25 19.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.48 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -73.48 -6.93 49.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -173.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.612 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 21.1 pt -65.82 166.56 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.182 0.515 . . . . 0.0 111.086 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 142' ' ' GLN . 12.4 p90 -165.58 148.99 7.02 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.923 -177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.437 ' HB3' ' O ' ' A' ' 102' ' ' LYS . 50.5 Cg_exo -42.71 118.32 1.13 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.915 3.077 . . . . 0.0 113.313 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 106.66 12.32 24.85 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.799 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.612 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 14.0 mt-30 -99.86 120.77 40.3 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.968 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 23.2 t -86.53 127.73 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.173 170.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.3 mt -117.72 143.28 46.35 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.754 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 68' ' ' GLU . 42.2 ttt180 -70.37 118.93 13.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.691 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.3 mm -111.16 90.19 11.13 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.766 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.54 176.67 9.77 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.32 2.013 . . . . 0.0 111.801 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.8 132.75 49.46 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.02 73.44 0.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.211 0.529 . . . . 0.0 111.925 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 77.4 mt -66.25 132.37 48.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.732 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.04 94.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.565 0.541 . . . . 0.0 111.597 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -136.72 -16.84 1.49 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.505 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -159.7 75.04 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -94.15 146.21 24.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.302 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -146.85 -60.86 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 0.0 110.918 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -77.02 130.62 37.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 110.372 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 75.1 m80 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.059 179.427 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 121.235 0.54 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.26 124.46 4.73 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.388 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 83' ' ' VAL . 47.9 tp 68.7 134.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.478 0.711 . . . . 0.0 111.981 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 1.669 ' HE1' ' CE2' ' A' ' 4' ' ' PHE . 83.4 m-85 -123.61 147.16 47.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.982 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -114.9 138.55 50.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.988 0.423 . . . . 0.0 111.165 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.534 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 37.8 m-85 -130.27 171.03 13.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.339 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.67 119.29 35.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.941 0.4 . . . . 0.0 110.009 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 81' ' ' ALA . 5.0 tmtp? -52.2 -40.34 61.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.232 -171.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.31 -17.07 35.52 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.277 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.07 164.65 15.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.927 0.394 . . . . 0.0 111.535 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.52 -170.92 14.29 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.061 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.97 125.47 26.06 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -77.27 59.94 1.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.219 1.009 . . . . 0.0 109.062 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 30' ' ' LYS . 17.3 tp -64.52 -51.57 62.21 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.428 -175.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.572 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 3.3 p90 -117.71 -0.53 11.78 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.168 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 18' ' ' VAL . 7.4 m-20 68.2 -36.23 0.3 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.814 0.846 . . . . 0.0 113.102 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' N ' ' HD1' ' A' ' 15' ' ' TRP . . . 77.18 -30.57 0.17 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.25 1.02 . . . . 0.0 111.455 177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.43 ' H ' ' C ' ' A' ' 16' ' ' ASP . 16.0 m -85.13 -15.68 10.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.474 174.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.412 ' O ' HG21 ' A' ' 19' ' ' THR . 7.2 t -179.09 105.57 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.484 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.37 -19.26 2.27 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.034 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.572 ' HB2' ' CD1' ' A' ' 15' ' ' TRP . 30.5 tt0 -98.61 141.25 31.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.335 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -132.8 -89.4 0.41 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.713 0.292 . . . . 0.0 111.293 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.575 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 8.1 m-20 -97.22 148.76 22.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.451 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -64.67 -38.38 90.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.069 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -72.57 -22.63 60.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.088 0.47 . . . . 0.0 110.203 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 12.8 t70 -74.95 -41.4 59.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.53 172.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 23' ' ' ASP . 24.8 mt-30 -57.65 -44.17 85.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.159 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.48 -44.87 73.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.966 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 52.5 tttm -66.35 -43.87 84.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.807 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -55.44 -42.61 74.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.339 178.063 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.641 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 43.2 t -66.16 -44.41 91.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.597 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.491 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 8.6 mm-40 -57.77 -46.58 84.34 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.548 0.213 . . . . 0.0 111.01 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.628 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.2 mt-10 -58.44 -46.33 86.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -55.78 -44.01 77.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.351 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 83.8 mt -64.16 -38.45 91.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 110.557 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -78.27 -22.83 47.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.197 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 32.5 mmmt -75.52 -48.07 24.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.903 0.382 . . . . 0.0 110.344 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 p -64.24 -38.71 92.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.505 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.32 32.69 3.63 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.585 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.503 HD11 ' HD2' ' A' ' 130' ' ' PRO . 29.9 mm -72.6 120.36 80.21 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -81.09 150.58 17.92 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 122.099 1.866 . . . . 0.0 111.876 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 65.57 11.9 7.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.259 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.42 -25.64 33.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.189 0.518 . . . . 0.0 110.045 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.03 -12.05 59.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.881 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -76.97 -25.23 52.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.841 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.14 168.11 3.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.397 0.618 . . . . 0.0 111.822 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -121.93 146.62 46.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.415 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.491 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 21.0 mm -105.63 137.07 37.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.878 0.37 . . . . 0.0 110.692 -177.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.407 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 98.6 mt-30 -134.04 145.68 49.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.564 HG22 ' NE2' ' A' ' 27' ' ' GLN . 26.0 mm -126.09 128.12 71.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.114 0.483 . . . . 0.0 111.754 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -119.22 89.2 3.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.046 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 63.85 -92.65 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.735 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.26 10.5 13.18 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.605 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 82' ' ' SER . 21.7 ttmm -104.18 112.84 26.01 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.088 0.471 . . . . 0.0 110.381 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -92.06 121.75 33.92 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.982 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 23.7 m -100.22 116.7 32.83 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.9 t -92.78 133.9 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.779 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -142.06 160.64 39.81 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.009 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.43 172.29 31.71 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.55 146.08 41.44 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.99 0.395 . . . . 0.0 110.22 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.63 10.74 78.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.229 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.86 168.7 19.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.122 0.487 . . . . 0.0 111.896 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.3 p -111.18 154.06 24.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.87 0.74 8.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.13 -51.46 4.62 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.72 90.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.746 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.423 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 19.8 ptmt -58.79 -34.63 71.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.671 0.272 . . . . 0.0 111.544 -174.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.524 ' O ' HG21 ' A' ' 72' ' ' VAL . 6.4 mm-40 -65.96 -29.45 69.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.215 0.531 . . . . 0.0 110.083 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -72.73 -40.8 65.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.599 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.41 ' O ' HG13 ' A' ' 74' ' ' VAL . 2.4 mp -63.11 -47.21 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 96.4 mt -53.73 -32.74 53.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.008 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 68' ' ' GLU . 47.0 t -72.15 -58.32 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.393 0.616 . . . . 0.0 110.975 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.38 -28.32 69.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.451 -173.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 31' ' ' VAL . 7.2 p -79.98 -26.14 12.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.337 0.589 . . . . 0.0 110.661 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.534 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -83.99 -34.16 18.94 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.543 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.57 60.95 2.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.018 0.437 . . . . 0.0 111.006 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.461 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 7.9 mm -126.22 128.81 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -65.11 113.4 3.92 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.28 -13.76 11.08 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.397 -171.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.461 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 37.4 mm -100.61 138.86 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.064 0.459 . . . . 0.0 110.133 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.55 ' CB ' ' HG2' ' A' ' 8' ' ' LYS . . . -125.55 -17.04 5.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.5 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 9.2 p -155.87 158.57 38.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.081 0.467 . . . . 0.0 111.321 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 56.0 t -133.23 130.5 57.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.949 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -104.05 124.58 49.3 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -95.23 101.41 13.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.302 -174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -119.11 11.84 12.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.121 0.486 . . . . 0.0 110.596 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.43 135.52 26.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.228 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -99.77 141.85 32.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.631 -173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.5 p -109.17 137.44 47.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.194 0.521 . . . . 0.0 111.445 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.62 -35.79 9.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.393 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 24.2 p -112.43 147.05 36.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.293 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 3.0 Cg_endo -80.43 143.09 15.18 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.417 2.744 . . . . 0.0 111.843 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -161.06 166.68 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.209 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.7 m -73.39 131.43 41.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.502 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.8 173.31 8.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.7 m -123.8 151.76 42.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.442 0.639 . . . . 0.0 111.297 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 17.9 tt0 -89.81 143.36 26.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.132 173.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -105.77 102.06 11.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.247 0.546 . . . . 0.0 111.067 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 93.3 t80 -102.14 135.99 42.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.219 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.0 m -105.46 122.29 45.7 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.49 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 1.2 m -67.37 126.74 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 140' ' ' PRO . 34.5 mmtp -87.18 -66.06 0.95 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -170.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.2 t -175.12 122.63 0.22 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.88 15.12 81.6 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -172.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.49 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -86.42 118.12 25.64 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.547 -0.827 . . . . 0.0 109.885 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.603 ' O ' HG21 ' A' ' 110' ' ' ILE . 22.7 p -109.03 157.8 18.34 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -55.29 -45.54 76.23 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.579 -174.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.4 m -61.09 -42.45 98.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.709 0.29 . . . . 0.0 110.82 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.36 87.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.341 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.603 HG21 ' O ' ' A' ' 106' ' ' THR . 1.2 pp -76.27 -26.52 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.74 0.305 . . . . 0.0 110.442 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.53 ' OG ' ' HA ' ' A' ' 121' ' ' TYR . 42.5 m -68.37 -46.45 70.05 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-O 121.204 0.526 . . . . 0.0 109.793 169.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -56.38 -30.61 62.93 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.326 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.902 HE21 ' HH ' ' A' ' 99' ' ' TYR . 1.6 tp-100 -68.52 -63.3 1.09 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.4 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' ' 115' ' ' TYR . 23.5 m -80.0 -40.98 20.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.111 -170.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.435 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 15.7 m-85 -91.27 -49.74 6.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.446 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.95 5.74 32.91 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.418 ' HB3' ' CD1' ' A' ' 120' ' ' LEU . 58.6 t-20 -135.17 113.91 11.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.52 -15.59 62.31 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -85.48 -2.87 58.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.04 0.448 . . . . 0.0 110.743 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . 63.4 mt -89.51 18.65 5.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.061 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.53 ' HA ' ' OG ' ' A' ' 111' ' ' SER . 47.5 p90 -68.94 -26.14 64.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.084 -174.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -68.93 -36.47 78.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.439 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.477 ' HZ2' ' CD ' ' A' ' 149' ' ' GLU . 31.6 mtmt -54.26 -52.76 60.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.328 0.585 . . . . 0.0 110.697 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.6 mt -68.75 -39.44 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.747 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.521 ' HA ' ' CD2' ' A' ' 132' ' ' LEU . 5.5 t80 -59.55 -52.91 63.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.745 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.438 ' HA ' ' HG3' ' A' ' 129' ' ' LYS . 2.2 mm-40 -60.99 -39.66 90.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.131 0.491 . . . . 0.0 111.507 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -63.85 -28.04 69.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.386 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.537 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 38.9 m-80 -98.99 6.69 46.57 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.438 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 20.9 mtmm -78.7 156.2 77.89 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 122.101 -0.374 . . . . 0.0 110.709 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.503 ' HD2' HD11 ' A' ' 40' ' ' ILE . 1.3 Cg_endo -87.73 14.62 46.83 Favored 'Cis proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.994 -1.253 . . . . 0.0 112.478 -3.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.537 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.0 tmm? -64.71 -39.23 93.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.521 ' CD2' ' HA ' ' A' ' 125' ' ' PHE . 35.0 tp -97.33 117.83 32.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.409 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 10.6 mptt -87.51 -33.9 18.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.899 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.456 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 15.1 p -161.8 155.0 17.56 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.137 0.494 . . . . 0.0 109.751 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 134' ' ' SER . 12.2 Cg_endo -60.75 -8.14 8.79 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 123.679 2.919 . . . . 0.0 113.117 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -113.72 -14.8 12.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.238 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -87.47 20.16 3.0 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.476 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 8.3 pt -79.06 172.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -154.12 142.05 13.99 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.428 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 102' ' ' LYS . 80.4 Cg_exo -51.07 114.27 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.261 2.641 . . . . 0.0 112.851 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.34 13.91 11.33 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.892 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.478 ' H ' HG23 ' A' ' 101' ' ' VAL . 41.5 tt0 -98.47 120.58 39.14 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.661 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.65 133.18 29.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.281 0.562 . . . . 0.0 109.999 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.1 mt -126.2 136.03 52.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.605 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.463 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 2.2 ptm180 -74.49 123.64 25.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.222 0.534 . . . . 0.0 110.026 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 37.0 mm -100.34 102.9 20.13 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.784 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 46.4 Cg_exo -56.77 145.37 83.45 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.377 2.052 . . . . 0.0 111.253 176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -57.21 119.81 7.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.618 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.477 ' CD ' ' HZ2' ' A' ' 123' ' ' LYS . 8.0 tp10 -66.15 125.7 26.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.979 -177.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 90.4 mt -120.07 13.48 12.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.658 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.55 112.04 2.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.259 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -102.17 -6.76 22.86 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -125.77 86.79 2.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.598 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -75.15 88.03 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.118 0.485 . . . . 0.0 110.798 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -146.75 130.66 17.16 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.406 ' HD2' ' OD1' ' A' ' 117' ' ' ASN . 31.6 m170 -61.76 -36.93 82.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.057 0.456 . . . . 0.0 110.74 -177.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 C--O 1.242 0.691 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.817 176.331 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 120.698 0.285 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.03 -7.98 1.92 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.476 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 23.9 tp -101.11 115.44 30.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.28 0.54 . . . . 0.0 110.82 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 82' ' ' SER . 82.8 m-85 -113.03 139.22 48.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.921 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -99.52 155.87 17.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.579 0.228 . . . . 0.0 110.909 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 1.652 ' HD2' ' CD1' ' A' ' 6' ' ' PHE . 94.2 m-85 -134.29 -158.73 0.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.977 0.418 . . . . 0.0 111.429 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.605 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 6.3 p -82.3 -23.14 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.462 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.556 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 18.5 tptm 75.82 -61.39 0.47 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.472 0.709 . . . . 0.0 111.891 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.44 -37.94 35.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -81.53 152.6 27.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.737 0.303 . . . . 0.0 110.622 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.25 -178.26 19.4 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.055 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.63 134.52 47.64 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -83.72 89.97 7.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.62 0.724 . . . . 0.0 112.287 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.408 HD21 HD13 ' A' ' 77' ' ' ILE . 6.4 mp -89.88 -39.15 13.23 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.672 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -136.33 151.51 49.68 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.33 -21.67 66.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.988 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 66.6 -1.25 1.34 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.101 0.56 . . . . 0.0 112.472 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 m -67.88 -41.05 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 120.976 0.417 . . . . 0.0 110.41 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.3 p -107.08 -3.87 19.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.486 174.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.47 -21.82 12.5 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.138 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 56.45 24.6 8.69 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.172 0.51 . . . . 0.0 110.796 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -75.25 -17.56 60.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.351 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -69.37 -12.92 62.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.94 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -101.62 145.0 29.66 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.698 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -92.44 -10.86 36.43 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.649 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 2.9 m-20 -73.26 -10.77 60.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.848 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -62.42 -31.83 72.58 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.929 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 48' ' ' ILE . . . -69.77 -35.0 74.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.313 0.578 . . . . 0.0 110.086 174.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -69.28 -38.99 78.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.642 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 75.3 mmtt -53.06 -43.4 66.67 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.556 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 51.7 t -69.73 -36.14 68.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.78 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -59.61 -43.52 93.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.0 mt-10 -57.7 -51.14 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.05 -47.11 53.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.347 177.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 91.6 mt -66.83 -41.95 86.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.192 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -72.13 -32.07 66.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.121 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 14.3 mmmm -72.34 -38.6 68.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 0.0 111.225 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.406 ' OG1' HG12 ' A' ' 40' ' ' ILE . 2.9 p -74.49 -31.42 62.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.156 0.503 . . . . 0.0 110.91 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.1 30.1 8.07 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.6 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.481 HD12 ' HD2' ' A' ' 130' ' ' PRO . 46.0 mm -59.3 129.01 86.34 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 122.264 0.226 . . . . 0.0 110.504 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -61.46 129.02 26.55 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.541 2.161 . . . . 0.0 112.637 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.16 22.75 10.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.53 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . . . -70.59 -20.04 62.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.207 0.527 . . . . 0.0 110.69 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -78.02 -15.78 58.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.244 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -87.53 -24.58 24.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.9 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.16 162.94 2.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.276 0.56 . . . . 0.0 111.73 -174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -126.92 150.49 49.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.328 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 56' ' ' THR . 60.6 mt -128.43 142.66 43.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.799 0.333 . . . . 0.0 111.549 -173.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -130.4 128.67 41.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.454 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 40.0 mm -106.1 119.66 55.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.028 0.442 . . . . 0.0 111.45 -175.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.75 79.27 1.2 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.182 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 69.38 -74.49 0.08 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.34 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.65 42.99 1.3 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 84' ' ' ASP . 49.4 tttm -141.98 114.25 8.24 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.453 ' O ' HG21 ' A' ' 83' ' ' VAL . . . -99.4 96.81 7.96 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.118 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 84' ' ' ASP . 21.1 m -84.83 112.83 20.89 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.414 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -101.2 131.15 49.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.273 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -130.71 160.57 33.91 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.389 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.59 142.24 3.65 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -122.98 150.72 42.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.947 0.403 . . . . 0.0 110.397 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.28 12.28 54.74 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.051 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.23 175.55 10.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.403 . . . . 0.0 111.768 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.7 p -127.05 144.98 50.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 172.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -46.74 -45.31 19.58 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 9.6 tp10 -61.14 -47.5 85.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.466 -174.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.33 -39.3 65.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.408 0.623 . . . . 0.0 110.315 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -52.34 -47.75 65.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.872 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -76.89 -20.2 56.53 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.548 -174.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 35.3 mmtm -62.26 -38.82 90.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mt -70.7 -58.51 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.421 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 mp -43.67 -48.25 7.8 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.35 -28.86 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.928 0.394 . . . . 0.0 111.439 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.86 -26.22 22.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -82.43 -23.71 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 110.835 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.68 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -81.4 -29.81 39.04 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.929 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -81.1 53.8 2.09 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.163 0.506 . . . . 0.0 111.232 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.508 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 26.1 mm -117.77 134.76 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -68.73 99.5 1.03 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.96 -14.71 5.7 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.299 -172.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 21.9 mm -98.4 122.67 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.314 0.578 . . . . 0.0 111.315 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.556 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -102.62 -14.73 16.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.705 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 25.8 p -160.26 158.31 29.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 112.413 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 55' ' ' ALA . 7.5 p -126.74 133.02 69.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.231 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.495 ' HB3' HG21 ' A' ' 56' ' ' THR . 10.7 t70 -107.6 95.48 5.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.39 107.57 5.76 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.375 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -115.13 22.21 13.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.218 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -83.26 131.32 34.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.962 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -105.29 129.01 53.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.405 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 p -97.45 136.44 37.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.485 0.66 . . . . 0.0 112.153 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.65 -44.16 10.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.937 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.7 p -114.43 137.73 22.75 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.588 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.59 152.91 29.99 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.61 2.207 . . . . 0.0 111.719 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -157.14 -174.1 4.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.419 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.0 m -64.3 132.55 50.53 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.368 0.418 . . . . 0.0 111.109 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.22 169.19 8.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.648 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.5 p -143.65 155.34 44.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.543 0.687 . . . . 0.0 112.105 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.4 tt0 -86.23 141.58 29.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.48 173.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.641 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 99.2 m-85 -101.59 101.73 12.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.963 0.411 . . . . 0.0 110.853 -176.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 93.6 t80 -107.07 141.16 38.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.547 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.6 m -104.19 122.41 45.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.183 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.445 HG21 ' H ' ' A' ' 142' ' ' GLN . 2.8 m -67.22 140.03 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.46 -162.19 0.93 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.112 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.2 t -56.62 -31.4 64.27 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 123.123 0.264 . . . . 0.0 111.219 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.28 49.23 2.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.155 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -64.92 109.24 2.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.44 1.114 . . . . 0.0 112.117 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.414 ' O ' HG22 ' A' ' 110' ' ' ILE . 86.4 m -151.39 129.24 11.66 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.616 170.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 15.2 mt -51.03 -48.74 61.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.878 0.763 . . . . 0.0 111.333 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 p -58.48 -37.61 75.88 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.297 0.373 . . . . 0.0 111.152 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.68 -50.63 49.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -74.17 -23.81 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.575 -176.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.6 t -69.78 -46.29 66.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . 61.7 tttm -60.88 -28.04 68.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.619 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.813 HE21 ' HH ' ' A' ' 99' ' ' TYR . 2.6 tp-100 -66.2 -64.18 0.91 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.21 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.462 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.8 m -78.23 -44.67 27.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.558 -170.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.462 ' N ' HG21 ' A' ' 114' ' ' VAL . 63.8 m-85 -81.61 -46.37 14.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.67 0.747 . . . . 0.0 110.343 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.94 -6.28 32.68 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.567 -170.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -127.98 131.34 49.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.221 -0.489 . . . . 0.0 110.161 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 112' ' ' LYS . . . -84.77 0.97 48.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.991 0.424 . . . . 0.0 110.717 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -93.68 0.09 56.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.739 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.76 21.18 17.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.377 0.608 . . . . 0.0 110.875 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.408 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 44.0 p90 -61.51 -32.33 72.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.479 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -79.27 -22.37 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.824 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -60.48 -48.75 80.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.373 0.606 . . . . 0.0 110.13 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.412 ' CG1' ' HE2' ' A' ' 115' ' ' TYR . 50.1 mt -63.83 -49.9 79.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.094 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -46.3 -53.34 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.806 0.691 . . . . 0.0 111.083 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.525 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 7.7 mm-40 -65.24 -29.36 70.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.621 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -77.2 -19.1 57.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.043 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.487 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 5.3 m120 -95.05 -2.1 50.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.511 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.525 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 6.5 mmmm -68.6 145.88 97.34 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.481 ' HD2' HD12 ' A' ' 40' ' ' ILE . 66.6 Cg_endo -96.36 22.97 25.96 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 124.059 -1.226 . . . . 0.0 112.027 -7.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.487 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 1.7 tmm? -70.81 -35.81 72.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.529 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.9 tp -90.33 119.31 30.53 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -77.96 -45.65 23.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.616 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -154.66 157.32 32.09 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.39 -51.89 9.84 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 C-N-CA 123.29 2.66 . . . . 0.0 112.83 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.06 6.49 18.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.407 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -98.93 15.22 26.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.639 0.257 . . . . 0.0 111.332 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.508 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 9.6 pt -78.0 175.55 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -159.63 144.25 11.17 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -52.3 112.31 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.277 2.651 . . . . 0.0 112.312 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 117.61 0.16 18.03 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.167 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.508 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 39.5 tt0 -88.28 122.78 32.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.965 0.412 . . . . 0.0 110.354 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 37.6 t -83.33 133.6 28.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.999 173.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 70.2 mt -124.02 151.04 44.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.284 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.441 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 58.0 mtp180 -80.07 122.82 27.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.229 177.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 25.4 mm -109.23 97.29 25.12 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.228 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.02 148.77 35.64 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.084 1.856 . . . . 0.0 111.312 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.33 133.8 50.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.532 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.77 25.65 0.43 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.97 31.36 4.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.197 0.522 . . . . 0.0 110.435 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -64.05 -77.96 0.05 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.702 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -168.73 -48.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.386 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -78.68 99.4 6.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.359 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -80.06 34.19 0.29 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.084 0.468 . . . . 0.0 111.513 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -82.88 81.45 8.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.09 0.471 . . . . 0.0 109.963 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -109.43 10.72 25.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.766 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.4 m170 . . . . . 0 C--O 1.243 0.738 0 CA-C-O 118.575 -0.726 . . . . 0.0 109.312 172.558 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.3 -122.71 3.73 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.072 -177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.7 tp -101.96 118.25 36.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.081 0.467 . . . . 0.0 110.733 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.451 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 86.7 m-85 -105.52 118.02 35.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.803 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -89.83 150.0 22.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.071 0.463 . . . . 0.0 111.351 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 1.658 ' HE1' ' CE2' ' A' ' 6' ' ' PHE . 74.8 m-85 -132.08 -156.72 0.77 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.928 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.605 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 5.7 p -88.6 -22.01 6.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.038 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.616 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 23.8 tptm 75.99 -57.84 0.56 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.549 0.739 . . . . 0.0 111.513 -175.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.58 -53.49 11.76 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.029 0.442 . . . . 0.0 111.726 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -73.31 146.24 45.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.126 -175.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.75 -167.73 29.29 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -72.03 124.79 25.69 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -73.01 83.13 1.25 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.445 HD22 ' O ' ' A' ' 30' ' ' LYS . 20.1 tp -94.33 -43.2 8.52 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.87 -170.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -127.66 14.53 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.361 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.479 ' HB3' HG11 ' A' ' 18' ' ' VAL . 10.1 m-20 61.41 99.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.865 0.728 . . . . 0.0 110.694 -175.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.41 -3.2 10.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.546 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 16' ' ' ASP . 14.5 p -64.48 -25.63 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.888 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.0 m -150.64 -61.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.727 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 141.75 -152.31 23.39 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -146.24 66.33 1.19 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.269 0.557 . . . . 0.0 110.643 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.3 m80 69.89 -73.89 0.09 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.274 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -116.15 142.15 47.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.856 0.36 . . . . 0.0 110.796 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HA ' ' OE1' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -67.22 -19.76 65.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.75 175.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.1 -35.43 64.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.536 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -77.16 -27.08 53.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.163 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.584 ' O ' HG21 ' A' ' 31' ' ' VAL . 54.9 mt-30 -64.74 -32.87 74.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.301 173.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.01 85.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.119 0.485 . . . . 0.0 110.416 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -64.18 -44.09 93.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.52 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -52.93 -44.74 67.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.689 175.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 27' ' ' GLN . 82.1 t -58.59 -48.92 84.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.303 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -63.92 -40.79 97.28 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.282 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 40.7 mt-10 -58.86 -46.29 88.09 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 65.7 t60 -52.7 -44.9 66.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.866 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 99.0 mt -66.08 -39.75 90.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.248 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -74.17 -39.35 63.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.228 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 62.2 mtpt -64.43 -44.54 90.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.016 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.7 p -66.05 -51.05 61.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.166 0.508 . . . . 0.0 110.037 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.71 30.54 1.98 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.928 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.4 mm -67.19 120.69 74.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.57 142.64 84.99 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.369 2.046 . . . . 0.0 112.961 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 58.54 25.47 13.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.473 -1.239 . . . . 0.0 112.645 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.51 -15.9 63.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.406 0.622 . . . . 0.0 110.14 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -86.61 -8.0 57.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.684 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -97.41 -8.81 28.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.738 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.84 172.1 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.317 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.69 131.19 25.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.458 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 56' ' ' THR . 4.1 mp -108.04 141.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.793 0.33 . . . . 0.0 110.794 -176.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -134.54 123.91 24.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.756 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mm -87.16 120.79 37.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.442 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -127.73 81.5 2.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.756 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 49.75 64.59 1.7 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.776 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.26 -26.53 14.88 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.54 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 30.8 mttp -90.06 114.16 26.01 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.152 0.501 . . . . 0.0 111.468 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.586 ' O ' HG21 ' A' ' 83' ' ' VAL . . . -89.49 94.68 9.97 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.221 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 21.1 m -77.55 125.9 30.05 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG21 HG13 ' A' ' 48' ' ' ILE . 42.8 t -119.01 109.68 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.127 0.489 . . . . 0.0 111.18 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.7 m -102.67 166.63 10.4 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.911 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 88' ' ' LYS . . . 168.44 170.5 33.21 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.475 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -155.89 138.71 15.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.065 0.46 . . . . 0.0 110.151 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.53 3.55 64.62 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.91 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.59 -177.14 2.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.333 0.587 . . . . 0.0 111.994 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.7 p -132.04 157.8 43.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.105 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.479 ' CD ' ' HA ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER -47.91 -41.77 25.44 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 123.165 0.291 . . . . 0.0 111.05 176.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.447 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 49.9 mm-40 -55.92 -64.87 0.72 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.515 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.78 95.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.169 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.65 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 49.1 tttm -50.09 -63.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.891 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.638 ' O ' HG22 ' A' ' 72' ' ' VAL . 5.6 mm-40 -64.67 -35.01 79.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.158 0.504 . . . . 0.0 110.489 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -62.24 -45.35 93.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.81 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.8 mt -62.2 -51.91 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.997 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 78.6 mt -47.44 -42.23 21.95 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.889 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 68' ' ' GLU . 62.0 t -67.25 -51.85 48.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.401 0.62 . . . . 0.0 110.739 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.22 72.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.222 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.3 m -81.37 -32.68 12.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.875 0.369 . . . . 0.0 110.788 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.648 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -70.66 -26.2 74.46 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.676 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -85.14 47.21 1.37 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.766 0.317 . . . . 0.0 111.341 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.8 mt -120.45 141.19 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 120.846 0.355 . . . . 0.0 110.478 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -66.26 105.3 1.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.216 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.89 -2.75 9.96 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.774 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.1 mm -106.24 117.79 52.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.579 0.704 . . . . 0.0 111.126 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -91.98 -27.51 17.8 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.229 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.457 ' OG ' ' HG2' ' A' ' 54' ' ' LYS . 5.5 p -164.48 161.06 21.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.184 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.586 HG21 ' O ' ' A' ' 55' ' ' ALA . 4.3 p -119.77 124.1 72.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.611 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -94.68 103.08 15.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.24 119.06 19.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.866 -174.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -127.22 28.64 5.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.854 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.48 123.81 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.209 0.528 . . . . 0.0 111.351 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 59' ' ' GLY . 13.9 tptm -90.23 124.66 35.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.265 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 p -100.02 135.06 42.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.199 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.12 -23.93 12.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.58 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 67.4 p -123.58 138.75 30.77 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.52 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 2.1 Cg_endo -80.96 158.88 20.92 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.181 2.588 . . . . 0.0 112.788 -176.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . . . -161.84 -176.84 5.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.168 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.3 m -82.42 125.02 30.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.479 ' HA ' ' CD ' ' A' ' 64' ' ' GLN . . . -73.24 145.48 46.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -123.96 172.09 9.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.388 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -106.66 153.88 21.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.784 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -111.63 116.98 31.69 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.667 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 88.3 t80 -123.52 142.43 51.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.588 0.232 . . . . 0.0 110.4 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 2.5 m -104.1 124.28 48.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.361 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.426 HG21 ' H ' ' A' ' 142' ' ' GLN . 2.8 m -68.09 134.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -98.36 -177.19 3.62 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.143 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 p -61.9 116.21 4.68 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.15 25.75 5.99 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -169.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.554 ' OD2' HG13 ' A' ' 138' ' ' ILE . 10.4 p-10 -53.94 118.91 4.37 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.218 1.009 . . . . 0.0 111.768 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.431 ' O ' HG21 ' A' ' 110' ' ' ILE . 92.6 m -144.35 127.37 16.49 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.498 HD22 ' HB2' ' A' ' 125' ' ' PHE . 22.9 tp -63.15 -31.09 72.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.255 -170.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 p -75.71 -26.95 57.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.371 0.605 . . . . 0.0 110.152 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.419 ' CB ' ' HB ' ' A' ' 106' ' ' THR . . . -75.77 -44.22 42.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.851 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.604 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.3 pp -78.35 -24.28 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.394 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.2 p -72.7 -45.33 59.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.95 0.405 . . . . 0.0 109.993 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HZ2' ' HB3' ' A' ' 112' ' ' LYS . 6.5 ttpm? -64.26 -18.48 64.6 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.277 0.561 . . . . 0.0 110.231 174.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.604 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 5.4 tp-100 -72.66 -60.98 1.97 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.859 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.515 HG21 ' N ' ' A' ' 115' ' ' TYR . 30.8 m -78.01 -48.52 23.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.072 -172.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.515 ' N ' HG21 ' A' ' 114' ' ' VAL . 83.4 m-85 -84.12 -36.21 23.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.327 0.584 . . . . 0.0 110.822 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 -2.54 56.74 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.096 -173.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.409 HD22 ' HB3' ' A' ' 119' ' ' ASN . 33.0 t30 -134.67 125.27 26.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.577 -0.311 . . . . 0.0 110.399 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.429 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -74.66 -22.78 58.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.56 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.409 ' HB3' HD22 ' A' ' 117' ' ' ASN . 7.9 t30 -63.78 -21.42 66.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.898 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.449 HD13 ' HB3' ' A' ' 115' ' ' TYR . 63.3 mt -85.83 15.8 4.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.498 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.432 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 35.2 p90 -62.0 -35.84 79.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.284 0.564 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.72 -33.07 75.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.676 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -57.0 -49.26 76.32 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.442 0.639 . . . . 0.0 109.67 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.497 HG23 ' OD1' ' A' ' 128' ' ' ASN . 27.7 mt -67.73 -43.98 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.896 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.601 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 43.2 t80 -53.54 -56.33 18.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.854 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.481 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 19.2 mt-10 -65.42 -25.81 67.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.559 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.39 -34.9 31.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.061 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.497 ' OD1' HG23 ' A' ' 124' ' ' ILE . 7.8 m120 -74.6 -30.54 61.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 7.2 mtpm? -57.25 148.41 52.73 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.559 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -87.78 8.74 64.56 Favored 'Cis proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.291 -1.545 . . . . 0.0 113.256 1.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.471 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -62.97 -39.98 96.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.108 0.48 . . . . 0.0 109.826 175.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.14 125.99 37.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -95.98 -36.64 10.98 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.442 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 19.7 m -150.79 153.2 33.31 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.063 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.5 -54.12 5.99 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 C-N-CA 123.318 2.679 . . . . 0.0 113.054 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -84.52 7.36 20.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.55 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.442 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 37.1 mmtm -92.13 4.59 52.84 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.751 0.31 . . . . 0.0 111.802 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.554 HG13 ' OD2' ' A' ' 105' ' ' ASP . 11.6 pt -67.71 173.72 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.517 171.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -158.59 141.93 10.87 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.604 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.75 117.11 3.02 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.374 2.716 . . . . 0.0 112.858 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' ' 7' ' ' VAL . . . 113.12 4.03 24.23 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.03 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.426 ' H ' HG21 ' A' ' 101' ' ' VAL . 34.3 tt0 -93.0 116.38 29.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.348 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 37.1 t -79.71 134.66 27.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.7 mt -123.51 143.43 50.19 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.091 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.542 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 34.8 ttt180 -74.64 109.79 8.4 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.96 105.61 14.3 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.701 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 32.0 Cg_exo -59.12 164.44 10.33 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.722 2.281 . . . . 0.0 111.907 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -83.71 139.81 32.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.96 72.73 6.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.351 0.596 . . . . 0.0 111.126 -176.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 83.9 mt -94.6 4.83 53.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.445 0.64 . . . . 0.0 109.835 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -96.46 138.57 33.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.187 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -81.54 43.71 0.76 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.277 0.56 . . . . 0.0 111.721 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -118.56 36.03 4.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' A' ' 155' ' ' HIS . 2.3 t-80 -82.81 159.87 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.947 -176.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 25.2 m-70 72.94 149.71 0.1 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.081 0.552 . . . . 0.0 110.683 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -120.51 12.81 11.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.033 0.444 . . . . 0.0 110.585 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.752 -0.642 . . . . 0.0 109.822 -178.422 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmt? . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.933 0.396 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.47 114.33 0.6 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.621 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.6 tp -126.04 114.6 18.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.356 0.598 . . . . 0.0 110.32 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.648 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 56.5 m-85 -106.76 131.56 53.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.608 -176.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.33 136.77 41.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.453 0.644 . . . . 0.0 112.252 -171.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.583 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 31.4 m-85 -123.03 -166.0 1.39 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.48 176.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.6 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 57.2 t -81.25 -81.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.98 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtt? 160.68 -74.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.91 -30.56 69.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.098 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.17 126.24 30.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.885 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.434 ' HA2' ' HH ' ' A' ' 139' ' ' TYR . . . 154.93 -178.26 31.73 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.02 125.83 25.32 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -74.67 69.24 1.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.975 0.893 . . . . 0.0 109.16 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 30' ' ' LYS . 19.4 tp -70.69 -50.18 39.24 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.214 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.425 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 13.2 p90 -120.24 27.64 8.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.826 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 15' ' ' TRP . 9.0 m-20 73.3 -52.96 0.7 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.923 -175.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 68.19 14.86 9.33 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.581 0.752 . . . . 0.0 112.001 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -88.5 -70.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.818 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -145.4 46.15 1.31 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.62 136.34 6.86 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.706 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.637 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . 2.0 mp0 68.41 108.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.383 0.611 . . . . 0.0 110.842 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -78.42 151.9 32.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.458 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 1.2 m-20 -68.21 72.36 0.19 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.556 0.535 . . . . 0.0 111.974 -175.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' HB3' ' H ' ' A' ' 25' ' ' ASP . 47.2 mmtm -131.94 -159.95 1.01 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.35 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.408 ' H ' ' HB3' ' A' ' 24' ' ' LYS . 53.3 m-20 -60.65 -25.17 66.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.985 0.421 . . . . 0.0 110.753 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.509 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 2.1 m-20 -58.29 -35.78 72.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.216 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.637 ' OE1' ' HB3' ' A' ' 21' ' ' GLN . 6.6 mm100 -75.88 -41.22 52.77 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -176.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.11 62.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.76 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 24.7 ttmm -67.1 -49.13 66.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.14 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 14.0 mptt -58.28 -41.51 84.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.673 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 27' ' ' GLN . 93.9 t -60.71 -43.46 95.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.731 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -58.13 -47.04 84.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.699 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 39.8 mt-10 -58.22 -47.17 84.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.065 176.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -51.67 -49.9 61.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.094 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 98.2 mt -63.58 -38.72 92.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.333 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -79.85 -33.14 40.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.549 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -71.65 -30.56 65.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.662 0.268 . . . . 0.0 110.908 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 p -80.18 -40.42 27.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.039 0.447 . . . . 0.0 110.547 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.07 26.81 5.35 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.248 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.434 HD11 ' HD2' ' A' ' 130' ' ' PRO . 35.9 mm -61.71 132.25 93.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 110.467 -0.198 . . . . 0.0 110.467 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -65.31 130.97 26.79 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.429 2.086 . . . . 0.0 112.819 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 59.44 29.56 19.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.819 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.87 -26.52 68.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.777 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -75.32 -26.06 58.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.733 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -74.07 -22.03 59.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.684 -174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.5 m -100.76 162.39 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.563 0.697 . . . . 0.0 111.816 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -128.83 129.76 46.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.878 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.74 133.73 46.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.963 0.411 . . . . 0.0 110.914 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -119.69 122.06 40.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.52 173.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.568 HG13 ' HB2' ' A' ' 27' ' ' GLN . 30.5 mm -97.59 108.36 21.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.212 0.529 . . . . 0.0 110.868 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.21 66.2 0.65 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.798 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 55.94 77.82 0.22 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.653 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.07 -18.24 32.84 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.219 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 82' ' ' SER . 28.0 ttpp -108.37 116.5 32.08 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.153 -0.616 . . . . 0.0 110.702 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.27 101.34 13.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.933 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.449 HG21 ' HB3' ' A' ' 84' ' ' ASP . 14.4 m -85.18 124.95 32.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.237 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.95 110.77 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 120.982 0.42 . . . . 0.0 111.436 -175.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -97.92 157.49 16.07 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.889 177.121 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 87' ' ' VAL . . . 163.1 165.98 21.13 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.432 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -148.37 143.01 26.54 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.916 0.389 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 90' ' ' ALA . . . 83.68 37.75 11.49 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.964 176.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.62 165.51 12.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.802 0.334 . . . . 0.0 110.961 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -93.57 160.65 14.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.998 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 7.6 tp60 -53.54 -58.0 8.71 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.222 0.326 . . . . 0.0 111.76 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG2' HH12 ' A' ' 145' ' ' ARG . 27.1 mt-10 -58.24 -46.78 85.32 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.23 76.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.113 0.482 . . . . 0.0 110.09 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.427 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 68.3 tttt -57.4 -46.33 83.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.528 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.64 ' O ' HG21 ' A' ' 72' ' ' VAL . 75.5 mt-10 -60.71 -47.53 85.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.653 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -55.8 -40.05 72.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.755 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 58.6 mt -63.03 -57.84 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.339 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 98.6 mt -48.03 -45.53 32.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.099 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.64 HG21 ' O ' ' A' ' 68' ' ' GLU . 30.9 t -68.64 -49.17 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.156 0.503 . . . . 0.0 110.593 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.41 74.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.486 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.14 -33.48 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.842 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.583 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -70.88 -35.4 65.55 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.247 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.05 38.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.801 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.5 mt -110.42 139.99 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.7 t -65.6 120.21 12.52 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.54 -22.93 11.49 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.411 HG22 ' HA2' ' A' ' 75' ' ' GLY . 45.8 mm -97.37 136.95 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.398 0.618 . . . . 0.0 110.196 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.476 ' HB3' ' HG2' ' A' ' 8' ' ' LYS . . . -126.45 -9.51 6.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.739 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 1.8 p -160.06 150.56 18.71 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.648 ' CG1' ' HB2' ' A' ' 4' ' ' PHE . 7.2 p -122.97 132.74 70.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.416 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.449 ' HB3' HG21 ' A' ' 56' ' ' THR . 9.9 t0 -111.29 110.99 21.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -78.24 123.21 26.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.993 -173.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 77.7 mm-40 -131.25 8.32 4.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.846 174.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 1.7 p -96.11 126.58 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.265 0.555 . . . . 0.0 111.17 -176.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.51 149.26 25.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.932 -176.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.2 p -104.37 121.29 43.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.926 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.429 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . . . -84.99 -41.87 15.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.027 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 p -117.19 127.36 26.75 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.799 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.82 153.08 13.12 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.77 2.313 . . . . 0.0 112.822 -175.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . . . -148.68 -161.14 1.28 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.506 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.4 m -76.04 127.81 33.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.929 0.395 . . . . 0.0 110.305 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.85 128.11 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.898 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.9 m -103.65 153.32 20.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.348 0.594 . . . . 0.0 111.84 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.465 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 8.6 tt0 -87.05 155.66 20.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.324 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -116.2 98.69 6.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.242 0.544 . . . . 0.0 110.517 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.668 ' HD2' ' CD1' ' A' ' 99' ' ' TYR . 78.8 t80 -101.49 136.33 41.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.553 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.421 ' OG1' HG23 ' A' ' 143' ' ' VAL . 5.4 m -102.09 126.93 49.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.557 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 142' ' ' GLN . 3.3 m -73.56 141.52 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -91.83 -165.56 1.38 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.931 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.3 m -62.38 -31.46 72.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.814 0.34 . . . . 0.0 111.091 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -96.37 44.8 1.95 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.651 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.447 ' OD2' HG13 ' A' ' 138' ' ' ILE . 7.8 p-10 -56.37 120.81 8.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 122.007 0.908 . . . . 0.0 112.137 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.478 ' O ' HG21 ' A' ' 110' ' ' ILE . 53.4 m -143.71 126.11 15.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 168.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 40.6 tp -61.1 -28.1 68.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.714 0.293 . . . . 0.0 110.765 -174.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.44 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 9.6 m -76.24 -29.87 57.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.302 0.572 . . . . 0.0 110.274 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.0 -44.86 45.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.802 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.1 pp -76.5 -21.58 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.976 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.2 p -77.05 -43.92 32.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.89 -23.28 63.33 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.317 0.58 . . . . 0.0 110.156 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -70.02 -61.93 1.58 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.142 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.414 HG21 ' N ' ' A' ' 115' ' ' TYR . 31.6 m -82.86 -39.51 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.376 -169.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.414 ' N ' HG21 ' A' ' 114' ' ' VAL . 40.9 m-85 -91.38 -36.17 13.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.62 -3.91 53.62 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.264 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -131.76 129.21 40.28 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 108' ' ' SER . . . -81.46 -13.7 57.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.495 -176.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.27 -18.14 55.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.381 0.61 . . . . 0.0 110.183 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -84.39 21.06 1.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.211 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.457 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 41.9 p90 -65.74 -33.41 75.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.566 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.564 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 7.9 p30 -68.11 -28.47 67.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.946 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -59.74 -49.69 76.76 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.337 0.589 . . . . 0.0 110.163 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.1 mt -65.82 -44.82 92.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.868 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.429 ' HB2' HD22 ' A' ' 107' ' ' LEU . 50.8 t80 -48.98 -56.73 8.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.171 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 29.5 mt-10 -68.43 -21.19 64.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.944 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.88 -23.39 36.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.063 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.494 ' OD1' HD23 ' A' ' 144' ' ' LEU . 7.6 m120 -88.3 -3.26 58.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.936 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.536 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 28.0 mmmt -72.07 148.52 91.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.434 ' HD2' HD11 ' A' ' 40' ' ' ILE . 72.1 Cg_endo -95.98 31.9 11.79 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.636 -1.401 . . . . 0.0 112.409 -2.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.462 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -84.87 -33.84 22.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.072 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.01 120.98 33.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.451 0.643 . . . . 0.0 110.578 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -67.24 -62.5 1.39 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.066 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.5 m -145.66 161.05 42.35 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.345 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.24 -41.49 65.56 Favored 'Trans proline' 0 C--N 1.332 -0.303 0 C-N-CA 123.216 2.611 . . . . 0.0 112.426 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.7 19.91 7.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -107.03 11.73 29.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.874 0.368 . . . . 0.0 111.335 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.447 HG13 ' OD2' ' A' ' 105' ' ' ASP . 15.0 pt -73.88 172.95 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.11 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.434 ' HH ' ' HA2' ' A' ' 11' ' ' GLY . 35.4 p90 -166.46 149.62 6.42 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.44 110.91 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.092 2.528 . . . . 0.0 112.515 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.88 4.68 26.01 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.522 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.444 ' H ' HG23 ' A' ' 101' ' ' VAL . 7.4 tp60 -82.37 112.27 19.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.713 0.292 . . . . 0.0 110.377 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.463 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 26.8 t -82.97 134.15 27.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.494 HD23 ' OD1' ' A' ' 128' ' ' ASN . 77.7 mt -121.29 144.0 48.86 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.068 0.461 . . . . 0.0 111.112 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.479 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 27.4 ttp85 -75.01 108.03 7.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.266 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 30.9 mm -99.02 103.04 17.38 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.57 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 20.9 Cg_exo -63.78 146.99 92.55 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.126 1.884 . . . . 0.0 111.382 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.1 131.89 47.74 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -63.05 100.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.956 0.408 . . . . 0.0 110.961 -175.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 74.5 mt -90.82 4.3 52.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.478 0.656 . . . . 0.0 109.722 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -76.98 -70.41 0.46 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.742 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.9 t60 66.57 -73.56 0.07 Allowed 'General case' 0 CA--C 1.529 0.149 0 O-C-N 124.083 0.865 . . . . 0.0 110.469 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -93.5 143.72 26.03 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 58.11 47.81 13.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.445 0.641 . . . . 0.0 109.754 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -91.75 29.05 1.62 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.621 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 69.62 176.02 0.28 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.157 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.7 p80 . . . . . 0 C--O 1.245 0.848 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.568 -178.027 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.52 -32.84 0.15 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.041 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.53 129.21 54.99 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.627 0.727 . . . . 0.0 111.121 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' A' ' 4' ' ' PHE . 87.0 m-85 -111.97 125.58 54.22 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.447 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -93.12 136.44 33.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.433 0.635 . . . . 0.0 111.839 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.518 ' CE2' ' HB ' ' A' ' 143' ' ' VAL . 32.7 m-85 -126.1 -167.47 1.71 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.858 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.5 t -116.0 113.81 44.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 19.2 ptmt -59.85 -29.03 68.01 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -171.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.97 -10.09 58.96 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.04 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.13 122.18 46.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.124 0.488 . . . . 0.0 111.222 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.647 ' HA2' ' HH ' ' A' ' 139' ' ' TYR . . . 157.76 179.18 32.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.972 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.17 132.91 48.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -86.53 80.36 8.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.188 0.518 . . . . 0.0 111.801 -173.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' ' 34' ' ' HIS . 7.1 mp -72.33 -46.76 54.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.244 172.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.402 ' C ' ' H ' ' A' ' 17' ' ' ALA . 43.8 p90 -127.72 169.87 13.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.491 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.71 16.94 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . 60.02 20.93 10.04 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.117 0.567 . . . . 0.0 111.865 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 t -93.05 65.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.9 p 66.46 -47.79 0.44 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.003 1.321 . . . . 0.0 112.464 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.536 ' HA2' ' NE2' ' A' ' 27' ' ' GLN . . . -155.05 162.57 30.98 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.546 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 6.2 tp-100 -69.55 -66.76 0.54 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -123.47 -50.43 1.88 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.402 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -133.01 -72.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.081 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -176.04 -55.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.091 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -63.26 -30.77 71.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.541 0.686 . . . . 0.0 110.398 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.546 ' OD2' ' HB3' ' A' ' 21' ' ' GLN . 1.2 p-10 -61.72 -36.78 81.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.076 176.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.563 ' O ' HG21 ' A' ' 31' ' ' VAL . 53.2 mt-30 -61.95 -45.77 92.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.348 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.62 71.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.805 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -70.52 -36.21 73.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.185 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 30.1 mmmt -62.7 -43.28 99.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.338 174.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 27' ' ' GLN . 72.6 t -62.59 -39.5 84.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.815 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -57.31 -43.9 83.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.592 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.35 -48.94 78.96 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.9 0.381 . . . . 0.0 110.579 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.47 ' HB2' HD23 ' A' ' 14' ' ' LEU . 58.5 t60 -52.51 -43.17 64.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.369 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.21 -39.71 65.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.471 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -82.19 -31.26 30.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.777 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -75.05 -23.45 58.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.608 0.242 . . . . 0.0 111.376 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 p -86.06 -39.08 17.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.232 0.539 . . . . 0.0 110.439 174.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.61 33.81 3.75 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.96 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.28 124.72 88.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.99 144.87 65.76 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.845 1.696 . . . . 0.0 112.379 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.471 ' HB3' HD21 ' A' ' 62' ' ' LEU . 12.0 m-20 65.9 3.41 2.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.419 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.55 -16.23 61.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.401 0.62 . . . . 0.0 110.518 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.66 -18.31 59.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.018 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -103.25 -0.6 30.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.531 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.428 HG13 HD12 ' A' ' 70' ' ' ILE . 30.7 m -103.02 171.13 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.181 0.515 . . . . 0.0 111.593 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -134.73 125.11 26.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.866 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.0 135.73 37.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.278 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 48.2 tt0 -127.7 125.33 39.83 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mm -97.26 134.86 33.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.893 0.378 . . . . 0.0 110.595 -177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.39 50.96 2.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.375 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 54' ' ' LYS . 27.3 t70 63.1 93.23 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.788 0.68 . . . . 0.0 111.483 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 78.41 -23.47 2.84 Favored Glycine 0 CA--C 1.517 0.176 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.585 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.509 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 0.8 OUTLIER -109.68 115.14 29.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -101.48 120.17 39.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.315 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.509 ' OG1' ' HE3' ' A' ' 54' ' ' LYS . 49.2 m -90.72 132.86 35.56 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.309 -0.244 . . . . 0.0 110.528 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.99 119.96 61.82 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.347 0.594 . . . . 0.0 110.396 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -117.62 162.24 18.34 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.226 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.85 156.87 8.21 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -138.54 144.83 40.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.912 0.387 . . . . 0.0 110.509 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.36 22.69 39.82 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.48 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' A' ' 42' ' ' ASP . 8.6 mt -100.08 -166.85 1.38 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.238 0.542 . . . . 0.0 109.952 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.4 p -125.73 168.26 14.03 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.923 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.659 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -63.22 -43.34 98.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.843 0.354 . . . . 0.0 110.522 -178.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.461 ' H ' ' HB1' ' A' ' 93' ' ' ALA . 42.7 tt0 -64.46 -42.82 95.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.622 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.42 -46.95 83.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.454 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 12.9 ptmm? -59.62 -37.34 78.35 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.915 -175.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.565 ' O ' HG21 ' A' ' 72' ' ' VAL . 85.9 mt-10 -64.75 -48.17 75.55 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.719 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 28.6 mtpp -54.22 -41.01 68.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.676 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.428 HD12 HG13 ' A' ' 46' ' ' VAL . 29.7 mt -71.38 -53.93 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.691 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 96.3 mt -48.95 -47.31 43.97 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.656 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 68' ' ' GLU . 70.0 t -65.37 -45.78 92.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.389 0.614 . . . . 0.0 110.647 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -61.72 -39.24 90.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.358 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 m -78.18 -31.21 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.718 0.294 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -69.6 -36.79 76.81 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.301 175.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -80.24 50.02 1.2 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.321 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.04 143.34 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 120.946 0.403 . . . . 0.0 110.387 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -67.66 115.11 6.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 111.29 -13.17 28.42 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.131 -172.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 50.6 mm -105.96 132.89 51.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.896 0.379 . . . . 0.0 110.684 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.513 ' HB3' ' HB3' ' A' ' 8' ' ' LYS . . . -131.29 -5.49 3.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.421 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 2.7 p -156.2 154.34 30.63 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.193 0.52 . . . . 0.0 111.317 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 4' ' ' PHE . 7.6 p -134.4 134.6 54.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.034 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.71 113.68 27.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -83.09 111.06 18.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.474 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -123.47 29.02 6.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.483 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.412 ' CG1' HD11 ' A' ' 62' ' ' LEU . 77.4 t -82.45 139.9 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.508 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -105.14 137.71 42.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.047 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.4 p -108.89 130.27 55.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.419 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.31 -29.46 13.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.104 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.7 p -127.27 140.29 37.51 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.707 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.04 153.47 25.08 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.754 2.303 . . . . 0.0 111.774 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.461 ' HB1' ' H ' ' A' ' 65' ' ' GLU . . . -159.58 -172.77 3.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.99 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.2 m -61.78 149.2 40.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.348 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.89 138.53 51.08 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.732 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.5 m -120.18 149.41 42.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.217 0.532 . . . . 0.0 111.709 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 8.8 tt0 -84.16 153.01 23.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.019 173.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.591 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 91.7 m-85 -110.67 96.17 6.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 0.0 111.167 -176.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.61 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 86.7 t80 -95.3 136.07 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.861 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.438 ' OG1' HG23 ' A' ' 143' ' ' VAL . 18.4 m -106.83 124.0 48.97 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.545 HG11 ' O ' ' A' ' 142' ' ' GLN . 0.8 OUTLIER -67.45 134.05 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.451 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 72.0 mmtt -86.67 -72.39 0.51 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.376 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 t -175.08 115.5 0.16 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -175.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.01 -3.81 85.71 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -171.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 1.0 OUTLIER -63.71 113.94 3.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.2 -1.0 . . . . 0.0 110.829 178.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.529 ' O ' HG21 ' A' ' 110' ' ' ILE . 40.0 p -104.97 158.28 16.65 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.664 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -57.37 -45.91 83.94 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.356 -172.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 17.2 m -65.47 -35.16 80.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.75 0.309 . . . . 0.0 110.588 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.98 77.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.106 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.5 pp -75.6 -29.68 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 120.833 0.349 . . . . 0.0 110.495 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.2 t -65.16 -45.69 83.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.232 0.539 . . . . 0.0 109.627 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -62.88 -30.33 71.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.455 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.5 OUTLIER -64.41 -62.86 1.34 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.229 176.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.456 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.2 m -77.21 -46.23 28.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.262 -170.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.747 ' HH ' ' HD2' ' A' ' 123' ' ' LYS . 15.8 m-85 -88.14 -50.46 6.36 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 120.5 -19.88 9.02 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -111.23 128.32 55.89 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 108' ' ' SER . . . -81.56 -8.59 59.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.981 0.42 . . . . 0.0 110.247 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -80.25 -12.3 59.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.395 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.462 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 55.7 mt -87.16 11.53 13.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.459 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.404 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 51.0 p90 -58.05 -30.78 66.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.196 0.522 . . . . 0.0 110.51 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 26.9 p-10 -76.27 -32.71 58.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.171 -176.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.747 ' HD2' ' HH ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -71.81 -24.31 61.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mt -83.99 -41.97 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.65 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.56 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 40.9 t80 -53.66 -59.76 4.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.359 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 30.2 mt-10 -60.6 -36.11 77.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.152 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.73 -32.34 73.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.045 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.512 ' O ' ' HB3' ' A' ' 131' ' ' MET . 40.8 m-80 -90.01 -8.15 52.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.939 0.399 . . . . 0.0 110.866 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 132' ' ' LEU . 30.4 mtpp -74.11 156.67 87.56 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.531 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HA ' ' HB3' ' A' ' 129' ' ' LYS . 88.9 Cg_endo -84.28 14.82 35.48 Favored 'Cis proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.383 -1.507 . . . . 0.0 113.365 -0.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.512 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 4.2 tmm? -67.31 -38.5 85.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.175 0.512 . . . . 0.0 109.75 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.625 ' O ' ' HG2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -90.9 111.69 23.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.485 ' HZ2' ' HB3' ' A' ' 133' ' ' LYS . 8.0 mtpm? -74.29 -60.34 2.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.335 -174.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 16.3 m -137.96 155.62 74.55 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.09 -23.64 73.45 Favored 'Trans proline' 0 CA--C 1.522 -0.097 0 C-N-CA 123.655 2.903 . . . . 0.0 113.134 -171.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -99.67 4.87 45.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.952 0.406 . . . . 0.0 110.668 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 134' ' ' SER . 27.3 mmmt -90.62 -0.77 57.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.756 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.4 pt -64.56 166.13 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.046 0.451 . . . . 0.0 110.833 174.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.647 ' HH ' ' HA2' ' A' ' 11' ' ' GLY . 5.2 p90 -155.24 144.65 15.25 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.917 -174.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -54.29 116.39 3.03 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.332 2.688 . . . . 0.0 112.71 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.46 14.52 14.22 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.202 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.545 ' O ' HG11 ' A' ' 101' ' ' VAL . 65.0 tt0 -99.78 130.83 46.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.899 0.381 . . . . 0.0 110.322 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.518 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 42.5 t -85.63 130.57 36.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.269 0.557 . . . . 0.0 109.957 174.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.0 mt -118.81 134.76 54.93 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.733 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.5 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 51.8 mtp180 -65.87 120.34 12.88 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.325 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 35.2 mm -111.46 82.65 3.74 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 31.9 Cg_exo -62.79 170.17 7.62 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.825 2.35 . . . . 0.0 112.215 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -51.66 133.21 31.05 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.64 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -78.69 77.6 5.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.3 tp -80.01 73.59 6.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.27 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.415 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . 38.1 tt0 62.41 -91.29 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.802 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.9 m80 55.85 54.33 8.27 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.677 0.391 . . . . 0.0 112.052 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 66.8 m80 60.45 87.0 0.09 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.075 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.415 ' CE1' ' HA ' ' A' ' 151' ' ' GLU . 18.7 m170 -81.42 -176.58 6.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.163 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 35.0 t60 60.36 77.72 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.315 0.579 . . . . 0.0 109.746 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -64.84 146.49 54.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.56 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 21.9 p80 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.032 177.688 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.954 0.406 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.63 65.23 0.93 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.896 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.1 tp -113.84 122.43 47.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 1.649 ' HE1' ' CE2' ' A' ' 4' ' ' PHE . 77.1 m-85 -121.39 133.62 55.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.329 -175.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.71 146.88 24.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.756 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.494 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 77.2 m-85 -128.23 -157.95 0.85 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.073 -176.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.505 HG23 ' HB1' ' A' ' 10' ' ' ALA . 22.8 m -83.73 -26.76 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 24.4 tptp 72.51 -53.37 0.7 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.248 0.619 . . . . 0.0 111.479 -174.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.39 -49.34 8.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.857 0.36 . . . . 0.0 111.831 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.505 ' HB1' HG23 ' A' ' 7' ' ' VAL . . . -76.21 -169.18 1.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.45 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.36 -160.02 19.2 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -76.82 127.1 32.12 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -74.64 63.42 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.017 0.913 . . . . 0.0 109.019 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.49 HD22 ' O ' ' A' ' 30' ' ' LYS . 11.8 tp -65.49 -50.72 64.25 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 113.793 -1.548 . . . . 0.0 110.491 -174.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.452 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 6.8 p90 -125.57 -35.8 2.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.725 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t70 51.1 -90.47 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.839 0.712 . . . . 0.0 110.474 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -160.76 26.51 0.15 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.42 ' C ' ' HG1' ' A' ' 19' ' ' THR . 2.9 p -142.15 126.9 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.263 -171.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.42 ' HG1' ' C ' ' A' ' 18' ' ' VAL . 65.1 p 47.79 37.22 6.8 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.363 0.602 . . . . 0.0 111.369 -176.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -172.45 169.81 42.9 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.452 ' HB2' ' CD1' ' A' ' 15' ' ' TRP . 6.1 tt0 63.3 56.24 1.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.374 0.607 . . . . 0.0 109.487 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -82.91 -16.2 48.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.978 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.45 ' H ' ' HB3' ' A' ' 26' ' ' ASP . 5.2 t70 -166.14 178.85 6.06 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -70.93 -47.08 61.03 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -75.92 -15.58 60.16 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.328 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 20.4 t70 -71.12 -35.92 71.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.065 0.46 . . . . 0.0 109.872 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -61.57 -45.12 95.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.973 174.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.71 84.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.603 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 51.6 tttp -60.67 -43.42 97.68 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.48 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 43.5 mmtt -62.66 -38.77 91.64 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.373 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 73.5 t -66.09 -42.92 92.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.267 176.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -55.44 -51.54 66.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 38.6 mt-10 -56.85 -46.92 81.42 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.255 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -52.59 -48.15 66.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.044 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 88.6 mt -65.81 -41.9 91.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.927 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -69.03 -41.77 77.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.347 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 99.3 mttt -65.17 -42.81 93.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.512 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 p -72.43 -40.64 66.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 111.141 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.01 32.67 2.99 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.234 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.407 HD11 ' HD2' ' A' ' 130' ' ' PRO . 26.2 mm -71.71 126.09 91.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.67 148.35 77.65 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.089 1.86 . . . . 0.0 112.604 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 61.78 16.44 7.9 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.737 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.32 70.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.125 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.49 -23.39 63.62 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.338 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -88.91 -27.92 20.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.322 -171.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.4 m -88.01 164.11 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.222 0.534 . . . . 0.0 111.833 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -128.32 135.06 49.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.973 173.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 48' ' ' ILE . 4.3 mp -108.79 131.01 60.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.815 0.34 . . . . 0.0 110.287 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -118.75 124.84 48.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.078 0.466 . . . . 0.0 110.539 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.0 mm -105.19 136.75 37.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.782 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.06 54.88 1.56 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.205 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 54' ' ' LYS . 5.0 m-20 62.7 88.57 0.09 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.98 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.4 -34.93 2.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.978 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 52' ' ' ASP . 22.6 tptm -84.1 119.95 25.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.983 0.421 . . . . 0.0 110.388 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -121.6 105.89 10.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.233 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.0 m -93.6 122.01 35.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.204 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.67 130.72 47.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.165 0.507 . . . . 0.0 109.989 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.55 136.78 54.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.135 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.78 168.22 40.77 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.6 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.446 ' HB3' ' HE3' ' A' ' 88' ' ' LYS . 3.5 p30 -157.17 142.57 17.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.991 0.424 . . . . 0.0 110.453 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.56 24.92 64.11 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.091 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD11 HG13 ' A' ' 87' ' ' VAL . 11.5 mt -99.41 -162.43 0.95 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.339 0.59 . . . . 0.0 109.916 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.2 p -120.73 155.59 33.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.968 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.413 ' NE2' ' HA ' ' A' ' 95' ' ' ALA . 59.8 tt0 -60.77 -35.29 76.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.893 0.378 . . . . 0.0 110.14 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -60.81 -44.27 97.09 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.538 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.55 -41.85 59.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -54.8 -57.07 13.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.753 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.505 ' O ' HG22 ' A' ' 72' ' ' VAL . 5.9 mm-40 -67.11 -15.77 63.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.043 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HB2' ' NZ ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -75.9 -48.32 21.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.269 0.557 . . . . 0.0 109.524 176.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.57 ' O ' HG13 ' A' ' 74' ' ' VAL . 47.6 mt -65.05 -52.35 54.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.817 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.6 mp -40.78 -46.49 2.69 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.83 0.706 . . . . 0.0 112.653 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 68' ' ' GLU . 98.9 t -71.81 -48.52 50.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.196 0.522 . . . . 0.0 110.872 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.413 ' HA ' ' SD ' ' A' ' 131' ' ' MET . . . -60.6 -32.11 71.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.182 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 70' ' ' ILE . 11.9 p -88.59 -28.28 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.276 0.56 . . . . 0.0 110.851 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.494 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -70.37 -35.25 69.02 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.02 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -83.42 58.86 4.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.795 0.331 . . . . 0.0 110.807 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.494 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 41.8 mm -123.78 132.75 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -63.81 95.42 0.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.53 -17.73 3.96 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.9 -173.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 35.3 mm -102.61 127.81 55.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.194 0.521 . . . . 0.0 111.471 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.51 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -111.48 -30.89 7.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.562 -174.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 p -150.69 150.6 31.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.313 0.577 . . . . 0.0 111.448 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 85.4 t -124.25 126.52 72.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.878 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -103.24 112.58 25.51 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -84.35 110.63 18.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.344 0.592 . . . . 0.0 111.427 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -119.22 33.04 5.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.461 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.428 HG13 HD11 ' A' ' 62' ' ' LEU . 77.6 t -95.73 123.64 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.22 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.446 ' HE3' ' HB3' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -89.71 123.18 33.5 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 174.185 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.4 p -102.82 126.46 49.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.82 0.343 . . . . 0.0 111.259 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.0 -27.81 23.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.424 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.8 p -121.04 129.46 25.28 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.998 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.53 164.5 16.46 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.815 2.343 . . . . 0.0 112.418 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.59 -155.04 0.58 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.7 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.6 m -86.62 122.77 31.0 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.413 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -62.92 142.66 58.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.607 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.9 m -127.57 143.27 51.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.116 0.484 . . . . 0.0 111.803 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.545 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 5.8 tt0 -91.85 153.4 19.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 171.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.647 ' HD1' ' CD2' ' A' ' 98' ' ' PHE . 31.1 m-85 -107.17 86.84 2.38 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.028 0.442 . . . . 0.0 110.264 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.622 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 82.1 t80 -84.63 131.77 34.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.707 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.473 ' OG1' HG21 ' A' ' 143' ' ' VAL . 20.0 m -103.31 120.43 40.75 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.973 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 142' ' ' GLN . 0.9 OUTLIER -68.44 129.86 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -78.62 -64.1 1.25 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.302 -169.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.9 t -159.18 -72.91 0.08 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.674 0.273 . . . . 0.0 110.505 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.35 51.6 4.58 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.509 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.1 m-20 -108.72 111.96 24.01 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.039 -0.58 . . . . 0.0 110.983 -171.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.504 ' O ' HG21 ' A' ' 110' ' ' ILE . 8.1 m -104.03 150.37 24.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 21.3 tp -57.87 -43.1 85.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.623 0.647 . . . . 0.0 110.944 -173.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.2 p -61.03 -39.98 91.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.22 0.533 . . . . 0.0 111.095 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.24 -40.87 74.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.354 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.7 pp -79.02 -23.84 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.2 p -71.22 -39.16 71.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.971 0.415 . . . . 0.0 110.03 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' A' ' 112' ' ' LYS . 8.3 tmtm? -64.03 -29.93 71.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.594 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -65.16 -52.75 53.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.318 177.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.473 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.7 m -87.78 -44.0 15.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.175 -171.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.473 ' N ' HG21 ' A' ' 114' ' ' VAL . 64.8 m-85 -89.56 -53.07 4.69 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.891 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.48 -22.86 7.71 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.061 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -116.51 124.33 49.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.356 -0.422 . . . . 0.0 109.903 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.91 -19.28 60.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.555 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -67.68 -11.39 58.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.187 0.517 . . . . 0.0 110.485 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 115' ' ' TYR . 39.1 mt -89.11 14.43 10.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.176 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.41 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 27.9 p90 -64.74 -28.91 69.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.049 0.452 . . . . 0.0 109.814 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.597 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 32.1 p30 -69.46 -29.6 67.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.878 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -58.69 -49.62 76.92 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.51 0.671 . . . . 0.0 110.078 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.78 -39.82 78.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.295 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.425 ' CE2' ' HD2' ' A' ' 129' ' ' LYS . 45.5 t80 -54.58 -55.76 26.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.758 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 35.1 mt-10 -63.51 -40.13 96.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.942 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.494 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -60.06 -28.47 67.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.115 -177.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.464 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 47.1 m-80 -99.93 0.01 40.36 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 120.619 0.247 . . . . 0.0 110.871 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 25.8 mtpp -79.36 150.75 74.27 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-O 120.644 0.259 . . . . 0.0 110.779 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.407 ' HD2' HD11 ' A' ' 40' ' ' ILE . 9.5 Cg_endo -90.5 25.1 21.4 Favored 'Cis proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.662 -1.391 . . . . 0.0 112.843 -0.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.464 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 1.0 OUTLIER -74.95 -34.7 62.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.372 . . . . 0.0 110.276 176.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.442 HD22 HE21 ' A' ' 142' ' ' GLN . 0.1 OUTLIER -93.03 117.76 30.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.98 -43.37 24.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.892 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.3 m -151.45 149.85 25.34 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.255 0.55 . . . . 0.0 110.762 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.97 -18.08 61.19 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 123.713 2.942 . . . . 0.0 112.875 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.12 -16.31 22.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.498 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -78.62 -1.2 33.05 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.8 pt -65.7 168.14 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.912 0.387 . . . . 0.0 110.063 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -163.9 154.96 13.86 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.343 -172.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -45.2 113.31 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.164 2.576 . . . . 0.0 112.662 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.29 34.65 5.77 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.339 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.573 ' O ' HG11 ' A' ' 101' ' ' VAL . 7.2 tp60 -107.08 116.6 32.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.835 0.318 . . . . 0.0 110.164 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.473 HG21 ' OG1' ' A' ' 100' ' ' THR . 46.7 t -80.5 132.08 32.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.066 0.46 . . . . 0.0 110.004 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -125.63 134.42 51.9 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.073 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 47.2 mtp180 -62.68 118.76 8.09 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.064 171.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 39.7 mm -106.24 93.27 7.79 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 173.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 38.5 Cg_exo -59.85 139.14 86.78 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.222 1.948 . . . . 0.0 111.184 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -53.24 127.3 24.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.014 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.51 ' CD ' ' HB3' ' A' ' 152' ' ' HIS . 27.8 tt0 -60.82 99.99 0.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.678 -176.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.0 mt -98.48 98.5 9.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.845 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 66.35 101.99 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.478 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.51 ' HB3' ' CD ' ' A' ' 149' ' ' GLU . 10.1 p80 -93.88 148.0 22.55 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -111.99 106.28 14.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -72.96 -5.22 37.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.996 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -96.46 11.08 36.23 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.129 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 60.46 -174.04 0.12 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.704 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.5 p80 . . . . . 0 C--O 1.244 0.765 0 CA-C-O 118.908 -0.567 . . . . 0.0 110.23 176.734 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.0 ttm . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.93 -17.93 71.2 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.8 tp -93.18 105.8 17.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.268 0.556 . . . . 0.0 110.108 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -93.6 138.81 31.47 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.26 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 5' ' ' ASN . 0.9 OUTLIER -97.57 138.31 35.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.018 0.437 . . . . 0.0 111.01 -177.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.404 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 59.5 m-85 -127.25 -179.12 4.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.496 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.583 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 23.7 m -81.26 -9.94 12.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -171.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 53.4 tptt 74.35 -54.95 0.67 Allowed 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.528 0.518 . . . . 0.0 112.141 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.62 -46.53 15.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.097 0.475 . . . . 0.0 111.963 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.583 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -81.29 126.93 32.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.183 -173.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.442 ' HA2' ' HH ' ' A' ' 139' ' ' TYR . . . 159.96 -173.1 36.59 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.371 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.04 129.59 41.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.35 54.98 1.8 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.992 0.901 . . . . 0.0 108.88 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 30' ' ' LYS . 14.7 tp -59.25 -45.98 89.73 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.8 -1.545 . . . . 0.0 111.312 -172.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -117.88 27.05 9.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.555 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.51 ' HB3' HG11 ' A' ' 18' ' ' VAL . 17.8 t70 62.49 6.14 1.88 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.664 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.71 23.4 13.28 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.159 0.583 . . . . 0.0 111.519 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.51 HG11 ' HB3' ' A' ' 16' ' ' ASP . 3.5 p -108.75 98.37 6.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.305 0.574 . . . . 0.0 110.99 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.8 m 72.06 -57.92 0.6 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.785 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 21' ' ' GLN . . . 156.22 -28.22 0.57 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.259 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 32.1 mm-40 75.24 122.45 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.29 0.636 . . . . 0.0 111.128 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 31.0 m80 65.01 -85.9 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.484 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -146.04 -177.16 5.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.439 ' HA ' ' OE1' ' A' ' 27' ' ' GLN . 41.1 ttmt -74.99 -41.89 58.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.024 0.44 . . . . 0.0 110.55 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.12 -23.27 64.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.093 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.544 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 19.0 t70 -72.22 -36.1 69.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.709 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.488 ' O ' HG21 ' A' ' 31' ' ' VAL . 51.5 mt-30 -59.92 -48.35 82.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.375 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.43 -34.7 72.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.765 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 38.6 ttpt -68.11 -39.99 82.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.985 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 74.6 mmtt -56.96 -44.96 83.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.063 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.6 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 47.5 t -59.96 -45.16 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.49 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -55.56 -47.64 76.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.868 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 38.2 mt-10 -58.91 -48.88 79.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.359 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -53.04 -39.37 63.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.456 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 85.7 mt -70.76 -40.91 72.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.013 0.435 . . . . 0.0 111.201 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -78.07 -31.01 50.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.175 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -67.92 -38.2 82.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.943 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 p -75.66 -36.42 60.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 110.789 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.92 35.29 4.32 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.167 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.8 mm -77.11 124.69 87.26 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.69 146.46 66.87 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.229 1.953 . . . . 0.0 112.396 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 64.34 -0.9 0.81 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.907 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.77 -9.89 59.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.341 0.591 . . . . 0.0 110.432 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -87.7 -9.53 53.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.276 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -91.72 -35.54 14.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.089 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.8 m -69.68 166.12 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.373 -175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -130.23 128.99 42.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.802 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 48' ' ' ILE . 3.6 mp -103.87 140.91 20.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.8 0.333 . . . . 0.0 110.869 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 38.5 tt0 -123.14 135.78 54.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 173.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.3 mm -104.35 111.72 35.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.079 0.466 . . . . 0.0 110.306 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.25 93.89 4.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.473 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.6 t70 64.18 -83.62 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.368 -171.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.77 13.96 4.73 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.637 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 38.0 mtmm -95.82 117.23 30.16 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.662 0.267 . . . . 0.0 110.475 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.458 ' O ' HG11 ' A' ' 83' ' ' VAL . . . -92.1 80.59 5.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.823 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 89.3 m -66.68 119.65 12.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.959 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 57' ' ' VAL . 7.3 p -106.89 109.97 30.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.441 0.638 . . . . 0.0 111.193 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.4 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.9 OUTLIER -100.68 154.41 18.62 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.028 178.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.93 160.23 17.72 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -151.75 146.08 25.47 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.241 0.543 . . . . 0.0 110.721 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.94 31.13 58.34 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.529 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.3 mt -98.83 -169.99 1.86 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.837 0.827 . . . . 0.0 110.851 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 m -108.96 128.78 55.24 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.718 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 9.4 tt0 -61.49 -31.51 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.946 -172.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HG3' ' NH2' ' A' ' 145' ' ' ARG . 42.2 tt0 -65.63 -39.53 91.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.069 0.461 . . . . 0.0 110.151 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.55 ' O ' HG13 ' A' ' 70' ' ' ILE . . . -72.92 -39.34 66.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.918 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.485 ' HE3' ' OD1' ' A' ' 85' ' ' ASP . 73.3 tttt -52.12 -53.68 39.77 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.593 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.585 ' O ' HG22 ' A' ' 72' ' ' VAL . 7.7 mm-40 -52.95 -35.25 58.51 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 28.7 ttpt -79.25 -32.55 43.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.505 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 66' ' ' ALA . 45.3 mt -61.89 -52.17 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 67' ' ' LYS . 9.8 mp -45.01 -43.84 9.53 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.646 173.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 68' ' ' GLU . 66.5 t -67.3 -51.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.465 0.65 . . . . 0.0 110.885 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.89 79.95 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.6 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.5 m -80.63 -25.94 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.029 0.442 . . . . 0.0 111.087 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -77.86 -28.87 55.95 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.832 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -83.39 42.61 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 111.404 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.2 mt -114.53 138.26 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-O 121.14 0.495 . . . . 0.0 110.488 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 t -71.49 111.91 7.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.182 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.09 -14.61 8.35 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -172.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.6 mm -98.74 121.83 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 110.902 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -104.14 -20.51 13.79 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.73 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.637 ' OG ' ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -158.83 153.85 25.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.465 -177.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 55' ' ' ALA . 68.1 t -127.84 124.27 62.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.789 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.8 105.85 18.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.485 ' OD1' ' HE3' ' A' ' 67' ' ' LYS . 3.3 t70 -72.84 116.54 13.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.224 0.535 . . . . 0.0 111.54 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.4 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 75.9 mt-30 -121.32 25.74 9.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.119 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.0 t -89.55 125.57 42.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.655 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -95.53 142.89 27.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.269 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.0 p -115.72 143.55 45.21 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.942 0.401 . . . . 0.0 111.548 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.91 -8.34 31.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.581 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.5 p -135.32 133.68 20.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.234 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.35 69.15 6.64 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.97 2.446 . . . . 0.0 111.283 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.44 -168.06 1.85 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.731 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.0 m -56.51 129.38 40.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.35 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.16 138.95 31.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.6 m -126.5 157.3 39.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.369 0.605 . . . . 0.0 112.02 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.522 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.9 tt0 -96.38 149.15 22.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.577 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -109.78 93.99 4.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.942 0.401 . . . . 0.0 110.603 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.63 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 83.2 t80 -98.2 139.18 34.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.272 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.6 m -104.54 123.44 47.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.345 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.9 m -70.92 134.87 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.4 mmtp -98.92 -165.61 1.26 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.481 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.401 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 13.9 m -65.1 122.87 18.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.633 0.254 . . . . 0.0 110.481 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.09 8.85 83.3 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.312 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 13.1 m-20 -88.31 105.18 17.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.367 0.603 . . . . 0.0 111.009 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.453 ' O ' HG21 ' A' ' 110' ' ' ILE . 5.8 m -102.69 161.09 14.01 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 138' ' ' ILE . 19.7 tp -56.39 -41.66 76.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.412 0.551 . . . . 0.0 111.699 -170.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 9.8 m -63.14 -41.57 99.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.955 0.407 . . . . 0.0 110.571 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.88 81.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.004 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -75.11 -24.52 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 120.917 0.389 . . . . 0.0 110.481 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.7 t -67.44 -44.14 79.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 170.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.79 -24.27 66.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.431 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 2.1 tp-100 -71.87 -59.87 2.53 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.924 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.8 m -82.83 -35.82 12.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.236 -170.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.474 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 19.0 m-30 -103.68 -23.89 13.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.05 -175.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.44 -6.31 82.34 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.909 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.447 HD22 ' HB3' ' A' ' 119' ' ' ASN . 41.0 t30 -133.94 124.0 25.62 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 108' ' ' SER . . . -76.18 -15.2 60.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.712 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.447 ' HB3' HD22 ' A' ' 117' ' ' ASN . 22.9 t-20 -68.68 -23.43 64.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.139 0.495 . . . . 0.0 110.596 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.449 HD13 ' HB3' ' A' ' 115' ' ' TYR . 67.1 mt -85.06 14.22 5.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.572 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.427 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 24.2 p90 -62.3 -31.61 72.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.189 0.519 . . . . 0.0 110.257 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.582 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 26.3 p-10 -68.89 -29.64 67.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.507 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -58.17 -47.47 83.29 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.543 0.687 . . . . 0.0 109.772 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.9 mt -71.8 -41.02 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.304 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.442 ' HB2' HD22 ' A' ' 107' ' ' LEU . 83.5 t80 -53.72 -51.76 62.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 40.2 mt-10 -62.74 -23.22 67.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.941 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.505 ' O ' ' HD3' ' A' ' 69' ' ' LYS . . . -86.87 -31.87 20.53 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.632 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.563 ' O ' ' HB3' ' A' ' 131' ' ' MET . 10.5 m120 -76.67 -42.07 43.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 58.5 pttt -64.47 153.72 85.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.949 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.1 Cg_endo -86.27 21.55 22.36 Favored 'Cis proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.225 -1.573 . . . . 0.0 112.892 0.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.563 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.2 tmm? -73.23 -26.73 61.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.465 HD13 ' H ' ' A' ' 133' ' ' LYS . 18.8 tp -111.72 133.75 53.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.078 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.465 ' H ' HD13 ' A' ' 132' ' ' LEU . 29.7 mtpp -81.67 -45.18 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.063 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.484 ' OG ' ' HG2' ' A' ' 137' ' ' LYS . 79.0 p -154.02 160.94 30.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.79 -17.75 52.05 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.528 2.819 . . . . 0.0 111.929 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -100.43 -12.98 18.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.511 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.484 ' HG2' ' OG ' ' A' ' 134' ' ' SER . 56.4 mmtt -81.49 -8.03 59.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.654 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 9.3 pt -68.43 168.9 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.098 0.475 . . . . 0.0 110.978 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.48 ' CE1' ' HG3' ' A' ' 142' ' ' GLN . 15.4 p90 -155.98 147.79 17.18 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.177 -174.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.401 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 88.7 Cg_exo -48.48 103.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.597 2.865 . . . . 0.0 113.037 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.19 8.81 5.86 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.601 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.654 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 1.7 mt-30 -94.37 121.97 36.45 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 117.341 0.571 . . . . 0.0 111.224 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.9 t -80.61 135.31 25.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.303 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.2 mt -126.36 145.31 50.5 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.063 0.459 . . . . 0.0 110.748 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.411 ' NH2' ' HG3' ' A' ' 65' ' ' GLU . 28.5 ttt180 -72.48 110.37 6.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.906 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 41.5 mm -94.7 112.38 57.72 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.497 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 32.4 Cg_exo -59.69 166.68 7.81 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.985 2.457 . . . . 0.0 113.109 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -84.24 121.13 27.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.922 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.95 25.56 3.62 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -175.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 63.5 mt -80.7 56.38 2.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.247 0.546 . . . . 0.0 110.822 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -92.72 -7.21 47.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.869 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 48.0 m80 75.35 132.7 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.621 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 63.16 85.11 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.43 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -59.77 121.27 11.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.511 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -77.46 -63.16 1.44 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.752 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -95.1 85.89 4.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.461 177.787 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.468 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . 85.6 mtp . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.688 0.28 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.94 78.7 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.501 HD11 ' N ' ' A' ' 4' ' ' PHE . 1.7 tm? -90.01 139.11 30.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.291 0.567 . . . . 0.0 111.31 -172.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.501 ' N ' HD11 ' A' ' 3' ' ' LEU . 86.5 m-85 -125.52 132.22 52.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.194 175.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -97.61 140.9 31.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.006 0.431 . . . . 0.0 110.997 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -127.75 -164.4 1.36 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.151 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.3 -10.81 8.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.794 0.331 . . . . 0.0 111.128 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 84.8 tttt 72.67 -67.19 0.27 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 176.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.31 -24.78 63.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.289 0.566 . . . . 0.0 110.504 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.26 119.98 31.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.711 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.01 -173.55 41.58 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.842 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -77.31 136.18 38.46 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 19.3 mtpt -77.97 86.05 4.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.45 0.643 . . . . 0.0 111.781 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 34' ' ' HIS . 8.9 mp -84.3 -40.81 17.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.005 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.466 ' CZ3' ' HB3' ' A' ' 27' ' ' GLN . 22.7 p90 -152.17 155.6 38.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.702 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.571 ' O ' HG21 ' A' ' 18' ' ' VAL . 23.7 m-20 -95.2 -6.39 41.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.592 171.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 65.27 -80.52 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.277 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 16' ' ' ASP . 6.9 m -47.02 -51.39 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 124.061 0.944 . . . . 0.0 112.731 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.2 p -121.64 28.22 7.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.646 0.736 . . . . 0.0 109.908 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.29 -33.18 0.74 Allowed Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.23 -173.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.581 ' NE2' ' HG2' ' A' ' 27' ' ' GLN . 2.9 tt0 -161.46 118.54 2.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.986 0.393 . . . . 0.0 110.453 -174.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -73.3 -42.43 62.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.582 -174.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.483 ' HB3' ' OD1' ' A' ' 25' ' ' ASP . 28.7 m-20 -107.21 138.01 44.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.089 0.471 . . . . 0.0 110.678 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 63.4 mttp -79.35 -17.2 54.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.875 -177.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.483 ' OD1' ' HB3' ' A' ' 23' ' ' ASP . 5.0 p-10 -73.41 -24.39 60.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.346 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -74.92 -25.91 59.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.138 0.494 . . . . 0.0 110.018 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.581 ' HG2' ' NE2' ' A' ' 21' ' ' GLN . 86.1 mt-30 -66.56 -33.78 76.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.154 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.23 72.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.763 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 17.4 tppt? -65.18 -43.29 92.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.589 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' N ' ' HD2' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -66.87 -32.06 73.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.046 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 75.3 t -63.59 -46.18 95.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.311 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.433 ' NE2' HD13 ' A' ' 35' ' ' LEU . 16.5 mm-40 -57.85 -41.42 82.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.516 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 54.6 mt-10 -56.95 -48.47 78.26 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.765 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.482 ' HB2' HD12 ' A' ' 14' ' ' LEU . 57.7 t60 -57.97 -37.02 73.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.428 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 64.4 mt -73.18 -40.65 64.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.008 0.433 . . . . 0.0 110.429 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -65.05 -48.0 75.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.419 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -58.03 -49.88 75.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.754 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.401 ' OG1' HG12 ' A' ' 40' ' ' ILE . 16.7 p -68.28 -44.38 75.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.37 35.49 3.85 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.792 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.401 HG12 ' OG1' ' A' ' 38' ' ' THR . 35.6 mm -66.67 124.04 87.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -66.38 138.65 51.48 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.989 1.793 . . . . 0.0 112.333 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 63.33 9.33 3.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.351 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HB3' HD11 ' A' ' 35' ' ' LEU . . . -75.94 -14.38 60.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.27 0.557 . . . . 0.0 110.367 177.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -81.36 -16.32 52.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.13 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -75.19 -44.1 48.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.614 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.5 m -77.34 163.63 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.595 -172.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -118.8 139.28 51.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.877 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.9 mm -102.39 139.78 22.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.026 0.441 . . . . 0.0 111.316 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 49.9 tt0 -138.97 128.7 24.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.327 172.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mm -108.91 116.57 52.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.672 0.272 . . . . 0.0 110.912 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.48 100.06 7.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.832 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 t70 66.11 -80.96 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.8 0.688 . . . . 0.0 110.757 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.06 18.51 2.53 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 82' ' ' SER . 38.9 ttmt -107.78 114.74 28.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.294 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.68 111.87 23.62 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.155 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 18.5 m -86.65 130.64 34.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.917 177.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 57' ' ' VAL . 5.3 p -114.74 106.93 21.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.337 0.589 . . . . 0.0 110.897 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 m -104.55 155.88 18.44 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.996 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.22 179.72 39.25 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.325 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.13 150.52 13.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 0.0 110.6 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.54 23.97 48.46 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.504 -0.771 . . . . 0.0 113.163 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.46 175.35 5.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.76 0.314 . . . . 0.0 110.667 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 91' ' ' THR . 14.3 m -104.75 157.95 16.85 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 93' ' ' ALA . 7.8 tp60 -53.85 -41.91 67.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.891 0.377 . . . . 0.0 110.227 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.675 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 61.1 mm-40 -49.84 -62.39 1.59 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.061 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.02 -37.69 84.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.685 0.279 . . . . 0.0 110.966 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -55.55 -51.77 65.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.625 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.585 ' O ' HG22 ' A' ' 72' ' ' VAL . 56.1 mt-10 -65.09 -33.56 76.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.106 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 29.8 mtpp -60.01 -42.73 94.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.867 0.365 . . . . 0.0 110.095 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 74' ' ' VAL . 52.6 mt -62.45 -57.38 12.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.322 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mp -41.9 -43.25 3.0 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.828 0.705 . . . . 0.0 112.406 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 68' ' ' GLU . 86.2 t -69.08 -53.19 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.33 0.586 . . . . 0.0 111.017 177.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.424 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -64.07 -31.09 72.16 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.588 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 70' ' ' ILE . 11.7 p -84.62 -23.35 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.492 0.663 . . . . 0.0 110.532 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.23 -35.37 34.1 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.196 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -82.07 60.29 4.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.64 0.257 . . . . 0.0 111.145 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.612 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 32.7 mm -118.13 142.24 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 13' ' ' LYS . 72.3 p -65.91 91.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.966 0.412 . . . . 0.0 110.492 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.98 -17.72 5.67 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.914 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 28.1 mm -86.51 113.06 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.667 0.746 . . . . 0.0 110.868 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.99 -24.61 15.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.03 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 5.4 p -150.05 156.83 42.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.293 0.568 . . . . 0.0 111.514 -178.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.5 130.23 59.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.737 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -104.95 106.71 17.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -72.65 117.27 14.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.539 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.468 ' HG2' ' HB2' ' A' ' 1' ' ' MET . 79.9 mt-30 -133.92 28.39 3.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.138 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.25 116.29 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.617 0.723 . . . . 0.0 110.712 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -82.37 144.46 30.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.766 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.9 p -112.17 127.43 55.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.19 0.519 . . . . 0.0 111.222 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.57 -27.75 23.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.23 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 63' ' ' SER . 16.3 p -119.93 132.24 24.13 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.332 176.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -91.3 168.09 3.46 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.793 2.329 . . . . 0.0 113.205 -175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . . . -158.51 -156.63 0.56 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.554 174.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.11 154.5 19.32 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.21 129.09 35.85 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.6 m -97.39 156.48 16.44 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.281 0.563 . . . . 0.0 111.006 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.9 tt0 -87.87 142.19 28.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.323 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.632 ' HE1' ' CE2' ' A' ' 98' ' ' PHE . 94.3 m-85 -106.76 90.55 3.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.442 . . . . 0.0 110.235 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.661 ' HD2' ' CD1' ' A' ' 99' ' ' TYR . 90.5 t80 -90.89 146.48 23.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.96 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.464 ' OG1' HG23 ' A' ' 143' ' ' VAL . 5.9 m -117.96 123.01 44.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.042 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.5 m -67.85 128.85 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -106.87 115.7 30.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.5 t 55.58 -90.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.822 173.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.5 19.32 53.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.427 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.531 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 2.2 m-20 -66.93 134.58 52.29 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.49 0.662 . . . . 0.0 111.253 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.619 ' O ' HG21 ' A' ' 110' ' ' ILE . 36.0 p -119.4 156.44 30.12 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.284 175.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 110' ' ' ILE . 20.9 tp -56.38 -40.86 75.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 118.185 0.448 . . . . 0.0 111.132 -171.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 4.6 m -63.77 -40.25 96.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.155 0.502 . . . . 0.0 110.378 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -73.83 -27.52 61.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.73 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.619 HG21 ' O ' ' A' ' 106' ' ' THR . 1.4 pp -85.34 -24.28 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.809 0.338 . . . . 0.0 110.958 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.3 p -76.3 -29.67 57.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 170.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 52.5 tptt -60.43 -26.33 66.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.842 170.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 16.2 mm-40 -75.69 -72.42 0.31 Allowed 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 122.282 1.039 . . . . 0.0 110.715 175.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.466 HG21 ' N ' ' A' ' 115' ' ' TYR . 28.8 m -70.41 -40.1 77.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 113.251 -1.795 . . . . 0.0 112.659 -167.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.466 ' N ' HG21 ' A' ' 114' ' ' VAL . 56.5 m-85 -96.97 -20.11 18.32 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.602 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 80.89 5.5 90.05 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.544 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.478 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 35.8 t30 -140.81 116.05 9.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.806 0.336 . . . . 0.0 110.318 -176.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.431 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -70.31 -11.11 60.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.553 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -81.76 -10.96 59.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.478 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 74.8 mt -96.11 22.68 7.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.76 -178.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.652 ' HE1' ' CE2' ' A' ' 121' ' ' TYR . 50.8 p90 -68.35 -29.13 67.79 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.041 -175.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.405 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 9.0 t30 -69.93 -30.51 67.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.084 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -53.83 -47.76 70.6 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.808 0.813 . . . . 0.0 109.484 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.535 HG23 ' OD1' ' A' ' 128' ' ' ASN . 55.7 mt -68.49 -46.71 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.491 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -53.96 -46.64 71.69 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.103 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.437 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 15.0 mt-10 -69.63 -24.67 63.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.96 0.41 . . . . 0.0 111.598 -176.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.49 29.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.951 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.535 ' OD1' HG23 ' A' ' 124' ' ' ILE . 8.3 m120 -74.82 -46.84 33.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.925 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 62.3 pttt -58.5 154.06 36.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.84 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.448 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.9 Cg_endo -80.86 15.18 20.15 Favored 'Cis proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.241 -1.566 . . . . 0.0 113.674 0.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.468 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.6 tmm? -70.03 -36.86 75.37 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.7 tp -94.45 115.88 28.14 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -73.81 -42.6 60.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.316 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.409 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 52.8 m -157.89 154.03 23.71 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 134' ' ' SER . 33.2 Cg_exo -61.72 -23.19 75.92 Favored 'Trans proline' 0 C--O 1.23 0.077 0 C-N-CA 123.76 2.974 . . . . 0.0 112.975 -173.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -105.38 7.16 33.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 110.689 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.409 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 30.9 mmtp -100.82 14.79 30.57 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.458 0.647 . . . . 0.0 110.692 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 106' ' ' THR . 17.6 pt -67.54 171.61 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.605 172.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -153.81 143.77 15.41 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.705 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.64 115.49 2.14 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.285 2.657 . . . . 0.0 112.898 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.01 26.0 7.68 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.357 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.529 ' H ' HG23 ' A' ' 101' ' ' VAL . 65.4 tt0 -100.21 121.62 41.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.871 0.367 . . . . 0.0 110.782 -175.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.464 HG23 ' OG1' ' A' ' 100' ' ' THR . 55.4 t -82.12 138.4 19.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.691 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.0 mt -132.52 146.38 51.88 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.441 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.675 ' NH2' ' HA ' ' A' ' 65' ' ' GLU . 32.7 ttt180 -75.65 113.4 13.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.746 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 36.4 mm -99.93 103.09 20.0 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.106 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 27.2 Cg_exo -61.96 160.55 29.22 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.33 2.02 . . . . 0.0 111.805 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -80.73 129.9 34.78 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -62.75 96.29 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.453 0.471 . . . . 0.0 110.757 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.9 tp -101.59 84.79 2.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.166 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.93 157.54 37.9 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -174.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -73.67 -8.21 55.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.952 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -99.28 151.17 21.34 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -151.33 20.71 0.74 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.28 0.562 . . . . 0.0 110.462 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -105.97 107.4 18.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.678 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.4 ' HB2' ' C ' ' A' ' 116' ' ' GLY . 15.0 p-80 -84.48 170.83 13.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.295 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.2 p80 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.066 -178.581 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.653 0.263 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.89 23.25 0.97 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.353 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.0 tp -110.13 129.53 55.69 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.913 0.387 . . . . 0.0 110.405 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 1.65 ' HE1' ' CE2' ' A' ' 4' ' ' PHE . 81.3 m-85 -120.85 133.63 55.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.902 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -102.64 151.08 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.971 0.415 . . . . 0.0 110.813 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.628 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 90.8 m-85 -131.68 -179.88 5.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.945 -175.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.23 -17.81 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.867 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 81.2 tttt 72.93 -69.46 0.19 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.403 0.681 . . . . 0.0 111.7 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.26 -25.11 65.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.823 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.76 124.57 42.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.714 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.39 -163.26 36.78 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.71 134.4 38.11 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -78.06 90.49 4.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.327 0.584 . . . . 0.0 111.359 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.69 -48.31 5.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.59 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -142.46 149.28 39.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.034 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.31 -1.07 35.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.301 0.572 . . . . 0.0 111.017 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 57.92 38.12 26.92 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.523 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.8 t -64.32 -73.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.993 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.8 p -130.03 23.94 5.28 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.28 -139.81 15.85 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.547 -171.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -156.01 93.81 1.47 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 34.5 m80 67.26 -72.14 0.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -168.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -122.67 -164.97 1.23 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.001 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HZ1' ' HB2' ' A' ' 52' ' ' ASP . 3.4 tppp? -94.73 -42.93 8.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.077 0.465 . . . . 0.0 109.794 177.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.77 -10.47 59.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.954 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 18.9 t70 -72.05 -21.79 61.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.277 0.56 . . . . 0.0 109.734 177.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.411 ' O ' HG21 ' A' ' 31' ' ' VAL . 17.6 mt-30 -69.09 -31.33 69.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.787 176.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 50' ' ' ILE . . . -62.89 -27.45 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.232 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.583 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 60.5 tttp -65.19 -42.76 93.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -64.04 -37.99 89.43 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.176 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.55 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 62.1 t -59.15 -51.68 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.893 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -54.58 -43.43 72.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.445 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 43.3 mt-10 -57.36 -56.74 17.93 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.105 0.478 . . . . 0.0 110.034 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -51.74 -42.76 62.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.283 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 99.2 mt -68.04 -42.76 80.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.645 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.51 -26.81 51.46 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.124 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -74.13 -32.43 63.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.688 0.28 . . . . 0.0 111.346 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' HG12 ' A' ' 40' ' ' ILE . 2.1 p -80.4 -30.64 37.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.905 0.383 . . . . 0.0 110.984 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.28 27.51 8.66 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.843 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.494 HD11 ' HD2' ' A' ' 130' ' ' PRO . 43.8 mm -58.41 129.75 84.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 122.402 0.281 . . . . 0.0 110.582 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -66.56 134.62 36.15 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.047 1.831 . . . . 0.0 111.981 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 62.96 21.69 13.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.804 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . . . -70.34 -20.53 62.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.089 0.471 . . . . 0.0 111.093 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -91.54 -9.59 43.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.322 0.582 . . . . 0.0 109.991 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.77 -14.31 30.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.203 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.4 m -97.87 177.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -142.09 133.16 26.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.063 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.04 132.98 58.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.003 0.43 . . . . 0.0 110.751 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -115.71 147.9 40.36 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 27' ' ' GLN . 23.0 mm -120.48 128.86 76.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.19 35.24 4.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.194 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.458 ' HB2' ' HZ1' ' A' ' 24' ' ' LYS . 25.8 t70 66.88 98.26 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.671 0.607 . . . . 0.0 110.992 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 75.49 7.26 82.67 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.835 -176.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -146.5 138.69 24.95 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -120.11 148.26 43.84 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.693 175.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.2 m -117.65 119.79 36.05 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.1 t -99.54 111.76 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.459 0.647 . . . . 0.0 110.522 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -113.12 160.5 18.14 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.977 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.78 161.93 15.93 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -139.87 150.66 44.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.127 0.464 . . . . 0.0 111.008 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.92 35.45 84.57 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.93 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.424 HD13 ' CG1' ' A' ' 87' ' ' VAL . 15.2 mt -107.67 -166.25 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.677 0.751 . . . . 0.0 111.305 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.559 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 79.5 p -141.59 159.06 43.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.2 -1.363 . . . . 0.0 107.862 174.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 13.4 mt-30 -68.26 -18.92 64.67 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.413 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.42 -44.9 96.33 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.86 -38.33 15.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.964 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -58.76 -41.26 86.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 -178.592 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.16 35.04 0.63 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.319 1.057 . . . . 0.0 110.304 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 67' ' ' LYS . 47.3 mmtm -123.75 -50.06 1.85 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.597 -1.638 . . . . 0.0 107.152 167.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.5 mt -61.99 -51.94 66.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.775 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp -67.43 -19.26 65.35 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.829 0.824 . . . . 0.0 110.419 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.4 t -86.14 -56.25 5.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.15 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.67 -23.23 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.151 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.5 p -76.28 -39.13 34.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.866 0.365 . . . . 0.0 110.662 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.628 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -71.24 -27.89 70.98 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.865 175.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -83.06 44.69 0.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 111.064 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.4 mt -119.71 141.28 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.424 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.3 m -68.27 103.19 1.53 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.548 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.462 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 130.62 -20.14 4.94 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.458 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.637 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 50.1 mm -94.73 116.85 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.439 . . . . 0.0 110.93 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.415 ' HB1' ' HB2' ' A' ' 8' ' ' LYS . . . -107.78 -10.11 15.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.249 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 5.4 p -162.32 156.93 22.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.983 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 11.5 p -140.93 136.58 34.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.586 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.82 114.46 28.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.542 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.7 112.39 18.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.088 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -129.64 35.91 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.385 0.612 . . . . 0.0 110.503 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.424 ' CG1' HD13 ' A' ' 62' ' ' LEU . 93.4 t -89.09 131.98 35.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.392 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -94.99 97.6 10.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.748 175.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.7 p -81.74 121.52 26.5 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.88 -32.69 20.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.57 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.559 ' OG1' ' HB3' ' A' ' 63' ' ' SER . 17.5 p -106.67 130.22 23.25 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.593 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.21 148.81 34.99 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.93 2.42 . . . . 0.0 112.795 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.429 ' HB1' ' HB2' ' A' ' 64' ' ' GLN . . . -157.12 166.75 32.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.818 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.0 m -74.76 127.24 32.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.871 0.367 . . . . 0.0 110.943 -177.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.417 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -75.75 136.04 40.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.902 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.9 m -112.96 172.84 6.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.195 0.521 . . . . 0.0 111.694 -174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.441 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.0 tt0 -96.79 143.25 27.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.232 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.659 ' HD1' ' CD2' ' A' ' 98' ' ' PHE . 35.4 m-85 -103.6 87.53 2.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.154 0.502 . . . . 0.0 110.456 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.644 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 89.7 t80 -88.11 136.71 32.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.115 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.426 ' OG1' HG23 ' A' ' 143' ' ' VAL . 6.6 m -105.7 123.64 48.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.338 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 142' ' ' GLN . 1.2 m -72.16 135.06 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.277 0.561 . . . . 0.0 109.633 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.438 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 75.2 mmtt -86.92 -165.29 1.25 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.154 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.3 m -55.45 -55.21 34.37 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.862 -173.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.13 26.53 20.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.818 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 7.9 m-20 -82.11 111.51 18.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.149 0.499 . . . . 0.0 111.111 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.551 ' O ' HG21 ' A' ' 110' ' ' ILE . 22.7 p -101.06 164.42 11.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.217 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 125' ' ' PHE . 18.2 tp -63.37 -36.49 83.88 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.165 -174.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -67.16 -35.83 80.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.958 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.85 -41.73 67.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.037 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.635 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -78.34 -24.3 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.622 -176.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 p -73.28 -40.63 64.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.405 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 27.4 ttpp -61.86 -21.92 65.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.292 0.568 . . . . 0.0 110.145 171.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.885 HE21 ' HH ' ' A' ' 99' ' ' TYR . 1.1 tp-100 -75.44 -63.86 1.19 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.8 176.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.438 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.4 m -76.76 -43.0 33.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.192 -170.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 149' ' ' GLU . 19.7 m-85 -92.96 -32.36 14.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.933 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 99.1 -4.62 58.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.192 -176.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.51 ' OD1' ' HG ' ' A' ' 120' ' ' LEU . 24.1 t-20 -126.59 121.99 33.78 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.495 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -77.12 -18.42 57.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -78.67 -14.45 59.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.146 0.498 . . . . 0.0 110.339 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.51 ' HG ' ' OD1' ' A' ' 117' ' ' ASN . 78.4 mt -84.62 14.99 4.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.582 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' A' ' 118' ' ' ALA . 38.8 p90 -63.08 -30.69 71.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.864 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.517 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 15.9 m120 -64.9 -32.76 74.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.515 ' HZ2' ' CD ' ' A' ' 149' ' ' GLU . 19.2 mtmt -61.12 -48.4 81.84 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.391 0.615 . . . . 0.0 110.187 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.06 -36.28 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.368 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.446 ' HB2' HD22 ' A' ' 107' ' ' LEU . 83.3 t80 -56.23 -53.82 52.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.406 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 26.6 mt-10 -70.72 -17.03 62.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.281 -175.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -84.86 -10.0 57.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.032 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.6 ' HB3' ' HE3' ' A' ' 131' ' ' MET . 29.6 m-80 -115.1 25.65 10.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.203 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 11.1 mmmm -86.31 150.21 51.31 Favored Pre-proline 0 C--N 1.326 -0.424 0 O-C-N 122.158 -0.339 . . . . 0.0 110.402 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.494 ' HD2' HD11 ' A' ' 40' ' ' ILE . 10.0 Cg_endo -95.87 15.99 37.75 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.441 -1.066 . . . . 0.0 111.969 -6.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.6 ' HE3' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -70.2 -14.71 62.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.222 178.349 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.67 124.21 49.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 168.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -99.43 -42.09 7.11 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.757 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.447 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 14.7 m -149.56 147.96 24.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.19 0.519 . . . . 0.0 109.786 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.63 -19.91 65.08 Favored 'Trans proline' 0 C--N 1.336 -0.129 0 C-N-CA 123.714 2.943 . . . . 0.0 112.851 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -96.88 -8.24 31.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.371 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 36.7 mmtm -91.44 9.13 33.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 106' ' ' THR . 10.3 pt -69.51 174.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.016 169.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -162.2 148.12 10.49 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.69 116.92 2.36 Favored 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.226 2.617 . . . . 0.0 112.136 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.99 14.32 23.11 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.1 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.495 ' O ' HG11 ' A' ' 101' ' ' VAL . 1.7 mm100 -86.5 108.71 18.66 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.16 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.426 HG23 ' OG1' ' A' ' 100' ' ' THR . 41.7 t -79.8 125.06 38.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 172.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.2 mt -118.96 140.17 50.45 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.81 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 35.6 ttt180 -74.74 111.54 10.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.544 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 33.3 mm -97.67 102.93 14.47 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.006 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 25.5 Cg_exo -63.13 145.76 93.9 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.55 2.167 . . . . 0.0 111.67 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.9 117.71 4.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.492 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.515 ' CD ' ' HZ2' ' A' ' 123' ' ' LYS . 8.5 tp10 -70.7 113.89 8.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.344 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.0 tp -154.42 29.69 0.44 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -112.95 78.84 1.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 53.93 57.54 5.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.413 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -88.75 -1.9 58.32 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.654 -174.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -89.27 0.94 56.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 171.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.422 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 11.4 t-80 -118.91 145.07 46.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 173.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 155' ' ' HIS . 67.7 m-70 66.26 88.08 0.11 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.177 0.513 . . . . 0.0 109.973 -171.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.347 -177.371 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.82 0.343 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.16 44.61 1.44 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.448 HD11 ' C ' ' A' ' 83' ' ' VAL . 19.4 tp -87.39 111.3 20.97 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.491 0.662 . . . . 0.0 111.612 -171.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 1.635 ' HE2' ' CE1' ' A' ' 4' ' ' PHE . 90.0 m-85 -93.88 140.71 29.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.039 174.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -92.19 124.89 36.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.846 0.355 . . . . 0.0 110.81 -176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.619 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 57.1 m-85 -110.41 -164.16 0.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.784 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 7.3 p -82.8 -28.26 8.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -173.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 22.2 tptm 76.44 -60.4 0.48 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.218 0.607 . . . . 0.0 111.33 -175.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.26 -42.62 36.38 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.522 ' HB1' HG13 ' A' ' 7' ' ' VAL . . . -84.22 179.05 7.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.034 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.2 -168.89 12.69 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' A' ' 14' ' ' LEU . 4.8 tp10 -60.19 122.87 15.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -77.68 64.75 3.03 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.257 1.027 . . . . 0.0 109.216 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.504 HD11 ' HG2' ' A' ' 12' ' ' GLU . 11.7 tp -75.47 -32.15 60.49 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 113.571 -1.65 . . . . 0.0 110.383 -174.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -151.27 176.8 10.88 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.016 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.47 113.02 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.023 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.8 47.76 1.13 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.74 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -119.53 97.28 5.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.485 0.66 . . . . 0.0 110.123 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.6 p 51.7 42.0 29.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.636 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.39 168.53 44.3 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.029 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -91.69 -57.59 2.7 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -179.97 -53.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.702 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -123.07 128.68 50.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.389 0.614 . . . . 0.0 110.936 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HD2' ' C ' ' A' ' 24' ' ' LYS . 4.7 tmmm? -69.76 -40.11 76.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.202 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.73 -27.32 66.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.924 0.392 . . . . 0.0 110.12 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.43 -45.35 60.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.198 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -57.89 -45.49 86.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.379 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.78 78.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.115 0.483 . . . . 0.0 110.734 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -70.93 -45.21 64.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.562 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' C ' HD22 ' A' ' 14' ' ' LEU . 30.1 mmtp -58.77 -39.38 80.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.397 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 98.1 t -64.81 -36.28 77.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.735 0.302 . . . . 0.0 110.372 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.412 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 25.6 mm-40 -64.4 -46.98 80.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.906 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.71 -38.71 78.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.246 0.546 . . . . 0.0 109.922 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -60.32 -40.47 90.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.381 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 95.9 mt -71.13 -38.79 72.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.244 0.545 . . . . 0.0 110.888 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -76.72 -32.41 57.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.487 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -75.33 -23.82 57.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.082 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -83.77 -32.72 25.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.288 0.566 . . . . 0.0 110.541 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.07 35.69 4.71 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.753 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.5 mm -74.75 126.19 88.74 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -71.59 144.89 45.7 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.079 1.853 . . . . 0.0 112.596 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 59.37 23.84 12.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.418 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.89 -42.6 73.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 -177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.64 -0.52 34.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.924 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -88.92 -11.23 45.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.014 0.435 . . . . 0.0 110.242 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.26 157.26 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.288 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -106.44 130.33 54.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.854 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.412 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 34.4 mm -90.54 135.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.337 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 27.0 mt-30 -132.86 140.34 47.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.956 175.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mm -118.35 120.65 65.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.48 60.46 1.01 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.068 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 53.68 76.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.039 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 86.59 20.72 53.55 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.641 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 82' ' ' SER . 3.1 ttmp? -146.69 124.21 11.73 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 122.682 -0.305 . . . . 0.0 110.479 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.483 ' O ' HG11 ' A' ' 83' ' ' VAL . . . -104.79 91.53 3.88 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.783 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.436 HG21 ' HB3' ' A' ' 84' ' ' ASP . 58.7 m -80.41 109.42 14.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.151 0.501 . . . . 0.0 109.899 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 12.2 p -93.83 136.87 24.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.124 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.406 HG21 ' HB3' ' A' ' 86' ' ' GLN . 1.4 m -132.01 157.17 44.82 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.0 171.62 29.48 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -155.15 144.52 21.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.873 0.368 . . . . 0.0 110.803 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.25 18.19 31.97 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.165 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.36 178.24 4.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.993 0.425 . . . . 0.0 111.265 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -111.68 170.28 8.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.959 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.548 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 47.8 tp60 -57.47 -53.57 56.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.448 ' HG3' ' NH1' ' A' ' 145' ' ' ARG . 39.5 tt0 -57.33 -49.37 76.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.175 -174.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.01 -49.12 77.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.688 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 41.6 tttp -45.94 -52.81 10.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.45 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.592 ' O ' HG21 ' A' ' 72' ' ' VAL . 53.7 mt-10 -74.79 -28.55 60.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.937 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 65' ' ' GLU . 13.4 tptm -63.32 -42.74 99.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.407 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.06 -49.65 80.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 77.3 mt -48.41 -47.42 37.84 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.164 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.592 HG21 ' O ' ' A' ' 68' ' ' GLU . 39.7 t -66.2 -52.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.308 0.575 . . . . 0.0 111.1 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.31 -30.35 70.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.565 -172.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -83.43 -23.15 8.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.061 0.457 . . . . 0.0 111.234 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.619 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -78.01 -33.06 42.28 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.821 176.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -80.15 61.28 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.716 0.293 . . . . 0.0 110.812 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.552 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 23.3 mm -122.51 132.71 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 t -65.22 101.81 0.59 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 173.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.417 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 126.8 -17.37 6.4 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.645 -172.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.552 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 39.2 mm -102.14 121.11 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.292 0.568 . . . . 0.0 110.822 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -98.86 -33.97 10.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.704 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 25.4 m -147.24 160.34 42.6 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.483 HG11 ' O ' ' A' ' 55' ' ' ALA . 55.7 t -132.34 121.72 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.671 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.436 ' HB3' HG21 ' A' ' 56' ' ' THR . 10.5 t70 -97.58 106.53 18.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.267 0.556 . . . . 0.0 109.597 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.98 115.64 9.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.034 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 26.7 mt-30 -125.86 35.05 4.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.305 171.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.02 118.86 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.959 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -86.4 131.88 34.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.824 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.6 p -104.39 120.81 42.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.056 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.88 -25.14 43.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.73 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -127.94 127.37 23.9 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.884 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.25 155.92 10.99 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.078 2.519 . . . . 0.0 112.25 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 64' ' ' GLN . . . -160.27 -157.97 0.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.463 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -71.81 121.09 18.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.875 0.369 . . . . 0.0 111.231 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.35 146.46 27.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.697 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.8 m -123.22 157.97 31.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.66 0.743 . . . . 0.0 112.258 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -96.46 155.38 16.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.278 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.584 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 90.7 m-85 -113.52 96.08 5.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.873 0.368 . . . . 0.0 110.776 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.663 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 90.3 t80 -96.23 142.63 28.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.453 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.426 ' OG1' HG23 ' A' ' 143' ' ' VAL . 3.8 m -109.13 120.86 43.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.517 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.3 m -72.21 139.89 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.7 mmtp -109.76 -165.9 1.05 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.002 0.429 . . . . 0.0 111.257 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 m -67.55 114.69 6.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.63 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.85 13.13 57.08 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.973 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 11.5 m-20 -94.48 123.53 37.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.346 0.593 . . . . 0.0 110.837 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.537 ' O ' HG21 ' A' ' 110' ' ' ILE . 24.7 p -111.39 155.85 22.51 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.346 174.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 2.3 pt? -55.52 -36.59 66.89 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.409 -176.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.522 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 m -66.32 -44.78 82.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.683 0.278 . . . . 0.0 110.804 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.32 -42.33 96.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.039 0.447 . . . . 0.0 110.831 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.598 ' HB ' ' CE2' ' A' ' 99' ' ' TYR . 1.4 pp -76.17 -25.11 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.3 t -66.0 -45.06 82.94 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -58.95 -33.77 71.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.345 0.593 . . . . 0.0 109.678 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.859 HE21 ' HH ' ' A' ' 99' ' ' TYR . 1.1 tp-100 -65.75 -56.82 10.0 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.53 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -86.3 -47.85 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.442 -171.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.463 ' N ' HG21 ' A' ' 114' ' ' VAL . 54.2 m-85 -82.48 -37.99 24.55 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.183 0.516 . . . . 0.0 110.695 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 106.92 -14.06 41.15 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -129.33 128.36 42.97 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.516 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -72.39 -24.9 61.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.747 -175.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -74.07 -0.19 15.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 0.0 111.92 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.3 mt -96.13 15.68 20.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.149 0.499 . . . . 0.0 110.764 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 53.6 p90 -62.83 -27.46 69.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.137 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.554 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 4.6 p30 -67.0 -35.2 79.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.869 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -60.07 -31.67 70.23 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.425 0.631 . . . . 0.0 110.059 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.575 HG23 ' OD1' ' A' ' 128' ' ' ASN . 39.3 mt -79.17 -52.09 15.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.448 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.411 ' CE2' ' HD3' ' A' ' 129' ' ' LYS . 76.6 t80 -49.76 -48.83 50.05 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.085 0.469 . . . . 0.0 111.355 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 42.6 mt-10 -63.63 -25.9 68.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.402 ' O ' ' HE3' ' A' ' 69' ' ' LYS . . . -94.77 -10.22 32.22 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.761 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.757 ' O ' ' HG3' ' A' ' 131' ' ' MET . 8.9 m120 -94.54 -43.97 8.08 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 126' ' ' GLU . 40.6 pttt -60.03 147.36 80.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.416 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -90.56 11.5 58.48 Favored 'Cis proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.554 -1.436 . . . . 0.0 114.574 6.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.757 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -81.05 -7.57 59.59 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.481 0.658 . . . . 0.0 110.297 174.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.451 ' HB3' ' CB ' ' A' ' 128' ' ' ASN . 12.9 tp -132.84 112.06 11.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.827 166.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.07 -26.5 20.23 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 25.5 m -151.49 153.82 32.69 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.353 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -53.17 -48.55 21.46 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 C-N-CA 123.197 2.598 . . . . 0.0 112.397 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -82.27 6.91 15.3 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.893 -175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 134' ' ' SER . 37.8 mmtm -89.79 -4.62 57.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.577 0.227 . . . . 0.0 111.441 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.637 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 15.8 pt -63.02 171.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 174.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -163.11 147.94 9.25 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.099 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -51.11 104.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.213 2.609 . . . . 0.0 112.251 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.472 ' O ' HG13 ' A' ' 7' ' ' VAL . . . 112.08 35.19 1.85 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.218 -177.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.637 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 45.8 tt0 -117.13 121.96 42.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.881 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 48.6 t -80.16 136.05 24.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.963 174.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.0 mt -124.31 145.18 49.57 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.067 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.542 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 37.3 ttt180 -73.51 117.06 14.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.593 176.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.7 88.66 4.5 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.961 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 24.7 Cg_exo -63.83 166.47 15.98 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.361 2.041 . . . . 0.0 111.927 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.99 131.55 46.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.455 ' OE2' ' HA ' ' A' ' 152' ' ' HIS . 0.4 OUTLIER -57.76 107.48 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.569 0.543 . . . . 0.0 110.3 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 151' ' ' GLU . 96.5 mt -98.87 133.23 43.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.112 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 154' ' ' HIS . 43.1 mm-40 68.04 72.03 0.31 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 123.868 0.73 . . . . 0.0 110.622 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.455 ' HA ' ' OE2' ' A' ' 149' ' ' GLU . 39.0 m-70 -66.64 110.38 3.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.084 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 62.24 51.87 3.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.201 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 151' ' ' GLU . 4.1 t-160 -84.56 -54.55 4.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.593 176.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -148.63 32.16 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.138 0.495 . . . . 0.0 110.449 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -138.88 142.25 38.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.209 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.8 t60 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.717 177.935 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 85' ' ' ASP . 16.3 mmt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.591 0.234 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.5 163.29 27.53 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.957 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.8 tp -116.09 118.12 31.98 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 1.659 ' HD2' ' CD1' ' A' ' 4' ' ' PHE . 82.1 m-85 -103.7 134.49 46.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.592 -176.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -96.06 132.57 41.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.732 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.487 ' CD2' HG22 ' A' ' 143' ' ' VAL . 50.2 m-85 -124.6 179.91 4.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.188 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.8 t -97.3 107.5 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 59.1 tttm -56.5 -51.74 67.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.337 -170.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.54 -12.81 61.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.026 0.441 . . . . 0.0 111.037 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 78' ' ' SER . . . -92.82 -164.06 1.13 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.528 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.94 -173.05 44.61 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.923 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.51 125.27 25.62 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -73.52 66.95 1.04 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.201 1.001 . . . . 0.0 109.541 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.438 HD22 ' O ' ' A' ' 30' ' ' LYS . 11.7 tp -69.4 -50.94 41.27 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.765 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 21' ' ' GLN . 7.8 p90 -126.17 16.65 7.82 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.785 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.406 ' HB3' HG13 ' A' ' 18' ' ' VAL . 2.1 m-20 71.86 -43.85 0.57 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.534 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 69.1 23.38 6.5 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.414 0.686 . . . . 0.0 111.251 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.406 HG13 ' HB3' ' A' ' 16' ' ' ASP . 2.5 p -137.82 97.68 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.364 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 m 56.86 36.2 27.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.811 0.815 . . . . 0.0 110.49 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.0 -115.03 2.3 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.498 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.466 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . 2.6 mp0 -80.14 125.34 29.7 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -123.11 -17.6 6.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.713 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.662 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 39.6 m-20 -74.34 107.51 6.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.854 0.359 . . . . 0.0 110.664 -174.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.552 ' O ' ' HB ' ' A' ' 50' ' ' ILE . 21.4 pttp -55.99 -37.31 68.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -170.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.79 -30.07 65.13 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.612 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 33.5 t70 -77.94 -30.59 50.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.873 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 7.0 mm100 -60.37 -41.75 94.4 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.62 -43.2 65.25 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.926 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.3 tttm -64.2 -44.11 92.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.064 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.438 ' O ' HD22 ' A' ' 14' ' ' LEU . 73.2 mmtt -61.85 -40.92 97.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.112 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.568 HG21 ' O ' ' A' ' 27' ' ' GLN . 92.2 t -62.52 -45.1 99.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.355 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.53 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 7.8 mm-40 -55.96 -46.41 78.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.615 173.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 50.4 mt-10 -55.74 -47.39 77.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.349 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -54.78 -45.84 74.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.326 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 80.3 mt -68.0 -35.52 78.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.968 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -73.43 -34.49 65.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.897 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 98.7 mttt -69.11 -46.12 68.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.131 178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.8 p -64.29 -34.14 77.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.099 0.476 . . . . 0.0 110.764 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.53 34.39 4.45 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.503 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.424 ' HB ' ' CB ' ' A' ' 43' ' ' ALA . 7.8 mm -80.31 116.34 61.02 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.25 -49.08 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.958 2.439 . . . . 0.0 113.346 -171.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.44 -5.99 54.03 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.428 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.424 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -72.72 -17.89 61.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.326 0.584 . . . . 0.0 110.149 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.09 -14.62 59.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.891 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.52 -0.76 37.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.21 -172.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -117.3 162.57 15.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.148 0.499 . . . . 0.0 111.216 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.33 138.2 42.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.043 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.53 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 31.2 mm -100.37 130.26 49.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.631 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.477 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 98.4 mt-30 -129.98 136.27 49.24 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 172.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 24' ' ' LYS . 26.8 mm -120.25 119.37 59.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.022 0.439 . . . . 0.0 111.167 -174.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 54' ' ' LYS . . . -100.46 59.53 0.98 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 172.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 70.15 -65.56 0.31 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.712 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 -17.62 6.49 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.246 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 40.7 ttmt -97.85 121.51 39.84 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.078 0.466 . . . . 0.0 110.718 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -100.38 114.62 28.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.078 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 47.3 m -92.9 123.81 36.43 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.836 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.02 125.16 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.813 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -131.59 143.34 50.27 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.479 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.9 174.56 36.93 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -146.56 149.64 33.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.874 0.337 . . . . 0.0 110.325 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.4 22.69 53.49 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.263 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 89' ' ' THR . 7.0 mp -99.07 176.18 5.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.847 0.356 . . . . 0.0 110.42 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.6 p -113.24 154.21 27.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.162 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.642 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 2.3 mm100 -51.27 -47.61 62.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.469 ' H ' ' HB1' ' A' ' 93' ' ' ALA . 7.4 tp10 -53.19 -48.6 67.94 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 111.051 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.19 -43.14 71.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.667 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.428 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 28.0 tttm -54.07 -45.22 71.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.735 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 6.1 mm-40 -60.72 -36.65 79.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.35 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -63.6 -40.09 96.06 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.6 mm -60.34 -54.6 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 88.8 mt -52.6 -39.47 61.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.824 -1.535 . . . . 0.0 112.224 -174.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 68' ' ' GLU . 42.9 t -76.74 -51.92 18.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.038 0.447 . . . . 0.0 110.878 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.53 72.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.716 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.487 HG22 HG12 ' A' ' 31' ' ' VAL . 9.1 p -80.47 -30.03 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.069 0.462 . . . . 0.0 110.849 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.33 -32.8 27.38 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.148 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.08 60.88 3.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 111.493 -178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.43 139.64 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.427 173.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 23.5 m -66.06 112.47 3.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.723 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.5 -28.09 5.59 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -173.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 46.0 mm -89.12 126.2 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.254 0.55 . . . . 0.0 110.475 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.94 -28.49 9.56 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.485 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.8 m -156.54 160.72 39.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.474 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 55.0 t -127.99 129.52 69.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.61 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -98.09 103.85 15.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.711 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.9 t70 -78.13 114.17 16.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.291 -176.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -132.26 18.9 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.615 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.56 115.15 27.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.451 0.643 . . . . 0.0 110.825 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -73.68 133.49 43.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.197 -175.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 12.4 p -99.54 110.28 22.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.587 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.66 -21.58 38.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.655 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 34.0 p -128.58 143.95 50.31 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 6.2 Cg_exo -77.38 140.28 19.23 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.296 2.664 . . . . 0.0 111.857 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.469 ' HB1' ' H ' ' A' ' 65' ' ' GLU . . . -162.14 -166.63 1.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.974 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 7.7 m -58.77 132.99 55.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.85 129.74 55.4 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 168.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.6 m -114.32 147.59 38.87 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.09 0.471 . . . . 0.0 111.67 -171.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.479 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 5.0 tt0 -80.5 136.17 36.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.597 ' HE1' ' CE2' ' A' ' 98' ' ' PHE . 90.7 m-85 -99.6 100.39 11.39 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.084 0.469 . . . . 0.0 110.471 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.633 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 92.0 t80 -100.93 136.95 39.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.621 176.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.487 ' OG1' HG23 ' A' ' 143' ' ' VAL . 16.9 m -106.22 124.84 50.21 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.95 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.525 HG23 ' H ' ' A' ' 142' ' ' GLN . 1.5 m -67.88 126.33 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -75.81 -56.89 4.24 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.289 -167.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.434 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 10.7 t -167.23 -71.05 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.773 0.32 . . . . 0.0 110.373 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.15 45.45 3.51 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.483 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 2.2 m-20 -103.06 143.1 33.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.119 0.485 . . . . 0.0 110.448 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.58 ' O ' HG21 ' A' ' 110' ' ' ILE . 61.6 p -122.11 159.58 26.84 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.827 173.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.517 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 30.9 tp -61.45 -36.88 81.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 118.506 0.593 . . . . 0.0 110.221 -174.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 p -69.79 -33.02 71.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.189 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.4 -43.69 59.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.969 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.58 HG21 ' O ' ' A' ' 106' ' ' THR . 1.3 pp -74.82 -25.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.18 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.3 p -71.42 -43.06 67.47 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.182 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -65.82 -23.95 66.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 110.393 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.577 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.0 OUTLIER -66.28 -52.85 43.33 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.167 175.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.448 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.1 m -89.99 -40.87 13.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.259 -171.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.448 ' N ' HG21 ' A' ' 114' ' ' VAL . 55.5 m-85 -88.9 -38.49 14.5 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.96 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.56 -8.02 59.91 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -169.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -124.42 125.95 45.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.64 -0.78 . . . . 0.0 109.576 -174.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.33 -8.76 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.308 . . . . 0.0 111.622 -175.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -76.52 -20.27 57.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.352 0.596 . . . . 0.0 109.754 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 50.7 mt -84.25 18.55 2.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.342 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.517 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 34.8 p90 -66.61 -33.75 76.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.349 0.595 . . . . 0.0 109.454 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -68.4 -35.26 77.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.267 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 27.7 mmmt -52.27 -54.52 30.29 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.611 0.72 . . . . 0.0 110.189 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.2 mt -63.2 -36.93 77.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.588 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.49 ' CE1' ' HA ' ' A' ' 134' ' ' SER . 30.8 t80 -61.54 -56.35 20.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.746 0.308 . . . . 0.0 110.734 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.64 -37.31 83.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.159 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.83 -31.26 70.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.928 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.578 ' HB3' ' HE3' ' A' ' 131' ' ' MET . 33.7 m-80 -93.18 8.69 39.14 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.366 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 9.1 mtpm? -84.9 153.83 60.68 Favored Pre-proline 0 C--N 1.318 -0.794 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.882 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -91.87 11.81 55.65 Favored 'Cis proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.946 -1.689 . . . . 0.0 112.752 -0.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.578 ' HE3' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -69.28 -24.38 63.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.708 0.289 . . . . 0.0 111.476 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.4 tp -98.48 121.68 40.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -74.68 -54.38 7.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.654 -172.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.49 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 49.5 m -156.44 157.66 31.12 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.722 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.8 -56.53 3.01 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 124.002 3.135 . . . . 0.0 113.889 -175.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.6 3.9 26.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 137' ' ' LYS . 13.7 mmmm -91.92 7.82 40.27 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 120.886 0.374 . . . . 0.0 111.414 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 106' ' ' THR . 19.1 pt -66.59 169.16 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.354 171.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 1.638 ' HE2' ' CE1' ' A' ' 139' ' ' TYR . 34.9 p90 -163.75 148.1 8.6 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.434 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 63.6 Cg_exo -46.13 120.47 3.67 Favored 'Trans proline' 0 CA--C 1.519 -0.267 0 C-N-CA 123.183 2.589 . . . . 0.0 112.621 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.554 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 94.21 24.68 18.64 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.297 -176.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.525 ' H ' HG23 ' A' ' 101' ' ' VAL . 7.3 tp60 -97.79 111.56 23.81 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.487 HG22 ' CD2' ' A' ' 6' ' ' PHE . 46.1 t -77.66 135.86 25.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.2 mt -130.9 137.59 49.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.829 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.451 ' HG2' HG23 ' A' ' 72' ' ' VAL . 25.4 mtm180 -69.1 123.31 20.72 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.083 174.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 24.9 mm -103.87 95.02 7.05 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.16 148.13 49.54 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.311 2.008 . . . . 0.0 111.799 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -65.5 114.48 4.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.489 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.32 86.22 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.577 175.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.07 46.15 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.467 0.651 . . . . 0.0 110.243 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.93 128.38 34.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.381 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -93.69 -10.66 33.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.764 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -97.11 168.32 10.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.119 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -118.9 42.18 2.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.883 0.849 . . . . 0.0 109.309 175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -81.41 -26.87 35.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.341 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -90.48 151.09 21.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.326 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.906 175.728 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.544 0.211 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.23 -152.28 9.5 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.313 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.1 tp -93.84 130.43 39.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.08 0.467 . . . . 0.0 110.69 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -105.99 129.18 54.17 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.597 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -99.32 134.8 41.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.548 0.69 . . . . 0.0 112.002 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 33.0 m-85 -121.19 -166.16 1.32 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.672 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.584 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 94.6 t -78.09 -83.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.571 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.3 tmtp? 163.53 -77.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.969 0.793 . . . . 0.0 109.167 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' H ' ' HB3' ' A' ' 8' ' ' LYS . 22.5 t70 -76.4 -25.49 54.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.711 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.34 125.15 28.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.497 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.43 -172.35 32.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.737 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -69.62 131.07 44.07 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -78.55 66.25 4.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.199 0.999 . . . . 0.0 108.84 173.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.532 HD22 ' O ' ' A' ' 30' ' ' LYS . 16.1 tp -72.59 -46.04 56.17 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.902 -172.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.401 ' HB2' ' H ' ' A' ' 16' ' ' ASP . 1.2 p90 -100.49 -162.73 0.97 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.574 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' H ' ' HB2' ' A' ' 15' ' ' TRP . 1.7 p30 -57.21 -33.05 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.799 0.333 . . . . 0.0 111.611 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 67.6 21.94 9.27 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.987 171.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 p -126.11 109.96 22.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.723 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.4 m 74.27 -44.79 0.57 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.144 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.75 141.36 4.12 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -72.92 135.06 45.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -81.93 -27.31 33.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.23 -173.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 75.2 m-20 -77.87 80.41 4.32 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.521 ' HA ' ' OE1' ' A' ' 27' ' ' GLN . 38.0 ttpt -59.95 -42.37 93.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.249 -173.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -74.3 -20.14 60.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 110.396 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -83.96 -28.49 27.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.007 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.521 ' OE1' ' HA ' ' A' ' 24' ' ' LYS . 56.1 mt-30 -58.92 -38.36 78.78 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.884 174.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 48' ' ' ILE . . . -56.99 -45.93 82.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.707 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 60.0 tttp -67.34 -39.47 85.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.532 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -53.08 -47.64 68.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 110.554 175.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.558 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 86.9 t -65.62 -39.57 85.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.825 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.51 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -60.02 -44.2 94.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.274 -0.171 . . . . 0.0 110.558 174.011 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 66.5 mm-40 -54.86 -49.27 71.54 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.193 0.521 . . . . 0.0 110.315 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -55.04 -33.07 62.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.603 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 79.5 mt -81.87 -44.59 16.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.061 0.458 . . . . 0.0 110.989 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -69.14 -35.02 75.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.64 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -77.36 -31.54 54.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.568 0.223 . . . . 0.0 111.467 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -76.63 -39.28 52.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.676 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.92 28.64 4.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.222 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.5 mm -62.61 130.7 93.76 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.1 130.83 23.7 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.234 1.956 . . . . 0.0 112.679 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 62.63 12.08 5.27 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.253 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 35' ' ' LEU . . . -71.64 -17.41 62.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.381 0.61 . . . . 0.0 110.796 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.01 -22.08 39.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.491 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -84.61 -23.65 29.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.168 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.32 177.59 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.61 129.77 25.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.086 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 3.2 mp -96.57 131.01 44.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -126.12 118.35 25.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.0 110.426 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.7 mm -89.33 132.7 33.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.514 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.11 -81.42 0.61 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.375 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -152.42 101.81 2.7 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.66 13.23 50.53 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 82' ' ' SER . 34.7 mtmm -133.2 124.44 27.43 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 120.844 0.354 . . . . 0.0 111.113 -174.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.38 104.77 14.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.498 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 m -82.58 113.88 20.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.322 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG21 HG13 ' A' ' 48' ' ' ILE . 62.9 t -100.62 113.46 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-O 121.089 0.471 . . . . 0.0 110.711 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -110.26 158.66 18.16 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.075 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.6 157.65 8.29 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.23 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -137.08 151.47 48.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 90' ' ' ALA . . . 86.85 38.55 7.96 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.98 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.2 163.93 18.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 0.0 111.201 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 m -106.01 151.21 24.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.54 173.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.584 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 11.2 mm100 -49.15 -48.23 45.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.33 -41.56 80.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 70' ' ' ILE . . . -72.55 -42.31 64.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.259 0.552 . . . . 0.0 109.936 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.462 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 50.1 tttm -55.26 -51.66 65.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.48 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 4.9 mm-40 -67.89 -28.87 67.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.3 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -65.43 -37.25 86.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.148 0.499 . . . . 0.0 109.989 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 66' ' ' ALA . 43.6 mt -70.09 -55.52 14.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.14 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 78.5 mt -50.06 -44.18 51.55 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.405 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.17 -34.55 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.964 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.57 -27.14 34.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.658 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.7 m -84.82 -22.5 7.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.223 0.535 . . . . 0.0 110.768 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -79.89 -35.51 27.76 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.32 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -79.91 55.84 2.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.025 0.44 . . . . 0.0 111.187 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.409 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 11.2 mm -118.67 138.13 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 t -68.21 92.07 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.241 0.543 . . . . 0.0 109.95 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.1 -19.93 3.05 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.409 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 48.2 mm -97.16 131.59 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.254 0.55 . . . . 0.0 110.026 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' HB3' ' HG2' ' A' ' 8' ' ' LYS . . . -124.27 -3.37 7.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.755 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -164.78 147.2 8.38 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.225 -179.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.25 122.79 69.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.782 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.51 92.05 7.41 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.28 123.08 20.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.508 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -126.49 14.65 7.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.053 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -73.92 118.54 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.12 0.486 . . . . 0.0 109.776 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -89.14 4.94 46.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.267 -170.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 90' ' ' ALA . 32.0 p 44.95 -153.92 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.765 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.477 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . . . -173.29 -41.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -118.16 131.97 23.95 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.564 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.8 144.34 48.21 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.868 2.379 . . . . 0.0 112.434 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 64' ' ' GLN . . . -158.74 -178.46 7.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.222 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.2 m -66.72 126.21 28.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.142 0.496 . . . . 0.0 111.258 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.53 164.47 20.85 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.8 m -121.37 145.13 48.21 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.622 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.448 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.5 tt0 -84.77 140.96 30.86 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -110.19 102.95 11.59 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.027 0.441 . . . . 0.0 110.504 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.599 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 76.9 t80 -106.27 133.52 50.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.011 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.441 ' OG1' HG23 ' A' ' 143' ' ' VAL . 7.8 m -100.02 122.46 42.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.346 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.514 HG23 ' H ' ' A' ' 142' ' ' GLN . 1.7 m -71.21 136.3 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -84.44 -163.9 0.87 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.451 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 1.6 p -60.33 -64.51 0.93 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.97 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.87 46.67 2.48 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.194 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.501 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 7.4 m-20 -104.79 127.81 52.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.131 0.491 . . . . 0.0 110.92 -177.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.539 ' O ' HG21 ' A' ' 110' ' ' ILE . 40.6 m -114.93 153.06 31.23 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.929 177.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 29.1 tp -51.97 -49.98 62.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.785 0.266 . . . . 0.0 111.63 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.44 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 m -66.66 -27.09 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.214 0.531 . . . . 0.0 111.156 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -73.33 -40.64 64.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.811 0.339 . . . . 0.0 110.375 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.539 HG21 ' O ' ' A' ' 106' ' ' THR . 1.2 pp -79.71 -25.29 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.106 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.3 p -70.28 -38.67 75.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.032 0.444 . . . . 0.0 109.824 173.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.429 ' HD3' ' O ' ' A' ' 112' ' ' LYS . 5.6 tmtm? -58.71 -35.84 73.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.449 173.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 13.6 mm100 -59.72 -65.05 0.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 122.241 1.02 . . . . 0.0 111.267 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -81.97 -37.47 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 113.679 -1.6 . . . . 0.0 112.643 -165.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.493 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 55.5 m-85 -89.58 -45.25 9.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.292 0.568 . . . . 0.0 110.65 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.86 -14.72 26.58 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.474 ' HB3' ' HG ' ' A' ' 120' ' ' LEU . 56.7 t-20 -123.19 121.71 36.61 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.85 62.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.619 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.422 ' C ' ' H ' ' A' ' 121' ' ' TYR . 25.2 t-20 -65.64 -21.63 66.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.07 0.462 . . . . 0.0 110.765 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.495 HD11 ' HE2' ' A' ' 123' ' ' LYS . 42.2 mt -79.78 29.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.703 -176.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.457 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 50.1 p90 -72.17 -35.27 68.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.166 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -71.05 -31.82 68.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.948 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.495 ' HE2' HD11 ' A' ' 120' ' ' LEU . 22.0 mtmt -52.44 -44.78 65.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.365 0.602 . . . . 0.0 110.439 173.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.4 HG23 ' OD1' ' A' ' 128' ' ' ASN . 46.2 mt -70.1 -44.67 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.278 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -52.97 -47.81 67.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.655 0.264 . . . . 0.0 111.043 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -66.03 -29.98 70.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.402 . . . . 0.0 110.908 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.07 -25.11 40.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.364 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.511 ' O ' ' HB3' ' A' ' 131' ' ' MET . 7.0 m120 -84.75 -41.87 15.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.106 0.479 . . . . 0.0 109.715 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.477 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 18.6 pttp -64.62 155.99 79.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.595 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 92.7 Cg_endo -81.97 17.69 18.8 Favored 'Cis proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.436 -1.485 . . . . 0.0 113.448 2.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.511 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -74.49 -36.27 63.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.874 0.368 . . . . 0.0 110.32 174.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.1 tp -88.95 126.81 35.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.014 0.435 . . . . 0.0 109.867 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -88.09 -38.77 15.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.426 -173.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.1 m -153.56 153.09 28.58 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.36 -18.41 38.92 Favored 'Trans proline' 0 C--O 1.23 0.089 0 C-N-CA 123.54 2.827 . . . . 0.0 112.312 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -101.95 -5.67 24.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.807 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -86.28 10.19 15.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.469 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 106' ' ' THR . 9.0 pt -62.88 173.69 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.189 170.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.557 ' CE1' ' HG2' ' A' ' 142' ' ' GLN . 5.9 p90 -166.19 150.85 7.34 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -175.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.453 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 84.9 Cg_exo -49.57 102.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.258 2.639 . . . . 0.0 112.656 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.33 23.53 5.12 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.473 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.557 ' HG2' ' CE1' ' A' ' 139' ' ' TYR . 0.5 OUTLIER -91.33 109.78 21.07 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.441 HG23 ' OG1' ' A' ' 100' ' ' THR . 39.3 t -80.58 122.2 35.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.448 0.642 . . . . 0.0 110.052 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.428 HD23 ' OD1' ' A' ' 128' ' ' ASN . 75.6 mt -117.39 139.91 50.26 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.863 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.434 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 48.4 mtp180 -69.79 119.09 13.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.084 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 31.7 mm -105.32 98.49 16.73 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.493 ' HD2' ' OH ' ' A' ' 115' ' ' TYR . 47.9 Cg_exo -56.64 154.04 32.96 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.827 2.351 . . . . 0.0 111.706 175.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 35.2 tt0 -67.86 126.3 29.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -51.26 101.71 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.209 0.943 . . . . 0.0 112.206 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 148' ' ' GLU . 92.3 mt -111.34 3.39 18.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.23 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.41 ' HB3' ' HB3' ' A' ' 155' ' ' HIS . 13.0 mp0 -113.62 47.02 1.21 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.048 0.927 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.417 ' C ' ' H ' ' A' ' 154' ' ' HIS . 8.1 t-80 -78.33 -11.47 59.94 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.49 -171.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -80.73 27.92 0.36 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.593 0.235 . . . . 0.0 111.062 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.417 ' H ' ' C ' ' A' ' 152' ' ' HIS . 35.4 m-70 58.48 38.65 25.53 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.195 -176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 151' ' ' GLU . 54.8 t-80 -73.79 95.98 2.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.518 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -110.4 146.1 36.44 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.697 -174.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.0 t60 . . . . . 0 C--O 1.248 0.999 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.885 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.606 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 87.0 mtp . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.684 0.278 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.53 177.52 44.65 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.7 tp -105.83 116.49 32.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.047 0.451 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -100.73 125.2 47.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.044 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -103.3 140.59 37.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.828 0.346 . . . . 0.0 110.648 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.447 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 73.5 m-85 -126.24 -161.14 1.03 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.751 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.61 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 7.3 p -79.75 -25.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 16.9 tptm 79.06 -66.26 0.19 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.488 0.715 . . . . 0.0 112.003 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.97 -36.01 36.73 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.742 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.61 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -79.17 152.17 30.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.498 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.65 -172.24 24.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.112 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -62.89 128.77 37.43 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.54 65.62 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.038 0.923 . . . . 0.0 108.969 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 30' ' ' LYS . 11.2 tp -75.82 -49.61 17.55 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.161 -175.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.46 ' CH2' HG22 ' A' ' 77' ' ' ILE . 9.0 p90 -124.51 -10.94 7.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.982 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.416 ' HB3' HG21 ' A' ' 18' ' ' VAL . 11.4 m-20 70.64 124.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 124.258 0.974 . . . . 0.0 111.961 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.72 49.39 1.72 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.722 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' A' ' 16' ' ' ASP . 22.1 t -67.52 -75.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.441 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.98 29.63 6.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.39 66.86 2.02 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.207 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 22' ' ' HIS . 47.8 mt-30 -70.81 161.62 30.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' GLN . 19.0 m-70 74.71 178.87 0.2 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.65 0.594 . . . . 0.0 111.151 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 15.2 m-20 -104.97 29.43 6.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.253 -171.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.503 ' HA ' ' OE1' ' A' ' 27' ' ' GLN . 21.1 pttp 61.28 -51.3 0.12 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.538 1.535 . . . . 0.0 113.897 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.91 -26.35 63.17 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.747 -0.596 . . . . 0.0 111.115 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.429 ' OD1' ' HB3' ' A' ' 22' ' ' HIS . 1.8 p-10 -81.27 -18.27 46.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.977 0.418 . . . . 0.0 110.017 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.503 ' OE1' ' HA ' ' A' ' 24' ' ' LYS . 98.9 mt-30 -65.04 -30.22 71.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.055 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.33 89.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.503 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 87.7 tttt -68.32 -36.84 79.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.177 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' O ' HD22 ' A' ' 14' ' ' LEU . 3.2 mptp? -58.63 -43.07 89.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.423 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.58 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 95.3 t -64.2 -44.61 97.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.218 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -52.25 -50.36 62.22 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.693 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 48.6 mt-10 -56.16 -51.66 67.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.181 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -53.72 -42.68 68.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.331 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 93.0 mt -70.13 -41.04 74.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.53 -39.48 67.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.189 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 74.6 mmtt -63.98 -36.86 85.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.152 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 p -78.74 -38.81 37.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.141 0.496 . . . . 0.0 110.868 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.41 31.95 4.43 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.998 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.2 mm -63.2 127.35 90.87 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -59.78 130.56 35.56 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.484 2.123 . . . . 0.0 112.729 -175.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.28 26.5 15.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.198 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.94 -17.15 64.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.192 0.52 . . . . 0.0 110.718 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -84.18 -16.25 44.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.639 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -86.04 -35.09 20.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.998 0.428 . . . . 0.0 110.363 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.2 m -83.73 166.25 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.554 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -134.33 131.05 37.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.542 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 mp -108.23 139.16 31.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.636 0.255 . . . . 0.0 110.652 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -123.89 140.8 52.63 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 172.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 24' ' ' LYS . 11.1 mm -118.14 133.05 66.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.9 0.381 . . . . 0.0 111.107 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.28 91.86 2.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.894 174.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.4 t70 65.9 -75.82 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.829 0.705 . . . . 0.0 111.215 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.38 6.2 4.6 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -98.68 110.88 23.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.809 0.338 . . . . 0.0 110.235 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -103.51 106.44 16.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.028 176.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.5 m -92.72 115.97 28.59 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.638 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.91 120.46 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.083 0.468 . . . . 0.0 110.295 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.22 160.47 21.54 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.09 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.21 178.3 28.48 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 6.3 p-10 -167.51 155.12 8.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.908 0.385 . . . . 0.0 110.513 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.34 15.99 63.27 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.145 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -95.56 -167.69 1.65 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.658 0.742 . . . . 0.0 110.723 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -124.19 152.27 43.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.241 -1.345 . . . . 0.0 108.658 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.504 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 51.7 tt0 -58.18 -42.02 85.18 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -166.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.54 -48.83 71.53 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.611 0.243 . . . . 0.0 111.374 -176.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.84 75.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.216 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.533 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 49.7 tttp -49.35 -53.43 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.452 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.651 ' O ' HG21 ' A' ' 72' ' ' VAL . 54.1 mt-10 -62.03 -48.01 82.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -59.98 -38.48 82.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.495 ' O ' HG13 ' A' ' 74' ' ' VAL . 57.8 mt -62.02 -56.1 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.085 174.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 91.0 mt -49.16 -42.11 38.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.105 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.651 HG21 ' O ' ' A' ' 68' ' ' GLU . 40.9 t -72.7 -44.63 59.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.902 0.382 . . . . 0.0 110.957 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.12 -35.58 81.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 70' ' ' ILE . 11.3 p -79.15 -26.83 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.328 0.585 . . . . 0.0 110.423 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.447 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -77.02 -11.82 85.22 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.535 173.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.529 ' OD1' ' HG3' ' A' ' 142' ' ' GLN . 5.8 m-80 -97.64 39.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.725 -0.238 . . . . 0.0 110.714 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.472 ' HB ' HG12 ' A' ' 80' ' ' ILE . 10.8 mm -115.44 132.38 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.4 t -65.46 99.25 0.41 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.4 -15.66 3.9 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.025 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 43.2 mm -96.78 121.65 47.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.157 0.503 . . . . 0.0 111.069 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.577 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -96.75 -37.19 10.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.393 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 p -150.87 154.2 36.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.456 0.646 . . . . 0.0 111.612 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 53.0 t -117.71 122.77 70.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.587 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -91.78 93.37 8.83 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.606 ' OD2' ' HA ' ' A' ' 1' ' ' MET . 17.7 t70 -71.78 112.51 7.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.157 -175.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.403 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 49.0 mt-30 -128.06 14.77 6.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.544 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 p -93.62 129.7 43.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.189 0.519 . . . . 0.0 111.4 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -96.77 158.22 15.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.068 -177.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.5 p -124.58 136.45 53.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.431 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.98 -28.07 16.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.608 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 p -123.07 138.89 30.5 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.852 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.53 160.16 28.63 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.785 2.323 . . . . 0.0 111.664 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.06 -167.31 2.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.938 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 88.4 m -57.95 138.7 55.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.476 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -108.01 125.25 51.31 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.347 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.1 m -110.69 146.49 36.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.424 0.63 . . . . 0.0 111.286 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.437 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 15.8 tt0 -87.86 138.82 31.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.772 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.582 ' HD1' ' CD2' ' A' ' 98' ' ' PHE . 90.7 m-85 -98.13 94.09 6.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.12 0.486 . . . . 0.0 110.699 -175.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.667 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 92.1 t80 -95.74 136.3 36.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.044 177.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.483 ' OG1' HG23 ' A' ' 143' ' ' VAL . 7.5 m -106.66 122.9 47.27 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.54 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -67.82 128.55 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -82.13 -57.9 3.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.861 -167.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' A' ' 140' ' ' PRO . 12.0 p -156.98 -87.61 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.112 -176.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.97 49.83 2.93 Favored Glycine 0 C--N 1.329 0.19 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.54 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -97.46 120.05 37.12 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.937 -0.631 . . . . 0.0 110.941 -174.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.558 ' O ' HG21 ' A' ' 110' ' ' ILE . 58.7 p -112.61 163.3 14.68 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -63.07 -40.45 97.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 118.837 0.744 . . . . 0.0 110.573 -174.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 15.6 m -69.98 -23.07 63.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 110.43 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.82 -47.42 13.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.236 -0.29 . . . . 0.0 110.759 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.6 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.4 pp -72.46 -23.57 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.141 -177.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 p -73.93 -48.01 33.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.729 0.3 . . . . 0.0 110.237 173.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -61.16 -21.84 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.451 0.643 . . . . 0.0 110.208 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.734 HE21 ' HH ' ' A' ' 99' ' ' TYR . 6.4 tp60 -71.84 -58.43 3.47 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.161 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.418 HG21 ' N ' ' A' ' 115' ' ' TYR . 23.0 m -85.39 -39.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.045 -172.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.418 ' N ' HG21 ' A' ' 114' ' ' VAL . 46.2 m-85 -88.48 -57.21 3.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.548 0.689 . . . . 0.0 110.43 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.04 -23.81 6.46 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.644 -171.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -105.52 124.09 48.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.079 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 108' ' ' SER . . . -72.12 -21.03 61.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.206 0.526 . . . . 0.0 110.346 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.85 -22.53 65.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.114 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.8 mt -84.29 16.13 3.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.191 -0.458 . . . . 0.0 112.202 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.452 ' HD1' ' O ' ' A' ' 118' ' ' ALA . 40.0 p90 -64.46 -27.27 68.87 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -54.82 -55.04 34.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.24 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -50.27 -51.75 42.19 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.474 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.479 HG23 ' OD1' ' A' ' 128' ' ' ASN . 35.8 mt -62.98 -45.17 99.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.419 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.482 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 62.6 t80 -56.7 -49.48 74.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.985 0.422 . . . . 0.0 110.846 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.505 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 17.4 mt-10 -70.02 -23.62 63.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.981 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.71 -28.88 30.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.262 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.654 ' O ' ' HG3' ' A' ' 131' ' ' MET . 7.0 m120 -81.62 -10.83 59.32 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 28.8 mtpp -76.27 153.38 84.17 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.704 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -91.95 13.43 51.71 Favored 'Cis proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.762 -1.766 . . . . 0.0 112.814 -0.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.654 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -76.25 -13.95 60.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.672 0.273 . . . . 0.0 111.71 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.3 tp -99.07 125.8 44.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 171.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -73.61 -56.62 4.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.966 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.2 m -153.22 155.65 31.99 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.003 0.43 . . . . 0.0 109.988 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.23 -27.24 56.27 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.906 3.071 . . . . 0.0 113.447 -170.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -99.76 0.87 42.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.99 0.424 . . . . 0.0 110.231 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -96.17 12.45 30.79 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.139 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.422 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 15.5 pt -72.57 168.51 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 1.634 ' HD2' ' CD1' ' A' ' 139' ' ' TYR . 26.3 p90 -158.78 144.06 11.93 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.143 -171.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.447 ' HG3' ' O ' ' A' ' 103' ' ' SER . 87.3 Cg_exo -49.41 110.11 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.605 2.87 . . . . 0.0 112.387 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.35 3.19 10.57 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.185 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.529 ' HG3' ' OD1' ' A' ' 76' ' ' ASN . 46.0 tt0 -93.13 118.21 30.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.518 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.483 HG23 ' OG1' ' A' ' 100' ' ' THR . 50.3 t -80.15 134.18 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.459 170.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 76.5 mt -130.21 147.98 51.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.575 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -77.41 119.11 20.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.972 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 38.9 mm -103.85 102.37 30.77 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.02 143.18 90.4 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.113 1.875 . . . . 0.0 110.746 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.39 132.01 52.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.455 ' CD ' ' HB2' ' A' ' 152' ' ' HIS . 33.7 tt0 -50.9 116.77 2.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.981 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.3 tp -107.8 102.93 12.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.007 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 64.52 86.22 0.13 Allowed 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.535 0.522 . . . . 0.0 111.328 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.455 ' HB2' ' CD ' ' A' ' 149' ' ' GLU . 22.2 t-80 -73.43 142.27 46.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.135 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -136.97 159.0 43.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.436 173.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -101.25 115.96 31.7 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -115.09 -24.11 8.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.846 -175.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -150.67 135.53 17.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.788 0.328 . . . . 0.0 110.146 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 . . . . . 0 C--N 1.321 -0.665 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.48 177.707 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.657 ' HA ' ' O ' ' A' ' 85' ' ' ASP . 27.9 ttt . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.12 163.79 32.17 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.73 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.429 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 20.1 tp -102.94 115.43 30.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.006 0.431 . . . . 0.0 109.953 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -101.21 123.32 45.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.374 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -78.77 141.54 37.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.539 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 1.665 ' HE1' ' CE2' ' A' ' 6' ' ' PHE . 93.6 m-85 -134.54 175.18 9.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.565 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.477 HG22 ' HA2' ' A' ' 141' ' ' GLY . 22.6 t -78.03 -15.06 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.791 -167.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.565 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 26.6 tptp 74.34 -49.82 0.67 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.946 0.498 . . . . 0.0 112.027 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -91.01 -36.06 14.29 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.73 0.3 . . . . 0.0 111.567 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.07 155.51 20.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.083 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.37 -160.91 24.34 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -76.58 125.46 29.28 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -86.07 65.47 9.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.482 0.658 . . . . 0.0 111.081 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.54 -55.5 30.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.549 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.453 ' O ' HG23 ' A' ' 18' ' ' VAL . 41.2 p90 -113.07 21.09 15.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.36 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 t70 55.99 23.07 6.34 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.492 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.57 37.66 29.17 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.922 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 15' ' ' TRP . 35.6 m -74.18 -172.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.343 174.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.4 p -78.71 53.72 1.39 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.95 -2.71 69.55 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.918 173.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 70.04 -70.09 0.16 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.069 0.547 . . . . 0.0 111.632 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -155.79 -35.14 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.711 0.291 . . . . 0.0 110.613 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -168.94 154.2 6.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -66.69 -34.78 78.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.073 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -73.22 -22.4 60.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.272 0.558 . . . . 0.0 109.9 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.487 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 34.5 t70 -74.58 -40.93 61.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.771 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.436 ' HB2' HG13 ' A' ' 50' ' ' ILE . 22.7 mt-30 -59.03 -41.49 87.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.729 174.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.71 -43.15 85.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.852 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 61.1 tttp -63.51 -44.81 93.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.373 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 12.9 mptt -57.71 -42.16 83.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.576 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 95.7 t -68.65 -41.92 82.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.892 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.502 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 2.9 mm-40 -56.45 -48.67 76.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.071 174.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 53.7 mt-10 -60.28 -40.59 90.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.817 0.341 . . . . 0.0 110.441 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -56.52 -38.24 71.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.212 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 88.7 mt -72.96 -43.63 62.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.2 0.524 . . . . 0.0 110.864 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -72.49 -35.7 68.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.48 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -71.9 -27.07 62.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.563 0.22 . . . . 0.0 111.56 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 p -83.85 -39.36 20.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.182 0.515 . . . . 0.0 110.514 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.85 31.14 3.73 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.806 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 30.5 mm -66.44 127.31 93.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -64.28 139.4 65.65 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.055 1.836 . . . . 0.0 112.509 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 57.18 24.8 10.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.103 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . . . -72.17 -17.67 61.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.271 0.558 . . . . 0.0 110.175 176.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.93 -19.92 36.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.026 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -83.0 -24.71 32.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.759 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.11 179.66 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.506 -177.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 27.0 t-20 -144.87 138.38 26.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.46 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.502 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 14.9 mm -108.48 126.56 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 123.26 0.35 . . . . 0.0 110.836 -175.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -132.18 123.21 26.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.115 0.483 . . . . 0.0 110.39 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 27' ' ' GLN . 26.8 mm -98.4 112.4 30.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.396 -173.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.85 86.4 2.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.844 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 67.53 -76.58 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.422 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.45 -2.3 4.08 Favored Glycine 0 N--CA 1.454 -0.138 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.569 ' HG2' ' HB3' ' A' ' 82' ' ' SER . 38.3 mtmm -99.0 118.7 36.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.817 0.341 . . . . 0.0 110.682 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.65 106.75 18.74 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.947 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -82.99 113.14 20.36 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 120.766 0.317 . . . . 0.0 110.322 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 97.6 t -99.67 109.99 25.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.199 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 m -104.9 164.38 11.83 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.871 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.5 172.65 28.04 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -162.66 148.08 12.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.987 0.422 . . . . 0.0 110.056 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 90' ' ' ALA . . . 97.5 6.97 57.23 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.103 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 89' ' ' THR . 6.8 mp -95.81 169.86 9.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.057 0.456 . . . . 0.0 110.856 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -110.66 154.9 23.17 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.651 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 7.5 tp60 -50.36 -47.79 55.93 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -173.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.463 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 43.9 mt-10 -52.17 -40.31 61.27 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -176.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.05 -45.53 13.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 110.338 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' HE3' ' OD1' ' A' ' 85' ' ' ASP . 75.7 tttt -51.54 -59.52 4.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.133 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 26.1 pt-20 -67.29 -18.07 65.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -72.33 -35.19 68.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.467 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.5 -46.56 92.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 10.1 mp -46.13 -43.62 15.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.652 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.573 HG21 ' O ' ' A' ' 68' ' ' GLU . 39.9 t -63.13 -58.92 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.379 0.609 . . . . 0.0 111.117 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.3 64.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.347 -173.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.443 HG11 HG12 ' A' ' 31' ' ' VAL . 53.3 t -87.61 -29.19 5.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 0.0 110.712 177.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.55 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -75.98 -34.46 47.43 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.824 177.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -79.92 58.73 2.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.608 0.242 . . . . 0.0 110.849 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.548 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 29.7 mm -124.7 130.42 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.1 m -66.13 102.81 0.87 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.52 -17.86 5.51 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.481 -172.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.548 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 38.9 mm -100.46 126.23 54.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.195 0.522 . . . . 0.0 110.729 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.565 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -105.27 -17.18 14.55 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.297 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.569 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . 16.1 t -166.96 167.23 14.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.204 0.525 . . . . 0.0 110.763 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.23 125.38 47.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.809 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -98.42 90.81 4.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.657 ' O ' ' HA ' ' A' ' 1' ' ' MET . 2.9 t70 -66.75 124.2 22.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.153 -177.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -134.67 27.03 3.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.239 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -85.96 127.05 40.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.889 0.376 . . . . 0.0 110.267 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -91.95 127.78 37.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.18 0.514 . . . . 0.0 111.005 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.2 p -89.86 124.47 34.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.416 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.437 ' HB3' ' HA2' ' A' ' 61' ' ' GLY . . . -79.77 -38.37 33.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.758 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.8 p -127.13 150.59 72.62 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.892 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.31 141.73 52.64 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.339 2.693 . . . . 0.0 112.063 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 64' ' ' GLN . . . -156.47 174.37 15.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.807 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.1 m -67.95 127.87 34.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.265 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.76 127.86 42.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.588 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 146' ' ' ILE . 14.1 m -106.03 171.55 7.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.124 0.488 . . . . 0.0 111.71 -175.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.552 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 13.7 tt0 -89.59 153.7 20.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.322 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.618 ' HE2' ' CE1' ' A' ' 98' ' ' PHE . 98.9 m-85 -111.78 91.5 3.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.648 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 76.3 t80 -98.79 118.68 36.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.34 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.8 m -85.59 121.03 27.7 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.057 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.559 HG11 ' O ' ' A' ' 142' ' ' GLN . 1.5 m -69.34 136.74 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -105.7 -166.16 1.18 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.985 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -62.02 116.84 5.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.108 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.39 18.23 64.82 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.658 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.516 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 9.3 m-20 -90.93 114.46 26.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.128 0.49 . . . . 0.0 110.833 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.546 ' O ' HG21 ' A' ' 110' ' ' ILE . 21.7 p -110.02 162.0 14.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.084 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.451 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 16.1 tp -62.02 -41.46 98.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 118.391 0.541 . . . . 0.0 111.356 -169.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.3 p -69.32 -27.33 65.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.213 0.53 . . . . 0.0 110.972 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.91 -41.78 50.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -78.89 -23.65 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.465 -176.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.3 p -71.11 -41.01 71.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 172.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.426 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 4.9 tmmm? -60.19 -29.87 68.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.986 171.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.9 OUTLIER -67.71 -63.52 1.04 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.018 177.335 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.481 HG21 ' N ' ' A' ' 115' ' ' TYR . 35.3 m -76.22 -46.3 33.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.406 -171.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.481 ' N ' HG21 ' A' ' 114' ' ' VAL . 59.6 m-85 -90.91 -30.94 16.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.193 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 92.47 -2.92 74.72 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -170.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -126.08 110.63 13.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.738 -0.731 . . . . 0.0 109.876 -173.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.44 -31.77 72.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.455 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -69.43 -14.75 63.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.627 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.5 mt -83.83 17.32 2.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.821 0.343 . . . . 0.0 111.318 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.451 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 31.3 p90 -66.58 -27.48 67.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.08 0.467 . . . . 0.0 110.106 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.517 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 25.7 p-10 -66.69 -33.69 76.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -57.25 -52.45 65.27 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.579 0.704 . . . . 0.0 109.495 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.9 mt -66.53 -40.21 85.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.251 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.566 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 20.4 t80 -54.27 -60.01 3.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.538 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 24.5 mt-10 -61.72 -34.5 75.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.689 -176.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.57 -31.29 70.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.835 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 131' ' ' MET . 36.4 m-80 -91.34 -18.78 23.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 28.4 mtpp -67.08 151.7 96.85 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.434 176.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -87.67 15.35 44.47 Favored 'Cis proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.987 -1.672 . . . . 0.0 113.474 1.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.476 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.3 OUTLIER -67.75 -33.18 74.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.024 0.44 . . . . 0.0 110.281 177.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.46 131.01 44.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -85.0 -49.56 8.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.598 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.463 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 46.5 p -154.08 161.45 29.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.973 0.416 . . . . 0.0 110.441 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.98 -15.29 48.35 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 123.631 2.887 . . . . 0.0 111.944 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -103.69 -16.34 15.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.206 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -81.74 -6.92 59.48 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 106' ' ' THR . 12.1 pt -65.6 168.53 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 0.0 110.709 172.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -165.06 148.29 7.2 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.476 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.78 115.13 0.62 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.51 2.807 . . . . 0.0 112.806 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 7' ' ' VAL . . . 109.51 6.89 28.67 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.445 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.559 ' O ' HG11 ' A' ' 101' ' ' VAL . 6.5 mm100 -87.7 110.08 20.17 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 41.5 t -77.63 119.63 26.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.403 0.62 . . . . 0.0 109.887 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.8 132.55 53.89 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.183 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.495 ' HB2' HG22 ' A' ' 72' ' ' VAL . 36.1 ttt180 -75.56 110.47 9.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.656 175.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 18.1 mm -94.08 108.63 36.86 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 34.8 Cg_exo -58.31 153.14 48.86 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.591 2.194 . . . . 0.0 111.938 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.85 124.37 23.5 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.602 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -67.38 115.6 7.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.21 -171.04 2.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.594 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 69.13 -77.04 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.732 0.645 . . . . 0.0 110.033 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.53 -74.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -178.57 143.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.288 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.2 t60 55.61 43.92 27.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.387 0.613 . . . . 0.0 110.096 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -99.39 -27.59 13.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -90.07 160.22 16.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.128 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.692 -176.309 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 121.075 0.464 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.21 166.13 35.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.869 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.5 tp -99.36 121.82 41.64 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.581 ' HB2' HG11 ' A' ' 83' ' ' VAL . 74.7 m-85 -99.47 125.29 45.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.362 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.32 144.64 28.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.946 -178.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 1.654 ' HE1' ' CE2' ' A' ' 6' ' ' PHE . 68.3 m-85 -130.07 -162.48 1.21 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.951 0.405 . . . . 0.0 111.658 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.561 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 5.9 p -73.32 -25.71 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.996 -176.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 49.9 tptt 78.17 -56.97 0.48 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.457 0.703 . . . . 0.0 111.575 -176.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.91 -47.99 14.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -73.71 151.79 40.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.889 0.376 . . . . 0.0 110.907 -176.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.83 173.94 14.29 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.437 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.18 125.49 24.23 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 122.485 0.314 . . . . 0.0 110.179 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 96.1 mttt -90.28 83.35 5.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.957 0.408 . . . . 0.0 110.892 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 34' ' ' HIS . 1.7 mm? -72.37 -44.21 62.88 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.479 0.657 . . . . 0.0 109.392 175.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.0 p90 -101.66 -173.34 2.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.042 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.28 -43.66 74.93 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.434 0.459 . . . . 0.0 111.598 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 63.22 54.34 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 110.575 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.61 -43.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.533 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.5 p -135.8 -61.27 0.72 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.302 0.573 . . . . 0.0 110.192 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.33 169.45 35.76 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -124.05 66.38 1.05 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.259 0.552 . . . . 0.0 109.849 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 4.0 t60 73.64 -58.04 0.61 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.766 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.537 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 41.7 m-20 -138.68 144.67 39.7 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HB2' ' HZ3' ' A' ' 24' ' ' LYS . 9.3 mtmp? -85.72 -18.54 32.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.411 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.46 -30.84 62.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.855 -175.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.537 ' OD2' ' HB2' ' A' ' 23' ' ' ASP . 4.0 p30 -90.49 -0.55 57.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.618 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.413 ' O ' HG21 ' A' ' 31' ' ' VAL . 28.1 mt-30 -67.3 -17.38 64.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 171.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . . . -59.92 -42.22 93.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.053 171.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -63.15 -42.36 99.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 3.6 mptp? -54.46 -36.87 64.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.264 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.546 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 96.0 t -69.36 -46.09 77.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.641 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.416 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 16.5 mm-40 -56.9 -42.04 79.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.97 174.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -57.62 -51.13 70.77 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.411 ' HB2' HD12 ' A' ' 14' ' ' LEU . 51.3 t60 -51.19 -42.45 60.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.624 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 86.2 mt -72.63 -41.61 65.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.543 -176.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -80.56 -26.43 37.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.82 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -69.74 -45.78 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.594 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.0 p -68.1 -40.16 82.65 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.836 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.55 31.22 4.06 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.879 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' HD2' ' A' ' 130' ' ' PRO . 30.8 mm -65.81 125.0 89.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.68 141.53 50.15 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.0 1.8 . . . . 0.0 112.545 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 55.68 20.27 3.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.538 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 35' ' ' LEU . . . -84.87 -17.26 38.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.988 0.423 . . . . 0.0 111.0 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -83.74 -16.71 43.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.731 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.58 -27.15 61.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.772 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 m -89.8 159.62 2.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.658 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -112.95 136.91 52.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.79 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.416 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 15.8 mm -106.07 143.61 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 123.375 0.422 . . . . 0.0 110.707 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 9.6 tt0 -144.98 126.68 15.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.5 mm -107.44 121.26 60.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.966 0.412 . . . . 0.0 111.553 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.47 76.74 1.07 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.56 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 69.1 -80.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.953 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.01 2.53 7.89 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -104.95 98.62 8.31 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -94.23 118.78 32.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.336 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 12.8 m -90.57 134.14 34.59 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.638 0.256 . . . . 0.0 110.319 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.5 t -120.7 109.77 26.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.087 0.47 . . . . 0.0 109.98 176.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.19 159.87 16.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.223 -177.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.62 172.57 39.14 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -155.98 139.33 15.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.052 0.453 . . . . 0.0 110.666 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.16 7.03 59.81 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.822 -0.626 . . . . 0.0 113.131 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 89' ' ' THR . 7.3 mp -92.94 168.6 11.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.023 0.44 . . . . 0.0 110.735 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 m -105.82 151.49 24.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.114 172.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.684 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 41.0 tt0 -56.55 -43.13 79.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.489 -173.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -54.18 -36.57 63.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.808 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.38 -38.97 29.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.355 176.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -55.91 -42.41 76.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.071 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 3.0 mm-40 -64.34 -23.69 67.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.659 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -66.42 -38.83 88.31 Favored 'General case' 0 N--CA 1.461 0.085 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.597 ' O ' HG13 ' A' ' 74' ' ' VAL . 4.0 mp -71.14 -55.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.203 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -48.7 -45.72 39.6 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.34 -30.49 43.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.963 0.411 . . . . 0.0 111.219 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -84.72 -30.64 24.59 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.284 -0.26 . . . . 0.0 111.555 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 70' ' ' ILE . 4.5 p -81.98 -39.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.018 0.437 . . . . 0.0 110.7 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.58 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -67.24 -26.01 73.49 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.656 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -88.39 48.19 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.299 . . . . 0.0 110.814 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.3 mt -121.21 142.93 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 121.225 0.536 . . . . 0.0 111.442 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.545 ' OG ' ' HA ' ' A' ' 13' ' ' LYS . 51.8 p -64.83 105.91 1.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.764 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.51 -11.86 10.35 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.685 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 35.8 mm -90.96 113.37 26.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.544 0.688 . . . . 0.0 111.105 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.552 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -92.82 -26.49 17.65 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.002 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 5.9 p -157.76 155.17 29.37 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.526 -177.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 4' ' ' PHE . 10.6 p -126.59 127.05 69.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.56 174.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.62 93.32 6.68 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -70.43 112.84 7.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.53 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -121.76 22.74 10.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.202 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.06 118.41 28.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.071 0.462 . . . . 0.0 110.523 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -80.05 123.58 27.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.356 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 5.1 p -92.53 111.38 22.94 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.234 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.58 -33.38 69.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.007 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 p -128.72 138.84 34.0 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.861 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.5 142.7 33.36 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.771 2.314 . . . . 0.0 111.724 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.25 174.18 10.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.967 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.8 m -61.65 137.03 58.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.935 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.63 143.2 27.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.646 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.1 m -110.69 137.35 48.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.08 0.467 . . . . 0.0 110.514 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 14.5 tt0 -86.67 147.23 25.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.242 177.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.659 ' HD2' ' CD1' ' A' ' 98' ' ' PHE . 98.4 m-85 -116.64 118.86 33.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.985 0.422 . . . . 0.0 111.24 -176.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.65 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 87.3 t80 -119.72 136.61 54.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.098 176.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.1 m -99.91 124.51 45.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.512 HG23 ' H ' ' A' ' 142' ' ' GLN . 2.4 m -71.4 136.42 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -93.31 -168.67 1.96 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.065 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 140' ' ' PRO . 27.4 m -56.51 -40.19 74.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.61 37.26 3.44 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.566 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.579 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 73.4 m-20 -99.36 128.57 45.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.411 0.624 . . . . 0.0 110.639 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.591 ' O ' HG21 ' A' ' 110' ' ' ILE . 1.5 p -114.48 153.82 29.29 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.205 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 27.6 tp -54.75 -43.33 72.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.307 0.503 . . . . 0.0 110.931 -172.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -62.39 -44.03 97.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.092 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.71 83.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.41 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.2 pp -73.73 -25.14 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.541 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.9 t -68.03 -46.82 70.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.131 0.491 . . . . 0.0 109.823 171.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 112' ' ' LYS . 12.6 tmtt? -60.61 -29.01 68.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.583 0.706 . . . . 0.0 109.194 175.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.616 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 6.4 tp60 -67.32 -62.27 1.5 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.43 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.471 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.5 m -79.6 -45.81 23.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.254 -172.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.471 ' N ' HG21 ' A' ' 114' ' ' VAL . 38.8 m-85 -81.42 -51.23 8.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.305 0.574 . . . . 0.0 110.509 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.51 -14.19 13.28 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.679 -174.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.452 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 17.7 t30 -123.34 126.93 47.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.154 -0.523 . . . . 0.0 109.829 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.01 -17.06 60.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.82 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -80.46 -13.24 59.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.061 0.458 . . . . 0.0 110.843 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.452 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 39.1 mt -82.47 14.14 3.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.448 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.443 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 53.6 p90 -60.07 -24.82 64.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.27 -178.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.475 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 51.0 m-80 -62.56 -38.9 91.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.09 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -55.57 -50.51 69.86 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.575 0.702 . . . . 0.0 109.805 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.97 -39.41 81.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.48 -177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -58.55 -53.95 52.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.512 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 21.5 mt-10 -66.04 -35.74 81.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.061 -176.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.425 ' HB1' ' HG3' ' A' ' 147' ' ' PRO . . . -64.14 -33.43 75.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.513 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.524 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 42.5 m-80 -95.72 -28.63 14.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.849 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 56.8 pttt -64.45 155.76 79.49 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 2.9 Cg_endo -82.0 10.63 36.33 Favored 'Cis proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.968 -1.263 . . . . 0.0 113.088 1.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.524 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.4 tmm? -66.31 -40.29 89.86 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.402 HD11 HE22 ' A' ' 142' ' ' GLN . 7.6 tp -86.24 113.38 22.2 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 171.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -76.9 -52.46 9.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.612 -170.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.485 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 24.0 m -142.38 155.74 64.23 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.011 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.72 -54.53 5.17 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.495 2.797 . . . . 0.0 113.258 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.07 9.78 29.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.219 0.533 . . . . 0.0 111.024 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.485 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 26.2 mmtp -92.27 13.09 20.28 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 106' ' ' THR . 18.3 pt -67.19 171.39 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 171.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -148.08 144.69 19.22 Favored Pre-proline 0 C--N 1.315 -0.898 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.64 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 103' ' ' SER . 81.5 Cg_exo -49.33 110.66 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.275 2.65 . . . . 0.0 112.47 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.515 ' O ' HG13 ' A' ' 7' ' ' VAL . . . 109.53 22.79 6.56 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.085 -176.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.512 ' H ' HG23 ' A' ' 101' ' ' VAL . 44.8 tt0 -105.56 118.63 37.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 117.613 0.706 . . . . 0.0 110.708 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 37.3 t -78.46 131.64 34.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.744 174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.7 mt -121.19 135.64 55.11 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.101 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -65.44 123.36 19.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.39 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 23.3 mm -106.24 97.86 17.44 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.425 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 39.5 Cg_endo -70.49 158.8 54.91 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.227 1.951 . . . . 0.0 111.871 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.28 104.64 14.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.492 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -78.05 134.23 37.8 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.145 0.498 . . . . 0.0 109.995 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 151' ' ' GLU . 0.8 OUTLIER -140.51 100.28 3.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 150' ' ' LEU . 25.3 tt0 71.41 106.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.038 0.836 . . . . 0.0 110.976 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -128.41 138.41 52.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -69.53 145.82 52.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.993 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -77.58 79.48 4.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.825 0.821 . . . . 0.0 111.648 -174.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -85.27 -47.47 10.03 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.772 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -179.62 107.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.428 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.47 178.358 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.507 0.67 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.14 -89.94 0.18 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.493 HD11 ' N ' ' A' ' 4' ' ' PHE . 2.6 tm? -139.46 140.74 37.36 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 1.661 ' HE1' ' CE2' ' A' ' 4' ' ' PHE . 98.4 m-85 -121.55 145.78 47.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.371 178.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.23 128.97 48.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 111.268 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.518 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 76.1 m-85 -124.77 -167.22 1.63 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.78 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.2 t -107.69 118.94 56.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.114 0.483 . . . . 0.0 110.262 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 22.5 tptm -60.7 -33.74 73.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.906 -172.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -90.23 -33.94 15.98 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.34 128.65 35.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.857 0.36 . . . . 0.0 111.426 -172.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' HA2' ' HH ' ' A' ' 139' ' ' TYR . . . 150.69 179.9 26.84 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.873 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.68 135.92 47.05 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -99.86 94.29 6.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.76 0.314 . . . . 0.0 110.525 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.419 ' CB ' ' HB3' ' A' ' 30' ' ' LYS . 1.8 mm? -81.78 -32.17 31.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.852 0.358 . . . . 0.0 111.062 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -118.66 22.08 12.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.336 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 56.97 83.47 0.1 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.639 -172.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.89 47.42 0.52 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.315 0.579 . . . . 0.0 111.868 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 p -98.78 -38.91 7.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.749 175.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -133.52 -30.3 1.29 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.92 -146.87 18.79 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.781 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.542 ' HA ' HE21 ' A' ' 21' ' ' GLN . 0.0 OUTLIER -129.18 -75.89 0.55 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 173.27 -53.13 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -113.88 133.58 55.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.672 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 24' ' ' LYS . 5.2 tmmm? -64.98 -23.56 67.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.69 176.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -60.41 -39.97 89.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.821 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.8 m-20 -66.9 -34.76 78.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.42 ' O ' HG21 ' A' ' 31' ' ' VAL . 97.7 mt-30 -63.05 -46.95 85.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.638 0.256 . . . . 0.0 110.721 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 48' ' ' ILE . . . -57.15 -30.58 64.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.326 0.584 . . . . 0.0 111.197 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 35.6 ttpt -80.03 -50.67 10.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.339 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 72.7 mmtt -51.74 -39.66 58.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.412 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 41.4 t -58.46 -52.06 64.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.694 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.475 ' HB3' HD11 ' A' ' 48' ' ' ILE . 3.0 pt20 -78.28 -21.1 50.26 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.464 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 46.9 mt-10 -64.99 -39.0 92.82 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 172.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.518 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 63.6 t60 -55.97 -37.49 69.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.02 172.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.6 mt -70.53 -45.84 64.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.22 -41.7 94.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.05 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 97.3 mttt -59.48 -54.85 41.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.053 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 p -62.74 -44.18 96.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.085 0.469 . . . . 0.0 111.142 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.54 33.75 1.86 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.899 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.441 HD11 ' HD2' ' A' ' 130' ' ' PRO . 24.3 mm -69.53 129.15 91.75 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.83 143.19 49.74 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.614 2.209 . . . . 0.0 113.207 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 57.15 28.57 15.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.697 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.83 -20.6 62.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.24 0.543 . . . . 0.0 110.349 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -81.32 -15.99 53.75 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.425 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -86.81 -11.28 51.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.816 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.08 177.31 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.113 0.483 . . . . 0.0 111.292 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 42.0 t30 -141.4 128.51 20.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.065 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 32' ' ' GLN . 3.2 mp -104.53 129.25 57.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 123.39 0.431 . . . . 0.0 110.608 -174.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -128.7 128.03 43.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.273 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.4 mm -98.74 120.59 48.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.001 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.45 88.01 2.86 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.769 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 67.33 -74.88 0.06 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.803 0.69 . . . . 0.0 111.134 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.38 -1.0 4.01 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.403 ' HD3' ' HB2' ' A' ' 84' ' ' ASP . 38.7 ttmt -96.74 115.74 27.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.959 0.409 . . . . 0.0 110.731 -178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.82 100.74 12.26 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 38.1 m -83.35 128.5 34.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.382 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -120.79 117.33 52.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.008 0.432 . . . . 0.0 111.043 177.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.455 HG21 ' HB3' ' A' ' 86' ' ' GLN . 2.2 m -100.52 162.96 12.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.789 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.8 166.68 33.64 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.801 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -156.13 138.07 14.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.875 0.369 . . . . 0.0 110.066 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.96 8.21 63.56 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.802 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.471 ' HG ' ' CG1' ' A' ' 87' ' ' VAL . 4.5 mm? -78.68 171.79 14.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.0 112.265 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -128.05 146.41 50.69 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 170.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.577 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 9.8 mt-30 -59.65 -22.48 61.95 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.303 0.377 . . . . 0.0 112.008 -175.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.67 -34.55 72.98 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.259 0.349 . . . . 0.0 111.311 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.42 -36.52 7.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.027 0.441 . . . . 0.0 110.475 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 52.5 tttm -50.91 -46.53 60.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.049 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 145' ' ' ARG . 21.7 mt-10 -87.92 20.58 3.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.415 0.626 . . . . 0.0 110.923 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -113.91 -41.7 3.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.059 170.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 54.6 mt -59.22 -59.3 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.245 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.52 HD11 ' O ' ' A' ' 67' ' ' LYS . 9.3 mp -42.86 -41.99 3.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.458 176.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.85 -53.39 30.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.99 -24.06 65.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.39 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.2 t -79.0 -40.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.171 0.51 . . . . 0.0 110.481 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.518 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -72.27 -25.94 73.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.506 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.419 ' HB3' ' OH ' ' A' ' 139' ' ' TYR . 90.4 m-20 -86.45 39.95 0.86 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.099 0.476 . . . . 0.0 111.056 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.449 ' CD1' HG11 ' A' ' 31' ' ' VAL . 92.9 mt -114.26 135.31 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.715 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -67.92 123.81 21.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.31 -9.27 38.72 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.252 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.1 mm -105.01 137.81 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -124.04 -19.47 5.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.721 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 p -152.97 157.04 39.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.065 0.459 . . . . 0.0 111.297 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.3 t -133.04 126.11 52.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.84 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.403 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . 15.1 t70 -102.37 110.64 22.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -92.49 100.47 13.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 122.145 0.974 . . . . 0.0 111.77 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.455 ' HB3' HG21 ' A' ' 58' ' ' THR . 43.0 mt-30 -98.98 18.47 17.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.163 172.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.471 ' CG1' ' HG ' ' A' ' 62' ' ' LEU . 43.1 t -80.01 108.08 13.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.437 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -86.59 137.57 32.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.075 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.8 p -102.45 130.42 49.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.058 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.08 -16.18 30.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.6 p -129.27 142.53 45.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.85 124.42 7.44 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.668 2.245 . . . . 0.0 111.842 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.35 168.87 18.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.5 m -65.18 140.77 58.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.434 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.89 154.7 17.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.08 0.467 . . . . 0.0 111.759 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.9 m -118.94 146.96 44.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.981 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 7.6 tt0 -91.3 150.73 21.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.425 175.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -105.82 100.83 10.37 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.103 0.477 . . . . 0.0 110.85 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.601 ' HD2' ' CD1' ' A' ' 99' ' ' TYR . 80.0 t80 -101.66 144.24 30.63 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.917 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 143' ' ' VAL . 17.1 m -110.94 124.15 51.57 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.358 -0.137 . . . . 0.0 110.675 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 142' ' ' GLN . 1.7 m -66.09 129.5 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -80.84 -81.51 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.969 -171.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.3 m -162.26 123.49 2.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.12 28.88 71.01 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.26 130.43 43.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.892 -0.654 . . . . 0.0 109.95 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.527 ' O ' HG21 ' A' ' 110' ' ' ILE . 7.6 p -115.76 162.61 17.04 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.878 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.57 ' CD1' ' HA ' ' A' ' 135' ' ' PRO . 22.9 mt -57.83 -42.67 84.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.76 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.4 m -59.63 -38.69 82.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.942 0.401 . . . . 0.0 110.822 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.7 -44.65 69.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.264 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.626 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.5 pp -78.22 -22.15 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.483 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.4 p -77.8 -42.67 33.05 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.243 -0.286 . . . . 0.0 110.564 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -62.73 -26.27 68.6 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.506 0.67 . . . . 0.0 109.75 171.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.626 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 4.7 tp60 -64.33 -55.02 24.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.949 175.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.498 HG21 ' N ' ' A' ' 115' ' ' TYR . 34.2 m -86.46 -51.25 13.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.349 -173.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.521 ' CE1' ' HB2' ' A' ' 149' ' ' GLU . 21.6 m-85 -87.67 -31.01 19.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.249 -176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.31 -19.51 39.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.102 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -114.1 120.61 41.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.19 -20.13 63.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.872 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -81.77 -0.15 41.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.985 0.421 . . . . 0.0 111.004 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.8 mt -91.28 17.43 8.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 1.652 ' HD1' ' CD2' ' A' ' 121' ' ' TYR . 42.3 p90 -60.84 -30.91 70.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.362 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -69.8 -30.54 68.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.522 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -63.11 -44.12 96.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.257 0.551 . . . . 0.0 110.341 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.3 mt -75.46 -36.88 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.163 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -53.26 -60.81 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.801 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.486 ' CD ' ' HZ3' ' A' ' 129' ' ' LYS . 11.6 mm-40 -50.43 -43.62 55.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.943 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.555 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -63.84 -33.08 74.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.32 -174.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.496 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 42.2 m-80 -92.8 5.17 52.17 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.715 0.293 . . . . 0.0 111.506 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.486 ' HZ3' ' CD ' ' A' ' 126' ' ' GLU . 15.3 mtmm -82.63 156.27 68.14 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.441 ' HD2' HD11 ' A' ' 40' ' ' ILE . 96.6 Cg_endo -86.39 15.37 41.24 Favored 'Cis proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.72 -1.367 . . . . 0.0 113.424 -1.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.496 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.3 OUTLIER -66.12 -41.94 89.84 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.128 0.49 . . . . 0.0 110.069 175.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 tp -95.03 124.41 39.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.441 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -101.6 -33.27 9.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.862 -172.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 69.0 m -155.42 153.64 26.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.57 0.224 . . . . 0.0 111.179 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.57 ' HA ' ' CD1' ' A' ' 107' ' ' LEU . 81.9 Cg_exo -48.67 -56.95 2.67 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.627 2.885 . . . . 0.0 113.382 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.01 -7.78 53.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.864 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 137' ' ' LYS . 30.2 mmtp -81.51 -2.72 50.88 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' A' ' 106' ' ' THR . 12.3 pt -68.37 167.55 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.972 0.415 . . . . 0.0 110.438 174.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.47 ' HH ' ' HA2' ' A' ' 11' ' ' GLY . 10.5 p90 -141.46 141.67 23.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.428 -174.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.81 111.02 0.5 Allowed 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 123.176 2.584 . . . . 0.0 112.248 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.24 23.47 6.35 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.907 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.517 ' H ' HG23 ' A' ' 101' ' ' VAL . 47.3 tt0 -104.48 121.8 44.2 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.572 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.449 HG23 ' OG1' ' A' ' 100' ' ' THR . 42.7 t -80.93 133.75 28.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.965 174.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.1 mt -126.15 135.67 51.94 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.673 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.571 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 3.1 ptm180 -73.84 123.78 24.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.289 0.566 . . . . 0.0 110.011 176.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 26.3 mm -103.84 91.29 3.45 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.038 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 37.1 Cg_exo -60.88 144.28 99.53 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.501 2.134 . . . . 0.0 111.318 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.72 116.3 3.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.18 0.515 . . . . 0.0 110.328 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 115' ' ' TYR . 41.0 tt0 -76.28 126.86 31.75 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.01 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.22 5.19 42.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.321 0.581 . . . . 0.0 109.743 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -88.0 98.53 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.525 177.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -101.3 -16.85 16.8 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.998 0.428 . . . . 0.0 110.654 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -91.58 81.34 5.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.126 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -89.46 -74.25 0.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.444 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 38.7 m80 53.55 52.28 13.6 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.987 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -134.57 -178.43 5.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.133 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.067 -177.995 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 27.1 ptm . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.43 -68.62 0.22 Allowed Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.7 tp -146.0 132.13 19.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 1.655 ' HD2' ' CD1' ' A' ' 4' ' ' PHE . 74.1 m-85 -114.16 133.92 55.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.645 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -109.85 134.56 51.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.272 0.558 . . . . 0.0 110.827 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.487 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 67.3 m-85 -118.03 -157.96 0.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.644 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.533 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 7.7 p -85.17 -24.61 6.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 28.9 tptp 74.83 -52.43 0.68 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.319 0.647 . . . . 0.0 111.881 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -85.81 -44.07 12.77 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HB1' ' CG1' ' A' ' 7' ' ' VAL . . . -78.8 172.33 13.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.761 -177.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.73 ' HA2' ' HH ' ' A' ' 139' ' ' TYR . . . 121.21 -173.72 15.65 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.32 121.29 15.4 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 57.6 mtmt -80.04 74.76 6.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.471 0.653 . . . . 0.0 111.601 -171.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp -67.15 -48.53 67.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.581 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -133.62 18.76 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 56.61 20.78 5.21 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.587 176.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.43 22.44 9.53 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -75.53 83.82 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.692 0.282 . . . . 0.0 110.879 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.9 p 46.51 39.45 6.75 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.15 6.61 74.89 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.123 -0.561 . . . . 0.0 113.126 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 55.41 41.64 30.82 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.972 0.509 . . . . 0.0 110.629 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 35.6 m80 68.06 -74.11 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.746 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 19.6 m-20 -79.45 87.92 5.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.653 -177.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.559 ' O ' ' HB ' ' A' ' 50' ' ' ILE . 17.9 ptpt -67.07 -31.38 71.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.444 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -71.29 -33.77 70.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.99 0.424 . . . . 0.0 111.022 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.11 -16.21 60.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.824 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 10.5 mm100 -67.18 -21.85 65.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.579 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.77 82.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.225 176.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.3 tptt -65.28 -45.9 82.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.317 176.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -55.73 -46.86 77.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.793 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.419 HG11 ' CD1' ' A' ' 77' ' ' ILE . 72.0 t -60.39 -49.31 84.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.941 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.458 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 3.2 mm-40 -53.11 -41.97 65.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.613 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 44.8 mt-10 -56.28 -44.84 80.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.498 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -56.16 -46.87 79.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.728 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.414 HD13 ' N ' ' A' ' 35' ' ' LEU . 8.3 mp -67.66 -39.21 84.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.826 0.346 . . . . 0.0 111.823 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -77.08 -24.36 51.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.488 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -82.54 -24.33 34.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.562 0.22 . . . . 0.0 111.353 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -83.75 -35.9 24.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.859 0.362 . . . . 0.0 110.955 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.69 24.15 6.23 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.162 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.88 125.56 91.01 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -78.53 149.32 23.96 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.978 1.786 . . . . 0.0 111.955 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.56 8.2 4.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.42 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.81 -13.24 56.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.054 0.454 . . . . 0.0 110.951 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.77 -7.46 56.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.634 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -89.36 -12.32 40.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.403 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.05 157.56 4.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.839 -178.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 18.3 m120 -119.27 132.96 55.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.646 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.458 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 13.4 mm -95.26 140.97 15.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -174.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -137.53 127.41 25.62 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' A' ' 24' ' ' LYS . 34.5 mm -117.91 116.58 52.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.185 0.517 . . . . 0.0 111.711 -172.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.05 70.81 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.915 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 t70 72.87 -66.45 0.31 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.185 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.422 ' O ' ' HB1' ' A' ' 81' ' ' ALA . . . -135.12 31.49 2.69 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.894 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.558 ' CE ' ' HB2' ' A' ' 84' ' ' ASP . 87.2 tttt -140.25 129.42 23.68 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.503 -0.41 . . . . 0.0 110.718 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -108.63 107.68 18.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.41 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.431 HG21 ' HB3' ' A' ' 84' ' ' ASP . 36.5 m -95.21 114.05 25.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -104.71 127.6 59.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.82 0.343 . . . . 0.0 111.609 -177.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.35 158.08 16.71 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.123 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.41 156.72 10.11 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.29 137.49 27.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.144 0.497 . . . . 0.0 110.533 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.43 0.58 61.05 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.514 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.64 178.1 2.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.176 0.512 . . . . 0.0 111.982 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.444 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 53.6 p -127.02 144.34 51.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.564 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.588 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 48.8 tp60 -45.64 -54.86 7.1 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.532 0.52 . . . . 0.0 112.076 -175.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.91 -35.13 72.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.03 -42.6 19.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.936 0.398 . . . . 0.0 110.077 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.522 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 79.8 tttt -54.54 -40.45 68.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.27 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 79.0 mt-10 -63.46 -35.47 80.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.44 -43.87 93.05 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 mp -62.26 -50.77 78.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.092 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 88.0 mt -53.97 -45.96 71.5 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.409 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 68' ' ' GLU . 46.5 t -72.0 -44.22 66.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.211 0.529 . . . . 0.0 110.83 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.45 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -62.9 -34.66 77.89 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.349 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 80' ' ' ILE . 22.5 m -82.18 -31.12 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.638 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.487 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -72.36 -32.8 62.06 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.766 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.25 41.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.941 0.4 . . . . 0.0 111.056 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.419 ' CD1' HG11 ' A' ' 31' ' ' VAL . 96.8 mt -115.54 134.75 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 121.061 0.458 . . . . 0.0 110.398 172.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 14.8 t -62.47 105.99 0.7 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.486 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.91 -15.42 5.65 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.565 -174.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 49.7 mm -100.85 120.57 50.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.128 0.49 . . . . 0.0 111.49 -177.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.536 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . . . -98.96 -38.26 9.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.685 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.4 p -142.7 159.6 41.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.48 0.657 . . . . 0.0 111.85 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 69.0 t -131.07 127.53 61.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.628 177.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.558 ' HB2' ' CE ' ' A' ' 54' ' ' LYS . 5.6 t70 -106.39 107.75 18.92 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.76 110.04 15.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.115 0.96 . . . . 0.0 111.032 -173.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -107.98 17.51 22.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.531 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -92.4 116.24 33.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.843 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -85.59 139.17 31.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.307 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.6 p -105.48 131.11 53.29 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.99 0.424 . . . . 0.0 111.202 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.77 -40.02 6.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 63' ' ' SER . 17.8 p -96.28 141.0 22.5 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.586 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.6 130.49 18.4 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.805 2.337 . . . . 0.0 112.293 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 64' ' ' GLN . . . -148.54 160.86 42.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.9 m -82.36 133.71 35.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.379 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.6 141.42 29.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.677 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.8 m -108.96 170.99 7.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.65 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.6 tt0 -96.33 147.7 23.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.518 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -104.29 107.08 17.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.976 0.417 . . . . 0.0 110.039 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.659 ' HD1' ' CD2' ' A' ' 99' ' ' TYR . 91.3 t80 -108.31 129.96 55.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.353 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.433 ' OG1' HG23 ' A' ' 143' ' ' VAL . 17.7 m -98.07 123.44 42.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.95 175.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -69.03 130.14 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.307 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.437 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 45.5 mmtm -80.18 -73.37 0.36 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.313 -170.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 140' ' ' PRO . 18.4 t -150.39 -68.66 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.765 -176.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.35 36.67 2.58 Favored Glycine 0 C--N 1.329 0.189 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -96.4 115.84 28.08 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.152 -172.2 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.602 ' O ' HG21 ' A' ' 110' ' ' ILE . 27.6 p -110.2 159.2 17.59 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.446 HD11 ' HA ' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -57.41 -45.12 84.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.178 0.444 . . . . 0.0 110.783 -171.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' A' ' 118' ' ' ALA . 14.3 m -63.04 -40.19 96.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.56 82.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.331 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.602 HG21 ' O ' ' A' ' 106' ' ' THR . 1.3 pp -74.11 -27.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 120.805 0.336 . . . . 0.0 110.503 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -67.19 -43.52 81.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.057 0.456 . . . . 0.0 110.133 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.16 -28.2 69.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.369 0.604 . . . . 0.0 109.964 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.592 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.1 tp-100 -67.42 -54.49 19.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.078 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.495 HG21 ' N ' ' A' ' 115' ' ' TYR . 27.4 m -85.18 -50.49 14.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.207 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.495 ' N ' HG21 ' A' ' 114' ' ' VAL . 68.9 m-85 -85.81 -42.13 14.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.057 0.456 . . . . 0.0 111.146 -177.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.8 -14.88 31.83 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.449 ' HB3' ' HG ' ' A' ' 120' ' ' LEU . 55.3 t-20 -118.75 120.15 36.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' A' ' 108' ' ' SER . . . -71.08 -22.24 62.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -174.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.08 -8.18 55.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.039 0.447 . . . . 0.0 111.106 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HG ' ' HB3' ' A' ' 117' ' ' ASN . 46.6 mt -86.4 10.8 13.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.648 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.425 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 51.0 p90 -59.14 -26.49 64.79 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.925 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -70.3 -31.54 68.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.112 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.421 ' HE2' HD11 ' A' ' 120' ' ' LEU . 33.6 mtmt -62.43 -45.29 93.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.717 0.77 . . . . 0.0 109.68 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.0 mt -66.62 -42.76 90.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.619 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -56.74 -53.78 53.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.367 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -65.45 -26.31 67.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 111.664 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.417 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -76.58 -25.83 54.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.708 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.527 ' O ' ' HB3' ' A' ' 131' ' ' MET . 39.2 m-80 -98.02 -30.59 12.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.272 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 19.4 pttp -66.14 156.91 83.22 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.483 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.4 Cg_endo -81.2 10.33 32.71 Favored 'Cis proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.494 -1.461 . . . . 0.0 113.4 2.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.527 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.6 tmm? -64.99 -37.96 89.39 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.466 HD11 HE22 ' A' ' 142' ' ' GLN . 7.8 tp -88.74 114.77 25.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.026 171.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -73.41 -46.65 47.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.684 -171.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' A' ' 135' ' ' PRO . 16.4 m -152.1 150.54 25.92 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 121.239 0.542 . . . . 0.0 109.928 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.446 ' HA ' HD11 ' A' ' 107' ' ' LEU . 28.0 Cg_endo -62.6 -20.78 71.79 Favored 'Trans proline' 0 C--N 1.334 -0.232 0 C-N-CA 123.784 2.99 . . . . 0.0 113.025 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -101.4 -0.45 35.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.564 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -98.35 16.18 22.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.464 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 19.0 pt -74.0 166.44 2.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 171.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.73 ' HH ' ' HA2' ' A' ' 11' ' ' GLY . 17.3 p90 -153.27 147.21 18.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.821 -173.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' A' ' 103' ' ' SER . 92.4 Cg_exo -47.53 113.68 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.573 2.849 . . . . 0.0 112.629 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 7' ' ' VAL . . . 104.57 30.63 4.86 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.315 -177.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.466 HE22 HD11 ' A' ' 132' ' ' LEU . 43.1 tt0 -114.02 124.9 53.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.629 0.714 . . . . 0.0 110.933 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.433 HG23 ' OG1' ' A' ' 100' ' ' THR . 45.1 t -82.69 134.73 26.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.757 173.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.4 mt -126.01 138.84 53.76 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.896 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.544 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 52.9 mtp180 -65.91 118.28 9.5 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.675 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 39.3 mm -105.96 90.16 4.24 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 24.5 Cg_exo -62.37 150.31 87.69 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.685 2.257 . . . . 0.0 111.443 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.423 ' O ' HD23 ' A' ' 150' ' ' LEU . 30.6 tt0 -64.96 126.67 28.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -74.34 116.22 14.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.801 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 148' ' ' GLU . 2.9 mm? -89.16 72.08 8.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.751 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 57.38 -127.76 1.73 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.106 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 69.9 m80 62.82 48.67 3.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.14 0.495 . . . . 0.0 110.645 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -143.87 121.2 11.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.857 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -108.04 -64.59 1.2 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.418 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -162.14 130.31 4.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.501 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -150.67 124.89 9.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.015 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 44.8 t60 . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.612 175.461 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 4' ' ' PHE . 3.1 tm? . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.061 0.458 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.475 ' N ' HD13 ' A' ' 3' ' ' LEU . 96.7 m-85 -126.09 136.35 52.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.223 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -108.44 147.25 31.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.447 0.641 . . . . 0.0 112.275 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.506 ' CD2' HG21 ' A' ' 143' ' ' VAL . 53.7 m-85 -130.47 -169.17 2.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.751 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.473 HG21 ' HA2' ' A' ' 141' ' ' GLY . 40.5 t -86.61 -13.38 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.536 0.207 . . . . 0.0 111.115 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 63.7 tttm 73.85 -68.71 0.21 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.083 0.553 . . . . 0.0 111.784 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.02 -26.24 65.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.905 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.503 ' CB ' ' HA3' ' A' ' 141' ' ' GLY . . . -100.28 125.53 46.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.153 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.11 -169.43 40.32 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -60.49 129.89 43.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -74.81 73.39 2.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.029 0.919 . . . . 0.0 109.717 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.409 HD21 ' O ' ' A' ' 30' ' ' LYS . 12.1 tp . . . . . 0 N--CA 1.436 -1.142 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.552 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.54 ' O ' HG23 ' A' ' 31' ' ' VAL . 95.8 mt-30 -63.88 -45.99 86.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.586 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.1 78.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.184 0.516 . . . . 0.0 110.727 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.09 -45.47 94.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.537 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.409 ' O ' HD21 ' A' ' 14' ' ' LEU . 68.5 mmtt -61.11 -35.21 76.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.852 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.559 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 97.4 t -62.74 -48.94 85.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -55.35 -48.56 74.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.569 172.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 66.1 mt-10 -55.71 -50.27 70.76 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -53.23 -43.95 67.7 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.698 0.624 . . . . 0.0 111.505 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 98.5 mt -62.76 -42.95 99.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.502 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -75.1 -25.39 58.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.989 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 13.2 mmmm -65.84 -51.99 54.25 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.222 0.534 . . . . 0.0 110.385 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 130' ' ' PRO . 2.4 p -73.3 -28.97 62.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.375 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.07 30.54 7.81 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.973 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.61 126.05 85.93 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.52 145.71 71.57 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.894 1.729 . . . . 0.0 112.107 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.29 21.45 11.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.804 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.11 -22.39 63.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.6 2.99 56.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.684 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -99.26 3.05 46.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.453 . . . . 0.0 110.155 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.12 172.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.025 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -137.3 131.73 32.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.627 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 mm -98.14 141.45 16.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.952 0.406 . . . . 0.0 111.21 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 49.2 tt0 -139.67 119.8 13.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.686 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 31' ' ' VAL . 43.5 mm -96.57 108.16 20.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.289 0.566 . . . . 0.0 110.833 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.56 72.48 2.04 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 68.08 -82.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.867 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.7 1.81 24.64 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.132 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -110.08 110.48 21.39 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.522 -0.399 . . . . 0.0 111.084 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.484 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -84.24 92.14 7.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.792 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 84' ' ' ASP . 43.3 m -75.78 122.62 24.33 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.905 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.4 t -112.01 113.61 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.115 0.483 . . . . 0.0 110.28 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -100.91 162.96 12.53 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.224 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.75 167.05 32.18 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.495 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -155.15 142.27 19.3 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.959 0.409 . . . . 0.0 110.319 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.11 7.83 86.41 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.384 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.44 169.23 18.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.381 0.61 . . . . 0.0 112.165 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.1 m -115.32 147.69 40.15 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 170.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.592 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 39.8 tt0 -51.93 -45.8 64.44 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -173.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.3 -50.35 62.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.945 0.403 . . . . 0.0 110.184 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.08 -43.06 96.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.066 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' O ' HD13 ' A' ' 71' ' ' LEU . 27.5 ttpp -59.13 -47.34 85.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 0.0 111.098 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 4.1 mm-40 -66.19 -15.88 63.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.091 0.472 . . . . 0.0 110.736 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -39.04 53.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.701 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.3 mm -65.31 -57.04 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.471 0.653 . . . . 0.0 109.915 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 67' ' ' LYS . 11.0 mp -42.44 -49.68 5.23 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.871 -177.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.662 HG21 ' HG2' ' A' ' 145' ' ' ARG . 57.5 t -69.85 -49.56 56.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.235 0.54 . . . . 0.0 111.199 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HA ' ' SD ' ' A' ' 131' ' ' MET . . . -64.02 -29.68 70.81 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.956 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.2 m -87.6 -29.08 5.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.988 0.423 . . . . 0.0 111.043 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -73.63 -33.46 58.13 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.443 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -80.01 54.26 1.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.773 0.32 . . . . 0.0 111.138 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -122.76 142.48 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 120.927 0.394 . . . . 0.0 110.551 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 t -70.83 103.26 2.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.504 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.61 -18.11 5.46 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.285 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 45.9 mm -94.34 117.17 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.455 0.645 . . . . 0.0 111.045 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.58 -30.47 13.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.881 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.42 ' HB2' HD21 ' A' ' 3' ' ' LEU . 11.7 p -153.17 160.23 42.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.261 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 55' ' ' ALA . 54.9 t -124.94 125.89 70.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.432 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.532 ' HB3' HG23 ' A' ' 56' ' ' THR . 6.4 t70 -97.98 96.84 8.44 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.45 104.98 5.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.117 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -115.94 19.45 15.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.111 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.9 114.91 20.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.997 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -83.19 122.33 28.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.1 p -99.43 130.72 45.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.155 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.47 -21.84 35.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.905 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -140.17 131.69 14.36 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.105 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.53 156.96 36.44 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.499 2.133 . . . . 0.0 111.066 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -150.64 -160.41 1.16 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.512 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.7 m -67.04 131.78 46.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 110.723 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.41 159.53 17.97 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.0 m -138.66 143.26 39.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.101 0.477 . . . . 0.0 110.814 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.474 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 41.6 tt0 -81.33 137.05 35.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.488 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -99.1 80.29 2.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.532 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -73.91 144.86 45.16 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.541 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.419 ' OG1' HG22 ' A' ' 143' ' ' VAL . 12.9 m -120.74 117.94 28.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 142' ' ' GLN . 0.6 OUTLIER -68.18 131.38 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.406 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 32.5 mmtp -84.0 -61.14 1.89 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.92 -170.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.8 t -163.15 -68.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.19 53.43 4.79 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.544 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.8 m-20 -113.1 112.65 24.19 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.129 0.49 . . . . 0.0 111.05 -172.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.472 ' O ' HG23 ' A' ' 110' ' ' ILE . 25.1 m -108.81 146.59 33.39 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.562 ' O ' HG13 ' A' ' 110' ' ' ILE . 25.4 tp -52.61 -45.89 66.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -168.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.619 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 38.9 m -67.19 -41.56 85.67 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.096 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HA ' ' HG3' ' A' ' 112' ' ' LYS . . . -64.37 -37.77 88.66 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.628 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.4 pp -76.96 -22.36 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 109.992 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -67.98 -49.38 62.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.05 171.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.694 ' HG2' ' HB2' ' A' ' 118' ' ' ALA . 22.2 mttt -55.26 -30.31 59.84 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 121.295 0.569 . . . . 0.0 110.155 172.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.628 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 4.5 tp60 -68.24 -56.82 7.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.617 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.47 HG21 HD12 ' A' ' 146' ' ' ILE . 33.8 m -86.32 -42.91 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.158 -172.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.5 ' HB3' HD12 ' A' ' 120' ' ' LEU . 17.6 m-85 -90.82 -26.18 19.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.747 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.14 -9.73 76.86 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.626 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.523 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 26.2 t30 -126.12 129.35 48.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.694 ' HB2' ' HG2' ' A' ' 112' ' ' LYS . . . -72.9 -28.95 62.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.631 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.82 -19.19 65.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.551 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.523 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 54.6 mt -82.99 13.93 3.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.122 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 42.6 p90 -61.2 -32.62 72.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.424 0.63 . . . . 0.0 110.333 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.484 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 11.7 p30 -69.57 -30.04 67.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.458 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -61.94 -46.55 88.84 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.285 0.564 . . . . 0.0 109.656 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.5 mt -64.52 -44.94 96.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.451 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.545 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 26.2 t80 -51.8 -59.44 4.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.207 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 45.4 mt-10 -59.22 -41.37 88.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.361 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -59.51 -31.62 69.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.377 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.494 ' OD1' ' HA ' ' A' ' 144' ' ' LEU . 43.0 m-80 -90.11 -1.63 57.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 132' ' ' LEU . 29.5 mtpp -81.84 155.19 70.63 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.683 0.277 . . . . 0.0 110.362 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' THR . 1.9 Cg_endo -87.58 24.56 18.33 Favored 'Cis proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.819 -1.326 . . . . 0.0 113.461 0.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.467 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.1 OUTLIER -76.35 -37.13 57.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.222 0.534 . . . . 0.0 110.044 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.625 ' O ' ' HG2' ' A' ' 129' ' ' LYS . 13.4 tp -98.0 117.13 31.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.891 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -81.24 -51.29 8.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.783 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.4 m -138.29 154.61 73.94 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.527 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.24 -54.4 5.51 Favored 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 123.415 2.743 . . . . 0.0 112.963 -175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.98 5.76 24.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.541 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -83.82 -0.94 53.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.628 0.251 . . . . 0.0 111.185 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.9 pt -65.76 168.36 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -158.49 153.48 21.43 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.07 112.85 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.043 2.496 . . . . 0.0 112.389 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.503 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 96.77 35.91 5.22 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.615 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.615 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.2 tp60 -108.78 121.43 45.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.988 0.394 . . . . 0.0 110.152 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.506 HG21 ' CD2' ' A' ' 6' ' ' PHE . 41.2 t -83.62 129.46 37.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.237 0.542 . . . . 0.0 110.645 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.494 ' HA ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -118.98 130.83 55.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.229 -177.14 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.662 ' HG2' HG21 ' A' ' 72' ' ' VAL . 55.3 mtp180 -69.52 119.26 13.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.334 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 27.6 mm -106.93 95.58 12.87 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 35.0 Cg_exo -61.49 149.88 87.71 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.656 2.237 . . . . 0.0 111.737 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.286 175.737 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 121.76 0.791 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.516 ' HB2' HG12 ' A' ' 83' ' ' VAL . 97.7 m-85 -101.44 127.11 48.25 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.358 175.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -87.43 134.08 33.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.704 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 50.7 m-85 -117.76 -158.15 0.7 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 88.5 t -89.36 -79.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.015 173.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.6 tmtp? 165.82 -71.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.017 0.823 . . . . 0.0 109.235 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.03 -25.95 34.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.355 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.79 124.06 23.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.963 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.21 -178.02 28.84 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -71.5 130.0 40.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 117.017 0.408 . . . . 0.0 109.911 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 48.0 mtmt -77.64 92.93 4.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.356 0.598 . . . . 0.0 111.554 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 34' ' ' HIS . 6.9 mp . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.556 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 24.2 t70 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 121.005 0.431 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.592 ' O ' HG23 ' A' ' 31' ' ' VAL . 88.3 mt-30 -61.55 -38.98 89.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.291 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.2 -42.89 96.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.101 0.477 . . . . 0.0 110.483 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 27.1 ttpp -62.04 -42.84 99.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.041 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 28.0 mmtp -60.44 -40.11 89.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.97 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 27' ' ' GLN . 95.3 t -58.29 -49.06 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.359 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -55.16 -46.61 75.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.922 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 46.6 mt-10 -57.28 -44.15 83.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.732 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.439 ' HB2' HD21 ' A' ' 14' ' ' LEU . 65.9 t60 -57.81 -44.74 86.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.979 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 91.3 mt -64.96 -40.79 95.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.964 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -72.5 -34.01 67.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.273 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -72.1 -33.19 67.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.42 -25.35 46.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.109 0.48 . . . . 0.0 110.854 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.35 26.91 12.71 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.082 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.0 mm -65.09 122.15 78.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -75.45 151.21 37.29 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.978 1.785 . . . . 0.0 111.745 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 63.78 6.72 2.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.949 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.24 -22.92 61.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.018 0.437 . . . . 0.0 111.001 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -77.32 -19.67 56.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.383 176.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -77.47 -21.81 52.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.986 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.5 m -101.34 173.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.338 0.59 . . . . 0.0 111.88 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -131.19 140.56 49.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.991 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.3 mm -102.99 138.68 26.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.957 0.408 . . . . 0.0 111.118 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -137.29 122.53 19.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.699 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 27' ' ' GLN . 17.4 mm -92.93 122.37 44.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.979 0.419 . . . . 0.0 110.597 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.7 70.41 0.71 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.98 -82.34 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.325 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 -5.86 23.34 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.989 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 106.3 17.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.941 0.401 . . . . 0.0 111.017 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.59 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -83.09 111.18 18.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.479 HG23 ' HB3' ' A' ' 84' ' ' ASP . 32.6 m -93.31 132.49 37.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.858 0.361 . . . . 0.0 111.32 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.99 123.56 65.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.0 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -122.75 158.04 31.02 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.385 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.22 177.7 28.75 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -160.16 145.18 14.89 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.053 0.426 . . . . 0.0 110.433 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 100.26 11.7 41.34 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.942 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 mp -96.12 165.67 12.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.172 0.51 . . . . 0.0 111.574 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.0 m -85.57 143.02 28.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.871 174.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 93' ' ' ALA . 20.1 tm0? -63.92 -28.18 69.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.466 -174.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.46 -29.59 59.67 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.904 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.38 -39.98 31.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.744 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -62.68 -31.97 72.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.679 -176.664 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.549 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.5 mm-40 -65.29 -42.59 92.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.148 0.499 . . . . 0.0 110.118 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.46 -43.9 96.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.668 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 67' ' ' LYS . 46.5 mt -61.52 -53.65 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.583 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 94.9 mt -44.65 -48.35 10.54 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.798 0.686 . . . . 0.0 111.917 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 68' ' ' GLU . 54.8 t -62.91 -52.11 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.141 0.496 . . . . 0.0 111.053 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.9 70.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.692 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.467 HG13 HG11 ' A' ' 31' ' ' VAL . 52.7 t -75.04 -43.38 45.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.704 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -71.8 -28.79 68.33 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.329 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -77.79 45.29 0.5 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.062 0.458 . . . . 0.0 111.919 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.3 mt -117.89 140.33 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.356 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.423 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 11.9 t -65.96 103.28 0.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.529 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.14 -19.71 4.08 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 55' ' ' ALA . 34.8 mm -97.13 133.24 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.301 0.572 . . . . 0.0 110.546 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.456 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -113.45 -14.21 12.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.479 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 p -165.26 150.77 9.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.777 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.539 HG12 ' HE1' ' A' ' 6' ' ' PHE . 15.0 p -120.3 134.23 64.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.835 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.479 ' HB3' HG23 ' A' ' 56' ' ' THR . 22.7 t0 -101.71 125.53 48.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.0 101.36 13.91 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.847 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -119.11 12.96 12.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.205 0.526 . . . . 0.0 110.217 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 p -86.77 128.28 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.432 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -89.18 147.35 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.841 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.4 p -108.01 142.09 38.68 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.83 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.435 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -95.2 -33.17 12.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.321 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 p -126.87 134.77 26.46 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.087 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.72 119.05 5.29 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.579 2.186 . . . . 0.0 111.102 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.403 ' H ' ' HB3' ' A' ' 64' ' ' GLN . . . -130.48 -160.91 1.08 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.658 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 m -76.47 116.87 17.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.101 0.477 . . . . 0.0 111.764 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.38 162.69 24.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.732 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 m -128.02 150.17 50.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.49 0.662 . . . . 0.0 112.308 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.423 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 23.9 tt0 -91.16 139.33 30.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.144 172.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -106.35 82.27 1.72 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.95 0.405 . . . . 0.0 110.838 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 75.6 t80 -84.71 141.32 30.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.062 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.2 m -107.44 118.8 37.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.694 0.283 . . . . 0.0 110.77 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.0 OUTLIER -72.56 134.05 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.478 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 33.4 mmtp -100.99 -166.03 1.27 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.397 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.8 t -72.77 122.64 21.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.948 0.404 . . . . 0.0 109.959 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.67 7.18 69.23 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.91 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 5.8 m-20 -82.6 118.84 23.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.211 0.529 . . . . 0.0 110.518 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.574 ' O ' HG23 ' A' ' 110' ' ' ILE . 7.1 m -100.74 149.43 23.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.81 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.548 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 24.4 tp -58.66 -35.21 72.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.571 0.623 . . . . 0.0 110.29 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.461 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 9.1 p -69.22 -40.33 78.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.401 0.62 . . . . 0.0 110.567 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -68.18 -38.92 82.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.152 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.615 ' HA ' ' CG ' ' A' ' 113' ' ' GLN . 1.5 pp -79.34 -23.79 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 124' ' ' ILE . 8.7 p -74.57 -34.96 63.02 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 5.7 tmmm? -58.34 -30.53 66.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.768 170.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.615 ' CG ' ' HA ' ' A' ' 110' ' ' ILE . 69.0 mm-40 -68.32 -72.22 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.126 0.965 . . . . 0.0 110.774 175.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 110' ' ' ILE . 29.2 m -73.32 -36.87 50.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 113.65 -1.613 . . . . 0.0 112.631 -166.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 120' ' ' LEU . 22.8 m-85 -97.46 -22.86 16.34 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.482 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.21 11.31 76.08 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.436 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -151.94 124.19 8.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.66 0.267 . . . . 0.0 110.791 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 108' ' ' SER . . . -73.58 -19.54 60.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.951 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -68.15 -24.64 65.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.443 HD12 ' HB3' ' A' ' 115' ' ' TYR . 51.6 mt -85.83 20.46 2.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.757 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.548 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 17.3 p90 -68.95 -28.42 66.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.121 0.486 . . . . 0.0 110.217 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.514 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 27.1 p-10 -70.63 -31.48 68.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.448 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 29.4 mmmt -54.81 -49.19 71.58 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.428 0.632 . . . . 0.0 110.158 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 111' ' ' SER . 47.7 mt -66.72 -47.51 82.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.315 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.539 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 44.7 t80 -49.32 -54.02 19.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.592 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 34.8 mt-10 -61.96 -36.62 81.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.244 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.37 -31.02 65.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.459 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 131' ' ' MET . 8.1 m120 -76.09 -27.95 57.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.969 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.592 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 29.5 mtpp -61.24 151.72 75.01 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.087 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -88.73 17.03 41.65 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.672 -1.803 . . . . 0.0 112.779 0.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.463 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -69.37 -37.56 77.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.417 177.176 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.74 117.01 29.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.66 -37.39 24.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.574 -174.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 137' ' ' LYS . 19.3 m -152.0 144.55 16.85 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.151 0.501 . . . . 0.0 109.879 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.41 -20.37 66.18 Favored 'Trans proline' 0 C--N 1.332 -0.32 0 C-N-CA 123.487 2.791 . . . . 0.0 112.545 -171.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -98.73 -4.65 33.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.909 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.435 ' HG3' ' HB2' ' A' ' 134' ' ' SER . 27.3 mtpp -90.15 9.28 28.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.928 0.394 . . . . 0.0 111.284 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 14.0 pt -58.89 169.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.569 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -157.21 143.87 13.29 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.069 -175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.6 112.73 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.281 2.654 . . . . 0.0 112.559 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 107.56 27.01 5.4 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.894 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.548 ' H ' HG22 ' A' ' 101' ' ' VAL . 48.1 tt0 -103.21 116.61 32.79 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.989 -175.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.661 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 25.7 t -80.63 130.88 35.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.7 mt -118.25 145.58 44.92 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.795 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.534 ' HB2' HG21 ' A' ' 72' ' ' VAL . 37.3 ttt180 -74.93 98.38 3.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.826 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 19.7 mm -87.51 106.55 11.8 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.65 156.04 67.65 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.718 1.612 . . . . 0.0 111.748 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.805 177.523 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 83' ' ' VAL . 41.3 tp . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.651 ' HB2' HG12 ' A' ' 83' ' ' VAL . 78.1 m-85 -124.72 138.9 54.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.901 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -98.19 140.99 31.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.618 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.639 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 86.7 m-85 -127.27 -171.69 2.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.037 0.446 . . . . 0.0 111.899 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.904 HG11 ' HB3' ' A' ' 10' ' ' ALA . 4.5 p -78.16 -26.44 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.176 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.604 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 25.1 tptp 78.95 -55.05 0.45 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.472 0.709 . . . . 0.0 112.295 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.08 7.23 43.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.904 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -125.21 157.62 36.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 121.243 -0.183 . . . . 0.0 110.561 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.6 -148.29 16.88 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.089 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.472 ' HG2' ' ND1' ' A' ' 34' ' ' HIS . 8.9 tp10 -82.39 129.87 34.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.007 0.404 . . . . 0.0 110.277 177.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -95.84 93.16 6.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.775 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 34' ' ' HIS . 1.4 mm? . . . . . 0 C--N 1.324 -0.54 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 24.3 t70 . . . . . 0 CA--C 1.522 -0.121 0 CA-C-O 121.117 0.484 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 31' ' ' VAL . 90.9 mt-30 -63.17 -36.46 83.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.379 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 50' ' ' ILE . . . -58.93 -41.06 86.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 174.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -63.68 -39.91 95.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.556 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -62.42 -32.94 73.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.157 177.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.554 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 84.6 t -68.48 -44.99 82.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.377 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -52.87 -52.26 58.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.311 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.32 -41.32 88.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.702 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.472 ' ND1' ' HG2' ' A' ' 12' ' ' GLU . 31.9 t60 -54.52 -48.67 71.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.805 0.336 . . . . 0.0 110.797 174.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 77.4 mt -66.92 -42.8 84.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.985 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -75.99 -27.11 57.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.725 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.55 -34.36 47.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.495 0.188 . . . . 0.0 111.159 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.424 ' O ' ' HG2' ' A' ' 130' ' ' PRO . 2.0 p -73.44 -44.55 57.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.675 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.2 32.86 1.58 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.529 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.55 HD13 ' HD2' ' A' ' 130' ' ' PRO . 35.8 mm -73.08 126.69 90.22 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 5.7 Cg_exo -73.54 145.09 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.374 2.049 . . . . 0.0 112.763 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 63.56 15.8 9.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.12 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.36 -23.8 63.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.239 0.542 . . . . 0.0 110.457 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.13 -20.51 62.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.801 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -92.03 -26.24 18.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.952 0.406 . . . . 0.0 110.984 -174.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.6 HG21 HG21 ' A' ' 70' ' ' ILE . 33.6 m -90.26 163.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -128.41 131.61 48.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.705 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.7 mp -105.79 128.89 59.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.08 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -117.15 132.74 56.59 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' A' ' 28' ' ' ALA . 14.2 mm -105.04 108.82 25.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.379 0.609 . . . . 0.0 111.331 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' ASP . . . -99.05 69.26 1.74 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.096 176.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 3.5 m-20 70.2 -80.04 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.132 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.75 -8.21 12.41 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.702 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' CE ' ' HB2' ' A' ' 84' ' ' ASP . 82.4 tttt -102.26 112.97 25.87 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.049 0.452 . . . . 0.0 110.688 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.532 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -94.54 121.39 36.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.139 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.0 m -99.93 118.24 35.94 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 74' ' ' VAL . 25.5 t -98.26 122.76 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.89 155.16 33.24 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.859 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.4 174.74 36.75 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 p-10 -153.02 142.31 21.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.975 0.417 . . . . 0.0 110.649 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.89 17.42 61.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.238 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mp -93.34 178.41 5.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.103 0.477 . . . . 0.0 111.201 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.8 m -126.82 149.55 49.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.99 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.516 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 15.7 mm100 -57.53 -26.59 61.6 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.988 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.82 -36.6 72.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.722 0.296 . . . . 0.0 111.785 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.85 -34.45 10.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.498 . . . . 0.0 110.396 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 82.3 tttt -61.0 -41.26 96.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.469 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 145' ' ' ARG . 7.1 mm-40 -78.25 8.92 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.086 0.469 . . . . 0.0 110.822 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -98.72 -46.44 5.68 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.6 HG21 HG21 ' A' ' 46' ' ' VAL . 20.7 mt -67.34 -55.34 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.352 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 tp -65.33 -16.85 64.02 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.099 -170.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 145' ' ' ARG . 63.9 t -90.6 -52.63 10.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.327 175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.32 -18.98 65.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.954 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.523 HG23 HG11 ' A' ' 31' ' ' VAL . 7.6 p -82.05 -42.74 19.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.875 0.369 . . . . 0.0 110.693 175.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.639 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -67.71 -35.92 86.54 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.135 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -85.3 38.23 0.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.546 0.689 . . . . 0.0 111.262 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.2 mt -102.29 144.13 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.116 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -70.47 99.26 1.58 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.428 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.97 -18.27 3.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.986 -175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 55' ' ' ALA . 41.0 mm -98.53 120.5 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.376 0.608 . . . . 0.0 110.991 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.604 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -98.55 -24.91 14.93 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.738 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.7 m -159.52 160.21 34.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.917 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 4' ' ' PHE . 4.3 p -131.31 138.4 53.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.891 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.422 ' HB2' ' CE ' ' A' ' 54' ' ' LYS . 31.3 t70 -111.36 120.53 42.51 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -88.54 121.46 30.95 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.107 0.479 . . . . 0.0 110.942 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -135.26 32.16 3.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.592 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.74 110.61 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.087 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 53.5 mttm -74.76 130.09 38.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.966 0.412 . . . . 0.0 110.144 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 p -105.29 124.6 49.82 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.767 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.97 -18.17 44.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.96 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.6 p -109.27 144.88 30.66 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.72 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.36 42.73 1.28 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.985 2.457 . . . . 0.0 111.988 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.85 156.59 32.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.899 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 m -74.07 129.13 37.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.182 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.74 164.17 23.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.397 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.9 m -120.16 148.16 43.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.189 0.518 . . . . 0.0 111.471 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.67 148.91 32.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.426 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -116.54 116.22 27.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.875 0.369 . . . . 0.0 110.531 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 143' ' ' VAL . 94.4 t80 -110.57 130.26 55.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.9 m -94.08 118.54 31.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.614 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 2.0 m -72.63 130.3 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 140' ' ' PRO . 73.3 mmtt -98.72 -60.43 1.54 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -169.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.4 t -164.0 122.76 1.92 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.745 0.307 . . . . 0.0 110.189 -174.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.62 11.06 72.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.827 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.614 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 2.0 m-20 -73.16 121.33 20.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.265 0.555 . . . . 0.0 110.431 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 110' ' ' ILE . 46.3 p -114.63 157.7 22.73 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 135' ' ' PRO . 26.0 tp -58.05 -40.55 81.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.583 0.629 . . . . 0.0 111.455 -170.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.459 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 13.3 m -76.54 -20.12 57.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.067 0.46 . . . . 0.0 111.05 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.8 -39.55 26.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.049 -0.407 . . . . 0.0 110.43 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.6 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.1 pp -80.25 -24.5 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.958 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.0 p -70.21 -45.12 67.24 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -61.41 -24.28 66.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.579 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -72.12 -57.75 4.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.977 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 115' ' ' TYR . 32.6 m -84.0 -48.43 17.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.043 -172.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.487 ' N ' HG23 ' A' ' 114' ' ' VAL . 56.2 m-85 -82.23 -41.23 20.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.056 0.455 . . . . 0.0 110.647 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.96 -14.73 34.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.997 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.402 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 27.6 t30 -123.0 123.12 40.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.815 0.341 . . . . 0.0 110.297 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -67.32 -27.59 67.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.675 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -74.58 -3.55 31.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 0.0 111.282 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 115' ' ' TYR . 68.4 mt -91.11 19.49 5.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.232 0.539 . . . . 0.0 110.682 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -63.09 -35.77 81.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.499 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -67.4 -27.64 67.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.723 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -60.08 -43.74 95.28 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.355 0.597 . . . . 0.0 109.921 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.429 HD13 HD11 ' A' ' 110' ' ' ILE . 62.0 mt -72.21 -43.35 65.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.296 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 134' ' ' SER . 61.1 t80 -55.54 -53.01 61.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.249 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 19.2 mt-10 -68.11 -24.01 64.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.349 0.595 . . . . 0.0 111.399 -177.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.437 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -79.38 -25.76 42.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.85 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.49 ' HB3' ' HE2' ' A' ' 131' ' ' MET . 24.1 m-80 -99.13 18.68 16.83 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.028 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.449 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 30.5 mmmt -79.76 140.83 55.0 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.209 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.55 ' HD2' HD13 ' A' ' 40' ' ' ILE . 19.6 Cg_endo -100.22 13.24 23.51 Favored 'Cis proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.84 -0.9 . . . . 0.0 112.078 -6.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.49 ' HE2' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -65.51 -25.93 67.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.712 -178.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 133' ' ' LYS . 9.0 tp -100.63 122.7 43.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 170.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.522 ' H ' ' HD2' ' A' ' 133' ' ' LYS . 9.6 mptt -81.05 -44.71 17.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.738 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.409 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 57.2 p -157.72 163.11 25.79 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.882 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.466 ' HA ' HD22 ' A' ' 107' ' ' LEU . 51.8 Cg_exo -54.5 -28.13 53.32 Favored 'Trans proline' 0 C--N 1.328 -0.526 0 C-N-CA 123.096 2.531 . . . . 0.0 112.316 175.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.11 -20.25 19.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.48 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 133' ' ' LYS . 22.9 mmtp -73.48 -6.93 49.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -173.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.614 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 21.1 pt -65.82 166.56 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.182 0.515 . . . . 0.0 111.086 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 142' ' ' GLN . 12.4 p90 -165.58 148.99 7.02 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.923 -177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 102' ' ' LYS . 50.5 Cg_exo -42.71 118.32 1.13 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.915 3.077 . . . . 0.0 113.313 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 106.66 12.32 24.85 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.799 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.614 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 14.0 mt-30 -99.86 120.77 40.3 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.968 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 23.2 t -86.53 127.73 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.173 170.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.3 mt -117.72 143.28 46.35 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.754 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 68' ' ' GLU . 42.2 ttt180 -70.37 118.93 13.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.691 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.3 mm -111.16 90.19 11.13 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.766 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.437 ' HG3' ' HB2' ' A' ' 127' ' ' ALA . 92.8 Cg_endo -77.54 176.67 9.77 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.32 2.013 . . . . 0.0 111.801 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 C--N 1.322 -0.593 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.542 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 83' ' ' VAL . 47.9 tp . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 121.582 0.706 . . . . 0.0 111.981 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -123.61 147.16 47.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.982 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -114.9 138.55 50.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.988 0.423 . . . . 0.0 111.165 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.539 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 37.8 m-85 -130.27 171.03 13.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.339 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 93.7 t -88.67 119.29 35.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.941 0.4 . . . . 0.0 110.009 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 1.069 ' HG2' ' HB2' ' A' ' 81' ' ' ALA . 5.0 tmtp? -52.2 -40.34 61.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.232 -171.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.31 -17.07 35.52 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.277 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . . . -88.07 164.65 15.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.927 0.394 . . . . 0.0 111.535 -174.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.52 -170.92 14.29 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.061 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.97 125.47 26.06 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -77.27 59.94 1.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.219 1.009 . . . . 0.0 109.062 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.411 HD21 ' O ' ' A' ' 30' ' ' LYS . 17.3 tp . . . . . 0 N--CA 1.437 -1.091 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.428 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 12.8 t70 . . . . . 0 CA--C 1.523 -0.059 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.492 ' O ' HG23 ' A' ' 31' ' ' VAL . 71.0 mt-30 -57.65 -44.17 85.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.159 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.48 -44.87 73.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.966 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 52.5 tttm -66.35 -43.87 84.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.807 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -55.44 -42.61 74.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.339 178.063 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.692 HG11 HG23 ' A' ' 74' ' ' VAL . 43.2 t -66.16 -44.41 91.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.597 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.507 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 8.6 mm-40 -57.77 -46.58 84.34 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.548 0.213 . . . . 0.0 111.01 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.2 mt-10 -58.44 -46.33 86.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -55.78 -44.01 77.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.351 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 83.8 mt -64.16 -38.45 91.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 110.557 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -78.27 -22.83 47.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.197 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 32.5 mmmt -75.52 -48.07 24.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.903 0.382 . . . . 0.0 110.344 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 p -64.24 -38.71 92.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.505 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.32 32.69 3.63 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.585 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.644 HD13 ' HD2' ' A' ' 130' ' ' PRO . 29.9 mm -72.6 120.36 80.21 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -81.09 150.58 17.92 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 122.099 1.866 . . . . 0.0 111.876 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 65.57 11.9 7.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.259 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.42 -25.64 33.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.189 0.518 . . . . 0.0 110.045 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.03 -12.05 59.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.881 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -76.97 -25.23 52.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.841 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.441 HG21 HG21 ' A' ' 70' ' ' ILE . 27.1 m -109.14 168.11 3.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.397 0.618 . . . . 0.0 111.822 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -121.93 146.62 46.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.415 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.507 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 21.0 mm -105.63 137.07 37.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.878 0.37 . . . . 0.0 110.692 -177.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.432 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 98.6 mt-30 -134.04 145.68 49.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 27' ' ' GLN . 26.0 mm -126.09 128.12 71.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.114 0.483 . . . . 0.0 111.754 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -119.22 89.2 3.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.046 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 63.85 -92.65 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.735 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.26 10.5 13.18 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.605 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 82' ' ' SER . 21.7 ttmm -104.18 112.84 26.01 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.088 0.471 . . . . 0.0 110.381 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -92.06 121.75 33.92 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.982 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.432 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 23.7 m -100.22 116.7 32.83 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.9 t -92.78 133.9 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.779 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -142.06 160.64 39.81 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.009 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.43 172.29 31.71 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.55 146.08 41.44 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.99 0.395 . . . . 0.0 110.22 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 84.63 10.74 78.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.229 177.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.86 168.7 19.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.122 0.487 . . . . 0.0 111.896 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.3 p -111.18 154.06 24.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.87 0.74 8.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.13 -51.46 4.62 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.72 90.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.746 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 19.8 ptmt -58.79 -34.63 71.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.671 0.272 . . . . 0.0 111.544 -174.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.533 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.4 mm-40 -65.96 -29.45 69.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.215 0.531 . . . . 0.0 110.083 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -72.73 -40.8 65.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.599 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.441 HG21 HG21 ' A' ' 46' ' ' VAL . 2.4 mp -63.11 -47.21 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 96.4 mt -53.73 -32.74 53.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.008 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 68' ' ' GLU . 47.0 t -72.15 -58.32 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.393 0.616 . . . . 0.0 110.975 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.38 -28.32 69.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.451 -173.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.692 HG23 HG11 ' A' ' 31' ' ' VAL . 7.2 p -79.98 -26.14 12.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.337 0.589 . . . . 0.0 110.661 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.539 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -83.99 -34.16 18.94 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.543 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.57 60.95 2.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.018 0.437 . . . . 0.0 111.006 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.484 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 7.9 mm -126.22 128.81 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -65.11 113.4 3.92 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.28 -13.76 11.08 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.397 -171.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.484 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 37.4 mm -100.61 138.86 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.064 0.459 . . . . 0.0 110.133 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.069 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -125.55 -17.04 5.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.5 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 9.2 p -155.87 158.57 38.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.081 0.467 . . . . 0.0 111.321 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 56.0 t -133.23 130.5 57.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.949 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HB3' HG23 ' A' ' 56' ' ' THR . 26.3 t0 -104.05 124.58 49.3 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -95.23 101.41 13.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.302 -174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -119.11 11.84 12.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.121 0.486 . . . . 0.0 110.596 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.43 135.52 26.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.228 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -99.77 141.85 32.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.631 -173.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.5 p -109.17 137.44 47.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.194 0.521 . . . . 0.0 111.445 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.447 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -99.62 -35.79 9.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.393 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 24.2 p -112.43 147.05 36.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.293 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 3.0 Cg_endo -80.43 143.09 15.18 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.417 2.744 . . . . 0.0 111.843 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -161.06 166.68 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.209 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.7 m -73.39 131.43 41.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.502 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.8 173.31 8.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.7 m -123.8 151.76 42.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.442 0.639 . . . . 0.0 111.297 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.448 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 17.9 tt0 -89.81 143.36 26.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.132 173.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -105.77 102.06 11.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.247 0.546 . . . . 0.0 111.067 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.467 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 93.3 t80 -102.14 135.99 42.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.219 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.401 ' OG1' HG22 ' A' ' 143' ' ' VAL . 3.0 m -105.46 122.29 45.7 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.2 m -67.37 126.74 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 140' ' ' PRO . 34.5 mmtp -87.18 -66.06 0.95 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -170.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.2 t -175.12 122.63 0.22 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.88 15.12 81.6 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -172.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.519 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -86.42 118.12 25.64 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.547 -0.827 . . . . 0.0 109.885 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 110' ' ' ILE . 22.7 p -109.03 157.8 18.34 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -55.29 -45.54 76.23 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.579 -174.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.436 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 7.4 m -61.09 -42.45 98.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.709 0.29 . . . . 0.0 110.82 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.36 87.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.341 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 106' ' ' THR . 1.2 pp -76.27 -26.52 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.74 0.305 . . . . 0.0 110.442 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.527 ' OG ' ' HA ' ' A' ' 121' ' ' TYR . 42.5 m -68.37 -46.45 70.05 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-O 121.204 0.526 . . . . 0.0 109.793 169.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -56.38 -30.61 62.93 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.326 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -68.52 -63.3 1.09 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.4 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.404 HG21 HD12 ' A' ' 146' ' ' ILE . 23.5 m -80.0 -40.98 20.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.111 -170.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.425 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 15.7 m-85 -91.27 -49.74 6.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.446 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.95 5.74 32.91 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 120' ' ' LEU . 58.6 t-20 -135.17 113.91 11.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -71.52 -15.59 62.31 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -85.48 -2.87 58.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.04 0.448 . . . . 0.0 110.743 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.443 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . 63.4 mt -89.51 18.65 5.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.061 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HA ' ' OG ' ' A' ' 111' ' ' SER . 47.5 p90 -68.94 -26.14 64.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.084 -174.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -68.93 -36.47 78.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.439 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 120' ' ' LEU . 31.6 mtmt -54.26 -52.76 60.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.328 0.585 . . . . 0.0 110.697 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.406 ' HB ' HD11 ' A' ' 107' ' ' LEU . 32.6 mt -68.75 -39.44 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.747 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.752 ' HA ' HD23 ' A' ' 132' ' ' LEU . 5.5 t80 -59.55 -52.91 63.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.745 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HA ' ' HG3' ' A' ' 129' ' ' LYS . 2.2 mm-40 -60.99 -39.66 90.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.131 0.491 . . . . 0.0 111.507 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -63.85 -28.04 69.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.386 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.541 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 38.9 m-80 -98.99 6.69 46.57 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 20.9 mtmm -78.7 156.2 77.89 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 122.101 -0.374 . . . . 0.0 110.709 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.644 ' HD2' HD13 ' A' ' 40' ' ' ILE . 1.3 Cg_endo -87.73 14.62 46.83 Favored 'Cis proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.994 -1.253 . . . . 0.0 112.478 -3.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.541 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.0 tmm? -64.71 -39.23 93.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 125' ' ' PHE . 35.0 tp -97.33 117.83 32.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.409 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 10.6 mptt -87.51 -33.9 18.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.899 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.456 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 15.1 p -161.8 155.0 17.56 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.137 0.494 . . . . 0.0 109.751 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 12.2 Cg_endo -60.75 -8.14 8.79 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 123.679 2.919 . . . . 0.0 113.117 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -113.72 -14.8 12.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.238 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -87.47 20.16 3.0 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 106' ' ' THR . 8.3 pt -79.06 172.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.2 p90 -154.12 142.05 13.99 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.428 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 139' ' ' TYR . 80.4 Cg_exo -51.07 114.27 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.261 2.641 . . . . 0.0 112.851 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.34 13.91 11.33 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.892 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.538 ' H ' HG22 ' A' ' 101' ' ' VAL . 41.5 tt0 -98.47 120.58 39.14 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.661 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 100' ' ' THR . 42.4 t -82.65 133.18 29.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.281 0.562 . . . . 0.0 109.999 174.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.1 mt -126.2 136.03 52.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.605 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.475 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 2.2 ptm180 -74.49 123.64 25.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.222 0.534 . . . . 0.0 110.026 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 37.0 mm -100.34 102.9 20.13 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.784 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 46.4 Cg_exo -56.77 145.37 83.45 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.377 2.052 . . . . 0.0 111.253 176.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.618 -178.426 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 23.9 tp . . . . . 0 N--CA 1.451 -0.375 0 CA-C-O 121.166 0.507 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 82' ' ' SER . 82.8 m-85 -113.03 139.22 48.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.921 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -99.52 155.87 17.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.579 0.228 . . . . 0.0 110.909 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.695 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 94.2 m-85 -134.29 -158.73 0.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.977 0.418 . . . . 0.0 111.429 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.008 HG11 ' HB3' ' A' ' 10' ' ' ALA . 6.3 p -82.3 -23.14 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.462 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.62 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 18.5 tptm 75.82 -61.39 0.47 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.472 0.709 . . . . 0.0 111.891 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.44 -37.94 35.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 1.008 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -81.53 152.6 27.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.737 0.303 . . . . 0.0 110.622 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.25 -178.26 19.4 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.055 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.63 134.52 47.64 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -83.72 89.97 7.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.62 0.724 . . . . 0.0 112.287 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.581 HD22 HD12 ' A' ' 77' ' ' ILE . 6.4 mp . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.672 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.653 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 2.9 m-20 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -62.42 -31.83 72.58 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.929 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.77 -35.0 74.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.313 0.578 . . . . 0.0 110.086 174.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -69.28 -38.99 78.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.642 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 75.3 mmtt -53.06 -43.4 66.67 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.556 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 51.7 t -69.73 -36.14 68.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.78 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -59.61 -43.52 93.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.0 mt-10 -57.7 -51.14 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.05 -47.11 53.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.347 177.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 91.6 mt -66.83 -41.95 86.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.192 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -72.13 -32.07 66.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.121 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 14.3 mmmm -72.34 -38.6 68.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 0.0 111.225 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' HG12 ' A' ' 40' ' ' ILE . 2.9 p -74.49 -31.42 62.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.156 0.503 . . . . 0.0 110.91 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.1 30.1 8.07 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.6 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.544 HD13 ' HD2' ' A' ' 130' ' ' PRO . 46.0 mm -59.3 129.01 86.34 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 122.264 0.226 . . . . 0.0 110.504 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -61.46 129.02 26.55 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.541 2.161 . . . . 0.0 112.637 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.16 22.75 10.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.53 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -70.59 -20.04 62.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.207 0.527 . . . . 0.0 110.69 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -78.02 -15.78 58.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.244 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -87.53 -24.58 24.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.9 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 70' ' ' ILE . 28.9 m -98.16 162.94 2.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.276 0.56 . . . . 0.0 111.73 -174.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -126.92 150.49 49.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.328 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 56' ' ' THR . 60.6 mt -128.43 142.66 43.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.799 0.333 . . . . 0.0 111.549 -173.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -130.4 128.67 41.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.454 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 55' ' ' ALA . 40.0 mm -106.1 119.66 55.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.028 0.442 . . . . 0.0 111.45 -175.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.75 79.27 1.2 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.182 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 69.38 -74.49 0.08 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.34 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.65 42.99 1.3 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.49 ' HE2' ' HB2' ' A' ' 84' ' ' ASP . 49.4 tttm -141.98 114.25 8.24 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.505 ' HA ' HD13 ' A' ' 50' ' ' ILE . . . -99.4 96.81 7.96 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.118 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.527 HG23 ' HB3' ' A' ' 84' ' ' ASP . 21.1 m -84.83 112.83 20.89 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.414 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -101.2 131.15 49.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.273 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -130.71 160.57 33.91 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.389 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.59 142.24 3.65 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -122.98 150.72 42.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.947 0.403 . . . . 0.0 110.397 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.28 12.28 54.74 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.051 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.23 175.55 10.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.403 . . . . 0.0 111.768 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.7 p -127.05 144.98 50.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 172.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -46.74 -45.31 19.58 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 9.6 tp10 -61.14 -47.5 85.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.466 -174.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.33 -39.3 65.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.408 0.623 . . . . 0.0 110.315 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -52.34 -47.75 65.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.872 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -76.89 -20.2 56.53 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.548 -174.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 35.3 mmtm -62.26 -38.82 90.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.456 HG21 HG21 ' A' ' 46' ' ' VAL . 28.4 mt -70.7 -58.51 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.421 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 mp -43.67 -48.25 7.8 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.35 -28.86 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.928 0.394 . . . . 0.0 111.439 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.86 -26.22 22.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -82.43 -23.71 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 110.835 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.695 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -81.4 -29.81 39.04 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.929 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -81.1 53.8 2.09 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.163 0.506 . . . . 0.0 111.232 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.581 HD12 HD22 ' A' ' 14' ' ' LEU . 26.1 mm -117.77 134.76 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -68.73 99.5 1.03 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.96 -14.71 5.7 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.299 -172.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 21.9 mm -98.4 122.67 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.314 0.578 . . . . 0.0 111.315 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -102.62 -14.73 16.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.705 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 25.8 p -160.26 158.31 29.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 112.413 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.524 HG12 ' CE2' ' A' ' 6' ' ' PHE . 7.5 p -126.74 133.02 69.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.231 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.7 t70 -107.6 95.48 5.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.39 107.57 5.76 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.375 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -115.13 22.21 13.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.218 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -83.26 131.32 34.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.962 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -105.29 129.01 53.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.405 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 p -97.45 136.44 37.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.485 0.66 . . . . 0.0 112.153 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.65 -44.16 10.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.937 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.7 p -114.43 137.73 22.75 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.588 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.59 152.91 29.99 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.61 2.207 . . . . 0.0 111.719 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.404 ' HB3' ' H ' ' A' ' 65' ' ' GLU . . . -157.14 -174.1 4.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.419 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.0 m -64.3 132.55 50.53 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.368 0.418 . . . . 0.0 111.109 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.22 169.19 8.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.648 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.5 p -143.65 155.34 44.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.543 0.687 . . . . 0.0 112.105 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.494 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 23.9 tt0 -86.23 141.58 29.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.48 173.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -101.59 101.73 12.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.963 0.411 . . . . 0.0 110.853 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 113' ' ' GLN . 93.6 t80 -107.07 141.16 38.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.547 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 4.6 m -104.19 122.41 45.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.183 177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.494 HG22 ' H ' ' A' ' 142' ' ' GLN . 2.8 m -67.22 140.03 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.46 -162.19 0.93 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.112 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.2 t -56.62 -31.4 64.27 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 123.123 0.264 . . . . 0.0 111.219 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.28 49.23 2.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.155 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -64.92 109.24 2.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.44 1.114 . . . . 0.0 112.117 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 110' ' ' ILE . 86.4 m -151.39 129.24 11.66 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.616 170.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 15.2 mt -51.03 -48.74 61.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.878 0.763 . . . . 0.0 111.333 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 p -58.48 -37.61 75.88 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.297 0.373 . . . . 0.0 111.152 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.68 -50.63 49.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -74.17 -23.81 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.575 -176.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.6 t -69.78 -46.29 66.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 61.7 tttm -60.88 -28.04 68.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.619 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.598 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 2.6 tp-100 -66.2 -64.18 0.91 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.21 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.8 m -78.23 -44.67 27.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.558 -170.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.435 ' N ' HG23 ' A' ' 114' ' ' VAL . 63.8 m-85 -81.61 -46.37 14.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.67 0.747 . . . . 0.0 110.343 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.94 -6.28 32.68 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.567 -170.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -127.98 131.34 49.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.221 -0.489 . . . . 0.0 110.161 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . . . -84.77 0.97 48.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.991 0.424 . . . . 0.0 110.717 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -93.68 0.09 56.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.739 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.76 21.18 17.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.377 0.608 . . . . 0.0 110.875 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 44.0 p90 -61.51 -32.33 72.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.479 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -79.27 -22.37 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.824 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -60.48 -48.75 80.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.373 0.606 . . . . 0.0 110.13 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.43 HD13 HD11 ' A' ' 110' ' ' ILE . 50.1 mt -63.83 -49.9 79.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.094 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -46.3 -53.34 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.806 0.691 . . . . 0.0 111.083 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.565 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 7.7 mm-40 -65.24 -29.36 70.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.621 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.443 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -77.2 -19.1 57.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.043 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.498 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 5.3 m120 -95.05 -2.1 50.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.511 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.565 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 6.5 mmmm -68.6 145.88 97.34 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.544 ' HD2' HD13 ' A' ' 40' ' ' ILE . 66.6 Cg_endo -96.36 22.97 25.96 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 124.059 -1.226 . . . . 0.0 112.027 -7.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.498 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 1.7 tmm? -70.81 -35.81 72.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.529 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.9 tp -90.33 119.31 30.53 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -77.96 -45.65 23.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.616 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -154.66 157.32 32.09 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.39 -51.89 9.84 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 C-N-CA 123.29 2.66 . . . . 0.0 112.83 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.06 6.49 18.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.407 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -98.93 15.22 26.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.639 0.257 . . . . 0.0 111.332 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.511 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 9.6 pt -78.0 175.55 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -159.63 144.25 11.17 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -52.3 112.31 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.277 2.651 . . . . 0.0 112.312 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 117.61 0.16 18.03 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.167 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.511 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 39.5 tt0 -88.28 122.78 32.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.965 0.412 . . . . 0.0 110.354 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 37.6 t -83.33 133.6 28.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.999 173.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 70.2 mt -124.02 151.04 44.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.284 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.473 ' H ' ' ND2' ' A' ' 128' ' ' ASN . 58.0 mtp180 -80.07 122.82 27.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.229 177.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 25.4 mm -109.23 97.29 25.12 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.228 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.02 148.77 35.64 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.084 1.856 . . . . 0.0 111.312 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.532 -178.369 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.7 tp . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.46 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 86.7 m-85 -105.52 118.02 35.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.803 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -89.83 150.0 22.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.071 0.463 . . . . 0.0 111.351 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.66 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 74.8 m-85 -132.08 -156.72 0.77 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.928 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.054 HG11 ' HB3' ' A' ' 10' ' ' ALA . 5.7 p -88.6 -22.01 6.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.038 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.81 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 23.8 tptm 75.99 -57.84 0.56 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.549 0.739 . . . . 0.0 111.513 -175.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.58 -53.49 11.76 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.029 0.442 . . . . 0.0 111.726 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 1.054 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -73.31 146.24 45.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.126 -175.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.75 -167.73 29.29 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -72.03 124.79 25.69 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -73.01 83.13 1.25 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.037 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.456 HD21 ' O ' ' A' ' 30' ' ' LYS . 20.1 tp . . . . . 0 N--CA 1.436 -1.164 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.87 -170.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.092 0.472 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.592 ' O ' HG23 ' A' ' 31' ' ' VAL . 54.9 mt-30 -64.74 -32.87 74.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.301 173.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.01 85.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.119 0.485 . . . . 0.0 110.416 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -64.18 -44.09 93.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.52 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -52.93 -44.74 67.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.689 175.158 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 27' ' ' GLN . 82.1 t -58.59 -48.92 84.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.303 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.405 ' HG2' HD13 ' A' ' 48' ' ' ILE . 26.6 mt-30 -63.92 -40.79 97.28 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.282 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 40.7 mt-10 -58.86 -46.29 88.09 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 65.7 t60 -52.7 -44.9 66.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.866 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 99.0 mt -66.08 -39.75 90.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.248 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -74.17 -39.35 63.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.228 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 62.2 mtpt -64.43 -44.54 90.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.016 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.7 p -66.05 -51.05 61.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.166 0.508 . . . . 0.0 110.037 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.71 30.54 1.98 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.928 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.473 HD11 ' HB2' ' A' ' 131' ' ' MET . 27.4 mm -67.19 120.69 74.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.57 142.64 84.99 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.369 2.046 . . . . 0.0 112.961 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 58.54 25.47 13.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.473 -1.239 . . . . 0.0 112.645 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.51 -15.9 63.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.406 0.622 . . . . 0.0 110.14 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -86.61 -8.0 57.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.684 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -97.41 -8.81 28.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.738 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.84 172.1 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.317 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.69 131.19 25.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.458 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 56' ' ' THR . 4.1 mp -108.04 141.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.793 0.33 . . . . 0.0 110.794 -176.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -134.54 123.91 24.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.756 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mm -87.16 120.79 37.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.442 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -127.73 81.5 2.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.756 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 49.75 64.59 1.7 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.776 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.26 -26.53 14.88 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.54 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.449 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 30.8 mttp -90.06 114.16 26.01 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.152 0.501 . . . . 0.0 111.468 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 83' ' ' VAL . . . -89.49 94.68 9.97 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.221 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 21.1 m -77.55 125.9 30.05 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG22 HG13 ' A' ' 48' ' ' ILE . 42.8 t -119.01 109.68 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.127 0.489 . . . . 0.0 111.18 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.7 m -102.67 166.63 10.4 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.911 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 88' ' ' LYS . . . 168.44 170.5 33.21 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.475 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -155.89 138.71 15.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.065 0.46 . . . . 0.0 110.151 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 93.53 3.55 64.62 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.91 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.59 -177.14 2.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.333 0.587 . . . . 0.0 111.994 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.7 p -132.04 157.8 43.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.105 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -47.91 -41.77 25.44 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 123.165 0.291 . . . . 0.0 111.05 176.019 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.461 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 49.9 mm-40 -55.92 -64.87 0.72 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.515 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.78 95.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.169 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.664 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 49.1 tttm -50.09 -63.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.891 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 72' ' ' VAL . 5.6 mm-40 -64.67 -35.01 79.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.158 0.504 . . . . 0.0 110.489 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -62.24 -45.35 93.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.81 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.404 ' O ' HG13 ' A' ' 74' ' ' VAL . 53.8 mt -62.2 -51.91 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.997 175.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 78.6 mt -47.44 -42.23 21.95 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.889 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 68' ' ' GLU . 62.0 t -67.25 -51.85 48.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.401 0.62 . . . . 0.0 110.739 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.22 72.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.222 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 70' ' ' ILE . 15.3 m -81.37 -32.68 12.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.875 0.369 . . . . 0.0 110.788 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.66 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -70.66 -26.2 74.46 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.676 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -85.14 47.21 1.37 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.766 0.317 . . . . 0.0 111.341 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.8 mt -120.45 141.19 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 120.846 0.355 . . . . 0.0 110.478 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -66.26 105.3 1.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.216 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.89 -2.75 9.96 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.774 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.1 mm -106.24 117.79 52.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.579 0.704 . . . . 0.0 111.126 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.81 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -91.98 -27.51 17.8 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.229 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.449 ' OG ' ' HG2' ' A' ' 54' ' ' LYS . 5.5 p -164.48 161.06 21.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.184 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 55' ' ' ALA . 4.3 p -119.77 124.1 72.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.611 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -94.68 103.08 15.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.24 119.06 19.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.866 -174.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -127.22 28.64 5.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.854 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.48 123.81 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.209 0.528 . . . . 0.0 111.351 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 59' ' ' GLY . 13.9 tptm -90.23 124.66 35.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.265 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 p -100.02 135.06 42.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.199 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.433 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -106.12 -23.93 12.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.58 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.447 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 67.4 p -123.58 138.75 30.77 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.52 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 2.1 Cg_endo -80.96 158.88 20.92 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.181 2.588 . . . . 0.0 112.788 -176.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -161.84 -176.84 5.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.168 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.3 m -82.42 125.02 30.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HA ' ' CD ' ' A' ' 64' ' ' GLN . . . -73.24 145.48 46.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -123.96 172.09 9.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.388 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -106.66 153.88 21.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.784 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -111.63 116.98 31.69 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.407 ' CZ ' ' HG2' ' A' ' 113' ' ' GLN . 88.3 t80 -123.52 142.43 51.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.588 0.232 . . . . 0.0 110.4 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 2.5 m -104.1 124.28 48.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.361 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 142' ' ' GLN . 2.8 m -68.09 134.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -98.36 -177.19 3.62 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.143 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 p -61.9 116.21 4.68 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.15 25.75 5.99 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -169.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.562 ' OD2' HG13 ' A' ' 138' ' ' ILE . 10.4 p-10 -53.94 118.91 4.37 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.218 1.009 . . . . 0.0 111.768 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 110' ' ' ILE . 92.6 m -144.35 127.37 16.49 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 125' ' ' PHE . 22.9 tp -63.15 -31.09 72.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.255 -170.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 p -75.71 -26.95 57.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.371 0.605 . . . . 0.0 110.152 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.431 ' CB ' ' HB ' ' A' ' 106' ' ' THR . . . -75.77 -44.22 42.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.851 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.609 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.3 pp -78.35 -24.28 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.394 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.2 p -72.7 -45.33 59.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.95 0.405 . . . . 0.0 109.993 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -64.26 -18.48 64.6 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.277 0.561 . . . . 0.0 110.231 174.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.609 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 45.9 tp60 -72.66 -60.98 1.97 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.859 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 115' ' ' TYR . 30.8 m -78.01 -48.52 23.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.072 -172.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.496 ' HB3' HD12 ' A' ' 120' ' ' LEU . 83.4 m-85 -84.12 -36.21 23.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.327 0.584 . . . . 0.0 110.822 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 -2.54 56.74 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.096 -173.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.435 HD21 ' HB3' ' A' ' 119' ' ' ASN . 33.0 t30 -134.67 125.27 26.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.577 -0.311 . . . . 0.0 110.399 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.427 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -74.66 -22.78 58.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.56 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.435 ' HB3' HD21 ' A' ' 117' ' ' ASN . 7.9 t30 -63.78 -21.42 66.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.898 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 115' ' ' TYR . 63.3 mt -85.83 15.8 4.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.498 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.459 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 35.2 p90 -62.0 -35.84 79.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.284 0.564 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.401 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 8.4 t30 -65.72 -33.07 75.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.676 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -57.0 -49.26 76.32 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.442 0.639 . . . . 0.0 109.67 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.506 HG22 ' OD1' ' A' ' 128' ' ' ASN . 27.7 mt -67.73 -43.98 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.896 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.594 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 43.2 t80 -53.54 -56.33 18.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.854 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 19.2 mt-10 -65.42 -25.81 67.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.559 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.39 -34.9 31.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.061 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 124' ' ' ILE . 7.8 m120 -74.6 -30.54 61.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 7.2 mtpm? -57.25 148.41 52.73 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.559 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -87.78 8.74 64.56 Favored 'Cis proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.291 -1.545 . . . . 0.0 113.256 1.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.477 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -62.97 -39.98 96.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.108 0.48 . . . . 0.0 109.826 175.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.14 125.99 37.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -95.98 -36.64 10.98 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.447 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 19.7 m -150.79 153.2 33.31 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.063 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.442 ' HA ' HD22 ' A' ' 107' ' ' LEU . 74.1 Cg_exo -50.5 -54.12 5.99 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 C-N-CA 123.318 2.679 . . . . 0.0 113.054 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -84.52 7.36 20.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.55 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 37.1 mmtm -92.13 4.59 52.84 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.751 0.31 . . . . 0.0 111.802 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.562 HG13 ' OD2' ' A' ' 105' ' ' ASP . 11.6 pt -67.71 173.72 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.517 171.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 6.6 p90 -158.59 141.93 10.87 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.604 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 139' ' ' TYR . 71.9 Cg_exo -50.75 117.11 3.02 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.374 2.716 . . . . 0.0 112.858 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.12 4.03 24.23 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.03 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.475 ' H ' HG22 ' A' ' 101' ' ' VAL . 34.3 tt0 -93.0 116.38 29.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.348 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 37.1 t -79.71 134.66 27.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.7 mt -123.51 143.43 50.19 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.091 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.551 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 34.8 ttt180 -74.64 109.79 8.4 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.96 105.61 14.3 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.701 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 32.0 Cg_exo -59.12 164.44 10.33 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.722 2.281 . . . . 0.0 111.907 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--N 1.321 -0.667 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.525 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.6 tp . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 121.356 0.598 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.65 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 56.5 m-85 -106.76 131.56 53.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.608 -176.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.33 136.77 41.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.453 0.644 . . . . 0.0 112.252 -171.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.621 ' HE1' HG12 ' A' ' 83' ' ' VAL . 31.4 m-85 -123.03 -166.0 1.39 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.48 176.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 57.2 t -81.25 -81.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.98 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtt? 160.68 -74.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.91 -30.56 69.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.098 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.17 126.24 30.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.885 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.93 -178.26 31.73 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.02 125.83 25.32 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -74.67 69.24 1.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.975 0.893 . . . . 0.0 109.16 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD21 ' O ' ' A' ' 30' ' ' LYS . 19.4 tp . . . . . 0 N--CA 1.439 -0.999 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.214 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.531 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 2.1 m-20 . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.626 0.25 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.607 ' HB2' HG13 ' A' ' 50' ' ' ILE . 6.6 mm100 -75.88 -41.22 52.77 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -176.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.11 62.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.76 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 24.7 ttmm -67.1 -49.13 66.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.14 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 14.0 mptt -58.28 -41.51 84.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.673 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 27' ' ' GLN . 93.9 t -60.71 -43.46 95.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.731 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -58.13 -47.04 84.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.699 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 39.8 mt-10 -58.22 -47.17 84.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.065 176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -51.67 -49.9 61.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.094 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 98.2 mt -63.58 -38.72 92.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.333 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -79.85 -33.14 40.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.549 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -71.65 -30.56 65.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.662 0.268 . . . . 0.0 110.908 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 p -80.18 -40.42 27.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.039 0.447 . . . . 0.0 110.547 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.07 26.81 5.35 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.248 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.459 HD13 ' HD2' ' A' ' 130' ' ' PRO . 35.9 mm -61.71 132.25 93.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 110.467 -0.198 . . . . 0.0 110.467 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 11.9 Cg_exo -65.31 130.97 26.79 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.429 2.086 . . . . 0.0 112.819 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 59.44 29.56 19.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.819 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.87 -26.52 68.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.777 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -75.32 -26.06 58.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.733 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -74.07 -22.03 59.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.684 -174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.404 HG21 HG21 ' A' ' 70' ' ' ILE . 23.5 m -100.76 162.39 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.563 0.697 . . . . 0.0 111.816 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -128.83 129.76 46.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.878 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.74 133.73 46.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.963 0.411 . . . . 0.0 110.914 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -119.69 122.06 40.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.52 173.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.607 HG13 ' HB2' ' A' ' 27' ' ' GLN . 30.5 mm -97.59 108.36 21.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.212 0.529 . . . . 0.0 110.868 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.21 66.2 0.65 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.798 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 55.94 77.82 0.22 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.653 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.07 -18.24 32.84 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.219 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 82' ' ' SER . 28.0 ttpp -108.37 116.5 32.08 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.153 -0.616 . . . . 0.0 110.702 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.27 101.34 13.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.933 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 84' ' ' ASP . 14.4 m -85.18 124.95 32.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.237 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.95 110.77 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 120.982 0.42 . . . . 0.0 111.436 -175.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.444 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -97.92 157.49 16.07 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.889 177.121 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 87' ' ' VAL . . . 163.1 165.98 21.13 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.432 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -148.37 143.01 26.54 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.916 0.389 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 83.68 37.75 11.49 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.964 176.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.62 165.51 12.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.802 0.334 . . . . 0.0 110.961 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -93.57 160.65 14.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.998 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.575 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 7.6 tp60 -53.54 -58.0 8.71 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.222 0.326 . . . . 0.0 111.76 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.413 ' HG2' HH12 ' A' ' 145' ' ' ARG . 27.1 mt-10 -58.24 -46.78 85.32 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.23 76.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.113 0.482 . . . . 0.0 110.09 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 68.3 tttt -57.4 -46.33 83.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.528 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 72' ' ' VAL . 75.5 mt-10 -60.71 -47.53 85.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.653 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -55.8 -40.05 72.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.755 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.404 HG21 HG21 ' A' ' 46' ' ' VAL . 58.6 mt -63.03 -57.84 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.339 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 98.6 mt -48.03 -45.53 32.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.099 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 68' ' ' GLU . 30.9 t -68.64 -49.17 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.156 0.503 . . . . 0.0 110.593 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.41 74.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.486 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.14 -33.48 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.842 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.586 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -70.88 -35.4 65.55 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.247 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.05 38.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.801 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.5 mt -110.42 139.99 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.7 t -65.6 120.21 12.52 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.54 -22.93 11.49 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.506 HG21 ' HA2' ' A' ' 75' ' ' GLY . 45.8 mm -97.37 136.95 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.398 0.618 . . . . 0.0 110.196 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -126.45 -9.51 6.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.739 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 1.8 p -160.06 150.56 18.71 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.65 ' CG1' ' HB2' ' A' ' 4' ' ' PHE . 7.2 p -122.97 132.74 70.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.416 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.9 t0 -111.29 110.99 21.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -78.24 123.21 26.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.993 -173.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 77.7 mm-40 -131.25 8.32 4.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.846 174.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 1.7 p -96.11 126.58 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.265 0.555 . . . . 0.0 111.17 -176.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -85.51 149.26 25.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.932 -176.312 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.2 p -104.37 121.29 43.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.926 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.481 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -84.99 -41.87 15.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.027 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 p -117.19 127.36 26.75 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.799 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.82 153.08 13.12 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.77 2.313 . . . . 0.0 112.822 -175.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -148.68 -161.14 1.28 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.506 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.4 m -76.04 127.81 33.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.929 0.395 . . . . 0.0 110.305 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.85 128.11 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.898 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.9 m -103.65 153.32 20.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.348 0.594 . . . . 0.0 111.84 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 58.7 tt0 -87.05 155.66 20.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.324 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -116.2 98.69 6.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.242 0.544 . . . . 0.0 110.517 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 78.8 t80 -101.49 136.33 41.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.553 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.432 ' OG1' HG22 ' A' ' 143' ' ' VAL . 5.4 m -102.09 126.93 49.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.557 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 142' ' ' GLN . 3.3 m -73.56 141.52 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -91.83 -165.56 1.38 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.931 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.3 m -62.38 -31.46 72.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.814 0.34 . . . . 0.0 111.091 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -96.37 44.8 1.95 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.651 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' OD2' HG13 ' A' ' 138' ' ' ILE . 7.8 p-10 -56.37 120.81 8.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 122.007 0.908 . . . . 0.0 112.137 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 110' ' ' ILE . 53.4 m -143.71 126.11 15.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 168.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 40.6 tp -61.1 -28.1 68.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.714 0.293 . . . . 0.0 110.765 -174.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.481 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 9.6 m -76.24 -29.87 57.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.302 0.572 . . . . 0.0 110.274 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.406 ' CB ' ' HB ' ' A' ' 106' ' ' THR . . . -75.0 -44.86 45.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.802 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.1 pp -76.5 -21.58 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.976 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.2 p -77.05 -43.92 32.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.89 -23.28 63.33 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.317 0.58 . . . . 0.0 110.156 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -70.02 -61.93 1.58 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.142 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.6 m -82.86 -39.51 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.376 -169.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.416 ' HB3' HD12 ' A' ' 120' ' ' LEU . 40.9 m-85 -91.38 -36.17 13.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.62 -3.91 53.62 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.264 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -131.76 129.21 40.28 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -81.46 -13.7 57.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.495 -176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.27 -18.14 55.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.381 0.61 . . . . 0.0 110.183 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 115' ' ' TYR . 64.8 mt -84.39 21.06 1.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.211 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.487 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 41.9 p90 -65.74 -33.41 75.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.566 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 7.9 p30 -68.11 -28.47 67.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.946 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' A' ' 123' ' ' LYS . 29.5 mmmt -59.74 -49.69 76.76 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.337 0.589 . . . . 0.0 110.163 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.1 mt -65.82 -44.82 92.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.868 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.465 ' HB2' HD21 ' A' ' 107' ' ' LEU . 50.8 t80 -48.98 -56.73 8.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.171 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.576 ' HA ' ' HG2' ' A' ' 129' ' ' LYS . 29.5 mt-10 -68.43 -21.19 64.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.944 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.88 -23.39 36.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.063 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.494 ' OD1' HD22 ' A' ' 144' ' ' LEU . 7.6 m120 -88.3 -3.26 58.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.936 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.576 ' HG2' ' HA ' ' A' ' 126' ' ' GLU . 28.0 mmmt -72.07 148.52 91.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HD2' HD13 ' A' ' 40' ' ' ILE . 72.1 Cg_endo -95.98 31.9 11.79 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.636 -1.401 . . . . 0.0 112.409 -2.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.47 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -84.87 -33.84 22.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.072 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.01 120.98 33.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.451 0.643 . . . . 0.0 110.578 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -67.24 -62.5 1.39 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.066 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.446 ' H ' ' HB2' ' A' ' 137' ' ' LYS . 26.5 m -145.66 161.05 42.35 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.345 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 134' ' ' SER . 78.3 Cg_exo -52.24 -41.49 65.56 Favored 'Trans proline' 0 C--N 1.332 -0.303 0 C-N-CA 123.216 2.611 . . . . 0.0 112.426 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.7 19.91 7.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.446 ' HB2' ' H ' ' A' ' 134' ' ' SER . 3.0 mmpt? -107.03 11.73 29.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.874 0.368 . . . . 0.0 111.335 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.441 HG13 ' OD2' ' A' ' 105' ' ' ASP . 15.0 pt -73.88 172.95 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.11 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -166.46 149.62 6.42 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -175.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.44 110.91 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.092 2.528 . . . . 0.0 112.515 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.88 4.68 26.01 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.522 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.488 ' H ' HG22 ' A' ' 101' ' ' VAL . 7.4 tp60 -82.37 112.27 19.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.713 0.292 . . . . 0.0 110.377 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.462 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 26.8 t -82.97 134.15 27.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.494 HD22 ' OD1' ' A' ' 128' ' ' ASN . 77.7 mt -121.29 144.0 48.86 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.068 0.461 . . . . 0.0 111.112 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 27.4 ttp85 -75.01 108.03 7.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.266 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 30.9 mm -99.02 103.04 17.38 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.57 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 20.9 Cg_exo -63.78 146.99 92.55 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.126 1.884 . . . . 0.0 111.382 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--N 1.321 -0.656 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.676 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 CA--C 1.509 -0.607 0 CA-C-O 121.627 0.727 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.581 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 87.0 m-85 -111.97 125.58 54.22 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.447 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -93.12 136.44 33.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.433 0.635 . . . . 0.0 111.839 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.564 ' HE1' HG12 ' A' ' 83' ' ' VAL . 32.7 m-85 -126.1 -167.47 1.71 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.858 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.5 t -116.0 113.81 44.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.815 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 19.2 ptmt -59.85 -29.03 68.01 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -171.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.97 -10.09 58.96 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.04 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.13 122.18 46.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.124 0.488 . . . . 0.0 111.222 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 157.76 179.18 32.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.972 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.17 132.91 48.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -86.53 80.36 8.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.188 0.518 . . . . 0.0 111.801 -173.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 34' ' ' HIS . 7.1 mp . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.244 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.2 p-10 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.63 0.252 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 31' ' ' VAL . 53.2 mt-30 -61.95 -45.77 92.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.348 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.62 71.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.805 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -70.52 -36.21 73.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.185 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 30.1 mmmt -62.7 -43.28 99.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.338 174.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 27' ' ' GLN . 72.6 t -62.59 -39.5 84.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.815 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -57.31 -43.9 83.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.592 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.35 -48.94 78.96 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.9 0.381 . . . . 0.0 110.579 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.502 ' HB2' HD21 ' A' ' 14' ' ' LEU . 58.5 t60 -52.51 -43.17 64.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.369 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.21 -39.71 65.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.471 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -82.19 -31.26 30.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.777 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -75.05 -23.45 58.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.608 0.242 . . . . 0.0 111.376 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 p -86.06 -39.08 17.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.232 0.539 . . . . 0.0 110.439 174.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.61 33.81 3.75 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.96 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.28 124.72 88.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.99 144.87 65.76 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.845 1.696 . . . . 0.0 112.379 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.557 ' HB3' HD22 ' A' ' 62' ' ' LEU . 12.0 m-20 65.9 3.41 2.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.419 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.55 -16.23 61.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.401 0.62 . . . . 0.0 110.518 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.66 -18.31 59.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.018 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -103.25 -0.6 30.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.531 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 70' ' ' ILE . 30.7 m -103.02 171.13 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.181 0.515 . . . . 0.0 111.593 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -134.73 125.11 26.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.866 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.0 135.73 37.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.278 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.478 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 48.2 tt0 -127.7 125.33 39.83 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 27' ' ' GLN . 21.5 mm -97.26 134.86 33.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.893 0.378 . . . . 0.0 110.595 -177.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.39 50.96 2.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.375 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 63.1 93.23 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.788 0.68 . . . . 0.0 111.483 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 78.41 -23.47 2.84 Favored Glycine 0 CA--C 1.517 0.176 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.585 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 0.8 OUTLIER -109.68 115.14 29.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.546 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -101.48 120.17 39.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.315 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.528 ' OG1' ' HE3' ' A' ' 54' ' ' LYS . 49.2 m -90.72 132.86 35.56 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.309 -0.244 . . . . 0.0 110.528 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.99 119.96 61.82 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.347 0.594 . . . . 0.0 110.396 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -117.62 162.24 18.34 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.226 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.85 156.87 8.21 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -138.54 144.83 40.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.912 0.387 . . . . 0.0 110.509 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 88.36 22.69 39.82 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.48 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.557 HD22 ' HB3' ' A' ' 42' ' ' ASP . 8.6 mt -100.08 -166.85 1.38 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.238 0.542 . . . . 0.0 109.952 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.4 p -125.73 168.26 14.03 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.923 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.675 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 3.1 tm0? -63.22 -43.34 98.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.843 0.354 . . . . 0.0 110.522 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.489 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 42.7 tt0 -64.46 -42.82 95.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.622 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.42 -46.95 83.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.454 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 12.9 ptmm? -59.62 -37.34 78.35 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.915 -175.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 72' ' ' VAL . 85.9 mt-10 -64.75 -48.17 75.55 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.719 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 28.6 mtpp -54.22 -41.01 68.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.676 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.618 HD13 HG11 ' A' ' 46' ' ' VAL . 29.7 mt -71.38 -53.93 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.691 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 96.3 mt -48.95 -47.31 43.97 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.656 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 68' ' ' GLU . 70.0 t -65.37 -45.78 92.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.389 0.614 . . . . 0.0 110.647 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.471 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -61.72 -39.24 90.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.358 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 m -78.18 -31.21 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.718 0.294 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' HA2' HG21 ' A' ' 80' ' ' ILE . . . -69.6 -36.79 76.81 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.301 175.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -80.24 50.02 1.2 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.321 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.473 HD13 HD22 ' A' ' 14' ' ' LEU . 96.8 mt -119.04 143.34 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 120.946 0.403 . . . . 0.0 110.387 173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -67.66 115.11 6.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.461 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 111.29 -13.17 28.42 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.131 -172.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 50.6 mm -105.96 132.89 51.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.896 0.379 . . . . 0.0 110.684 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.815 ' HB2' ' HB3' ' A' ' 8' ' ' LYS . . . -131.29 -5.49 3.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.421 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 2.7 p -156.2 154.34 30.63 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.193 0.52 . . . . 0.0 111.317 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.6 p -134.4 134.6 54.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.034 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.71 113.68 27.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -83.09 111.06 18.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.474 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -123.47 29.02 6.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.483 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.483 ' CG1' HD12 ' A' ' 62' ' ' LEU . 77.4 t -82.45 139.9 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.508 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -105.14 137.71 42.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.047 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.4 p -108.89 130.27 55.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.419 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.455 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -97.31 -29.46 13.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.104 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.7 p -127.27 140.29 37.51 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.707 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.04 153.47 25.08 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.754 2.303 . . . . 0.0 111.774 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.489 ' HB3' ' H ' ' A' ' 65' ' ' GLU . . . -159.58 -172.77 3.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.99 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.2 m -61.78 149.2 40.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.348 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.89 138.53 51.08 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.732 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.5 m -120.18 149.41 42.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.217 0.532 . . . . 0.0 111.709 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 59.3 tt0 -84.16 153.01 23.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.019 173.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -110.67 96.17 6.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 0.0 111.167 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -95.3 136.07 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.861 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.435 ' OG1' HG22 ' A' ' 143' ' ' VAL . 18.4 m -106.83 124.0 48.97 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 142' ' ' GLN . 0.8 OUTLIER -67.45 134.05 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 72.0 mmtt -86.67 -72.39 0.51 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.376 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 t -175.08 115.5 0.16 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -175.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.01 -3.81 85.71 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -171.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 1.0 OUTLIER -63.71 113.94 3.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.2 -1.0 . . . . 0.0 110.829 178.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 110' ' ' ILE . 40.0 p -104.97 158.28 16.65 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.664 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -57.37 -45.91 83.94 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.356 -172.319 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.575 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 17.2 m -65.47 -35.16 80.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.75 0.309 . . . . 0.0 110.588 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.98 77.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.106 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.584 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.5 pp -75.6 -29.68 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 120.833 0.349 . . . . 0.0 110.495 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.2 t -65.16 -45.69 83.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.232 0.539 . . . . 0.0 109.627 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -62.88 -30.33 71.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.455 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.5 OUTLIER -64.41 -62.86 1.34 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.229 176.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 115' ' ' TYR . 34.2 m -77.21 -46.23 28.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.262 -170.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.699 ' CE2' ' HD2' ' A' ' 123' ' ' LYS . 15.8 m-85 -88.14 -50.46 6.36 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 120.5 -19.88 9.02 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -111.23 128.32 55.89 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.575 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -81.56 -8.59 59.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.981 0.42 . . . . 0.0 110.247 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -80.25 -12.3 59.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.395 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.483 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 55.7 mt -87.16 11.53 13.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.459 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 51.0 p90 -58.05 -30.78 66.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.196 0.522 . . . . 0.0 110.51 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.455 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 26.9 p-10 -76.27 -32.71 58.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.171 -176.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.699 ' HD2' ' CE2' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -71.81 -24.31 61.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.204 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mt -83.99 -41.97 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.65 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.567 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 40.9 t80 -53.66 -59.76 4.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.359 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 30.2 mt-10 -60.6 -36.11 77.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.152 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.73 -32.34 73.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.045 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.523 ' O ' ' HB3' ' A' ' 131' ' ' MET . 40.8 m-80 -90.01 -8.15 52.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.939 0.399 . . . . 0.0 110.866 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 132' ' ' LEU . 30.4 mtpp -74.11 156.67 87.56 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.531 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -84.28 14.82 35.48 Favored 'Cis proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.383 -1.507 . . . . 0.0 113.365 -0.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.523 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 4.2 tmm? -67.31 -38.5 85.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.175 0.512 . . . . 0.0 109.75 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.637 ' O ' ' HG2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -90.9 111.69 23.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.684 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -74.29 -60.34 2.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.335 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 16.3 m -137.96 155.62 74.55 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 134' ' ' SER . 25.8 Cg_exo -63.09 -23.64 73.45 Favored 'Trans proline' 0 CA--C 1.522 -0.097 0 C-N-CA 123.655 2.903 . . . . 0.0 113.134 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -99.67 4.87 45.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.952 0.406 . . . . 0.0 110.668 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 134' ' ' SER . 27.3 mmmt -90.62 -0.77 57.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.756 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.407 HD11 ' HA ' ' A' ' 106' ' ' THR . 21.4 pt -64.56 166.13 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.046 0.451 . . . . 0.0 110.833 174.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -155.24 144.65 15.25 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.917 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -54.29 116.39 3.03 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.332 2.688 . . . . 0.0 112.71 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.46 14.52 14.22 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.202 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.57 ' O ' HG13 ' A' ' 101' ' ' VAL . 65.0 tt0 -99.78 130.83 46.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.899 0.381 . . . . 0.0 110.322 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 42.5 t -85.63 130.57 36.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.269 0.557 . . . . 0.0 109.957 174.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.0 mt -118.81 134.76 54.93 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.733 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.521 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 51.8 mtp180 -65.87 120.34 12.88 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.325 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 35.2 mm -111.46 82.65 3.74 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 31.9 Cg_exo -62.79 170.17 7.62 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.825 2.35 . . . . 0.0 112.215 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.64 174.283 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.1 tp . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -121.39 133.62 55.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.329 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.71 146.88 24.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.756 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CD2' HG21 ' A' ' 143' ' ' VAL . 77.2 m-85 -128.23 -157.95 0.85 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.073 -176.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.667 HG21 ' HB3' ' A' ' 10' ' ' ALA . 22.8 m -83.73 -26.76 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 24.4 tptp 72.51 -53.37 0.7 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.248 0.619 . . . . 0.0 111.479 -174.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.39 -49.34 8.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.857 0.36 . . . . 0.0 111.831 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.667 ' HB3' HG21 ' A' ' 7' ' ' VAL . . . -76.21 -169.18 1.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.45 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.36 -160.02 19.2 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -76.82 127.1 32.12 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -74.64 63.42 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.017 0.913 . . . . 0.0 109.019 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 77' ' ' ILE . 11.8 tp . . . . . 0 N--CA 1.436 -1.153 0 CA-C-N 113.793 -1.548 . . . . 0.0 110.491 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.526 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 20.4 t70 . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 121.065 0.46 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -61.57 -45.12 95.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.973 174.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.71 84.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.603 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 51.6 tttp -60.67 -43.42 97.68 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.48 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 43.5 mmtt -62.66 -38.77 91.64 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.373 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.615 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 73.5 t -66.09 -42.92 92.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.267 176.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -55.44 -51.54 66.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 38.6 mt-10 -56.85 -46.92 81.42 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.255 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -52.59 -48.15 66.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.044 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 88.6 mt -65.81 -41.9 91.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.927 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -69.03 -41.77 77.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.347 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 99.3 mttt -65.17 -42.81 93.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.512 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 p -72.43 -40.64 66.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 111.141 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.01 32.67 2.99 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.234 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.445 HD13 ' HD2' ' A' ' 130' ' ' PRO . 26.2 mm -71.71 126.09 91.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.67 148.35 77.65 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.089 1.86 . . . . 0.0 112.604 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 61.78 16.44 7.9 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.737 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.32 70.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.125 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.49 -23.39 63.62 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.338 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -88.91 -27.92 20.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.322 -171.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 70' ' ' ILE . 24.4 m -88.01 164.11 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.222 0.534 . . . . 0.0 111.833 -177.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -128.32 135.06 49.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.973 173.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.79 131.01 60.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.815 0.34 . . . . 0.0 110.287 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -118.75 124.84 48.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.078 0.466 . . . . 0.0 110.539 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.0 mm -105.19 136.75 37.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.782 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.06 54.88 1.56 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.205 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.7 88.57 0.09 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.98 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.4 -34.93 2.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.978 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -84.1 119.95 25.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.983 0.421 . . . . 0.0 110.388 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.61 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -121.6 105.89 10.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.233 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.0 m -93.6 122.01 35.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.204 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.67 130.72 47.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.165 0.507 . . . . 0.0 109.989 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.55 136.78 54.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.135 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.78 168.22 40.77 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.6 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.477 ' HB3' ' HE3' ' A' ' 88' ' ' LYS . 3.5 p30 -157.17 142.57 17.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.991 0.424 . . . . 0.0 110.453 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.56 24.92 64.11 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.091 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.538 HD12 HG11 ' A' ' 87' ' ' VAL . 11.5 mt -99.41 -162.43 0.95 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.339 0.59 . . . . 0.0 109.916 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.2 p -120.73 155.59 33.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.968 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.423 ' NE2' ' HA ' ' A' ' 95' ' ' ALA . 59.8 tt0 -60.77 -35.29 76.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.893 0.378 . . . . 0.0 110.14 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -60.81 -44.27 97.09 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.538 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.55 -41.85 59.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -54.8 -57.07 13.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.753 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 72' ' ' VAL . 5.9 mm-40 -67.11 -15.77 63.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.043 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -75.9 -48.32 21.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.269 0.557 . . . . 0.0 109.524 176.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.568 ' O ' HG12 ' A' ' 74' ' ' VAL . 47.6 mt -65.05 -52.35 54.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.817 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 85' ' ' ASP . 7.6 mp -40.78 -46.49 2.69 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.83 0.706 . . . . 0.0 112.653 175.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.493 HG21 ' HG3' ' A' ' 145' ' ' ARG . 98.9 t -71.81 -48.52 50.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.196 0.522 . . . . 0.0 110.872 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HA ' ' SD ' ' A' ' 131' ' ' MET . . . -60.6 -32.11 71.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.182 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 70' ' ' ILE . 11.9 p -88.59 -28.28 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.276 0.56 . . . . 0.0 110.851 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.503 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -70.37 -35.25 69.02 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.02 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -83.42 58.86 4.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.795 0.331 . . . . 0.0 110.807 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.636 HD12 HD22 ' A' ' 14' ' ' LEU . 41.8 mm -123.78 132.75 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -63.81 95.42 0.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.53 -17.73 3.96 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.9 -173.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.61 HD12 ' HB2' ' A' ' 55' ' ' ALA . 35.3 mm -102.61 127.81 55.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.194 0.521 . . . . 0.0 111.471 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -111.48 -30.89 7.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.562 -174.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 p -150.69 150.6 31.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.313 0.577 . . . . 0.0 111.448 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 85.4 t -124.25 126.52 72.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.878 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -103.24 112.58 25.51 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.412 ' HB2' HD21 ' A' ' 71' ' ' LEU . 6.3 t0 -84.35 110.63 18.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.344 0.592 . . . . 0.0 111.427 -176.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -119.22 33.04 5.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.461 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 62' ' ' LEU . 77.6 t -95.73 123.64 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.22 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -89.71 123.18 33.5 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 174.185 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.4 p -102.82 126.46 49.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.82 0.343 . . . . 0.0 111.259 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.0 -27.81 23.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.424 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.8 p -121.04 129.46 25.28 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.998 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.53 164.5 16.46 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.815 2.343 . . . . 0.0 112.418 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.59 -155.04 0.58 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.7 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.6 m -86.62 122.77 31.0 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.423 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -62.92 142.66 58.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.607 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.9 m -127.57 143.27 51.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.116 0.484 . . . . 0.0 111.803 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.578 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 5.8 tt0 -91.85 153.4 19.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 171.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.455 ' N ' ' HG2' ' A' ' 97' ' ' GLN . 31.1 m-85 -107.17 86.84 2.38 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.028 0.442 . . . . 0.0 110.264 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -84.63 131.77 34.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.707 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.449 ' OG1' HG22 ' A' ' 143' ' ' VAL . 20.0 m -103.31 120.43 40.75 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.973 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 142' ' ' GLN . 0.9 OUTLIER -68.44 129.86 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.433 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 72.3 mmtt -78.62 -64.1 1.25 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.302 -169.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.9 t -159.18 -72.91 0.08 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.674 0.273 . . . . 0.0 110.505 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.35 51.6 4.58 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.539 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.1 m-20 -108.72 111.96 24.01 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.039 -0.58 . . . . 0.0 110.983 -171.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 110' ' ' ILE . 8.1 m -104.03 150.37 24.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 21.3 tp -57.87 -43.1 85.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.623 0.647 . . . . 0.0 110.944 -173.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.2 p -61.03 -39.98 91.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.22 0.533 . . . . 0.0 111.095 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.24 -40.87 74.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.354 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.7 pp -79.02 -23.84 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.2 p -71.22 -39.16 71.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.971 0.415 . . . . 0.0 110.03 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 8.3 tmtm? -64.03 -29.93 71.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 5.6 tp60 -65.16 -52.75 53.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.318 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.441 HG21 HD12 ' A' ' 146' ' ' ILE . 34.7 m -87.78 -44.0 15.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.175 -171.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.425 ' HB3' HD12 ' A' ' 120' ' ' LEU . 64.8 m-85 -89.56 -53.07 4.69 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.891 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.48 -22.86 7.71 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.061 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -116.51 124.33 49.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.356 -0.422 . . . . 0.0 109.903 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.91 -19.28 60.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.555 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -67.68 -11.39 58.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.187 0.517 . . . . 0.0 110.485 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 115' ' ' TYR . 39.1 mt -89.11 14.43 10.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.176 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.435 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 27.9 p90 -64.74 -28.91 69.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.049 0.452 . . . . 0.0 109.814 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.596 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 32.1 p30 -69.46 -29.6 67.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.878 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -58.69 -49.62 76.92 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.51 0.671 . . . . 0.0 110.078 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.78 -39.82 78.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.295 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.443 ' CE2' ' HD2' ' A' ' 129' ' ' LYS . 45.5 t80 -54.58 -55.76 26.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.758 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 35.1 mt-10 -63.51 -40.13 96.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.942 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.504 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -60.06 -28.47 67.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.115 -177.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.467 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 47.1 m-80 -99.93 0.01 40.36 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 120.619 0.247 . . . . 0.0 110.871 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.547 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 25.8 mtpp -79.36 150.75 74.27 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-O 120.644 0.259 . . . . 0.0 110.779 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.445 ' HD2' HD13 ' A' ' 40' ' ' ILE . 9.5 Cg_endo -90.5 25.1 21.4 Favored 'Cis proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.662 -1.391 . . . . 0.0 112.843 -0.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.467 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 1.0 OUTLIER -74.95 -34.7 62.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.372 . . . . 0.0 110.276 176.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.486 HD21 HE21 ' A' ' 142' ' ' GLN . 0.1 OUTLIER -93.03 117.76 30.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.98 -43.37 24.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.892 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.3 m -151.45 149.85 25.34 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.255 0.55 . . . . 0.0 110.762 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.97 -18.08 61.19 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 123.713 2.942 . . . . 0.0 112.875 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.12 -16.31 22.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.498 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -78.62 -1.2 33.05 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.8 pt -65.7 168.14 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.912 0.387 . . . . 0.0 110.063 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -163.9 154.96 13.86 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.343 -172.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -45.2 113.31 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.164 2.576 . . . . 0.0 112.662 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.29 34.65 5.77 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.339 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.572 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.2 tp60 -107.08 116.6 32.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.835 0.318 . . . . 0.0 110.164 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.526 HG21 ' CD2' ' A' ' 6' ' ' PHE . 46.7 t -80.5 132.08 32.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.066 0.46 . . . . 0.0 110.004 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -125.63 134.42 51.9 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.073 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.504 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 47.2 mtp180 -62.68 118.76 8.09 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.064 171.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 39.7 mm -106.24 93.27 7.79 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 173.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 38.5 Cg_exo -59.85 139.14 86.78 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.222 1.948 . . . . 0.0 111.184 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 C--N 1.32 -0.678 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.014 176.171 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 121.268 0.556 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -93.6 138.81 31.47 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.26 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.57 138.31 35.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.018 0.437 . . . . 0.0 111.01 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.414 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 59.5 m-85 -127.25 -179.12 4.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.496 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.95 HG21 ' HB3' ' A' ' 10' ' ' ALA . 23.7 m -81.26 -9.94 12.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -171.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.644 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 53.4 tptt 74.35 -54.95 0.67 Allowed 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.528 0.518 . . . . 0.0 112.141 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.62 -46.53 15.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.097 0.475 . . . . 0.0 111.963 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.95 ' HB3' HG21 ' A' ' 7' ' ' VAL . . . -81.29 126.93 32.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.183 -173.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.96 -173.1 36.59 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.371 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.04 129.59 41.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.35 54.98 1.8 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.992 0.901 . . . . 0.0 108.88 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 30' ' ' LYS . 14.7 tp . . . . . 0 C--N 1.315 -0.896 0 CA-C-N 113.8 -1.545 . . . . 0.0 111.312 -172.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 19.0 t70 . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 31' ' ' VAL . 51.5 mt-30 -59.92 -48.35 82.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.375 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.43 -34.7 72.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.765 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 38.6 ttpt -68.11 -39.99 82.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.985 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 74.6 mmtt -56.96 -44.96 83.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.063 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.611 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 47.5 t -59.96 -45.16 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.49 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -55.56 -47.64 76.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.868 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 38.2 mt-10 -58.91 -48.88 79.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.359 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -53.04 -39.37 63.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.456 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 85.7 mt -70.76 -40.91 72.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.013 0.435 . . . . 0.0 111.201 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -78.07 -31.01 50.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.175 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -67.92 -38.2 82.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.943 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 p -75.66 -36.42 60.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 110.789 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.92 35.29 4.32 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.167 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.8 mm -77.11 124.69 87.26 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.69 146.46 66.87 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.229 1.953 . . . . 0.0 112.396 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 64.34 -0.9 0.81 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.907 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 35' ' ' LEU . . . -80.77 -9.89 59.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.341 0.591 . . . . 0.0 110.432 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -87.7 -9.53 53.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.276 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -91.72 -35.54 14.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.089 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.8 m -69.68 166.12 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.373 -175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -130.23 128.99 42.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.802 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 48' ' ' ILE . 3.6 mp -103.87 140.91 20.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.8 0.333 . . . . 0.0 110.869 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 38.5 tt0 -123.14 135.78 54.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 173.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.3 mm -104.35 111.72 35.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.079 0.466 . . . . 0.0 110.306 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.25 93.89 4.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.473 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.6 t70 64.18 -83.62 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.368 -171.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.77 13.96 4.73 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.656 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 38.0 mtmm -95.82 117.23 30.16 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.662 0.267 . . . . 0.0 110.475 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -92.1 80.59 5.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.823 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 89.3 m -66.68 119.65 12.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.959 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 57' ' ' VAL . 7.3 p -106.89 109.97 30.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.441 0.638 . . . . 0.0 111.193 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.9 OUTLIER -100.68 154.41 18.62 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.028 178.44 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.93 160.23 17.72 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -151.75 146.08 25.47 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.241 0.543 . . . . 0.0 110.721 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.94 31.13 58.34 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.529 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.45 HD12 ' CG1' ' A' ' 87' ' ' VAL . 18.3 mt -98.83 -169.99 1.86 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.837 0.827 . . . . 0.0 110.851 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 m -108.96 128.78 55.24 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.718 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.51 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 9.4 tt0 -61.49 -31.51 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.946 -172.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HG3' ' NH2' ' A' ' 145' ' ' ARG . 42.2 tt0 -65.63 -39.53 91.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.069 0.461 . . . . 0.0 110.151 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.549 ' O ' HG13 ' A' ' 70' ' ' ILE . . . -72.92 -39.34 66.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.918 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.638 ' HA ' HD12 ' A' ' 70' ' ' ILE . 73.3 tttt -52.12 -53.68 39.77 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.593 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 72' ' ' VAL . 7.7 mm-40 -52.95 -35.25 58.51 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 28.7 ttpt -79.25 -32.55 43.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.505 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 67' ' ' LYS . 45.3 mt -61.89 -52.17 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 67' ' ' LYS . 9.8 mp -45.01 -43.84 9.53 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.646 173.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 68' ' ' GLU . 66.5 t -67.3 -51.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.465 0.65 . . . . 0.0 110.885 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.89 79.95 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.6 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.41 HG23 HG21 ' A' ' 83' ' ' VAL . 22.5 m -80.63 -25.94 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.029 0.442 . . . . 0.0 111.087 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -77.86 -28.87 55.95 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.832 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -83.39 42.61 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 111.404 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.2 mt -114.53 138.26 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-O 121.14 0.495 . . . . 0.0 110.488 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 t -71.49 111.91 7.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.182 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.09 -14.61 8.35 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -172.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.6 mm -98.74 121.83 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 110.902 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.644 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -104.14 -20.51 13.79 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.73 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.656 ' OG ' ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -158.83 153.85 25.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.465 -177.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 55' ' ' ALA . 68.1 t -127.84 124.27 62.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.789 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.8 105.85 18.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.494 ' OD1' ' HE3' ' A' ' 67' ' ' LYS . 3.3 t70 -72.84 116.54 13.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.224 0.535 . . . . 0.0 111.54 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 75.9 mt-30 -121.32 25.74 9.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.119 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.45 ' CG1' HD12 ' A' ' 62' ' ' LEU . 88.0 t -89.55 125.57 42.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.655 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -95.53 142.89 27.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.269 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.0 p -115.72 143.55 45.21 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.942 0.401 . . . . 0.0 111.548 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.91 -8.34 31.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.581 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.5 p -135.32 133.68 20.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.234 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.35 69.15 6.64 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.97 2.446 . . . . 0.0 111.283 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.44 -168.06 1.85 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.731 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.0 m -56.51 129.38 40.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.35 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.16 138.95 31.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.6 m -126.5 157.3 39.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.369 0.605 . . . . 0.0 112.02 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.9 tt0 -96.38 149.15 22.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.577 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -109.78 93.99 4.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.942 0.401 . . . . 0.0 110.603 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -98.2 139.18 34.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.272 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.6 m -104.54 123.44 47.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.345 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.9 m -70.92 134.87 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.4 mmtp -98.92 -165.61 1.26 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.481 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.427 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 13.9 m -65.1 122.87 18.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.633 0.254 . . . . 0.0 110.481 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.09 8.85 83.3 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.312 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.589 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 13.1 m-20 -88.31 105.18 17.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.367 0.603 . . . . 0.0 111.009 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 110' ' ' ILE . 5.8 m -102.69 161.09 14.01 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.488 ' N ' HD11 ' A' ' 138' ' ' ILE . 19.7 tp -56.39 -41.66 76.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.412 0.551 . . . . 0.0 111.699 -170.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.496 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 9.8 m -63.14 -41.57 99.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.955 0.407 . . . . 0.0 110.571 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.88 81.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.004 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.625 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -75.11 -24.52 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 120.917 0.389 . . . . 0.0 110.481 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.7 t -67.44 -44.14 79.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 170.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.79 -24.27 66.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.431 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 28.5 tp60 -71.87 -59.87 2.53 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.924 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.8 m -82.83 -35.82 12.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.236 -170.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.507 ' HB3' HD12 ' A' ' 120' ' ' LEU . 19.0 m-30 -103.68 -23.89 13.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.05 -175.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.44 -6.31 82.34 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.909 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.472 HD21 ' HB3' ' A' ' 119' ' ' ASN . 41.0 t30 -133.94 124.0 25.62 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -76.18 -15.2 60.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.712 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 117' ' ' ASN . 22.9 t-20 -68.68 -23.43 64.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.139 0.495 . . . . 0.0 110.596 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 115' ' ' TYR . 67.1 mt -85.06 14.22 5.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.572 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.46 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 24.2 p90 -62.3 -31.61 72.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.189 0.519 . . . . 0.0 110.257 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.582 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 26.3 p-10 -68.89 -29.64 67.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.507 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -58.17 -47.47 83.29 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.543 0.687 . . . . 0.0 109.772 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.9 mt -71.8 -41.02 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.304 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.465 ' HB2' HD21 ' A' ' 107' ' ' LEU . 83.5 t80 -53.72 -51.76 62.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 40.2 mt-10 -62.74 -23.22 67.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.941 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.558 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -86.87 -31.87 20.53 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.632 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.574 ' O ' ' HB3' ' A' ' 131' ' ' MET . 10.5 m120 -76.67 -42.07 43.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 58.5 pttt -64.47 153.72 85.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.949 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.1 Cg_endo -86.27 21.55 22.36 Favored 'Cis proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.225 -1.573 . . . . 0.0 112.892 0.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.574 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.2 tmm? -73.23 -26.73 61.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.465 HD12 ' H ' ' A' ' 133' ' ' LYS . 18.8 tp -111.72 133.75 53.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.078 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.465 ' H ' HD12 ' A' ' 132' ' ' LEU . 29.7 mtpp -81.67 -45.18 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.063 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.499 ' OG ' ' HG2' ' A' ' 137' ' ' LYS . 79.0 p -154.02 160.94 30.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.79 -17.75 52.05 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.528 2.819 . . . . 0.0 111.929 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -100.43 -12.98 18.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.511 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HG2' ' OG ' ' A' ' 134' ' ' SER . 56.4 mmtt -81.49 -8.03 59.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.655 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 9.3 pt -68.43 168.9 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.098 0.475 . . . . 0.0 110.978 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.492 ' CE1' ' HG3' ' A' ' 142' ' ' GLN . 15.4 p90 -155.98 147.79 17.18 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.177 -174.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.427 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 88.7 Cg_exo -48.48 103.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.597 2.865 . . . . 0.0 113.037 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.406 ' HA2' HG11 ' A' ' 7' ' ' VAL . . . 124.19 8.81 5.86 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.601 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.655 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 1.7 mt-30 -94.37 121.97 36.45 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 117.341 0.571 . . . . 0.0 111.224 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 41.9 t -80.61 135.31 25.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.303 172.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.2 mt -126.36 145.31 50.5 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.063 0.459 . . . . 0.0 110.748 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HB2' HG21 ' A' ' 72' ' ' VAL . 28.5 ttt180 -72.48 110.37 6.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.906 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 41.5 mm -94.7 112.38 57.72 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.558 ' HG3' ' HB2' ' A' ' 127' ' ' ALA . 32.4 Cg_exo -59.69 166.68 7.81 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.985 2.457 . . . . 0.0 113.109 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.922 176.942 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.51 HD13 ' N ' ' A' ' 4' ' ' PHE . 1.7 tm? . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.291 0.567 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.51 ' N ' HD13 ' A' ' 3' ' ' LEU . 86.5 m-85 -125.52 132.22 52.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.194 175.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -97.61 140.9 31.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.006 0.431 . . . . 0.0 110.997 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -127.75 -164.4 1.36 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.151 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.3 -10.81 8.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.794 0.331 . . . . 0.0 111.128 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 84.8 tttt 72.67 -67.19 0.27 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 176.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.31 -24.78 63.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.289 0.566 . . . . 0.0 110.504 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.26 119.98 31.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.711 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.01 -173.55 41.58 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.842 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -77.31 136.18 38.46 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 19.3 mtpt -77.97 86.05 4.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.45 0.643 . . . . 0.0 111.781 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 77' ' ' ILE . 8.9 mp . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.005 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 121.138 0.494 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -66.56 -33.78 76.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.154 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.23 72.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.763 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 17.4 tppt? -65.18 -43.29 92.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.589 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -66.87 -32.06 73.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.046 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.612 HG11 HG23 ' A' ' 74' ' ' VAL . 75.3 t -63.59 -46.18 95.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.311 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -57.85 -41.42 82.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.516 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 54.6 mt-10 -56.95 -48.47 78.26 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.765 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.499 ' HB2' HD11 ' A' ' 14' ' ' LEU . 57.7 t60 -57.97 -37.02 73.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.428 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 64.4 mt -73.18 -40.65 64.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.008 0.433 . . . . 0.0 110.429 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -65.05 -48.0 75.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.419 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -58.03 -49.88 75.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.754 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.405 ' OG1' HG12 ' A' ' 40' ' ' ILE . 16.7 p -68.28 -44.38 75.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.37 35.49 3.85 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.792 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.405 HG12 ' OG1' ' A' ' 38' ' ' THR . 35.6 mm -66.67 124.04 87.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -66.38 138.65 51.48 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.989 1.793 . . . . 0.0 112.333 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 63.33 9.33 3.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.351 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -75.94 -14.38 60.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.27 0.557 . . . . 0.0 110.367 177.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -81.36 -16.32 52.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.13 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -75.19 -44.1 48.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.614 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.5 m -77.34 163.63 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.595 -172.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -118.8 139.28 51.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.877 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.9 mm -102.39 139.78 22.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.026 0.441 . . . . 0.0 111.316 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 49.9 tt0 -138.97 128.7 24.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.327 172.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mm -108.91 116.57 52.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.672 0.272 . . . . 0.0 110.912 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.48 100.06 7.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.832 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 t70 66.11 -80.96 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.8 0.688 . . . . 0.0 110.757 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.06 18.51 2.53 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 82' ' ' SER . 38.9 ttmt -107.78 114.74 28.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.294 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.68 111.87 23.62 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.155 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 18.5 m -86.65 130.64 34.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.917 177.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 57' ' ' VAL . 5.3 p -114.74 106.93 21.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.337 0.589 . . . . 0.0 110.897 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 m -104.55 155.88 18.44 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.996 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.22 179.72 39.25 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.325 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.13 150.52 13.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 0.0 110.6 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.54 23.97 48.46 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.504 -0.771 . . . . 0.0 113.163 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.46 175.35 5.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.76 0.314 . . . . 0.0 110.667 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 91' ' ' THR . 14.3 m -104.75 157.95 16.85 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 7.8 tp60 -53.85 -41.91 67.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.891 0.377 . . . . 0.0 110.227 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.689 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 61.1 mm-40 -49.84 -62.39 1.59 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.061 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.02 -37.69 84.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.685 0.279 . . . . 0.0 110.966 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -55.55 -51.77 65.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.625 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.558 ' O ' HG23 ' A' ' 72' ' ' VAL . 56.1 mt-10 -65.09 -33.56 76.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.106 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 29.8 mtpp -60.01 -42.73 94.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.867 0.365 . . . . 0.0 110.095 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.512 ' O ' HG12 ' A' ' 74' ' ' VAL . 52.6 mt -62.45 -57.38 12.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.322 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mp -41.9 -43.25 3.0 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.828 0.705 . . . . 0.0 112.406 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 68' ' ' GLU . 86.2 t -69.08 -53.19 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.33 0.586 . . . . 0.0 111.017 177.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.419 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -64.07 -31.09 72.16 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.588 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.612 HG23 HG11 ' A' ' 31' ' ' VAL . 11.7 p -84.62 -23.35 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.492 0.663 . . . . 0.0 110.532 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.23 -35.37 34.1 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.196 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -82.07 60.29 4.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.64 0.257 . . . . 0.0 111.145 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.625 HD12 HD22 ' A' ' 14' ' ' LEU . 32.7 mm -118.13 142.24 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.495 ' OG ' ' HA ' ' A' ' 13' ' ' LYS . 72.3 p -65.91 91.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.966 0.412 . . . . 0.0 110.492 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.98 -17.72 5.67 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.914 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 28.1 mm -86.51 113.06 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.667 0.746 . . . . 0.0 110.868 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.99 -24.61 15.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.03 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 5.4 p -150.05 156.83 42.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.293 0.568 . . . . 0.0 111.514 -178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.412 HG21 HG13 ' A' ' 74' ' ' VAL . 61.7 t -132.5 130.23 59.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.737 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -104.95 106.71 17.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -72.65 117.27 14.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.539 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -133.92 28.39 3.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.138 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.25 116.29 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.617 0.723 . . . . 0.0 110.712 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -82.37 144.46 30.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.766 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.9 p -112.17 127.43 55.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.19 0.519 . . . . 0.0 111.222 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.57 -27.75 23.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.23 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 16.3 p -119.93 132.24 24.13 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.332 176.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 50.4 Cg_endo -91.3 168.09 3.46 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.793 2.329 . . . . 0.0 113.205 -175.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -158.51 -156.63 0.56 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.554 174.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.11 154.5 19.32 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.21 129.09 35.85 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.6 m -97.39 156.48 16.44 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.281 0.563 . . . . 0.0 111.006 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.427 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 31.6 tt0 -87.87 142.19 28.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.323 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -106.76 90.55 3.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.442 . . . . 0.0 110.235 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 90.5 t80 -90.89 146.48 23.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.96 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.478 ' OG1' HG22 ' A' ' 143' ' ' VAL . 5.9 m -117.96 123.01 44.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.042 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.623 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.5 m -67.85 128.85 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -106.87 115.7 30.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.5 t 55.58 -90.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.822 173.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.5 19.32 53.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.427 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.578 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 2.2 m-20 -66.93 134.58 52.29 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.49 0.662 . . . . 0.0 111.253 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.629 ' O ' HG23 ' A' ' 110' ' ' ILE . 36.0 p -119.4 156.44 30.12 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.284 175.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 110' ' ' ILE . 20.9 tp -56.38 -40.86 75.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 118.185 0.448 . . . . 0.0 111.132 -171.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 4.6 m -63.77 -40.25 96.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.155 0.502 . . . . 0.0 110.378 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -73.83 -27.52 61.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.73 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 106' ' ' THR . 1.4 pp -85.34 -24.28 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.809 0.338 . . . . 0.0 110.958 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.494 ' HB3' HD12 ' A' ' 124' ' ' ILE . 11.3 p -76.3 -29.67 57.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 170.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 52.5 tptt -60.43 -26.33 66.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.842 170.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 16.2 mm-40 -75.69 -72.42 0.31 Allowed 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 122.282 1.039 . . . . 0.0 110.715 175.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.479 HG23 ' CD2' ' A' ' 115' ' ' TYR . 28.8 m -70.41 -40.1 77.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 113.251 -1.795 . . . . 0.0 112.659 -167.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.489 ' HB3' HD12 ' A' ' 120' ' ' LEU . 56.5 m-85 -96.97 -20.11 18.32 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.602 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 80.89 5.5 90.05 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.544 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.484 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 35.8 t30 -140.81 116.05 9.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.806 0.336 . . . . 0.0 110.318 -176.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.43 ' O ' ' HD2' ' A' ' 121' ' ' TYR . . . -70.31 -11.11 60.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.553 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -81.76 -10.96 59.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.489 HD12 ' HB3' ' A' ' 115' ' ' TYR . 74.8 mt -96.11 22.68 7.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.76 -178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.452 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 50.8 p90 -68.35 -29.13 67.79 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.041 -175.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.411 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 9.0 t30 -69.93 -30.51 67.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.084 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -53.83 -47.76 70.6 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.808 0.813 . . . . 0.0 109.484 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.548 HG22 ' OD1' ' A' ' 128' ' ' ASN . 55.7 mt -68.49 -46.71 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.491 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -53.96 -46.64 71.69 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.103 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.434 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 15.0 mt-10 -69.63 -24.67 63.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.96 0.41 . . . . 0.0 111.598 -176.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.49 29.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.951 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.548 ' OD1' HG22 ' A' ' 124' ' ' ILE . 8.3 m120 -74.82 -46.84 33.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.925 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 62.3 pttt -58.5 154.06 36.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.84 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.463 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.9 Cg_endo -80.86 15.18 20.15 Favored 'Cis proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.241 -1.566 . . . . 0.0 113.674 0.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.477 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.6 tmm? -70.03 -36.86 75.37 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.7 tp -94.45 115.88 28.14 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -73.81 -42.6 60.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.316 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 52.8 m -157.89 154.03 23.71 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 134' ' ' SER . 33.2 Cg_exo -61.72 -23.19 75.92 Favored 'Trans proline' 0 C--O 1.23 0.077 0 C-N-CA 123.76 2.974 . . . . 0.0 112.975 -173.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -105.38 7.16 33.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 110.689 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.416 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 30.9 mmtp -100.82 14.79 30.57 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.458 0.647 . . . . 0.0 110.692 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 106' ' ' THR . 17.6 pt -67.54 171.61 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.605 172.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 12.0 p90 -153.81 143.77 15.41 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.705 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 139' ' ' TYR . 58.0 Cg_exo -51.64 115.49 2.14 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.285 2.657 . . . . 0.0 112.898 -178.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.01 26.0 7.68 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.357 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.623 ' H ' HG22 ' A' ' 101' ' ' VAL . 65.4 tt0 -100.21 121.62 41.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.871 0.367 . . . . 0.0 110.782 -175.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.478 HG22 ' OG1' ' A' ' 100' ' ' THR . 55.4 t -82.12 138.4 19.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.691 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.0 mt -132.52 146.38 51.88 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.441 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.689 ' NH2' ' HA ' ' A' ' 65' ' ' GLU . 32.7 ttt180 -75.65 113.4 13.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.746 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 36.4 mm -99.93 103.09 20.0 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.106 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 27.2 Cg_exo -61.96 160.55 29.22 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.33 2.02 . . . . 0.0 111.805 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.955 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.0 tp . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 120.913 0.387 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 82' ' ' SER . 81.3 m-85 -120.85 133.63 55.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.902 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -102.64 151.08 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.971 0.415 . . . . 0.0 110.813 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.747 ' HE1' HG12 ' A' ' 83' ' ' VAL . 90.8 m-85 -131.68 -179.88 5.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.945 -175.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.23 -17.81 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.867 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 81.2 tttt 72.93 -69.46 0.19 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.403 0.681 . . . . 0.0 111.7 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.26 -25.11 65.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.823 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.76 124.57 42.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.714 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.39 -163.26 36.78 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.71 134.4 38.11 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -78.06 90.49 4.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.327 0.584 . . . . 0.0 111.359 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.406 HD22 HD13 ' A' ' 77' ' ' ILE . 8.0 mp . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.59 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 18.9 t70 . . . . . 0 CA--C 1.523 -0.077 0 CA-C-O 121.277 0.56 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.434 ' HB2' HG13 ' A' ' 50' ' ' ILE . 60.0 mt-30 -69.09 -31.33 69.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.787 176.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 50' ' ' ILE . . . -62.89 -27.45 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.232 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.589 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 60.5 tttp -65.19 -42.76 93.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -64.04 -37.99 89.43 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.176 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.565 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 62.1 t -59.15 -51.68 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.893 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -54.58 -43.43 72.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.445 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 43.3 mt-10 -57.36 -56.74 17.93 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.105 0.478 . . . . 0.0 110.034 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -51.74 -42.76 62.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.283 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 99.2 mt -68.04 -42.76 80.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.645 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.51 -26.81 51.46 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.124 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -74.13 -32.43 63.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.688 0.28 . . . . 0.0 111.346 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.416 ' OG1' HG12 ' A' ' 40' ' ' ILE . 2.1 p -80.4 -30.64 37.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.905 0.383 . . . . 0.0 110.984 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.28 27.51 8.66 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.843 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.548 HD13 ' HD2' ' A' ' 130' ' ' PRO . 43.8 mm -58.41 129.75 84.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 122.402 0.281 . . . . 0.0 110.582 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -66.56 134.62 36.15 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.047 1.831 . . . . 0.0 111.981 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.484 ' HB3' HD22 ' A' ' 62' ' ' LEU . 7.5 m-20 62.96 21.69 13.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.804 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.493 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -70.34 -20.53 62.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.089 0.471 . . . . 0.0 111.093 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -91.54 -9.59 43.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.322 0.582 . . . . 0.0 109.991 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.77 -14.31 30.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.203 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.569 HG11 HD13 ' A' ' 70' ' ' ILE . 18.4 m -97.87 177.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -142.09 133.16 26.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.063 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.04 132.98 58.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.003 0.43 . . . . 0.0 110.751 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.424 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 95.3 mt-30 -115.71 147.9 40.36 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.46 HG22 ' H ' ' A' ' 52' ' ' ASP . 23.0 mm -120.48 128.86 76.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.19 35.24 4.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.194 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.46 ' H ' HG22 ' A' ' 50' ' ' ILE . 25.8 t70 66.88 98.26 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.671 0.607 . . . . 0.0 110.992 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 75.49 7.26 82.67 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.835 -176.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -146.5 138.69 24.95 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -120.11 148.26 43.84 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.693 175.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 61.2 m -117.65 119.79 36.05 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.1 t -99.54 111.76 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.459 0.647 . . . . 0.0 110.522 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -113.12 160.5 18.14 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.977 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.78 161.93 15.93 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -139.87 150.66 44.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.127 0.464 . . . . 0.0 111.008 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.92 35.45 84.57 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.93 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 42' ' ' ASP . 15.2 mt -107.67 -166.25 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.677 0.751 . . . . 0.0 111.305 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 79.5 p -141.59 159.06 43.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.2 -1.363 . . . . 0.0 107.862 174.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 58.3 mt-30 -68.26 -18.92 64.67 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.413 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.42 -44.9 96.33 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.86 -38.33 15.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.964 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -58.76 -41.26 86.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 -178.592 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.16 35.04 0.63 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.319 1.057 . . . . 0.0 110.304 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -123.75 -50.06 1.85 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.597 -1.638 . . . . 0.0 107.152 167.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.569 HD13 HG11 ' A' ' 46' ' ' VAL . 16.5 mt -61.99 -51.94 66.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.775 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp -67.43 -19.26 65.35 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.829 0.824 . . . . 0.0 110.419 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.4 t -86.14 -56.25 5.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.15 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.67 -23.23 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.151 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.412 HG23 HG11 ' A' ' 31' ' ' VAL . 14.5 p -76.28 -39.13 34.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.866 0.365 . . . . 0.0 110.662 176.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.639 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -71.24 -27.89 70.98 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.865 175.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -83.06 44.69 0.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 111.064 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.406 HD13 HD22 ' A' ' 14' ' ' LEU . 96.4 mt -119.71 141.28 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.424 174.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.3 m -68.27 103.19 1.53 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.548 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 130.62 -20.14 4.94 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.458 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.656 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 50.1 mm -94.73 116.85 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.439 . . . . 0.0 110.93 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 8' ' ' LYS . . . -107.78 -10.11 15.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.249 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 5.4 p -162.32 156.93 22.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.983 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.747 HG12 ' HE1' ' A' ' 6' ' ' PHE . 11.5 p -140.93 136.58 34.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.586 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.82 114.46 28.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.542 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.7 112.39 18.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.088 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -129.64 35.91 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.385 0.612 . . . . 0.0 110.503 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.481 HG11 HD12 ' A' ' 62' ' ' LEU . 93.4 t -89.09 131.98 35.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.392 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -94.99 97.6 10.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.748 175.011 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.7 p -81.74 121.52 26.5 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.88 -32.69 20.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.57 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 63' ' ' SER . 17.5 p -106.67 130.22 23.25 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.593 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.21 148.81 34.99 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.93 2.42 . . . . 0.0 112.795 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 64' ' ' GLN . . . -157.12 166.75 32.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.818 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.0 m -74.76 127.24 32.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.871 0.367 . . . . 0.0 110.943 -177.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.75 136.04 40.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.902 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.9 m -112.96 172.84 6.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.195 0.521 . . . . 0.0 111.694 -174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.0 tt0 -96.79 143.25 27.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.232 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -103.6 87.53 2.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.154 0.502 . . . . 0.0 110.456 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -88.11 136.71 32.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.115 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.437 ' OG1' HG22 ' A' ' 143' ' ' VAL . 6.6 m -105.7 123.64 48.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.338 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.559 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.2 m -72.16 135.06 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.277 0.561 . . . . 0.0 109.633 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.492 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 75.2 mmtt -86.92 -165.29 1.25 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.154 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.3 m -55.45 -55.21 34.37 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.862 -173.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.13 26.53 20.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.818 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 7.9 m-20 -82.11 111.51 18.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.149 0.499 . . . . 0.0 111.111 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.604 ' HA ' HD11 ' A' ' 138' ' ' ILE . 22.7 p -101.06 164.42 11.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.217 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 125' ' ' PHE . 18.2 tp -63.37 -36.49 83.88 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.165 -174.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -67.16 -35.83 80.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.958 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.85 -41.73 67.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.037 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -78.34 -24.3 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.622 -176.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 p -73.28 -40.63 64.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -61.86 -21.92 65.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.292 0.568 . . . . 0.0 110.145 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.637 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.1 tp-100 -75.44 -63.86 1.19 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.8 176.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -76.76 -43.0 33.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.192 -170.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.482 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 19.7 m-85 -92.96 -32.36 14.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.933 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.1 -4.62 58.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.192 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.522 ' OD1' ' HG ' ' A' ' 120' ' ' LEU . 24.1 t-20 -126.59 121.99 33.78 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.494 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -77.12 -18.42 57.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -78.67 -14.45 59.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.146 0.498 . . . . 0.0 110.339 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.522 ' HG ' ' OD1' ' A' ' 117' ' ' ASN . 78.4 mt -84.62 14.99 4.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.582 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.494 ' HD1' ' O ' ' A' ' 118' ' ' ALA . 38.8 p90 -63.08 -30.69 71.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.864 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.52 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 15.9 m120 -64.9 -32.76 74.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -61.12 -48.4 81.84 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.391 0.615 . . . . 0.0 110.187 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.06 -36.28 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.368 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.481 ' HB2' HD21 ' A' ' 107' ' ' LEU . 83.3 t80 -56.23 -53.82 52.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.406 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 26.6 mt-10 -70.72 -17.03 62.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.281 -175.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -84.86 -10.0 57.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.032 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -115.1 25.65 10.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.203 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 11.1 mmmm -86.31 150.21 51.31 Favored Pre-proline 0 C--N 1.326 -0.424 0 O-C-N 122.158 -0.339 . . . . 0.0 110.402 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.548 ' HD2' HD13 ' A' ' 40' ' ' ILE . 10.0 Cg_endo -95.87 15.99 37.75 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.441 -1.066 . . . . 0.0 111.969 -6.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -14.71 62.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.222 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.424 HD21 HE21 ' A' ' 142' ' ' GLN . 0.9 OUTLIER -107.67 124.21 49.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 168.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -99.43 -42.09 7.11 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.757 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.453 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 14.7 m -149.56 147.96 24.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.19 0.519 . . . . 0.0 109.786 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.63 -19.91 65.08 Favored 'Trans proline' 0 C--N 1.336 -0.129 0 C-N-CA 123.714 2.943 . . . . 0.0 112.851 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -96.88 -8.24 31.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.371 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.453 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 36.7 mmtm -91.44 9.13 33.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.604 HD11 ' HA ' ' A' ' 106' ' ' THR . 10.3 pt -69.51 174.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.016 169.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -162.2 148.12 10.49 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.69 116.92 2.36 Favored 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.226 2.617 . . . . 0.0 112.136 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.99 14.32 23.11 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.1 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.559 ' H ' HG22 ' A' ' 101' ' ' VAL . 1.7 mm100 -86.5 108.71 18.66 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.16 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.437 HG22 ' OG1' ' A' ' 100' ' ' THR . 41.7 t -79.8 125.06 38.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 172.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.2 mt -118.96 140.17 50.45 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.81 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.534 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 35.6 ttt180 -74.74 111.54 10.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.544 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 33.3 mm -97.67 102.93 14.47 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.006 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 25.5 Cg_exo -63.13 145.76 93.9 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.55 2.167 . . . . 0.0 111.67 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.492 177.171 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 83' ' ' VAL . 19.4 tp . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 121.491 0.662 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -93.88 140.71 29.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.039 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -92.19 124.89 36.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.846 0.355 . . . . 0.0 110.81 -176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.628 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 57.1 m-85 -110.41 -164.16 0.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.784 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.857 HG11 ' HB3' ' A' ' 10' ' ' ALA . 7.3 p -82.8 -28.26 8.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -173.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.796 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 22.2 tptm 76.44 -60.4 0.48 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.218 0.607 . . . . 0.0 111.33 -175.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.26 -42.62 36.38 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.857 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -84.22 179.05 7.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.034 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.2 -168.89 12.69 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.553 ' HG2' HD13 ' A' ' 14' ' ' LEU . 4.8 tp10 -60.19 122.87 15.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -77.68 64.75 3.03 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.257 1.027 . . . . 0.0 109.216 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.553 HD13 ' HG2' ' A' ' 12' ' ' GLU . 11.7 tp . . . . . 0 N--CA 1.438 -1.066 0 CA-C-N 113.571 -1.65 . . . . 0.0 110.383 -174.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' VAL . 82.9 mt-30 -57.89 -45.49 86.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.379 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.78 78.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.115 0.483 . . . . 0.0 110.734 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -70.93 -45.21 64.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.562 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' C ' HD21 ' A' ' 14' ' ' LEU . 30.1 mmtp -58.77 -39.38 80.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.397 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 98.1 t -64.81 -36.28 77.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.735 0.302 . . . . 0.0 110.372 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.425 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 25.6 mm-40 -64.4 -46.98 80.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.906 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.71 -38.71 78.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.246 0.546 . . . . 0.0 109.922 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -60.32 -40.47 90.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.381 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 95.9 mt -71.13 -38.79 72.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.244 0.545 . . . . 0.0 110.888 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -76.72 -32.41 57.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.487 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -75.33 -23.82 57.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.082 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -83.77 -32.72 25.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.288 0.566 . . . . 0.0 110.541 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.07 35.69 4.71 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.753 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.5 mm -74.75 126.19 88.74 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -71.59 144.89 45.7 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.079 1.853 . . . . 0.0 112.596 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 59.37 23.84 12.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.418 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.89 -42.6 73.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 -177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.64 -0.52 34.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.924 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -88.92 -11.23 45.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.014 0.435 . . . . 0.0 110.242 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.26 157.26 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.288 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -106.44 130.33 54.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.854 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.437 HG21 ' HB ' ' A' ' 31' ' ' VAL . 34.4 mm -90.54 135.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.337 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 98.2 mt-30 -132.86 140.34 47.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.956 175.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mm -118.35 120.65 65.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.48 60.46 1.01 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.068 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 53.68 76.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.039 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 86.59 20.72 53.55 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.641 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 82' ' ' SER . 3.1 ttmp? -146.69 124.21 11.73 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 122.682 -0.305 . . . . 0.0 110.479 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 83' ' ' VAL . . . -104.79 91.53 3.88 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.783 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.545 HG23 ' HB3' ' A' ' 84' ' ' ASP . 58.7 m -80.41 109.42 14.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.151 0.501 . . . . 0.0 109.899 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 12.2 p -93.83 136.87 24.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.124 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 86' ' ' GLN . 1.4 m -132.01 157.17 44.82 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.0 171.62 29.48 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -155.15 144.52 21.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.873 0.368 . . . . 0.0 110.803 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.25 18.19 31.97 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.165 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.36 178.24 4.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.993 0.425 . . . . 0.0 111.265 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -111.68 170.28 8.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.959 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 47.8 tp60 -57.47 -53.57 56.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' HG3' ' NH1' ' A' ' 145' ' ' ARG . 39.5 tt0 -57.33 -49.37 76.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.175 -174.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.01 -49.12 77.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.688 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.508 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 41.6 tttp -45.94 -52.81 10.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.45 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 72' ' ' VAL . 53.7 mt-10 -74.79 -28.55 60.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.937 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 65' ' ' GLU . 13.4 tptm -63.32 -42.74 99.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.407 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.06 -49.65 80.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 77.3 mt -48.41 -47.42 37.84 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.164 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 68' ' ' GLU . 39.7 t -66.2 -52.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.308 0.575 . . . . 0.0 111.1 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.31 -30.35 70.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.565 -172.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -83.43 -23.15 8.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.061 0.457 . . . . 0.0 111.234 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.628 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -78.01 -33.06 42.28 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.821 176.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -80.15 61.28 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.716 0.293 . . . . 0.0 110.812 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.571 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 23.3 mm -122.51 132.71 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 t -65.22 101.81 0.59 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 173.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.427 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 126.8 -17.37 6.4 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.645 -172.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.571 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 39.2 mm -102.14 121.11 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.292 0.568 . . . . 0.0 110.822 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.796 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -98.86 -33.97 10.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.704 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 25.4 m -147.24 160.34 42.6 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.49 HG22 ' HB3' ' A' ' 55' ' ' ALA . 55.7 t -132.34 121.72 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.671 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.545 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.5 t70 -97.58 106.53 18.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.267 0.556 . . . . 0.0 109.597 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.98 115.64 9.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.034 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 96.9 mt-30 -125.86 35.05 4.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.305 171.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.02 118.86 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.959 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -86.4 131.88 34.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.824 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.6 p -104.39 120.81 42.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.056 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.88 -25.14 43.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.73 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -127.94 127.37 23.9 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.884 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.25 155.92 10.99 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.078 2.519 . . . . 0.0 112.25 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -160.27 -157.97 0.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.463 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -71.81 121.09 18.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.875 0.369 . . . . 0.0 111.231 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.35 146.46 27.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.697 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.8 m -123.22 157.97 31.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.66 0.743 . . . . 0.0 112.258 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -96.46 155.38 16.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.278 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -113.52 96.08 5.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.873 0.368 . . . . 0.0 110.776 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 90.3 t80 -96.23 142.63 28.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.453 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.8 m -109.13 120.86 43.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.517 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.3 m -72.21 139.89 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.7 mmtp -109.76 -165.9 1.05 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.002 0.429 . . . . 0.0 111.257 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 m -67.55 114.69 6.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.63 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.85 13.13 57.08 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.973 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 11.5 m-20 -94.48 123.53 37.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.346 0.593 . . . . 0.0 110.837 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 110' ' ' ILE . 24.7 p -111.39 155.85 22.51 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.346 174.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.532 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 2.3 pt? -55.52 -36.59 66.89 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.409 -176.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 m -66.32 -44.78 82.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.683 0.278 . . . . 0.0 110.804 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.32 -42.33 96.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.039 0.447 . . . . 0.0 110.831 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 99' ' ' TYR . 1.4 pp -76.17 -25.11 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.3 t -66.0 -45.06 82.94 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -58.95 -33.77 71.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.345 0.593 . . . . 0.0 109.678 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.1 tp-100 -65.75 -56.82 10.0 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.53 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -86.3 -47.85 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.442 -171.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.454 ' HB3' HD12 ' A' ' 120' ' ' LEU . 54.2 m-85 -82.48 -37.99 24.55 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.183 0.516 . . . . 0.0 110.695 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 106.92 -14.06 41.15 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -129.33 128.36 42.97 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.516 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -72.39 -24.9 61.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.747 -175.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -74.07 -0.19 15.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 0.0 111.92 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 115' ' ' TYR . 72.3 mt -96.13 15.68 20.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.149 0.499 . . . . 0.0 110.764 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 53.6 p90 -62.83 -27.46 69.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.137 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.551 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 4.6 p30 -67.0 -35.2 79.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.869 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -60.07 -31.67 70.23 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.425 0.631 . . . . 0.0 110.059 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.586 HG22 ' OD1' ' A' ' 128' ' ' ASN . 39.3 mt -79.17 -52.09 15.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.448 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.433 ' CE2' ' HD3' ' A' ' 129' ' ' LYS . 76.6 t80 -49.76 -48.83 50.05 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.085 0.469 . . . . 0.0 111.355 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 42.6 mt-10 -63.63 -25.9 68.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -94.77 -10.22 32.22 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.761 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.761 ' O ' ' HG3' ' A' ' 131' ' ' MET . 8.9 m120 -94.54 -43.97 8.08 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.444 ' HA ' ' H ' ' A' ' 132' ' ' LEU . 40.6 pttt -60.03 147.36 80.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.416 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -90.56 11.5 58.48 Favored 'Cis proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.554 -1.436 . . . . 0.0 114.574 6.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.761 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -81.05 -7.57 59.59 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.481 0.658 . . . . 0.0 110.297 174.575 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.47 ' HB3' ' CB ' ' A' ' 128' ' ' ASN . 12.9 tp -132.84 112.06 11.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.827 166.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.07 -26.5 20.23 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 25.5 m -151.49 153.82 32.69 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.353 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -53.17 -48.55 21.46 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 C-N-CA 123.197 2.598 . . . . 0.0 112.397 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -82.27 6.91 15.3 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.893 -175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 134' ' ' SER . 37.8 mmtm -89.79 -4.62 57.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.577 0.227 . . . . 0.0 111.441 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.634 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 15.8 pt -63.02 171.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 174.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -163.11 147.94 9.25 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.099 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -51.11 104.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.213 2.609 . . . . 0.0 112.251 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.08 35.19 1.85 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.218 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.634 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 45.8 tt0 -117.13 121.96 42.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.881 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 48.6 t -80.16 136.05 24.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.963 174.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.0 mt -124.31 145.18 49.57 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.067 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.558 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 37.3 ttt180 -73.51 117.06 14.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.593 176.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.7 88.66 4.5 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.961 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 24.7 Cg_exo -63.83 166.47 15.98 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.361 2.041 . . . . 0.0 111.927 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--N 1.321 -0.653 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.704 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 83' ' ' VAL . 58.8 tp . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -103.7 134.49 46.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.592 -176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -96.06 132.57 41.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.732 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.524 ' CD2' HG21 ' A' ' 143' ' ' VAL . 50.2 m-85 -124.6 179.91 4.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.188 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.8 t -97.3 107.5 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 59.1 tttm -56.5 -51.74 67.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.337 -170.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.54 -12.81 61.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.026 0.441 . . . . 0.0 111.037 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.565 ' CB ' ' HA3' ' A' ' 141' ' ' GLY . . . -92.82 -164.06 1.13 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.528 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.94 -173.05 44.61 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.923 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.51 125.27 25.62 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -73.52 66.95 1.04 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.201 1.001 . . . . 0.0 109.541 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.435 HD21 ' O ' ' A' ' 30' ' ' LYS . 11.7 tp . . . . . 0 N--CA 1.439 -1.014 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.765 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 33.5 t70 . . . . . 0 C--O 1.23 0.063 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.579 ' O ' HG23 ' A' ' 31' ' ' VAL . 7.0 mm100 -60.37 -41.75 94.4 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.62 -43.2 65.25 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.926 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.3 tttm -64.2 -44.11 92.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.064 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 73.2 mmtt -61.85 -40.92 97.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.112 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.62 HG11 HG23 ' A' ' 74' ' ' VAL . 92.2 t -62.52 -45.1 99.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.355 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.558 ' HG2' HG13 ' A' ' 48' ' ' ILE . 7.8 mm-40 -55.96 -46.41 78.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.615 173.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 50.4 mt-10 -55.74 -47.39 77.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.349 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -54.78 -45.84 74.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.326 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 80.3 mt -68.0 -35.52 78.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.968 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -73.43 -34.49 65.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.897 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 98.7 mttt -69.11 -46.12 68.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.131 178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.8 p -64.29 -34.14 77.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.099 0.476 . . . . 0.0 110.764 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.53 34.39 4.45 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.503 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.421 ' HB ' ' CB ' ' A' ' 43' ' ' ALA . 7.8 mm -80.31 116.34 61.02 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.25 -49.08 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.958 2.439 . . . . 0.0 113.346 -171.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.44 -5.99 54.03 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.428 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.484 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -72.72 -17.89 61.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.326 0.584 . . . . 0.0 110.149 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.09 -14.62 59.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.891 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.52 -0.76 37.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.21 -172.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -117.3 162.57 15.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.148 0.499 . . . . 0.0 111.216 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -106.33 138.2 42.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.043 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.558 HG13 ' HG2' ' A' ' 32' ' ' GLN . 31.2 mm -100.37 130.26 49.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.631 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.503 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 98.4 mt-30 -129.98 136.27 49.24 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 172.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.25 119.37 59.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.022 0.439 . . . . 0.0 111.167 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 54' ' ' LYS . . . -100.46 59.53 0.98 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 172.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 70.15 -65.56 0.31 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.712 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 -17.62 6.49 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.246 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 40.7 ttmt -97.85 121.51 39.84 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.078 0.466 . . . . 0.0 110.718 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -100.38 114.62 28.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.078 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 47.3 m -92.9 123.81 36.43 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.836 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.02 125.16 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.813 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -131.59 143.34 50.27 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.479 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.9 174.56 36.93 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 p-10 -146.56 149.64 33.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.874 0.337 . . . . 0.0 110.325 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 84.4 22.69 53.49 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.263 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 89' ' ' THR . 7.0 mp -99.07 176.18 5.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.847 0.356 . . . . 0.0 110.42 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.6 p -113.24 154.21 27.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.162 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.657 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 2.3 mm100 -51.27 -47.61 62.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.492 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 7.4 tp10 -53.19 -48.6 67.94 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 111.051 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.19 -43.14 71.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.667 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.44 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 28.0 tttm -54.07 -45.22 71.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.735 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 6.1 mm-40 -60.72 -36.65 79.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.35 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -63.6 -40.09 96.06 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 67' ' ' LYS . 3.6 mm -60.34 -54.6 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 88.8 mt -52.6 -39.47 61.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.824 -1.535 . . . . 0.0 112.224 -174.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.529 HG21 ' HG2' ' A' ' 145' ' ' ARG . 42.9 t -76.74 -51.92 18.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.038 0.447 . . . . 0.0 110.878 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.53 72.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.716 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.62 HG23 HG11 ' A' ' 31' ' ' VAL . 9.1 p -80.47 -30.03 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.069 0.462 . . . . 0.0 110.849 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.33 -32.8 27.38 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.148 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.08 60.88 3.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 111.493 -178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.43 139.64 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.427 173.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 23.5 m -66.06 112.47 3.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.723 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.5 -28.09 5.59 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -173.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 46.0 mm -89.12 126.2 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.254 0.55 . . . . 0.0 110.475 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.94 -28.49 9.56 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.485 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.409 ' HA ' ' HD1' ' A' ' 6' ' ' PHE . 41.8 m -156.54 160.72 39.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.474 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 55.0 t -127.99 129.52 69.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.61 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -98.09 103.85 15.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.711 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -78.13 114.17 16.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.291 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -132.26 18.9 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.615 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.56 115.15 27.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.451 0.643 . . . . 0.0 110.825 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 57.1 mttm -73.68 133.49 43.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.197 -175.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 12.4 p -99.54 110.28 22.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.587 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.491 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -81.66 -21.58 38.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.655 -178.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 34.0 p -128.58 143.95 50.31 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 6.2 Cg_exo -77.38 140.28 19.23 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.296 2.664 . . . . 0.0 111.857 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.492 ' HB3' ' H ' ' A' ' 65' ' ' GLU . . . -162.14 -166.63 1.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.974 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.474 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 7.7 m -58.77 132.99 55.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.85 129.74 55.4 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 168.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.6 m -114.32 147.59 38.87 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.09 0.471 . . . . 0.0 111.67 -171.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.501 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 33.1 tt0 -80.5 136.17 36.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -99.6 100.39 11.39 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.084 0.469 . . . . 0.0 110.471 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.453 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 92.0 t80 -100.93 136.95 39.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.621 176.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.489 ' OG1' HG22 ' A' ' 143' ' ' VAL . 16.9 m -106.22 124.84 50.21 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.95 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.616 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.5 m -67.88 126.33 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -75.81 -56.89 4.24 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.289 -167.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.44 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 10.7 t -167.23 -71.05 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.773 0.32 . . . . 0.0 110.373 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.15 45.45 3.51 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.521 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 2.2 m-20 -103.06 143.1 33.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.119 0.485 . . . . 0.0 110.448 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 110' ' ' ILE . 61.6 p -122.11 159.58 26.84 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.827 173.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.55 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 30.9 tp -61.45 -36.88 81.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 118.506 0.593 . . . . 0.0 110.221 -174.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 p -69.79 -33.02 71.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.189 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HB3' ' H ' ' A' ' 106' ' ' THR . . . -73.4 -43.69 59.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.969 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 106' ' ' THR . 1.3 pp -74.82 -25.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.18 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.467 ' HB3' HD12 ' A' ' 124' ' ' ILE . 13.3 p -71.42 -43.06 67.47 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.182 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -65.82 -23.95 66.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 110.393 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.581 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.0 OUTLIER -66.28 -52.85 43.33 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.167 175.508 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 146' ' ' ILE . 34.1 m -89.99 -40.87 13.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.259 -171.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.414 ' N ' HG23 ' A' ' 114' ' ' VAL . 55.5 m-85 -88.9 -38.49 14.5 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.96 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.56 -8.02 59.91 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -169.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -124.42 125.95 45.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.64 -0.78 . . . . 0.0 109.576 -174.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.33 -8.76 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.308 . . . . 0.0 111.622 -175.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -76.52 -20.27 57.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.352 0.596 . . . . 0.0 109.754 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 50.7 mt -84.25 18.55 2.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.342 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.55 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 34.8 p90 -66.61 -33.75 76.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.349 0.595 . . . . 0.0 109.454 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -68.4 -35.26 77.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.267 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 27.7 mmmt -52.27 -54.52 30.29 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.611 0.72 . . . . 0.0 110.189 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 111' ' ' SER . 52.2 mt -63.2 -36.93 77.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.588 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 134' ' ' SER . 30.8 t80 -61.54 -56.35 20.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.746 0.308 . . . . 0.0 110.734 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 18.3 mt-10 -61.64 -37.31 83.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.159 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.83 -31.26 70.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.928 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.573 ' O ' ' HG3' ' A' ' 131' ' ' MET . 33.7 m-80 -93.18 8.69 39.14 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.366 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 9.1 mtpm? -84.9 153.83 60.68 Favored Pre-proline 0 C--N 1.318 -0.794 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.882 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -91.87 11.81 55.65 Favored 'Cis proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.946 -1.689 . . . . 0.0 112.752 -0.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.573 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -69.28 -24.38 63.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.708 0.289 . . . . 0.0 111.476 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.4 tp -98.48 121.68 40.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -74.68 -54.38 7.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.654 -172.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.494 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 49.5 m -156.44 157.66 31.12 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.722 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.409 ' HA ' HD22 ' A' ' 107' ' ' LEU . 83.2 Cg_exo -47.8 -56.53 3.01 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 124.002 3.135 . . . . 0.0 113.889 -175.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.6 3.9 26.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -91.92 7.82 40.27 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 120.886 0.374 . . . . 0.0 111.414 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.495 HD11 ' HA ' ' A' ' 106' ' ' THR . 19.1 pt -66.59 169.16 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.354 171.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -163.75 148.1 8.6 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.44 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 63.6 Cg_exo -46.13 120.47 3.67 Favored 'Trans proline' 0 CA--C 1.519 -0.267 0 C-N-CA 123.183 2.589 . . . . 0.0 112.621 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 94.21 24.68 18.64 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.297 -176.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.616 ' H ' HG22 ' A' ' 101' ' ' VAL . 7.3 tp60 -97.79 111.56 23.81 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.524 HG21 ' CD2' ' A' ' 6' ' ' PHE . 46.1 t -77.66 135.86 25.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.2 mt -130.9 137.59 49.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.829 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.529 ' HG2' HG21 ' A' ' 72' ' ' VAL . 25.4 mtm180 -69.1 123.31 20.72 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.083 174.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 24.9 mm -103.87 95.02 7.05 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.16 148.13 49.54 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.311 2.008 . . . . 0.0 111.799 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.489 -179.99 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 82' ' ' SER . 42.1 tp . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -105.99 129.18 54.17 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.597 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -99.32 134.8 41.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.548 0.69 . . . . 0.0 112.002 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 33.0 m-85 -121.19 -166.16 1.32 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.672 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 94.6 t -78.09 -83.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.571 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.3 tmtp? 163.53 -77.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.969 0.793 . . . . 0.0 109.167 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.4 -25.49 54.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.711 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.34 125.15 28.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.497 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.43 -172.35 32.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.737 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -69.62 131.07 44.07 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -78.55 66.25 4.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.199 0.999 . . . . 0.0 108.84 173.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.515 HD21 ' O ' ' A' ' 30' ' ' LYS . 16.1 tp . . . . . 0 N--CA 1.44 -0.96 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.902 -172.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.903 0.382 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -58.92 -38.36 78.78 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.884 174.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 48' ' ' ILE . . . -56.99 -45.93 82.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.707 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 60.0 tttp -67.34 -39.47 85.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.515 ' O ' HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -53.08 -47.64 68.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 110.554 175.409 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.57 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 86.9 t -65.62 -39.57 85.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.825 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -60.02 -44.2 94.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.274 -0.171 . . . . 0.0 110.558 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 66.5 mm-40 -54.86 -49.27 71.54 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.193 0.521 . . . . 0.0 110.315 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -55.04 -33.07 62.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.603 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 79.5 mt -81.87 -44.59 16.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.061 0.458 . . . . 0.0 110.989 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -69.14 -35.02 75.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.64 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -77.36 -31.54 54.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.568 0.223 . . . . 0.0 111.467 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -76.63 -39.28 52.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.676 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.92 28.64 4.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.222 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.5 mm -62.61 130.7 93.76 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.1 130.83 23.7 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.234 1.956 . . . . 0.0 112.679 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 62.63 12.08 5.27 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.253 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 35' ' ' LEU . . . -71.64 -17.41 62.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.381 0.61 . . . . 0.0 110.796 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.01 -22.08 39.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.491 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -84.61 -23.65 29.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.168 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.32 177.59 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.61 129.77 25.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.086 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.425 HG13 HG22 ' A' ' 57' ' ' VAL . 3.2 mp -96.57 131.01 44.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -126.12 118.35 25.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.0 110.426 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.7 mm -89.33 132.7 33.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.514 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.11 -81.42 0.61 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.375 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -152.42 101.81 2.7 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.66 13.23 50.53 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 82' ' ' SER . 34.7 mtmm -133.2 124.44 27.43 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 120.844 0.354 . . . . 0.0 111.113 -174.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.38 104.77 14.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.498 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 m -82.58 113.88 20.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.322 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.425 HG22 HG13 ' A' ' 48' ' ' ILE . 62.9 t -100.62 113.46 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-O 121.089 0.471 . . . . 0.0 110.711 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 1.3 m -110.26 158.66 18.16 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.075 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.6 157.65 8.29 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.23 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -137.08 151.47 48.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 86.85 38.55 7.96 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.98 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.2 163.93 18.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 0.0 111.201 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 m -106.01 151.21 24.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.54 173.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 73.8 mm-40 -49.15 -48.23 45.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.33 -41.56 80.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.55 -42.31 64.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.259 0.552 . . . . 0.0 109.936 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.474 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 50.1 tttm -55.26 -51.66 65.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.48 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 4.9 mm-40 -67.89 -28.87 67.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.3 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -65.43 -37.25 86.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.148 0.499 . . . . 0.0 109.989 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.6 mt -70.09 -55.52 14.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.14 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 78.5 mt -50.06 -44.18 51.55 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.405 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.17 -34.55 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.964 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.57 -27.14 34.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.658 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.7 m -84.82 -22.5 7.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.223 0.535 . . . . 0.0 110.768 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -79.89 -35.51 27.76 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.32 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -79.91 55.84 2.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.025 0.44 . . . . 0.0 111.187 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.441 ' HB ' HG12 ' A' ' 80' ' ' ILE . 11.2 mm -118.67 138.13 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 t -68.21 92.07 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.241 0.543 . . . . 0.0 109.95 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.1 -19.93 3.05 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 77' ' ' ILE . 48.2 mm -97.16 131.59 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.254 0.55 . . . . 0.0 110.026 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -124.27 -3.37 7.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.755 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -164.78 147.2 8.38 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.225 -179.367 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.25 122.79 69.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.782 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.51 92.05 7.41 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.28 123.08 20.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.508 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.406 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 81.8 mm-40 -126.49 14.65 7.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.053 177.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 89' ' ' THR . 52.1 t -73.92 118.54 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.12 0.486 . . . . 0.0 109.776 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -89.14 4.94 46.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.267 -170.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.455 ' H ' HG12 ' A' ' 87' ' ' VAL . 32.0 p 44.95 -153.92 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.765 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.571 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -173.29 -41.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -118.16 131.97 23.95 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.564 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.8 144.34 48.21 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.868 2.379 . . . . 0.0 112.434 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 64' ' ' GLN . . . -158.74 -178.46 7.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.222 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.2 m -66.72 126.21 28.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.142 0.496 . . . . 0.0 111.258 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.53 164.47 20.85 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.8 m -121.37 145.13 48.21 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.622 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.447 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 29.0 tt0 -84.77 140.96 30.86 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -110.19 102.95 11.59 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.027 0.441 . . . . 0.0 110.504 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -106.27 133.52 50.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.011 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.444 ' OG1' HG22 ' A' ' 143' ' ' VAL . 7.8 m -100.02 122.46 42.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.346 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.577 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.7 m -71.21 136.3 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.406 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 40.7 mmtm -84.44 -163.9 0.87 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.451 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 1.6 p -60.33 -64.51 0.93 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.97 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.87 46.67 2.48 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.194 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.544 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 7.4 m-20 -104.79 127.81 52.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.131 0.491 . . . . 0.0 110.92 -177.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.549 ' O ' HG23 ' A' ' 110' ' ' ILE . 40.6 m -114.93 153.06 31.23 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.929 177.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 29.1 tp -51.97 -49.98 62.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.785 0.266 . . . . 0.0 111.63 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.456 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 m -66.66 -27.09 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.214 0.531 . . . . 0.0 111.156 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.572 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -73.33 -40.64 64.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.811 0.339 . . . . 0.0 110.375 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 106' ' ' THR . 1.2 pp -79.71 -25.29 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.106 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.3 p -70.28 -38.67 75.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.032 0.444 . . . . 0.0 109.824 173.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 5.6 tmtm? -58.71 -35.84 73.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.449 173.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 13.6 mm100 -59.72 -65.05 0.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 122.241 1.02 . . . . 0.0 111.267 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -81.97 -37.47 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 113.679 -1.6 . . . . 0.0 112.643 -165.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.478 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 55.5 m-85 -89.58 -45.25 9.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.292 0.568 . . . . 0.0 110.65 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.86 -14.72 26.58 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.475 ' HB3' ' HG ' ' A' ' 120' ' ' LEU . 56.7 t-20 -123.19 121.71 36.61 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.85 62.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.619 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -65.64 -21.63 66.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.07 0.462 . . . . 0.0 110.765 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.598 HD13 ' HE2' ' A' ' 123' ' ' LYS . 42.2 mt -79.78 29.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.703 -176.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 50.1 p90 -72.17 -35.27 68.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.166 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.403 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 24.7 t-20 -71.05 -31.82 68.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.948 -176.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.598 ' HE2' HD13 ' A' ' 120' ' ' LEU . 22.0 mtmt -52.44 -44.78 65.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.365 0.602 . . . . 0.0 110.439 173.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.413 HG22 ' OD1' ' A' ' 128' ' ' ASN . 46.2 mt -70.1 -44.67 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.278 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -52.97 -47.81 67.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.655 0.264 . . . . 0.0 111.043 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 31.7 mt-10 -66.03 -29.98 70.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.402 . . . . 0.0 110.908 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.07 -25.11 40.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.364 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 131' ' ' MET . 7.0 m120 -84.75 -41.87 15.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.106 0.479 . . . . 0.0 109.715 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 18.6 pttp -64.62 155.99 79.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.595 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 92.7 Cg_endo -81.97 17.69 18.8 Favored 'Cis proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.436 -1.485 . . . . 0.0 113.448 2.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.526 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -74.49 -36.27 63.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.874 0.368 . . . . 0.0 110.32 174.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.1 tp -88.95 126.81 35.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.014 0.435 . . . . 0.0 109.867 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -88.09 -38.77 15.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.426 -173.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.414 ' HB2' ' HG2' ' A' ' 137' ' ' LYS . 29.1 m -153.56 153.09 28.58 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.36 -18.41 38.92 Favored 'Trans proline' 0 C--O 1.23 0.089 0 C-N-CA 123.54 2.827 . . . . 0.0 112.312 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -101.95 -5.67 24.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.807 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 25.6 mmmt -86.28 10.19 15.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.469 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.464 HD11 ' HA ' ' A' ' 106' ' ' THR . 9.0 pt -62.88 173.69 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.189 170.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.572 ' CE1' ' HG2' ' A' ' 142' ' ' GLN . 5.9 p90 -166.19 150.85 7.34 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -175.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 84.9 Cg_exo -49.57 102.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.258 2.639 . . . . 0.0 112.656 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.41 ' CA ' HG21 ' A' ' 7' ' ' VAL . . . 113.33 23.53 5.12 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.473 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.577 ' H ' HG22 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -91.33 109.78 21.07 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.444 HG22 ' OG1' ' A' ' 100' ' ' THR . 39.3 t -80.58 122.2 35.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.448 0.642 . . . . 0.0 110.052 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.437 HD22 ' OD1' ' A' ' 128' ' ' ASN . 75.6 mt -117.39 139.91 50.26 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.863 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.454 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 48.4 mtp180 -69.79 119.09 13.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.084 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 31.7 mm -105.32 98.49 16.73 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.478 ' HD2' ' OH ' ' A' ' 115' ' ' TYR . 47.9 Cg_exo -56.64 154.04 32.96 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.827 2.351 . . . . 0.0 111.706 175.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--N 1.32 -0.706 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.21 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.7 tp . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.047 0.451 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -100.73 125.2 47.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.044 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -103.3 140.59 37.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.828 0.346 . . . . 0.0 110.648 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 73.5 m-85 -126.24 -161.14 1.03 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.751 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.95 HG11 ' HB3' ' A' ' 10' ' ' ALA . 7.3 p -79.75 -25.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.643 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 16.9 tptm 79.06 -66.26 0.19 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.488 0.715 . . . . 0.0 112.003 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.97 -36.01 36.73 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.742 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.95 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -79.17 152.17 30.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.498 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.65 -172.24 24.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.112 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -62.89 128.77 37.43 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.54 65.62 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.038 0.923 . . . . 0.0 108.969 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 77' ' ' ILE . 11.2 tp . . . . . 0 N--CA 1.436 -1.129 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.161 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.977 0.418 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.417 ' OE1' HG21 ' A' ' 50' ' ' ILE . 98.9 mt-30 -65.04 -30.22 71.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.055 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.33 89.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.503 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.575 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 87.7 tttt -68.32 -36.84 79.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.177 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' HD21 ' A' ' 14' ' ' LEU . 3.2 mptp? -58.63 -43.07 89.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.423 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 95.3 t -64.2 -44.61 97.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.218 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -52.25 -50.36 62.22 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.693 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 48.6 mt-10 -56.16 -51.66 67.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.181 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -53.72 -42.68 68.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.331 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 93.0 mt -70.13 -41.04 74.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.53 -39.48 67.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.189 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 74.6 mmtt -63.98 -36.86 85.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.152 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 p -78.74 -38.81 37.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.141 0.496 . . . . 0.0 110.868 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.41 31.95 4.43 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.998 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.2 mm -63.2 127.35 90.87 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -59.78 130.56 35.56 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.484 2.123 . . . . 0.0 112.729 -175.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.28 26.5 15.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.198 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.94 -17.15 64.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.192 0.52 . . . . 0.0 110.718 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -84.18 -16.25 44.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.639 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -86.04 -35.09 20.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.998 0.428 . . . . 0.0 110.363 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.2 m -83.73 166.25 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.554 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -134.33 131.05 37.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.542 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 mp -108.23 139.16 31.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.636 0.255 . . . . 0.0 110.652 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -123.89 140.8 52.63 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 172.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.417 HG21 ' OE1' ' A' ' 27' ' ' GLN . 11.1 mm -118.14 133.05 66.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.9 0.381 . . . . 0.0 111.107 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.28 91.86 2.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.894 174.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.4 t70 65.9 -75.82 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.829 0.705 . . . . 0.0 111.215 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.38 6.2 4.6 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -98.68 110.88 23.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.809 0.338 . . . . 0.0 110.235 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.634 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -103.51 106.44 16.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.028 176.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 84' ' ' ASP . 33.5 m -92.72 115.97 28.59 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.638 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.91 120.46 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.083 0.468 . . . . 0.0 110.295 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.22 160.47 21.54 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.09 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.21 178.3 28.48 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 6.3 p-10 -167.51 155.12 8.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.908 0.385 . . . . 0.0 110.513 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.34 15.99 63.27 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.145 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -95.56 -167.69 1.65 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.658 0.742 . . . . 0.0 110.723 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -124.19 152.27 43.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.241 -1.345 . . . . 0.0 108.658 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 51.7 tt0 -58.18 -42.02 85.18 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -166.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG3' ' HB1' ' A' ' 93' ' ' ALA . 45.5 mt-10 -54.54 -48.83 71.53 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.611 0.243 . . . . 0.0 111.374 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.84 75.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.216 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.545 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 49.7 tttp -49.35 -53.43 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.452 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 72' ' ' VAL . 54.1 mt-10 -62.03 -48.01 82.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -59.98 -38.48 82.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 74' ' ' VAL . 57.8 mt -62.02 -56.1 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.085 174.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 91.0 mt -49.16 -42.11 38.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.105 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 68' ' ' GLU . 40.9 t -72.7 -44.63 59.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.902 0.382 . . . . 0.0 110.957 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.12 -35.58 81.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 70' ' ' ILE . 11.3 p -79.15 -26.83 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.328 0.585 . . . . 0.0 110.423 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -77.02 -11.82 85.22 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.535 173.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.532 ' OD1' ' HG3' ' A' ' 142' ' ' GLN . 5.8 m-80 -97.64 39.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.725 -0.238 . . . . 0.0 110.714 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.536 HD12 HD22 ' A' ' 14' ' ' LEU . 10.8 mm -115.44 132.38 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.4 t -65.46 99.25 0.41 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.4 -15.66 3.9 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.025 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.634 HD12 ' HB2' ' A' ' 55' ' ' ALA . 43.2 mm -96.78 121.65 47.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.157 0.503 . . . . 0.0 111.069 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.643 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -96.75 -37.19 10.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.393 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 p -150.87 154.2 36.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.456 0.646 . . . . 0.0 111.612 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 53.0 t -117.71 122.77 70.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.587 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 56' ' ' THR . 7.1 t70 -91.78 93.37 8.83 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -71.78 112.51 7.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.157 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -128.06 14.77 6.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.544 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 p -93.62 129.7 43.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.189 0.519 . . . . 0.0 111.4 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -96.77 158.22 15.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.068 -177.35 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.5 p -124.58 136.45 53.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.431 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.98 -28.07 16.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.608 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 p -123.07 138.89 30.5 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.852 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.53 160.16 28.63 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.785 2.323 . . . . 0.0 111.664 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 65' ' ' GLU . . . -159.06 -167.31 2.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.938 -177.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 88.4 m -57.95 138.7 55.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.483 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -108.01 125.25 51.31 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.347 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.1 m -110.69 146.49 36.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.424 0.63 . . . . 0.0 111.286 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 15.8 tt0 -87.86 138.82 31.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.772 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -98.13 94.09 6.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.12 0.486 . . . . 0.0 110.699 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -95.74 136.3 36.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.044 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.492 ' OG1' HG22 ' A' ' 143' ' ' VAL . 7.5 m -106.66 122.9 47.27 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.568 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -67.82 128.55 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -82.13 -57.9 3.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.861 -167.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 140' ' ' PRO . 12.0 p -156.98 -87.61 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.112 -176.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.97 49.83 2.93 Favored Glycine 0 C--N 1.329 0.19 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.568 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -97.46 120.05 37.12 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.937 -0.631 . . . . 0.0 110.941 -174.172 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 110' ' ' ILE . 58.7 p -112.61 163.3 14.68 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -63.07 -40.45 97.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 118.837 0.744 . . . . 0.0 110.573 -174.665 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.514 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 15.6 m -69.98 -23.07 63.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 110.43 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.461 ' HB3' ' H ' ' A' ' 106' ' ' THR . . . -80.82 -47.42 13.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.236 -0.29 . . . . 0.0 110.759 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.608 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.4 pp -72.46 -23.57 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.141 -177.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 p -73.93 -48.01 33.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.729 0.3 . . . . 0.0 110.237 173.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -61.16 -21.84 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.451 0.643 . . . . 0.0 110.208 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.608 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 6.4 tp60 -71.84 -58.43 3.47 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.161 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.0 m -85.39 -39.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.045 -172.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -88.48 -57.21 3.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.548 0.689 . . . . 0.0 110.43 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.04 -23.81 6.46 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.644 -171.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -105.52 124.09 48.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.079 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -72.12 -21.03 61.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.206 0.526 . . . . 0.0 110.346 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.85 -22.53 65.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.114 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.8 mt -84.29 16.13 3.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.191 -0.458 . . . . 0.0 112.202 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.451 ' HD1' ' O ' ' A' ' 118' ' ' ALA . 40.0 p90 -64.46 -27.27 68.87 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -54.82 -55.04 34.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.24 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -50.27 -51.75 42.19 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.474 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.491 HG22 ' OD1' ' A' ' 128' ' ' ASN . 35.8 mt -62.98 -45.17 99.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.419 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.483 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 62.6 t80 -56.7 -49.48 74.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.985 0.422 . . . . 0.0 110.846 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.528 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 17.4 mt-10 -70.02 -23.62 63.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.981 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.71 -28.88 30.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.262 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.653 ' O ' ' HG3' ' A' ' 131' ' ' MET . 7.0 m120 -81.62 -10.83 59.32 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 28.8 mtpp -76.27 153.38 84.17 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.704 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -91.95 13.43 51.71 Favored 'Cis proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.762 -1.766 . . . . 0.0 112.814 -0.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.653 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -76.25 -13.95 60.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.672 0.273 . . . . 0.0 111.71 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.3 tp -99.07 125.8 44.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 171.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -73.61 -56.62 4.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.966 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.2 m -153.22 155.65 31.99 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.003 0.43 . . . . 0.0 109.988 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.405 ' HA ' HD12 ' A' ' 107' ' ' LEU . 24.2 Cg_exo -65.23 -27.24 56.27 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.906 3.071 . . . . 0.0 113.447 -170.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -99.76 0.87 42.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.99 0.424 . . . . 0.0 110.231 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -96.17 12.45 30.79 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.139 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.431 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 15.5 pt -72.57 168.51 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -158.78 144.06 11.93 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.143 -171.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.458 ' HG3' ' O ' ' A' ' 103' ' ' SER . 87.3 Cg_exo -49.41 110.11 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.605 2.87 . . . . 0.0 112.387 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.35 3.19 10.57 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.185 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.532 ' HG3' ' OD1' ' A' ' 76' ' ' ASN . 46.0 tt0 -93.13 118.21 30.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.518 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.492 HG22 ' OG1' ' A' ' 100' ' ' THR . 50.3 t -80.15 134.18 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.459 170.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 76.5 mt -130.21 147.98 51.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.575 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.405 ' HG2' HG21 ' A' ' 72' ' ' VAL . 25.6 mtm180 -77.41 119.11 20.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.972 175.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 38.9 mm -103.85 102.37 30.77 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.02 143.18 90.4 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.113 1.875 . . . . 0.0 110.746 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.571 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 20.1 tp . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.006 0.431 . . . . 0.0 109.953 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -101.21 123.32 45.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.374 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -78.77 141.54 37.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.539 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.566 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 93.6 m-85 -134.54 175.18 9.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.565 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.522 HG21 ' HA2' ' A' ' 141' ' ' GLY . 22.6 t -78.03 -15.06 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.791 -167.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.668 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 26.6 tptp 74.34 -49.82 0.67 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.946 0.498 . . . . 0.0 112.027 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -91.01 -36.06 14.29 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.73 0.3 . . . . 0.0 111.567 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.07 155.51 20.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.083 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.37 -160.91 24.34 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -76.58 125.46 29.28 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -86.07 65.47 9.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.482 0.658 . . . . 0.0 111.081 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.6 mt . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.549 178.631 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 34.5 t70 . . . . . 0 CA--C 1.521 -0.152 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.478 ' HB2' HG13 ' A' ' 50' ' ' ILE . 70.3 mt-30 -59.03 -41.49 87.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.729 174.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB2' HG12 ' A' ' 50' ' ' ILE . . . -57.71 -43.15 85.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.852 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 61.1 tttp -63.51 -44.81 93.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.373 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 12.9 mptt -57.71 -42.16 83.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.576 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.491 HG11 HG13 ' A' ' 74' ' ' VAL . 95.7 t -68.65 -41.92 82.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.892 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.51 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 2.9 mm100 -56.45 -48.67 76.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.071 174.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 53.7 mt-10 -60.28 -40.59 90.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.817 0.341 . . . . 0.0 110.441 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -56.52 -38.24 71.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.212 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 88.7 mt -72.96 -43.63 62.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.2 0.524 . . . . 0.0 110.864 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -72.49 -35.7 68.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.48 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -71.9 -27.07 62.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.563 0.22 . . . . 0.0 111.56 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 p -83.85 -39.36 20.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.182 0.515 . . . . 0.0 110.514 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.85 31.14 3.73 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.806 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 30.5 mm -66.44 127.31 93.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -64.28 139.4 65.65 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.055 1.836 . . . . 0.0 112.509 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 57.18 24.8 10.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.103 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -72.17 -17.67 61.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.271 0.558 . . . . 0.0 110.175 176.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.93 -19.92 36.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.026 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -83.0 -24.71 32.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.759 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.11 179.66 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.506 -177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 27.0 t-20 -144.87 138.38 26.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.46 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.51 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 14.9 mm -108.48 126.56 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 123.26 0.35 . . . . 0.0 110.836 -175.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -132.18 123.21 26.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.115 0.483 . . . . 0.0 110.39 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 27' ' ' GLN . 26.8 mm -98.4 112.4 30.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.396 -173.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.85 86.4 2.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.844 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 67.53 -76.58 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.422 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.45 -2.3 4.08 Favored Glycine 0 N--CA 1.454 -0.138 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.607 ' HG2' ' HB3' ' A' ' 82' ' ' SER . 38.3 mtmm -99.0 118.7 36.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.817 0.341 . . . . 0.0 110.682 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -94.65 106.75 18.74 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.947 176.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -82.99 113.14 20.36 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 120.766 0.317 . . . . 0.0 110.322 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 97.6 t -99.67 109.99 25.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.199 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 m -104.9 164.38 11.83 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.871 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.5 172.65 28.04 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -162.66 148.08 12.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.987 0.422 . . . . 0.0 110.056 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 97.5 6.97 57.23 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.103 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 89' ' ' THR . 6.8 mp -95.81 169.86 9.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.057 0.456 . . . . 0.0 110.856 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -110.66 154.9 23.17 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.658 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 7.5 tp60 -50.36 -47.79 55.93 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -173.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.46 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 43.9 mt-10 -52.17 -40.31 61.27 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -176.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.05 -45.53 13.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 110.338 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.491 ' HE3' ' OD1' ' A' ' 85' ' ' ASP . 75.7 tttt -51.54 -59.52 4.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.133 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 26.1 pt-20 -67.29 -18.07 65.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -72.33 -35.19 68.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.467 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.5 -46.56 92.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 10.1 mp -46.13 -43.62 15.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.652 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.627 HG21 ' HB2' ' A' ' 145' ' ' ARG . 39.9 t -63.13 -58.92 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.379 0.609 . . . . 0.0 111.117 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.3 64.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.347 -173.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.491 HG13 HG11 ' A' ' 31' ' ' VAL . 53.3 t -87.61 -29.19 5.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 0.0 110.712 177.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.566 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -75.98 -34.46 47.43 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.824 177.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -79.92 58.73 2.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.608 0.242 . . . . 0.0 110.849 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.559 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 29.7 mm -124.7 130.42 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.1 m -66.13 102.81 0.87 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.52 -17.86 5.51 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.481 -172.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.559 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 38.9 mm -100.46 126.23 54.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.195 0.522 . . . . 0.0 110.729 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.668 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -105.27 -17.18 14.55 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.297 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.607 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . 16.1 t -166.96 167.23 14.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.204 0.525 . . . . 0.0 110.763 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.23 125.38 47.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.809 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -98.42 90.81 4.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.491 ' OD1' ' HE3' ' A' ' 67' ' ' LYS . 2.9 t70 -66.75 124.2 22.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.153 -177.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -134.67 27.03 3.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.239 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -85.96 127.05 40.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.889 0.376 . . . . 0.0 110.267 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -91.95 127.78 37.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.18 0.514 . . . . 0.0 111.005 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.2 p -89.86 124.47 34.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.416 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.466 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -79.77 -38.37 33.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.758 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.8 p -127.13 150.59 72.62 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.892 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.31 141.73 52.64 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.339 2.693 . . . . 0.0 112.063 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -156.47 174.37 15.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.807 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.1 m -67.95 127.87 34.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.265 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.76 127.86 42.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.588 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 146' ' ' ILE . 14.1 m -106.03 171.55 7.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.124 0.488 . . . . 0.0 111.71 -175.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.617 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 13.7 tt0 -89.59 153.7 20.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.322 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -111.78 91.5 3.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -98.79 118.68 36.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.34 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.8 m -85.59 121.03 27.7 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.057 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 142' ' ' GLN . 1.5 m -69.34 136.74 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -105.7 -166.16 1.18 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.985 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.415 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 49.5 m -62.02 116.84 5.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.108 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.39 18.23 64.82 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.658 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 9.3 m-20 -90.93 114.46 26.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.128 0.49 . . . . 0.0 110.833 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 110' ' ' ILE . 21.7 p -110.02 162.0 14.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.084 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 16.1 tp -62.02 -41.46 98.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 118.391 0.541 . . . . 0.0 111.356 -169.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.3 p -69.32 -27.33 65.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.213 0.53 . . . . 0.0 110.972 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.91 -41.78 50.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -78.89 -23.65 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.465 -176.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.3 p -71.11 -41.01 71.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 172.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 4.9 tmmm? -60.19 -29.87 68.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.986 171.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 15.2 tp60 -67.71 -63.52 1.04 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.018 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 115' ' ' TYR . 35.3 m -76.22 -46.3 33.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.406 -171.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.455 ' N ' HG23 ' A' ' 114' ' ' VAL . 59.6 m-85 -90.91 -30.94 16.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.193 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 92.47 -2.92 74.72 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -170.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.446 ' HB3' HD12 ' A' ' 120' ' ' LEU . 16.3 t-20 -126.08 110.63 13.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.738 -0.731 . . . . 0.0 109.876 -173.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.44 -31.77 72.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.455 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -69.43 -14.75 63.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.627 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 117' ' ' ASN . 50.5 mt -83.83 17.32 2.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.821 0.343 . . . . 0.0 111.318 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 31.3 p90 -66.58 -27.48 67.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.08 0.467 . . . . 0.0 110.106 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.521 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 25.7 p-10 -66.69 -33.69 76.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -57.25 -52.45 65.27 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.579 0.704 . . . . 0.0 109.495 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.9 mt -66.53 -40.21 85.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.251 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.564 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 20.4 t80 -54.27 -60.01 3.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.538 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.526 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 24.5 mt-10 -61.72 -34.5 75.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.689 -176.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.426 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -68.57 -31.29 70.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.835 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 131' ' ' MET . 36.4 m-80 -91.34 -18.78 23.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 28.4 mtpp -67.08 151.7 96.85 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.434 176.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -87.67 15.35 44.47 Favored 'Cis proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.987 -1.672 . . . . 0.0 113.474 1.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.3 OUTLIER -67.75 -33.18 74.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.024 0.44 . . . . 0.0 110.281 177.319 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.434 HD11 HG23 ' A' ' 138' ' ' ILE . 0.1 OUTLIER -97.46 131.01 44.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -85.0 -49.56 8.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.598 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.467 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 46.5 p -154.08 161.45 29.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.973 0.416 . . . . 0.0 110.441 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.98 -15.29 48.35 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 123.631 2.887 . . . . 0.0 111.944 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -103.69 -16.34 15.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.206 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -81.74 -6.92 59.48 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 106' ' ' THR . 12.1 pt -65.6 168.53 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 0.0 110.709 172.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -165.06 148.29 7.2 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.476 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.415 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 75.1 Cg_exo -43.78 115.13 0.62 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.51 2.807 . . . . 0.0 112.806 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.522 ' HA2' HG21 ' A' ' 7' ' ' VAL . . . 109.51 6.89 28.67 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.445 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.575 ' O ' HG13 ' A' ' 101' ' ' VAL . 6.5 mm100 -87.7 110.08 20.17 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 41.5 t -77.63 119.63 26.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.403 0.62 . . . . 0.0 109.887 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.8 132.55 53.89 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.183 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.627 ' HB2' HG21 ' A' ' 72' ' ' VAL . 36.1 ttt180 -75.56 110.47 9.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.656 175.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 18.1 mm -94.08 108.63 36.86 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 34.8 Cg_exo -58.31 153.14 48.86 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.591 2.194 . . . . 0.0 111.938 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.602 176.973 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.5 tp . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.519 ' HB2' HG12 ' A' ' 83' ' ' VAL . 74.7 m-85 -99.47 125.29 45.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.362 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -99.32 144.64 28.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.946 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.591 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 68.3 m-85 -130.07 -162.48 1.21 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.951 0.405 . . . . 0.0 111.658 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.946 HG11 ' HB3' ' A' ' 10' ' ' ALA . 5.9 p -73.32 -25.71 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.996 -176.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.753 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 49.9 tptt 78.17 -56.97 0.48 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.457 0.703 . . . . 0.0 111.575 -176.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.91 -47.99 14.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.946 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -73.71 151.79 40.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.889 0.376 . . . . 0.0 110.907 -176.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.83 173.94 14.29 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.437 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.18 125.49 24.23 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 122.485 0.314 . . . . 0.0 110.179 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 96.1 mttt -90.28 83.35 5.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.957 0.408 . . . . 0.0 110.892 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 34' ' ' HIS . 1.7 mm? . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 121.479 0.657 . . . . 0.0 109.392 175.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 CA--C 1.522 -0.115 0 CA-C-O 120.966 0.412 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' VAL . 76.7 mt-30 -67.3 -17.38 64.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 171.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 48' ' ' ILE . . . -59.92 -42.22 93.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.053 171.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -63.15 -42.36 99.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 3.6 mptp? -54.46 -36.87 64.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.264 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.561 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 96.0 t -69.36 -46.09 77.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.641 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.426 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 16.5 mm-40 -56.9 -42.04 79.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.97 174.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -57.62 -51.13 70.77 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.455 ' HB2' HD11 ' A' ' 14' ' ' LEU . 51.3 t60 -51.19 -42.45 60.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.624 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 86.2 mt -72.63 -41.61 65.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.543 -176.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -80.56 -26.43 37.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.82 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -69.74 -45.78 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.594 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.0 p -68.1 -40.16 82.65 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.836 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.55 31.22 4.06 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.879 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.459 HD13 ' HD2' ' A' ' 130' ' ' PRO . 30.8 mm -65.81 125.0 89.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.68 141.53 50.15 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.0 1.8 . . . . 0.0 112.545 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 55.68 20.27 3.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.538 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 35' ' ' LEU . . . -84.87 -17.26 38.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.988 0.423 . . . . 0.0 111.0 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -83.74 -16.71 43.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.731 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.58 -27.15 61.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.772 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 m -89.8 159.62 2.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.658 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -112.95 136.91 52.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.79 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.426 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 15.8 mm -106.07 143.61 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 123.375 0.422 . . . . 0.0 110.707 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 64.2 tt0 -144.98 126.68 15.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.5 mm -107.44 121.26 60.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.966 0.412 . . . . 0.0 111.553 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.47 76.74 1.07 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.56 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 69.1 -80.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.953 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.01 2.53 7.89 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -104.95 98.62 8.31 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -94.23 118.78 32.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.336 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 12.8 m -90.57 134.14 34.59 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.638 0.256 . . . . 0.0 110.319 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.5 t -120.7 109.77 26.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.087 0.47 . . . . 0.0 109.98 176.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.19 159.87 16.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.223 -177.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.62 172.57 39.14 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -155.98 139.33 15.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.052 0.453 . . . . 0.0 110.666 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 95.16 7.03 59.81 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.822 -0.626 . . . . 0.0 113.131 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 89' ' ' THR . 7.3 mp -92.94 168.6 11.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.023 0.44 . . . . 0.0 110.735 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 m -105.82 151.49 24.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.114 172.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.695 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 41.0 tt0 -56.55 -43.13 79.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.489 -173.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -54.18 -36.57 63.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.808 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.38 -38.97 29.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.355 176.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -55.91 -42.41 76.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.071 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 3.0 mm-40 -64.34 -23.69 67.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.659 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -66.42 -38.83 88.31 Favored 'General case' 0 N--CA 1.461 0.085 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.602 ' O ' HG12 ' A' ' 74' ' ' VAL . 4.0 mp -71.14 -55.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.203 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -48.7 -45.72 39.6 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.34 -30.49 43.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.963 0.411 . . . . 0.0 111.219 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -84.72 -30.64 24.59 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.284 -0.26 . . . . 0.0 111.555 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 70' ' ' ILE . 4.5 p -81.98 -39.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.018 0.437 . . . . 0.0 110.7 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.591 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -67.24 -26.01 73.49 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.656 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -88.39 48.19 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.299 . . . . 0.0 110.814 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 31' ' ' VAL . 96.3 mt -121.21 142.93 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 121.225 0.536 . . . . 0.0 111.442 175.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 13' ' ' LYS . 51.8 p -64.83 105.91 1.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.764 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.51 -11.86 10.35 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.685 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 35.8 mm -90.96 113.37 26.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.544 0.688 . . . . 0.0 111.105 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.753 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -92.82 -26.49 17.65 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.002 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 5.9 p -157.76 155.17 29.37 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.526 -177.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 10.6 p -126.59 127.05 69.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.56 174.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.62 93.32 6.68 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -70.43 112.84 7.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.53 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -121.76 22.74 10.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.202 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.06 118.41 28.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.071 0.462 . . . . 0.0 110.523 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -80.05 123.58 27.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.356 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 5.1 p -92.53 111.38 22.94 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.234 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.478 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -71.58 -33.38 69.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.007 178.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 p -128.72 138.84 34.0 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.861 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.5 142.7 33.36 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.771 2.314 . . . . 0.0 111.724 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.25 174.18 10.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.967 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.8 m -61.65 137.03 58.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.935 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.63 143.2 27.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.646 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.1 m -110.69 137.35 48.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.08 0.467 . . . . 0.0 110.514 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 18.2 tt0 -86.67 147.23 25.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.242 177.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.64 118.86 33.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.985 0.422 . . . . 0.0 111.24 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -119.72 136.61 54.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.098 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.1 m -99.91 124.51 45.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 142' ' ' GLN . 2.4 m -71.4 136.42 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.421 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 34.0 mmtp -93.31 -168.67 1.96 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.065 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.476 ' HA ' ' HB3' ' A' ' 140' ' ' PRO . 27.4 m -56.51 -40.19 74.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.61 37.26 3.44 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.566 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.578 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 73.4 m-20 -99.36 128.57 45.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.411 0.624 . . . . 0.0 110.639 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 110' ' ' ILE . 1.5 p -114.48 153.82 29.29 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.205 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.487 HD22 ' HA ' ' A' ' 135' ' ' PRO . 27.6 tp -54.75 -43.33 72.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.307 0.503 . . . . 0.0 110.931 -172.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -62.39 -44.03 97.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.092 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.71 83.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.41 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.2 pp -73.73 -25.14 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.541 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.9 t -68.03 -46.82 70.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.131 0.491 . . . . 0.0 109.823 171.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.508 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 12.6 tmtt? -60.61 -29.01 68.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.583 0.706 . . . . 0.0 109.194 175.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 6.4 tp60 -67.32 -62.27 1.5 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.43 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 146' ' ' ILE . 34.5 m -79.6 -45.81 23.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.254 -172.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 114' ' ' VAL . 38.8 m-85 -81.42 -51.23 8.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.305 0.574 . . . . 0.0 110.509 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.51 -14.19 13.28 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.679 -174.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.46 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 17.7 t30 -123.34 126.93 47.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.154 -0.523 . . . . 0.0 109.829 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . . . -75.01 -17.06 60.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.82 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -80.46 -13.24 59.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.061 0.458 . . . . 0.0 110.843 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.46 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 39.1 mt -82.47 14.14 3.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.448 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.474 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 53.6 p90 -60.07 -24.82 64.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.27 -178.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.482 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 51.0 m-80 -62.56 -38.9 91.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.09 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -55.57 -50.51 69.86 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.575 0.702 . . . . 0.0 109.805 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.97 -39.41 81.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.48 -177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.446 ' HA ' HD23 ' A' ' 132' ' ' LEU . 85.8 t80 -58.55 -53.95 52.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.512 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 21.5 mt-10 -66.04 -35.74 81.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.061 -176.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.425 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -64.14 -33.43 75.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.513 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.525 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 42.5 m-80 -95.72 -28.63 14.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.849 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 56.8 pttt -64.45 155.76 79.49 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.472 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 2.9 Cg_endo -82.0 10.63 36.33 Favored 'Cis proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.968 -1.263 . . . . 0.0 113.088 1.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.525 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.4 tmm? -66.31 -40.29 89.86 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.448 HD13 HE22 ' A' ' 142' ' ' GLN . 7.6 tp -86.24 113.38 22.2 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 171.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -76.9 -52.46 9.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.612 -170.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.492 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 24.0 m -142.38 155.74 64.23 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.011 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.487 ' HA ' HD22 ' A' ' 107' ' ' LEU . 74.4 Cg_exo -51.72 -54.53 5.17 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.495 2.797 . . . . 0.0 113.258 -172.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.07 9.78 29.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.219 0.533 . . . . 0.0 111.024 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 26.2 mmtp -92.27 13.09 20.28 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.549 HD11 ' HA ' ' A' ' 106' ' ' THR . 18.3 pt -67.19 171.39 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 171.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -148.08 144.69 19.22 Favored Pre-proline 0 C--N 1.315 -0.898 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.64 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.476 ' HB3' ' HA ' ' A' ' 103' ' ' SER . 81.5 Cg_exo -49.33 110.66 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.275 2.65 . . . . 0.0 112.47 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.53 22.79 6.56 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.085 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.578 ' H ' HG22 ' A' ' 101' ' ' VAL . 44.8 tt0 -105.56 118.63 37.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 117.613 0.706 . . . . 0.0 110.708 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 37.3 t -78.46 131.64 34.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.744 174.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.7 mt -121.19 135.64 55.11 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.101 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 145' ' ' ARG . 46.8 mtp180 -65.44 123.36 19.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.39 173.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 114' ' ' VAL . 23.3 mm -106.24 97.86 17.44 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.425 ' HG3' ' HB2' ' A' ' 127' ' ' ALA . 39.5 Cg_endo -70.49 158.8 54.91 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.227 1.951 . . . . 0.0 111.871 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.492 -177.482 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.504 HD13 ' N ' ' A' ' 4' ' ' PHE . 2.6 tm? . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.504 ' N ' HD13 ' A' ' 3' ' ' LEU . 98.4 m-85 -121.55 145.78 47.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.371 178.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.23 128.97 48.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 111.268 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 76.1 m-85 -124.77 -167.22 1.63 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.78 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 10' ' ' ALA . 91.2 t -107.69 118.94 56.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.114 0.483 . . . . 0.0 110.262 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.624 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 22.5 tptm -60.7 -33.74 73.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.906 -172.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -90.23 -33.94 15.98 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -87.34 128.65 35.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.857 0.36 . . . . 0.0 111.426 -172.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.69 179.9 26.84 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.873 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.68 135.92 47.05 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -99.86 94.29 6.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.76 0.314 . . . . 0.0 110.525 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 34' ' ' HIS . 1.8 mm? . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.852 0.358 . . . . 0.0 111.062 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.8 m-20 . . . . . 0 CA--C 1.516 -0.355 0 CA-C-O 120.285 0.088 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.41 ' O ' HG23 ' A' ' 31' ' ' VAL . 97.7 mt-30 -63.05 -46.95 85.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.638 0.256 . . . . 0.0 110.721 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 48' ' ' ILE . . . -57.15 -30.58 64.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.326 0.584 . . . . 0.0 111.197 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 35.6 ttpt -80.03 -50.67 10.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.339 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 72.7 mmtt -51.74 -39.66 58.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.412 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 41.4 t -58.46 -52.06 64.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.694 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.611 ' HB3' HD13 ' A' ' 48' ' ' ILE . 26.5 pt20 -78.28 -21.1 50.26 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.464 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 46.9 mt-10 -64.99 -39.0 92.82 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 172.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.529 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 63.6 t60 -55.97 -37.49 69.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.02 172.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.6 mt -70.53 -45.84 64.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.22 -41.7 94.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.05 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 97.3 mttt -59.48 -54.85 41.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.053 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 p -62.74 -44.18 96.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.085 0.469 . . . . 0.0 111.142 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.54 33.75 1.86 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.899 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.453 HD13 ' HD2' ' A' ' 130' ' ' PRO . 24.3 mm -69.53 129.15 91.75 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.83 143.19 49.74 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.614 2.209 . . . . 0.0 113.207 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 57.15 28.57 15.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.697 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.83 -20.6 62.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.24 0.543 . . . . 0.0 110.349 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -81.32 -15.99 53.75 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.425 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -86.81 -11.28 51.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.816 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.08 177.31 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.113 0.483 . . . . 0.0 111.292 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.63 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 42.0 t30 -141.4 128.51 20.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.065 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 32' ' ' GLN . 3.2 mp -104.53 129.25 57.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 123.39 0.431 . . . . 0.0 110.608 -174.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -128.7 128.03 43.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.273 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.4 mm -98.74 120.59 48.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.001 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.45 88.01 2.86 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.769 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 67.33 -74.88 0.06 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.803 0.69 . . . . 0.0 111.134 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.38 -1.0 4.01 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 84' ' ' ASP . 38.7 ttmt -96.74 115.74 27.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.959 0.409 . . . . 0.0 110.731 -178.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.82 100.74 12.26 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.1 m -83.35 128.5 34.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.382 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -120.79 117.33 52.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.008 0.432 . . . . 0.0 111.043 177.363 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.486 HG23 ' HB3' ' A' ' 86' ' ' GLN . 2.2 m -100.52 162.96 12.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.789 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.8 166.68 33.64 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.801 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -156.13 138.07 14.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.875 0.369 . . . . 0.0 110.066 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 91.96 8.21 63.56 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.802 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.504 ' HG ' ' CG1' ' A' ' 87' ' ' VAL . 4.5 mm? -78.68 171.79 14.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.0 112.265 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -128.05 146.41 50.69 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 170.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.614 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 46.9 mt-30 -59.65 -22.48 61.95 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.303 0.377 . . . . 0.0 112.008 -175.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.67 -34.55 72.98 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.259 0.349 . . . . 0.0 111.311 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.42 -36.52 7.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.027 0.441 . . . . 0.0 110.475 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 52.5 tttm -50.91 -46.53 60.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.049 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.415 ' O ' ' HD2' ' A' ' 145' ' ' ARG . 21.7 mt-10 -87.92 20.58 3.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.415 0.626 . . . . 0.0 110.923 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -113.91 -41.7 3.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.059 170.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 54.6 mt -59.22 -59.3 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.245 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 67' ' ' LYS . 9.3 mp -42.86 -41.99 3.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.458 176.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.85 -53.39 30.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.99 -24.06 65.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.39 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.2 t -79.0 -40.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.171 0.51 . . . . 0.0 110.481 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -72.27 -25.94 73.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.506 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.426 ' HB3' ' OH ' ' A' ' 139' ' ' TYR . 90.4 m-20 -86.45 39.95 0.86 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.099 0.476 . . . . 0.0 111.056 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.457 ' CD1' HG13 ' A' ' 31' ' ' VAL . 92.9 mt -114.26 135.31 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.715 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -67.92 123.81 21.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.31 -9.27 38.72 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.252 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.1 mm -105.01 137.81 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.624 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -124.04 -19.47 5.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.721 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 p -152.97 157.04 39.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.065 0.459 . . . . 0.0 111.297 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.3 t -133.04 126.11 52.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.84 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . 15.1 t70 -102.37 110.64 22.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.409 ' CB ' HD21 ' A' ' 71' ' ' LEU . 9.0 p-10 -92.49 100.47 13.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 122.145 0.974 . . . . 0.0 111.77 -174.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.486 ' HB3' HG23 ' A' ' 58' ' ' THR . 49.2 mt-30 -98.98 18.47 17.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.163 172.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.504 ' CG1' ' HG ' ' A' ' 62' ' ' LEU . 43.1 t -80.01 108.08 13.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.437 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -86.59 137.57 32.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.075 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.8 p -102.45 130.42 49.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.058 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.441 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -90.08 -16.18 30.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.6 p -129.27 142.53 45.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.85 124.42 7.44 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.668 2.245 . . . . 0.0 111.842 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.35 168.87 18.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.5 m -65.18 140.77 58.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.434 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.89 154.7 17.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.08 0.467 . . . . 0.0 111.759 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.9 m -118.94 146.96 44.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.981 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.482 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 52.9 tt0 -91.3 150.73 21.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.425 175.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -105.82 100.83 10.37 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.103 0.477 . . . . 0.0 110.85 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.441 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 80.0 t80 -101.66 144.24 30.63 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.917 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 143' ' ' VAL . 17.1 m -110.94 124.15 51.57 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.358 -0.137 . . . . 0.0 110.675 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.675 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.7 m -66.09 129.5 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -80.84 -81.51 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.969 -171.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.3 m -162.26 123.49 2.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.12 28.88 71.01 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.26 130.43 43.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.892 -0.654 . . . . 0.0 109.95 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.561 ' HA ' HD11 ' A' ' 138' ' ' ILE . 7.6 p -115.76 162.61 17.04 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.878 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 22.9 mt -57.83 -42.67 84.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.76 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.4 m -59.63 -38.69 82.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.942 0.401 . . . . 0.0 110.822 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.7 -44.65 69.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.264 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.5 pp -78.22 -22.15 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.483 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.4 p -77.8 -42.67 33.05 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.243 -0.286 . . . . 0.0 110.564 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 61.3 tttp -62.73 -26.27 68.6 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.506 0.67 . . . . 0.0 109.75 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.637 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 4.7 tp60 -64.33 -55.02 24.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.949 175.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 115' ' ' TYR . 34.2 m -86.46 -51.25 13.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.349 -173.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.473 ' N ' HG23 ' A' ' 114' ' ' VAL . 21.6 m-85 -87.67 -31.01 19.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.249 -176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.31 -19.51 39.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.102 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -114.1 120.61 41.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . . . -69.19 -20.13 63.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.872 -175.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -81.77 -0.15 41.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.985 0.421 . . . . 0.0 111.004 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.8 mt -91.28 17.43 8.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 42.3 p90 -60.84 -30.91 70.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.362 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -69.8 -30.54 68.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.522 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -63.11 -44.12 96.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.257 0.551 . . . . 0.0 110.341 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.3 mt -75.46 -36.88 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.163 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -53.26 -60.81 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.801 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.472 ' CD ' ' HZ2' ' A' ' 129' ' ' LYS . 11.6 mm-40 -50.43 -43.62 55.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.943 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.565 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -63.84 -33.08 74.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.32 -174.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.497 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 42.2 m-80 -92.8 5.17 52.17 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.715 0.293 . . . . 0.0 111.506 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.472 ' HZ2' ' CD ' ' A' ' 126' ' ' GLU . 15.3 mtmm -82.63 156.27 68.14 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HD2' HD13 ' A' ' 40' ' ' ILE . 96.6 Cg_endo -86.39 15.37 41.24 Favored 'Cis proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.72 -1.367 . . . . 0.0 113.424 -1.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.497 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.3 OUTLIER -66.12 -41.94 89.84 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.128 0.49 . . . . 0.0 110.069 175.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 tp -95.03 124.41 39.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.441 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -101.6 -33.27 9.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.862 -172.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 69.0 m -155.42 153.64 26.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.57 0.224 . . . . 0.0 111.179 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.523 ' HA ' ' CD1' ' A' ' 107' ' ' LEU . 81.9 Cg_exo -48.67 -56.95 2.67 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.627 2.885 . . . . 0.0 113.382 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.01 -7.78 53.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.864 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 134' ' ' SER . 30.2 mmtp -81.51 -2.72 50.88 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.561 HD11 ' HA ' ' A' ' 106' ' ' THR . 12.3 pt -68.37 167.55 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.972 0.415 . . . . 0.0 110.438 174.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 76' ' ' ASN . 10.5 p90 -141.46 141.67 23.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.428 -174.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.81 111.02 0.5 Allowed 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 123.176 2.584 . . . . 0.0 112.248 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.24 23.47 6.35 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.907 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.675 ' H ' HG22 ' A' ' 101' ' ' VAL . 47.3 tt0 -104.48 121.8 44.2 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.572 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.442 HG22 ' OG1' ' A' ' 100' ' ' THR . 42.7 t -80.93 133.75 28.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.965 174.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.1 mt -126.15 135.67 51.94 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.673 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.583 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 3.1 ptm180 -73.84 123.78 24.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.289 0.566 . . . . 0.0 110.011 176.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.482 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 26.3 mm -103.84 91.29 3.45 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.038 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 37.1 Cg_exo -60.88 144.28 99.53 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.501 2.134 . . . . 0.0 111.318 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 121.18 0.515 . . . . 0.0 110.328 -179.5 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.7 tp . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 82' ' ' SER . 74.1 m-85 -114.16 133.92 55.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.645 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -109.85 134.56 51.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.272 0.558 . . . . 0.0 110.827 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 67.3 m-85 -118.03 -157.96 0.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.644 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.957 HG11 ' HB3' ' A' ' 10' ' ' ALA . 7.7 p -85.17 -24.61 6.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.914 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 28.9 tptp 74.83 -52.43 0.68 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.319 0.647 . . . . 0.0 111.881 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -85.81 -44.07 12.77 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.957 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -78.8 172.33 13.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.761 -177.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.21 -173.72 15.65 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.32 121.29 15.4 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 57.6 mtmt -80.04 74.76 6.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.471 0.653 . . . . 0.0 111.601 -171.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.581 175.882 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.845 0.355 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.407 ' O ' HG23 ' A' ' 31' ' ' VAL . 10.5 mm100 -67.18 -21.85 65.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.579 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.77 82.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.225 176.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.3 tptt -65.28 -45.9 82.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.317 176.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -55.73 -46.86 77.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.793 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 77' ' ' ILE . 72.0 t -60.39 -49.31 84.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.941 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 3.2 mm-40 -53.11 -41.97 65.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.613 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 44.8 mt-10 -56.28 -44.84 80.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.498 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -56.16 -46.87 79.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.728 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.66 -39.21 84.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.826 0.346 . . . . 0.0 111.823 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -77.08 -24.36 51.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.488 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -82.54 -24.33 34.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.562 0.22 . . . . 0.0 111.353 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -83.75 -35.9 24.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.859 0.362 . . . . 0.0 110.955 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.69 24.15 6.23 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.162 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.88 125.56 91.01 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -78.53 149.32 23.96 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.978 1.786 . . . . 0.0 111.955 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.56 8.2 4.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.42 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.81 -13.24 56.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.054 0.454 . . . . 0.0 110.951 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.77 -7.46 56.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.634 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -89.36 -12.32 40.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.403 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.412 HG21 HG21 ' A' ' 70' ' ' ILE . 35.0 m -103.05 157.56 4.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.839 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 18.3 m120 -119.27 132.96 55.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.646 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.468 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 13.4 mm -95.26 140.97 15.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -174.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 52.6 mt-30 -137.53 127.41 25.62 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 34.5 mm -117.91 116.58 52.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.185 0.517 . . . . 0.0 111.711 -172.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.05 70.81 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.915 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 t70 72.87 -66.45 0.31 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.185 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.12 31.49 2.69 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.894 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.569 ' CE ' ' HB2' ' A' ' 84' ' ' ASP . 87.2 tttt -140.25 129.42 23.68 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.503 -0.41 . . . . 0.0 110.718 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 83' ' ' VAL . . . -108.63 107.68 18.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.41 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 84' ' ' ASP . 36.5 m -95.21 114.05 25.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -104.71 127.6 59.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.82 0.343 . . . . 0.0 111.609 -177.588 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -104.35 158.08 16.71 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.123 177.293 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.41 156.72 10.11 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.29 137.49 27.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.144 0.497 . . . . 0.0 110.533 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 96.43 0.58 61.05 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.514 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 89' ' ' THR . 4.6 mm? -68.64 178.1 2.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.176 0.512 . . . . 0.0 111.982 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.464 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 53.6 p -127.02 144.34 51.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.564 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.623 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 48.8 tp60 -45.64 -54.86 7.1 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.532 0.52 . . . . 0.0 112.076 -175.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.91 -35.13 72.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.03 -42.6 19.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.936 0.398 . . . . 0.0 110.077 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 79.8 tttt -54.54 -40.45 68.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.27 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 79.0 mt-10 -63.46 -35.47 80.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.44 -43.87 93.05 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.412 HG21 HG21 ' A' ' 46' ' ' VAL . 2.8 mp -62.26 -50.77 78.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.092 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 88.0 mt -53.97 -45.96 71.5 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.409 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 68' ' ' GLU . 46.5 t -72.0 -44.22 66.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.211 0.529 . . . . 0.0 110.83 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -62.9 -34.66 77.89 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.349 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 80' ' ' ILE . 22.5 m -82.18 -31.12 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.638 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -72.36 -32.8 62.06 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.766 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.25 41.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.941 0.4 . . . . 0.0 111.056 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.432 ' CD1' HG13 ' A' ' 31' ' ' VAL . 96.8 mt -115.54 134.75 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 121.061 0.458 . . . . 0.0 110.398 172.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.53 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 14.8 t -62.47 105.99 0.7 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.486 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.91 -15.42 5.65 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.565 -174.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 49.7 mm -100.85 120.57 50.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.128 0.49 . . . . 0.0 111.49 -177.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.914 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -98.96 -38.26 9.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.685 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.4 p -142.7 159.6 41.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.48 0.657 . . . . 0.0 111.85 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 55' ' ' ALA . 69.0 t -131.07 127.53 61.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.628 177.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.569 ' HB2' ' CE ' ' A' ' 54' ' ' LYS . 5.6 t70 -106.39 107.75 18.92 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.76 110.04 15.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.115 0.96 . . . . 0.0 111.032 -173.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 14.6 mm-40 -107.98 17.51 22.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.531 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -92.4 116.24 33.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.843 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -85.59 139.17 31.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.307 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 16.6 p -105.48 131.11 53.29 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.99 0.424 . . . . 0.0 111.202 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.462 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -103.77 -40.02 6.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -176.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 63' ' ' SER . 17.8 p -96.28 141.0 22.5 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.586 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.6 130.49 18.4 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.805 2.337 . . . . 0.0 112.293 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.623 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -148.54 160.86 42.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.9 m -82.36 133.71 35.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.379 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.6 141.42 29.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.677 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.8 m -108.96 170.99 7.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.65 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.513 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.6 tt0 -96.33 147.7 23.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.518 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -104.29 107.08 17.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.976 0.417 . . . . 0.0 110.039 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -108.31 129.96 55.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.353 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.431 ' OG1' HG22 ' A' ' 143' ' ' VAL . 17.7 m -98.07 123.44 42.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.95 175.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -69.03 130.14 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.307 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.47 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 45.5 mmtm -80.18 -73.37 0.36 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.313 -170.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 140' ' ' PRO . 18.4 t -150.39 -68.66 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.765 -176.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.35 36.67 2.58 Favored Glycine 0 C--N 1.329 0.189 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -96.4 115.84 28.08 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.152 -172.2 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 110' ' ' ILE . 27.6 p -110.2 159.2 17.59 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -57.41 -45.12 84.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.178 0.444 . . . . 0.0 110.783 -171.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.505 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 14.3 m -63.04 -40.19 96.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.56 82.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.331 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 106' ' ' THR . 1.3 pp -74.11 -27.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 120.805 0.336 . . . . 0.0 110.503 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -67.19 -43.52 81.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.057 0.456 . . . . 0.0 110.133 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.16 -28.2 69.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.369 0.604 . . . . 0.0 109.964 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.596 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 17.4 tp60 -67.42 -54.49 19.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.078 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 115' ' ' TYR . 27.4 m -85.18 -50.49 14.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.207 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.475 ' N ' HG23 ' A' ' 114' ' ' VAL . 68.9 m-85 -85.81 -42.13 14.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.057 0.456 . . . . 0.0 111.146 -177.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.8 -14.88 31.83 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.447 ' HB3' ' HG ' ' A' ' 120' ' ' LEU . 55.3 t-20 -118.75 120.15 36.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.505 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -71.08 -22.24 62.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -174.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.08 -8.18 55.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.039 0.447 . . . . 0.0 111.106 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' ' 117' ' ' ASN . 46.6 mt -86.4 10.8 13.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.648 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 51.0 p90 -59.14 -26.49 64.79 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.925 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -70.3 -31.54 68.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.112 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.434 ' HE2' HD13 ' A' ' 120' ' ' LEU . 33.6 mtmt -62.43 -45.29 93.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.717 0.77 . . . . 0.0 109.68 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.0 mt -66.62 -42.76 90.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.619 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -56.74 -53.78 53.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.367 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -65.45 -26.31 67.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 111.664 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -76.58 -25.83 54.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.708 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 131' ' ' MET . 39.2 m-80 -98.02 -30.59 12.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.272 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 19.4 pttp -66.14 156.91 83.22 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.4 Cg_endo -81.2 10.33 32.71 Favored 'Cis proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.494 -1.461 . . . . 0.0 113.4 2.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.54 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.6 tmm? -64.99 -37.96 89.39 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.534 HD13 HE22 ' A' ' 142' ' ' GLN . 7.8 tp -88.74 114.77 25.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.026 171.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -73.41 -46.65 47.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.684 -171.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 135' ' ' PRO . 16.4 m -152.1 150.54 25.92 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 121.239 0.542 . . . . 0.0 109.928 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 107' ' ' LEU . 28.0 Cg_endo -62.6 -20.78 71.79 Favored 'Trans proline' 0 C--N 1.334 -0.232 0 C-N-CA 123.784 2.99 . . . . 0.0 113.025 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -101.4 -0.45 35.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.564 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -98.35 16.18 22.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.464 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 19.0 pt -74.0 166.44 2.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 171.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -153.27 147.21 18.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.821 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.413 ' HB3' ' HA ' ' A' ' 103' ' ' SER . 92.4 Cg_exo -47.53 113.68 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.573 2.849 . . . . 0.0 112.629 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.57 30.63 4.86 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.315 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.534 HE22 HD13 ' A' ' 132' ' ' LEU . 43.1 tt0 -114.02 124.9 53.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.629 0.714 . . . . 0.0 110.933 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.431 HG22 ' OG1' ' A' ' 100' ' ' THR . 45.1 t -82.69 134.73 26.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.757 173.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.4 mt -126.01 138.84 53.76 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.896 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.557 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 52.9 mtp180 -65.91 118.28 9.5 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.675 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 39.3 mm -105.96 90.16 4.24 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 24.5 Cg_exo -62.37 150.31 87.69 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.685 2.257 . . . . 0.0 111.443 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--N 1.321 -0.657 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.34 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 110.736 -0.098 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.48 -135.4 3.12 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.995 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 4' ' ' PHE . 3.1 tm? -96.2 136.93 36.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.061 0.458 . . . . 0.0 110.283 -175.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' N ' HD13 ' A' ' 3' ' ' LEU . 96.7 m-85 -126.09 136.35 52.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.223 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -108.44 147.25 31.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.447 0.641 . . . . 0.0 112.275 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.506 ' CD2' HG21 ' A' ' 143' ' ' VAL . 53.7 m-85 -130.47 -169.17 2.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.751 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.473 HG21 ' HA2' ' A' ' 141' ' ' GLY . 40.5 t -86.61 -13.38 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.536 0.207 . . . . 0.0 111.115 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 63.7 tttm 73.85 -68.71 0.21 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.083 0.553 . . . . 0.0 111.784 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.02 -26.24 65.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.905 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.503 ' CB ' ' HA3' ' A' ' 141' ' ' GLY . . . -100.28 125.53 46.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.153 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.11 -169.43 40.32 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -60.49 129.89 43.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -74.81 73.39 2.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.029 0.919 . . . . 0.0 109.717 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.541 HD23 ' CZ3' ' A' ' 15' ' ' TRP . 12.1 tp -89.5 -45.25 9.55 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.552 -174.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.541 ' CZ3' HD23 ' A' ' 14' ' ' LEU . 18.0 p90 -143.71 -29.61 0.51 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.087 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 54.76 81.91 0.1 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.795 0.331 . . . . 0.0 110.46 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 67.1 4.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.151 0.501 . . . . 0.0 111.578 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.1 t -88.24 -68.14 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.28 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.7 p -94.62 -20.53 19.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.408 0.623 . . . . 0.0 109.763 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.84 118.59 4.17 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.758 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -125.49 -0.49 7.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.576 0.227 . . . . 0.0 111.061 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -164.67 147.83 8.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.912 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 5.3 t70 -79.9 169.99 17.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.156 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 63.8 mmtt -59.34 -48.66 80.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.878 0.37 . . . . 0.0 111.185 -171.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.51 -30.6 70.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -71.3 -36.2 71.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.86 0.362 . . . . 0.0 110.099 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.54 ' O ' HG23 ' A' ' 31' ' ' VAL . 95.8 mt-30 -63.88 -45.99 86.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.586 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.1 78.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.184 0.516 . . . . 0.0 110.727 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.09 -45.47 94.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.537 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' O ' HD21 ' A' ' 14' ' ' LEU . 68.5 mmtt -61.11 -35.21 76.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.852 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.559 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 97.4 t -62.74 -48.94 85.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -55.35 -48.56 74.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.569 172.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 66.1 mt-10 -55.71 -50.27 70.76 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -53.23 -43.95 67.7 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.698 0.624 . . . . 0.0 111.505 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 98.5 mt -62.76 -42.95 99.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.502 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -75.1 -25.39 58.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.989 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 13.2 mmmm -65.84 -51.99 54.25 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.222 0.534 . . . . 0.0 110.385 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 130' ' ' PRO . 2.4 p -73.3 -28.97 62.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.375 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.07 30.54 7.81 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.973 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.61 126.05 85.93 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.52 145.71 71.57 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.894 1.729 . . . . 0.0 112.107 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.29 21.45 11.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.804 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.11 -22.39 63.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.6 2.99 56.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.684 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -99.26 3.05 46.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.453 . . . . 0.0 110.155 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.12 172.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.025 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -137.3 131.73 32.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.627 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 mm -98.14 141.45 16.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.952 0.406 . . . . 0.0 111.21 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 49.2 tt0 -139.67 119.8 13.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.686 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 31' ' ' VAL . 43.5 mm -96.57 108.16 20.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.289 0.566 . . . . 0.0 110.833 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.56 72.48 2.04 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 68.08 -82.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.867 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.7 1.81 24.64 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.132 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -110.08 110.48 21.39 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.522 -0.399 . . . . 0.0 111.084 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.484 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -84.24 92.14 7.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.792 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 84' ' ' ASP . 43.3 m -75.78 122.62 24.33 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.905 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.4 t -112.01 113.61 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.115 0.483 . . . . 0.0 110.28 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -100.91 162.96 12.53 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.224 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.75 167.05 32.18 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.495 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -155.15 142.27 19.3 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.959 0.409 . . . . 0.0 110.319 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.11 7.83 86.41 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.384 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.44 169.23 18.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.381 0.61 . . . . 0.0 112.165 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.1 m -115.32 147.69 40.15 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 170.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.592 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 39.8 tt0 -51.93 -45.8 64.44 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -173.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.3 -50.35 62.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.945 0.403 . . . . 0.0 110.184 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.08 -43.06 96.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.066 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' O ' HD13 ' A' ' 71' ' ' LEU . 27.5 ttpp -59.13 -47.34 85.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 0.0 111.098 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 4.1 mm-40 -66.19 -15.88 63.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.091 0.472 . . . . 0.0 110.736 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -39.04 53.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.701 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.3 mm -65.31 -57.04 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.471 0.653 . . . . 0.0 109.915 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 67' ' ' LYS . 11.0 mp -42.44 -49.68 5.23 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.871 -177.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.662 HG21 ' HG2' ' A' ' 145' ' ' ARG . 57.5 t -69.85 -49.56 56.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.235 0.54 . . . . 0.0 111.199 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HA ' ' SD ' ' A' ' 131' ' ' MET . . . -64.02 -29.68 70.81 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.956 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.2 m -87.6 -29.08 5.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.988 0.423 . . . . 0.0 111.043 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -73.63 -33.46 58.13 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.443 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -80.01 54.26 1.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.773 0.32 . . . . 0.0 111.138 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -122.76 142.48 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 120.927 0.394 . . . . 0.0 110.551 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 t -70.83 103.26 2.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.504 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.61 -18.11 5.46 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.285 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 45.9 mm -94.34 117.17 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.455 0.645 . . . . 0.0 111.045 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.58 -30.47 13.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.881 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.42 ' HB2' HD21 ' A' ' 3' ' ' LEU . 11.7 p -153.17 160.23 42.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.261 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 55' ' ' ALA . 54.9 t -124.94 125.89 70.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.432 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.532 ' HB3' HG23 ' A' ' 56' ' ' THR . 6.4 t70 -97.98 96.84 8.44 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.45 104.98 5.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.117 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -115.94 19.45 15.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.111 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.9 114.91 20.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.997 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -83.19 122.33 28.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.1 p -99.43 130.72 45.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.155 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.47 -21.84 35.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.905 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -140.17 131.69 14.36 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.105 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.53 156.96 36.44 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.499 2.133 . . . . 0.0 111.066 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -150.64 -160.41 1.16 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.512 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.7 m -67.04 131.78 46.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 110.723 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.41 159.53 17.97 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.0 m -138.66 143.26 39.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.101 0.477 . . . . 0.0 110.814 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.474 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 41.6 tt0 -81.33 137.05 35.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.488 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -99.1 80.29 2.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.532 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -73.91 144.86 45.16 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.541 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.419 ' OG1' HG22 ' A' ' 143' ' ' VAL . 12.9 m -120.74 117.94 28.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 142' ' ' GLN . 0.6 OUTLIER -68.18 131.38 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.406 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 32.5 mmtp -84.0 -61.14 1.89 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.92 -170.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.8 t -163.15 -68.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.19 53.43 4.79 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.544 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.8 m-20 -113.1 112.65 24.19 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.129 0.49 . . . . 0.0 111.05 -172.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.472 ' O ' HG23 ' A' ' 110' ' ' ILE . 25.1 m -108.81 146.59 33.39 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.562 ' O ' HG13 ' A' ' 110' ' ' ILE . 25.4 tp -52.61 -45.89 66.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -168.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.619 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 38.9 m -67.19 -41.56 85.67 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.096 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HA ' ' HG3' ' A' ' 112' ' ' LYS . . . -64.37 -37.77 88.66 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.628 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.4 pp -76.96 -22.36 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 109.992 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -67.98 -49.38 62.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.05 171.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.694 ' HG2' ' HB2' ' A' ' 118' ' ' ALA . 22.2 mttt -55.26 -30.31 59.84 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 121.295 0.569 . . . . 0.0 110.155 172.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.628 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 4.5 tp60 -68.24 -56.82 7.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.617 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.47 HG21 HD12 ' A' ' 146' ' ' ILE . 33.8 m -86.32 -42.91 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.158 -172.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.5 ' HB3' HD12 ' A' ' 120' ' ' LEU . 17.6 m-85 -90.82 -26.18 19.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.747 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.14 -9.73 76.86 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.626 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.523 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 26.2 t30 -126.12 129.35 48.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.694 ' HB2' ' HG2' ' A' ' 112' ' ' LYS . . . -72.9 -28.95 62.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.631 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.82 -19.19 65.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.551 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.523 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 54.6 mt -82.99 13.93 3.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.122 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 42.6 p90 -61.2 -32.62 72.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.424 0.63 . . . . 0.0 110.333 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.484 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 11.7 p30 -69.57 -30.04 67.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.458 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -61.94 -46.55 88.84 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.285 0.564 . . . . 0.0 109.656 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.5 mt -64.52 -44.94 96.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.451 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.545 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 26.2 t80 -51.8 -59.44 4.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.207 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 45.4 mt-10 -59.22 -41.37 88.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.361 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -59.51 -31.62 69.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.377 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.494 ' OD1' ' HA ' ' A' ' 144' ' ' LEU . 43.0 m-80 -90.11 -1.63 57.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 132' ' ' LEU . 29.5 mtpp -81.84 155.19 70.63 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.683 0.277 . . . . 0.0 110.362 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' THR . 1.9 Cg_endo -87.58 24.56 18.33 Favored 'Cis proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.819 -1.326 . . . . 0.0 113.461 0.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.467 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.1 OUTLIER -76.35 -37.13 57.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.222 0.534 . . . . 0.0 110.044 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.625 ' O ' ' HG2' ' A' ' 129' ' ' LYS . 13.4 tp -98.0 117.13 31.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.891 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -81.24 -51.29 8.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.783 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.4 m -138.29 154.61 73.94 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.527 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.24 -54.4 5.51 Favored 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 123.415 2.743 . . . . 0.0 112.963 -175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.98 5.76 24.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.541 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -83.82 -0.94 53.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.628 0.251 . . . . 0.0 111.185 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.9 pt -65.76 168.36 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -158.49 153.48 21.43 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.07 112.85 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.043 2.496 . . . . 0.0 112.389 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.503 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 96.77 35.91 5.22 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.615 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.615 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.2 tp60 -108.78 121.43 45.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.988 0.394 . . . . 0.0 110.152 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.506 HG21 ' CD2' ' A' ' 6' ' ' PHE . 41.2 t -83.62 129.46 37.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.237 0.542 . . . . 0.0 110.645 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.494 ' HA ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -118.98 130.83 55.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.229 -177.14 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.662 ' HG2' HG21 ' A' ' 72' ' ' VAL . 55.3 mtp180 -69.52 119.26 13.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.334 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 27.6 mm -106.93 95.58 12.87 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 35.0 Cg_exo -61.49 149.88 87.71 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.656 2.237 . . . . 0.0 111.737 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -58.55 132.23 53.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.286 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -73.46 67.5 1.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.152 0.501 . . . . 0.0 110.961 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 150' ' ' LEU . 0.4 OUTLIER -88.67 61.52 6.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 172.402 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -140.38 121.52 14.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.647 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -117.96 152.28 35.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.659 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 60.14 57.11 3.08 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.709 0.631 . . . . 0.0 111.032 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -111.81 122.97 49.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.258 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 5.7 t-80 -60.99 134.93 57.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.167 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.528 ' HB2' ' O ' ' A' ' 155' ' ' HIS . 13.0 m-70 75.15 126.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.959 0.787 . . . . 0.0 110.65 -173.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 . . . . . 0 C--O 1.247 0.949 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.117 177.345 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.43 68.73 1.48 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.995 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.1 mt -73.51 134.01 43.76 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.76 0.791 . . . . 0.0 112.225 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.516 ' HB2' HG12 ' A' ' 83' ' ' VAL . 97.7 m-85 -101.44 127.11 48.25 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.358 175.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -87.43 134.08 33.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.704 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 50.7 m-85 -117.76 -158.15 0.7 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 88.5 t -89.36 -79.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.015 173.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.6 tmtp? 165.82 -71.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.017 0.823 . . . . 0.0 109.235 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.03 -25.95 34.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.355 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.79 124.06 23.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.963 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.21 -178.02 28.84 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -71.5 130.0 40.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 117.017 0.408 . . . . 0.0 109.911 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 48.0 mtmt -77.64 92.93 4.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.356 0.598 . . . . 0.0 111.554 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 34' ' ' HIS . 6.9 mp -91.98 -42.54 9.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.556 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.43 ' CB ' ' HG2' ' A' ' 21' ' ' GLN . 38.5 p90 -136.14 23.86 3.27 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.708 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 66.26 -6.46 0.48 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.419 ' HB2' ' C ' ' A' ' 78' ' ' SER . . . 62.22 29.27 17.4 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.815 0.446 . . . . 0.0 111.951 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.0 t -106.24 -71.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.006 0.431 . . . . 0.0 110.461 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 p -121.04 -39.79 2.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.92 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 145.93 -139.78 8.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.731 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.43 ' HG2' ' CB ' ' A' ' 15' ' ' TRP . 15.2 mm-40 -141.13 -91.54 0.15 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.408 0.146 . . . . 0.0 110.645 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -94.38 -35.12 12.51 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.437 ' H ' ' HB3' ' A' ' 26' ' ' ASP . 4.3 t70 -169.15 -175.04 2.16 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -81.18 -39.21 25.84 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.702 0.287 . . . . 0.0 110.405 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -72.07 -21.54 61.5 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 24.2 t70 -64.34 -37.37 87.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.957 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.592 ' O ' HG23 ' A' ' 31' ' ' VAL . 20.7 mt-30 -61.55 -38.98 89.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.291 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.2 -42.89 96.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.101 0.477 . . . . 0.0 110.483 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 27.1 ttpp -62.04 -42.84 99.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.041 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 28.0 mmtp -60.44 -40.11 89.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.97 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 27' ' ' GLN . 95.3 t -58.29 -49.06 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.359 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -55.16 -46.61 75.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.922 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 46.6 mt-10 -57.28 -44.15 83.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.732 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.439 ' HB2' HD21 ' A' ' 14' ' ' LEU . 65.9 t60 -57.81 -44.74 86.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.979 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 91.3 mt -64.96 -40.79 95.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.964 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -72.5 -34.01 67.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.273 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -72.1 -33.19 67.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.42 -25.35 46.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.109 0.48 . . . . 0.0 110.854 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.35 26.91 12.71 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.082 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.0 mm -65.09 122.15 78.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -75.45 151.21 37.29 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.978 1.785 . . . . 0.0 111.745 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 63.78 6.72 2.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.949 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.24 -22.92 61.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.018 0.437 . . . . 0.0 111.001 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -77.32 -19.67 56.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.383 176.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -77.47 -21.81 52.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.986 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.5 m -101.34 173.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.338 0.59 . . . . 0.0 111.88 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -131.19 140.56 49.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.991 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.3 mm -102.99 138.68 26.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.957 0.408 . . . . 0.0 111.118 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -137.29 122.53 19.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.699 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 27' ' ' GLN . 17.4 mm -92.93 122.37 44.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.979 0.419 . . . . 0.0 110.597 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.7 70.41 0.71 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.98 -82.34 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.325 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 -5.86 23.34 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.989 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 106.3 17.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.941 0.401 . . . . 0.0 111.017 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.59 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -83.09 111.18 18.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.479 HG23 ' HB3' ' A' ' 84' ' ' ASP . 32.6 m -93.31 132.49 37.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.858 0.361 . . . . 0.0 111.32 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.99 123.56 65.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.0 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -122.75 158.04 31.02 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.385 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.22 177.7 28.75 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -160.16 145.18 14.89 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.053 0.426 . . . . 0.0 110.433 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 100.26 11.7 41.34 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.942 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 mp -96.12 165.67 12.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.172 0.51 . . . . 0.0 111.574 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.0 m -85.57 143.02 28.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.871 174.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 93' ' ' ALA . 20.1 tm0? -63.92 -28.18 69.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.466 -174.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.46 -29.59 59.67 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.904 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.38 -39.98 31.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.744 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -62.68 -31.97 72.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.679 -176.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.549 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.5 mm-40 -65.29 -42.59 92.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.148 0.499 . . . . 0.0 110.118 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.46 -43.9 96.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.668 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 67' ' ' LYS . 46.5 mt -61.52 -53.65 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.583 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 94.9 mt -44.65 -48.35 10.54 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.798 0.686 . . . . 0.0 111.917 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 68' ' ' GLU . 54.8 t -62.91 -52.11 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.141 0.496 . . . . 0.0 111.053 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.9 70.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.692 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.467 HG13 HG11 ' A' ' 31' ' ' VAL . 52.7 t -75.04 -43.38 45.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.704 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -71.8 -28.79 68.33 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.329 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -77.79 45.29 0.5 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.062 0.458 . . . . 0.0 111.919 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.3 mt -117.89 140.33 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.356 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.423 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 11.9 t -65.96 103.28 0.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.529 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.14 -19.71 4.08 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 55' ' ' ALA . 34.8 mm -97.13 133.24 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.301 0.572 . . . . 0.0 110.546 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -113.45 -14.21 12.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.479 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 p -165.26 150.77 9.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.777 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.539 HG12 ' HE1' ' A' ' 6' ' ' PHE . 15.0 p -120.3 134.23 64.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.835 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.479 ' HB3' HG23 ' A' ' 56' ' ' THR . 22.7 t0 -101.71 125.53 48.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.0 101.36 13.91 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.847 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -119.11 12.96 12.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.205 0.526 . . . . 0.0 110.217 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 p -86.77 128.28 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.432 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -89.18 147.35 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.841 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.4 p -108.01 142.09 38.68 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.83 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.435 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -95.2 -33.17 12.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.321 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 p -126.87 134.77 26.46 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.087 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.72 119.05 5.29 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.579 2.186 . . . . 0.0 111.102 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.403 ' H ' ' HB3' ' A' ' 64' ' ' GLN . . . -130.48 -160.91 1.08 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.658 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 m -76.47 116.87 17.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.101 0.477 . . . . 0.0 111.764 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.38 162.69 24.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.732 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 m -128.02 150.17 50.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.49 0.662 . . . . 0.0 112.308 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.423 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 23.9 tt0 -91.16 139.33 30.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.144 172.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -106.35 82.27 1.72 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.95 0.405 . . . . 0.0 110.838 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 75.6 t80 -84.71 141.32 30.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.062 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.2 m -107.44 118.8 37.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.694 0.283 . . . . 0.0 110.77 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.0 OUTLIER -72.56 134.05 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.478 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 33.4 mmtp -100.99 -166.03 1.27 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.397 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.8 t -72.77 122.64 21.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.948 0.404 . . . . 0.0 109.959 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.67 7.18 69.23 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.91 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 5.8 m-20 -82.6 118.84 23.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.211 0.529 . . . . 0.0 110.518 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.574 ' O ' HG23 ' A' ' 110' ' ' ILE . 7.1 m -100.74 149.43 23.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.81 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.548 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 24.4 tp -58.66 -35.21 72.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.571 0.623 . . . . 0.0 110.29 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.461 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 9.1 p -69.22 -40.33 78.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.401 0.62 . . . . 0.0 110.567 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -68.18 -38.92 82.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.152 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.615 ' HA ' ' CG ' ' A' ' 113' ' ' GLN . 1.5 pp -79.34 -23.79 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 124' ' ' ILE . 8.7 p -74.57 -34.96 63.02 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 5.7 tmmm? -58.34 -30.53 66.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.768 170.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.615 ' CG ' ' HA ' ' A' ' 110' ' ' ILE . 69.0 mm-40 -68.32 -72.22 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.126 0.965 . . . . 0.0 110.774 175.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 110' ' ' ILE . 29.2 m -73.32 -36.87 50.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 113.65 -1.613 . . . . 0.0 112.631 -166.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 120' ' ' LEU . 22.8 m-85 -97.46 -22.86 16.34 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.482 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.21 11.31 76.08 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.436 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -151.94 124.19 8.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.66 0.267 . . . . 0.0 110.791 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 108' ' ' SER . . . -73.58 -19.54 60.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.951 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -68.15 -24.64 65.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.443 HD12 ' HB3' ' A' ' 115' ' ' TYR . 51.6 mt -85.83 20.46 2.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.757 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.548 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 17.3 p90 -68.95 -28.42 66.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.121 0.486 . . . . 0.0 110.217 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.514 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 27.1 p-10 -70.63 -31.48 68.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.448 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 29.4 mmmt -54.81 -49.19 71.58 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.428 0.632 . . . . 0.0 110.158 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 111' ' ' SER . 47.7 mt -66.72 -47.51 82.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.315 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.539 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 44.7 t80 -49.32 -54.02 19.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.592 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 34.8 mt-10 -61.96 -36.62 81.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.244 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.37 -31.02 65.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.459 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 131' ' ' MET . 8.1 m120 -76.09 -27.95 57.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.969 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.592 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 29.5 mtpp -61.24 151.72 75.01 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.087 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -88.73 17.03 41.65 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.672 -1.803 . . . . 0.0 112.779 0.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.463 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -69.37 -37.56 77.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.417 177.176 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.74 117.01 29.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.66 -37.39 24.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.574 -174.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 137' ' ' LYS . 19.3 m -152.0 144.55 16.85 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.151 0.501 . . . . 0.0 109.879 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.41 -20.37 66.18 Favored 'Trans proline' 0 C--N 1.332 -0.32 0 C-N-CA 123.487 2.791 . . . . 0.0 112.545 -171.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -98.73 -4.65 33.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.909 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.435 ' HG3' ' HB2' ' A' ' 134' ' ' SER . 27.3 mtpp -90.15 9.28 28.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.928 0.394 . . . . 0.0 111.284 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 14.0 pt -58.89 169.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.569 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -157.21 143.87 13.29 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.069 -175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.6 112.73 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.281 2.654 . . . . 0.0 112.559 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 107.56 27.01 5.4 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.894 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.548 ' H ' HG22 ' A' ' 101' ' ' VAL . 48.1 tt0 -103.21 116.61 32.79 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.989 -175.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.661 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 25.7 t -80.63 130.88 35.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.7 mt -118.25 145.58 44.92 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.795 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.534 ' HB2' HG21 ' A' ' 72' ' ' VAL . 37.3 ttt180 -74.93 98.38 3.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.826 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 19.7 mm -87.51 106.55 11.8 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.65 156.04 67.65 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.718 1.612 . . . . 0.0 111.748 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.89 136.08 56.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.805 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -67.73 101.63 1.08 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.092 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 151' ' ' GLU . 44.0 tp -103.58 90.5 3.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 150' ' ' LEU . 34.4 tt0 71.11 147.58 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.93 0.769 . . . . 0.0 110.035 -172.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -134.78 123.57 23.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.407 0.622 . . . . 0.0 112.484 -175.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -82.45 78.88 9.04 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.02 41.34 0.36 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -169.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -136.5 114.47 11.36 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.277 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -113.97 -30.52 6.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.827 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 38.6 t60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.739 -178.197 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.685 0.279 . . . . 0.0 110.397 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.42 167.33 16.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.064 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 83' ' ' VAL . 41.3 tp -134.87 125.78 27.46 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.651 ' HB2' HG12 ' A' ' 83' ' ' VAL . 78.1 m-85 -124.72 138.9 54.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.901 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -98.19 140.99 31.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.618 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.639 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 86.7 m-85 -127.27 -171.69 2.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.037 0.446 . . . . 0.0 111.899 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.904 HG11 ' HB3' ' A' ' 10' ' ' ALA . 4.5 p -78.16 -26.44 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.176 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.604 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 25.1 tptp 78.95 -55.05 0.45 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.472 0.709 . . . . 0.0 112.295 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.08 7.23 43.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.904 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -125.21 157.62 36.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 121.243 -0.183 . . . . 0.0 110.561 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.6 -148.29 16.88 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.089 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.472 ' HG2' ' ND1' ' A' ' 34' ' ' HIS . 8.9 tp10 -82.39 129.87 34.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.007 0.404 . . . . 0.0 110.277 177.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -95.84 93.16 6.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.775 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 34' ' ' HIS . 1.4 mm? -86.36 -51.32 6.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -105.97 2.34 27.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.218 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 63.09 104.93 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.117 0.885 . . . . 0.0 111.214 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' A' ' 78' ' ' SER . . . -73.02 79.97 1.2 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.386 0.612 . . . . 0.0 110.371 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.0 p -170.26 -35.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.514 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 p -103.59 -62.03 1.35 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.323 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.79 73.16 1.08 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -84.74 121.46 27.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.138 -0.531 . . . . 0.0 111.765 -171.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 38.3 m80 65.81 -170.65 0.19 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.134 174.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -67.69 163.98 20.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.459 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -70.31 -30.14 67.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.651 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -67.78 -31.32 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.956 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 24.3 t70 -70.26 -35.88 74.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.734 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 31' ' ' VAL . 90.9 mt-30 -63.17 -36.46 83.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.379 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 50' ' ' ILE . . . -58.93 -41.06 86.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 174.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -63.68 -39.91 95.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.556 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -62.42 -32.94 73.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.157 177.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.554 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 84.6 t -68.48 -44.99 82.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.377 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -52.87 -52.26 58.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.311 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.32 -41.32 88.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.702 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.472 ' ND1' ' HG2' ' A' ' 12' ' ' GLU . 31.9 t60 -54.52 -48.67 71.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.805 0.336 . . . . 0.0 110.797 174.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 77.4 mt -66.92 -42.8 84.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.985 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -75.99 -27.11 57.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.725 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.55 -34.36 47.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.495 0.188 . . . . 0.0 111.159 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.424 ' O ' ' HG2' ' A' ' 130' ' ' PRO . 2.0 p -73.44 -44.55 57.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.675 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.2 32.86 1.58 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.529 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.55 HD13 ' HD2' ' A' ' 130' ' ' PRO . 35.8 mm -73.08 126.69 90.22 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 5.7 Cg_exo -73.54 145.09 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.374 2.049 . . . . 0.0 112.763 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 63.56 15.8 9.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.12 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.36 -23.8 63.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.239 0.542 . . . . 0.0 110.457 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.13 -20.51 62.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.801 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -92.03 -26.24 18.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.952 0.406 . . . . 0.0 110.984 -174.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.6 HG21 HG21 ' A' ' 70' ' ' ILE . 33.6 m -90.26 163.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -128.41 131.61 48.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.705 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.7 mp -105.79 128.89 59.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.08 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -117.15 132.74 56.59 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' A' ' 28' ' ' ALA . 14.2 mm -105.04 108.82 25.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.379 0.609 . . . . 0.0 111.331 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' ASP . . . -99.05 69.26 1.74 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.096 176.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 3.5 m-20 70.2 -80.04 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.132 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.75 -8.21 12.41 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.702 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' CE ' ' HB2' ' A' ' 84' ' ' ASP . 82.4 tttt -102.26 112.97 25.87 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.049 0.452 . . . . 0.0 110.688 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.532 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -94.54 121.39 36.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.139 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.0 m -99.93 118.24 35.94 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 74' ' ' VAL . 25.5 t -98.26 122.76 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.89 155.16 33.24 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.859 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.4 174.74 36.75 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 p-10 -153.02 142.31 21.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.975 0.417 . . . . 0.0 110.649 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.89 17.42 61.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.238 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mp -93.34 178.41 5.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.103 0.477 . . . . 0.0 111.201 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.8 m -126.82 149.55 49.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.99 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.516 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 15.7 mm100 -57.53 -26.59 61.6 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.988 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.82 -36.6 72.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.722 0.296 . . . . 0.0 111.785 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.85 -34.45 10.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.498 . . . . 0.0 110.396 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 82.3 tttt -61.0 -41.26 96.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.469 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 145' ' ' ARG . 7.1 mm-40 -78.25 8.92 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.086 0.469 . . . . 0.0 110.822 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -98.72 -46.44 5.68 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.6 HG21 HG21 ' A' ' 46' ' ' VAL . 20.7 mt -67.34 -55.34 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.352 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 tp -65.33 -16.85 64.02 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.099 -170.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 145' ' ' ARG . 63.9 t -90.6 -52.63 10.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.327 175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.32 -18.98 65.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.954 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.523 HG23 HG11 ' A' ' 31' ' ' VAL . 7.6 p -82.05 -42.74 19.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.875 0.369 . . . . 0.0 110.693 175.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.639 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -67.71 -35.92 86.54 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.135 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -85.3 38.23 0.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.546 0.689 . . . . 0.0 111.262 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.2 mt -102.29 144.13 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.116 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.424 ' C ' ' HB2' ' A' ' 17' ' ' ALA . 67.8 m -70.47 99.26 1.58 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.428 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.97 -18.27 3.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.986 -175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 55' ' ' ALA . 41.0 mm -98.53 120.5 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.376 0.608 . . . . 0.0 110.991 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.604 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -98.55 -24.91 14.93 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.738 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.7 m -159.52 160.21 34.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.917 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 4' ' ' PHE . 4.3 p -131.31 138.4 53.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.891 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.422 ' HB2' ' CE ' ' A' ' 54' ' ' LYS . 31.3 t70 -111.36 120.53 42.51 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' A' ' 1' ' ' MET . 7.1 t0 -88.54 121.46 30.95 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.107 0.479 . . . . 0.0 110.942 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -135.26 32.16 3.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.592 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.74 110.61 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.087 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 53.5 mttm -74.76 130.09 38.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.966 0.412 . . . . 0.0 110.144 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 p -105.29 124.6 49.82 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.767 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.97 -18.17 44.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.96 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.6 p -109.27 144.88 30.66 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.72 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.36 42.73 1.28 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.985 2.457 . . . . 0.0 111.988 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.85 156.59 32.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.899 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 m -74.07 129.13 37.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.182 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.74 164.17 23.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.397 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.9 m -120.16 148.16 43.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.189 0.518 . . . . 0.0 111.471 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.67 148.91 32.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.426 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -116.54 116.22 27.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.875 0.369 . . . . 0.0 110.531 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 143' ' ' VAL . 94.4 t80 -110.57 130.26 55.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.9 m -94.08 118.54 31.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.614 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 2.0 m -72.63 130.3 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 140' ' ' PRO . 73.3 mmtt -98.72 -60.43 1.54 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -169.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.4 t -164.0 122.76 1.92 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.745 0.307 . . . . 0.0 110.189 -174.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.62 11.06 72.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.827 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.614 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 2.0 m-20 -73.16 121.33 20.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.265 0.555 . . . . 0.0 110.431 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 110' ' ' ILE . 46.3 p -114.63 157.7 22.73 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 135' ' ' PRO . 26.0 tp -58.05 -40.55 81.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.583 0.629 . . . . 0.0 111.455 -170.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.459 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 13.3 m -76.54 -20.12 57.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.067 0.46 . . . . 0.0 111.05 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.8 -39.55 26.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.049 -0.407 . . . . 0.0 110.43 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.6 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.1 pp -80.25 -24.5 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.958 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.0 p -70.21 -45.12 67.24 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -61.41 -24.28 66.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.579 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -72.12 -57.75 4.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.977 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 115' ' ' TYR . 32.6 m -84.0 -48.43 17.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.043 -172.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.487 ' N ' HG23 ' A' ' 114' ' ' VAL . 56.2 m-85 -82.23 -41.23 20.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.056 0.455 . . . . 0.0 110.647 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.96 -14.73 34.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.997 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.402 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 27.6 t30 -123.0 123.12 40.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.815 0.341 . . . . 0.0 110.297 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -67.32 -27.59 67.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.675 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -74.58 -3.55 31.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 0.0 111.282 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 115' ' ' TYR . 68.4 mt -91.11 19.49 5.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.232 0.539 . . . . 0.0 110.682 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -63.09 -35.77 81.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.499 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -67.4 -27.64 67.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.723 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -60.08 -43.74 95.28 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.355 0.597 . . . . 0.0 109.921 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.429 HD13 HD11 ' A' ' 110' ' ' ILE . 62.0 mt -72.21 -43.35 65.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.296 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 134' ' ' SER . 61.1 t80 -55.54 -53.01 61.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.249 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 19.2 mt-10 -68.11 -24.01 64.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.349 0.595 . . . . 0.0 111.399 -177.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.437 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -79.38 -25.76 42.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.85 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.49 ' HB3' ' HE2' ' A' ' 131' ' ' MET . 24.1 m-80 -99.13 18.68 16.83 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.028 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.449 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 30.5 mmmt -79.76 140.83 55.0 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.209 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.55 ' HD2' HD13 ' A' ' 40' ' ' ILE . 19.6 Cg_endo -100.22 13.24 23.51 Favored 'Cis proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.84 -0.9 . . . . 0.0 112.078 -6.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.49 ' HE2' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -65.51 -25.93 67.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.712 -178.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 133' ' ' LYS . 9.0 tp -100.63 122.7 43.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 170.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.522 ' H ' ' HD2' ' A' ' 133' ' ' LYS . 9.6 mptt -81.05 -44.71 17.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.738 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.409 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 57.2 p -157.72 163.11 25.79 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.882 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.466 ' HA ' HD22 ' A' ' 107' ' ' LEU . 51.8 Cg_exo -54.5 -28.13 53.32 Favored 'Trans proline' 0 C--N 1.328 -0.526 0 C-N-CA 123.096 2.531 . . . . 0.0 112.316 175.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.11 -20.25 19.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.48 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 133' ' ' LYS . 22.9 mmtp -73.48 -6.93 49.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -173.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.614 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 21.1 pt -65.82 166.56 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.182 0.515 . . . . 0.0 111.086 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 142' ' ' GLN . 12.4 p90 -165.58 148.99 7.02 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.923 -177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 102' ' ' LYS . 50.5 Cg_exo -42.71 118.32 1.13 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.915 3.077 . . . . 0.0 113.313 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 106.66 12.32 24.85 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.799 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.614 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 14.0 mt-30 -99.86 120.77 40.3 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.968 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 23.2 t -86.53 127.73 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.173 170.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.3 mt -117.72 143.28 46.35 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.754 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 68' ' ' GLU . 42.2 ttt180 -70.37 118.93 13.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.691 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.3 mm -111.16 90.19 11.13 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.766 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.437 ' HG3' ' HB2' ' A' ' 127' ' ' ALA . 92.8 Cg_endo -77.54 176.67 9.77 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.32 2.013 . . . . 0.0 111.801 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.8 132.75 49.46 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 149' ' ' GLU . 1.4 pm0 -69.02 73.44 0.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.211 0.529 . . . . 0.0 111.925 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 77.4 mt -66.25 132.37 48.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.732 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.04 94.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.565 0.541 . . . . 0.0 111.597 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -136.72 -16.84 1.49 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.505 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -159.7 75.04 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -94.15 146.21 24.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.302 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -146.85 -60.86 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 0.0 110.918 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -77.02 130.62 37.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 110.372 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 75.1 m80 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.059 179.427 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 121.235 0.54 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.26 124.46 4.73 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.388 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 83' ' ' VAL . 47.9 tp 68.7 134.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.478 0.711 . . . . 0.0 111.981 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -123.61 147.16 47.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.982 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -114.9 138.55 50.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.988 0.423 . . . . 0.0 111.165 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.539 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 37.8 m-85 -130.27 171.03 13.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.339 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 93.7 t -88.67 119.29 35.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.941 0.4 . . . . 0.0 110.009 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 1.069 ' HG2' ' HB2' ' A' ' 81' ' ' ALA . 5.0 tmtp? -52.2 -40.34 61.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.232 -171.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.31 -17.07 35.52 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.277 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . . . -88.07 164.65 15.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.927 0.394 . . . . 0.0 111.535 -174.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.52 -170.92 14.29 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.061 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.97 125.47 26.06 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -77.27 59.94 1.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.219 1.009 . . . . 0.0 109.062 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.411 HD21 ' O ' ' A' ' 30' ' ' LYS . 17.3 tp -64.52 -51.57 62.21 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.428 -175.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.571 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 3.3 p90 -117.71 -0.53 11.78 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.168 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 68.2 -36.23 0.3 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.814 0.846 . . . . 0.0 113.102 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.484 ' N ' ' HD1' ' A' ' 15' ' ' TRP . . . 77.18 -30.57 0.17 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.25 1.02 . . . . 0.0 111.455 177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 m -85.13 -15.68 10.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.474 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 t -179.09 105.57 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.484 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.37 -19.26 2.27 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.034 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.571 ' HB2' ' CD1' ' A' ' 15' ' ' TRP . 30.5 tt0 -98.61 141.25 31.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.335 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -132.8 -89.4 0.41 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.713 0.292 . . . . 0.0 111.293 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.582 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 8.1 m-20 -97.22 148.76 22.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.451 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' HD2' ' H ' ' A' ' 52' ' ' ASP . 33.9 mtmm -64.67 -38.38 90.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.069 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -72.57 -22.63 60.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.088 0.47 . . . . 0.0 110.203 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 12.8 t70 -74.95 -41.4 59.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.53 172.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 23' ' ' ASP . 71.0 mt-30 -57.65 -44.17 85.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.159 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.48 -44.87 73.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.966 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 52.5 tttm -66.35 -43.87 84.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.807 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -55.44 -42.61 74.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.339 178.063 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.692 HG11 HG23 ' A' ' 74' ' ' VAL . 43.2 t -66.16 -44.41 91.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.597 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.507 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 8.6 mm-40 -57.77 -46.58 84.34 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.548 0.213 . . . . 0.0 111.01 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.2 mt-10 -58.44 -46.33 86.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -55.78 -44.01 77.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.351 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 83.8 mt -64.16 -38.45 91.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 110.557 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -78.27 -22.83 47.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.197 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 32.5 mmmt -75.52 -48.07 24.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.903 0.382 . . . . 0.0 110.344 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 p -64.24 -38.71 92.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.505 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.32 32.69 3.63 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.585 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.644 HD13 ' HD2' ' A' ' 130' ' ' PRO . 29.9 mm -72.6 120.36 80.21 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -81.09 150.58 17.92 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 122.099 1.866 . . . . 0.0 111.876 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 65.57 11.9 7.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.259 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.42 -25.64 33.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.189 0.518 . . . . 0.0 110.045 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.03 -12.05 59.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.881 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -76.97 -25.23 52.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.841 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.441 HG21 HG21 ' A' ' 70' ' ' ILE . 27.1 m -109.14 168.11 3.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.397 0.618 . . . . 0.0 111.822 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -121.93 146.62 46.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.415 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.507 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 21.0 mm -105.63 137.07 37.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.878 0.37 . . . . 0.0 110.692 -177.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.432 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 98.6 mt-30 -134.04 145.68 49.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 27' ' ' GLN . 26.0 mm -126.09 128.12 71.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.114 0.483 . . . . 0.0 111.754 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -119.22 89.2 3.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.046 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.427 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 3.2 m-20 63.85 -92.65 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.735 -174.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.26 10.5 13.18 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.605 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 82' ' ' SER . 21.7 ttmm -104.18 112.84 26.01 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.088 0.471 . . . . 0.0 110.381 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -92.06 121.75 33.92 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.982 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.432 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 23.7 m -100.22 116.7 32.83 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.9 t -92.78 133.9 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.779 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -142.06 160.64 39.81 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.009 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.43 172.29 31.71 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.55 146.08 41.44 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.99 0.395 . . . . 0.0 110.22 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 84.63 10.74 78.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.229 177.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.86 168.7 19.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.122 0.487 . . . . 0.0 111.896 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.3 p -111.18 154.06 24.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.87 0.74 8.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.13 -51.46 4.62 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.72 90.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.746 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 19.8 ptmt -58.79 -34.63 71.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.671 0.272 . . . . 0.0 111.544 -174.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.533 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.4 mm-40 -65.96 -29.45 69.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.215 0.531 . . . . 0.0 110.083 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -72.73 -40.8 65.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.599 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.441 HG21 HG21 ' A' ' 46' ' ' VAL . 2.4 mp -63.11 -47.21 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 96.4 mt -53.73 -32.74 53.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.008 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 68' ' ' GLU . 47.0 t -72.15 -58.32 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.393 0.616 . . . . 0.0 110.975 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.38 -28.32 69.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.451 -173.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.692 HG23 HG11 ' A' ' 31' ' ' VAL . 7.2 p -79.98 -26.14 12.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.337 0.589 . . . . 0.0 110.661 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.539 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -83.99 -34.16 18.94 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.543 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.57 60.95 2.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.018 0.437 . . . . 0.0 111.006 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.484 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 7.9 mm -126.22 128.81 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -65.11 113.4 3.92 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.28 -13.76 11.08 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.397 -171.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.484 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 37.4 mm -100.61 138.86 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.064 0.459 . . . . 0.0 110.133 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.069 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -125.55 -17.04 5.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.5 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 9.2 p -155.87 158.57 38.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.081 0.467 . . . . 0.0 111.321 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 56.0 t -133.23 130.5 57.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.949 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HB3' HG23 ' A' ' 56' ' ' THR . 26.3 t0 -104.05 124.58 49.3 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -95.23 101.41 13.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.302 -174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -119.11 11.84 12.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.121 0.486 . . . . 0.0 110.596 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.43 135.52 26.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.228 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -99.77 141.85 32.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.631 -173.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.5 p -109.17 137.44 47.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.194 0.521 . . . . 0.0 111.445 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.447 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -99.62 -35.79 9.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.393 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 24.2 p -112.43 147.05 36.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.293 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 3.0 Cg_endo -80.43 143.09 15.18 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.417 2.744 . . . . 0.0 111.843 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -161.06 166.68 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.209 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.7 m -73.39 131.43 41.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.502 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.8 173.31 8.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.7 m -123.8 151.76 42.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.442 0.639 . . . . 0.0 111.297 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.448 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 17.9 tt0 -89.81 143.36 26.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.132 173.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -105.77 102.06 11.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.247 0.546 . . . . 0.0 111.067 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.467 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 93.3 t80 -102.14 135.99 42.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.219 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.401 ' OG1' HG22 ' A' ' 143' ' ' VAL . 3.0 m -105.46 122.29 45.7 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.2 m -67.37 126.74 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 140' ' ' PRO . 34.5 mmtp -87.18 -66.06 0.95 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -170.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.2 t -175.12 122.63 0.22 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.88 15.12 81.6 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -172.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.519 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -86.42 118.12 25.64 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.547 -0.827 . . . . 0.0 109.885 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 110' ' ' ILE . 22.7 p -109.03 157.8 18.34 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -55.29 -45.54 76.23 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.579 -174.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.436 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 7.4 m -61.09 -42.45 98.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.709 0.29 . . . . 0.0 110.82 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.36 87.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.341 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 106' ' ' THR . 1.2 pp -76.27 -26.52 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.74 0.305 . . . . 0.0 110.442 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.527 ' OG ' ' HA ' ' A' ' 121' ' ' TYR . 42.5 m -68.37 -46.45 70.05 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-O 121.204 0.526 . . . . 0.0 109.793 169.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -56.38 -30.61 62.93 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.326 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -68.52 -63.3 1.09 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.4 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.404 HG21 HD12 ' A' ' 146' ' ' ILE . 23.5 m -80.0 -40.98 20.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.111 -170.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.425 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 15.7 m-85 -91.27 -49.74 6.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.446 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.95 5.74 32.91 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 120' ' ' LEU . 58.6 t-20 -135.17 113.91 11.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -71.52 -15.59 62.31 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -85.48 -2.87 58.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.04 0.448 . . . . 0.0 110.743 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.443 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . 63.4 mt -89.51 18.65 5.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.061 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HA ' ' OG ' ' A' ' 111' ' ' SER . 47.5 p90 -68.94 -26.14 64.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.084 -174.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -68.93 -36.47 78.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.439 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 120' ' ' LEU . 31.6 mtmt -54.26 -52.76 60.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.328 0.585 . . . . 0.0 110.697 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.406 ' HB ' HD11 ' A' ' 107' ' ' LEU . 32.6 mt -68.75 -39.44 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.747 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.752 ' HA ' HD23 ' A' ' 132' ' ' LEU . 5.5 t80 -59.55 -52.91 63.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.745 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HA ' ' HG3' ' A' ' 129' ' ' LYS . 2.2 mm-40 -60.99 -39.66 90.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.131 0.491 . . . . 0.0 111.507 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -63.85 -28.04 69.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.386 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.541 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 38.9 m-80 -98.99 6.69 46.57 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 20.9 mtmm -78.7 156.2 77.89 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 122.101 -0.374 . . . . 0.0 110.709 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.644 ' HD2' HD13 ' A' ' 40' ' ' ILE . 1.3 Cg_endo -87.73 14.62 46.83 Favored 'Cis proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.994 -1.253 . . . . 0.0 112.478 -3.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.541 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.0 tmm? -64.71 -39.23 93.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 125' ' ' PHE . 35.0 tp -97.33 117.83 32.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.409 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 10.6 mptt -87.51 -33.9 18.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.899 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.456 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 15.1 p -161.8 155.0 17.56 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.137 0.494 . . . . 0.0 109.751 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 12.2 Cg_endo -60.75 -8.14 8.79 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 123.679 2.919 . . . . 0.0 113.117 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -113.72 -14.8 12.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.238 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -87.47 20.16 3.0 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 106' ' ' THR . 8.3 pt -79.06 172.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.2 p90 -154.12 142.05 13.99 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.428 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 139' ' ' TYR . 80.4 Cg_exo -51.07 114.27 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.261 2.641 . . . . 0.0 112.851 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.34 13.91 11.33 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.892 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.538 ' H ' HG22 ' A' ' 101' ' ' VAL . 41.5 tt0 -98.47 120.58 39.14 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.661 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 100' ' ' THR . 42.4 t -82.65 133.18 29.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.281 0.562 . . . . 0.0 109.999 174.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.1 mt -126.2 136.03 52.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.605 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.475 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 2.2 ptm180 -74.49 123.64 25.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.222 0.534 . . . . 0.0 110.026 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 37.0 mm -100.34 102.9 20.13 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.784 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 46.4 Cg_exo -56.77 145.37 83.45 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.377 2.052 . . . . 0.0 111.253 176.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -57.21 119.81 7.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.618 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.15 125.7 26.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.979 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 90.4 mt -120.07 13.48 12.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.658 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.55 112.04 2.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.259 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -102.17 -6.76 22.86 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -125.77 86.79 2.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.598 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -75.15 88.03 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.118 0.485 . . . . 0.0 110.798 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -146.75 130.66 17.16 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -61.76 -36.93 82.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.057 0.456 . . . . 0.0 110.74 -177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 C--O 1.242 0.691 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.817 176.331 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 120.698 0.285 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.03 -7.98 1.92 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.476 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 23.9 tp -101.11 115.44 30.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.28 0.54 . . . . 0.0 110.82 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 82' ' ' SER . 82.8 m-85 -113.03 139.22 48.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.921 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -99.52 155.87 17.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.579 0.228 . . . . 0.0 110.909 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.695 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 94.2 m-85 -134.29 -158.73 0.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.977 0.418 . . . . 0.0 111.429 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.008 HG11 ' HB3' ' A' ' 10' ' ' ALA . 6.3 p -82.3 -23.14 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.462 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.62 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 18.5 tptm 75.82 -61.39 0.47 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.472 0.709 . . . . 0.0 111.891 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.44 -37.94 35.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 1.008 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -81.53 152.6 27.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.737 0.303 . . . . 0.0 110.622 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.25 -178.26 19.4 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.055 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.63 134.52 47.64 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -83.72 89.97 7.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.62 0.724 . . . . 0.0 112.287 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.581 HD22 HD12 ' A' ' 77' ' ' ILE . 6.4 mp -89.88 -39.15 13.23 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.672 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -136.33 151.51 49.68 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.33 -21.67 66.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.988 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 66.6 -1.25 1.34 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.101 0.56 . . . . 0.0 112.472 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 m -67.88 -41.05 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 120.976 0.417 . . . . 0.0 110.41 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.3 p -107.08 -3.87 19.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.486 174.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.47 -21.82 12.5 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.138 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 56.45 24.6 8.69 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.172 0.51 . . . . 0.0 110.796 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -75.25 -17.56 60.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.351 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -69.37 -12.92 62.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.94 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -101.62 145.0 29.66 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.698 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -92.44 -10.86 36.43 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.653 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 2.9 m-20 -73.26 -10.77 60.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.848 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -62.42 -31.83 72.58 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.929 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.77 -35.0 74.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.313 0.578 . . . . 0.0 110.086 174.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -69.28 -38.99 78.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.642 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 75.3 mmtt -53.06 -43.4 66.67 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.556 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 51.7 t -69.73 -36.14 68.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.78 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -59.61 -43.52 93.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.0 mt-10 -57.7 -51.14 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.05 -47.11 53.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.347 177.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 91.6 mt -66.83 -41.95 86.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.192 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -72.13 -32.07 66.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.121 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 14.3 mmmm -72.34 -38.6 68.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 0.0 111.225 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' HG12 ' A' ' 40' ' ' ILE . 2.9 p -74.49 -31.42 62.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.156 0.503 . . . . 0.0 110.91 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.1 30.1 8.07 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.6 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.544 HD13 ' HD2' ' A' ' 130' ' ' PRO . 46.0 mm -59.3 129.01 86.34 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 122.264 0.226 . . . . 0.0 110.504 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -61.46 129.02 26.55 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.541 2.161 . . . . 0.0 112.637 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.16 22.75 10.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.53 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -70.59 -20.04 62.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.207 0.527 . . . . 0.0 110.69 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -78.02 -15.78 58.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.244 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -87.53 -24.58 24.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.9 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 70' ' ' ILE . 28.9 m -98.16 162.94 2.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.276 0.56 . . . . 0.0 111.73 -174.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -126.92 150.49 49.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.328 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 56' ' ' THR . 60.6 mt -128.43 142.66 43.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.799 0.333 . . . . 0.0 111.549 -173.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -130.4 128.67 41.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.454 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 55' ' ' ALA . 40.0 mm -106.1 119.66 55.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.028 0.442 . . . . 0.0 111.45 -175.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.75 79.27 1.2 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.182 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 69.38 -74.49 0.08 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.34 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.65 42.99 1.3 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.49 ' HE2' ' HB2' ' A' ' 84' ' ' ASP . 49.4 tttm -141.98 114.25 8.24 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.505 ' HA ' HD13 ' A' ' 50' ' ' ILE . . . -99.4 96.81 7.96 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.118 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.527 HG23 ' HB3' ' A' ' 84' ' ' ASP . 21.1 m -84.83 112.83 20.89 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.414 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -101.2 131.15 49.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.273 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -130.71 160.57 33.91 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.389 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.59 142.24 3.65 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -122.98 150.72 42.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.947 0.403 . . . . 0.0 110.397 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.28 12.28 54.74 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.051 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.23 175.55 10.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.403 . . . . 0.0 111.768 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.7 p -127.05 144.98 50.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 172.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -46.74 -45.31 19.58 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 9.6 tp10 -61.14 -47.5 85.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.466 -174.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.33 -39.3 65.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.408 0.623 . . . . 0.0 110.315 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -52.34 -47.75 65.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.872 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -76.89 -20.2 56.53 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.548 -174.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 35.3 mmtm -62.26 -38.82 90.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.456 HG21 HG21 ' A' ' 46' ' ' VAL . 28.4 mt -70.7 -58.51 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.421 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 mp -43.67 -48.25 7.8 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.35 -28.86 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.928 0.394 . . . . 0.0 111.439 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.86 -26.22 22.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -82.43 -23.71 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 110.835 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.695 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -81.4 -29.81 39.04 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.929 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -81.1 53.8 2.09 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.163 0.506 . . . . 0.0 111.232 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.581 HD12 HD22 ' A' ' 14' ' ' LEU . 26.1 mm -117.77 134.76 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -68.73 99.5 1.03 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.96 -14.71 5.7 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.299 -172.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 21.9 mm -98.4 122.67 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.314 0.578 . . . . 0.0 111.315 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -102.62 -14.73 16.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.705 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 25.8 p -160.26 158.31 29.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 112.413 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.524 HG12 ' CE2' ' A' ' 6' ' ' PHE . 7.5 p -126.74 133.02 69.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.231 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.7 t70 -107.6 95.48 5.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.39 107.57 5.76 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.375 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -115.13 22.21 13.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.218 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -83.26 131.32 34.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.962 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -105.29 129.01 53.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.405 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 p -97.45 136.44 37.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.485 0.66 . . . . 0.0 112.153 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.65 -44.16 10.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.937 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.7 p -114.43 137.73 22.75 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.588 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.59 152.91 29.99 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.61 2.207 . . . . 0.0 111.719 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.404 ' HB3' ' H ' ' A' ' 65' ' ' GLU . . . -157.14 -174.1 4.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.419 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.0 m -64.3 132.55 50.53 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.368 0.418 . . . . 0.0 111.109 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.22 169.19 8.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.648 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.5 p -143.65 155.34 44.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.543 0.687 . . . . 0.0 112.105 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.494 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 23.9 tt0 -86.23 141.58 29.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.48 173.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -101.59 101.73 12.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.963 0.411 . . . . 0.0 110.853 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 113' ' ' GLN . 93.6 t80 -107.07 141.16 38.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.547 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 4.6 m -104.19 122.41 45.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.183 177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.494 HG22 ' H ' ' A' ' 142' ' ' GLN . 2.8 m -67.22 140.03 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.46 -162.19 0.93 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.112 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.2 t -56.62 -31.4 64.27 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 123.123 0.264 . . . . 0.0 111.219 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.28 49.23 2.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.155 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -64.92 109.24 2.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.44 1.114 . . . . 0.0 112.117 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 110' ' ' ILE . 86.4 m -151.39 129.24 11.66 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.616 170.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 15.2 mt -51.03 -48.74 61.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.878 0.763 . . . . 0.0 111.333 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 p -58.48 -37.61 75.88 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.297 0.373 . . . . 0.0 111.152 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.68 -50.63 49.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -74.17 -23.81 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.575 -176.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.6 t -69.78 -46.29 66.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 61.7 tttm -60.88 -28.04 68.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.619 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.598 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 2.6 tp-100 -66.2 -64.18 0.91 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.21 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.8 m -78.23 -44.67 27.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.558 -170.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.435 ' N ' HG23 ' A' ' 114' ' ' VAL . 63.8 m-85 -81.61 -46.37 14.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.67 0.747 . . . . 0.0 110.343 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.94 -6.28 32.68 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.567 -170.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -127.98 131.34 49.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.221 -0.489 . . . . 0.0 110.161 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . . . -84.77 0.97 48.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.991 0.424 . . . . 0.0 110.717 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -93.68 0.09 56.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.739 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.76 21.18 17.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.377 0.608 . . . . 0.0 110.875 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 44.0 p90 -61.51 -32.33 72.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.479 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -79.27 -22.37 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.824 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -60.48 -48.75 80.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.373 0.606 . . . . 0.0 110.13 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.43 HD13 HD11 ' A' ' 110' ' ' ILE . 50.1 mt -63.83 -49.9 79.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.094 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -46.3 -53.34 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.806 0.691 . . . . 0.0 111.083 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.565 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 7.7 mm-40 -65.24 -29.36 70.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.621 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.443 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -77.2 -19.1 57.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.043 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.498 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 5.3 m120 -95.05 -2.1 50.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.511 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.565 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 6.5 mmmm -68.6 145.88 97.34 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.544 ' HD2' HD13 ' A' ' 40' ' ' ILE . 66.6 Cg_endo -96.36 22.97 25.96 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 124.059 -1.226 . . . . 0.0 112.027 -7.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.498 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 1.7 tmm? -70.81 -35.81 72.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.529 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.9 tp -90.33 119.31 30.53 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -77.96 -45.65 23.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.616 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -154.66 157.32 32.09 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.39 -51.89 9.84 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 C-N-CA 123.29 2.66 . . . . 0.0 112.83 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.06 6.49 18.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.407 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -98.93 15.22 26.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.639 0.257 . . . . 0.0 111.332 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.511 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 9.6 pt -78.0 175.55 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -159.63 144.25 11.17 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -52.3 112.31 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.277 2.651 . . . . 0.0 112.312 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 117.61 0.16 18.03 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.167 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.511 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 39.5 tt0 -88.28 122.78 32.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.965 0.412 . . . . 0.0 110.354 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 37.6 t -83.33 133.6 28.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.999 173.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 70.2 mt -124.02 151.04 44.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.284 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.473 ' H ' ' ND2' ' A' ' 128' ' ' ASN . 58.0 mtp180 -80.07 122.82 27.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.229 177.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 25.4 mm -109.23 97.29 25.12 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.228 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.02 148.77 35.64 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.084 1.856 . . . . 0.0 111.312 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.33 133.8 50.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.532 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.77 25.65 0.43 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.97 31.36 4.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.197 0.522 . . . . 0.0 110.435 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -64.05 -77.96 0.05 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.702 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -168.73 -48.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.386 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -78.68 99.4 6.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.359 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -80.06 34.19 0.29 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.084 0.468 . . . . 0.0 111.513 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -82.88 81.45 8.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.09 0.471 . . . . 0.0 109.963 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -109.43 10.72 25.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.766 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 . . . . . 0 C--O 1.243 0.738 0 CA-C-O 118.575 -0.726 . . . . 0.0 109.312 172.558 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.3 -122.71 3.73 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.072 -177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.7 tp -101.96 118.25 36.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.081 0.467 . . . . 0.0 110.733 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.46 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 86.7 m-85 -105.52 118.02 35.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.803 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -89.83 150.0 22.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.071 0.463 . . . . 0.0 111.351 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.66 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 74.8 m-85 -132.08 -156.72 0.77 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.928 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.054 HG11 ' HB3' ' A' ' 10' ' ' ALA . 5.7 p -88.6 -22.01 6.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.038 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.81 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 23.8 tptm 75.99 -57.84 0.56 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.549 0.739 . . . . 0.0 111.513 -175.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.58 -53.49 11.76 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.029 0.442 . . . . 0.0 111.726 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 1.054 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -73.31 146.24 45.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.126 -175.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.75 -167.73 29.29 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -72.03 124.79 25.69 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -73.01 83.13 1.25 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.037 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.456 HD21 ' O ' ' A' ' 30' ' ' LYS . 20.1 tp -94.33 -43.2 8.52 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.87 -170.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -127.66 14.53 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.361 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.588 ' HB3' HG12 ' A' ' 18' ' ' VAL . 10.1 m-20 61.41 99.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.865 0.728 . . . . 0.0 110.694 -175.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.41 -3.2 10.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.546 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 16' ' ' ASP . 14.5 p -64.48 -25.63 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.888 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.0 m -150.64 -61.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.727 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 141.75 -152.31 23.39 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -146.24 66.33 1.19 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.269 0.557 . . . . 0.0 110.643 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.3 m80 69.89 -73.89 0.09 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.274 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -116.15 142.15 47.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.856 0.36 . . . . 0.0 110.796 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.423 ' HA ' ' OE1' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -67.22 -19.76 65.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.75 175.043 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.1 -35.43 64.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.536 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -77.16 -27.08 53.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.163 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.592 ' O ' HG23 ' A' ' 31' ' ' VAL . 54.9 mt-30 -64.74 -32.87 74.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.301 173.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.01 85.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.119 0.485 . . . . 0.0 110.416 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -64.18 -44.09 93.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.52 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -52.93 -44.74 67.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.689 175.158 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 27' ' ' GLN . 82.1 t -58.59 -48.92 84.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.303 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.405 ' HG2' HD13 ' A' ' 48' ' ' ILE . 26.6 mt-30 -63.92 -40.79 97.28 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.282 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 40.7 mt-10 -58.86 -46.29 88.09 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 65.7 t60 -52.7 -44.9 66.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.866 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 99.0 mt -66.08 -39.75 90.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.248 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -74.17 -39.35 63.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.228 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 62.2 mtpt -64.43 -44.54 90.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.016 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.7 p -66.05 -51.05 61.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.166 0.508 . . . . 0.0 110.037 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.71 30.54 1.98 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.928 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.473 HD11 ' HB2' ' A' ' 131' ' ' MET . 27.4 mm -67.19 120.69 74.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.57 142.64 84.99 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.369 2.046 . . . . 0.0 112.961 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 58.54 25.47 13.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.473 -1.239 . . . . 0.0 112.645 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.51 -15.9 63.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.406 0.622 . . . . 0.0 110.14 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -86.61 -8.0 57.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.684 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -97.41 -8.81 28.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.738 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.84 172.1 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.317 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.69 131.19 25.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.458 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 56' ' ' THR . 4.1 mp -108.04 141.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.793 0.33 . . . . 0.0 110.794 -176.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -134.54 123.91 24.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.756 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mm -87.16 120.79 37.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.442 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -127.73 81.5 2.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.756 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 49.75 64.59 1.7 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.776 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.26 -26.53 14.88 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.54 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.449 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 30.8 mttp -90.06 114.16 26.01 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.152 0.501 . . . . 0.0 111.468 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 83' ' ' VAL . . . -89.49 94.68 9.97 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.221 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 21.1 m -77.55 125.9 30.05 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG22 HG13 ' A' ' 48' ' ' ILE . 42.8 t -119.01 109.68 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.127 0.489 . . . . 0.0 111.18 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.7 m -102.67 166.63 10.4 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.911 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 88' ' ' LYS . . . 168.44 170.5 33.21 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.475 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -155.89 138.71 15.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.065 0.46 . . . . 0.0 110.151 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 93.53 3.55 64.62 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.91 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.59 -177.14 2.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.333 0.587 . . . . 0.0 111.994 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.7 p -132.04 157.8 43.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.105 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -47.91 -41.77 25.44 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 123.165 0.291 . . . . 0.0 111.05 176.019 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.461 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 49.9 mm-40 -55.92 -64.87 0.72 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.515 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.78 95.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.169 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.664 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 49.1 tttm -50.09 -63.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.891 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 72' ' ' VAL . 5.6 mm-40 -64.67 -35.01 79.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.158 0.504 . . . . 0.0 110.489 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -62.24 -45.35 93.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.81 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.404 ' O ' HG13 ' A' ' 74' ' ' VAL . 53.8 mt -62.2 -51.91 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.997 175.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 78.6 mt -47.44 -42.23 21.95 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.889 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 68' ' ' GLU . 62.0 t -67.25 -51.85 48.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.401 0.62 . . . . 0.0 110.739 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.22 72.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.222 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 70' ' ' ILE . 15.3 m -81.37 -32.68 12.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.875 0.369 . . . . 0.0 110.788 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.66 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -70.66 -26.2 74.46 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.676 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -85.14 47.21 1.37 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.766 0.317 . . . . 0.0 111.341 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.8 mt -120.45 141.19 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 120.846 0.355 . . . . 0.0 110.478 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -66.26 105.3 1.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.216 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.89 -2.75 9.96 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.774 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.1 mm -106.24 117.79 52.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.579 0.704 . . . . 0.0 111.126 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.81 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -91.98 -27.51 17.8 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.229 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.449 ' OG ' ' HG2' ' A' ' 54' ' ' LYS . 5.5 p -164.48 161.06 21.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.184 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 55' ' ' ALA . 4.3 p -119.77 124.1 72.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.611 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -94.68 103.08 15.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.24 119.06 19.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.866 -174.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -127.22 28.64 5.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.854 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.48 123.81 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.209 0.528 . . . . 0.0 111.351 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 59' ' ' GLY . 13.9 tptm -90.23 124.66 35.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.265 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 p -100.02 135.06 42.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.199 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.433 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -106.12 -23.93 12.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.58 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.447 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 67.4 p -123.58 138.75 30.77 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.52 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 2.1 Cg_endo -80.96 158.88 20.92 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.181 2.588 . . . . 0.0 112.788 -176.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -161.84 -176.84 5.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.168 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.3 m -82.42 125.02 30.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HA ' ' CD ' ' A' ' 64' ' ' GLN . . . -73.24 145.48 46.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -123.96 172.09 9.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.388 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -106.66 153.88 21.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.784 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -111.63 116.98 31.69 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.407 ' CZ ' ' HG2' ' A' ' 113' ' ' GLN . 88.3 t80 -123.52 142.43 51.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.588 0.232 . . . . 0.0 110.4 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 2.5 m -104.1 124.28 48.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.361 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 142' ' ' GLN . 2.8 m -68.09 134.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -98.36 -177.19 3.62 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.143 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 p -61.9 116.21 4.68 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.15 25.75 5.99 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -169.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.562 ' OD2' HG13 ' A' ' 138' ' ' ILE . 10.4 p-10 -53.94 118.91 4.37 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.218 1.009 . . . . 0.0 111.768 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 110' ' ' ILE . 92.6 m -144.35 127.37 16.49 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 125' ' ' PHE . 22.9 tp -63.15 -31.09 72.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.255 -170.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 p -75.71 -26.95 57.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.371 0.605 . . . . 0.0 110.152 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.431 ' CB ' ' HB ' ' A' ' 106' ' ' THR . . . -75.77 -44.22 42.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.851 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.609 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.3 pp -78.35 -24.28 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.394 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.2 p -72.7 -45.33 59.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.95 0.405 . . . . 0.0 109.993 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -64.26 -18.48 64.6 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.277 0.561 . . . . 0.0 110.231 174.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.609 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 45.9 tp60 -72.66 -60.98 1.97 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.859 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 115' ' ' TYR . 30.8 m -78.01 -48.52 23.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.072 -172.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.496 ' HB3' HD12 ' A' ' 120' ' ' LEU . 83.4 m-85 -84.12 -36.21 23.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.327 0.584 . . . . 0.0 110.822 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 -2.54 56.74 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.096 -173.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.435 HD21 ' HB3' ' A' ' 119' ' ' ASN . 33.0 t30 -134.67 125.27 26.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.577 -0.311 . . . . 0.0 110.399 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.427 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -74.66 -22.78 58.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.56 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.435 ' HB3' HD21 ' A' ' 117' ' ' ASN . 7.9 t30 -63.78 -21.42 66.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.898 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 115' ' ' TYR . 63.3 mt -85.83 15.8 4.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.498 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.459 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 35.2 p90 -62.0 -35.84 79.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.284 0.564 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.401 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 8.4 t30 -65.72 -33.07 75.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.676 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -57.0 -49.26 76.32 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.442 0.639 . . . . 0.0 109.67 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.506 HG22 ' OD1' ' A' ' 128' ' ' ASN . 27.7 mt -67.73 -43.98 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.896 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.594 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 43.2 t80 -53.54 -56.33 18.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.854 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 19.2 mt-10 -65.42 -25.81 67.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.559 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.39 -34.9 31.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.061 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 124' ' ' ILE . 7.8 m120 -74.6 -30.54 61.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 7.2 mtpm? -57.25 148.41 52.73 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.559 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -87.78 8.74 64.56 Favored 'Cis proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.291 -1.545 . . . . 0.0 113.256 1.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.477 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -62.97 -39.98 96.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.108 0.48 . . . . 0.0 109.826 175.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.14 125.99 37.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -95.98 -36.64 10.98 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.447 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 19.7 m -150.79 153.2 33.31 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.063 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.442 ' HA ' HD22 ' A' ' 107' ' ' LEU . 74.1 Cg_exo -50.5 -54.12 5.99 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 C-N-CA 123.318 2.679 . . . . 0.0 113.054 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -84.52 7.36 20.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.55 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 37.1 mmtm -92.13 4.59 52.84 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.751 0.31 . . . . 0.0 111.802 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.562 HG13 ' OD2' ' A' ' 105' ' ' ASP . 11.6 pt -67.71 173.72 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.517 171.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 6.6 p90 -158.59 141.93 10.87 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.604 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 139' ' ' TYR . 71.9 Cg_exo -50.75 117.11 3.02 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.374 2.716 . . . . 0.0 112.858 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.12 4.03 24.23 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.03 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.475 ' H ' HG22 ' A' ' 101' ' ' VAL . 34.3 tt0 -93.0 116.38 29.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.348 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 37.1 t -79.71 134.66 27.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.7 mt -123.51 143.43 50.19 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.091 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.551 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 34.8 ttt180 -74.64 109.79 8.4 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.96 105.61 14.3 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.701 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 32.0 Cg_exo -59.12 164.44 10.33 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.722 2.281 . . . . 0.0 111.907 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -83.71 139.81 32.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.96 72.73 6.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.351 0.596 . . . . 0.0 111.126 -176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 83.9 mt -94.6 4.83 53.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.445 0.64 . . . . 0.0 109.835 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -96.46 138.57 33.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.187 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -81.54 43.71 0.76 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.277 0.56 . . . . 0.0 111.721 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -118.56 36.03 4.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 155' ' ' HIS . 2.3 t-80 -82.81 159.87 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.947 -176.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 25.2 m-70 72.94 149.71 0.1 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.081 0.552 . . . . 0.0 110.683 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -120.51 12.81 11.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.033 0.444 . . . . 0.0 110.585 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.752 -0.642 . . . . 0.0 109.822 -178.422 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmt? . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.933 0.396 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.47 114.33 0.6 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.621 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.6 tp -126.04 114.6 18.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.356 0.598 . . . . 0.0 110.32 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.65 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 56.5 m-85 -106.76 131.56 53.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.608 -176.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.33 136.77 41.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.453 0.644 . . . . 0.0 112.252 -171.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.621 ' HE1' HG12 ' A' ' 83' ' ' VAL . 31.4 m-85 -123.03 -166.0 1.39 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.48 176.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 57.2 t -81.25 -81.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.98 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtt? 160.68 -74.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.91 -30.56 69.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.098 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.17 126.24 30.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.885 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.93 -178.26 31.73 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.02 125.83 25.32 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -74.67 69.24 1.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.975 0.893 . . . . 0.0 109.16 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD21 ' O ' ' A' ' 30' ' ' LYS . 19.4 tp -70.69 -50.18 39.24 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.214 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.423 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 13.2 p90 -120.24 27.64 8.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.826 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 15' ' ' TRP . 9.0 m-20 73.3 -52.96 0.7 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.923 -175.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 68.19 14.86 9.33 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.581 0.752 . . . . 0.0 112.001 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -88.5 -70.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.818 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -145.4 46.15 1.31 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.62 136.34 6.86 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.706 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.642 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . 2.0 mp0 68.41 108.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.383 0.611 . . . . 0.0 110.842 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -78.42 151.9 32.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.458 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.537 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 1.2 m-20 -68.21 72.36 0.19 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.556 0.535 . . . . 0.0 111.974 -175.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -131.94 -159.95 1.01 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.35 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -60.65 -25.17 66.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.985 0.421 . . . . 0.0 110.753 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.531 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 2.1 m-20 -58.29 -35.78 72.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.216 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.642 ' OE1' ' HB3' ' A' ' 21' ' ' GLN . 6.6 mm100 -75.88 -41.22 52.77 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -176.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.11 62.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.76 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 24.7 ttmm -67.1 -49.13 66.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.14 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 14.0 mptt -58.28 -41.51 84.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.673 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 27' ' ' GLN . 93.9 t -60.71 -43.46 95.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.731 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -58.13 -47.04 84.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.699 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 39.8 mt-10 -58.22 -47.17 84.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.065 176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -51.67 -49.9 61.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.094 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 98.2 mt -63.58 -38.72 92.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.333 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -79.85 -33.14 40.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.549 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -71.65 -30.56 65.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.662 0.268 . . . . 0.0 110.908 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 p -80.18 -40.42 27.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.039 0.447 . . . . 0.0 110.547 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.07 26.81 5.35 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.248 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.459 HD13 ' HD2' ' A' ' 130' ' ' PRO . 35.9 mm -61.71 132.25 93.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 110.467 -0.198 . . . . 0.0 110.467 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 11.9 Cg_exo -65.31 130.97 26.79 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.429 2.086 . . . . 0.0 112.819 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 59.44 29.56 19.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.819 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.87 -26.52 68.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.777 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -75.32 -26.06 58.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.733 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -74.07 -22.03 59.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.684 -174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.404 HG21 HG21 ' A' ' 70' ' ' ILE . 23.5 m -100.76 162.39 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.563 0.697 . . . . 0.0 111.816 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -128.83 129.76 46.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.878 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.74 133.73 46.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.963 0.411 . . . . 0.0 110.914 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -119.69 122.06 40.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.52 173.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.607 HG13 ' HB2' ' A' ' 27' ' ' GLN . 30.5 mm -97.59 108.36 21.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.212 0.529 . . . . 0.0 110.868 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.21 66.2 0.65 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.798 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 55.94 77.82 0.22 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.653 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.07 -18.24 32.84 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.219 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 82' ' ' SER . 28.0 ttpp -108.37 116.5 32.08 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.153 -0.616 . . . . 0.0 110.702 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.27 101.34 13.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.933 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 84' ' ' ASP . 14.4 m -85.18 124.95 32.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.237 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.95 110.77 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 120.982 0.42 . . . . 0.0 111.436 -175.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.444 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -97.92 157.49 16.07 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.889 177.121 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 87' ' ' VAL . . . 163.1 165.98 21.13 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.432 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -148.37 143.01 26.54 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.916 0.389 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 83.68 37.75 11.49 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.964 176.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.62 165.51 12.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.802 0.334 . . . . 0.0 110.961 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -93.57 160.65 14.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.998 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.575 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 7.6 tp60 -53.54 -58.0 8.71 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.222 0.326 . . . . 0.0 111.76 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.413 ' HG2' HH12 ' A' ' 145' ' ' ARG . 27.1 mt-10 -58.24 -46.78 85.32 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.23 76.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.113 0.482 . . . . 0.0 110.09 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 68.3 tttt -57.4 -46.33 83.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.528 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 72' ' ' VAL . 75.5 mt-10 -60.71 -47.53 85.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.653 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -55.8 -40.05 72.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.755 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.404 HG21 HG21 ' A' ' 46' ' ' VAL . 58.6 mt -63.03 -57.84 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.339 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 98.6 mt -48.03 -45.53 32.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.099 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 68' ' ' GLU . 30.9 t -68.64 -49.17 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.156 0.503 . . . . 0.0 110.593 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.41 74.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.486 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.14 -33.48 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.842 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.586 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -70.88 -35.4 65.55 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.247 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.05 38.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.801 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.5 mt -110.42 139.99 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.7 t -65.6 120.21 12.52 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.54 -22.93 11.49 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.506 HG21 ' HA2' ' A' ' 75' ' ' GLY . 45.8 mm -97.37 136.95 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.398 0.618 . . . . 0.0 110.196 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -126.45 -9.51 6.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.739 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 1.8 p -160.06 150.56 18.71 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.65 ' CG1' ' HB2' ' A' ' 4' ' ' PHE . 7.2 p -122.97 132.74 70.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.416 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.9 t0 -111.29 110.99 21.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -78.24 123.21 26.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.993 -173.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 77.7 mm-40 -131.25 8.32 4.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.846 174.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 1.7 p -96.11 126.58 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.265 0.555 . . . . 0.0 111.17 -176.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -85.51 149.26 25.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.932 -176.312 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.2 p -104.37 121.29 43.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.926 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.481 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -84.99 -41.87 15.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.027 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 p -117.19 127.36 26.75 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.799 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.82 153.08 13.12 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.77 2.313 . . . . 0.0 112.822 -175.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -148.68 -161.14 1.28 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.506 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.4 m -76.04 127.81 33.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.929 0.395 . . . . 0.0 110.305 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.85 128.11 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.898 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.9 m -103.65 153.32 20.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.348 0.594 . . . . 0.0 111.84 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 58.7 tt0 -87.05 155.66 20.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.324 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -116.2 98.69 6.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.242 0.544 . . . . 0.0 110.517 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 78.8 t80 -101.49 136.33 41.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.553 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.432 ' OG1' HG22 ' A' ' 143' ' ' VAL . 5.4 m -102.09 126.93 49.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.557 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 142' ' ' GLN . 3.3 m -73.56 141.52 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -91.83 -165.56 1.38 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.931 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.3 m -62.38 -31.46 72.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.814 0.34 . . . . 0.0 111.091 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -96.37 44.8 1.95 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.651 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' OD2' HG13 ' A' ' 138' ' ' ILE . 7.8 p-10 -56.37 120.81 8.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 122.007 0.908 . . . . 0.0 112.137 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 110' ' ' ILE . 53.4 m -143.71 126.11 15.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 168.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 40.6 tp -61.1 -28.1 68.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.714 0.293 . . . . 0.0 110.765 -174.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.481 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 9.6 m -76.24 -29.87 57.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.302 0.572 . . . . 0.0 110.274 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.406 ' CB ' ' HB ' ' A' ' 106' ' ' THR . . . -75.0 -44.86 45.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.802 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.1 pp -76.5 -21.58 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.976 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.2 p -77.05 -43.92 32.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.89 -23.28 63.33 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.317 0.58 . . . . 0.0 110.156 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -70.02 -61.93 1.58 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.142 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.6 m -82.86 -39.51 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.376 -169.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.416 ' HB3' HD12 ' A' ' 120' ' ' LEU . 40.9 m-85 -91.38 -36.17 13.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.62 -3.91 53.62 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.264 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -131.76 129.21 40.28 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -81.46 -13.7 57.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.495 -176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.27 -18.14 55.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.381 0.61 . . . . 0.0 110.183 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 115' ' ' TYR . 64.8 mt -84.39 21.06 1.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.211 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.487 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 41.9 p90 -65.74 -33.41 75.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.566 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 7.9 p30 -68.11 -28.47 67.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.946 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' A' ' 123' ' ' LYS . 29.5 mmmt -59.74 -49.69 76.76 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.337 0.589 . . . . 0.0 110.163 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.1 mt -65.82 -44.82 92.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.868 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.465 ' HB2' HD21 ' A' ' 107' ' ' LEU . 50.8 t80 -48.98 -56.73 8.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.171 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.576 ' HA ' ' HG2' ' A' ' 129' ' ' LYS . 29.5 mt-10 -68.43 -21.19 64.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.944 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.88 -23.39 36.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.063 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.494 ' OD1' HD22 ' A' ' 144' ' ' LEU . 7.6 m120 -88.3 -3.26 58.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.936 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.576 ' HG2' ' HA ' ' A' ' 126' ' ' GLU . 28.0 mmmt -72.07 148.52 91.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HD2' HD13 ' A' ' 40' ' ' ILE . 72.1 Cg_endo -95.98 31.9 11.79 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.636 -1.401 . . . . 0.0 112.409 -2.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.47 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -84.87 -33.84 22.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.072 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.01 120.98 33.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.451 0.643 . . . . 0.0 110.578 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -67.24 -62.5 1.39 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.066 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.446 ' H ' ' HB2' ' A' ' 137' ' ' LYS . 26.5 m -145.66 161.05 42.35 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.345 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 134' ' ' SER . 78.3 Cg_exo -52.24 -41.49 65.56 Favored 'Trans proline' 0 C--N 1.332 -0.303 0 C-N-CA 123.216 2.611 . . . . 0.0 112.426 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.7 19.91 7.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.446 ' HB2' ' H ' ' A' ' 134' ' ' SER . 3.0 mmpt? -107.03 11.73 29.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.874 0.368 . . . . 0.0 111.335 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.441 HG13 ' OD2' ' A' ' 105' ' ' ASP . 15.0 pt -73.88 172.95 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.11 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -166.46 149.62 6.42 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -175.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.44 110.91 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.092 2.528 . . . . 0.0 112.515 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.88 4.68 26.01 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.522 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.488 ' H ' HG22 ' A' ' 101' ' ' VAL . 7.4 tp60 -82.37 112.27 19.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.713 0.292 . . . . 0.0 110.377 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.462 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 26.8 t -82.97 134.15 27.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.494 HD22 ' OD1' ' A' ' 128' ' ' ASN . 77.7 mt -121.29 144.0 48.86 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.068 0.461 . . . . 0.0 111.112 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 27.4 ttp85 -75.01 108.03 7.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.266 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 30.9 mm -99.02 103.04 17.38 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.57 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 20.9 Cg_exo -63.78 146.99 92.55 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.126 1.884 . . . . 0.0 111.382 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.1 131.89 47.74 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -63.05 100.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.956 0.408 . . . . 0.0 110.961 -175.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 74.5 mt -90.82 4.3 52.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.478 0.656 . . . . 0.0 109.722 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -76.98 -70.41 0.46 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.742 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.9 t60 66.57 -73.56 0.07 Allowed 'General case' 0 CA--C 1.529 0.149 0 O-C-N 124.083 0.865 . . . . 0.0 110.469 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -93.5 143.72 26.03 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 58.11 47.81 13.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.445 0.641 . . . . 0.0 109.754 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -91.75 29.05 1.62 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.621 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 69.62 176.02 0.28 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.157 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.7 p80 . . . . . 0 C--O 1.245 0.848 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.568 -178.027 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.52 -32.84 0.15 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.041 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.53 129.21 54.99 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.627 0.727 . . . . 0.0 111.121 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.581 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 87.0 m-85 -111.97 125.58 54.22 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.447 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -93.12 136.44 33.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.433 0.635 . . . . 0.0 111.839 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.564 ' HE1' HG12 ' A' ' 83' ' ' VAL . 32.7 m-85 -126.1 -167.47 1.71 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.858 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.5 t -116.0 113.81 44.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.815 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 19.2 ptmt -59.85 -29.03 68.01 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -171.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.97 -10.09 58.96 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.04 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.13 122.18 46.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.124 0.488 . . . . 0.0 111.222 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 157.76 179.18 32.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.972 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.17 132.91 48.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -86.53 80.36 8.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.188 0.518 . . . . 0.0 111.801 -173.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 34' ' ' HIS . 7.1 mp -72.33 -46.76 54.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.244 172.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.403 ' HE1' ' HA3' ' A' ' 79' ' ' GLY . 43.8 p90 -127.72 169.87 13.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.491 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.71 16.94 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.02 20.93 10.04 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.117 0.567 . . . . 0.0 111.865 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 t -93.05 65.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.9 p 66.46 -47.79 0.44 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.003 1.321 . . . . 0.0 112.464 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.546 ' HA2' ' NE2' ' A' ' 27' ' ' GLN . . . -155.05 162.57 30.98 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.549 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 22.3 tp60 -69.55 -66.76 0.54 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -123.47 -50.43 1.88 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.402 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -133.01 -72.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.081 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -176.04 -55.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.091 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -63.26 -30.77 71.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.541 0.686 . . . . 0.0 110.398 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.549 ' OD2' ' HB3' ' A' ' 21' ' ' GLN . 1.2 p-10 -61.72 -36.78 81.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.076 176.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 31' ' ' VAL . 53.2 mt-30 -61.95 -45.77 92.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.348 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.62 71.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.805 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -70.52 -36.21 73.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.185 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 30.1 mmmt -62.7 -43.28 99.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.338 174.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 27' ' ' GLN . 72.6 t -62.59 -39.5 84.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.815 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -57.31 -43.9 83.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.592 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.35 -48.94 78.96 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.9 0.381 . . . . 0.0 110.579 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.502 ' HB2' HD21 ' A' ' 14' ' ' LEU . 58.5 t60 -52.51 -43.17 64.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.369 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.21 -39.71 65.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.471 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -82.19 -31.26 30.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.777 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -75.05 -23.45 58.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.608 0.242 . . . . 0.0 111.376 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 p -86.06 -39.08 17.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.232 0.539 . . . . 0.0 110.439 174.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.61 33.81 3.75 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.96 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.28 124.72 88.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.99 144.87 65.76 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.845 1.696 . . . . 0.0 112.379 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.557 ' HB3' HD22 ' A' ' 62' ' ' LEU . 12.0 m-20 65.9 3.41 2.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.419 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.55 -16.23 61.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.401 0.62 . . . . 0.0 110.518 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.66 -18.31 59.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.018 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -103.25 -0.6 30.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.531 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 70' ' ' ILE . 30.7 m -103.02 171.13 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.181 0.515 . . . . 0.0 111.593 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -134.73 125.11 26.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.866 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.0 135.73 37.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.278 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.478 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 48.2 tt0 -127.7 125.33 39.83 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 27' ' ' GLN . 21.5 mm -97.26 134.86 33.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.893 0.378 . . . . 0.0 110.595 -177.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.39 50.96 2.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.375 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 63.1 93.23 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.788 0.68 . . . . 0.0 111.483 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 78.41 -23.47 2.84 Favored Glycine 0 CA--C 1.517 0.176 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.585 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 0.8 OUTLIER -109.68 115.14 29.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -101.48 120.17 39.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.315 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.528 ' OG1' ' HE3' ' A' ' 54' ' ' LYS . 49.2 m -90.72 132.86 35.56 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.309 -0.244 . . . . 0.0 110.528 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.99 119.96 61.82 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.347 0.594 . . . . 0.0 110.396 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -117.62 162.24 18.34 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.226 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.85 156.87 8.21 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -138.54 144.83 40.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.912 0.387 . . . . 0.0 110.509 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 88.36 22.69 39.82 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.48 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.557 HD22 ' HB3' ' A' ' 42' ' ' ASP . 8.6 mt -100.08 -166.85 1.38 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.238 0.542 . . . . 0.0 109.952 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.4 p -125.73 168.26 14.03 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.923 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.675 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 3.1 tm0? -63.22 -43.34 98.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.843 0.354 . . . . 0.0 110.522 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.489 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 42.7 tt0 -64.46 -42.82 95.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.622 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.42 -46.95 83.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.454 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 12.9 ptmm? -59.62 -37.34 78.35 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.915 -175.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 72' ' ' VAL . 85.9 mt-10 -64.75 -48.17 75.55 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.719 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 28.6 mtpp -54.22 -41.01 68.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.676 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.618 HD13 HG11 ' A' ' 46' ' ' VAL . 29.7 mt -71.38 -53.93 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.691 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 96.3 mt -48.95 -47.31 43.97 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.656 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 68' ' ' GLU . 70.0 t -65.37 -45.78 92.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.389 0.614 . . . . 0.0 110.647 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.471 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -61.72 -39.24 90.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.358 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 m -78.18 -31.21 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.718 0.294 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' HA2' HG21 ' A' ' 80' ' ' ILE . . . -69.6 -36.79 76.81 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.301 175.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -80.24 50.02 1.2 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.321 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.473 HD13 HD22 ' A' ' 14' ' ' LEU . 96.8 mt -119.04 143.34 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 120.946 0.403 . . . . 0.0 110.387 173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -67.66 115.11 6.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.461 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 111.29 -13.17 28.42 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.131 -172.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 50.6 mm -105.96 132.89 51.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.896 0.379 . . . . 0.0 110.684 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.815 ' HB2' ' HB3' ' A' ' 8' ' ' LYS . . . -131.29 -5.49 3.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.421 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 2.7 p -156.2 154.34 30.63 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.193 0.52 . . . . 0.0 111.317 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.6 p -134.4 134.6 54.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.034 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.71 113.68 27.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -83.09 111.06 18.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.474 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -123.47 29.02 6.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.483 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.483 ' CG1' HD12 ' A' ' 62' ' ' LEU . 77.4 t -82.45 139.9 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.508 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -105.14 137.71 42.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.047 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.4 p -108.89 130.27 55.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.419 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.455 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -97.31 -29.46 13.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.104 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.7 p -127.27 140.29 37.51 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.707 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.04 153.47 25.08 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.754 2.303 . . . . 0.0 111.774 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.489 ' HB3' ' H ' ' A' ' 65' ' ' GLU . . . -159.58 -172.77 3.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.99 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.2 m -61.78 149.2 40.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.348 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.89 138.53 51.08 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.732 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.5 m -120.18 149.41 42.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.217 0.532 . . . . 0.0 111.709 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 59.3 tt0 -84.16 153.01 23.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.019 173.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -110.67 96.17 6.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 0.0 111.167 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -95.3 136.07 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.861 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.435 ' OG1' HG22 ' A' ' 143' ' ' VAL . 18.4 m -106.83 124.0 48.97 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 142' ' ' GLN . 0.8 OUTLIER -67.45 134.05 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 72.0 mmtt -86.67 -72.39 0.51 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.376 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 t -175.08 115.5 0.16 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -175.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.01 -3.81 85.71 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -171.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 1.0 OUTLIER -63.71 113.94 3.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.2 -1.0 . . . . 0.0 110.829 178.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 110' ' ' ILE . 40.0 p -104.97 158.28 16.65 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.664 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -57.37 -45.91 83.94 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.356 -172.319 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.575 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 17.2 m -65.47 -35.16 80.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.75 0.309 . . . . 0.0 110.588 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.98 77.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.106 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.584 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.5 pp -75.6 -29.68 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 120.833 0.349 . . . . 0.0 110.495 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.2 t -65.16 -45.69 83.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.232 0.539 . . . . 0.0 109.627 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -62.88 -30.33 71.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.455 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.5 OUTLIER -64.41 -62.86 1.34 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.229 176.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 115' ' ' TYR . 34.2 m -77.21 -46.23 28.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.262 -170.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.699 ' CE2' ' HD2' ' A' ' 123' ' ' LYS . 15.8 m-85 -88.14 -50.46 6.36 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 120.5 -19.88 9.02 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -111.23 128.32 55.89 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.575 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -81.56 -8.59 59.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.981 0.42 . . . . 0.0 110.247 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -80.25 -12.3 59.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.395 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.483 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 55.7 mt -87.16 11.53 13.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.459 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 51.0 p90 -58.05 -30.78 66.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.196 0.522 . . . . 0.0 110.51 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.455 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 26.9 p-10 -76.27 -32.71 58.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.171 -176.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.699 ' HD2' ' CE2' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -71.81 -24.31 61.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.204 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mt -83.99 -41.97 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.65 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.567 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 40.9 t80 -53.66 -59.76 4.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.359 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 30.2 mt-10 -60.6 -36.11 77.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.152 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.73 -32.34 73.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.045 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.523 ' O ' ' HB3' ' A' ' 131' ' ' MET . 40.8 m-80 -90.01 -8.15 52.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.939 0.399 . . . . 0.0 110.866 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 132' ' ' LEU . 30.4 mtpp -74.11 156.67 87.56 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.531 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -84.28 14.82 35.48 Favored 'Cis proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.383 -1.507 . . . . 0.0 113.365 -0.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.523 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 4.2 tmm? -67.31 -38.5 85.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.175 0.512 . . . . 0.0 109.75 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.637 ' O ' ' HG2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -90.9 111.69 23.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.684 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -74.29 -60.34 2.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.335 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 16.3 m -137.96 155.62 74.55 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 134' ' ' SER . 25.8 Cg_exo -63.09 -23.64 73.45 Favored 'Trans proline' 0 CA--C 1.522 -0.097 0 C-N-CA 123.655 2.903 . . . . 0.0 113.134 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -99.67 4.87 45.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.952 0.406 . . . . 0.0 110.668 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 134' ' ' SER . 27.3 mmmt -90.62 -0.77 57.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.756 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.407 HD11 ' HA ' ' A' ' 106' ' ' THR . 21.4 pt -64.56 166.13 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.046 0.451 . . . . 0.0 110.833 174.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -155.24 144.65 15.25 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.917 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -54.29 116.39 3.03 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.332 2.688 . . . . 0.0 112.71 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.46 14.52 14.22 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.202 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.57 ' O ' HG13 ' A' ' 101' ' ' VAL . 65.0 tt0 -99.78 130.83 46.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.899 0.381 . . . . 0.0 110.322 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 42.5 t -85.63 130.57 36.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.269 0.557 . . . . 0.0 109.957 174.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.0 mt -118.81 134.76 54.93 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.733 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.521 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 51.8 mtp180 -65.87 120.34 12.88 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.325 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 35.2 mm -111.46 82.65 3.74 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 31.9 Cg_exo -62.79 170.17 7.62 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.825 2.35 . . . . 0.0 112.215 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -51.66 133.21 31.05 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.64 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -78.69 77.6 5.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.3 tp -80.01 73.59 6.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.27 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.425 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . 38.1 tt0 62.41 -91.29 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.802 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.9 m80 55.85 54.33 8.27 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.677 0.391 . . . . 0.0 112.052 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 66.8 m80 60.45 87.0 0.09 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.075 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.425 ' CE1' ' HA ' ' A' ' 151' ' ' GLU . 18.7 m170 -81.42 -176.58 6.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.163 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 35.0 t60 60.36 77.72 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.315 0.579 . . . . 0.0 109.746 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -64.84 146.49 54.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.56 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 21.9 p80 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.032 177.688 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.954 0.406 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.63 65.23 0.93 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.896 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.1 tp -113.84 122.43 47.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -121.39 133.62 55.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.329 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.71 146.88 24.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.756 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CD2' HG21 ' A' ' 143' ' ' VAL . 77.2 m-85 -128.23 -157.95 0.85 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.073 -176.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.667 HG21 ' HB3' ' A' ' 10' ' ' ALA . 22.8 m -83.73 -26.76 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 24.4 tptp 72.51 -53.37 0.7 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.248 0.619 . . . . 0.0 111.479 -174.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.39 -49.34 8.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.857 0.36 . . . . 0.0 111.831 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.667 ' HB3' HG21 ' A' ' 7' ' ' VAL . . . -76.21 -169.18 1.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.45 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.36 -160.02 19.2 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -76.82 127.1 32.12 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -74.64 63.42 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.017 0.913 . . . . 0.0 109.019 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 77' ' ' ILE . 11.8 tp -65.49 -50.72 64.25 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 113.793 -1.548 . . . . 0.0 110.491 -174.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 6.8 p90 -125.57 -35.8 2.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.725 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t70 51.1 -90.47 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.839 0.712 . . . . 0.0 110.474 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -160.76 26.51 0.15 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 p -142.15 126.9 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.263 -171.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.1 p 47.79 37.22 6.8 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.363 0.602 . . . . 0.0 111.369 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -172.45 169.81 42.9 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 15' ' ' TRP . 6.1 tt0 63.3 56.24 1.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.374 0.607 . . . . 0.0 109.487 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -82.91 -16.2 48.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.978 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' H ' ' HB3' ' A' ' 26' ' ' ASP . 5.2 t70 -166.14 178.85 6.06 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -70.93 -47.08 61.03 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -75.92 -15.58 60.16 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.328 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.526 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 20.4 t70 -71.12 -35.92 71.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.065 0.46 . . . . 0.0 109.872 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -61.57 -45.12 95.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.973 174.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.71 84.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.603 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 51.6 tttp -60.67 -43.42 97.68 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.48 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 43.5 mmtt -62.66 -38.77 91.64 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.373 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.615 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 73.5 t -66.09 -42.92 92.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.267 176.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -55.44 -51.54 66.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 38.6 mt-10 -56.85 -46.92 81.42 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.255 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -52.59 -48.15 66.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.044 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 88.6 mt -65.81 -41.9 91.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.927 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -69.03 -41.77 77.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.347 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 99.3 mttt -65.17 -42.81 93.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.512 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 p -72.43 -40.64 66.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 111.141 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.01 32.67 2.99 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.234 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.445 HD13 ' HD2' ' A' ' 130' ' ' PRO . 26.2 mm -71.71 126.09 91.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.67 148.35 77.65 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.089 1.86 . . . . 0.0 112.604 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 61.78 16.44 7.9 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.737 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.32 70.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.125 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.49 -23.39 63.62 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.338 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -88.91 -27.92 20.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.322 -171.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 70' ' ' ILE . 24.4 m -88.01 164.11 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.222 0.534 . . . . 0.0 111.833 -177.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -128.32 135.06 49.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.973 173.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.79 131.01 60.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.815 0.34 . . . . 0.0 110.287 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -118.75 124.84 48.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.078 0.466 . . . . 0.0 110.539 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.0 mm -105.19 136.75 37.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.782 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.06 54.88 1.56 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.205 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.7 88.57 0.09 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.98 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.4 -34.93 2.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.978 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -84.1 119.95 25.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.983 0.421 . . . . 0.0 110.388 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.61 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -121.6 105.89 10.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.233 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.0 m -93.6 122.01 35.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.204 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.67 130.72 47.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.165 0.507 . . . . 0.0 109.989 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.55 136.78 54.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.135 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.78 168.22 40.77 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.6 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.477 ' HB3' ' HE3' ' A' ' 88' ' ' LYS . 3.5 p30 -157.17 142.57 17.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.991 0.424 . . . . 0.0 110.453 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.56 24.92 64.11 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.091 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.538 HD12 HG11 ' A' ' 87' ' ' VAL . 11.5 mt -99.41 -162.43 0.95 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.339 0.59 . . . . 0.0 109.916 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.2 p -120.73 155.59 33.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.968 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.423 ' NE2' ' HA ' ' A' ' 95' ' ' ALA . 59.8 tt0 -60.77 -35.29 76.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.893 0.378 . . . . 0.0 110.14 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -60.81 -44.27 97.09 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.538 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.55 -41.85 59.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -54.8 -57.07 13.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.753 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 72' ' ' VAL . 5.9 mm-40 -67.11 -15.77 63.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.043 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -75.9 -48.32 21.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.269 0.557 . . . . 0.0 109.524 176.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.568 ' O ' HG12 ' A' ' 74' ' ' VAL . 47.6 mt -65.05 -52.35 54.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.817 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 85' ' ' ASP . 7.6 mp -40.78 -46.49 2.69 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.83 0.706 . . . . 0.0 112.653 175.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.493 HG21 ' HG3' ' A' ' 145' ' ' ARG . 98.9 t -71.81 -48.52 50.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.196 0.522 . . . . 0.0 110.872 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HA ' ' SD ' ' A' ' 131' ' ' MET . . . -60.6 -32.11 71.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.182 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 70' ' ' ILE . 11.9 p -88.59 -28.28 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.276 0.56 . . . . 0.0 110.851 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.503 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -70.37 -35.25 69.02 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.02 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -83.42 58.86 4.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.795 0.331 . . . . 0.0 110.807 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.636 HD12 HD22 ' A' ' 14' ' ' LEU . 41.8 mm -123.78 132.75 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -63.81 95.42 0.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.53 -17.73 3.96 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.9 -173.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.61 HD12 ' HB2' ' A' ' 55' ' ' ALA . 35.3 mm -102.61 127.81 55.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.194 0.521 . . . . 0.0 111.471 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -111.48 -30.89 7.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.562 -174.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 p -150.69 150.6 31.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.313 0.577 . . . . 0.0 111.448 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 85.4 t -124.25 126.52 72.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.878 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -103.24 112.58 25.51 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.412 ' HB2' HD21 ' A' ' 71' ' ' LEU . 6.3 t0 -84.35 110.63 18.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.344 0.592 . . . . 0.0 111.427 -176.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -119.22 33.04 5.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.461 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 62' ' ' LEU . 77.6 t -95.73 123.64 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.22 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -89.71 123.18 33.5 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 174.185 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.4 p -102.82 126.46 49.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.82 0.343 . . . . 0.0 111.259 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.0 -27.81 23.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.424 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.8 p -121.04 129.46 25.28 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.998 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.53 164.5 16.46 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.815 2.343 . . . . 0.0 112.418 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.59 -155.04 0.58 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.7 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.6 m -86.62 122.77 31.0 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.423 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -62.92 142.66 58.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.607 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.9 m -127.57 143.27 51.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.116 0.484 . . . . 0.0 111.803 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.578 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 5.8 tt0 -91.85 153.4 19.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 171.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.455 ' N ' ' HG2' ' A' ' 97' ' ' GLN . 31.1 m-85 -107.17 86.84 2.38 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.028 0.442 . . . . 0.0 110.264 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -84.63 131.77 34.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.707 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.449 ' OG1' HG22 ' A' ' 143' ' ' VAL . 20.0 m -103.31 120.43 40.75 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.973 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 142' ' ' GLN . 0.9 OUTLIER -68.44 129.86 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.433 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 72.3 mmtt -78.62 -64.1 1.25 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.302 -169.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.9 t -159.18 -72.91 0.08 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.674 0.273 . . . . 0.0 110.505 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.35 51.6 4.58 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.539 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.1 m-20 -108.72 111.96 24.01 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.039 -0.58 . . . . 0.0 110.983 -171.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 110' ' ' ILE . 8.1 m -104.03 150.37 24.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 21.3 tp -57.87 -43.1 85.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.623 0.647 . . . . 0.0 110.944 -173.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.2 p -61.03 -39.98 91.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.22 0.533 . . . . 0.0 111.095 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.24 -40.87 74.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.354 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.7 pp -79.02 -23.84 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.2 p -71.22 -39.16 71.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.971 0.415 . . . . 0.0 110.03 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 8.3 tmtm? -64.03 -29.93 71.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 5.6 tp60 -65.16 -52.75 53.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.318 177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.441 HG21 HD12 ' A' ' 146' ' ' ILE . 34.7 m -87.78 -44.0 15.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.175 -171.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.425 ' HB3' HD12 ' A' ' 120' ' ' LEU . 64.8 m-85 -89.56 -53.07 4.69 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.891 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.48 -22.86 7.71 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.061 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -116.51 124.33 49.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.356 -0.422 . . . . 0.0 109.903 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.91 -19.28 60.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.555 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -67.68 -11.39 58.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.187 0.517 . . . . 0.0 110.485 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 115' ' ' TYR . 39.1 mt -89.11 14.43 10.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.176 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.435 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 27.9 p90 -64.74 -28.91 69.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.049 0.452 . . . . 0.0 109.814 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.596 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 32.1 p30 -69.46 -29.6 67.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.878 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -58.69 -49.62 76.92 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.51 0.671 . . . . 0.0 110.078 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.78 -39.82 78.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.295 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.443 ' CE2' ' HD2' ' A' ' 129' ' ' LYS . 45.5 t80 -54.58 -55.76 26.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.758 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 35.1 mt-10 -63.51 -40.13 96.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.942 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.504 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -60.06 -28.47 67.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.115 -177.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.467 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 47.1 m-80 -99.93 0.01 40.36 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 120.619 0.247 . . . . 0.0 110.871 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.547 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 25.8 mtpp -79.36 150.75 74.27 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-O 120.644 0.259 . . . . 0.0 110.779 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.445 ' HD2' HD13 ' A' ' 40' ' ' ILE . 9.5 Cg_endo -90.5 25.1 21.4 Favored 'Cis proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.662 -1.391 . . . . 0.0 112.843 -0.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.467 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 1.0 OUTLIER -74.95 -34.7 62.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.372 . . . . 0.0 110.276 176.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.486 HD21 HE21 ' A' ' 142' ' ' GLN . 0.1 OUTLIER -93.03 117.76 30.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.98 -43.37 24.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.892 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.3 m -151.45 149.85 25.34 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.255 0.55 . . . . 0.0 110.762 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.97 -18.08 61.19 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 123.713 2.942 . . . . 0.0 112.875 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.12 -16.31 22.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.498 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -78.62 -1.2 33.05 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.8 pt -65.7 168.14 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.912 0.387 . . . . 0.0 110.063 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -163.9 154.96 13.86 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.343 -172.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -45.2 113.31 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.164 2.576 . . . . 0.0 112.662 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.29 34.65 5.77 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.339 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.572 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.2 tp60 -107.08 116.6 32.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.835 0.318 . . . . 0.0 110.164 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.526 HG21 ' CD2' ' A' ' 6' ' ' PHE . 46.7 t -80.5 132.08 32.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.066 0.46 . . . . 0.0 110.004 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -125.63 134.42 51.9 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.073 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.504 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 47.2 mtp180 -62.68 118.76 8.09 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.064 171.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 39.7 mm -106.24 93.27 7.79 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 173.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 38.5 Cg_exo -59.85 139.14 86.78 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.222 1.948 . . . . 0.0 111.184 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -53.24 127.3 24.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.014 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.52 ' CD ' ' HB3' ' A' ' 152' ' ' HIS . 27.8 tt0 -60.82 99.99 0.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.678 -176.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.0 mt -98.48 98.5 9.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.845 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 66.35 101.99 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.478 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.52 ' HB3' ' CD ' ' A' ' 149' ' ' GLU . 10.1 p80 -93.88 148.0 22.55 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -111.99 106.28 14.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -72.96 -5.22 37.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.996 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -96.46 11.08 36.23 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.129 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 60.46 -174.04 0.12 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.704 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.5 p80 . . . . . 0 C--O 1.244 0.765 0 CA-C-O 118.908 -0.567 . . . . 0.0 110.23 176.734 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.0 ttm . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.93 -17.93 71.2 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.8 tp -93.18 105.8 17.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.268 0.556 . . . . 0.0 110.108 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -93.6 138.81 31.47 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.26 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.57 138.31 35.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.018 0.437 . . . . 0.0 111.01 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.414 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 59.5 m-85 -127.25 -179.12 4.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.496 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.95 HG21 ' HB3' ' A' ' 10' ' ' ALA . 23.7 m -81.26 -9.94 12.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -171.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.644 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 53.4 tptt 74.35 -54.95 0.67 Allowed 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.528 0.518 . . . . 0.0 112.141 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.62 -46.53 15.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.097 0.475 . . . . 0.0 111.963 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.95 ' HB3' HG21 ' A' ' 7' ' ' VAL . . . -81.29 126.93 32.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.183 -173.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.96 -173.1 36.59 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.371 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.04 129.59 41.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.35 54.98 1.8 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.992 0.901 . . . . 0.0 108.88 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 30' ' ' LYS . 14.7 tp -59.25 -45.98 89.73 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.8 -1.545 . . . . 0.0 111.312 -172.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -117.88 27.05 9.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.555 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.616 ' HB3' HG12 ' A' ' 18' ' ' VAL . 17.8 t70 62.49 6.14 1.88 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.664 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.71 23.4 13.28 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.159 0.583 . . . . 0.0 111.519 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.616 HG12 ' HB3' ' A' ' 16' ' ' ASP . 3.5 p -108.75 98.37 6.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.305 0.574 . . . . 0.0 110.99 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.8 m 72.06 -57.92 0.6 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.785 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 21' ' ' GLN . . . 156.22 -28.22 0.57 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.259 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 16.1 mm100 75.24 122.45 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.29 0.636 . . . . 0.0 111.128 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 31.0 m80 65.01 -85.9 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.484 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -146.04 -177.16 5.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HA ' ' OE1' ' A' ' 27' ' ' GLN . 41.1 ttmt -74.99 -41.89 58.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.024 0.44 . . . . 0.0 110.55 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.12 -23.27 64.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.093 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 19.0 t70 -72.22 -36.1 69.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.709 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 31' ' ' VAL . 51.5 mt-30 -59.92 -48.35 82.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.375 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.43 -34.7 72.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.765 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 38.6 ttpt -68.11 -39.99 82.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.985 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 74.6 mmtt -56.96 -44.96 83.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.063 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.611 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 47.5 t -59.96 -45.16 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.49 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -55.56 -47.64 76.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.868 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 38.2 mt-10 -58.91 -48.88 79.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.359 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -53.04 -39.37 63.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.456 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 85.7 mt -70.76 -40.91 72.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.013 0.435 . . . . 0.0 111.201 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -78.07 -31.01 50.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.175 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -67.92 -38.2 82.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.943 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 p -75.66 -36.42 60.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 110.789 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.92 35.29 4.32 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.167 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.8 mm -77.11 124.69 87.26 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.69 146.46 66.87 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.229 1.953 . . . . 0.0 112.396 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 64.34 -0.9 0.81 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.907 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 35' ' ' LEU . . . -80.77 -9.89 59.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.341 0.591 . . . . 0.0 110.432 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -87.7 -9.53 53.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.276 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -91.72 -35.54 14.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.089 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.8 m -69.68 166.12 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.373 -175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -130.23 128.99 42.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.802 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 48' ' ' ILE . 3.6 mp -103.87 140.91 20.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.8 0.333 . . . . 0.0 110.869 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 38.5 tt0 -123.14 135.78 54.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 173.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.3 mm -104.35 111.72 35.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.079 0.466 . . . . 0.0 110.306 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.25 93.89 4.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.473 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.6 t70 64.18 -83.62 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.368 -171.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.77 13.96 4.73 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.656 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 38.0 mtmm -95.82 117.23 30.16 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.662 0.267 . . . . 0.0 110.475 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -92.1 80.59 5.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.823 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 89.3 m -66.68 119.65 12.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.959 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 57' ' ' VAL . 7.3 p -106.89 109.97 30.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.441 0.638 . . . . 0.0 111.193 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.9 OUTLIER -100.68 154.41 18.62 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.028 178.44 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.93 160.23 17.72 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -151.75 146.08 25.47 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.241 0.543 . . . . 0.0 110.721 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.94 31.13 58.34 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.529 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.45 HD12 ' CG1' ' A' ' 87' ' ' VAL . 18.3 mt -98.83 -169.99 1.86 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.837 0.827 . . . . 0.0 110.851 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 m -108.96 128.78 55.24 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.718 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.51 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 9.4 tt0 -61.49 -31.51 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.946 -172.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HG3' ' NH2' ' A' ' 145' ' ' ARG . 42.2 tt0 -65.63 -39.53 91.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.069 0.461 . . . . 0.0 110.151 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.549 ' O ' HG13 ' A' ' 70' ' ' ILE . . . -72.92 -39.34 66.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.918 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.638 ' HA ' HD12 ' A' ' 70' ' ' ILE . 73.3 tttt -52.12 -53.68 39.77 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.593 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 72' ' ' VAL . 7.7 mm-40 -52.95 -35.25 58.51 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 28.7 ttpt -79.25 -32.55 43.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.505 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 67' ' ' LYS . 45.3 mt -61.89 -52.17 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 67' ' ' LYS . 9.8 mp -45.01 -43.84 9.53 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.646 173.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 68' ' ' GLU . 66.5 t -67.3 -51.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.465 0.65 . . . . 0.0 110.885 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.89 79.95 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.6 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.41 HG23 HG21 ' A' ' 83' ' ' VAL . 22.5 m -80.63 -25.94 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.029 0.442 . . . . 0.0 111.087 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -77.86 -28.87 55.95 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.832 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -83.39 42.61 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 111.404 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.2 mt -114.53 138.26 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-O 121.14 0.495 . . . . 0.0 110.488 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 t -71.49 111.91 7.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.182 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.09 -14.61 8.35 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -172.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.6 mm -98.74 121.83 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 110.902 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.644 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -104.14 -20.51 13.79 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.73 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.656 ' OG ' ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -158.83 153.85 25.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.465 -177.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 55' ' ' ALA . 68.1 t -127.84 124.27 62.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.789 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.8 105.85 18.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.494 ' OD1' ' HE3' ' A' ' 67' ' ' LYS . 3.3 t70 -72.84 116.54 13.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.224 0.535 . . . . 0.0 111.54 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 75.9 mt-30 -121.32 25.74 9.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.119 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.45 ' CG1' HD12 ' A' ' 62' ' ' LEU . 88.0 t -89.55 125.57 42.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.655 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -95.53 142.89 27.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.269 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.0 p -115.72 143.55 45.21 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.942 0.401 . . . . 0.0 111.548 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.91 -8.34 31.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.581 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.5 p -135.32 133.68 20.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.234 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.35 69.15 6.64 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.97 2.446 . . . . 0.0 111.283 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.44 -168.06 1.85 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.731 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.0 m -56.51 129.38 40.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.35 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.16 138.95 31.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.6 m -126.5 157.3 39.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.369 0.605 . . . . 0.0 112.02 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.9 tt0 -96.38 149.15 22.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.577 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -109.78 93.99 4.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.942 0.401 . . . . 0.0 110.603 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -98.2 139.18 34.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.272 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.6 m -104.54 123.44 47.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.345 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.9 m -70.92 134.87 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.4 mmtp -98.92 -165.61 1.26 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.481 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.427 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 13.9 m -65.1 122.87 18.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.633 0.254 . . . . 0.0 110.481 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.09 8.85 83.3 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.312 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.589 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 13.1 m-20 -88.31 105.18 17.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.367 0.603 . . . . 0.0 111.009 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 110' ' ' ILE . 5.8 m -102.69 161.09 14.01 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.488 ' N ' HD11 ' A' ' 138' ' ' ILE . 19.7 tp -56.39 -41.66 76.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.412 0.551 . . . . 0.0 111.699 -170.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.496 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 9.8 m -63.14 -41.57 99.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.955 0.407 . . . . 0.0 110.571 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.88 81.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.004 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.625 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -75.11 -24.52 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 120.917 0.389 . . . . 0.0 110.481 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.7 t -67.44 -44.14 79.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 170.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.79 -24.27 66.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.431 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 28.5 tp60 -71.87 -59.87 2.53 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.924 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.8 m -82.83 -35.82 12.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.236 -170.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.507 ' HB3' HD12 ' A' ' 120' ' ' LEU . 19.0 m-30 -103.68 -23.89 13.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.05 -175.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.44 -6.31 82.34 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.909 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.472 HD21 ' HB3' ' A' ' 119' ' ' ASN . 41.0 t30 -133.94 124.0 25.62 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -76.18 -15.2 60.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.712 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 117' ' ' ASN . 22.9 t-20 -68.68 -23.43 64.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.139 0.495 . . . . 0.0 110.596 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 115' ' ' TYR . 67.1 mt -85.06 14.22 5.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.572 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.46 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 24.2 p90 -62.3 -31.61 72.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.189 0.519 . . . . 0.0 110.257 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.582 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 26.3 p-10 -68.89 -29.64 67.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.507 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -58.17 -47.47 83.29 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.543 0.687 . . . . 0.0 109.772 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.9 mt -71.8 -41.02 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.304 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.465 ' HB2' HD21 ' A' ' 107' ' ' LEU . 83.5 t80 -53.72 -51.76 62.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 40.2 mt-10 -62.74 -23.22 67.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.941 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.558 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -86.87 -31.87 20.53 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.632 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.574 ' O ' ' HB3' ' A' ' 131' ' ' MET . 10.5 m120 -76.67 -42.07 43.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 58.5 pttt -64.47 153.72 85.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.949 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.1 Cg_endo -86.27 21.55 22.36 Favored 'Cis proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.225 -1.573 . . . . 0.0 112.892 0.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.574 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.2 tmm? -73.23 -26.73 61.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.465 HD12 ' H ' ' A' ' 133' ' ' LYS . 18.8 tp -111.72 133.75 53.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.078 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.465 ' H ' HD12 ' A' ' 132' ' ' LEU . 29.7 mtpp -81.67 -45.18 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.063 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.499 ' OG ' ' HG2' ' A' ' 137' ' ' LYS . 79.0 p -154.02 160.94 30.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.79 -17.75 52.05 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.528 2.819 . . . . 0.0 111.929 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -100.43 -12.98 18.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.511 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HG2' ' OG ' ' A' ' 134' ' ' SER . 56.4 mmtt -81.49 -8.03 59.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.655 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 9.3 pt -68.43 168.9 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.098 0.475 . . . . 0.0 110.978 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.492 ' CE1' ' HG3' ' A' ' 142' ' ' GLN . 15.4 p90 -155.98 147.79 17.18 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.177 -174.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.427 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 88.7 Cg_exo -48.48 103.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.597 2.865 . . . . 0.0 113.037 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.406 ' HA2' HG11 ' A' ' 7' ' ' VAL . . . 124.19 8.81 5.86 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.601 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.655 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 1.7 mt-30 -94.37 121.97 36.45 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 117.341 0.571 . . . . 0.0 111.224 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 41.9 t -80.61 135.31 25.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.303 172.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.2 mt -126.36 145.31 50.5 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.063 0.459 . . . . 0.0 110.748 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HB2' HG21 ' A' ' 72' ' ' VAL . 28.5 ttt180 -72.48 110.37 6.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.906 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 41.5 mm -94.7 112.38 57.72 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.558 ' HG3' ' HB2' ' A' ' 127' ' ' ALA . 32.4 Cg_exo -59.69 166.68 7.81 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.985 2.457 . . . . 0.0 113.109 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -84.24 121.13 27.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.922 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.95 25.56 3.62 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -175.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 63.5 mt -80.7 56.38 2.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.247 0.546 . . . . 0.0 110.822 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -92.72 -7.21 47.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.869 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 48.0 m80 75.35 132.7 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.621 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 63.16 85.11 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.43 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -59.77 121.27 11.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.511 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -77.46 -63.16 1.44 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.752 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -95.1 85.89 4.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.461 177.787 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.499 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . 85.6 mtp . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.688 0.28 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.94 78.7 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.51 HD13 ' N ' ' A' ' 4' ' ' PHE . 1.7 tm? -90.01 139.11 30.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.291 0.567 . . . . 0.0 111.31 -172.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.51 ' N ' HD13 ' A' ' 3' ' ' LEU . 86.5 m-85 -125.52 132.22 52.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.194 175.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -97.61 140.9 31.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.006 0.431 . . . . 0.0 110.997 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -127.75 -164.4 1.36 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.151 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.3 -10.81 8.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.794 0.331 . . . . 0.0 111.128 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 84.8 tttt 72.67 -67.19 0.27 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 176.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.31 -24.78 63.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.289 0.566 . . . . 0.0 110.504 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.26 119.98 31.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.711 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.01 -173.55 41.58 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.842 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -77.31 136.18 38.46 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 19.3 mtpt -77.97 86.05 4.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.45 0.643 . . . . 0.0 111.781 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 77' ' ' ILE . 8.9 mp -84.3 -40.81 17.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.005 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.471 ' CZ3' ' HB3' ' A' ' 27' ' ' GLN . 22.7 p90 -152.17 155.6 38.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.702 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 18' ' ' VAL . 23.7 m-20 -95.2 -6.39 41.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.592 171.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 65.27 -80.52 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.277 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 16' ' ' ASP . 6.9 m -47.02 -51.39 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 124.061 0.944 . . . . 0.0 112.731 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.468 ' H ' HG23 ' A' ' 18' ' ' VAL . 4.2 p -121.64 28.22 7.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.646 0.736 . . . . 0.0 109.908 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.29 -33.18 0.74 Allowed Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.23 -173.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.596 ' NE2' ' HG2' ' A' ' 27' ' ' GLN . 2.9 tt0 -161.46 118.54 2.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.986 0.393 . . . . 0.0 110.453 -174.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -73.3 -42.43 62.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.582 -174.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.492 ' HB3' ' OD1' ' A' ' 25' ' ' ASP . 28.7 m-20 -107.21 138.01 44.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.089 0.471 . . . . 0.0 110.678 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.412 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 63.4 mttp -79.35 -17.2 54.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.875 -177.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.492 ' OD1' ' HB3' ' A' ' 23' ' ' ASP . 5.0 p-10 -73.41 -24.39 60.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.346 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -74.92 -25.91 59.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.138 0.494 . . . . 0.0 110.018 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.596 ' HG2' ' NE2' ' A' ' 21' ' ' GLN . 86.1 mt-30 -66.56 -33.78 76.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.154 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.23 72.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.763 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 17.4 tppt? -65.18 -43.29 92.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.589 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -66.87 -32.06 73.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.046 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.612 HG11 HG23 ' A' ' 74' ' ' VAL . 75.3 t -63.59 -46.18 95.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.311 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -57.85 -41.42 82.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.516 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 54.6 mt-10 -56.95 -48.47 78.26 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.765 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.499 ' HB2' HD11 ' A' ' 14' ' ' LEU . 57.7 t60 -57.97 -37.02 73.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.428 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 64.4 mt -73.18 -40.65 64.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.008 0.433 . . . . 0.0 110.429 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -65.05 -48.0 75.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.419 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -58.03 -49.88 75.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.754 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.405 ' OG1' HG12 ' A' ' 40' ' ' ILE . 16.7 p -68.28 -44.38 75.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.37 35.49 3.85 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.792 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.405 HG12 ' OG1' ' A' ' 38' ' ' THR . 35.6 mm -66.67 124.04 87.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -66.38 138.65 51.48 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.989 1.793 . . . . 0.0 112.333 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 63.33 9.33 3.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.351 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -75.94 -14.38 60.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.27 0.557 . . . . 0.0 110.367 177.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -81.36 -16.32 52.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.13 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -75.19 -44.1 48.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.614 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.5 m -77.34 163.63 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.595 -172.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -118.8 139.28 51.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.877 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.9 mm -102.39 139.78 22.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.026 0.441 . . . . 0.0 111.316 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 49.9 tt0 -138.97 128.7 24.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.327 172.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mm -108.91 116.57 52.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.672 0.272 . . . . 0.0 110.912 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.48 100.06 7.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.832 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 t70 66.11 -80.96 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.8 0.688 . . . . 0.0 110.757 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.06 18.51 2.53 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 82' ' ' SER . 38.9 ttmt -107.78 114.74 28.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.294 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.68 111.87 23.62 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.155 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 18.5 m -86.65 130.64 34.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.917 177.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 57' ' ' VAL . 5.3 p -114.74 106.93 21.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.337 0.589 . . . . 0.0 110.897 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 m -104.55 155.88 18.44 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.996 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.22 179.72 39.25 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.325 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.13 150.52 13.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 0.0 110.6 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.54 23.97 48.46 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.504 -0.771 . . . . 0.0 113.163 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.46 175.35 5.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.76 0.314 . . . . 0.0 110.667 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 91' ' ' THR . 14.3 m -104.75 157.95 16.85 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 7.8 tp60 -53.85 -41.91 67.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.891 0.377 . . . . 0.0 110.227 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.689 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 61.1 mm-40 -49.84 -62.39 1.59 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.061 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.02 -37.69 84.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.685 0.279 . . . . 0.0 110.966 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -55.55 -51.77 65.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.625 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.558 ' O ' HG23 ' A' ' 72' ' ' VAL . 56.1 mt-10 -65.09 -33.56 76.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.106 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 29.8 mtpp -60.01 -42.73 94.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.867 0.365 . . . . 0.0 110.095 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.512 ' O ' HG12 ' A' ' 74' ' ' VAL . 52.6 mt -62.45 -57.38 12.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.322 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mp -41.9 -43.25 3.0 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.828 0.705 . . . . 0.0 112.406 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 68' ' ' GLU . 86.2 t -69.08 -53.19 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.33 0.586 . . . . 0.0 111.017 177.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.419 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -64.07 -31.09 72.16 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.588 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.612 HG23 HG11 ' A' ' 31' ' ' VAL . 11.7 p -84.62 -23.35 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.492 0.663 . . . . 0.0 110.532 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.23 -35.37 34.1 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.196 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -82.07 60.29 4.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.64 0.257 . . . . 0.0 111.145 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.625 HD12 HD22 ' A' ' 14' ' ' LEU . 32.7 mm -118.13 142.24 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.495 ' OG ' ' HA ' ' A' ' 13' ' ' LYS . 72.3 p -65.91 91.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.966 0.412 . . . . 0.0 110.492 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.98 -17.72 5.67 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.914 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 28.1 mm -86.51 113.06 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.667 0.746 . . . . 0.0 110.868 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.99 -24.61 15.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.03 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 5.4 p -150.05 156.83 42.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.293 0.568 . . . . 0.0 111.514 -178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.412 HG21 HG13 ' A' ' 74' ' ' VAL . 61.7 t -132.5 130.23 59.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.737 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -104.95 106.71 17.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -72.65 117.27 14.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.539 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 1' ' ' MET . 79.9 mt-30 -133.92 28.39 3.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.138 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.25 116.29 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.617 0.723 . . . . 0.0 110.712 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -82.37 144.46 30.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.766 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.9 p -112.17 127.43 55.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.19 0.519 . . . . 0.0 111.222 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.57 -27.75 23.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.23 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 16.3 p -119.93 132.24 24.13 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.332 176.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 50.4 Cg_endo -91.3 168.09 3.46 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.793 2.329 . . . . 0.0 113.205 -175.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -158.51 -156.63 0.56 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.554 174.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.11 154.5 19.32 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.21 129.09 35.85 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.6 m -97.39 156.48 16.44 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.281 0.563 . . . . 0.0 111.006 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.427 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 31.6 tt0 -87.87 142.19 28.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.323 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -106.76 90.55 3.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.442 . . . . 0.0 110.235 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 90.5 t80 -90.89 146.48 23.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.96 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.478 ' OG1' HG22 ' A' ' 143' ' ' VAL . 5.9 m -117.96 123.01 44.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.042 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.623 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.5 m -67.85 128.85 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -106.87 115.7 30.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.5 t 55.58 -90.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.822 173.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.5 19.32 53.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.427 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.578 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 2.2 m-20 -66.93 134.58 52.29 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.49 0.662 . . . . 0.0 111.253 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.629 ' O ' HG23 ' A' ' 110' ' ' ILE . 36.0 p -119.4 156.44 30.12 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.284 175.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 110' ' ' ILE . 20.9 tp -56.38 -40.86 75.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 118.185 0.448 . . . . 0.0 111.132 -171.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 4.6 m -63.77 -40.25 96.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.155 0.502 . . . . 0.0 110.378 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -73.83 -27.52 61.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.73 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 106' ' ' THR . 1.4 pp -85.34 -24.28 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.809 0.338 . . . . 0.0 110.958 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.494 ' HB3' HD12 ' A' ' 124' ' ' ILE . 11.3 p -76.3 -29.67 57.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 170.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 52.5 tptt -60.43 -26.33 66.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.842 170.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 16.2 mm-40 -75.69 -72.42 0.31 Allowed 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 122.282 1.039 . . . . 0.0 110.715 175.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.479 HG23 ' CD2' ' A' ' 115' ' ' TYR . 28.8 m -70.41 -40.1 77.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 113.251 -1.795 . . . . 0.0 112.659 -167.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.489 ' HB3' HD12 ' A' ' 120' ' ' LEU . 56.5 m-85 -96.97 -20.11 18.32 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.602 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 80.89 5.5 90.05 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.544 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.484 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 35.8 t30 -140.81 116.05 9.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.806 0.336 . . . . 0.0 110.318 -176.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.43 ' O ' ' HD2' ' A' ' 121' ' ' TYR . . . -70.31 -11.11 60.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.553 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -81.76 -10.96 59.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.489 HD12 ' HB3' ' A' ' 115' ' ' TYR . 74.8 mt -96.11 22.68 7.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.76 -178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.452 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 50.8 p90 -68.35 -29.13 67.79 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.041 -175.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.411 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 9.0 t30 -69.93 -30.51 67.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.084 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -53.83 -47.76 70.6 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.808 0.813 . . . . 0.0 109.484 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.548 HG22 ' OD1' ' A' ' 128' ' ' ASN . 55.7 mt -68.49 -46.71 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.491 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -53.96 -46.64 71.69 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.103 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.434 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 15.0 mt-10 -69.63 -24.67 63.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.96 0.41 . . . . 0.0 111.598 -176.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.49 29.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.951 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.548 ' OD1' HG22 ' A' ' 124' ' ' ILE . 8.3 m120 -74.82 -46.84 33.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.925 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 62.3 pttt -58.5 154.06 36.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.84 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.463 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.9 Cg_endo -80.86 15.18 20.15 Favored 'Cis proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.241 -1.566 . . . . 0.0 113.674 0.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.477 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.6 tmm? -70.03 -36.86 75.37 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.7 tp -94.45 115.88 28.14 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -73.81 -42.6 60.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.316 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 52.8 m -157.89 154.03 23.71 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 134' ' ' SER . 33.2 Cg_exo -61.72 -23.19 75.92 Favored 'Trans proline' 0 C--O 1.23 0.077 0 C-N-CA 123.76 2.974 . . . . 0.0 112.975 -173.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -105.38 7.16 33.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 110.689 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.416 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 30.9 mmtp -100.82 14.79 30.57 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.458 0.647 . . . . 0.0 110.692 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 106' ' ' THR . 17.6 pt -67.54 171.61 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.605 172.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 12.0 p90 -153.81 143.77 15.41 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.705 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 139' ' ' TYR . 58.0 Cg_exo -51.64 115.49 2.14 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.285 2.657 . . . . 0.0 112.898 -178.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.01 26.0 7.68 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.357 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.623 ' H ' HG22 ' A' ' 101' ' ' VAL . 65.4 tt0 -100.21 121.62 41.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.871 0.367 . . . . 0.0 110.782 -175.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.478 HG22 ' OG1' ' A' ' 100' ' ' THR . 55.4 t -82.12 138.4 19.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.691 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.0 mt -132.52 146.38 51.88 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.441 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.689 ' NH2' ' HA ' ' A' ' 65' ' ' GLU . 32.7 ttt180 -75.65 113.4 13.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.746 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 36.4 mm -99.93 103.09 20.0 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.106 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 27.2 Cg_exo -61.96 160.55 29.22 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.33 2.02 . . . . 0.0 111.805 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -80.73 129.9 34.78 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -62.75 96.29 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.453 0.471 . . . . 0.0 110.757 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.9 tp -101.59 84.79 2.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.166 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.93 157.54 37.9 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -174.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -73.67 -8.21 55.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.952 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -99.28 151.17 21.34 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -151.33 20.71 0.74 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.28 0.562 . . . . 0.0 110.462 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -105.97 107.4 18.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.678 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.405 ' HB2' ' C ' ' A' ' 116' ' ' GLY . 15.0 p-80 -84.48 170.83 13.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.295 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.2 p80 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.066 -178.581 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.653 0.263 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.89 23.25 0.97 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.353 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.0 tp -110.13 129.53 55.69 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.913 0.387 . . . . 0.0 110.405 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 82' ' ' SER . 81.3 m-85 -120.85 133.63 55.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.902 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -102.64 151.08 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.971 0.415 . . . . 0.0 110.813 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.747 ' HE1' HG12 ' A' ' 83' ' ' VAL . 90.8 m-85 -131.68 -179.88 5.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.945 -175.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.23 -17.81 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.867 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 81.2 tttt 72.93 -69.46 0.19 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.403 0.681 . . . . 0.0 111.7 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.26 -25.11 65.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.823 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.76 124.57 42.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.714 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.39 -163.26 36.78 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.71 134.4 38.11 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -78.06 90.49 4.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.327 0.584 . . . . 0.0 111.359 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.406 HD22 HD13 ' A' ' 77' ' ' ILE . 8.0 mp -97.69 -48.31 5.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.59 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -142.46 149.28 39.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.034 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.31 -1.07 35.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.301 0.572 . . . . 0.0 111.017 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 57.92 38.12 26.92 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.523 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.8 t -64.32 -73.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.993 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.8 p -130.03 23.94 5.28 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.28 -139.81 15.85 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.547 -171.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -156.01 93.81 1.47 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 34.5 m80 67.26 -72.14 0.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -168.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -122.67 -164.97 1.23 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.001 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -94.73 -42.93 8.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.077 0.465 . . . . 0.0 109.794 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.77 -10.47 59.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.954 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 18.9 t70 -72.05 -21.79 61.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.277 0.56 . . . . 0.0 109.734 177.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.434 ' HB2' HG13 ' A' ' 50' ' ' ILE . 17.6 mt-30 -69.09 -31.33 69.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.787 176.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 50' ' ' ILE . . . -62.89 -27.45 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.232 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.589 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 60.5 tttp -65.19 -42.76 93.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -64.04 -37.99 89.43 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.176 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.565 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 62.1 t -59.15 -51.68 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.893 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -54.58 -43.43 72.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.445 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 43.3 mt-10 -57.36 -56.74 17.93 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.105 0.478 . . . . 0.0 110.034 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -51.74 -42.76 62.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.283 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 99.2 mt -68.04 -42.76 80.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.645 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.51 -26.81 51.46 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.124 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -74.13 -32.43 63.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.688 0.28 . . . . 0.0 111.346 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.416 ' OG1' HG12 ' A' ' 40' ' ' ILE . 2.1 p -80.4 -30.64 37.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.905 0.383 . . . . 0.0 110.984 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.28 27.51 8.66 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.843 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.548 HD13 ' HD2' ' A' ' 130' ' ' PRO . 43.8 mm -58.41 129.75 84.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 122.402 0.281 . . . . 0.0 110.582 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -66.56 134.62 36.15 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.047 1.831 . . . . 0.0 111.981 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.484 ' HB3' HD22 ' A' ' 62' ' ' LEU . 7.5 m-20 62.96 21.69 13.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.804 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.493 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -70.34 -20.53 62.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.089 0.471 . . . . 0.0 111.093 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -91.54 -9.59 43.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.322 0.582 . . . . 0.0 109.991 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.77 -14.31 30.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.203 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.569 HG11 HD13 ' A' ' 70' ' ' ILE . 18.4 m -97.87 177.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -142.09 133.16 26.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.063 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.04 132.98 58.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.003 0.43 . . . . 0.0 110.751 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.424 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 95.3 mt-30 -115.71 147.9 40.36 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.46 HG22 ' H ' ' A' ' 52' ' ' ASP . 23.0 mm -120.48 128.86 76.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.19 35.24 4.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.194 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' H ' HG22 ' A' ' 50' ' ' ILE . 25.8 t70 66.88 98.26 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.671 0.607 . . . . 0.0 110.992 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 75.49 7.26 82.67 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.835 -176.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -146.5 138.69 24.95 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -120.11 148.26 43.84 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.693 175.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 61.2 m -117.65 119.79 36.05 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.1 t -99.54 111.76 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.459 0.647 . . . . 0.0 110.522 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -113.12 160.5 18.14 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.977 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.78 161.93 15.93 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -139.87 150.66 44.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.127 0.464 . . . . 0.0 111.008 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.92 35.45 84.57 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.93 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 42' ' ' ASP . 15.2 mt -107.67 -166.25 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.677 0.751 . . . . 0.0 111.305 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 79.5 p -141.59 159.06 43.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.2 -1.363 . . . . 0.0 107.862 174.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 58.3 mt-30 -68.26 -18.92 64.67 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.413 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.42 -44.9 96.33 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.86 -38.33 15.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.964 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -58.76 -41.26 86.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 -178.592 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.16 35.04 0.63 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.319 1.057 . . . . 0.0 110.304 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -123.75 -50.06 1.85 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.597 -1.638 . . . . 0.0 107.152 167.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.569 HD13 HG11 ' A' ' 46' ' ' VAL . 16.5 mt -61.99 -51.94 66.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.775 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp -67.43 -19.26 65.35 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.829 0.824 . . . . 0.0 110.419 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.4 t -86.14 -56.25 5.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.15 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.67 -23.23 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.151 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.412 HG23 HG11 ' A' ' 31' ' ' VAL . 14.5 p -76.28 -39.13 34.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.866 0.365 . . . . 0.0 110.662 176.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.639 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -71.24 -27.89 70.98 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.865 175.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -83.06 44.69 0.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 111.064 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.406 HD13 HD22 ' A' ' 14' ' ' LEU . 96.4 mt -119.71 141.28 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.424 174.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.3 m -68.27 103.19 1.53 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.548 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 130.62 -20.14 4.94 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.458 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.656 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 50.1 mm -94.73 116.85 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.439 . . . . 0.0 110.93 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 8' ' ' LYS . . . -107.78 -10.11 15.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.249 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 5.4 p -162.32 156.93 22.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.983 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.747 HG12 ' HE1' ' A' ' 6' ' ' PHE . 11.5 p -140.93 136.58 34.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.586 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.82 114.46 28.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.542 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.7 112.39 18.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.088 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -129.64 35.91 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.385 0.612 . . . . 0.0 110.503 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.481 HG11 HD12 ' A' ' 62' ' ' LEU . 93.4 t -89.09 131.98 35.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.392 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -94.99 97.6 10.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.748 175.011 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.7 p -81.74 121.52 26.5 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.88 -32.69 20.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.57 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 63' ' ' SER . 17.5 p -106.67 130.22 23.25 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.593 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.21 148.81 34.99 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.93 2.42 . . . . 0.0 112.795 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 64' ' ' GLN . . . -157.12 166.75 32.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.818 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.0 m -74.76 127.24 32.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.871 0.367 . . . . 0.0 110.943 -177.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.75 136.04 40.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.902 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.9 m -112.96 172.84 6.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.195 0.521 . . . . 0.0 111.694 -174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.0 tt0 -96.79 143.25 27.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.232 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -103.6 87.53 2.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.154 0.502 . . . . 0.0 110.456 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -88.11 136.71 32.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.115 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.437 ' OG1' HG22 ' A' ' 143' ' ' VAL . 6.6 m -105.7 123.64 48.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.338 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.559 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.2 m -72.16 135.06 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.277 0.561 . . . . 0.0 109.633 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.492 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 75.2 mmtt -86.92 -165.29 1.25 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.154 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.3 m -55.45 -55.21 34.37 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.862 -173.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.13 26.53 20.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.818 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 7.9 m-20 -82.11 111.51 18.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.149 0.499 . . . . 0.0 111.111 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.604 ' HA ' HD11 ' A' ' 138' ' ' ILE . 22.7 p -101.06 164.42 11.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.217 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 125' ' ' PHE . 18.2 tp -63.37 -36.49 83.88 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.165 -174.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -67.16 -35.83 80.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.958 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.85 -41.73 67.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.037 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -78.34 -24.3 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.622 -176.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 p -73.28 -40.63 64.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -61.86 -21.92 65.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.292 0.568 . . . . 0.0 110.145 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.637 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.1 tp-100 -75.44 -63.86 1.19 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.8 176.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -76.76 -43.0 33.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.192 -170.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.497 ' CD1' ' HB2' ' A' ' 149' ' ' GLU . 19.7 m-85 -92.96 -32.36 14.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.933 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.1 -4.62 58.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.192 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.522 ' OD1' ' HG ' ' A' ' 120' ' ' LEU . 24.1 t-20 -126.59 121.99 33.78 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.494 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -77.12 -18.42 57.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -78.67 -14.45 59.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.146 0.498 . . . . 0.0 110.339 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.522 ' HG ' ' OD1' ' A' ' 117' ' ' ASN . 78.4 mt -84.62 14.99 4.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.582 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.494 ' HD1' ' O ' ' A' ' 118' ' ' ALA . 38.8 p90 -63.08 -30.69 71.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.864 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.52 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 15.9 m120 -64.9 -32.76 74.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -61.12 -48.4 81.84 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.391 0.615 . . . . 0.0 110.187 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.06 -36.28 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.368 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.481 ' HB2' HD21 ' A' ' 107' ' ' LEU . 83.3 t80 -56.23 -53.82 52.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.406 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 26.6 mt-10 -70.72 -17.03 62.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.281 -175.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -84.86 -10.0 57.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.032 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -115.1 25.65 10.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.203 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 11.1 mmmm -86.31 150.21 51.31 Favored Pre-proline 0 C--N 1.326 -0.424 0 O-C-N 122.158 -0.339 . . . . 0.0 110.402 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.548 ' HD2' HD13 ' A' ' 40' ' ' ILE . 10.0 Cg_endo -95.87 15.99 37.75 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.441 -1.066 . . . . 0.0 111.969 -6.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -14.71 62.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.222 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.424 HD21 HE21 ' A' ' 142' ' ' GLN . 0.9 OUTLIER -107.67 124.21 49.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 168.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -99.43 -42.09 7.11 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.757 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.453 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 14.7 m -149.56 147.96 24.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.19 0.519 . . . . 0.0 109.786 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.63 -19.91 65.08 Favored 'Trans proline' 0 C--N 1.336 -0.129 0 C-N-CA 123.714 2.943 . . . . 0.0 112.851 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -96.88 -8.24 31.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.371 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.453 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 36.7 mmtm -91.44 9.13 33.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.604 HD11 ' HA ' ' A' ' 106' ' ' THR . 10.3 pt -69.51 174.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.016 169.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -162.2 148.12 10.49 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.69 116.92 2.36 Favored 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.226 2.617 . . . . 0.0 112.136 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.99 14.32 23.11 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.1 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.559 ' H ' HG22 ' A' ' 101' ' ' VAL . 1.7 mm100 -86.5 108.71 18.66 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.16 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.437 HG22 ' OG1' ' A' ' 100' ' ' THR . 41.7 t -79.8 125.06 38.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 172.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.2 mt -118.96 140.17 50.45 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.81 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.534 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 35.6 ttt180 -74.74 111.54 10.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.544 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 33.3 mm -97.67 102.93 14.47 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.006 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 25.5 Cg_exo -63.13 145.76 93.9 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.55 2.167 . . . . 0.0 111.67 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.9 117.71 4.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.492 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.497 ' HB2' ' CD1' ' A' ' 115' ' ' TYR . 8.5 tp10 -70.7 113.89 8.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.344 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.0 tp -154.42 29.69 0.44 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -112.95 78.84 1.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 53.93 57.54 5.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.413 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -88.75 -1.9 58.32 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.654 -174.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -89.27 0.94 56.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 171.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 11.4 t-80 -118.91 145.07 46.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 173.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 155' ' ' HIS . 67.7 m-70 66.26 88.08 0.11 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.177 0.513 . . . . 0.0 109.973 -171.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.347 -177.371 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.82 0.343 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.16 44.61 1.44 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 83' ' ' VAL . 19.4 tp -87.39 111.3 20.97 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.491 0.662 . . . . 0.0 111.612 -171.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -93.88 140.71 29.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.039 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -92.19 124.89 36.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.846 0.355 . . . . 0.0 110.81 -176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.628 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 57.1 m-85 -110.41 -164.16 0.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.784 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.857 HG11 ' HB3' ' A' ' 10' ' ' ALA . 7.3 p -82.8 -28.26 8.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -173.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.796 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 22.2 tptm 76.44 -60.4 0.48 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.218 0.607 . . . . 0.0 111.33 -175.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.26 -42.62 36.38 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.857 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -84.22 179.05 7.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.034 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.2 -168.89 12.69 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.553 ' HG2' HD13 ' A' ' 14' ' ' LEU . 4.8 tp10 -60.19 122.87 15.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -77.68 64.75 3.03 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.257 1.027 . . . . 0.0 109.216 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.553 HD13 ' HG2' ' A' ' 12' ' ' GLU . 11.7 tp -75.47 -32.15 60.49 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 113.571 -1.65 . . . . 0.0 110.383 -174.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -151.27 176.8 10.88 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.016 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.47 113.02 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.023 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.8 47.76 1.13 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.74 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -119.53 97.28 5.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.485 0.66 . . . . 0.0 110.123 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.6 p 51.7 42.0 29.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.636 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.39 168.53 44.3 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.029 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -91.69 -57.59 2.7 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -179.97 -53.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.702 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -123.07 128.68 50.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.389 0.614 . . . . 0.0 110.936 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -69.76 -40.11 76.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.202 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.73 -27.32 66.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.924 0.392 . . . . 0.0 110.12 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.43 -45.35 60.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.198 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' VAL . 82.9 mt-30 -57.89 -45.49 86.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.379 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.78 78.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.115 0.483 . . . . 0.0 110.734 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -70.93 -45.21 64.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.562 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' C ' HD21 ' A' ' 14' ' ' LEU . 30.1 mmtp -58.77 -39.38 80.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.397 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 98.1 t -64.81 -36.28 77.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.735 0.302 . . . . 0.0 110.372 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.425 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 25.6 mm-40 -64.4 -46.98 80.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.906 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.71 -38.71 78.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.246 0.546 . . . . 0.0 109.922 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -60.32 -40.47 90.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.381 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 95.9 mt -71.13 -38.79 72.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.244 0.545 . . . . 0.0 110.888 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -76.72 -32.41 57.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.487 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -75.33 -23.82 57.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.082 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -83.77 -32.72 25.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.288 0.566 . . . . 0.0 110.541 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.07 35.69 4.71 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.753 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.5 mm -74.75 126.19 88.74 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -71.59 144.89 45.7 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.079 1.853 . . . . 0.0 112.596 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 59.37 23.84 12.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.418 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.89 -42.6 73.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 -177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.64 -0.52 34.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.924 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -88.92 -11.23 45.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.014 0.435 . . . . 0.0 110.242 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.26 157.26 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.288 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -106.44 130.33 54.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.854 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.437 HG21 ' HB ' ' A' ' 31' ' ' VAL . 34.4 mm -90.54 135.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.337 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 98.2 mt-30 -132.86 140.34 47.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.956 175.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mm -118.35 120.65 65.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.48 60.46 1.01 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.068 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 53.68 76.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.039 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 86.59 20.72 53.55 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.641 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 82' ' ' SER . 3.1 ttmp? -146.69 124.21 11.73 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 122.682 -0.305 . . . . 0.0 110.479 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 83' ' ' VAL . . . -104.79 91.53 3.88 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.783 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.545 HG23 ' HB3' ' A' ' 84' ' ' ASP . 58.7 m -80.41 109.42 14.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.151 0.501 . . . . 0.0 109.899 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 12.2 p -93.83 136.87 24.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.124 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 86' ' ' GLN . 1.4 m -132.01 157.17 44.82 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.0 171.62 29.48 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -155.15 144.52 21.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.873 0.368 . . . . 0.0 110.803 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.25 18.19 31.97 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.165 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.36 178.24 4.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.993 0.425 . . . . 0.0 111.265 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -111.68 170.28 8.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.959 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 47.8 tp60 -57.47 -53.57 56.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' HG3' ' NH1' ' A' ' 145' ' ' ARG . 39.5 tt0 -57.33 -49.37 76.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.175 -174.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.01 -49.12 77.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.688 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.508 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 41.6 tttp -45.94 -52.81 10.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.45 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 72' ' ' VAL . 53.7 mt-10 -74.79 -28.55 60.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.937 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 65' ' ' GLU . 13.4 tptm -63.32 -42.74 99.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.407 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.06 -49.65 80.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 77.3 mt -48.41 -47.42 37.84 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.164 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 68' ' ' GLU . 39.7 t -66.2 -52.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.308 0.575 . . . . 0.0 111.1 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.31 -30.35 70.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.565 -172.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -83.43 -23.15 8.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.061 0.457 . . . . 0.0 111.234 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.628 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -78.01 -33.06 42.28 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.821 176.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -80.15 61.28 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.716 0.293 . . . . 0.0 110.812 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.571 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 23.3 mm -122.51 132.71 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 t -65.22 101.81 0.59 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 173.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.427 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 126.8 -17.37 6.4 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.645 -172.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.571 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 39.2 mm -102.14 121.11 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.292 0.568 . . . . 0.0 110.822 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.796 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -98.86 -33.97 10.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.704 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 25.4 m -147.24 160.34 42.6 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.49 HG22 ' HB3' ' A' ' 55' ' ' ALA . 55.7 t -132.34 121.72 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.671 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.545 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.5 t70 -97.58 106.53 18.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.267 0.556 . . . . 0.0 109.597 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.98 115.64 9.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.034 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 96.9 mt-30 -125.86 35.05 4.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.305 171.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.02 118.86 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.959 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -86.4 131.88 34.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.824 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.6 p -104.39 120.81 42.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.056 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.88 -25.14 43.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.73 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -127.94 127.37 23.9 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.884 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.25 155.92 10.99 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.078 2.519 . . . . 0.0 112.25 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -160.27 -157.97 0.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.463 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -71.81 121.09 18.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.875 0.369 . . . . 0.0 111.231 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.35 146.46 27.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.697 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.8 m -123.22 157.97 31.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.66 0.743 . . . . 0.0 112.258 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -96.46 155.38 16.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.278 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -113.52 96.08 5.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.873 0.368 . . . . 0.0 110.776 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 90.3 t80 -96.23 142.63 28.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.453 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.8 m -109.13 120.86 43.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.517 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.3 m -72.21 139.89 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.7 mmtp -109.76 -165.9 1.05 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.002 0.429 . . . . 0.0 111.257 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 m -67.55 114.69 6.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.63 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.85 13.13 57.08 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.973 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 11.5 m-20 -94.48 123.53 37.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.346 0.593 . . . . 0.0 110.837 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 110' ' ' ILE . 24.7 p -111.39 155.85 22.51 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.346 174.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.532 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 2.3 pt? -55.52 -36.59 66.89 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.409 -176.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 m -66.32 -44.78 82.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.683 0.278 . . . . 0.0 110.804 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.32 -42.33 96.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.039 0.447 . . . . 0.0 110.831 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 99' ' ' TYR . 1.4 pp -76.17 -25.11 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.3 t -66.0 -45.06 82.94 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -58.95 -33.77 71.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.345 0.593 . . . . 0.0 109.678 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.1 tp-100 -65.75 -56.82 10.0 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.53 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -86.3 -47.85 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.442 -171.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.454 ' HB3' HD12 ' A' ' 120' ' ' LEU . 54.2 m-85 -82.48 -37.99 24.55 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.183 0.516 . . . . 0.0 110.695 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 106.92 -14.06 41.15 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -129.33 128.36 42.97 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.516 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -72.39 -24.9 61.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.747 -175.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -74.07 -0.19 15.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 0.0 111.92 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 115' ' ' TYR . 72.3 mt -96.13 15.68 20.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.149 0.499 . . . . 0.0 110.764 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 53.6 p90 -62.83 -27.46 69.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.137 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.551 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 4.6 p30 -67.0 -35.2 79.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.869 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -60.07 -31.67 70.23 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.425 0.631 . . . . 0.0 110.059 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.586 HG22 ' OD1' ' A' ' 128' ' ' ASN . 39.3 mt -79.17 -52.09 15.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.448 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.433 ' CE2' ' HD3' ' A' ' 129' ' ' LYS . 76.6 t80 -49.76 -48.83 50.05 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.085 0.469 . . . . 0.0 111.355 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 42.6 mt-10 -63.63 -25.9 68.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -94.77 -10.22 32.22 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.761 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.761 ' O ' ' HG3' ' A' ' 131' ' ' MET . 8.9 m120 -94.54 -43.97 8.08 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.444 ' HA ' ' H ' ' A' ' 132' ' ' LEU . 40.6 pttt -60.03 147.36 80.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.416 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -90.56 11.5 58.48 Favored 'Cis proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.554 -1.436 . . . . 0.0 114.574 6.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.761 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -81.05 -7.57 59.59 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.481 0.658 . . . . 0.0 110.297 174.575 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.47 ' HB3' ' CB ' ' A' ' 128' ' ' ASN . 12.9 tp -132.84 112.06 11.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.827 166.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.07 -26.5 20.23 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 25.5 m -151.49 153.82 32.69 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.353 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -53.17 -48.55 21.46 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 C-N-CA 123.197 2.598 . . . . 0.0 112.397 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -82.27 6.91 15.3 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.893 -175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 134' ' ' SER . 37.8 mmtm -89.79 -4.62 57.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.577 0.227 . . . . 0.0 111.441 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.634 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 15.8 pt -63.02 171.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 174.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -163.11 147.94 9.25 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.099 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -51.11 104.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.213 2.609 . . . . 0.0 112.251 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.08 35.19 1.85 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.218 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.634 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 45.8 tt0 -117.13 121.96 42.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.881 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 48.6 t -80.16 136.05 24.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.963 174.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.0 mt -124.31 145.18 49.57 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.067 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.558 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 37.3 ttt180 -73.51 117.06 14.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.593 176.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.7 88.66 4.5 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.961 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 24.7 Cg_exo -63.83 166.47 15.98 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.361 2.041 . . . . 0.0 111.927 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.99 131.55 46.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.465 ' OE2' ' HA ' ' A' ' 152' ' ' HIS . 0.4 OUTLIER -57.76 107.48 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.569 0.543 . . . . 0.0 110.3 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 96.5 mt -98.87 133.23 43.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.112 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 154' ' ' HIS . 43.1 mm-40 68.04 72.03 0.31 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 123.868 0.73 . . . . 0.0 110.622 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.465 ' HA ' ' OE2' ' A' ' 149' ' ' GLU . 39.0 m-70 -66.64 110.38 3.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.084 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 62.24 51.87 3.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.201 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 151' ' ' GLU . 4.1 t-160 -84.56 -54.55 4.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.593 176.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -148.63 32.16 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.138 0.495 . . . . 0.0 110.449 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -138.88 142.25 38.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.209 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.8 t60 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.717 177.935 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 85' ' ' ASP . 16.3 mmt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.591 0.234 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.5 163.29 27.53 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.957 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 83' ' ' VAL . 58.8 tp -116.09 118.12 31.98 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -103.7 134.49 46.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.592 -176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -96.06 132.57 41.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.732 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.524 ' CD2' HG21 ' A' ' 143' ' ' VAL . 50.2 m-85 -124.6 179.91 4.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.188 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.8 t -97.3 107.5 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 59.1 tttm -56.5 -51.74 67.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.337 -170.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.54 -12.81 61.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.026 0.441 . . . . 0.0 111.037 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.565 ' CB ' ' HA3' ' A' ' 141' ' ' GLY . . . -92.82 -164.06 1.13 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.528 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.94 -173.05 44.61 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.923 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.51 125.27 25.62 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -73.52 66.95 1.04 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.201 1.001 . . . . 0.0 109.541 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.435 HD21 ' O ' ' A' ' 30' ' ' LYS . 11.7 tp -69.4 -50.94 41.27 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.765 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 21' ' ' GLN . 7.8 p90 -126.17 16.65 7.82 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.785 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.417 ' HB3' HG12 ' A' ' 18' ' ' VAL . 2.1 m-20 71.86 -43.85 0.57 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.534 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 69.1 23.38 6.5 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.414 0.686 . . . . 0.0 111.251 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' A' ' 16' ' ' ASP . 2.5 p -137.82 97.68 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.364 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 m 56.86 36.2 27.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.811 0.815 . . . . 0.0 110.49 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.0 -115.03 2.3 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.498 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.48 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . 2.6 mp0 -80.14 125.34 29.7 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -123.11 -17.6 6.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.713 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.665 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 39.6 m-20 -74.34 107.51 6.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.854 0.359 . . . . 0.0 110.664 -174.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.562 ' O ' ' HB ' ' A' ' 50' ' ' ILE . 21.4 pttp -55.99 -37.31 68.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -170.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.79 -30.07 65.13 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.612 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 33.5 t70 -77.94 -30.59 50.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.873 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 7.0 mm100 -60.37 -41.75 94.4 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.62 -43.2 65.25 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.926 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.3 tttm -64.2 -44.11 92.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.064 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 73.2 mmtt -61.85 -40.92 97.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.112 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.62 HG11 HG23 ' A' ' 74' ' ' VAL . 92.2 t -62.52 -45.1 99.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.355 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.558 ' HG2' HG13 ' A' ' 48' ' ' ILE . 7.8 mm-40 -55.96 -46.41 78.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.615 173.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 50.4 mt-10 -55.74 -47.39 77.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.349 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -54.78 -45.84 74.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.326 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 80.3 mt -68.0 -35.52 78.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.968 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -73.43 -34.49 65.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.897 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 98.7 mttt -69.11 -46.12 68.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.131 178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.8 p -64.29 -34.14 77.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.099 0.476 . . . . 0.0 110.764 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.53 34.39 4.45 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.503 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.421 ' HB ' ' CB ' ' A' ' 43' ' ' ALA . 7.8 mm -80.31 116.34 61.02 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.25 -49.08 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.958 2.439 . . . . 0.0 113.346 -171.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.44 -5.99 54.03 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.428 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.484 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -72.72 -17.89 61.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.326 0.584 . . . . 0.0 110.149 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.09 -14.62 59.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.891 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.52 -0.76 37.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.21 -172.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -117.3 162.57 15.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.148 0.499 . . . . 0.0 111.216 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -106.33 138.2 42.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.043 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.558 HG13 ' HG2' ' A' ' 32' ' ' GLN . 31.2 mm -100.37 130.26 49.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.631 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.503 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 98.4 mt-30 -129.98 136.27 49.24 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 172.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' A' ' 24' ' ' LYS . 26.8 mm -120.25 119.37 59.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.022 0.439 . . . . 0.0 111.167 -174.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 54' ' ' LYS . . . -100.46 59.53 0.98 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 172.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 70.15 -65.56 0.31 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.712 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 -17.62 6.49 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.246 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 40.7 ttmt -97.85 121.51 39.84 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.078 0.466 . . . . 0.0 110.718 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -100.38 114.62 28.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.078 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 47.3 m -92.9 123.81 36.43 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.836 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.02 125.16 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.813 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -131.59 143.34 50.27 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.479 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.9 174.56 36.93 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 p-10 -146.56 149.64 33.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.874 0.337 . . . . 0.0 110.325 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 84.4 22.69 53.49 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.263 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 89' ' ' THR . 7.0 mp -99.07 176.18 5.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.847 0.356 . . . . 0.0 110.42 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.6 p -113.24 154.21 27.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.162 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.657 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 2.3 mm100 -51.27 -47.61 62.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.492 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 7.4 tp10 -53.19 -48.6 67.94 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 111.051 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.19 -43.14 71.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.667 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.44 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 28.0 tttm -54.07 -45.22 71.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.735 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 6.1 mm-40 -60.72 -36.65 79.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.35 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -63.6 -40.09 96.06 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 67' ' ' LYS . 3.6 mm -60.34 -54.6 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 88.8 mt -52.6 -39.47 61.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.824 -1.535 . . . . 0.0 112.224 -174.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.529 HG21 ' HG2' ' A' ' 145' ' ' ARG . 42.9 t -76.74 -51.92 18.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.038 0.447 . . . . 0.0 110.878 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.53 72.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.716 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.62 HG23 HG11 ' A' ' 31' ' ' VAL . 9.1 p -80.47 -30.03 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.069 0.462 . . . . 0.0 110.849 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.33 -32.8 27.38 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.148 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.08 60.88 3.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 111.493 -178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.43 139.64 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.427 173.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 23.5 m -66.06 112.47 3.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.723 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.5 -28.09 5.59 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -173.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 46.0 mm -89.12 126.2 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.254 0.55 . . . . 0.0 110.475 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.94 -28.49 9.56 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.485 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.409 ' HA ' ' HD1' ' A' ' 6' ' ' PHE . 41.8 m -156.54 160.72 39.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.474 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 55.0 t -127.99 129.52 69.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.61 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -98.09 103.85 15.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.711 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.9 t70 -78.13 114.17 16.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.291 -176.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -132.26 18.9 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.615 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.56 115.15 27.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.451 0.643 . . . . 0.0 110.825 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 57.1 mttm -73.68 133.49 43.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.197 -175.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 12.4 p -99.54 110.28 22.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.587 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.491 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -81.66 -21.58 38.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.655 -178.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 34.0 p -128.58 143.95 50.31 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 6.2 Cg_exo -77.38 140.28 19.23 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.296 2.664 . . . . 0.0 111.857 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.492 ' HB3' ' H ' ' A' ' 65' ' ' GLU . . . -162.14 -166.63 1.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.974 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.474 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 7.7 m -58.77 132.99 55.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.85 129.74 55.4 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 168.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.6 m -114.32 147.59 38.87 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.09 0.471 . . . . 0.0 111.67 -171.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.501 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 33.1 tt0 -80.5 136.17 36.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -99.6 100.39 11.39 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.084 0.469 . . . . 0.0 110.471 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.453 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 92.0 t80 -100.93 136.95 39.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.621 176.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.489 ' OG1' HG22 ' A' ' 143' ' ' VAL . 16.9 m -106.22 124.84 50.21 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.95 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.616 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.5 m -67.88 126.33 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -75.81 -56.89 4.24 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.289 -167.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.44 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 10.7 t -167.23 -71.05 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.773 0.32 . . . . 0.0 110.373 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.15 45.45 3.51 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.521 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 2.2 m-20 -103.06 143.1 33.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.119 0.485 . . . . 0.0 110.448 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 110' ' ' ILE . 61.6 p -122.11 159.58 26.84 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.827 173.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.55 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 30.9 tp -61.45 -36.88 81.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 118.506 0.593 . . . . 0.0 110.221 -174.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 p -69.79 -33.02 71.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.189 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HB3' ' H ' ' A' ' 106' ' ' THR . . . -73.4 -43.69 59.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.969 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 106' ' ' THR . 1.3 pp -74.82 -25.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.18 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.467 ' HB3' HD12 ' A' ' 124' ' ' ILE . 13.3 p -71.42 -43.06 67.47 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.182 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -65.82 -23.95 66.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 110.393 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.581 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.0 OUTLIER -66.28 -52.85 43.33 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.167 175.508 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 146' ' ' ILE . 34.1 m -89.99 -40.87 13.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.259 -171.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.414 ' N ' HG23 ' A' ' 114' ' ' VAL . 55.5 m-85 -88.9 -38.49 14.5 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.96 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.56 -8.02 59.91 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -169.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -124.42 125.95 45.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.64 -0.78 . . . . 0.0 109.576 -174.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.33 -8.76 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.308 . . . . 0.0 111.622 -175.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -76.52 -20.27 57.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.352 0.596 . . . . 0.0 109.754 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 50.7 mt -84.25 18.55 2.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.342 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.55 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 34.8 p90 -66.61 -33.75 76.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.349 0.595 . . . . 0.0 109.454 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -68.4 -35.26 77.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.267 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 27.7 mmmt -52.27 -54.52 30.29 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.611 0.72 . . . . 0.0 110.189 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 111' ' ' SER . 52.2 mt -63.2 -36.93 77.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.588 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 134' ' ' SER . 30.8 t80 -61.54 -56.35 20.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.746 0.308 . . . . 0.0 110.734 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 18.3 mt-10 -61.64 -37.31 83.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.159 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.83 -31.26 70.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.928 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.573 ' O ' ' HG3' ' A' ' 131' ' ' MET . 33.7 m-80 -93.18 8.69 39.14 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.366 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 9.1 mtpm? -84.9 153.83 60.68 Favored Pre-proline 0 C--N 1.318 -0.794 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.882 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -91.87 11.81 55.65 Favored 'Cis proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.946 -1.689 . . . . 0.0 112.752 -0.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.573 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -69.28 -24.38 63.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.708 0.289 . . . . 0.0 111.476 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.4 tp -98.48 121.68 40.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -74.68 -54.38 7.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.654 -172.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.494 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 49.5 m -156.44 157.66 31.12 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.722 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.409 ' HA ' HD22 ' A' ' 107' ' ' LEU . 83.2 Cg_exo -47.8 -56.53 3.01 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 124.002 3.135 . . . . 0.0 113.889 -175.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.6 3.9 26.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -91.92 7.82 40.27 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 120.886 0.374 . . . . 0.0 111.414 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.495 HD11 ' HA ' ' A' ' 106' ' ' THR . 19.1 pt -66.59 169.16 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.354 171.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -163.75 148.1 8.6 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.44 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 63.6 Cg_exo -46.13 120.47 3.67 Favored 'Trans proline' 0 CA--C 1.519 -0.267 0 C-N-CA 123.183 2.589 . . . . 0.0 112.621 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 94.21 24.68 18.64 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.297 -176.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.616 ' H ' HG22 ' A' ' 101' ' ' VAL . 7.3 tp60 -97.79 111.56 23.81 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.524 HG21 ' CD2' ' A' ' 6' ' ' PHE . 46.1 t -77.66 135.86 25.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.2 mt -130.9 137.59 49.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.829 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.529 ' HG2' HG21 ' A' ' 72' ' ' VAL . 25.4 mtm180 -69.1 123.31 20.72 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.083 174.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 24.9 mm -103.87 95.02 7.05 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.16 148.13 49.54 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.311 2.008 . . . . 0.0 111.799 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -65.5 114.48 4.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.489 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.32 86.22 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.577 175.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.07 46.15 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.467 0.651 . . . . 0.0 110.243 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.93 128.38 34.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.381 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -93.69 -10.66 33.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.764 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -97.11 168.32 10.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.119 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -118.9 42.18 2.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.883 0.849 . . . . 0.0 109.309 175.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -81.41 -26.87 35.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.341 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -90.48 151.09 21.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.326 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 66.7 m80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.906 175.728 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.544 0.211 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.23 -152.28 9.5 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.313 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 82' ' ' SER . 42.1 tp -93.84 130.43 39.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.08 0.467 . . . . 0.0 110.69 -177.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -105.99 129.18 54.17 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.597 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -99.32 134.8 41.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.548 0.69 . . . . 0.0 112.002 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 33.0 m-85 -121.19 -166.16 1.32 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.672 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 94.6 t -78.09 -83.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.571 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.3 tmtp? 163.53 -77.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.969 0.793 . . . . 0.0 109.167 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.4 -25.49 54.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.711 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.34 125.15 28.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.497 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.43 -172.35 32.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.737 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -69.62 131.07 44.07 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -78.55 66.25 4.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.199 0.999 . . . . 0.0 108.84 173.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.515 HD21 ' O ' ' A' ' 30' ' ' LYS . 16.1 tp -72.59 -46.04 56.17 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.902 -172.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.455 ' HD1' ' H ' ' A' ' 17' ' ' ALA . 1.2 p90 -100.49 -162.73 0.97 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.574 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -57.21 -33.05 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.799 0.333 . . . . 0.0 111.611 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' H ' ' HD1' ' A' ' 15' ' ' TRP . . . 67.6 21.94 9.27 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.987 171.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 p -126.11 109.96 22.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.723 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.4 m 74.27 -44.79 0.57 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.144 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.75 141.36 4.12 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -72.92 135.06 45.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -81.93 -27.31 33.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.23 -173.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 75.2 m-20 -77.87 80.41 4.32 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.523 ' HA ' ' OE1' ' A' ' 27' ' ' GLN . 38.0 ttpt -59.95 -42.37 93.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.249 -173.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -74.3 -20.14 60.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 110.396 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . 36.2 t70 -83.96 -28.49 27.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.007 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.523 ' OE1' ' HA ' ' A' ' 24' ' ' LYS . 56.1 mt-30 -58.92 -38.36 78.78 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.884 174.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 48' ' ' ILE . . . -56.99 -45.93 82.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.707 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 60.0 tttp -67.34 -39.47 85.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.515 ' O ' HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -53.08 -47.64 68.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 110.554 175.409 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.57 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 86.9 t -65.62 -39.57 85.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.825 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -60.02 -44.2 94.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.274 -0.171 . . . . 0.0 110.558 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 66.5 mm-40 -54.86 -49.27 71.54 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.193 0.521 . . . . 0.0 110.315 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -55.04 -33.07 62.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.603 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 79.5 mt -81.87 -44.59 16.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.061 0.458 . . . . 0.0 110.989 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -69.14 -35.02 75.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.64 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -77.36 -31.54 54.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.568 0.223 . . . . 0.0 111.467 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -76.63 -39.28 52.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.676 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.92 28.64 4.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.222 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.5 mm -62.61 130.7 93.76 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.1 130.83 23.7 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.234 1.956 . . . . 0.0 112.679 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 62.63 12.08 5.27 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.253 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 35' ' ' LEU . . . -71.64 -17.41 62.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.381 0.61 . . . . 0.0 110.796 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.01 -22.08 39.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.491 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -84.61 -23.65 29.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.168 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.32 177.59 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.61 129.77 25.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.086 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.425 HG13 HG22 ' A' ' 57' ' ' VAL . 3.2 mp -96.57 131.01 44.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -126.12 118.35 25.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.0 110.426 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.7 mm -89.33 132.7 33.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.514 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.11 -81.42 0.61 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.375 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -152.42 101.81 2.7 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.66 13.23 50.53 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 82' ' ' SER . 34.7 mtmm -133.2 124.44 27.43 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 120.844 0.354 . . . . 0.0 111.113 -174.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.38 104.77 14.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.498 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 m -82.58 113.88 20.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.322 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.425 HG22 HG13 ' A' ' 48' ' ' ILE . 62.9 t -100.62 113.46 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-O 121.089 0.471 . . . . 0.0 110.711 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 1.3 m -110.26 158.66 18.16 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.075 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.6 157.65 8.29 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.23 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -137.08 151.47 48.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 86.85 38.55 7.96 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.98 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.2 163.93 18.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 0.0 111.201 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 m -106.01 151.21 24.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.54 173.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 73.8 mm-40 -49.15 -48.23 45.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.33 -41.56 80.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.55 -42.31 64.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.259 0.552 . . . . 0.0 109.936 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 50.1 tttm -55.26 -51.66 65.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.48 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 4.9 mm-40 -67.89 -28.87 67.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.3 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -65.43 -37.25 86.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.148 0.499 . . . . 0.0 109.989 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.6 mt -70.09 -55.52 14.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.14 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 78.5 mt -50.06 -44.18 51.55 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.405 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.17 -34.55 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.964 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.57 -27.14 34.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.658 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.7 m -84.82 -22.5 7.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.223 0.535 . . . . 0.0 110.768 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -79.89 -35.51 27.76 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.32 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -79.91 55.84 2.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.025 0.44 . . . . 0.0 111.187 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.441 ' HB ' HG12 ' A' ' 80' ' ' ILE . 11.2 mm -118.67 138.13 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 t -68.21 92.07 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.241 0.543 . . . . 0.0 109.95 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.1 -19.93 3.05 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 77' ' ' ILE . 48.2 mm -97.16 131.59 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.254 0.55 . . . . 0.0 110.026 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -124.27 -3.37 7.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.755 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -164.78 147.2 8.38 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.225 -179.367 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.25 122.79 69.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.782 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.51 92.05 7.41 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.28 123.08 20.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.508 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.406 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 81.8 mm-40 -126.49 14.65 7.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.053 177.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 89' ' ' THR . 52.1 t -73.92 118.54 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.12 0.486 . . . . 0.0 109.776 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -89.14 4.94 46.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.267 -170.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.455 ' H ' HG12 ' A' ' 87' ' ' VAL . 32.0 p 44.95 -153.92 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.765 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.571 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -173.29 -41.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -118.16 131.97 23.95 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.564 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.8 144.34 48.21 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.868 2.379 . . . . 0.0 112.434 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 64' ' ' GLN . . . -158.74 -178.46 7.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.222 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.2 m -66.72 126.21 28.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.142 0.496 . . . . 0.0 111.258 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.53 164.47 20.85 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.8 m -121.37 145.13 48.21 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.622 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.447 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 29.0 tt0 -84.77 140.96 30.86 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -110.19 102.95 11.59 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.027 0.441 . . . . 0.0 110.504 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -106.27 133.52 50.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.011 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.444 ' OG1' HG22 ' A' ' 143' ' ' VAL . 7.8 m -100.02 122.46 42.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.346 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.577 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.7 m -71.21 136.3 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.406 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 40.7 mmtm -84.44 -163.9 0.87 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.451 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 1.6 p -60.33 -64.51 0.93 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.97 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.87 46.67 2.48 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.194 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.544 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 7.4 m-20 -104.79 127.81 52.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.131 0.491 . . . . 0.0 110.92 -177.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.549 ' O ' HG23 ' A' ' 110' ' ' ILE . 40.6 m -114.93 153.06 31.23 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.929 177.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 29.1 tp -51.97 -49.98 62.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.785 0.266 . . . . 0.0 111.63 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.456 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 m -66.66 -27.09 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.214 0.531 . . . . 0.0 111.156 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.572 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -73.33 -40.64 64.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.811 0.339 . . . . 0.0 110.375 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 106' ' ' THR . 1.2 pp -79.71 -25.29 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.106 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.3 p -70.28 -38.67 75.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.032 0.444 . . . . 0.0 109.824 173.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 5.6 tmtm? -58.71 -35.84 73.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.449 173.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 13.6 mm100 -59.72 -65.05 0.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 122.241 1.02 . . . . 0.0 111.267 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -81.97 -37.47 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 113.679 -1.6 . . . . 0.0 112.643 -165.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.478 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 55.5 m-85 -89.58 -45.25 9.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.292 0.568 . . . . 0.0 110.65 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.86 -14.72 26.58 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.475 ' HB3' ' HG ' ' A' ' 120' ' ' LEU . 56.7 t-20 -123.19 121.71 36.61 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.85 62.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.619 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -65.64 -21.63 66.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.07 0.462 . . . . 0.0 110.765 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.598 HD13 ' HE2' ' A' ' 123' ' ' LYS . 42.2 mt -79.78 29.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.703 -176.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 50.1 p90 -72.17 -35.27 68.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.166 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.403 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 24.7 t-20 -71.05 -31.82 68.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.948 -176.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.598 ' HE2' HD13 ' A' ' 120' ' ' LEU . 22.0 mtmt -52.44 -44.78 65.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.365 0.602 . . . . 0.0 110.439 173.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.413 HG22 ' OD1' ' A' ' 128' ' ' ASN . 46.2 mt -70.1 -44.67 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.278 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -52.97 -47.81 67.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.655 0.264 . . . . 0.0 111.043 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 31.7 mt-10 -66.03 -29.98 70.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.402 . . . . 0.0 110.908 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.07 -25.11 40.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.364 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 131' ' ' MET . 7.0 m120 -84.75 -41.87 15.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.106 0.479 . . . . 0.0 109.715 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 18.6 pttp -64.62 155.99 79.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.595 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 92.7 Cg_endo -81.97 17.69 18.8 Favored 'Cis proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.436 -1.485 . . . . 0.0 113.448 2.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.526 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -74.49 -36.27 63.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.874 0.368 . . . . 0.0 110.32 174.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.1 tp -88.95 126.81 35.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.014 0.435 . . . . 0.0 109.867 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -88.09 -38.77 15.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.426 -173.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.414 ' HB2' ' HG2' ' A' ' 137' ' ' LYS . 29.1 m -153.56 153.09 28.58 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.36 -18.41 38.92 Favored 'Trans proline' 0 C--O 1.23 0.089 0 C-N-CA 123.54 2.827 . . . . 0.0 112.312 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -101.95 -5.67 24.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.807 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 25.6 mmmt -86.28 10.19 15.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.469 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.464 HD11 ' HA ' ' A' ' 106' ' ' THR . 9.0 pt -62.88 173.69 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.189 170.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.572 ' CE1' ' HG2' ' A' ' 142' ' ' GLN . 5.9 p90 -166.19 150.85 7.34 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -175.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 84.9 Cg_exo -49.57 102.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.258 2.639 . . . . 0.0 112.656 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.41 ' CA ' HG21 ' A' ' 7' ' ' VAL . . . 113.33 23.53 5.12 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.473 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.577 ' H ' HG22 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -91.33 109.78 21.07 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.444 HG22 ' OG1' ' A' ' 100' ' ' THR . 39.3 t -80.58 122.2 35.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.448 0.642 . . . . 0.0 110.052 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.437 HD22 ' OD1' ' A' ' 128' ' ' ASN . 75.6 mt -117.39 139.91 50.26 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.863 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.454 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 48.4 mtp180 -69.79 119.09 13.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.084 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 31.7 mm -105.32 98.49 16.73 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.478 ' HD2' ' OH ' ' A' ' 115' ' ' TYR . 47.9 Cg_exo -56.64 154.04 32.96 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.827 2.351 . . . . 0.0 111.706 175.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 35.2 tt0 -67.86 126.3 29.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -51.26 101.71 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.209 0.943 . . . . 0.0 112.206 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 148' ' ' GLU . 92.3 mt -111.34 3.39 18.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.23 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 155' ' ' HIS . 13.0 mp0 -113.62 47.02 1.21 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.048 0.927 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -78.33 -11.47 59.94 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.49 -171.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -80.73 27.92 0.36 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.593 0.235 . . . . 0.0 111.062 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 58.48 38.65 25.53 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.195 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 151' ' ' GLU . 54.8 t-80 -73.79 95.98 2.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.518 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -110.4 146.1 36.44 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.697 -174.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.0 t60 . . . . . 0 C--O 1.248 0.999 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.885 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.612 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 87.0 mtp . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.684 0.278 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.53 177.52 44.65 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.7 tp -105.83 116.49 32.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.047 0.451 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -100.73 125.2 47.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.044 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -103.3 140.59 37.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.828 0.346 . . . . 0.0 110.648 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 73.5 m-85 -126.24 -161.14 1.03 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.751 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.95 HG11 ' HB3' ' A' ' 10' ' ' ALA . 7.3 p -79.75 -25.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.643 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 16.9 tptm 79.06 -66.26 0.19 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.488 0.715 . . . . 0.0 112.003 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.97 -36.01 36.73 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.742 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.95 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -79.17 152.17 30.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.498 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.65 -172.24 24.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.112 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -62.89 128.77 37.43 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.54 65.62 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.038 0.923 . . . . 0.0 108.969 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 77' ' ' ILE . 11.2 tp -75.82 -49.61 17.55 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.161 -175.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.472 ' CH2' HG21 ' A' ' 77' ' ' ILE . 9.0 p90 -124.51 -10.94 7.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.982 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.454 ' HB3' HG23 ' A' ' 18' ' ' VAL . 11.4 m-20 70.64 124.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 124.258 0.974 . . . . 0.0 111.961 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.72 49.39 1.72 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.722 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 16' ' ' ASP . 22.1 t -67.52 -75.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.441 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.98 29.63 6.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.39 66.86 2.02 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.207 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 22' ' ' HIS . 47.8 mt-30 -70.81 161.62 30.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 21' ' ' GLN . 19.0 m-70 74.71 178.87 0.2 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.65 0.594 . . . . 0.0 111.151 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 15.2 m-20 -104.97 29.43 6.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.253 -171.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 21.1 pttp 61.28 -51.3 0.12 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.538 1.535 . . . . 0.0 113.897 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.91 -26.35 63.17 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.747 -0.596 . . . . 0.0 111.115 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' OD1' ' HB3' ' A' ' 22' ' ' HIS . 1.8 p-10 -81.27 -18.27 46.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.977 0.418 . . . . 0.0 110.017 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 24' ' ' LYS . 98.9 mt-30 -65.04 -30.22 71.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.055 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.33 89.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.503 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.575 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 87.7 tttt -68.32 -36.84 79.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.177 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' HD21 ' A' ' 14' ' ' LEU . 3.2 mptp? -58.63 -43.07 89.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.423 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 95.3 t -64.2 -44.61 97.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.218 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -52.25 -50.36 62.22 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.693 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 48.6 mt-10 -56.16 -51.66 67.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.181 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -53.72 -42.68 68.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.331 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 93.0 mt -70.13 -41.04 74.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.53 -39.48 67.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.189 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 74.6 mmtt -63.98 -36.86 85.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.152 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 p -78.74 -38.81 37.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.141 0.496 . . . . 0.0 110.868 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.41 31.95 4.43 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.998 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.2 mm -63.2 127.35 90.87 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -59.78 130.56 35.56 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.484 2.123 . . . . 0.0 112.729 -175.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.28 26.5 15.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.198 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.94 -17.15 64.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.192 0.52 . . . . 0.0 110.718 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -84.18 -16.25 44.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.639 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -86.04 -35.09 20.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.998 0.428 . . . . 0.0 110.363 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.2 m -83.73 166.25 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.554 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -134.33 131.05 37.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.542 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 mp -108.23 139.16 31.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.636 0.255 . . . . 0.0 110.652 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -123.89 140.8 52.63 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 172.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' A' ' 24' ' ' LYS . 11.1 mm -118.14 133.05 66.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.9 0.381 . . . . 0.0 111.107 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.28 91.86 2.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.894 174.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.4 t70 65.9 -75.82 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.829 0.705 . . . . 0.0 111.215 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.38 6.2 4.6 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -98.68 110.88 23.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.809 0.338 . . . . 0.0 110.235 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.634 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -103.51 106.44 16.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.028 176.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 84' ' ' ASP . 33.5 m -92.72 115.97 28.59 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.638 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.91 120.46 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.083 0.468 . . . . 0.0 110.295 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.22 160.47 21.54 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.09 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.21 178.3 28.48 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 6.3 p-10 -167.51 155.12 8.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.908 0.385 . . . . 0.0 110.513 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.34 15.99 63.27 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.145 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -95.56 -167.69 1.65 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.658 0.742 . . . . 0.0 110.723 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -124.19 152.27 43.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.241 -1.345 . . . . 0.0 108.658 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 51.7 tt0 -58.18 -42.02 85.18 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -166.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG3' ' HB1' ' A' ' 93' ' ' ALA . 45.5 mt-10 -54.54 -48.83 71.53 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.611 0.243 . . . . 0.0 111.374 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.84 75.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.216 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.545 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 49.7 tttp -49.35 -53.43 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.452 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 72' ' ' VAL . 54.1 mt-10 -62.03 -48.01 82.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -59.98 -38.48 82.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 74' ' ' VAL . 57.8 mt -62.02 -56.1 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.085 174.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 91.0 mt -49.16 -42.11 38.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.105 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 68' ' ' GLU . 40.9 t -72.7 -44.63 59.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.902 0.382 . . . . 0.0 110.957 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.12 -35.58 81.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 70' ' ' ILE . 11.3 p -79.15 -26.83 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.328 0.585 . . . . 0.0 110.423 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -77.02 -11.82 85.22 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.535 173.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.532 ' OD1' ' HG3' ' A' ' 142' ' ' GLN . 5.8 m-80 -97.64 39.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.725 -0.238 . . . . 0.0 110.714 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.536 HD12 HD22 ' A' ' 14' ' ' LEU . 10.8 mm -115.44 132.38 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.4 t -65.46 99.25 0.41 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.4 -15.66 3.9 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.025 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.634 HD12 ' HB2' ' A' ' 55' ' ' ALA . 43.2 mm -96.78 121.65 47.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.157 0.503 . . . . 0.0 111.069 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.643 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -96.75 -37.19 10.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.393 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 p -150.87 154.2 36.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.456 0.646 . . . . 0.0 111.612 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 53.0 t -117.71 122.77 70.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.587 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 56' ' ' THR . 7.1 t70 -91.78 93.37 8.83 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.612 ' OD2' ' HA ' ' A' ' 1' ' ' MET . 17.7 t70 -71.78 112.51 7.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.157 -175.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -128.06 14.77 6.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.544 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 p -93.62 129.7 43.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.189 0.519 . . . . 0.0 111.4 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -96.77 158.22 15.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.068 -177.35 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.5 p -124.58 136.45 53.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.431 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.98 -28.07 16.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.608 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 p -123.07 138.89 30.5 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.852 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.53 160.16 28.63 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.785 2.323 . . . . 0.0 111.664 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 65' ' ' GLU . . . -159.06 -167.31 2.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.938 -177.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 88.4 m -57.95 138.7 55.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.483 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -108.01 125.25 51.31 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.347 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.1 m -110.69 146.49 36.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.424 0.63 . . . . 0.0 111.286 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 15.8 tt0 -87.86 138.82 31.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.772 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -98.13 94.09 6.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.12 0.486 . . . . 0.0 110.699 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -95.74 136.3 36.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.044 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.492 ' OG1' HG22 ' A' ' 143' ' ' VAL . 7.5 m -106.66 122.9 47.27 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.568 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -67.82 128.55 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -82.13 -57.9 3.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.861 -167.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 140' ' ' PRO . 12.0 p -156.98 -87.61 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.112 -176.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.97 49.83 2.93 Favored Glycine 0 C--N 1.329 0.19 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.568 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -97.46 120.05 37.12 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.937 -0.631 . . . . 0.0 110.941 -174.172 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 110' ' ' ILE . 58.7 p -112.61 163.3 14.68 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -63.07 -40.45 97.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 118.837 0.744 . . . . 0.0 110.573 -174.665 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.514 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 15.6 m -69.98 -23.07 63.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 110.43 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.461 ' HB3' ' H ' ' A' ' 106' ' ' THR . . . -80.82 -47.42 13.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.236 -0.29 . . . . 0.0 110.759 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.608 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.4 pp -72.46 -23.57 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.141 -177.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 p -73.93 -48.01 33.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.729 0.3 . . . . 0.0 110.237 173.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -61.16 -21.84 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.451 0.643 . . . . 0.0 110.208 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.608 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 6.4 tp60 -71.84 -58.43 3.47 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.161 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.0 m -85.39 -39.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.045 -172.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -88.48 -57.21 3.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.548 0.689 . . . . 0.0 110.43 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.04 -23.81 6.46 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.644 -171.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -105.52 124.09 48.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.079 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -72.12 -21.03 61.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.206 0.526 . . . . 0.0 110.346 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.85 -22.53 65.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.114 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.8 mt -84.29 16.13 3.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.191 -0.458 . . . . 0.0 112.202 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.451 ' HD1' ' O ' ' A' ' 118' ' ' ALA . 40.0 p90 -64.46 -27.27 68.87 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -54.82 -55.04 34.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.24 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -50.27 -51.75 42.19 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.474 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.491 HG22 ' OD1' ' A' ' 128' ' ' ASN . 35.8 mt -62.98 -45.17 99.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.419 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.483 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 62.6 t80 -56.7 -49.48 74.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.985 0.422 . . . . 0.0 110.846 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.528 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 17.4 mt-10 -70.02 -23.62 63.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.981 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.71 -28.88 30.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.262 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.653 ' O ' ' HG3' ' A' ' 131' ' ' MET . 7.0 m120 -81.62 -10.83 59.32 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 28.8 mtpp -76.27 153.38 84.17 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.704 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -91.95 13.43 51.71 Favored 'Cis proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.762 -1.766 . . . . 0.0 112.814 -0.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.653 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -76.25 -13.95 60.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.672 0.273 . . . . 0.0 111.71 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.3 tp -99.07 125.8 44.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 171.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -73.61 -56.62 4.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.966 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.2 m -153.22 155.65 31.99 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.003 0.43 . . . . 0.0 109.988 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.405 ' HA ' HD12 ' A' ' 107' ' ' LEU . 24.2 Cg_exo -65.23 -27.24 56.27 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.906 3.071 . . . . 0.0 113.447 -170.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -99.76 0.87 42.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.99 0.424 . . . . 0.0 110.231 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -96.17 12.45 30.79 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.139 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.431 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 15.5 pt -72.57 168.51 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -158.78 144.06 11.93 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.143 -171.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.458 ' HG3' ' O ' ' A' ' 103' ' ' SER . 87.3 Cg_exo -49.41 110.11 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.605 2.87 . . . . 0.0 112.387 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.35 3.19 10.57 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.185 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.532 ' HG3' ' OD1' ' A' ' 76' ' ' ASN . 46.0 tt0 -93.13 118.21 30.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.518 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.492 HG22 ' OG1' ' A' ' 100' ' ' THR . 50.3 t -80.15 134.18 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.459 170.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 76.5 mt -130.21 147.98 51.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.575 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.405 ' HG2' HG21 ' A' ' 72' ' ' VAL . 25.6 mtm180 -77.41 119.11 20.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.972 175.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 38.9 mm -103.85 102.37 30.77 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.02 143.18 90.4 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.113 1.875 . . . . 0.0 110.746 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.39 132.01 52.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.457 ' CD ' ' HB2' ' A' ' 152' ' ' HIS . 33.7 tt0 -50.9 116.77 2.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.981 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.3 tp -107.8 102.93 12.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.007 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 64.52 86.22 0.13 Allowed 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.535 0.522 . . . . 0.0 111.328 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.457 ' HB2' ' CD ' ' A' ' 149' ' ' GLU . 22.2 t-80 -73.43 142.27 46.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.135 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -136.97 159.0 43.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.436 173.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -101.25 115.96 31.7 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -115.09 -24.11 8.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.846 -175.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -150.67 135.53 17.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.788 0.328 . . . . 0.0 110.146 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 . . . . . 0 C--N 1.321 -0.665 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.48 177.707 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.663 ' HA ' ' O ' ' A' ' 85' ' ' ASP . 27.9 ttt . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.12 163.79 32.17 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.73 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 20.1 tp -102.94 115.43 30.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.006 0.431 . . . . 0.0 109.953 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -101.21 123.32 45.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.374 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -78.77 141.54 37.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.539 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.566 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 93.6 m-85 -134.54 175.18 9.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.565 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.522 HG21 ' HA2' ' A' ' 141' ' ' GLY . 22.6 t -78.03 -15.06 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.791 -167.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.668 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 26.6 tptp 74.34 -49.82 0.67 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.946 0.498 . . . . 0.0 112.027 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -91.01 -36.06 14.29 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.73 0.3 . . . . 0.0 111.567 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.07 155.51 20.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.083 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.37 -160.91 24.34 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -76.58 125.46 29.28 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -86.07 65.47 9.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.482 0.658 . . . . 0.0 111.081 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.54 -55.5 30.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.549 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.442 ' O ' HG22 ' A' ' 18' ' ' VAL . 41.2 p90 -113.07 21.09 15.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.36 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 t70 55.99 23.07 6.34 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.492 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.57 37.66 29.17 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.922 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 21' ' ' GLN . 35.6 m -74.18 -172.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.343 174.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.4 p -78.71 53.72 1.39 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.95 -2.71 69.55 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.918 173.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.448 ' H ' HG23 ' A' ' 18' ' ' VAL . 5.9 tp-100 70.04 -70.09 0.16 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.069 0.547 . . . . 0.0 111.632 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -155.79 -35.14 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.711 0.291 . . . . 0.0 110.613 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 23.3 t70 -168.94 154.2 6.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -66.69 -34.78 78.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.073 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -73.22 -22.4 60.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.272 0.558 . . . . 0.0 109.9 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 34.5 t70 -74.58 -40.93 61.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.771 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.478 ' HB2' HG13 ' A' ' 50' ' ' ILE . 22.7 mt-30 -59.03 -41.49 87.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.729 174.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB2' HG12 ' A' ' 50' ' ' ILE . . . -57.71 -43.15 85.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.852 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 61.1 tttp -63.51 -44.81 93.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.373 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 12.9 mptt -57.71 -42.16 83.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.576 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.491 HG11 HG13 ' A' ' 74' ' ' VAL . 95.7 t -68.65 -41.92 82.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.892 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.51 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 2.9 mm100 -56.45 -48.67 76.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.071 174.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 53.7 mt-10 -60.28 -40.59 90.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.817 0.341 . . . . 0.0 110.441 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -56.52 -38.24 71.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.212 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 88.7 mt -72.96 -43.63 62.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.2 0.524 . . . . 0.0 110.864 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -72.49 -35.7 68.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.48 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -71.9 -27.07 62.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.563 0.22 . . . . 0.0 111.56 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 p -83.85 -39.36 20.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.182 0.515 . . . . 0.0 110.514 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.85 31.14 3.73 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.806 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 30.5 mm -66.44 127.31 93.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -64.28 139.4 65.65 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.055 1.836 . . . . 0.0 112.509 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 57.18 24.8 10.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.103 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -72.17 -17.67 61.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.271 0.558 . . . . 0.0 110.175 176.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.93 -19.92 36.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.026 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -83.0 -24.71 32.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.759 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.11 179.66 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.506 -177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 27.0 t-20 -144.87 138.38 26.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.46 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.51 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 14.9 mm -108.48 126.56 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 123.26 0.35 . . . . 0.0 110.836 -175.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -132.18 123.21 26.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.115 0.483 . . . . 0.0 110.39 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 27' ' ' GLN . 26.8 mm -98.4 112.4 30.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.396 -173.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.85 86.4 2.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.844 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 67.53 -76.58 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.422 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.45 -2.3 4.08 Favored Glycine 0 N--CA 1.454 -0.138 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.607 ' HG2' ' HB3' ' A' ' 82' ' ' SER . 38.3 mtmm -99.0 118.7 36.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.817 0.341 . . . . 0.0 110.682 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -94.65 106.75 18.74 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.947 176.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -82.99 113.14 20.36 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 120.766 0.317 . . . . 0.0 110.322 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 97.6 t -99.67 109.99 25.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.199 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 m -104.9 164.38 11.83 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.871 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.5 172.65 28.04 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -162.66 148.08 12.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.987 0.422 . . . . 0.0 110.056 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 97.5 6.97 57.23 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.103 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 89' ' ' THR . 6.8 mp -95.81 169.86 9.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.057 0.456 . . . . 0.0 110.856 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -110.66 154.9 23.17 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.658 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 7.5 tp60 -50.36 -47.79 55.93 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -173.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.46 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 43.9 mt-10 -52.17 -40.31 61.27 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -176.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.05 -45.53 13.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 110.338 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.491 ' HE3' ' OD1' ' A' ' 85' ' ' ASP . 75.7 tttt -51.54 -59.52 4.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.133 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 26.1 pt-20 -67.29 -18.07 65.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -72.33 -35.19 68.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.467 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.5 -46.56 92.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 10.1 mp -46.13 -43.62 15.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.652 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.627 HG21 ' HB2' ' A' ' 145' ' ' ARG . 39.9 t -63.13 -58.92 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.379 0.609 . . . . 0.0 111.117 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.3 64.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.347 -173.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.491 HG13 HG11 ' A' ' 31' ' ' VAL . 53.3 t -87.61 -29.19 5.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 0.0 110.712 177.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.566 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -75.98 -34.46 47.43 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.824 177.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -79.92 58.73 2.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.608 0.242 . . . . 0.0 110.849 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.559 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 29.7 mm -124.7 130.42 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.1 m -66.13 102.81 0.87 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.52 -17.86 5.51 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.481 -172.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.559 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 38.9 mm -100.46 126.23 54.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.195 0.522 . . . . 0.0 110.729 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.668 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -105.27 -17.18 14.55 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.297 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.607 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . 16.1 t -166.96 167.23 14.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.204 0.525 . . . . 0.0 110.763 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.23 125.38 47.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.809 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -98.42 90.81 4.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.663 ' O ' ' HA ' ' A' ' 1' ' ' MET . 2.9 t70 -66.75 124.2 22.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.153 -177.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -134.67 27.03 3.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.239 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -85.96 127.05 40.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.889 0.376 . . . . 0.0 110.267 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -91.95 127.78 37.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.18 0.514 . . . . 0.0 111.005 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.2 p -89.86 124.47 34.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.416 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.466 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -79.77 -38.37 33.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.758 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.8 p -127.13 150.59 72.62 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.892 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.31 141.73 52.64 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.339 2.693 . . . . 0.0 112.063 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -156.47 174.37 15.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.807 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.1 m -67.95 127.87 34.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.265 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.76 127.86 42.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.588 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 146' ' ' ILE . 14.1 m -106.03 171.55 7.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.124 0.488 . . . . 0.0 111.71 -175.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.617 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 13.7 tt0 -89.59 153.7 20.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.322 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -111.78 91.5 3.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -98.79 118.68 36.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.34 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.8 m -85.59 121.03 27.7 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.057 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 142' ' ' GLN . 1.5 m -69.34 136.74 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -105.7 -166.16 1.18 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.985 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.415 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 49.5 m -62.02 116.84 5.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.108 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.39 18.23 64.82 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.658 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 9.3 m-20 -90.93 114.46 26.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.128 0.49 . . . . 0.0 110.833 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 110' ' ' ILE . 21.7 p -110.02 162.0 14.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.084 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 16.1 tp -62.02 -41.46 98.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 118.391 0.541 . . . . 0.0 111.356 -169.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.3 p -69.32 -27.33 65.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.213 0.53 . . . . 0.0 110.972 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.91 -41.78 50.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -78.89 -23.65 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.465 -176.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.3 p -71.11 -41.01 71.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 172.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 4.9 tmmm? -60.19 -29.87 68.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.986 171.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 15.2 tp60 -67.71 -63.52 1.04 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.018 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 115' ' ' TYR . 35.3 m -76.22 -46.3 33.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.406 -171.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.455 ' N ' HG23 ' A' ' 114' ' ' VAL . 59.6 m-85 -90.91 -30.94 16.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.193 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 92.47 -2.92 74.72 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -170.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.446 ' HB3' HD12 ' A' ' 120' ' ' LEU . 16.3 t-20 -126.08 110.63 13.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.738 -0.731 . . . . 0.0 109.876 -173.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.44 -31.77 72.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.455 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -69.43 -14.75 63.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.627 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 117' ' ' ASN . 50.5 mt -83.83 17.32 2.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.821 0.343 . . . . 0.0 111.318 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 31.3 p90 -66.58 -27.48 67.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.08 0.467 . . . . 0.0 110.106 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.521 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 25.7 p-10 -66.69 -33.69 76.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -57.25 -52.45 65.27 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.579 0.704 . . . . 0.0 109.495 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.9 mt -66.53 -40.21 85.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.251 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.564 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 20.4 t80 -54.27 -60.01 3.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.538 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.526 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 24.5 mt-10 -61.72 -34.5 75.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.689 -176.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.426 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -68.57 -31.29 70.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.835 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 131' ' ' MET . 36.4 m-80 -91.34 -18.78 23.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 28.4 mtpp -67.08 151.7 96.85 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.434 176.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -87.67 15.35 44.47 Favored 'Cis proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.987 -1.672 . . . . 0.0 113.474 1.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.3 OUTLIER -67.75 -33.18 74.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.024 0.44 . . . . 0.0 110.281 177.319 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.434 HD11 HG23 ' A' ' 138' ' ' ILE . 0.1 OUTLIER -97.46 131.01 44.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -85.0 -49.56 8.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.598 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.467 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 46.5 p -154.08 161.45 29.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.973 0.416 . . . . 0.0 110.441 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.98 -15.29 48.35 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 123.631 2.887 . . . . 0.0 111.944 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -103.69 -16.34 15.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.206 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -81.74 -6.92 59.48 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 106' ' ' THR . 12.1 pt -65.6 168.53 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 0.0 110.709 172.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -165.06 148.29 7.2 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.476 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.415 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 75.1 Cg_exo -43.78 115.13 0.62 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.51 2.807 . . . . 0.0 112.806 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.522 ' HA2' HG21 ' A' ' 7' ' ' VAL . . . 109.51 6.89 28.67 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.445 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.575 ' O ' HG13 ' A' ' 101' ' ' VAL . 6.5 mm100 -87.7 110.08 20.17 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 41.5 t -77.63 119.63 26.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.403 0.62 . . . . 0.0 109.887 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.8 132.55 53.89 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.183 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.627 ' HB2' HG21 ' A' ' 72' ' ' VAL . 36.1 ttt180 -75.56 110.47 9.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.656 175.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 18.1 mm -94.08 108.63 36.86 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 34.8 Cg_exo -58.31 153.14 48.86 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.591 2.194 . . . . 0.0 111.938 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.85 124.37 23.5 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.602 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -67.38 115.6 7.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.21 -171.04 2.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.594 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 69.13 -77.04 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.732 0.645 . . . . 0.0 110.033 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.53 -74.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -178.57 143.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.288 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.2 t60 55.61 43.92 27.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.387 0.613 . . . . 0.0 110.096 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -99.39 -27.59 13.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -90.07 160.22 16.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.128 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.692 -176.309 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 121.075 0.464 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.21 166.13 35.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.869 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.5 tp -99.36 121.82 41.64 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.519 ' HB2' HG12 ' A' ' 83' ' ' VAL . 74.7 m-85 -99.47 125.29 45.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.362 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -99.32 144.64 28.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.946 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.591 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 68.3 m-85 -130.07 -162.48 1.21 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.951 0.405 . . . . 0.0 111.658 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.946 HG11 ' HB3' ' A' ' 10' ' ' ALA . 5.9 p -73.32 -25.71 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.996 -176.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.753 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 49.9 tptt 78.17 -56.97 0.48 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.457 0.703 . . . . 0.0 111.575 -176.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.91 -47.99 14.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.946 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -73.71 151.79 40.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.889 0.376 . . . . 0.0 110.907 -176.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.83 173.94 14.29 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.437 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.18 125.49 24.23 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 122.485 0.314 . . . . 0.0 110.179 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 96.1 mttt -90.28 83.35 5.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.957 0.408 . . . . 0.0 110.892 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 34' ' ' HIS . 1.7 mm? -72.37 -44.21 62.88 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.479 0.657 . . . . 0.0 109.392 175.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.44 ' HD1' ' H ' ' A' ' 17' ' ' ALA . 20.0 p90 -101.66 -173.34 2.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.042 178.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.28 -43.66 74.93 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.434 0.459 . . . . 0.0 111.598 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' H ' ' HD1' ' A' ' 15' ' ' TRP . . . 63.22 54.34 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 110.575 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.61 -43.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.533 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.5 p -135.8 -61.27 0.72 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.302 0.573 . . . . 0.0 110.192 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.33 169.45 35.76 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -124.05 66.38 1.05 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.259 0.552 . . . . 0.0 109.849 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 4.0 t60 73.64 -58.04 0.61 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.766 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.552 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 41.7 m-20 -138.68 144.67 39.7 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.412 ' NZ ' ' HB2' ' A' ' 24' ' ' LYS . 9.3 mtmp? -85.72 -18.54 32.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.411 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.46 -30.84 62.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.855 -175.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' A' ' 23' ' ' ASP . 4.0 p30 -90.49 -0.55 57.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.618 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' VAL . 28.1 mt-30 -67.3 -17.38 64.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 171.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 48' ' ' ILE . . . -59.92 -42.22 93.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.053 171.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -63.15 -42.36 99.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 3.6 mptp? -54.46 -36.87 64.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.264 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.561 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 96.0 t -69.36 -46.09 77.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.641 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.426 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 16.5 mm-40 -56.9 -42.04 79.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.97 174.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -57.62 -51.13 70.77 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.455 ' HB2' HD11 ' A' ' 14' ' ' LEU . 51.3 t60 -51.19 -42.45 60.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.624 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 86.2 mt -72.63 -41.61 65.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.543 -176.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -80.56 -26.43 37.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.82 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -69.74 -45.78 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.594 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.0 p -68.1 -40.16 82.65 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.836 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.55 31.22 4.06 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.879 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.459 HD13 ' HD2' ' A' ' 130' ' ' PRO . 30.8 mm -65.81 125.0 89.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.68 141.53 50.15 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.0 1.8 . . . . 0.0 112.545 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 55.68 20.27 3.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.538 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 35' ' ' LEU . . . -84.87 -17.26 38.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.988 0.423 . . . . 0.0 111.0 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -83.74 -16.71 43.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.731 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.58 -27.15 61.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.772 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 m -89.8 159.62 2.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.658 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -112.95 136.91 52.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.79 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.426 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 15.8 mm -106.07 143.61 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 123.375 0.422 . . . . 0.0 110.707 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 64.2 tt0 -144.98 126.68 15.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.5 mm -107.44 121.26 60.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.966 0.412 . . . . 0.0 111.553 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.47 76.74 1.07 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.56 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 69.1 -80.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.953 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.01 2.53 7.89 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -104.95 98.62 8.31 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -94.23 118.78 32.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.336 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 12.8 m -90.57 134.14 34.59 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.638 0.256 . . . . 0.0 110.319 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.5 t -120.7 109.77 26.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.087 0.47 . . . . 0.0 109.98 176.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.19 159.87 16.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.223 -177.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.62 172.57 39.14 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -155.98 139.33 15.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.052 0.453 . . . . 0.0 110.666 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 95.16 7.03 59.81 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.822 -0.626 . . . . 0.0 113.131 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 89' ' ' THR . 7.3 mp -92.94 168.6 11.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.023 0.44 . . . . 0.0 110.735 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 m -105.82 151.49 24.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.114 172.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.695 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 41.0 tt0 -56.55 -43.13 79.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.489 -173.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -54.18 -36.57 63.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.808 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.38 -38.97 29.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.355 176.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -55.91 -42.41 76.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.071 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 3.0 mm-40 -64.34 -23.69 67.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.659 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -66.42 -38.83 88.31 Favored 'General case' 0 N--CA 1.461 0.085 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.602 ' O ' HG12 ' A' ' 74' ' ' VAL . 4.0 mp -71.14 -55.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.203 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -48.7 -45.72 39.6 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.34 -30.49 43.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.963 0.411 . . . . 0.0 111.219 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -84.72 -30.64 24.59 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.284 -0.26 . . . . 0.0 111.555 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 70' ' ' ILE . 4.5 p -81.98 -39.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.018 0.437 . . . . 0.0 110.7 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.591 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -67.24 -26.01 73.49 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.656 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -88.39 48.19 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.299 . . . . 0.0 110.814 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 31' ' ' VAL . 96.3 mt -121.21 142.93 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 121.225 0.536 . . . . 0.0 111.442 175.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 13' ' ' LYS . 51.8 p -64.83 105.91 1.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.764 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.51 -11.86 10.35 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.685 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 35.8 mm -90.96 113.37 26.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.544 0.688 . . . . 0.0 111.105 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.753 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -92.82 -26.49 17.65 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.002 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 5.9 p -157.76 155.17 29.37 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.526 -177.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 10.6 p -126.59 127.05 69.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.56 174.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.62 93.32 6.68 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -70.43 112.84 7.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.53 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -121.76 22.74 10.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.202 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.06 118.41 28.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.071 0.462 . . . . 0.0 110.523 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -80.05 123.58 27.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.356 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 5.1 p -92.53 111.38 22.94 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.234 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.478 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -71.58 -33.38 69.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.007 178.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 p -128.72 138.84 34.0 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.861 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.5 142.7 33.36 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.771 2.314 . . . . 0.0 111.724 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.25 174.18 10.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.967 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.8 m -61.65 137.03 58.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.935 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.63 143.2 27.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.646 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.1 m -110.69 137.35 48.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.08 0.467 . . . . 0.0 110.514 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 18.2 tt0 -86.67 147.23 25.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.242 177.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.64 118.86 33.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.985 0.422 . . . . 0.0 111.24 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -119.72 136.61 54.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.098 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.1 m -99.91 124.51 45.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 142' ' ' GLN . 2.4 m -71.4 136.42 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.421 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 34.0 mmtp -93.31 -168.67 1.96 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.065 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.476 ' HA ' ' HB3' ' A' ' 140' ' ' PRO . 27.4 m -56.51 -40.19 74.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.61 37.26 3.44 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.566 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.578 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 73.4 m-20 -99.36 128.57 45.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.411 0.624 . . . . 0.0 110.639 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 110' ' ' ILE . 1.5 p -114.48 153.82 29.29 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.205 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.487 HD22 ' HA ' ' A' ' 135' ' ' PRO . 27.6 tp -54.75 -43.33 72.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.307 0.503 . . . . 0.0 110.931 -172.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -62.39 -44.03 97.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.092 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.71 83.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.41 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.2 pp -73.73 -25.14 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.541 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.9 t -68.03 -46.82 70.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.131 0.491 . . . . 0.0 109.823 171.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.508 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 12.6 tmtt? -60.61 -29.01 68.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.583 0.706 . . . . 0.0 109.194 175.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 6.4 tp60 -67.32 -62.27 1.5 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.43 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 146' ' ' ILE . 34.5 m -79.6 -45.81 23.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.254 -172.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 114' ' ' VAL . 38.8 m-85 -81.42 -51.23 8.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.305 0.574 . . . . 0.0 110.509 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.51 -14.19 13.28 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.679 -174.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.46 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 17.7 t30 -123.34 126.93 47.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.154 -0.523 . . . . 0.0 109.829 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . . . -75.01 -17.06 60.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.82 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -80.46 -13.24 59.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.061 0.458 . . . . 0.0 110.843 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.46 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 39.1 mt -82.47 14.14 3.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.448 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.474 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 53.6 p90 -60.07 -24.82 64.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.27 -178.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.482 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 51.0 m-80 -62.56 -38.9 91.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.09 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -55.57 -50.51 69.86 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.575 0.702 . . . . 0.0 109.805 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.97 -39.41 81.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.48 -177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.446 ' HA ' HD23 ' A' ' 132' ' ' LEU . 85.8 t80 -58.55 -53.95 52.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.512 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 21.5 mt-10 -66.04 -35.74 81.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.061 -176.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.425 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -64.14 -33.43 75.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.513 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.525 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 42.5 m-80 -95.72 -28.63 14.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.849 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 56.8 pttt -64.45 155.76 79.49 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.472 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 2.9 Cg_endo -82.0 10.63 36.33 Favored 'Cis proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.968 -1.263 . . . . 0.0 113.088 1.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.525 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.4 tmm? -66.31 -40.29 89.86 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.448 HD13 HE22 ' A' ' 142' ' ' GLN . 7.6 tp -86.24 113.38 22.2 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 171.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -76.9 -52.46 9.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.612 -170.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.492 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 24.0 m -142.38 155.74 64.23 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.011 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.487 ' HA ' HD22 ' A' ' 107' ' ' LEU . 74.4 Cg_exo -51.72 -54.53 5.17 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.495 2.797 . . . . 0.0 113.258 -172.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.07 9.78 29.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.219 0.533 . . . . 0.0 111.024 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 26.2 mmtp -92.27 13.09 20.28 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.549 HD11 ' HA ' ' A' ' 106' ' ' THR . 18.3 pt -67.19 171.39 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 171.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -148.08 144.69 19.22 Favored Pre-proline 0 C--N 1.315 -0.898 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.64 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.476 ' HB3' ' HA ' ' A' ' 103' ' ' SER . 81.5 Cg_exo -49.33 110.66 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.275 2.65 . . . . 0.0 112.47 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.53 22.79 6.56 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.085 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.578 ' H ' HG22 ' A' ' 101' ' ' VAL . 44.8 tt0 -105.56 118.63 37.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 117.613 0.706 . . . . 0.0 110.708 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 37.3 t -78.46 131.64 34.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.744 174.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.7 mt -121.19 135.64 55.11 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.101 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 145' ' ' ARG . 46.8 mtp180 -65.44 123.36 19.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.39 173.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 114' ' ' VAL . 23.3 mm -106.24 97.86 17.44 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.425 ' HG3' ' HB2' ' A' ' 127' ' ' ALA . 39.5 Cg_endo -70.49 158.8 54.91 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.227 1.951 . . . . 0.0 111.871 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.28 104.64 14.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.492 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -78.05 134.23 37.8 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.145 0.498 . . . . 0.0 109.995 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 151' ' ' GLU . 0.8 OUTLIER -140.51 100.28 3.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 150' ' ' LEU . 25.3 tt0 71.41 106.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.038 0.836 . . . . 0.0 110.976 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -128.41 138.41 52.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -69.53 145.82 52.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.993 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -77.58 79.48 4.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.825 0.821 . . . . 0.0 111.648 -174.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -85.27 -47.47 10.03 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.772 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -179.62 107.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.428 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.47 178.358 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.507 0.67 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.14 -89.94 0.18 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.504 HD13 ' N ' ' A' ' 4' ' ' PHE . 2.6 tm? -139.46 140.74 37.36 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.504 ' N ' HD13 ' A' ' 3' ' ' LEU . 98.4 m-85 -121.55 145.78 47.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.371 178.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.23 128.97 48.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 111.268 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 76.1 m-85 -124.77 -167.22 1.63 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.78 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 10' ' ' ALA . 91.2 t -107.69 118.94 56.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.114 0.483 . . . . 0.0 110.262 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.624 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 22.5 tptm -60.7 -33.74 73.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.906 -172.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -90.23 -33.94 15.98 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -87.34 128.65 35.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.857 0.36 . . . . 0.0 111.426 -172.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.69 179.9 26.84 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.873 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.68 135.92 47.05 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -99.86 94.29 6.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.76 0.314 . . . . 0.0 110.525 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 34' ' ' HIS . 1.8 mm? -81.78 -32.17 31.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.852 0.358 . . . . 0.0 111.062 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -118.66 22.08 12.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.336 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 56.97 83.47 0.1 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.639 -172.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.89 47.42 0.52 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.315 0.579 . . . . 0.0 111.868 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 p -98.78 -38.91 7.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.749 175.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -133.52 -30.3 1.29 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.92 -146.87 18.79 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.781 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -129.18 -75.89 0.55 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 173.27 -53.13 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -113.88 133.58 55.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.672 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -64.98 -23.56 67.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.69 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -60.41 -39.97 89.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.821 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.8 m-20 -66.9 -34.76 78.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.41 ' O ' HG23 ' A' ' 31' ' ' VAL . 97.7 mt-30 -63.05 -46.95 85.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.638 0.256 . . . . 0.0 110.721 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 48' ' ' ILE . . . -57.15 -30.58 64.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.326 0.584 . . . . 0.0 111.197 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 35.6 ttpt -80.03 -50.67 10.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.339 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 72.7 mmtt -51.74 -39.66 58.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.412 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 41.4 t -58.46 -52.06 64.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.694 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.611 ' HB3' HD13 ' A' ' 48' ' ' ILE . 26.5 pt20 -78.28 -21.1 50.26 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.464 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 46.9 mt-10 -64.99 -39.0 92.82 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 172.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.529 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 63.6 t60 -55.97 -37.49 69.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.02 172.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.6 mt -70.53 -45.84 64.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.22 -41.7 94.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.05 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 97.3 mttt -59.48 -54.85 41.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.053 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 p -62.74 -44.18 96.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.085 0.469 . . . . 0.0 111.142 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.54 33.75 1.86 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.899 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.453 HD13 ' HD2' ' A' ' 130' ' ' PRO . 24.3 mm -69.53 129.15 91.75 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.83 143.19 49.74 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.614 2.209 . . . . 0.0 113.207 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 57.15 28.57 15.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.697 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.83 -20.6 62.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.24 0.543 . . . . 0.0 110.349 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -81.32 -15.99 53.75 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.425 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -86.81 -11.28 51.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.816 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.08 177.31 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.113 0.483 . . . . 0.0 111.292 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.63 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 42.0 t30 -141.4 128.51 20.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.065 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 32' ' ' GLN . 3.2 mp -104.53 129.25 57.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 123.39 0.431 . . . . 0.0 110.608 -174.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -128.7 128.03 43.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.273 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.4 mm -98.74 120.59 48.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.001 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.45 88.01 2.86 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.769 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 67.33 -74.88 0.06 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.803 0.69 . . . . 0.0 111.134 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.38 -1.0 4.01 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 84' ' ' ASP . 38.7 ttmt -96.74 115.74 27.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.959 0.409 . . . . 0.0 110.731 -178.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.82 100.74 12.26 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.1 m -83.35 128.5 34.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.382 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -120.79 117.33 52.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.008 0.432 . . . . 0.0 111.043 177.363 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.486 HG23 ' HB3' ' A' ' 86' ' ' GLN . 2.2 m -100.52 162.96 12.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.789 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.8 166.68 33.64 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.801 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -156.13 138.07 14.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.875 0.369 . . . . 0.0 110.066 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 91.96 8.21 63.56 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.802 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.504 ' HG ' ' CG1' ' A' ' 87' ' ' VAL . 4.5 mm? -78.68 171.79 14.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.0 112.265 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -128.05 146.41 50.69 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 170.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.614 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 46.9 mt-30 -59.65 -22.48 61.95 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.303 0.377 . . . . 0.0 112.008 -175.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.67 -34.55 72.98 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.259 0.349 . . . . 0.0 111.311 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.42 -36.52 7.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.027 0.441 . . . . 0.0 110.475 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 52.5 tttm -50.91 -46.53 60.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.049 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.415 ' O ' ' HD2' ' A' ' 145' ' ' ARG . 21.7 mt-10 -87.92 20.58 3.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.415 0.626 . . . . 0.0 110.923 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -113.91 -41.7 3.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.059 170.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 54.6 mt -59.22 -59.3 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.245 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 67' ' ' LYS . 9.3 mp -42.86 -41.99 3.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.458 176.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.85 -53.39 30.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.99 -24.06 65.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.39 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.2 t -79.0 -40.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.171 0.51 . . . . 0.0 110.481 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -72.27 -25.94 73.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.506 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.426 ' HB3' ' OH ' ' A' ' 139' ' ' TYR . 90.4 m-20 -86.45 39.95 0.86 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.099 0.476 . . . . 0.0 111.056 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.457 ' CD1' HG13 ' A' ' 31' ' ' VAL . 92.9 mt -114.26 135.31 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.715 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -67.92 123.81 21.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.31 -9.27 38.72 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.252 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.1 mm -105.01 137.81 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.624 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -124.04 -19.47 5.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.721 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 p -152.97 157.04 39.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.065 0.459 . . . . 0.0 111.297 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.3 t -133.04 126.11 52.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.84 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . 15.1 t70 -102.37 110.64 22.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.409 ' CB ' HD21 ' A' ' 71' ' ' LEU . 9.0 p-10 -92.49 100.47 13.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 122.145 0.974 . . . . 0.0 111.77 -174.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.486 ' HB3' HG23 ' A' ' 58' ' ' THR . 49.2 mt-30 -98.98 18.47 17.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.163 172.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.504 ' CG1' ' HG ' ' A' ' 62' ' ' LEU . 43.1 t -80.01 108.08 13.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.437 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -86.59 137.57 32.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.075 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.8 p -102.45 130.42 49.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.058 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.441 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -90.08 -16.18 30.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.6 p -129.27 142.53 45.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.85 124.42 7.44 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.668 2.245 . . . . 0.0 111.842 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.35 168.87 18.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.5 m -65.18 140.77 58.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.434 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.89 154.7 17.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.08 0.467 . . . . 0.0 111.759 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.9 m -118.94 146.96 44.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.981 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.482 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 52.9 tt0 -91.3 150.73 21.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.425 175.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -105.82 100.83 10.37 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.103 0.477 . . . . 0.0 110.85 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.441 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 80.0 t80 -101.66 144.24 30.63 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.917 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 143' ' ' VAL . 17.1 m -110.94 124.15 51.57 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.358 -0.137 . . . . 0.0 110.675 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.675 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.7 m -66.09 129.5 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -80.84 -81.51 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.969 -171.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.3 m -162.26 123.49 2.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.12 28.88 71.01 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.26 130.43 43.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.892 -0.654 . . . . 0.0 109.95 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.561 ' HA ' HD11 ' A' ' 138' ' ' ILE . 7.6 p -115.76 162.61 17.04 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.878 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 22.9 mt -57.83 -42.67 84.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.76 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.4 m -59.63 -38.69 82.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.942 0.401 . . . . 0.0 110.822 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.7 -44.65 69.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.264 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.5 pp -78.22 -22.15 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.483 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.4 p -77.8 -42.67 33.05 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.243 -0.286 . . . . 0.0 110.564 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 61.3 tttp -62.73 -26.27 68.6 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.506 0.67 . . . . 0.0 109.75 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.637 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 4.7 tp60 -64.33 -55.02 24.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.949 175.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 115' ' ' TYR . 34.2 m -86.46 -51.25 13.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.349 -173.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.538 ' CE1' ' HB2' ' A' ' 149' ' ' GLU . 21.6 m-85 -87.67 -31.01 19.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.249 -176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.31 -19.51 39.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.102 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -114.1 120.61 41.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . . . -69.19 -20.13 63.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.872 -175.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -81.77 -0.15 41.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.985 0.421 . . . . 0.0 111.004 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.8 mt -91.28 17.43 8.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 42.3 p90 -60.84 -30.91 70.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.362 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -69.8 -30.54 68.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.522 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -63.11 -44.12 96.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.257 0.551 . . . . 0.0 110.341 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.3 mt -75.46 -36.88 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.163 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -53.26 -60.81 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.801 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.472 ' CD ' ' HZ2' ' A' ' 129' ' ' LYS . 11.6 mm-40 -50.43 -43.62 55.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.943 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.565 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -63.84 -33.08 74.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.32 -174.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.497 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 42.2 m-80 -92.8 5.17 52.17 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.715 0.293 . . . . 0.0 111.506 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.472 ' HZ2' ' CD ' ' A' ' 126' ' ' GLU . 15.3 mtmm -82.63 156.27 68.14 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HD2' HD13 ' A' ' 40' ' ' ILE . 96.6 Cg_endo -86.39 15.37 41.24 Favored 'Cis proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.72 -1.367 . . . . 0.0 113.424 -1.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.497 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.3 OUTLIER -66.12 -41.94 89.84 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.128 0.49 . . . . 0.0 110.069 175.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 tp -95.03 124.41 39.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.441 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -101.6 -33.27 9.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.862 -172.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 69.0 m -155.42 153.64 26.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.57 0.224 . . . . 0.0 111.179 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.523 ' HA ' ' CD1' ' A' ' 107' ' ' LEU . 81.9 Cg_exo -48.67 -56.95 2.67 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.627 2.885 . . . . 0.0 113.382 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.01 -7.78 53.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.864 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 134' ' ' SER . 30.2 mmtp -81.51 -2.72 50.88 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.561 HD11 ' HA ' ' A' ' 106' ' ' THR . 12.3 pt -68.37 167.55 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.972 0.415 . . . . 0.0 110.438 174.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 76' ' ' ASN . 10.5 p90 -141.46 141.67 23.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.428 -174.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.81 111.02 0.5 Allowed 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 123.176 2.584 . . . . 0.0 112.248 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.24 23.47 6.35 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.907 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.675 ' H ' HG22 ' A' ' 101' ' ' VAL . 47.3 tt0 -104.48 121.8 44.2 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.572 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.442 HG22 ' OG1' ' A' ' 100' ' ' THR . 42.7 t -80.93 133.75 28.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.965 174.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.1 mt -126.15 135.67 51.94 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.673 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.583 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 3.1 ptm180 -73.84 123.78 24.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.289 0.566 . . . . 0.0 110.011 176.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.482 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 26.3 mm -103.84 91.29 3.45 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.038 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 37.1 Cg_exo -60.88 144.28 99.53 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.501 2.134 . . . . 0.0 111.318 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.72 116.3 3.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.18 0.515 . . . . 0.0 110.328 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.538 ' HB2' ' CE1' ' A' ' 115' ' ' TYR . 41.0 tt0 -76.28 126.86 31.75 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.01 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.22 5.19 42.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.321 0.581 . . . . 0.0 109.743 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 149' ' ' GLU . 51.5 tt0 -88.0 98.53 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.525 177.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -101.3 -16.85 16.8 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.998 0.428 . . . . 0.0 110.654 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -91.58 81.34 5.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.126 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -89.46 -74.25 0.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.444 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 38.7 m80 53.55 52.28 13.6 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.987 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -134.57 -178.43 5.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.133 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.067 -177.995 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 27.1 ptm . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.43 -68.62 0.22 Allowed Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.7 tp -146.0 132.13 19.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.473 ' CZ ' ' HA ' ' A' ' 1' ' ' MET . 74.1 m-85 -114.16 133.92 55.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.645 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -109.85 134.56 51.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.272 0.558 . . . . 0.0 110.827 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 67.3 m-85 -118.03 -157.96 0.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.644 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.957 HG11 ' HB3' ' A' ' 10' ' ' ALA . 7.7 p -85.17 -24.61 6.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.914 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 28.9 tptp 74.83 -52.43 0.68 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.319 0.647 . . . . 0.0 111.881 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -85.81 -44.07 12.77 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.957 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -78.8 172.33 13.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.761 -177.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.21 -173.72 15.65 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.32 121.29 15.4 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 57.6 mtmt -80.04 74.76 6.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.471 0.653 . . . . 0.0 111.601 -171.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp -67.15 -48.53 67.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.581 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -133.62 18.76 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 56.61 20.78 5.21 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.587 176.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.43 22.44 9.53 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -75.53 83.82 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.692 0.282 . . . . 0.0 110.879 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.9 p 46.51 39.45 6.75 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.15 6.61 74.89 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.123 -0.561 . . . . 0.0 113.126 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 55.41 41.64 30.82 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.972 0.509 . . . . 0.0 110.629 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 35.6 m80 68.06 -74.11 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.746 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 19.6 m-20 -79.45 87.92 5.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.653 -177.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.563 ' O ' ' HB ' ' A' ' 50' ' ' ILE . 17.9 ptpt -67.07 -31.38 71.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.444 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -71.29 -33.77 70.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.99 0.424 . . . . 0.0 111.022 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.11 -16.21 60.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.824 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 10.5 mm100 -67.18 -21.85 65.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.579 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.77 82.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.225 176.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.3 tptt -65.28 -45.9 82.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.317 176.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -55.73 -46.86 77.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.793 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 77' ' ' ILE . 72.0 t -60.39 -49.31 84.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.941 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 3.2 mm-40 -53.11 -41.97 65.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.613 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 44.8 mt-10 -56.28 -44.84 80.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.498 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -56.16 -46.87 79.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.728 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.66 -39.21 84.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.826 0.346 . . . . 0.0 111.823 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -77.08 -24.36 51.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.488 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -82.54 -24.33 34.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.562 0.22 . . . . 0.0 111.353 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -83.75 -35.9 24.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.859 0.362 . . . . 0.0 110.955 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.69 24.15 6.23 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.162 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.88 125.56 91.01 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -78.53 149.32 23.96 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.978 1.786 . . . . 0.0 111.955 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.56 8.2 4.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.42 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.81 -13.24 56.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.054 0.454 . . . . 0.0 110.951 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.77 -7.46 56.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.634 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -89.36 -12.32 40.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.403 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.412 HG21 HG21 ' A' ' 70' ' ' ILE . 35.0 m -103.05 157.56 4.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.839 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 18.3 m120 -119.27 132.96 55.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.646 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.468 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 13.4 mm -95.26 140.97 15.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -174.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 52.6 mt-30 -137.53 127.41 25.62 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 24' ' ' LYS . 34.5 mm -117.91 116.58 52.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.185 0.517 . . . . 0.0 111.711 -172.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.05 70.81 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.915 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 t70 72.87 -66.45 0.31 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.185 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.12 31.49 2.69 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.894 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.569 ' CE ' ' HB2' ' A' ' 84' ' ' ASP . 87.2 tttt -140.25 129.42 23.68 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.503 -0.41 . . . . 0.0 110.718 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 83' ' ' VAL . . . -108.63 107.68 18.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.41 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 84' ' ' ASP . 36.5 m -95.21 114.05 25.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -104.71 127.6 59.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.82 0.343 . . . . 0.0 111.609 -177.588 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -104.35 158.08 16.71 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.123 177.293 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.41 156.72 10.11 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.29 137.49 27.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.144 0.497 . . . . 0.0 110.533 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 96.43 0.58 61.05 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.514 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 89' ' ' THR . 4.6 mm? -68.64 178.1 2.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.176 0.512 . . . . 0.0 111.982 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.464 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 53.6 p -127.02 144.34 51.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.564 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.623 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 48.8 tp60 -45.64 -54.86 7.1 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.532 0.52 . . . . 0.0 112.076 -175.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.91 -35.13 72.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.03 -42.6 19.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.936 0.398 . . . . 0.0 110.077 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 79.8 tttt -54.54 -40.45 68.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.27 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 79.0 mt-10 -63.46 -35.47 80.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.44 -43.87 93.05 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.412 HG21 HG21 ' A' ' 46' ' ' VAL . 2.8 mp -62.26 -50.77 78.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.092 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 88.0 mt -53.97 -45.96 71.5 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.409 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 68' ' ' GLU . 46.5 t -72.0 -44.22 66.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.211 0.529 . . . . 0.0 110.83 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -62.9 -34.66 77.89 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.349 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 80' ' ' ILE . 22.5 m -82.18 -31.12 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.638 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -72.36 -32.8 62.06 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.766 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.25 41.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.941 0.4 . . . . 0.0 111.056 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.432 ' CD1' HG13 ' A' ' 31' ' ' VAL . 96.8 mt -115.54 134.75 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 121.061 0.458 . . . . 0.0 110.398 172.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.53 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 14.8 t -62.47 105.99 0.7 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.486 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.91 -15.42 5.65 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.565 -174.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 49.7 mm -100.85 120.57 50.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.128 0.49 . . . . 0.0 111.49 -177.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.914 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -98.96 -38.26 9.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.685 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.4 p -142.7 159.6 41.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.48 0.657 . . . . 0.0 111.85 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 55' ' ' ALA . 69.0 t -131.07 127.53 61.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.628 177.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.569 ' HB2' ' CE ' ' A' ' 54' ' ' LYS . 5.6 t70 -106.39 107.75 18.92 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.76 110.04 15.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.115 0.96 . . . . 0.0 111.032 -173.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 14.6 mm-40 -107.98 17.51 22.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.531 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -92.4 116.24 33.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.843 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -85.59 139.17 31.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.307 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 16.6 p -105.48 131.11 53.29 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.99 0.424 . . . . 0.0 111.202 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.462 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -103.77 -40.02 6.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -176.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 63' ' ' SER . 17.8 p -96.28 141.0 22.5 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.586 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.6 130.49 18.4 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.805 2.337 . . . . 0.0 112.293 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.623 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -148.54 160.86 42.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.9 m -82.36 133.71 35.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.379 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.6 141.42 29.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.677 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.8 m -108.96 170.99 7.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.65 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.513 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.6 tt0 -96.33 147.7 23.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.518 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -104.29 107.08 17.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.976 0.417 . . . . 0.0 110.039 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -108.31 129.96 55.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.353 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.431 ' OG1' HG22 ' A' ' 143' ' ' VAL . 17.7 m -98.07 123.44 42.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.95 175.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -69.03 130.14 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.307 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.47 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 45.5 mmtm -80.18 -73.37 0.36 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.313 -170.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 140' ' ' PRO . 18.4 t -150.39 -68.66 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.765 -176.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.35 36.67 2.58 Favored Glycine 0 C--N 1.329 0.189 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -96.4 115.84 28.08 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.152 -172.2 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 110' ' ' ILE . 27.6 p -110.2 159.2 17.59 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -57.41 -45.12 84.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.178 0.444 . . . . 0.0 110.783 -171.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.505 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 14.3 m -63.04 -40.19 96.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.56 82.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.331 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 106' ' ' THR . 1.3 pp -74.11 -27.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 120.805 0.336 . . . . 0.0 110.503 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -67.19 -43.52 81.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.057 0.456 . . . . 0.0 110.133 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.16 -28.2 69.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.369 0.604 . . . . 0.0 109.964 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.596 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 17.4 tp60 -67.42 -54.49 19.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.078 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 115' ' ' TYR . 27.4 m -85.18 -50.49 14.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.207 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.475 ' N ' HG23 ' A' ' 114' ' ' VAL . 68.9 m-85 -85.81 -42.13 14.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.057 0.456 . . . . 0.0 111.146 -177.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.8 -14.88 31.83 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.447 ' HB3' ' HG ' ' A' ' 120' ' ' LEU . 55.3 t-20 -118.75 120.15 36.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.505 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -71.08 -22.24 62.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -174.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.08 -8.18 55.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.039 0.447 . . . . 0.0 111.106 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' ' 117' ' ' ASN . 46.6 mt -86.4 10.8 13.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.648 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 51.0 p90 -59.14 -26.49 64.79 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.925 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -70.3 -31.54 68.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.112 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.434 ' HE2' HD13 ' A' ' 120' ' ' LEU . 33.6 mtmt -62.43 -45.29 93.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.717 0.77 . . . . 0.0 109.68 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.0 mt -66.62 -42.76 90.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.619 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -56.74 -53.78 53.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.367 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -65.45 -26.31 67.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 111.664 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -76.58 -25.83 54.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.708 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 131' ' ' MET . 39.2 m-80 -98.02 -30.59 12.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.272 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 19.4 pttp -66.14 156.91 83.22 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.4 Cg_endo -81.2 10.33 32.71 Favored 'Cis proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.494 -1.461 . . . . 0.0 113.4 2.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.54 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.6 tmm? -64.99 -37.96 89.39 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.534 HD13 HE22 ' A' ' 142' ' ' GLN . 7.8 tp -88.74 114.77 25.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.026 171.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -73.41 -46.65 47.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.684 -171.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 135' ' ' PRO . 16.4 m -152.1 150.54 25.92 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 121.239 0.542 . . . . 0.0 109.928 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 107' ' ' LEU . 28.0 Cg_endo -62.6 -20.78 71.79 Favored 'Trans proline' 0 C--N 1.334 -0.232 0 C-N-CA 123.784 2.99 . . . . 0.0 113.025 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -101.4 -0.45 35.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.564 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -98.35 16.18 22.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.464 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 19.0 pt -74.0 166.44 2.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 171.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -153.27 147.21 18.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.821 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.413 ' HB3' ' HA ' ' A' ' 103' ' ' SER . 92.4 Cg_exo -47.53 113.68 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.573 2.849 . . . . 0.0 112.629 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.57 30.63 4.86 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.315 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.534 HE22 HD13 ' A' ' 132' ' ' LEU . 43.1 tt0 -114.02 124.9 53.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.629 0.714 . . . . 0.0 110.933 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.431 HG22 ' OG1' ' A' ' 100' ' ' THR . 45.1 t -82.69 134.73 26.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.757 173.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.4 mt -126.01 138.84 53.76 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.896 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.557 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 52.9 mtp180 -65.91 118.28 9.5 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.675 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 39.3 mm -105.96 90.16 4.24 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 24.5 Cg_exo -62.37 150.31 87.69 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.685 2.257 . . . . 0.0 111.443 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.431 ' O ' HD22 ' A' ' 150' ' ' LEU . 30.6 tt0 -64.96 126.67 28.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -74.34 116.22 14.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.801 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 148' ' ' GLU . 2.9 mm? -89.16 72.08 8.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.751 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 57.38 -127.76 1.73 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.106 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 69.9 m80 62.82 48.67 3.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.14 0.495 . . . . 0.0 110.645 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -143.87 121.2 11.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.857 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -108.04 -64.59 1.2 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.418 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -162.14 130.31 4.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.501 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -150.67 124.89 9.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.015 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 44.8 t60 . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.612 175.461 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 4' ' ' PHE . 3.1 tm? . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.061 0.458 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.475 ' N ' HD13 ' A' ' 3' ' ' LEU . 96.7 m-85 -126.09 136.35 52.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.223 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -108.44 147.25 31.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.447 0.641 . . . . 0.0 112.275 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.506 ' CD2' HG21 ' A' ' 143' ' ' VAL . 53.7 m-85 -130.47 -169.17 2.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.751 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.473 HG21 ' HA2' ' A' ' 141' ' ' GLY . 40.5 t -86.61 -13.38 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.536 0.207 . . . . 0.0 111.115 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 63.7 tttm 73.85 -68.71 0.21 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.083 0.553 . . . . 0.0 111.784 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.02 -26.24 65.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.905 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.503 ' CB ' ' HA3' ' A' ' 141' ' ' GLY . . . -100.28 125.53 46.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.153 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.11 -169.43 40.32 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -60.49 129.89 43.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -74.81 73.39 2.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.029 0.919 . . . . 0.0 109.717 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.409 HD21 ' O ' ' A' ' 30' ' ' LYS . 12.1 tp . . . . . 0 N--CA 1.436 -1.142 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.552 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.54 ' O ' HG23 ' A' ' 31' ' ' VAL . 95.8 mt-30 -63.88 -45.99 86.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.586 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.1 78.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.184 0.516 . . . . 0.0 110.727 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.09 -45.47 94.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.537 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.409 ' O ' HD21 ' A' ' 14' ' ' LEU . 68.5 mmtt -61.11 -35.21 76.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.852 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.559 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 97.4 t -62.74 -48.94 85.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -55.35 -48.56 74.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.569 172.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 66.1 mt-10 -55.71 -50.27 70.76 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -53.23 -43.95 67.7 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.698 0.624 . . . . 0.0 111.505 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 98.5 mt -62.76 -42.95 99.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.502 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -75.1 -25.39 58.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.989 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 13.2 mmmm -65.84 -51.99 54.25 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.222 0.534 . . . . 0.0 110.385 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 130' ' ' PRO . 2.4 p -73.3 -28.97 62.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.375 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.07 30.54 7.81 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.973 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.61 126.05 85.93 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.52 145.71 71.57 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.894 1.729 . . . . 0.0 112.107 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.29 21.45 11.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.804 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.11 -22.39 63.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.6 2.99 56.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.684 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -99.26 3.05 46.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.453 . . . . 0.0 110.155 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.12 172.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.025 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -137.3 131.73 32.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.627 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 mm -98.14 141.45 16.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.952 0.406 . . . . 0.0 111.21 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 49.2 tt0 -139.67 119.8 13.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.686 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 31' ' ' VAL . 43.5 mm -96.57 108.16 20.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.289 0.566 . . . . 0.0 110.833 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.56 72.48 2.04 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 68.08 -82.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.867 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.7 1.81 24.64 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.132 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -110.08 110.48 21.39 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.522 -0.399 . . . . 0.0 111.084 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.484 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -84.24 92.14 7.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.792 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 84' ' ' ASP . 43.3 m -75.78 122.62 24.33 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.905 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.4 t -112.01 113.61 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.115 0.483 . . . . 0.0 110.28 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -100.91 162.96 12.53 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.224 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.75 167.05 32.18 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.495 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -155.15 142.27 19.3 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.959 0.409 . . . . 0.0 110.319 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.11 7.83 86.41 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.384 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.44 169.23 18.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.381 0.61 . . . . 0.0 112.165 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.1 m -115.32 147.69 40.15 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 170.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.592 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 39.8 tt0 -51.93 -45.8 64.44 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -173.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.3 -50.35 62.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.945 0.403 . . . . 0.0 110.184 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.08 -43.06 96.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.066 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' O ' HD13 ' A' ' 71' ' ' LEU . 27.5 ttpp -59.13 -47.34 85.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 0.0 111.098 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 4.1 mm-40 -66.19 -15.88 63.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.091 0.472 . . . . 0.0 110.736 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -39.04 53.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.701 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.3 mm -65.31 -57.04 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.471 0.653 . . . . 0.0 109.915 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 67' ' ' LYS . 11.0 mp -42.44 -49.68 5.23 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.871 -177.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.662 HG21 ' HG2' ' A' ' 145' ' ' ARG . 57.5 t -69.85 -49.56 56.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.235 0.54 . . . . 0.0 111.199 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HA ' ' SD ' ' A' ' 131' ' ' MET . . . -64.02 -29.68 70.81 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.956 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.2 m -87.6 -29.08 5.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.988 0.423 . . . . 0.0 111.043 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -73.63 -33.46 58.13 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.443 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -80.01 54.26 1.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.773 0.32 . . . . 0.0 111.138 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -122.76 142.48 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 120.927 0.394 . . . . 0.0 110.551 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 t -70.83 103.26 2.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.504 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.61 -18.11 5.46 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.285 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 45.9 mm -94.34 117.17 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.455 0.645 . . . . 0.0 111.045 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.58 -30.47 13.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.881 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.42 ' HB2' HD21 ' A' ' 3' ' ' LEU . 11.7 p -153.17 160.23 42.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.261 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 55' ' ' ALA . 54.9 t -124.94 125.89 70.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.432 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.532 ' HB3' HG23 ' A' ' 56' ' ' THR . 6.4 t70 -97.98 96.84 8.44 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.45 104.98 5.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.117 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -115.94 19.45 15.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.111 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.9 114.91 20.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.997 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -83.19 122.33 28.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.1 p -99.43 130.72 45.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.155 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.47 -21.84 35.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.905 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -140.17 131.69 14.36 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.105 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.53 156.96 36.44 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.499 2.133 . . . . 0.0 111.066 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -150.64 -160.41 1.16 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.512 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.7 m -67.04 131.78 46.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 110.723 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.41 159.53 17.97 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.0 m -138.66 143.26 39.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.101 0.477 . . . . 0.0 110.814 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.474 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 6.5 tt0 -81.33 137.05 35.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.488 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -99.1 80.29 2.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.532 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -73.91 144.86 45.16 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.541 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.419 ' OG1' HG22 ' A' ' 143' ' ' VAL . 12.9 m -120.74 117.94 28.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 142' ' ' GLN . 0.6 OUTLIER -68.18 131.38 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.406 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 32.5 mmtp -84.0 -61.14 1.89 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.92 -170.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.8 t -163.15 -68.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.19 53.43 4.79 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.544 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.8 m-20 -113.1 112.65 24.19 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.129 0.49 . . . . 0.0 111.05 -172.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.472 ' O ' HG23 ' A' ' 110' ' ' ILE . 25.1 m -108.81 146.59 33.39 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.562 ' O ' HG13 ' A' ' 110' ' ' ILE . 25.4 tp -52.61 -45.89 66.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -168.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.619 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 38.9 m -67.19 -41.56 85.67 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.096 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HA ' ' HG3' ' A' ' 112' ' ' LYS . . . -64.37 -37.77 88.66 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.628 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.4 pp -76.96 -22.36 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 109.992 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -67.98 -49.38 62.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.05 171.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.694 ' HG2' ' HB2' ' A' ' 118' ' ' ALA . 22.2 mttt -55.26 -30.31 59.84 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 121.295 0.569 . . . . 0.0 110.155 172.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.628 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 4.5 tp60 -68.24 -56.82 7.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.617 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.47 HG21 HD12 ' A' ' 146' ' ' ILE . 33.8 m -86.32 -42.91 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.158 -172.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.5 ' HB3' HD12 ' A' ' 120' ' ' LEU . 17.6 m-85 -90.82 -26.18 19.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.747 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.14 -9.73 76.86 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.626 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.523 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 26.2 t30 -126.12 129.35 48.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.694 ' HB2' ' HG2' ' A' ' 112' ' ' LYS . . . -72.9 -28.95 62.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.631 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.82 -19.19 65.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.551 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.523 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 54.6 mt -82.99 13.93 3.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.122 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 42.6 p90 -61.2 -32.62 72.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.424 0.63 . . . . 0.0 110.333 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.484 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 11.7 p30 -69.57 -30.04 67.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.458 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -61.94 -46.55 88.84 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.285 0.564 . . . . 0.0 109.656 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.5 mt -64.52 -44.94 96.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.451 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.545 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 26.2 t80 -51.8 -59.44 4.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.207 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 45.4 mt-10 -59.22 -41.37 88.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.361 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -59.51 -31.62 69.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.377 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.494 ' OD1' ' HA ' ' A' ' 144' ' ' LEU . 43.0 m-80 -90.11 -1.63 57.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 132' ' ' LEU . 29.5 mtpp -81.84 155.19 70.63 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.683 0.277 . . . . 0.0 110.362 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' THR . 1.9 Cg_endo -87.58 24.56 18.33 Favored 'Cis proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.819 -1.326 . . . . 0.0 113.461 0.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.467 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.1 OUTLIER -76.35 -37.13 57.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.222 0.534 . . . . 0.0 110.044 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.625 ' O ' ' HG2' ' A' ' 129' ' ' LYS . 13.4 tp -98.0 117.13 31.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.891 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -81.24 -51.29 8.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.783 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.4 m -138.29 154.61 73.94 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.527 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.24 -54.4 5.51 Favored 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 123.415 2.743 . . . . 0.0 112.963 -175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.98 5.76 24.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.541 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -83.82 -0.94 53.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.628 0.251 . . . . 0.0 111.185 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.9 pt -65.76 168.36 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -158.49 153.48 21.43 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.07 112.85 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.043 2.496 . . . . 0.0 112.389 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.503 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 96.77 35.91 5.22 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.615 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.615 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.2 tp60 -108.78 121.43 45.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.988 0.394 . . . . 0.0 110.152 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.506 HG21 ' CD2' ' A' ' 6' ' ' PHE . 41.2 t -83.62 129.46 37.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.237 0.542 . . . . 0.0 110.645 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.494 ' HA ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -118.98 130.83 55.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.229 -177.14 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.662 ' HG2' HG21 ' A' ' 72' ' ' VAL . 55.3 mtp180 -69.52 119.26 13.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.334 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 27.6 mm -106.93 95.58 12.87 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 35.0 Cg_exo -61.49 149.88 87.71 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.656 2.237 . . . . 0.0 111.737 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.286 175.737 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 121.76 0.791 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.516 ' HB2' HG12 ' A' ' 83' ' ' VAL . 97.7 m-85 -101.44 127.11 48.25 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.358 175.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -87.43 134.08 33.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.704 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 50.7 m-85 -117.76 -158.15 0.7 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 88.5 t -89.36 -79.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.015 173.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.6 tmtp? 165.82 -71.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.017 0.823 . . . . 0.0 109.235 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.03 -25.95 34.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.355 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.79 124.06 23.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.963 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.21 -178.02 28.84 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -71.5 130.0 40.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 117.017 0.408 . . . . 0.0 109.911 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 48.0 mtmt -77.64 92.93 4.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.356 0.598 . . . . 0.0 111.554 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 34' ' ' HIS . 6.9 mp . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.556 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 24.2 t70 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 121.005 0.431 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.592 ' O ' HG23 ' A' ' 31' ' ' VAL . 20.7 mt-30 -61.55 -38.98 89.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.291 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.2 -42.89 96.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.101 0.477 . . . . 0.0 110.483 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 27.1 ttpp -62.04 -42.84 99.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.041 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 28.0 mmtp -60.44 -40.11 89.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.97 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 27' ' ' GLN . 95.3 t -58.29 -49.06 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.359 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -55.16 -46.61 75.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.922 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 46.6 mt-10 -57.28 -44.15 83.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.732 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.439 ' HB2' HD21 ' A' ' 14' ' ' LEU . 65.9 t60 -57.81 -44.74 86.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.979 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 91.3 mt -64.96 -40.79 95.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.964 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -72.5 -34.01 67.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.273 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -72.1 -33.19 67.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.42 -25.35 46.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.109 0.48 . . . . 0.0 110.854 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.35 26.91 12.71 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.082 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.0 mm -65.09 122.15 78.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -75.45 151.21 37.29 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.978 1.785 . . . . 0.0 111.745 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 63.78 6.72 2.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.949 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.24 -22.92 61.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.018 0.437 . . . . 0.0 111.001 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -77.32 -19.67 56.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.383 176.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -77.47 -21.81 52.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.986 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.5 m -101.34 173.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.338 0.59 . . . . 0.0 111.88 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -131.19 140.56 49.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.991 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.3 mm -102.99 138.68 26.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.957 0.408 . . . . 0.0 111.118 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -137.29 122.53 19.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.699 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 27' ' ' GLN . 17.4 mm -92.93 122.37 44.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.979 0.419 . . . . 0.0 110.597 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.7 70.41 0.71 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.98 -82.34 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.325 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 -5.86 23.34 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.989 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 106.3 17.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.941 0.401 . . . . 0.0 111.017 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.59 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -83.09 111.18 18.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.479 HG23 ' HB3' ' A' ' 84' ' ' ASP . 32.6 m -93.31 132.49 37.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.858 0.361 . . . . 0.0 111.32 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.99 123.56 65.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.0 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -122.75 158.04 31.02 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.385 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.22 177.7 28.75 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -160.16 145.18 14.89 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.053 0.426 . . . . 0.0 110.433 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 100.26 11.7 41.34 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.942 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 mp -96.12 165.67 12.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.172 0.51 . . . . 0.0 111.574 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.0 m -85.57 143.02 28.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.871 174.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 93' ' ' ALA . 20.1 tm0? -63.92 -28.18 69.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.466 -174.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.46 -29.59 59.67 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.904 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.38 -39.98 31.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.744 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -62.68 -31.97 72.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.679 -176.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.549 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.5 mm-40 -65.29 -42.59 92.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.148 0.499 . . . . 0.0 110.118 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.46 -43.9 96.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.668 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 67' ' ' LYS . 46.5 mt -61.52 -53.65 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.583 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 94.9 mt -44.65 -48.35 10.54 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.798 0.686 . . . . 0.0 111.917 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 68' ' ' GLU . 54.8 t -62.91 -52.11 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.141 0.496 . . . . 0.0 111.053 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.9 70.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.692 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.467 HG13 HG11 ' A' ' 31' ' ' VAL . 52.7 t -75.04 -43.38 45.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.704 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -71.8 -28.79 68.33 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.329 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -77.79 45.29 0.5 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.062 0.458 . . . . 0.0 111.919 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.3 mt -117.89 140.33 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.356 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.423 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 11.9 t -65.96 103.28 0.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.529 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.14 -19.71 4.08 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 55' ' ' ALA . 34.8 mm -97.13 133.24 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.301 0.572 . . . . 0.0 110.546 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.456 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -113.45 -14.21 12.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.479 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 p -165.26 150.77 9.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.777 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.539 HG12 ' HE1' ' A' ' 6' ' ' PHE . 15.0 p -120.3 134.23 64.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.835 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.479 ' HB3' HG23 ' A' ' 56' ' ' THR . 22.7 t0 -101.71 125.53 48.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.0 101.36 13.91 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.847 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -119.11 12.96 12.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.205 0.526 . . . . 0.0 110.217 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 p -86.77 128.28 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.432 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -89.18 147.35 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.841 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.4 p -108.01 142.09 38.68 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.83 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.435 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -95.2 -33.17 12.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.321 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 p -126.87 134.77 26.46 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.087 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.72 119.05 5.29 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.579 2.186 . . . . 0.0 111.102 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.403 ' H ' ' HB3' ' A' ' 64' ' ' GLN . . . -130.48 -160.91 1.08 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.658 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 m -76.47 116.87 17.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.101 0.477 . . . . 0.0 111.764 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.38 162.69 24.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.732 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 m -128.02 150.17 50.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.49 0.662 . . . . 0.0 112.308 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.423 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.6 tt0 -91.16 139.33 30.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.144 172.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -106.35 82.27 1.72 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.95 0.405 . . . . 0.0 110.838 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 75.6 t80 -84.71 141.32 30.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.062 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.2 m -107.44 118.8 37.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.694 0.283 . . . . 0.0 110.77 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.0 OUTLIER -72.56 134.05 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.478 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 33.4 mmtp -100.99 -166.03 1.27 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.397 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.8 t -72.77 122.64 21.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.948 0.404 . . . . 0.0 109.959 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.67 7.18 69.23 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.91 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 5.8 m-20 -82.6 118.84 23.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.211 0.529 . . . . 0.0 110.518 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.574 ' O ' HG23 ' A' ' 110' ' ' ILE . 7.1 m -100.74 149.43 23.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.81 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.548 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 24.4 tp -58.66 -35.21 72.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.571 0.623 . . . . 0.0 110.29 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.461 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 9.1 p -69.22 -40.33 78.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.401 0.62 . . . . 0.0 110.567 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -68.18 -38.92 82.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.152 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.615 ' HA ' ' CG ' ' A' ' 113' ' ' GLN . 1.5 pp -79.34 -23.79 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 124' ' ' ILE . 8.7 p -74.57 -34.96 63.02 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 5.7 tmmm? -58.34 -30.53 66.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.768 170.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.615 ' CG ' ' HA ' ' A' ' 110' ' ' ILE . 11.0 mm100 -68.32 -72.22 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.126 0.965 . . . . 0.0 110.774 175.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 110' ' ' ILE . 29.2 m -73.32 -36.87 50.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 113.65 -1.613 . . . . 0.0 112.631 -166.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 120' ' ' LEU . 22.8 m-85 -97.46 -22.86 16.34 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.482 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.21 11.31 76.08 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.436 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -151.94 124.19 8.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.66 0.267 . . . . 0.0 110.791 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 108' ' ' SER . . . -73.58 -19.54 60.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.951 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -68.15 -24.64 65.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.443 HD12 ' HB3' ' A' ' 115' ' ' TYR . 51.6 mt -85.83 20.46 2.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.757 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.548 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 17.3 p90 -68.95 -28.42 66.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.121 0.486 . . . . 0.0 110.217 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.514 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 27.1 p-10 -70.63 -31.48 68.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.448 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 29.4 mmmt -54.81 -49.19 71.58 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.428 0.632 . . . . 0.0 110.158 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 111' ' ' SER . 47.7 mt -66.72 -47.51 82.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.315 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.539 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 44.7 t80 -49.32 -54.02 19.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.592 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 34.8 mt-10 -61.96 -36.62 81.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.244 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.37 -31.02 65.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.459 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 131' ' ' MET . 8.1 m120 -76.09 -27.95 57.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.969 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.592 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 29.5 mtpp -61.24 151.72 75.01 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.087 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -88.73 17.03 41.65 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.672 -1.803 . . . . 0.0 112.779 0.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.463 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -69.37 -37.56 77.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.417 177.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.74 117.01 29.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.66 -37.39 24.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.574 -174.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 137' ' ' LYS . 19.3 m -152.0 144.55 16.85 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.151 0.501 . . . . 0.0 109.879 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.41 -20.37 66.18 Favored 'Trans proline' 0 C--N 1.332 -0.32 0 C-N-CA 123.487 2.791 . . . . 0.0 112.545 -171.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -98.73 -4.65 33.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.909 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.435 ' HG3' ' HB2' ' A' ' 134' ' ' SER . 27.3 mtpp -90.15 9.28 28.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.928 0.394 . . . . 0.0 111.284 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 14.0 pt -58.89 169.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.569 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -157.21 143.87 13.29 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.069 -175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.6 112.73 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.281 2.654 . . . . 0.0 112.559 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 107.56 27.01 5.4 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.894 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.548 ' H ' HG22 ' A' ' 101' ' ' VAL . 48.1 tt0 -103.21 116.61 32.79 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.989 -175.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.661 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 25.7 t -80.63 130.88 35.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.7 mt -118.25 145.58 44.92 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.795 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.534 ' HB2' HG21 ' A' ' 72' ' ' VAL . 37.3 ttt180 -74.93 98.38 3.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.826 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 19.7 mm -87.51 106.55 11.8 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.65 156.04 67.65 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.718 1.612 . . . . 0.0 111.748 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.805 177.523 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 83' ' ' VAL . 41.3 tp . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.651 ' HB2' HG12 ' A' ' 83' ' ' VAL . 78.1 m-85 -124.72 138.9 54.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.901 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -98.19 140.99 31.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.618 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.639 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 86.7 m-85 -127.27 -171.69 2.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.037 0.446 . . . . 0.0 111.899 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.904 HG11 ' HB3' ' A' ' 10' ' ' ALA . 4.5 p -78.16 -26.44 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.176 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.604 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 25.1 tptp 78.95 -55.05 0.45 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.472 0.709 . . . . 0.0 112.295 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.08 7.23 43.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.904 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -125.21 157.62 36.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 121.243 -0.183 . . . . 0.0 110.561 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.6 -148.29 16.88 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.089 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.472 ' HG2' ' ND1' ' A' ' 34' ' ' HIS . 8.9 tp10 -82.39 129.87 34.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.007 0.404 . . . . 0.0 110.277 177.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -95.84 93.16 6.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.775 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 34' ' ' HIS . 1.4 mm? . . . . . 0 C--N 1.324 -0.54 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 24.3 t70 . . . . . 0 CA--C 1.522 -0.121 0 CA-C-O 121.117 0.484 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 31' ' ' VAL . 90.9 mt-30 -63.17 -36.46 83.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.379 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 50' ' ' ILE . . . -58.93 -41.06 86.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 174.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -63.68 -39.91 95.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.556 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -62.42 -32.94 73.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.157 177.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.554 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 84.6 t -68.48 -44.99 82.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.377 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -52.87 -52.26 58.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.311 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.32 -41.32 88.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.702 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.472 ' ND1' ' HG2' ' A' ' 12' ' ' GLU . 31.9 t60 -54.52 -48.67 71.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.805 0.336 . . . . 0.0 110.797 174.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 77.4 mt -66.92 -42.8 84.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.985 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -75.99 -27.11 57.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.725 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.55 -34.36 47.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.495 0.188 . . . . 0.0 111.159 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.424 ' O ' ' HG2' ' A' ' 130' ' ' PRO . 2.0 p -73.44 -44.55 57.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.675 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.2 32.86 1.58 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.529 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.55 HD13 ' HD2' ' A' ' 130' ' ' PRO . 35.8 mm -73.08 126.69 90.22 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 5.7 Cg_exo -73.54 145.09 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.374 2.049 . . . . 0.0 112.763 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 63.56 15.8 9.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.12 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.36 -23.8 63.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.239 0.542 . . . . 0.0 110.457 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.13 -20.51 62.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.801 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -92.03 -26.24 18.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.952 0.406 . . . . 0.0 110.984 -174.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.6 HG21 HG21 ' A' ' 70' ' ' ILE . 33.6 m -90.26 163.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -128.41 131.61 48.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.705 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.7 mp -105.79 128.89 59.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.08 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -117.15 132.74 56.59 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' A' ' 28' ' ' ALA . 14.2 mm -105.04 108.82 25.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.379 0.609 . . . . 0.0 111.331 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' ASP . . . -99.05 69.26 1.74 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.096 176.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 3.5 m-20 70.2 -80.04 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.132 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.75 -8.21 12.41 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.702 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' CE ' ' HB2' ' A' ' 84' ' ' ASP . 82.4 tttt -102.26 112.97 25.87 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.049 0.452 . . . . 0.0 110.688 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.532 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -94.54 121.39 36.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.139 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.409 ' CG2' HE21 ' A' ' 86' ' ' GLN . 35.0 m -99.93 118.24 35.94 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 74' ' ' VAL . 25.5 t -98.26 122.76 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.89 155.16 33.24 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.859 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.4 174.74 36.75 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 p-10 -153.02 142.31 21.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.975 0.417 . . . . 0.0 110.649 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.89 17.42 61.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.238 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mp -93.34 178.41 5.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.103 0.477 . . . . 0.0 111.201 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.8 m -126.82 149.55 49.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.99 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.516 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 15.7 mm100 -57.53 -26.59 61.6 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.988 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.82 -36.6 72.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.722 0.296 . . . . 0.0 111.785 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.85 -34.45 10.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.498 . . . . 0.0 110.396 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 82.3 tttt -61.0 -41.26 96.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.469 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 145' ' ' ARG . 7.1 mm-40 -78.25 8.92 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.086 0.469 . . . . 0.0 110.822 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -98.72 -46.44 5.68 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.6 HG21 HG21 ' A' ' 46' ' ' VAL . 20.7 mt -67.34 -55.34 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.352 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 tp -65.33 -16.85 64.02 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.099 -170.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 145' ' ' ARG . 63.9 t -90.6 -52.63 10.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.327 175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.32 -18.98 65.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.954 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.523 HG23 HG11 ' A' ' 31' ' ' VAL . 7.6 p -82.05 -42.74 19.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.875 0.369 . . . . 0.0 110.693 175.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.639 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -67.71 -35.92 86.54 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.135 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -85.3 38.23 0.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.546 0.689 . . . . 0.0 111.262 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.2 mt -102.29 144.13 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.116 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -70.47 99.26 1.58 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.428 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.97 -18.27 3.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.986 -175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 55' ' ' ALA . 41.0 mm -98.53 120.5 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.376 0.608 . . . . 0.0 110.991 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.604 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -98.55 -24.91 14.93 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.738 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.7 m -159.52 160.21 34.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.917 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 4' ' ' PHE . 4.3 p -131.31 138.4 53.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.891 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.422 ' HB2' ' CE ' ' A' ' 54' ' ' LYS . 31.3 t70 -111.36 120.53 42.51 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -88.54 121.46 30.95 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.107 0.479 . . . . 0.0 110.942 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.409 HE21 ' CG2' ' A' ' 56' ' ' THR . 40.3 mt-30 -135.26 32.16 3.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.592 172.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.74 110.61 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.087 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 53.5 mttm -74.76 130.09 38.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.966 0.412 . . . . 0.0 110.144 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 p -105.29 124.6 49.82 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.767 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.97 -18.17 44.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.96 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.6 p -109.27 144.88 30.66 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.72 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.36 42.73 1.28 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.985 2.457 . . . . 0.0 111.988 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.85 156.59 32.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.899 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 m -74.07 129.13 37.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.182 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.74 164.17 23.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.397 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.9 m -120.16 148.16 43.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.189 0.518 . . . . 0.0 111.471 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -78.67 148.91 32.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.426 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -116.54 116.22 27.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.875 0.369 . . . . 0.0 110.531 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 143' ' ' VAL . 94.4 t80 -110.57 130.26 55.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.9 m -94.08 118.54 31.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.614 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 2.0 m -72.63 130.3 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 140' ' ' PRO . 73.3 mmtt -98.72 -60.43 1.54 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -169.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.4 t -164.0 122.76 1.92 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.745 0.307 . . . . 0.0 110.189 -174.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.62 11.06 72.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.827 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.614 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 2.0 m-20 -73.16 121.33 20.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.265 0.555 . . . . 0.0 110.431 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 110' ' ' ILE . 46.3 p -114.63 157.7 22.73 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 135' ' ' PRO . 26.0 tp -58.05 -40.55 81.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.583 0.629 . . . . 0.0 111.455 -170.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.459 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 13.3 m -76.54 -20.12 57.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.067 0.46 . . . . 0.0 111.05 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.8 -39.55 26.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.049 -0.407 . . . . 0.0 110.43 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.6 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.1 pp -80.25 -24.5 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.958 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.0 p -70.21 -45.12 67.24 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -61.41 -24.28 66.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.579 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -72.12 -57.75 4.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.977 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 115' ' ' TYR . 32.6 m -84.0 -48.43 17.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.043 -172.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.487 ' N ' HG23 ' A' ' 114' ' ' VAL . 56.2 m-85 -82.23 -41.23 20.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.056 0.455 . . . . 0.0 110.647 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.96 -14.73 34.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.997 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.402 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 27.6 t30 -123.0 123.12 40.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.815 0.341 . . . . 0.0 110.297 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -67.32 -27.59 67.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.675 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -74.58 -3.55 31.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 0.0 111.282 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 115' ' ' TYR . 68.4 mt -91.11 19.49 5.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.232 0.539 . . . . 0.0 110.682 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -63.09 -35.77 81.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.499 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -67.4 -27.64 67.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.723 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -60.08 -43.74 95.28 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.355 0.597 . . . . 0.0 109.921 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.429 HD13 HD11 ' A' ' 110' ' ' ILE . 62.0 mt -72.21 -43.35 65.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.296 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 134' ' ' SER . 61.1 t80 -55.54 -53.01 61.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.249 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 19.2 mt-10 -68.11 -24.01 64.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.349 0.595 . . . . 0.0 111.399 -177.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.437 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -79.38 -25.76 42.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.85 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.49 ' HB3' ' HE2' ' A' ' 131' ' ' MET . 24.1 m-80 -99.13 18.68 16.83 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.028 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.449 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 30.5 mmmt -79.76 140.83 55.0 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.209 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.55 ' HD2' HD13 ' A' ' 40' ' ' ILE . 19.6 Cg_endo -100.22 13.24 23.51 Favored 'Cis proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.84 -0.9 . . . . 0.0 112.078 -6.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.49 ' HE2' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -65.51 -25.93 67.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.712 -178.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 133' ' ' LYS . 9.0 tp -100.63 122.7 43.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 170.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.522 ' H ' ' HD2' ' A' ' 133' ' ' LYS . 9.6 mptt -81.05 -44.71 17.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.738 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.409 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 57.2 p -157.72 163.11 25.79 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.882 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.466 ' HA ' HD22 ' A' ' 107' ' ' LEU . 51.8 Cg_exo -54.5 -28.13 53.32 Favored 'Trans proline' 0 C--N 1.328 -0.526 0 C-N-CA 123.096 2.531 . . . . 0.0 112.316 175.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.11 -20.25 19.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.48 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 133' ' ' LYS . 22.9 mmtp -73.48 -6.93 49.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -173.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.614 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 21.1 pt -65.82 166.56 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.182 0.515 . . . . 0.0 111.086 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 142' ' ' GLN . 12.4 p90 -165.58 148.99 7.02 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.923 -177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 102' ' ' LYS . 50.5 Cg_exo -42.71 118.32 1.13 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.915 3.077 . . . . 0.0 113.313 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 106.66 12.32 24.85 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.799 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.614 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 14.0 mt-30 -99.86 120.77 40.3 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.968 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 23.2 t -86.53 127.73 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.173 170.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.3 mt -117.72 143.28 46.35 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.754 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 68' ' ' GLU . 42.2 ttt180 -70.37 118.93 13.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.691 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.3 mm -111.16 90.19 11.13 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.766 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.437 ' HG3' ' HB2' ' A' ' 127' ' ' ALA . 92.8 Cg_endo -77.54 176.67 9.77 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.32 2.013 . . . . 0.0 111.801 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 C--N 1.322 -0.593 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.542 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 83' ' ' VAL . 47.9 tp . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 121.582 0.706 . . . . 0.0 111.981 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -123.61 147.16 47.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.982 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -114.9 138.55 50.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.988 0.423 . . . . 0.0 111.165 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.539 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 37.8 m-85 -130.27 171.03 13.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.339 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 93.7 t -88.67 119.29 35.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.941 0.4 . . . . 0.0 110.009 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 1.069 ' HG2' ' HB2' ' A' ' 81' ' ' ALA . 5.0 tmtp? -52.2 -40.34 61.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.232 -171.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.31 -17.07 35.52 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.277 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . . . -88.07 164.65 15.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.927 0.394 . . . . 0.0 111.535 -174.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.52 -170.92 14.29 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.061 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.97 125.47 26.06 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -77.27 59.94 1.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.219 1.009 . . . . 0.0 109.062 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.411 HD21 ' O ' ' A' ' 30' ' ' LYS . 17.3 tp . . . . . 0 N--CA 1.437 -1.091 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.428 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 12.8 t70 . . . . . 0 CA--C 1.523 -0.059 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.573 ' NE2' HG21 ' A' ' 50' ' ' ILE . 24.8 mt-30 -57.65 -44.17 85.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.159 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.48 -44.87 73.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.966 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 52.5 tttm -66.35 -43.87 84.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.807 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -55.44 -42.61 74.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.339 178.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.692 HG11 HG23 ' A' ' 74' ' ' VAL . 43.2 t -66.16 -44.41 91.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.597 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.507 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 8.6 mm-40 -57.77 -46.58 84.34 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.548 0.213 . . . . 0.0 111.01 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.2 mt-10 -58.44 -46.33 86.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -55.78 -44.01 77.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.351 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 83.8 mt -64.16 -38.45 91.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 110.557 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -78.27 -22.83 47.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.197 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 32.5 mmmt -75.52 -48.07 24.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.903 0.382 . . . . 0.0 110.344 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 p -64.24 -38.71 92.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.505 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.32 32.69 3.63 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.585 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.644 HD13 ' HD2' ' A' ' 130' ' ' PRO . 29.9 mm -72.6 120.36 80.21 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -81.09 150.58 17.92 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 122.099 1.866 . . . . 0.0 111.876 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 65.57 11.9 7.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.259 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.42 -25.64 33.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.189 0.518 . . . . 0.0 110.045 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.03 -12.05 59.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.881 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -76.97 -25.23 52.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.841 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.441 HG21 HG21 ' A' ' 70' ' ' ILE . 27.1 m -109.14 168.11 3.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.397 0.618 . . . . 0.0 111.822 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -121.93 146.62 46.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.415 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.507 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 21.0 mm -105.63 137.07 37.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.878 0.37 . . . . 0.0 110.692 -177.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.432 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 98.6 mt-30 -134.04 145.68 49.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.573 HG21 ' NE2' ' A' ' 27' ' ' GLN . 26.0 mm -126.09 128.12 71.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.114 0.483 . . . . 0.0 111.754 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -119.22 89.2 3.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.046 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 63.85 -92.65 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.735 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.26 10.5 13.18 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.605 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 82' ' ' SER . 21.7 ttmm -104.18 112.84 26.01 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.088 0.471 . . . . 0.0 110.381 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -92.06 121.75 33.92 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.982 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.432 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 23.7 m -100.22 116.7 32.83 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.9 t -92.78 133.9 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.779 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -142.06 160.64 39.81 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.009 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.43 172.29 31.71 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.55 146.08 41.44 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.99 0.395 . . . . 0.0 110.22 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 84.63 10.74 78.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.229 177.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.86 168.7 19.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.122 0.487 . . . . 0.0 111.896 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.3 p -111.18 154.06 24.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.408 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -71.87 0.74 8.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.13 -51.46 4.62 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.72 90.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.746 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 19.8 ptmt -58.79 -34.63 71.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.671 0.272 . . . . 0.0 111.544 -174.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.533 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.4 mm-40 -65.96 -29.45 69.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.215 0.531 . . . . 0.0 110.083 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -72.73 -40.8 65.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.599 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.441 HG21 HG21 ' A' ' 46' ' ' VAL . 2.4 mp -63.11 -47.21 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 96.4 mt -53.73 -32.74 53.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.008 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 68' ' ' GLU . 47.0 t -72.15 -58.32 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.393 0.616 . . . . 0.0 110.975 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.38 -28.32 69.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.451 -173.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.692 HG23 HG11 ' A' ' 31' ' ' VAL . 7.2 p -79.98 -26.14 12.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.337 0.589 . . . . 0.0 110.661 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.539 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -83.99 -34.16 18.94 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.543 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.57 60.95 2.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.018 0.437 . . . . 0.0 111.006 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.484 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 7.9 mm -126.22 128.81 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -65.11 113.4 3.92 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.28 -13.76 11.08 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.397 -171.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.484 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 37.4 mm -100.61 138.86 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.064 0.459 . . . . 0.0 110.133 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.069 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -125.55 -17.04 5.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.5 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 9.2 p -155.87 158.57 38.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.081 0.467 . . . . 0.0 111.321 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 56.0 t -133.23 130.5 57.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.949 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HB3' HG23 ' A' ' 56' ' ' THR . 26.3 t0 -104.05 124.58 49.3 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -95.23 101.41 13.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.302 -174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -119.11 11.84 12.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.121 0.486 . . . . 0.0 110.596 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.43 135.52 26.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.228 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -99.77 141.85 32.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.631 -173.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.5 p -109.17 137.44 47.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.194 0.521 . . . . 0.0 111.445 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.447 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -99.62 -35.79 9.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.393 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 24.2 p -112.43 147.05 36.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.293 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 3.0 Cg_endo -80.43 143.09 15.18 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.417 2.744 . . . . 0.0 111.843 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -161.06 166.68 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.209 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.7 m -73.39 131.43 41.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.502 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.8 173.31 8.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.7 m -123.8 151.76 42.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.442 0.639 . . . . 0.0 111.297 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.448 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 17.9 tt0 -89.81 143.36 26.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.132 173.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -105.77 102.06 11.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.247 0.546 . . . . 0.0 111.067 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.467 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 93.3 t80 -102.14 135.99 42.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.219 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.401 ' OG1' HG22 ' A' ' 143' ' ' VAL . 3.0 m -105.46 122.29 45.7 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.2 m -67.37 126.74 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 140' ' ' PRO . 34.5 mmtp -87.18 -66.06 0.95 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -170.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.2 t -175.12 122.63 0.22 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.88 15.12 81.6 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -172.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.519 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -86.42 118.12 25.64 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.547 -0.827 . . . . 0.0 109.885 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 110' ' ' ILE . 22.7 p -109.03 157.8 18.34 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -55.29 -45.54 76.23 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.579 -174.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.436 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 7.4 m -61.09 -42.45 98.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.709 0.29 . . . . 0.0 110.82 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.36 87.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.341 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 106' ' ' THR . 1.2 pp -76.27 -26.52 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.74 0.305 . . . . 0.0 110.442 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.527 ' OG ' ' HA ' ' A' ' 121' ' ' TYR . 42.5 m -68.37 -46.45 70.05 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-O 121.204 0.526 . . . . 0.0 109.793 169.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -56.38 -30.61 62.93 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.326 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -68.52 -63.3 1.09 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.4 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.404 HG21 HD12 ' A' ' 146' ' ' ILE . 23.5 m -80.0 -40.98 20.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.111 -170.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.425 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 15.7 m-85 -91.27 -49.74 6.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.446 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.95 5.74 32.91 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 120' ' ' LEU . 58.6 t-20 -135.17 113.91 11.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -71.52 -15.59 62.31 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -85.48 -2.87 58.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.04 0.448 . . . . 0.0 110.743 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.443 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . 63.4 mt -89.51 18.65 5.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.061 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HA ' ' OG ' ' A' ' 111' ' ' SER . 47.5 p90 -68.94 -26.14 64.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.084 -174.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -68.93 -36.47 78.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.439 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 120' ' ' LEU . 31.6 mtmt -54.26 -52.76 60.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.328 0.585 . . . . 0.0 110.697 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.406 ' HB ' HD11 ' A' ' 107' ' ' LEU . 32.6 mt -68.75 -39.44 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.747 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.752 ' HA ' HD23 ' A' ' 132' ' ' LEU . 5.5 t80 -59.55 -52.91 63.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.745 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HA ' ' HG3' ' A' ' 129' ' ' LYS . 2.2 mm-40 -60.99 -39.66 90.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.131 0.491 . . . . 0.0 111.507 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -63.85 -28.04 69.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.386 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.541 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 38.9 m-80 -98.99 6.69 46.57 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 20.9 mtmm -78.7 156.2 77.89 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 122.101 -0.374 . . . . 0.0 110.709 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.644 ' HD2' HD13 ' A' ' 40' ' ' ILE . 1.3 Cg_endo -87.73 14.62 46.83 Favored 'Cis proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.994 -1.253 . . . . 0.0 112.478 -3.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.541 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.0 tmm? -64.71 -39.23 93.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 125' ' ' PHE . 35.0 tp -97.33 117.83 32.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.409 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 10.6 mptt -87.51 -33.9 18.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.899 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.456 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 15.1 p -161.8 155.0 17.56 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.137 0.494 . . . . 0.0 109.751 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 12.2 Cg_endo -60.75 -8.14 8.79 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 123.679 2.919 . . . . 0.0 113.117 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -113.72 -14.8 12.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.238 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -87.47 20.16 3.0 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 106' ' ' THR . 8.3 pt -79.06 172.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.2 p90 -154.12 142.05 13.99 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.428 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 139' ' ' TYR . 80.4 Cg_exo -51.07 114.27 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.261 2.641 . . . . 0.0 112.851 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.34 13.91 11.33 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.892 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.538 ' H ' HG22 ' A' ' 101' ' ' VAL . 41.5 tt0 -98.47 120.58 39.14 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.661 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 100' ' ' THR . 42.4 t -82.65 133.18 29.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.281 0.562 . . . . 0.0 109.999 174.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.1 mt -126.2 136.03 52.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.605 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.475 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 2.2 ptm180 -74.49 123.64 25.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.222 0.534 . . . . 0.0 110.026 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 37.0 mm -100.34 102.9 20.13 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.784 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 46.4 Cg_exo -56.77 145.37 83.45 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.377 2.052 . . . . 0.0 111.253 176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.618 -178.426 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 23.9 tp . . . . . 0 N--CA 1.451 -0.375 0 CA-C-O 121.166 0.507 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 82' ' ' SER . 82.8 m-85 -113.03 139.22 48.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.921 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -99.52 155.87 17.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.579 0.228 . . . . 0.0 110.909 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.695 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 94.2 m-85 -134.29 -158.73 0.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.977 0.418 . . . . 0.0 111.429 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.008 HG11 ' HB3' ' A' ' 10' ' ' ALA . 6.3 p -82.3 -23.14 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.462 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.62 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 18.5 tptm 75.82 -61.39 0.47 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.472 0.709 . . . . 0.0 111.891 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.44 -37.94 35.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 1.008 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -81.53 152.6 27.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.737 0.303 . . . . 0.0 110.622 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.25 -178.26 19.4 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.055 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.63 134.52 47.64 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -83.72 89.97 7.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.62 0.724 . . . . 0.0 112.287 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.581 HD22 HD12 ' A' ' 77' ' ' ILE . 6.4 mp . . . . . 0 C--N 1.317 -0.837 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.672 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.653 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 2.9 m-20 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -62.42 -31.83 72.58 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.929 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.77 -35.0 74.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.313 0.578 . . . . 0.0 110.086 174.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -69.28 -38.99 78.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.642 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 75.3 mmtt -53.06 -43.4 66.67 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.556 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 51.7 t -69.73 -36.14 68.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.78 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -59.61 -43.52 93.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.0 mt-10 -57.7 -51.14 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.05 -47.11 53.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.347 177.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 91.6 mt -66.83 -41.95 86.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.192 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -72.13 -32.07 66.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.121 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 14.3 mmmm -72.34 -38.6 68.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 0.0 111.225 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' HG12 ' A' ' 40' ' ' ILE . 2.9 p -74.49 -31.42 62.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.156 0.503 . . . . 0.0 110.91 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.1 30.1 8.07 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.6 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.544 HD13 ' HD2' ' A' ' 130' ' ' PRO . 46.0 mm -59.3 129.01 86.34 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 122.264 0.226 . . . . 0.0 110.504 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -61.46 129.02 26.55 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.541 2.161 . . . . 0.0 112.637 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.16 22.75 10.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.53 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -70.59 -20.04 62.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.207 0.527 . . . . 0.0 110.69 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -78.02 -15.78 58.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.244 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -87.53 -24.58 24.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.9 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 70' ' ' ILE . 28.9 m -98.16 162.94 2.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.276 0.56 . . . . 0.0 111.73 -174.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -126.92 150.49 49.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.328 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 56' ' ' THR . 60.6 mt -128.43 142.66 43.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.799 0.333 . . . . 0.0 111.549 -173.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -130.4 128.67 41.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.454 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 55' ' ' ALA . 40.0 mm -106.1 119.66 55.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.028 0.442 . . . . 0.0 111.45 -175.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.75 79.27 1.2 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.182 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 69.38 -74.49 0.08 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.34 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.65 42.99 1.3 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.49 ' HE2' ' HB2' ' A' ' 84' ' ' ASP . 49.4 tttm -141.98 114.25 8.24 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.505 ' HA ' HD13 ' A' ' 50' ' ' ILE . . . -99.4 96.81 7.96 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.118 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.527 HG23 ' HB3' ' A' ' 84' ' ' ASP . 21.1 m -84.83 112.83 20.89 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.414 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -101.2 131.15 49.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.273 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -130.71 160.57 33.91 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.389 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.59 142.24 3.65 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -122.98 150.72 42.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.947 0.403 . . . . 0.0 110.397 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.28 12.28 54.74 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.051 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.23 175.55 10.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.403 . . . . 0.0 111.768 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.7 p -127.05 144.98 50.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 172.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -46.74 -45.31 19.58 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 9.6 tp10 -61.14 -47.5 85.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.466 -174.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.33 -39.3 65.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.408 0.623 . . . . 0.0 110.315 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -52.34 -47.75 65.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.872 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -76.89 -20.2 56.53 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.548 -174.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 35.3 mmtm -62.26 -38.82 90.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.456 HG21 HG21 ' A' ' 46' ' ' VAL . 28.4 mt -70.7 -58.51 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.421 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 mp -43.67 -48.25 7.8 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.35 -28.86 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.928 0.394 . . . . 0.0 111.439 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.86 -26.22 22.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -82.43 -23.71 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 110.835 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.695 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -81.4 -29.81 39.04 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.929 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -81.1 53.8 2.09 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.163 0.506 . . . . 0.0 111.232 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.581 HD12 HD22 ' A' ' 14' ' ' LEU . 26.1 mm -117.77 134.76 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -68.73 99.5 1.03 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.96 -14.71 5.7 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.299 -172.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 21.9 mm -98.4 122.67 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.314 0.578 . . . . 0.0 111.315 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -102.62 -14.73 16.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.705 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 25.8 p -160.26 158.31 29.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 112.413 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.524 HG12 ' CE2' ' A' ' 6' ' ' PHE . 7.5 p -126.74 133.02 69.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.231 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.7 t70 -107.6 95.48 5.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.39 107.57 5.76 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.375 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -115.13 22.21 13.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.218 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -83.26 131.32 34.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.962 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -105.29 129.01 53.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.405 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 p -97.45 136.44 37.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.485 0.66 . . . . 0.0 112.153 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.65 -44.16 10.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.937 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.7 p -114.43 137.73 22.75 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.588 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.59 152.91 29.99 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.61 2.207 . . . . 0.0 111.719 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.404 ' HB3' ' H ' ' A' ' 65' ' ' GLU . . . -157.14 -174.1 4.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.419 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.0 m -64.3 132.55 50.53 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.368 0.418 . . . . 0.0 111.109 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.22 169.19 8.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.648 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.5 p -143.65 155.34 44.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.543 0.687 . . . . 0.0 112.105 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.494 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.4 tt0 -86.23 141.58 29.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.48 173.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -101.59 101.73 12.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.963 0.411 . . . . 0.0 110.853 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 113' ' ' GLN . 93.6 t80 -107.07 141.16 38.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.547 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 4.6 m -104.19 122.41 45.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.183 177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.494 HG22 ' H ' ' A' ' 142' ' ' GLN . 2.8 m -67.22 140.03 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.46 -162.19 0.93 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.112 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.2 t -56.62 -31.4 64.27 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 123.123 0.264 . . . . 0.0 111.219 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.28 49.23 2.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.155 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -64.92 109.24 2.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.44 1.114 . . . . 0.0 112.117 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 110' ' ' ILE . 86.4 m -151.39 129.24 11.66 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.616 170.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 15.2 mt -51.03 -48.74 61.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.878 0.763 . . . . 0.0 111.333 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 p -58.48 -37.61 75.88 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.297 0.373 . . . . 0.0 111.152 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.68 -50.63 49.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -74.17 -23.81 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.575 -176.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.6 t -69.78 -46.29 66.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 61.7 tttm -60.88 -28.04 68.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.619 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.598 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 2.6 tp-100 -66.2 -64.18 0.91 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.21 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.8 m -78.23 -44.67 27.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.558 -170.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.435 ' N ' HG23 ' A' ' 114' ' ' VAL . 63.8 m-85 -81.61 -46.37 14.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.67 0.747 . . . . 0.0 110.343 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.94 -6.28 32.68 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.567 -170.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -127.98 131.34 49.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.221 -0.489 . . . . 0.0 110.161 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . . . -84.77 0.97 48.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.991 0.424 . . . . 0.0 110.717 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -93.68 0.09 56.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.739 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.76 21.18 17.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.377 0.608 . . . . 0.0 110.875 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 44.0 p90 -61.51 -32.33 72.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.479 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -79.27 -22.37 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.824 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -60.48 -48.75 80.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.373 0.606 . . . . 0.0 110.13 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.43 HD13 HD11 ' A' ' 110' ' ' ILE . 50.1 mt -63.83 -49.9 79.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.094 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -46.3 -53.34 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.806 0.691 . . . . 0.0 111.083 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.565 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 7.7 mm-40 -65.24 -29.36 70.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.621 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.443 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -77.2 -19.1 57.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.043 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.498 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 5.3 m120 -95.05 -2.1 50.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.511 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.565 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 6.5 mmmm -68.6 145.88 97.34 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.544 ' HD2' HD13 ' A' ' 40' ' ' ILE . 66.6 Cg_endo -96.36 22.97 25.96 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 124.059 -1.226 . . . . 0.0 112.027 -7.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.498 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 1.7 tmm? -70.81 -35.81 72.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.529 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.9 tp -90.33 119.31 30.53 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -77.96 -45.65 23.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.616 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -154.66 157.32 32.09 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.39 -51.89 9.84 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 C-N-CA 123.29 2.66 . . . . 0.0 112.83 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.06 6.49 18.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.407 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -98.93 15.22 26.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.639 0.257 . . . . 0.0 111.332 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.511 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 9.6 pt -78.0 175.55 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -159.63 144.25 11.17 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -52.3 112.31 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.277 2.651 . . . . 0.0 112.312 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 117.61 0.16 18.03 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.167 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.511 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 39.5 tt0 -88.28 122.78 32.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.965 0.412 . . . . 0.0 110.354 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 37.6 t -83.33 133.6 28.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.999 173.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 70.2 mt -124.02 151.04 44.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.284 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.473 ' H ' ' ND2' ' A' ' 128' ' ' ASN . 58.0 mtp180 -80.07 122.82 27.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.229 177.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 25.4 mm -109.23 97.29 25.12 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.228 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.02 148.77 35.64 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.084 1.856 . . . . 0.0 111.312 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.532 -178.369 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.7 tp . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.46 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 86.7 m-85 -105.52 118.02 35.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.803 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -89.83 150.0 22.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.071 0.463 . . . . 0.0 111.351 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.66 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 74.8 m-85 -132.08 -156.72 0.77 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.928 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.054 HG11 ' HB3' ' A' ' 10' ' ' ALA . 5.7 p -88.6 -22.01 6.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.038 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.81 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 23.8 tptm 75.99 -57.84 0.56 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.549 0.739 . . . . 0.0 111.513 -175.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.58 -53.49 11.76 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.029 0.442 . . . . 0.0 111.726 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 1.054 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -73.31 146.24 45.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.126 -175.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.75 -167.73 29.29 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -72.03 124.79 25.69 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -73.01 83.13 1.25 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.456 HD21 ' O ' ' A' ' 30' ' ' LYS . 20.1 tp . . . . . 0 N--CA 1.436 -1.164 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.87 -170.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.092 0.472 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.592 ' O ' HG23 ' A' ' 31' ' ' VAL . 54.9 mt-30 -64.74 -32.87 74.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.301 173.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.01 85.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.119 0.485 . . . . 0.0 110.416 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -64.18 -44.09 93.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.52 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -52.93 -44.74 67.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.689 175.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 27' ' ' GLN . 82.1 t -58.59 -48.92 84.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.303 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.405 ' HG2' HD13 ' A' ' 48' ' ' ILE . 26.6 mt-30 -63.92 -40.79 97.28 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.282 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 40.7 mt-10 -58.86 -46.29 88.09 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 65.7 t60 -52.7 -44.9 66.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.866 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 99.0 mt -66.08 -39.75 90.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.248 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -74.17 -39.35 63.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.228 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 62.2 mtpt -64.43 -44.54 90.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.016 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.7 p -66.05 -51.05 61.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.166 0.508 . . . . 0.0 110.037 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.71 30.54 1.98 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.928 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.473 HD11 ' HB2' ' A' ' 131' ' ' MET . 27.4 mm -67.19 120.69 74.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.57 142.64 84.99 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.369 2.046 . . . . 0.0 112.961 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 58.54 25.47 13.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.473 -1.239 . . . . 0.0 112.645 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.51 -15.9 63.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.406 0.622 . . . . 0.0 110.14 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -86.61 -8.0 57.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.684 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -97.41 -8.81 28.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.738 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.84 172.1 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.317 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.69 131.19 25.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.458 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 56' ' ' THR . 4.1 mp -108.04 141.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.793 0.33 . . . . 0.0 110.794 -176.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -134.54 123.91 24.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.756 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mm -87.16 120.79 37.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.442 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -127.73 81.5 2.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.756 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 49.75 64.59 1.7 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.776 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.26 -26.53 14.88 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.54 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.449 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 30.8 mttp -90.06 114.16 26.01 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.152 0.501 . . . . 0.0 111.468 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 83' ' ' VAL . . . -89.49 94.68 9.97 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.221 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 21.1 m -77.55 125.9 30.05 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG22 HG13 ' A' ' 48' ' ' ILE . 42.8 t -119.01 109.68 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.127 0.489 . . . . 0.0 111.18 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.7 m -102.67 166.63 10.4 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.911 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 88' ' ' LYS . . . 168.44 170.5 33.21 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.475 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -155.89 138.71 15.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.065 0.46 . . . . 0.0 110.151 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 93.53 3.55 64.62 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.91 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.59 -177.14 2.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.333 0.587 . . . . 0.0 111.994 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.7 p -132.04 157.8 43.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.105 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -47.91 -41.77 25.44 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 123.165 0.291 . . . . 0.0 111.05 176.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.461 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 49.9 mm-40 -55.92 -64.87 0.72 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.515 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.78 95.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.169 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.664 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 49.1 tttm -50.09 -63.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.891 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 72' ' ' VAL . 5.6 mm-40 -64.67 -35.01 79.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.158 0.504 . . . . 0.0 110.489 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -62.24 -45.35 93.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.81 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.404 ' O ' HG13 ' A' ' 74' ' ' VAL . 53.8 mt -62.2 -51.91 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.997 175.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 78.6 mt -47.44 -42.23 21.95 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.889 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 68' ' ' GLU . 62.0 t -67.25 -51.85 48.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.401 0.62 . . . . 0.0 110.739 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.22 72.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.222 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 70' ' ' ILE . 15.3 m -81.37 -32.68 12.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.875 0.369 . . . . 0.0 110.788 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.66 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -70.66 -26.2 74.46 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.676 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -85.14 47.21 1.37 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.766 0.317 . . . . 0.0 111.341 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.8 mt -120.45 141.19 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 120.846 0.355 . . . . 0.0 110.478 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -66.26 105.3 1.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.216 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.89 -2.75 9.96 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.774 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.1 mm -106.24 117.79 52.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.579 0.704 . . . . 0.0 111.126 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.81 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -91.98 -27.51 17.8 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.229 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.449 ' OG ' ' HG2' ' A' ' 54' ' ' LYS . 5.5 p -164.48 161.06 21.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.184 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 55' ' ' ALA . 4.3 p -119.77 124.1 72.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.611 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -94.68 103.08 15.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.24 119.06 19.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.866 -174.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -127.22 28.64 5.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.854 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.48 123.81 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.209 0.528 . . . . 0.0 111.351 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 59' ' ' GLY . 13.9 tptm -90.23 124.66 35.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.265 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 p -100.02 135.06 42.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.199 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.433 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -106.12 -23.93 12.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.58 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.447 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 67.4 p -123.58 138.75 30.77 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.52 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 2.1 Cg_endo -80.96 158.88 20.92 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.181 2.588 . . . . 0.0 112.788 -176.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -161.84 -176.84 5.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.168 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.3 m -82.42 125.02 30.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HA ' ' CD ' ' A' ' 64' ' ' GLN . . . -73.24 145.48 46.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -123.96 172.09 9.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.388 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -106.66 153.88 21.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.784 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -111.63 116.98 31.69 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.407 ' CZ ' ' HG2' ' A' ' 113' ' ' GLN . 88.3 t80 -123.52 142.43 51.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.588 0.232 . . . . 0.0 110.4 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 2.5 m -104.1 124.28 48.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.361 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 142' ' ' GLN . 2.8 m -68.09 134.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -98.36 -177.19 3.62 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.143 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 p -61.9 116.21 4.68 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.15 25.75 5.99 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -169.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.562 ' OD2' HG13 ' A' ' 138' ' ' ILE . 10.4 p-10 -53.94 118.91 4.37 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.218 1.009 . . . . 0.0 111.768 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 110' ' ' ILE . 92.6 m -144.35 127.37 16.49 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 125' ' ' PHE . 22.9 tp -63.15 -31.09 72.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.255 -170.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 p -75.71 -26.95 57.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.371 0.605 . . . . 0.0 110.152 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.431 ' CB ' ' HB ' ' A' ' 106' ' ' THR . . . -75.77 -44.22 42.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.851 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.609 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.3 pp -78.35 -24.28 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.394 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.2 p -72.7 -45.33 59.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.95 0.405 . . . . 0.0 109.993 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -64.26 -18.48 64.6 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.277 0.561 . . . . 0.0 110.231 174.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.609 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 5.4 tp-100 -72.66 -60.98 1.97 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.859 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 115' ' ' TYR . 30.8 m -78.01 -48.52 23.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.072 -172.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.496 ' HB3' HD12 ' A' ' 120' ' ' LEU . 83.4 m-85 -84.12 -36.21 23.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.327 0.584 . . . . 0.0 110.822 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 -2.54 56.74 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.096 -173.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.435 HD21 ' HB3' ' A' ' 119' ' ' ASN . 33.0 t30 -134.67 125.27 26.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.577 -0.311 . . . . 0.0 110.399 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.427 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -74.66 -22.78 58.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.56 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.435 ' HB3' HD21 ' A' ' 117' ' ' ASN . 7.9 t30 -63.78 -21.42 66.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.898 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 115' ' ' TYR . 63.3 mt -85.83 15.8 4.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.498 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.459 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 35.2 p90 -62.0 -35.84 79.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.284 0.564 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.401 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 8.4 t30 -65.72 -33.07 75.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.676 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -57.0 -49.26 76.32 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.442 0.639 . . . . 0.0 109.67 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.506 HG22 ' OD1' ' A' ' 128' ' ' ASN . 27.7 mt -67.73 -43.98 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.896 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.594 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 43.2 t80 -53.54 -56.33 18.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.854 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 19.2 mt-10 -65.42 -25.81 67.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.559 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.39 -34.9 31.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.061 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 124' ' ' ILE . 7.8 m120 -74.6 -30.54 61.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 7.2 mtpm? -57.25 148.41 52.73 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.559 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -87.78 8.74 64.56 Favored 'Cis proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.291 -1.545 . . . . 0.0 113.256 1.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.477 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -62.97 -39.98 96.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.108 0.48 . . . . 0.0 109.826 175.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.14 125.99 37.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -95.98 -36.64 10.98 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.447 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 19.7 m -150.79 153.2 33.31 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.063 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.442 ' HA ' HD22 ' A' ' 107' ' ' LEU . 74.1 Cg_exo -50.5 -54.12 5.99 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 C-N-CA 123.318 2.679 . . . . 0.0 113.054 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -84.52 7.36 20.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.55 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 37.1 mmtm -92.13 4.59 52.84 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.751 0.31 . . . . 0.0 111.802 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.562 HG13 ' OD2' ' A' ' 105' ' ' ASP . 11.6 pt -67.71 173.72 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.517 171.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 6.6 p90 -158.59 141.93 10.87 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.604 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 139' ' ' TYR . 71.9 Cg_exo -50.75 117.11 3.02 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.374 2.716 . . . . 0.0 112.858 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.12 4.03 24.23 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.03 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.475 ' H ' HG22 ' A' ' 101' ' ' VAL . 34.3 tt0 -93.0 116.38 29.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.348 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 37.1 t -79.71 134.66 27.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.7 mt -123.51 143.43 50.19 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.091 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.551 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 34.8 ttt180 -74.64 109.79 8.4 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.96 105.61 14.3 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.701 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 32.0 Cg_exo -59.12 164.44 10.33 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.722 2.281 . . . . 0.0 111.907 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--N 1.321 -0.667 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.525 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.6 tp . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 121.356 0.598 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.65 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 56.5 m-85 -106.76 131.56 53.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.608 -176.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.33 136.77 41.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.453 0.644 . . . . 0.0 112.252 -171.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.621 ' HE1' HG12 ' A' ' 83' ' ' VAL . 31.4 m-85 -123.03 -166.0 1.39 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.48 176.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 57.2 t -81.25 -81.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.98 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtt? 160.68 -74.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.91 -30.56 69.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.098 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.17 126.24 30.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.885 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.93 -178.26 31.73 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.02 125.83 25.32 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -74.67 69.24 1.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.975 0.893 . . . . 0.0 109.16 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD21 ' O ' ' A' ' 30' ' ' LYS . 19.4 tp . . . . . 0 N--CA 1.439 -0.999 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.214 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.531 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 2.1 m-20 . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.626 0.25 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.607 ' HB2' HG13 ' A' ' 50' ' ' ILE . 6.6 mm100 -75.88 -41.22 52.77 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -176.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.11 62.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.76 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 24.7 ttmm -67.1 -49.13 66.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.14 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 14.0 mptt -58.28 -41.51 84.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.673 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 27' ' ' GLN . 93.9 t -60.71 -43.46 95.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.731 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -58.13 -47.04 84.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.699 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 39.8 mt-10 -58.22 -47.17 84.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.065 176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -51.67 -49.9 61.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.094 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 98.2 mt -63.58 -38.72 92.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.333 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -79.85 -33.14 40.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.549 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -71.65 -30.56 65.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.662 0.268 . . . . 0.0 110.908 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 p -80.18 -40.42 27.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.039 0.447 . . . . 0.0 110.547 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.07 26.81 5.35 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.248 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.459 HD13 ' HD2' ' A' ' 130' ' ' PRO . 35.9 mm -61.71 132.25 93.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 110.467 -0.198 . . . . 0.0 110.467 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 11.9 Cg_exo -65.31 130.97 26.79 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.429 2.086 . . . . 0.0 112.819 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 59.44 29.56 19.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.819 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.87 -26.52 68.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.777 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -75.32 -26.06 58.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.733 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -74.07 -22.03 59.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.684 -174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.404 HG21 HG21 ' A' ' 70' ' ' ILE . 23.5 m -100.76 162.39 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.563 0.697 . . . . 0.0 111.816 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -128.83 129.76 46.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.878 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.74 133.73 46.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.963 0.411 . . . . 0.0 110.914 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -119.69 122.06 40.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.52 173.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.607 HG13 ' HB2' ' A' ' 27' ' ' GLN . 30.5 mm -97.59 108.36 21.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.212 0.529 . . . . 0.0 110.868 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.21 66.2 0.65 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.798 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 55.94 77.82 0.22 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.653 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.07 -18.24 32.84 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.219 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 82' ' ' SER . 28.0 ttpp -108.37 116.5 32.08 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.153 -0.616 . . . . 0.0 110.702 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.27 101.34 13.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.933 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 84' ' ' ASP . 14.4 m -85.18 124.95 32.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.237 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.95 110.77 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 120.982 0.42 . . . . 0.0 111.436 -175.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.444 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -97.92 157.49 16.07 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.889 177.121 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 87' ' ' VAL . . . 163.1 165.98 21.13 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.432 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -148.37 143.01 26.54 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.916 0.389 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 83.68 37.75 11.49 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.964 176.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.62 165.51 12.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.802 0.334 . . . . 0.0 110.961 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -93.57 160.65 14.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.998 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.575 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 7.6 tp60 -53.54 -58.0 8.71 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.222 0.326 . . . . 0.0 111.76 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.413 ' HG2' HH12 ' A' ' 145' ' ' ARG . 27.1 mt-10 -58.24 -46.78 85.32 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.23 76.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.113 0.482 . . . . 0.0 110.09 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 68.3 tttt -57.4 -46.33 83.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.528 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 72' ' ' VAL . 75.5 mt-10 -60.71 -47.53 85.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.653 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -55.8 -40.05 72.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.755 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.404 HG21 HG21 ' A' ' 46' ' ' VAL . 58.6 mt -63.03 -57.84 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.339 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 98.6 mt -48.03 -45.53 32.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.099 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 68' ' ' GLU . 30.9 t -68.64 -49.17 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.156 0.503 . . . . 0.0 110.593 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.41 74.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.486 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.14 -33.48 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.842 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.586 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -70.88 -35.4 65.55 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.247 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.05 38.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.801 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.5 mt -110.42 139.99 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.7 t -65.6 120.21 12.52 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.54 -22.93 11.49 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.506 HG21 ' HA2' ' A' ' 75' ' ' GLY . 45.8 mm -97.37 136.95 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.398 0.618 . . . . 0.0 110.196 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -126.45 -9.51 6.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.739 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 1.8 p -160.06 150.56 18.71 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.65 ' CG1' ' HB2' ' A' ' 4' ' ' PHE . 7.2 p -122.97 132.74 70.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.416 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.9 t0 -111.29 110.99 21.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -78.24 123.21 26.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.993 -173.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 77.7 mm-40 -131.25 8.32 4.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.846 174.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 1.7 p -96.11 126.58 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.265 0.555 . . . . 0.0 111.17 -176.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -85.51 149.26 25.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.932 -176.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.2 p -104.37 121.29 43.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.926 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.481 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -84.99 -41.87 15.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.027 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 p -117.19 127.36 26.75 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.799 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.82 153.08 13.12 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.77 2.313 . . . . 0.0 112.822 -175.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -148.68 -161.14 1.28 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.506 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.4 m -76.04 127.81 33.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.929 0.395 . . . . 0.0 110.305 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.85 128.11 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.898 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.9 m -103.65 153.32 20.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.348 0.594 . . . . 0.0 111.84 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 8.6 tt0 -87.05 155.66 20.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.324 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -116.2 98.69 6.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.242 0.544 . . . . 0.0 110.517 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 78.8 t80 -101.49 136.33 41.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.553 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.432 ' OG1' HG22 ' A' ' 143' ' ' VAL . 5.4 m -102.09 126.93 49.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.557 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 142' ' ' GLN . 3.3 m -73.56 141.52 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -91.83 -165.56 1.38 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.931 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.3 m -62.38 -31.46 72.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.814 0.34 . . . . 0.0 111.091 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -96.37 44.8 1.95 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.651 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.441 ' OD2' HG13 ' A' ' 138' ' ' ILE . 7.8 p-10 -56.37 120.81 8.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 122.007 0.908 . . . . 0.0 112.137 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 110' ' ' ILE . 53.4 m -143.71 126.11 15.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 168.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 40.6 tp -61.1 -28.1 68.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.714 0.293 . . . . 0.0 110.765 -174.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.481 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 9.6 m -76.24 -29.87 57.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.302 0.572 . . . . 0.0 110.274 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.406 ' CB ' ' HB ' ' A' ' 106' ' ' THR . . . -75.0 -44.86 45.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.802 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.1 pp -76.5 -21.58 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.976 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.2 p -77.05 -43.92 32.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.89 -23.28 63.33 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.317 0.58 . . . . 0.0 110.156 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -70.02 -61.93 1.58 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.142 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.6 m -82.86 -39.51 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.376 -169.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.416 ' HB3' HD12 ' A' ' 120' ' ' LEU . 40.9 m-85 -91.38 -36.17 13.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.62 -3.91 53.62 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.264 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -131.76 129.21 40.28 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -81.46 -13.7 57.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.495 -176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.27 -18.14 55.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.381 0.61 . . . . 0.0 110.183 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 115' ' ' TYR . 64.8 mt -84.39 21.06 1.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.211 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.487 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 41.9 p90 -65.74 -33.41 75.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.566 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 7.9 p30 -68.11 -28.47 67.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.946 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' A' ' 123' ' ' LYS . 29.5 mmmt -59.74 -49.69 76.76 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.337 0.589 . . . . 0.0 110.163 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.1 mt -65.82 -44.82 92.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.868 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.465 ' HB2' HD21 ' A' ' 107' ' ' LEU . 50.8 t80 -48.98 -56.73 8.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.171 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.576 ' HA ' ' HG2' ' A' ' 129' ' ' LYS . 29.5 mt-10 -68.43 -21.19 64.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.944 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.88 -23.39 36.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.063 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.494 ' OD1' HD22 ' A' ' 144' ' ' LEU . 7.6 m120 -88.3 -3.26 58.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.936 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.576 ' HG2' ' HA ' ' A' ' 126' ' ' GLU . 28.0 mmmt -72.07 148.52 91.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HD2' HD13 ' A' ' 40' ' ' ILE . 72.1 Cg_endo -95.98 31.9 11.79 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.636 -1.401 . . . . 0.0 112.409 -2.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.47 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -84.87 -33.84 22.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.072 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.01 120.98 33.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.451 0.643 . . . . 0.0 110.578 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -67.24 -62.5 1.39 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.066 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.446 ' H ' ' HB2' ' A' ' 137' ' ' LYS . 26.5 m -145.66 161.05 42.35 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.345 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 134' ' ' SER . 78.3 Cg_exo -52.24 -41.49 65.56 Favored 'Trans proline' 0 C--N 1.332 -0.303 0 C-N-CA 123.216 2.611 . . . . 0.0 112.426 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.7 19.91 7.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.446 ' HB2' ' H ' ' A' ' 134' ' ' SER . 3.0 mmpt? -107.03 11.73 29.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.874 0.368 . . . . 0.0 111.335 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.441 HG13 ' OD2' ' A' ' 105' ' ' ASP . 15.0 pt -73.88 172.95 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.11 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -166.46 149.62 6.42 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -175.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.44 110.91 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.092 2.528 . . . . 0.0 112.515 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.88 4.68 26.01 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.522 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.488 ' H ' HG22 ' A' ' 101' ' ' VAL . 7.4 tp60 -82.37 112.27 19.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.713 0.292 . . . . 0.0 110.377 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.462 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 26.8 t -82.97 134.15 27.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.494 HD22 ' OD1' ' A' ' 128' ' ' ASN . 77.7 mt -121.29 144.0 48.86 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.068 0.461 . . . . 0.0 111.112 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 27.4 ttp85 -75.01 108.03 7.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.266 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 30.9 mm -99.02 103.04 17.38 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.57 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 20.9 Cg_exo -63.78 146.99 92.55 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.126 1.884 . . . . 0.0 111.382 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--N 1.321 -0.656 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.676 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 CA--C 1.509 -0.607 0 CA-C-O 121.627 0.727 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.581 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 87.0 m-85 -111.97 125.58 54.22 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.447 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -93.12 136.44 33.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.433 0.635 . . . . 0.0 111.839 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.564 ' HE1' HG12 ' A' ' 83' ' ' VAL . 32.7 m-85 -126.1 -167.47 1.71 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.858 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.5 t -116.0 113.81 44.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.815 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 19.2 ptmt -59.85 -29.03 68.01 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -171.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.97 -10.09 58.96 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.04 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.13 122.18 46.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.124 0.488 . . . . 0.0 111.222 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 157.76 179.18 32.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.972 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.17 132.91 48.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -86.53 80.36 8.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.188 0.518 . . . . 0.0 111.801 -173.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 34' ' ' HIS . 7.1 mp . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.244 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.2 p-10 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.63 0.252 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 31' ' ' VAL . 53.2 mt-30 -61.95 -45.77 92.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.348 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.62 71.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.805 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -70.52 -36.21 73.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.185 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 30.1 mmmt -62.7 -43.28 99.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.338 174.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 27' ' ' GLN . 72.6 t -62.59 -39.5 84.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.815 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -57.31 -43.9 83.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.592 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.35 -48.94 78.96 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.9 0.381 . . . . 0.0 110.579 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.502 ' HB2' HD21 ' A' ' 14' ' ' LEU . 58.5 t60 -52.51 -43.17 64.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.369 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.21 -39.71 65.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.471 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -82.19 -31.26 30.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.777 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -75.05 -23.45 58.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.608 0.242 . . . . 0.0 111.376 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 p -86.06 -39.08 17.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.232 0.539 . . . . 0.0 110.439 174.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.61 33.81 3.75 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.96 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.28 124.72 88.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.99 144.87 65.76 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.845 1.696 . . . . 0.0 112.379 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.557 ' HB3' HD22 ' A' ' 62' ' ' LEU . 12.0 m-20 65.9 3.41 2.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.419 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.55 -16.23 61.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.401 0.62 . . . . 0.0 110.518 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.66 -18.31 59.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.018 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -103.25 -0.6 30.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.531 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 70' ' ' ILE . 30.7 m -103.02 171.13 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.181 0.515 . . . . 0.0 111.593 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -134.73 125.11 26.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.866 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.0 135.73 37.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.278 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.478 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 48.2 tt0 -127.7 125.33 39.83 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 27' ' ' GLN . 21.5 mm -97.26 134.86 33.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.893 0.378 . . . . 0.0 110.595 -177.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.39 50.96 2.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.375 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 63.1 93.23 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.788 0.68 . . . . 0.0 111.483 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 78.41 -23.47 2.84 Favored Glycine 0 CA--C 1.517 0.176 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.585 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 0.8 OUTLIER -109.68 115.14 29.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -101.48 120.17 39.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.315 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.528 ' OG1' ' HE3' ' A' ' 54' ' ' LYS . 49.2 m -90.72 132.86 35.56 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.309 -0.244 . . . . 0.0 110.528 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.99 119.96 61.82 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.347 0.594 . . . . 0.0 110.396 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -117.62 162.24 18.34 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.226 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.85 156.87 8.21 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -138.54 144.83 40.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.912 0.387 . . . . 0.0 110.509 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 88.36 22.69 39.82 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.48 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.557 HD22 ' HB3' ' A' ' 42' ' ' ASP . 8.6 mt -100.08 -166.85 1.38 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.238 0.542 . . . . 0.0 109.952 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.4 p -125.73 168.26 14.03 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.923 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.675 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -63.22 -43.34 98.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.843 0.354 . . . . 0.0 110.522 -178.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.489 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 42.7 tt0 -64.46 -42.82 95.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.622 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.42 -46.95 83.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.454 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 12.9 ptmm? -59.62 -37.34 78.35 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.915 -175.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 72' ' ' VAL . 85.9 mt-10 -64.75 -48.17 75.55 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.719 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 28.6 mtpp -54.22 -41.01 68.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.676 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.618 HD13 HG11 ' A' ' 46' ' ' VAL . 29.7 mt -71.38 -53.93 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.691 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 96.3 mt -48.95 -47.31 43.97 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.656 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 68' ' ' GLU . 70.0 t -65.37 -45.78 92.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.389 0.614 . . . . 0.0 110.647 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.471 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -61.72 -39.24 90.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.358 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 m -78.18 -31.21 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.718 0.294 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' HA2' HG21 ' A' ' 80' ' ' ILE . . . -69.6 -36.79 76.81 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.301 175.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -80.24 50.02 1.2 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.321 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.473 HD13 HD22 ' A' ' 14' ' ' LEU . 96.8 mt -119.04 143.34 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 120.946 0.403 . . . . 0.0 110.387 173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -67.66 115.11 6.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.461 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 111.29 -13.17 28.42 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.131 -172.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 50.6 mm -105.96 132.89 51.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.896 0.379 . . . . 0.0 110.684 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.815 ' HB2' ' HB3' ' A' ' 8' ' ' LYS . . . -131.29 -5.49 3.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.421 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 2.7 p -156.2 154.34 30.63 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.193 0.52 . . . . 0.0 111.317 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.6 p -134.4 134.6 54.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.034 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.71 113.68 27.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -83.09 111.06 18.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.474 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -123.47 29.02 6.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.483 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.483 ' CG1' HD12 ' A' ' 62' ' ' LEU . 77.4 t -82.45 139.9 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.508 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -105.14 137.71 42.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.047 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.4 p -108.89 130.27 55.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.419 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.455 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -97.31 -29.46 13.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.104 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.7 p -127.27 140.29 37.51 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.707 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.04 153.47 25.08 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.754 2.303 . . . . 0.0 111.774 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.489 ' HB3' ' H ' ' A' ' 65' ' ' GLU . . . -159.58 -172.77 3.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.99 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.2 m -61.78 149.2 40.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.348 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.89 138.53 51.08 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.732 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.5 m -120.18 149.41 42.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.217 0.532 . . . . 0.0 111.709 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 8.8 tt0 -84.16 153.01 23.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.019 173.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -110.67 96.17 6.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 0.0 111.167 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -95.3 136.07 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.861 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.435 ' OG1' HG22 ' A' ' 143' ' ' VAL . 18.4 m -106.83 124.0 48.97 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 142' ' ' GLN . 0.8 OUTLIER -67.45 134.05 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 72.0 mmtt -86.67 -72.39 0.51 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.376 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 t -175.08 115.5 0.16 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -175.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.01 -3.81 85.71 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -171.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 1.0 OUTLIER -63.71 113.94 3.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.2 -1.0 . . . . 0.0 110.829 178.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 110' ' ' ILE . 40.0 p -104.97 158.28 16.65 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.664 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -57.37 -45.91 83.94 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.356 -172.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.575 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 17.2 m -65.47 -35.16 80.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.75 0.309 . . . . 0.0 110.588 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.98 77.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.106 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.584 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.5 pp -75.6 -29.68 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 120.833 0.349 . . . . 0.0 110.495 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.2 t -65.16 -45.69 83.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.232 0.539 . . . . 0.0 109.627 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -62.88 -30.33 71.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.455 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.5 OUTLIER -64.41 -62.86 1.34 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.229 176.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 115' ' ' TYR . 34.2 m -77.21 -46.23 28.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.262 -170.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.699 ' CE2' ' HD2' ' A' ' 123' ' ' LYS . 15.8 m-85 -88.14 -50.46 6.36 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 120.5 -19.88 9.02 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -111.23 128.32 55.89 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.575 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -81.56 -8.59 59.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.981 0.42 . . . . 0.0 110.247 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -80.25 -12.3 59.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.395 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.483 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 55.7 mt -87.16 11.53 13.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.459 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 51.0 p90 -58.05 -30.78 66.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.196 0.522 . . . . 0.0 110.51 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.455 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 26.9 p-10 -76.27 -32.71 58.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.171 -176.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.699 ' HD2' ' CE2' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -71.81 -24.31 61.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mt -83.99 -41.97 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.65 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.567 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 40.9 t80 -53.66 -59.76 4.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.359 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 30.2 mt-10 -60.6 -36.11 77.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.152 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.73 -32.34 73.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.045 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.523 ' O ' ' HB3' ' A' ' 131' ' ' MET . 40.8 m-80 -90.01 -8.15 52.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.939 0.399 . . . . 0.0 110.866 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 132' ' ' LEU . 30.4 mtpp -74.11 156.67 87.56 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.531 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -84.28 14.82 35.48 Favored 'Cis proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.383 -1.507 . . . . 0.0 113.365 -0.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.523 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 4.2 tmm? -67.31 -38.5 85.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.175 0.512 . . . . 0.0 109.75 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.637 ' O ' ' HG2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -90.9 111.69 23.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -74.29 -60.34 2.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.335 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 16.3 m -137.96 155.62 74.55 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 134' ' ' SER . 25.8 Cg_exo -63.09 -23.64 73.45 Favored 'Trans proline' 0 CA--C 1.522 -0.097 0 C-N-CA 123.655 2.903 . . . . 0.0 113.134 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -99.67 4.87 45.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.952 0.406 . . . . 0.0 110.668 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 134' ' ' SER . 27.3 mmmt -90.62 -0.77 57.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.756 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.407 HD11 ' HA ' ' A' ' 106' ' ' THR . 21.4 pt -64.56 166.13 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.046 0.451 . . . . 0.0 110.833 174.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -155.24 144.65 15.25 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.917 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -54.29 116.39 3.03 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.332 2.688 . . . . 0.0 112.71 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.46 14.52 14.22 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.202 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.57 ' O ' HG13 ' A' ' 101' ' ' VAL . 65.0 tt0 -99.78 130.83 46.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.899 0.381 . . . . 0.0 110.322 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 42.5 t -85.63 130.57 36.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.269 0.557 . . . . 0.0 109.957 174.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.0 mt -118.81 134.76 54.93 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.733 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.521 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 51.8 mtp180 -65.87 120.34 12.88 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.325 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 35.2 mm -111.46 82.65 3.74 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 31.9 Cg_exo -62.79 170.17 7.62 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.825 2.35 . . . . 0.0 112.215 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.64 174.283 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.1 tp . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -121.39 133.62 55.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.329 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.71 146.88 24.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.756 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CD2' HG21 ' A' ' 143' ' ' VAL . 77.2 m-85 -128.23 -157.95 0.85 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.073 -176.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.667 HG21 ' HB3' ' A' ' 10' ' ' ALA . 22.8 m -83.73 -26.76 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 24.4 tptp 72.51 -53.37 0.7 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.248 0.619 . . . . 0.0 111.479 -174.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.39 -49.34 8.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.857 0.36 . . . . 0.0 111.831 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.667 ' HB3' HG21 ' A' ' 7' ' ' VAL . . . -76.21 -169.18 1.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.45 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.36 -160.02 19.2 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -76.82 127.1 32.12 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -74.64 63.42 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.017 0.913 . . . . 0.0 109.019 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 77' ' ' ILE . 11.8 tp . . . . . 0 N--CA 1.436 -1.153 0 CA-C-N 113.793 -1.548 . . . . 0.0 110.491 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.526 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 20.4 t70 . . . . . 0 CA--C 1.521 -0.161 0 CA-C-O 121.065 0.46 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -61.57 -45.12 95.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.973 174.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.71 84.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.603 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 51.6 tttp -60.67 -43.42 97.68 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.48 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 43.5 mmtt -62.66 -38.77 91.64 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.373 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.615 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 73.5 t -66.09 -42.92 92.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.267 176.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -55.44 -51.54 66.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 38.6 mt-10 -56.85 -46.92 81.42 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.255 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -52.59 -48.15 66.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.044 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 88.6 mt -65.81 -41.9 91.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.927 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -69.03 -41.77 77.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.347 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 99.3 mttt -65.17 -42.81 93.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.512 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 p -72.43 -40.64 66.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 111.141 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.01 32.67 2.99 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.234 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.445 HD13 ' HD2' ' A' ' 130' ' ' PRO . 26.2 mm -71.71 126.09 91.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.67 148.35 77.65 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.089 1.86 . . . . 0.0 112.604 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 61.78 16.44 7.9 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.737 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.32 70.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.125 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.49 -23.39 63.62 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.338 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -88.91 -27.92 20.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.322 -171.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 70' ' ' ILE . 24.4 m -88.01 164.11 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.222 0.534 . . . . 0.0 111.833 -177.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -128.32 135.06 49.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.973 173.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.79 131.01 60.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.815 0.34 . . . . 0.0 110.287 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -118.75 124.84 48.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.078 0.466 . . . . 0.0 110.539 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.0 mm -105.19 136.75 37.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.782 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.06 54.88 1.56 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.205 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.7 88.57 0.09 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.98 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.4 -34.93 2.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.978 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -84.1 119.95 25.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.983 0.421 . . . . 0.0 110.388 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.61 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -121.6 105.89 10.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.233 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.0 m -93.6 122.01 35.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.204 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.67 130.72 47.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.165 0.507 . . . . 0.0 109.989 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.55 136.78 54.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.135 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.78 168.22 40.77 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.6 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.477 ' HB3' ' HE3' ' A' ' 88' ' ' LYS . 3.5 p30 -157.17 142.57 17.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.991 0.424 . . . . 0.0 110.453 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.56 24.92 64.11 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.091 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.538 HD12 HG11 ' A' ' 87' ' ' VAL . 11.5 mt -99.41 -162.43 0.95 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.339 0.59 . . . . 0.0 109.916 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.2 p -120.73 155.59 33.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.968 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.423 ' NE2' ' HA ' ' A' ' 95' ' ' ALA . 59.8 tt0 -60.77 -35.29 76.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.893 0.378 . . . . 0.0 110.14 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -60.81 -44.27 97.09 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.538 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.55 -41.85 59.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -54.8 -57.07 13.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.753 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 72' ' ' VAL . 5.9 mm-40 -67.11 -15.77 63.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.043 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -75.9 -48.32 21.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.269 0.557 . . . . 0.0 109.524 176.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.568 ' O ' HG12 ' A' ' 74' ' ' VAL . 47.6 mt -65.05 -52.35 54.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.817 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 85' ' ' ASP . 7.6 mp -40.78 -46.49 2.69 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.83 0.706 . . . . 0.0 112.653 175.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.493 HG21 ' HG3' ' A' ' 145' ' ' ARG . 98.9 t -71.81 -48.52 50.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.196 0.522 . . . . 0.0 110.872 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HA ' ' SD ' ' A' ' 131' ' ' MET . . . -60.6 -32.11 71.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.182 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 70' ' ' ILE . 11.9 p -88.59 -28.28 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.276 0.56 . . . . 0.0 110.851 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.503 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -70.37 -35.25 69.02 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.02 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -83.42 58.86 4.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.795 0.331 . . . . 0.0 110.807 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.636 HD12 HD22 ' A' ' 14' ' ' LEU . 41.8 mm -123.78 132.75 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -63.81 95.42 0.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.53 -17.73 3.96 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.9 -173.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.61 HD12 ' HB2' ' A' ' 55' ' ' ALA . 35.3 mm -102.61 127.81 55.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.194 0.521 . . . . 0.0 111.471 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -111.48 -30.89 7.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.562 -174.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 p -150.69 150.6 31.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.313 0.577 . . . . 0.0 111.448 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 85.4 t -124.25 126.52 72.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.878 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -103.24 112.58 25.51 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.412 ' HB2' HD21 ' A' ' 71' ' ' LEU . 6.3 t0 -84.35 110.63 18.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.344 0.592 . . . . 0.0 111.427 -176.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -119.22 33.04 5.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.461 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 62' ' ' LEU . 77.6 t -95.73 123.64 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.22 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -89.71 123.18 33.5 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 174.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.4 p -102.82 126.46 49.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.82 0.343 . . . . 0.0 111.259 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.0 -27.81 23.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.424 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.8 p -121.04 129.46 25.28 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.998 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.53 164.5 16.46 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.815 2.343 . . . . 0.0 112.418 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.59 -155.04 0.58 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.7 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.6 m -86.62 122.77 31.0 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.423 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -62.92 142.66 58.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.607 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.9 m -127.57 143.27 51.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.116 0.484 . . . . 0.0 111.803 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.578 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 5.8 tt0 -91.85 153.4 19.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 171.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.455 ' N ' ' HG2' ' A' ' 97' ' ' GLN . 31.1 m-85 -107.17 86.84 2.38 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.028 0.442 . . . . 0.0 110.264 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -84.63 131.77 34.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.707 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.449 ' OG1' HG22 ' A' ' 143' ' ' VAL . 20.0 m -103.31 120.43 40.75 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.973 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 142' ' ' GLN . 0.9 OUTLIER -68.44 129.86 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.433 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 72.3 mmtt -78.62 -64.1 1.25 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.302 -169.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.9 t -159.18 -72.91 0.08 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.674 0.273 . . . . 0.0 110.505 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.35 51.6 4.58 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.539 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.1 m-20 -108.72 111.96 24.01 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.039 -0.58 . . . . 0.0 110.983 -171.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 110' ' ' ILE . 8.1 m -104.03 150.37 24.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 21.3 tp -57.87 -43.1 85.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.623 0.647 . . . . 0.0 110.944 -173.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.2 p -61.03 -39.98 91.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.22 0.533 . . . . 0.0 111.095 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.24 -40.87 74.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.354 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.7 pp -79.02 -23.84 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.2 p -71.22 -39.16 71.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.971 0.415 . . . . 0.0 110.03 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 8.3 tmtm? -64.03 -29.93 71.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -65.16 -52.75 53.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.318 177.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.441 HG21 HD12 ' A' ' 146' ' ' ILE . 34.7 m -87.78 -44.0 15.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.175 -171.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.425 ' HB3' HD12 ' A' ' 120' ' ' LEU . 64.8 m-85 -89.56 -53.07 4.69 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.891 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.48 -22.86 7.71 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.061 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -116.51 124.33 49.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.356 -0.422 . . . . 0.0 109.903 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.91 -19.28 60.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.555 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -67.68 -11.39 58.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.187 0.517 . . . . 0.0 110.485 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 115' ' ' TYR . 39.1 mt -89.11 14.43 10.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.176 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.435 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 27.9 p90 -64.74 -28.91 69.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.049 0.452 . . . . 0.0 109.814 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.596 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 32.1 p30 -69.46 -29.6 67.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.878 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -58.69 -49.62 76.92 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.51 0.671 . . . . 0.0 110.078 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.78 -39.82 78.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.295 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.443 ' CE2' ' HD2' ' A' ' 129' ' ' LYS . 45.5 t80 -54.58 -55.76 26.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.758 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 35.1 mt-10 -63.51 -40.13 96.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.942 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.504 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -60.06 -28.47 67.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.115 -177.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.467 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 47.1 m-80 -99.93 0.01 40.36 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 120.619 0.247 . . . . 0.0 110.871 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.547 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 25.8 mtpp -79.36 150.75 74.27 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-O 120.644 0.259 . . . . 0.0 110.779 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.445 ' HD2' HD13 ' A' ' 40' ' ' ILE . 9.5 Cg_endo -90.5 25.1 21.4 Favored 'Cis proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.662 -1.391 . . . . 0.0 112.843 -0.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.467 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 1.0 OUTLIER -74.95 -34.7 62.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.372 . . . . 0.0 110.276 176.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.486 HD21 HE21 ' A' ' 142' ' ' GLN . 0.1 OUTLIER -93.03 117.76 30.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.98 -43.37 24.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.892 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.3 m -151.45 149.85 25.34 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.255 0.55 . . . . 0.0 110.762 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.97 -18.08 61.19 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 123.713 2.942 . . . . 0.0 112.875 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.12 -16.31 22.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.498 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -78.62 -1.2 33.05 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.8 pt -65.7 168.14 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.912 0.387 . . . . 0.0 110.063 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -163.9 154.96 13.86 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.343 -172.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -45.2 113.31 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.164 2.576 . . . . 0.0 112.662 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.29 34.65 5.77 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.339 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.572 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.2 tp60 -107.08 116.6 32.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.835 0.318 . . . . 0.0 110.164 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.526 HG21 ' CD2' ' A' ' 6' ' ' PHE . 46.7 t -80.5 132.08 32.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.066 0.46 . . . . 0.0 110.004 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -125.63 134.42 51.9 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.073 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.504 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 47.2 mtp180 -62.68 118.76 8.09 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.064 171.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 39.7 mm -106.24 93.27 7.79 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 173.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 38.5 Cg_exo -59.85 139.14 86.78 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.222 1.948 . . . . 0.0 111.184 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 C--N 1.32 -0.678 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.014 176.171 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 121.268 0.556 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -93.6 138.81 31.47 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.26 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.417 HD22 ' N ' ' A' ' 5' ' ' ASN . 0.9 OUTLIER -97.57 138.31 35.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.018 0.437 . . . . 0.0 111.01 -177.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.414 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 59.5 m-85 -127.25 -179.12 4.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.496 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.95 HG21 ' HB3' ' A' ' 10' ' ' ALA . 23.7 m -81.26 -9.94 12.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -171.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.644 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 53.4 tptt 74.35 -54.95 0.67 Allowed 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.528 0.518 . . . . 0.0 112.141 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.62 -46.53 15.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.097 0.475 . . . . 0.0 111.963 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.95 ' HB3' HG21 ' A' ' 7' ' ' VAL . . . -81.29 126.93 32.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.183 -173.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.96 -173.1 36.59 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.371 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.04 129.59 41.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.35 54.98 1.8 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.992 0.901 . . . . 0.0 108.88 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 30' ' ' LYS . 14.7 tp . . . . . 0 C--N 1.315 -0.896 0 CA-C-N 113.8 -1.545 . . . . 0.0 111.312 -172.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 19.0 t70 . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 31' ' ' VAL . 51.5 mt-30 -59.92 -48.35 82.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.375 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.43 -34.7 72.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.765 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 38.6 ttpt -68.11 -39.99 82.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.985 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 74.6 mmtt -56.96 -44.96 83.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.063 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.611 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 47.5 t -59.96 -45.16 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.49 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -55.56 -47.64 76.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.868 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 38.2 mt-10 -58.91 -48.88 79.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.359 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -53.04 -39.37 63.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.456 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 85.7 mt -70.76 -40.91 72.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.013 0.435 . . . . 0.0 111.201 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -78.07 -31.01 50.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.175 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -67.92 -38.2 82.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.943 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 p -75.66 -36.42 60.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 110.789 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.92 35.29 4.32 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.167 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.8 mm -77.11 124.69 87.26 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.69 146.46 66.87 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.229 1.953 . . . . 0.0 112.396 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 64.34 -0.9 0.81 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.907 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 35' ' ' LEU . . . -80.77 -9.89 59.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.341 0.591 . . . . 0.0 110.432 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -87.7 -9.53 53.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.276 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -91.72 -35.54 14.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.089 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.8 m -69.68 166.12 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.373 -175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -130.23 128.99 42.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.802 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 48' ' ' ILE . 3.6 mp -103.87 140.91 20.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.8 0.333 . . . . 0.0 110.869 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 38.5 tt0 -123.14 135.78 54.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 173.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.3 mm -104.35 111.72 35.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.079 0.466 . . . . 0.0 110.306 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.25 93.89 4.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.473 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.6 t70 64.18 -83.62 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.368 -171.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.77 13.96 4.73 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.656 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 38.0 mtmm -95.82 117.23 30.16 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.662 0.267 . . . . 0.0 110.475 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -92.1 80.59 5.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.823 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 89.3 m -66.68 119.65 12.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.959 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 57' ' ' VAL . 7.3 p -106.89 109.97 30.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.441 0.638 . . . . 0.0 111.193 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.9 OUTLIER -100.68 154.41 18.62 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.028 178.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.93 160.23 17.72 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -151.75 146.08 25.47 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.241 0.543 . . . . 0.0 110.721 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.94 31.13 58.34 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.529 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.45 HD12 ' CG1' ' A' ' 87' ' ' VAL . 18.3 mt -98.83 -169.99 1.86 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.837 0.827 . . . . 0.0 110.851 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 m -108.96 128.78 55.24 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.718 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.51 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 9.4 tt0 -61.49 -31.51 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.946 -172.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HG3' ' NH2' ' A' ' 145' ' ' ARG . 42.2 tt0 -65.63 -39.53 91.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.069 0.461 . . . . 0.0 110.151 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.549 ' O ' HG13 ' A' ' 70' ' ' ILE . . . -72.92 -39.34 66.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.918 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.638 ' HA ' HD12 ' A' ' 70' ' ' ILE . 73.3 tttt -52.12 -53.68 39.77 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.593 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 72' ' ' VAL . 7.7 mm-40 -52.95 -35.25 58.51 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 28.7 ttpt -79.25 -32.55 43.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.505 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 67' ' ' LYS . 45.3 mt -61.89 -52.17 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 67' ' ' LYS . 9.8 mp -45.01 -43.84 9.53 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.646 173.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 68' ' ' GLU . 66.5 t -67.3 -51.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.465 0.65 . . . . 0.0 110.885 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.89 79.95 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.6 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.41 HG23 HG21 ' A' ' 83' ' ' VAL . 22.5 m -80.63 -25.94 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.029 0.442 . . . . 0.0 111.087 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -77.86 -28.87 55.95 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.832 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -83.39 42.61 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 111.404 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.2 mt -114.53 138.26 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-O 121.14 0.495 . . . . 0.0 110.488 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 t -71.49 111.91 7.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.182 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.09 -14.61 8.35 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -172.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.6 mm -98.74 121.83 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 110.902 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.644 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -104.14 -20.51 13.79 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.73 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.656 ' OG ' ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -158.83 153.85 25.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.465 -177.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 55' ' ' ALA . 68.1 t -127.84 124.27 62.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.789 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.8 105.85 18.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.494 ' OD1' ' HE3' ' A' ' 67' ' ' LYS . 3.3 t70 -72.84 116.54 13.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.224 0.535 . . . . 0.0 111.54 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 75.9 mt-30 -121.32 25.74 9.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.119 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.45 ' CG1' HD12 ' A' ' 62' ' ' LEU . 88.0 t -89.55 125.57 42.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.655 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -95.53 142.89 27.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.269 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.0 p -115.72 143.55 45.21 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.942 0.401 . . . . 0.0 111.548 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.91 -8.34 31.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.581 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.5 p -135.32 133.68 20.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.234 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.35 69.15 6.64 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.97 2.446 . . . . 0.0 111.283 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.44 -168.06 1.85 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.731 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.0 m -56.51 129.38 40.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.35 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.16 138.95 31.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.6 m -126.5 157.3 39.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.369 0.605 . . . . 0.0 112.02 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.9 tt0 -96.38 149.15 22.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.577 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -109.78 93.99 4.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.942 0.401 . . . . 0.0 110.603 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -98.2 139.18 34.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.272 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.6 m -104.54 123.44 47.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.345 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.9 m -70.92 134.87 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.4 mmtp -98.92 -165.61 1.26 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.481 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.427 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 13.9 m -65.1 122.87 18.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.633 0.254 . . . . 0.0 110.481 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.09 8.85 83.3 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.312 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.589 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 13.1 m-20 -88.31 105.18 17.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.367 0.603 . . . . 0.0 111.009 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 110' ' ' ILE . 5.8 m -102.69 161.09 14.01 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.488 ' N ' HD11 ' A' ' 138' ' ' ILE . 19.7 tp -56.39 -41.66 76.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.412 0.551 . . . . 0.0 111.699 -170.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.496 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 9.8 m -63.14 -41.57 99.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.955 0.407 . . . . 0.0 110.571 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.88 81.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.004 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.625 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -75.11 -24.52 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 120.917 0.389 . . . . 0.0 110.481 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.7 t -67.44 -44.14 79.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 170.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.79 -24.27 66.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.431 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 2.1 tp-100 -71.87 -59.87 2.53 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.924 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.8 m -82.83 -35.82 12.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.236 -170.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.507 ' HB3' HD12 ' A' ' 120' ' ' LEU . 19.0 m-30 -103.68 -23.89 13.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.05 -175.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.44 -6.31 82.34 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.909 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.472 HD21 ' HB3' ' A' ' 119' ' ' ASN . 41.0 t30 -133.94 124.0 25.62 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -76.18 -15.2 60.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.712 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 117' ' ' ASN . 22.9 t-20 -68.68 -23.43 64.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.139 0.495 . . . . 0.0 110.596 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 115' ' ' TYR . 67.1 mt -85.06 14.22 5.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.572 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.46 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 24.2 p90 -62.3 -31.61 72.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.189 0.519 . . . . 0.0 110.257 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.582 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 26.3 p-10 -68.89 -29.64 67.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.507 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -58.17 -47.47 83.29 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.543 0.687 . . . . 0.0 109.772 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.9 mt -71.8 -41.02 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.304 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.465 ' HB2' HD21 ' A' ' 107' ' ' LEU . 83.5 t80 -53.72 -51.76 62.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 40.2 mt-10 -62.74 -23.22 67.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.941 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.558 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -86.87 -31.87 20.53 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.632 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.574 ' O ' ' HB3' ' A' ' 131' ' ' MET . 10.5 m120 -76.67 -42.07 43.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 58.5 pttt -64.47 153.72 85.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.949 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.1 Cg_endo -86.27 21.55 22.36 Favored 'Cis proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.225 -1.573 . . . . 0.0 112.892 0.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.574 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.2 tmm? -73.23 -26.73 61.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.465 HD12 ' H ' ' A' ' 133' ' ' LYS . 18.8 tp -111.72 133.75 53.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.078 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.465 ' H ' HD12 ' A' ' 132' ' ' LEU . 29.7 mtpp -81.67 -45.18 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.063 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.499 ' OG ' ' HG2' ' A' ' 137' ' ' LYS . 79.0 p -154.02 160.94 30.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.79 -17.75 52.05 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.528 2.819 . . . . 0.0 111.929 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -100.43 -12.98 18.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.511 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HG2' ' OG ' ' A' ' 134' ' ' SER . 56.4 mmtt -81.49 -8.03 59.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.655 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 9.3 pt -68.43 168.9 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.098 0.475 . . . . 0.0 110.978 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.492 ' CE1' ' HG3' ' A' ' 142' ' ' GLN . 15.4 p90 -155.98 147.79 17.18 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.177 -174.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.427 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 88.7 Cg_exo -48.48 103.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.597 2.865 . . . . 0.0 113.037 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.406 ' HA2' HG11 ' A' ' 7' ' ' VAL . . . 124.19 8.81 5.86 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.601 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.655 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 1.7 mt-30 -94.37 121.97 36.45 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 117.341 0.571 . . . . 0.0 111.224 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 41.9 t -80.61 135.31 25.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.303 172.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.2 mt -126.36 145.31 50.5 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.063 0.459 . . . . 0.0 110.748 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HB2' HG21 ' A' ' 72' ' ' VAL . 28.5 ttt180 -72.48 110.37 6.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.906 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 41.5 mm -94.7 112.38 57.72 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.558 ' HG3' ' HB2' ' A' ' 127' ' ' ALA . 32.4 Cg_exo -59.69 166.68 7.81 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.985 2.457 . . . . 0.0 113.109 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.922 176.942 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.51 HD13 ' N ' ' A' ' 4' ' ' PHE . 1.7 tm? . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.291 0.567 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.51 ' N ' HD13 ' A' ' 3' ' ' LEU . 86.5 m-85 -125.52 132.22 52.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.194 175.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -97.61 140.9 31.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.006 0.431 . . . . 0.0 110.997 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -127.75 -164.4 1.36 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.151 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.3 -10.81 8.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.794 0.331 . . . . 0.0 111.128 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 84.8 tttt 72.67 -67.19 0.27 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 176.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.31 -24.78 63.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.289 0.566 . . . . 0.0 110.504 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.26 119.98 31.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.711 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.01 -173.55 41.58 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.842 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -77.31 136.18 38.46 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 19.3 mtpt -77.97 86.05 4.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.45 0.643 . . . . 0.0 111.781 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 77' ' ' ILE . 8.9 mp . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.005 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 121.138 0.494 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -66.56 -33.78 76.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.154 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.23 72.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.763 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 17.4 tppt? -65.18 -43.29 92.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.589 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -66.87 -32.06 73.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.046 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.612 HG11 HG23 ' A' ' 74' ' ' VAL . 75.3 t -63.59 -46.18 95.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.311 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.424 ' NE2' HD12 ' A' ' 35' ' ' LEU . 16.5 mm-40 -57.85 -41.42 82.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.516 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 54.6 mt-10 -56.95 -48.47 78.26 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.765 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.499 ' HB2' HD11 ' A' ' 14' ' ' LEU . 57.7 t60 -57.97 -37.02 73.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.428 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 64.4 mt -73.18 -40.65 64.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.008 0.433 . . . . 0.0 110.429 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -65.05 -48.0 75.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.419 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -58.03 -49.88 75.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.754 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.405 ' OG1' HG12 ' A' ' 40' ' ' ILE . 16.7 p -68.28 -44.38 75.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.37 35.49 3.85 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.792 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.405 HG12 ' OG1' ' A' ' 38' ' ' THR . 35.6 mm -66.67 124.04 87.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -66.38 138.65 51.48 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.989 1.793 . . . . 0.0 112.333 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 63.33 9.33 3.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.351 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -75.94 -14.38 60.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.27 0.557 . . . . 0.0 110.367 177.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -81.36 -16.32 52.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.13 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -75.19 -44.1 48.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.614 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.5 m -77.34 163.63 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.595 -172.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -118.8 139.28 51.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.877 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.9 mm -102.39 139.78 22.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.026 0.441 . . . . 0.0 111.316 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 49.9 tt0 -138.97 128.7 24.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.327 172.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mm -108.91 116.57 52.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.672 0.272 . . . . 0.0 110.912 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.48 100.06 7.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.832 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 t70 66.11 -80.96 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.8 0.688 . . . . 0.0 110.757 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.06 18.51 2.53 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 82' ' ' SER . 38.9 ttmt -107.78 114.74 28.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.294 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.68 111.87 23.62 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.155 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 18.5 m -86.65 130.64 34.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.917 177.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 57' ' ' VAL . 5.3 p -114.74 106.93 21.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.337 0.589 . . . . 0.0 110.897 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 m -104.55 155.88 18.44 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.996 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.22 179.72 39.25 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.325 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.13 150.52 13.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 0.0 110.6 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.54 23.97 48.46 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.504 -0.771 . . . . 0.0 113.163 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.46 175.35 5.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.76 0.314 . . . . 0.0 110.667 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 91' ' ' THR . 14.3 m -104.75 157.95 16.85 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 7.8 tp60 -53.85 -41.91 67.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.891 0.377 . . . . 0.0 110.227 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.689 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 61.1 mm-40 -49.84 -62.39 1.59 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.061 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.02 -37.69 84.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.685 0.279 . . . . 0.0 110.966 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -55.55 -51.77 65.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.625 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.558 ' O ' HG23 ' A' ' 72' ' ' VAL . 56.1 mt-10 -65.09 -33.56 76.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.106 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 29.8 mtpp -60.01 -42.73 94.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.867 0.365 . . . . 0.0 110.095 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.512 ' O ' HG12 ' A' ' 74' ' ' VAL . 52.6 mt -62.45 -57.38 12.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.322 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mp -41.9 -43.25 3.0 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.828 0.705 . . . . 0.0 112.406 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 68' ' ' GLU . 86.2 t -69.08 -53.19 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.33 0.586 . . . . 0.0 111.017 177.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.419 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -64.07 -31.09 72.16 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.588 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.612 HG23 HG11 ' A' ' 31' ' ' VAL . 11.7 p -84.62 -23.35 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.492 0.663 . . . . 0.0 110.532 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.23 -35.37 34.1 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.196 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -82.07 60.29 4.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.64 0.257 . . . . 0.0 111.145 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.625 HD12 HD22 ' A' ' 14' ' ' LEU . 32.7 mm -118.13 142.24 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.495 ' OG ' ' HA ' ' A' ' 13' ' ' LYS . 72.3 p -65.91 91.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.966 0.412 . . . . 0.0 110.492 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.98 -17.72 5.67 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.914 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 28.1 mm -86.51 113.06 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.667 0.746 . . . . 0.0 110.868 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.99 -24.61 15.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.03 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 5.4 p -150.05 156.83 42.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.293 0.568 . . . . 0.0 111.514 -178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.412 HG21 HG13 ' A' ' 74' ' ' VAL . 61.7 t -132.5 130.23 59.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.737 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -104.95 106.71 17.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -72.65 117.27 14.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.539 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -133.92 28.39 3.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.138 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.25 116.29 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.617 0.723 . . . . 0.0 110.712 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -82.37 144.46 30.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.766 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.9 p -112.17 127.43 55.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.19 0.519 . . . . 0.0 111.222 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.57 -27.75 23.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.23 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 16.3 p -119.93 132.24 24.13 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.332 176.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 50.4 Cg_endo -91.3 168.09 3.46 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.793 2.329 . . . . 0.0 113.205 -175.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -158.51 -156.63 0.56 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.554 174.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.11 154.5 19.32 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.21 129.09 35.85 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.6 m -97.39 156.48 16.44 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.281 0.563 . . . . 0.0 111.006 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.427 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.9 tt0 -87.87 142.19 28.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.323 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -106.76 90.55 3.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.442 . . . . 0.0 110.235 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 90.5 t80 -90.89 146.48 23.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.96 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.478 ' OG1' HG22 ' A' ' 143' ' ' VAL . 5.9 m -117.96 123.01 44.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.042 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.623 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.5 m -67.85 128.85 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -106.87 115.7 30.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.5 t 55.58 -90.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.822 173.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.5 19.32 53.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.427 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.578 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 2.2 m-20 -66.93 134.58 52.29 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.49 0.662 . . . . 0.0 111.253 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.629 ' O ' HG23 ' A' ' 110' ' ' ILE . 36.0 p -119.4 156.44 30.12 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.284 175.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 110' ' ' ILE . 20.9 tp -56.38 -40.86 75.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 118.185 0.448 . . . . 0.0 111.132 -171.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 4.6 m -63.77 -40.25 96.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.155 0.502 . . . . 0.0 110.378 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -73.83 -27.52 61.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.73 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 106' ' ' THR . 1.4 pp -85.34 -24.28 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.809 0.338 . . . . 0.0 110.958 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.494 ' HB3' HD12 ' A' ' 124' ' ' ILE . 11.3 p -76.3 -29.67 57.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 170.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 52.5 tptt -60.43 -26.33 66.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.842 170.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 16.2 mm-40 -75.69 -72.42 0.31 Allowed 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 122.282 1.039 . . . . 0.0 110.715 175.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.479 HG23 ' CD2' ' A' ' 115' ' ' TYR . 28.8 m -70.41 -40.1 77.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 113.251 -1.795 . . . . 0.0 112.659 -167.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.489 ' HB3' HD12 ' A' ' 120' ' ' LEU . 56.5 m-85 -96.97 -20.11 18.32 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.602 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 80.89 5.5 90.05 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.544 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.484 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 35.8 t30 -140.81 116.05 9.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.806 0.336 . . . . 0.0 110.318 -176.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.43 ' O ' ' HD2' ' A' ' 121' ' ' TYR . . . -70.31 -11.11 60.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.553 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -81.76 -10.96 59.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.489 HD12 ' HB3' ' A' ' 115' ' ' TYR . 74.8 mt -96.11 22.68 7.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.76 -178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.452 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 50.8 p90 -68.35 -29.13 67.79 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.041 -175.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.411 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 9.0 t30 -69.93 -30.51 67.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.084 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -53.83 -47.76 70.6 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.808 0.813 . . . . 0.0 109.484 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.548 HG22 ' OD1' ' A' ' 128' ' ' ASN . 55.7 mt -68.49 -46.71 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.491 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -53.96 -46.64 71.69 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.103 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.434 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 15.0 mt-10 -69.63 -24.67 63.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.96 0.41 . . . . 0.0 111.598 -176.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.49 29.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.951 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.548 ' OD1' HG22 ' A' ' 124' ' ' ILE . 8.3 m120 -74.82 -46.84 33.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.925 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 62.3 pttt -58.5 154.06 36.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.84 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.463 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.9 Cg_endo -80.86 15.18 20.15 Favored 'Cis proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.241 -1.566 . . . . 0.0 113.674 0.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.477 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.6 tmm? -70.03 -36.86 75.37 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.7 tp -94.45 115.88 28.14 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -73.81 -42.6 60.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.316 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 52.8 m -157.89 154.03 23.71 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 134' ' ' SER . 33.2 Cg_exo -61.72 -23.19 75.92 Favored 'Trans proline' 0 C--O 1.23 0.077 0 C-N-CA 123.76 2.974 . . . . 0.0 112.975 -173.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -105.38 7.16 33.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 110.689 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.416 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 30.9 mmtp -100.82 14.79 30.57 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.458 0.647 . . . . 0.0 110.692 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 106' ' ' THR . 17.6 pt -67.54 171.61 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.605 172.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 12.0 p90 -153.81 143.77 15.41 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.705 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 139' ' ' TYR . 58.0 Cg_exo -51.64 115.49 2.14 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.285 2.657 . . . . 0.0 112.898 -178.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.01 26.0 7.68 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.357 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.623 ' H ' HG22 ' A' ' 101' ' ' VAL . 65.4 tt0 -100.21 121.62 41.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.871 0.367 . . . . 0.0 110.782 -175.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.478 HG22 ' OG1' ' A' ' 100' ' ' THR . 55.4 t -82.12 138.4 19.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.691 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.0 mt -132.52 146.38 51.88 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.441 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.689 ' NH2' ' HA ' ' A' ' 65' ' ' GLU . 32.7 ttt180 -75.65 113.4 13.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.746 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 36.4 mm -99.93 103.09 20.0 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.106 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 27.2 Cg_exo -61.96 160.55 29.22 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.33 2.02 . . . . 0.0 111.805 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.0 tp . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 120.913 0.387 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 82' ' ' SER . 81.3 m-85 -120.85 133.63 55.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.902 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -102.64 151.08 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.971 0.415 . . . . 0.0 110.813 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.747 ' HE1' HG12 ' A' ' 83' ' ' VAL . 90.8 m-85 -131.68 -179.88 5.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.945 -175.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.23 -17.81 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.867 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 81.2 tttt 72.93 -69.46 0.19 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.403 0.681 . . . . 0.0 111.7 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.26 -25.11 65.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.823 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.76 124.57 42.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.714 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.39 -163.26 36.78 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.71 134.4 38.11 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -78.06 90.49 4.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.327 0.584 . . . . 0.0 111.359 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.406 HD22 HD13 ' A' ' 77' ' ' ILE . 8.0 mp . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.59 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 18.9 t70 . . . . . 0 CA--C 1.523 -0.077 0 CA-C-O 121.277 0.56 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.434 ' HB2' HG13 ' A' ' 50' ' ' ILE . 17.6 mt-30 -69.09 -31.33 69.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.787 176.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 50' ' ' ILE . . . -62.89 -27.45 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.232 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.589 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 60.5 tttp -65.19 -42.76 93.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -64.04 -37.99 89.43 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.176 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.565 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 62.1 t -59.15 -51.68 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.893 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -54.58 -43.43 72.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.445 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 43.3 mt-10 -57.36 -56.74 17.93 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.105 0.478 . . . . 0.0 110.034 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -51.74 -42.76 62.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.283 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 99.2 mt -68.04 -42.76 80.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.645 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.51 -26.81 51.46 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.124 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -74.13 -32.43 63.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.688 0.28 . . . . 0.0 111.346 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.416 ' OG1' HG12 ' A' ' 40' ' ' ILE . 2.1 p -80.4 -30.64 37.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.905 0.383 . . . . 0.0 110.984 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.28 27.51 8.66 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.843 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.548 HD13 ' HD2' ' A' ' 130' ' ' PRO . 43.8 mm -58.41 129.75 84.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 122.402 0.281 . . . . 0.0 110.582 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -66.56 134.62 36.15 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.047 1.831 . . . . 0.0 111.981 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.484 ' HB3' HD22 ' A' ' 62' ' ' LEU . 7.5 m-20 62.96 21.69 13.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.804 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.493 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -70.34 -20.53 62.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.089 0.471 . . . . 0.0 111.093 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -91.54 -9.59 43.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.322 0.582 . . . . 0.0 109.991 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.77 -14.31 30.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.203 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.569 HG11 HD13 ' A' ' 70' ' ' ILE . 18.4 m -97.87 177.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -142.09 133.16 26.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.063 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.04 132.98 58.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.003 0.43 . . . . 0.0 110.751 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.424 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 95.3 mt-30 -115.71 147.9 40.36 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.46 HG22 ' H ' ' A' ' 52' ' ' ASP . 23.0 mm -120.48 128.86 76.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.19 35.24 4.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.194 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.46 ' H ' HG22 ' A' ' 50' ' ' ILE . 25.8 t70 66.88 98.26 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.671 0.607 . . . . 0.0 110.992 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 75.49 7.26 82.67 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.835 -176.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -146.5 138.69 24.95 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -120.11 148.26 43.84 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.693 175.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 61.2 m -117.65 119.79 36.05 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.1 t -99.54 111.76 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.459 0.647 . . . . 0.0 110.522 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -113.12 160.5 18.14 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.977 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.78 161.93 15.93 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -139.87 150.66 44.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.127 0.464 . . . . 0.0 111.008 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.92 35.45 84.57 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.93 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 42' ' ' ASP . 15.2 mt -107.67 -166.25 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.677 0.751 . . . . 0.0 111.305 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 79.5 p -141.59 159.06 43.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.2 -1.363 . . . . 0.0 107.862 174.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 13.4 mt-30 -68.26 -18.92 64.67 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.413 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.42 -44.9 96.33 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.86 -38.33 15.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.964 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -58.76 -41.26 86.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 -178.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.16 35.04 0.63 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.319 1.057 . . . . 0.0 110.304 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -123.75 -50.06 1.85 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.597 -1.638 . . . . 0.0 107.152 167.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.569 HD13 HG11 ' A' ' 46' ' ' VAL . 16.5 mt -61.99 -51.94 66.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.775 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp -67.43 -19.26 65.35 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.829 0.824 . . . . 0.0 110.419 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.4 t -86.14 -56.25 5.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.15 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.67 -23.23 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.151 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.412 HG23 HG11 ' A' ' 31' ' ' VAL . 14.5 p -76.28 -39.13 34.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.866 0.365 . . . . 0.0 110.662 176.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.639 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -71.24 -27.89 70.98 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.865 175.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -83.06 44.69 0.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 111.064 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.406 HD13 HD22 ' A' ' 14' ' ' LEU . 96.4 mt -119.71 141.28 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.424 174.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.3 m -68.27 103.19 1.53 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.548 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 130.62 -20.14 4.94 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.458 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.656 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 50.1 mm -94.73 116.85 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.439 . . . . 0.0 110.93 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 8' ' ' LYS . . . -107.78 -10.11 15.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.249 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 5.4 p -162.32 156.93 22.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.983 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.747 HG12 ' HE1' ' A' ' 6' ' ' PHE . 11.5 p -140.93 136.58 34.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.586 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.82 114.46 28.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.542 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.7 112.39 18.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.088 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -129.64 35.91 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.385 0.612 . . . . 0.0 110.503 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.481 HG11 HD12 ' A' ' 62' ' ' LEU . 93.4 t -89.09 131.98 35.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.392 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -94.99 97.6 10.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.748 175.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.7 p -81.74 121.52 26.5 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.88 -32.69 20.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.57 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 63' ' ' SER . 17.5 p -106.67 130.22 23.25 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.593 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.21 148.81 34.99 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.93 2.42 . . . . 0.0 112.795 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 64' ' ' GLN . . . -157.12 166.75 32.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.818 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.0 m -74.76 127.24 32.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.871 0.367 . . . . 0.0 110.943 -177.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.421 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -75.75 136.04 40.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.902 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.9 m -112.96 172.84 6.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.195 0.521 . . . . 0.0 111.694 -174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.0 tt0 -96.79 143.25 27.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.232 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -103.6 87.53 2.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.154 0.502 . . . . 0.0 110.456 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -88.11 136.71 32.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.115 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.437 ' OG1' HG22 ' A' ' 143' ' ' VAL . 6.6 m -105.7 123.64 48.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.338 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.559 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.2 m -72.16 135.06 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.277 0.561 . . . . 0.0 109.633 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.492 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 75.2 mmtt -86.92 -165.29 1.25 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.154 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.3 m -55.45 -55.21 34.37 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.862 -173.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.13 26.53 20.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.818 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 7.9 m-20 -82.11 111.51 18.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.149 0.499 . . . . 0.0 111.111 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.604 ' HA ' HD11 ' A' ' 138' ' ' ILE . 22.7 p -101.06 164.42 11.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.217 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 125' ' ' PHE . 18.2 tp -63.37 -36.49 83.88 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.165 -174.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -67.16 -35.83 80.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.958 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.85 -41.73 67.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.037 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -78.34 -24.3 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.622 -176.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 p -73.28 -40.63 64.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -61.86 -21.92 65.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.292 0.568 . . . . 0.0 110.145 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.637 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.1 tp-100 -75.44 -63.86 1.19 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.8 176.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -76.76 -43.0 33.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.192 -170.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.482 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 19.7 m-85 -92.96 -32.36 14.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.933 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.1 -4.62 58.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.192 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.522 ' OD1' ' HG ' ' A' ' 120' ' ' LEU . 24.1 t-20 -126.59 121.99 33.78 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.494 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -77.12 -18.42 57.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -78.67 -14.45 59.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.146 0.498 . . . . 0.0 110.339 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.522 ' HG ' ' OD1' ' A' ' 117' ' ' ASN . 78.4 mt -84.62 14.99 4.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.582 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.494 ' HD1' ' O ' ' A' ' 118' ' ' ALA . 38.8 p90 -63.08 -30.69 71.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.864 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.52 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 15.9 m120 -64.9 -32.76 74.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -61.12 -48.4 81.84 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.391 0.615 . . . . 0.0 110.187 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.06 -36.28 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.368 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.481 ' HB2' HD21 ' A' ' 107' ' ' LEU . 83.3 t80 -56.23 -53.82 52.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.406 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 26.6 mt-10 -70.72 -17.03 62.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.281 -175.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -84.86 -10.0 57.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.032 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -115.1 25.65 10.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.203 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 11.1 mmmm -86.31 150.21 51.31 Favored Pre-proline 0 C--N 1.326 -0.424 0 O-C-N 122.158 -0.339 . . . . 0.0 110.402 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.548 ' HD2' HD13 ' A' ' 40' ' ' ILE . 10.0 Cg_endo -95.87 15.99 37.75 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.441 -1.066 . . . . 0.0 111.969 -6.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -14.71 62.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.222 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.424 HD21 HE21 ' A' ' 142' ' ' GLN . 0.9 OUTLIER -107.67 124.21 49.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 168.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -99.43 -42.09 7.11 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.757 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.453 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 14.7 m -149.56 147.96 24.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.19 0.519 . . . . 0.0 109.786 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.63 -19.91 65.08 Favored 'Trans proline' 0 C--N 1.336 -0.129 0 C-N-CA 123.714 2.943 . . . . 0.0 112.851 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -96.88 -8.24 31.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.371 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.453 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 36.7 mmtm -91.44 9.13 33.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.604 HD11 ' HA ' ' A' ' 106' ' ' THR . 10.3 pt -69.51 174.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.016 169.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -162.2 148.12 10.49 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.69 116.92 2.36 Favored 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.226 2.617 . . . . 0.0 112.136 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.99 14.32 23.11 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.1 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.559 ' H ' HG22 ' A' ' 101' ' ' VAL . 1.7 mm100 -86.5 108.71 18.66 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.16 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.437 HG22 ' OG1' ' A' ' 100' ' ' THR . 41.7 t -79.8 125.06 38.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 172.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.2 mt -118.96 140.17 50.45 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.81 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.534 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 35.6 ttt180 -74.74 111.54 10.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.544 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 33.3 mm -97.67 102.93 14.47 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.006 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 25.5 Cg_exo -63.13 145.76 93.9 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.55 2.167 . . . . 0.0 111.67 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.492 177.171 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 83' ' ' VAL . 19.4 tp . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 121.491 0.662 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -93.88 140.71 29.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.039 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -92.19 124.89 36.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.846 0.355 . . . . 0.0 110.81 -176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.628 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 57.1 m-85 -110.41 -164.16 0.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.784 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.857 HG11 ' HB3' ' A' ' 10' ' ' ALA . 7.3 p -82.8 -28.26 8.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -173.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.796 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 22.2 tptm 76.44 -60.4 0.48 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.218 0.607 . . . . 0.0 111.33 -175.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.26 -42.62 36.38 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.857 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -84.22 179.05 7.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.034 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.2 -168.89 12.69 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.553 ' HG2' HD13 ' A' ' 14' ' ' LEU . 4.8 tp10 -60.19 122.87 15.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -77.68 64.75 3.03 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.257 1.027 . . . . 0.0 109.216 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.553 HD13 ' HG2' ' A' ' 12' ' ' GLU . 11.7 tp . . . . . 0 N--CA 1.438 -1.066 0 CA-C-N 113.571 -1.65 . . . . 0.0 110.383 -174.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' VAL . 82.9 mt-30 -57.89 -45.49 86.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.379 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.78 78.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.115 0.483 . . . . 0.0 110.734 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -70.93 -45.21 64.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.562 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' C ' HD21 ' A' ' 14' ' ' LEU . 30.1 mmtp -58.77 -39.38 80.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.397 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 98.1 t -64.81 -36.28 77.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.735 0.302 . . . . 0.0 110.372 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.425 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 25.6 mm-40 -64.4 -46.98 80.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.906 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.71 -38.71 78.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.246 0.546 . . . . 0.0 109.922 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -60.32 -40.47 90.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.381 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 95.9 mt -71.13 -38.79 72.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.244 0.545 . . . . 0.0 110.888 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -76.72 -32.41 57.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.487 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -75.33 -23.82 57.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.082 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -83.77 -32.72 25.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.288 0.566 . . . . 0.0 110.541 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.07 35.69 4.71 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.753 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.5 mm -74.75 126.19 88.74 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -71.59 144.89 45.7 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.079 1.853 . . . . 0.0 112.596 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 59.37 23.84 12.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.418 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.89 -42.6 73.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 -177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.64 -0.52 34.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.924 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -88.92 -11.23 45.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.014 0.435 . . . . 0.0 110.242 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.26 157.26 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.288 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -106.44 130.33 54.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.854 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.437 HG21 ' HB ' ' A' ' 31' ' ' VAL . 34.4 mm -90.54 135.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.337 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 27.0 mt-30 -132.86 140.34 47.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.956 175.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mm -118.35 120.65 65.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.48 60.46 1.01 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.068 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 53.68 76.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.039 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 86.59 20.72 53.55 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.641 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 82' ' ' SER . 3.1 ttmp? -146.69 124.21 11.73 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 122.682 -0.305 . . . . 0.0 110.479 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 83' ' ' VAL . . . -104.79 91.53 3.88 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.783 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.545 HG23 ' HB3' ' A' ' 84' ' ' ASP . 58.7 m -80.41 109.42 14.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.151 0.501 . . . . 0.0 109.899 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 12.2 p -93.83 136.87 24.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.124 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 86' ' ' GLN . 1.4 m -132.01 157.17 44.82 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.0 171.62 29.48 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -155.15 144.52 21.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.873 0.368 . . . . 0.0 110.803 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.25 18.19 31.97 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.165 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.36 178.24 4.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.993 0.425 . . . . 0.0 111.265 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -111.68 170.28 8.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.959 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 47.8 tp60 -57.47 -53.57 56.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' HG3' ' NH1' ' A' ' 145' ' ' ARG . 39.5 tt0 -57.33 -49.37 76.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.175 -174.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.01 -49.12 77.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.688 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.508 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 41.6 tttp -45.94 -52.81 10.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.45 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 72' ' ' VAL . 53.7 mt-10 -74.79 -28.55 60.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.937 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 65' ' ' GLU . 13.4 tptm -63.32 -42.74 99.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.407 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.06 -49.65 80.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 77.3 mt -48.41 -47.42 37.84 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.164 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 68' ' ' GLU . 39.7 t -66.2 -52.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.308 0.575 . . . . 0.0 111.1 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.31 -30.35 70.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.565 -172.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -83.43 -23.15 8.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.061 0.457 . . . . 0.0 111.234 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.628 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -78.01 -33.06 42.28 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.821 176.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -80.15 61.28 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.716 0.293 . . . . 0.0 110.812 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.571 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 23.3 mm -122.51 132.71 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 t -65.22 101.81 0.59 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 173.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.427 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 126.8 -17.37 6.4 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.645 -172.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.571 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 39.2 mm -102.14 121.11 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.292 0.568 . . . . 0.0 110.822 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.796 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -98.86 -33.97 10.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.704 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 25.4 m -147.24 160.34 42.6 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.49 HG22 ' HB3' ' A' ' 55' ' ' ALA . 55.7 t -132.34 121.72 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.671 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.545 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.5 t70 -97.58 106.53 18.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.267 0.556 . . . . 0.0 109.597 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.98 115.64 9.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.034 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 26.7 mt-30 -125.86 35.05 4.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.305 171.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.02 118.86 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.959 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -86.4 131.88 34.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.824 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.6 p -104.39 120.81 42.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.056 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.88 -25.14 43.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.73 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -127.94 127.37 23.9 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.884 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.25 155.92 10.99 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.078 2.519 . . . . 0.0 112.25 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -160.27 -157.97 0.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.463 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -71.81 121.09 18.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.875 0.369 . . . . 0.0 111.231 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.35 146.46 27.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.697 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.8 m -123.22 157.97 31.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.66 0.743 . . . . 0.0 112.258 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -96.46 155.38 16.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.278 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -113.52 96.08 5.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.873 0.368 . . . . 0.0 110.776 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 90.3 t80 -96.23 142.63 28.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.453 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.8 m -109.13 120.86 43.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.517 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.3 m -72.21 139.89 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.7 mmtp -109.76 -165.9 1.05 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.002 0.429 . . . . 0.0 111.257 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 m -67.55 114.69 6.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.63 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.85 13.13 57.08 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.973 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 11.5 m-20 -94.48 123.53 37.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.346 0.593 . . . . 0.0 110.837 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 110' ' ' ILE . 24.7 p -111.39 155.85 22.51 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.346 174.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.532 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 2.3 pt? -55.52 -36.59 66.89 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.409 -176.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 m -66.32 -44.78 82.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.683 0.278 . . . . 0.0 110.804 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.32 -42.33 96.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.039 0.447 . . . . 0.0 110.831 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 99' ' ' TYR . 1.4 pp -76.17 -25.11 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.3 t -66.0 -45.06 82.94 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -58.95 -33.77 71.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.345 0.593 . . . . 0.0 109.678 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.1 tp-100 -65.75 -56.82 10.0 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.53 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -86.3 -47.85 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.442 -171.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.454 ' HB3' HD12 ' A' ' 120' ' ' LEU . 54.2 m-85 -82.48 -37.99 24.55 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.183 0.516 . . . . 0.0 110.695 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 106.92 -14.06 41.15 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -129.33 128.36 42.97 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.516 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -72.39 -24.9 61.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.747 -175.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -74.07 -0.19 15.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 0.0 111.92 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 115' ' ' TYR . 72.3 mt -96.13 15.68 20.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.149 0.499 . . . . 0.0 110.764 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 53.6 p90 -62.83 -27.46 69.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.137 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.551 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 4.6 p30 -67.0 -35.2 79.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.869 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -60.07 -31.67 70.23 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.425 0.631 . . . . 0.0 110.059 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.586 HG22 ' OD1' ' A' ' 128' ' ' ASN . 39.3 mt -79.17 -52.09 15.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.448 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.433 ' CE2' ' HD3' ' A' ' 129' ' ' LYS . 76.6 t80 -49.76 -48.83 50.05 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.085 0.469 . . . . 0.0 111.355 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 42.6 mt-10 -63.63 -25.9 68.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -94.77 -10.22 32.22 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.761 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.761 ' O ' ' HG3' ' A' ' 131' ' ' MET . 8.9 m120 -94.54 -43.97 8.08 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.444 ' HA ' ' H ' ' A' ' 132' ' ' LEU . 40.6 pttt -60.03 147.36 80.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.416 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -90.56 11.5 58.48 Favored 'Cis proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.554 -1.436 . . . . 0.0 114.574 6.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.761 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -81.05 -7.57 59.59 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.481 0.658 . . . . 0.0 110.297 174.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.47 ' HB3' ' CB ' ' A' ' 128' ' ' ASN . 12.9 tp -132.84 112.06 11.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.827 166.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.07 -26.5 20.23 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 25.5 m -151.49 153.82 32.69 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.353 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -53.17 -48.55 21.46 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 C-N-CA 123.197 2.598 . . . . 0.0 112.397 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -82.27 6.91 15.3 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.893 -175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 134' ' ' SER . 37.8 mmtm -89.79 -4.62 57.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.577 0.227 . . . . 0.0 111.441 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.634 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 15.8 pt -63.02 171.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 174.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -163.11 147.94 9.25 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.099 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -51.11 104.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.213 2.609 . . . . 0.0 112.251 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.08 35.19 1.85 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.218 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.634 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 45.8 tt0 -117.13 121.96 42.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.881 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 48.6 t -80.16 136.05 24.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.963 174.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.0 mt -124.31 145.18 49.57 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.067 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.558 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 37.3 ttt180 -73.51 117.06 14.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.593 176.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.7 88.66 4.5 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.961 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 24.7 Cg_exo -63.83 166.47 15.98 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.361 2.041 . . . . 0.0 111.927 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--N 1.321 -0.653 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.704 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 83' ' ' VAL . 58.8 tp . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -103.7 134.49 46.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.592 -176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -96.06 132.57 41.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.732 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.524 ' CD2' HG21 ' A' ' 143' ' ' VAL . 50.2 m-85 -124.6 179.91 4.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.188 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.8 t -97.3 107.5 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 59.1 tttm -56.5 -51.74 67.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.337 -170.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.54 -12.81 61.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.026 0.441 . . . . 0.0 111.037 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.565 ' CB ' ' HA3' ' A' ' 141' ' ' GLY . . . -92.82 -164.06 1.13 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.528 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.94 -173.05 44.61 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.923 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.51 125.27 25.62 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -73.52 66.95 1.04 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.201 1.001 . . . . 0.0 109.541 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.435 HD21 ' O ' ' A' ' 30' ' ' LYS . 11.7 tp . . . . . 0 N--CA 1.439 -1.014 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.765 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 33.5 t70 . . . . . 0 C--O 1.23 0.063 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.579 ' O ' HG23 ' A' ' 31' ' ' VAL . 7.0 mm100 -60.37 -41.75 94.4 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.62 -43.2 65.25 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.926 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.3 tttm -64.2 -44.11 92.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.064 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 73.2 mmtt -61.85 -40.92 97.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.112 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.62 HG11 HG23 ' A' ' 74' ' ' VAL . 92.2 t -62.52 -45.1 99.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.355 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.558 ' HG2' HG13 ' A' ' 48' ' ' ILE . 7.8 mm-40 -55.96 -46.41 78.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.615 173.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 50.4 mt-10 -55.74 -47.39 77.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.349 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -54.78 -45.84 74.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.326 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 80.3 mt -68.0 -35.52 78.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.968 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -73.43 -34.49 65.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.897 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 98.7 mttt -69.11 -46.12 68.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.131 178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.8 p -64.29 -34.14 77.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.099 0.476 . . . . 0.0 110.764 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.53 34.39 4.45 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.503 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.421 ' HB ' ' CB ' ' A' ' 43' ' ' ALA . 7.8 mm -80.31 116.34 61.02 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.25 -49.08 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.958 2.439 . . . . 0.0 113.346 -171.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.44 -5.99 54.03 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.428 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.484 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -72.72 -17.89 61.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.326 0.584 . . . . 0.0 110.149 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.09 -14.62 59.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.891 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.52 -0.76 37.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.21 -172.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -117.3 162.57 15.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.148 0.499 . . . . 0.0 111.216 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.33 138.2 42.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.043 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.558 HG13 ' HG2' ' A' ' 32' ' ' GLN . 31.2 mm -100.37 130.26 49.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.631 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.503 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 98.4 mt-30 -129.98 136.27 49.24 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 172.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.25 119.37 59.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.022 0.439 . . . . 0.0 111.167 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 54' ' ' LYS . . . -100.46 59.53 0.98 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 172.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 70.15 -65.56 0.31 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.712 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 -17.62 6.49 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.246 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 40.7 ttmt -97.85 121.51 39.84 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.078 0.466 . . . . 0.0 110.718 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -100.38 114.62 28.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.078 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 47.3 m -92.9 123.81 36.43 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.836 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.02 125.16 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.813 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -131.59 143.34 50.27 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.479 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.9 174.56 36.93 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 p-10 -146.56 149.64 33.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.874 0.337 . . . . 0.0 110.325 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 84.4 22.69 53.49 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.263 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 89' ' ' THR . 7.0 mp -99.07 176.18 5.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.847 0.356 . . . . 0.0 110.42 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.6 p -113.24 154.21 27.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.162 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.657 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 2.3 mm100 -51.27 -47.61 62.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.492 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 7.4 tp10 -53.19 -48.6 67.94 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 111.051 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.19 -43.14 71.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.667 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.44 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 28.0 tttm -54.07 -45.22 71.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.735 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 6.1 mm-40 -60.72 -36.65 79.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.35 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -63.6 -40.09 96.06 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 67' ' ' LYS . 3.6 mm -60.34 -54.6 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 88.8 mt -52.6 -39.47 61.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.824 -1.535 . . . . 0.0 112.224 -174.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.529 HG21 ' HG2' ' A' ' 145' ' ' ARG . 42.9 t -76.74 -51.92 18.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.038 0.447 . . . . 0.0 110.878 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.53 72.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.716 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.62 HG23 HG11 ' A' ' 31' ' ' VAL . 9.1 p -80.47 -30.03 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.069 0.462 . . . . 0.0 110.849 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.33 -32.8 27.38 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.148 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.08 60.88 3.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 111.493 -178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.43 139.64 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.427 173.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 23.5 m -66.06 112.47 3.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.723 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.5 -28.09 5.59 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -173.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 46.0 mm -89.12 126.2 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.254 0.55 . . . . 0.0 110.475 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.94 -28.49 9.56 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.485 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.409 ' HA ' ' HD1' ' A' ' 6' ' ' PHE . 41.8 m -156.54 160.72 39.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.474 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 55.0 t -127.99 129.52 69.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.61 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -98.09 103.85 15.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.711 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -78.13 114.17 16.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.291 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -132.26 18.9 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.615 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.56 115.15 27.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.451 0.643 . . . . 0.0 110.825 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 57.1 mttm -73.68 133.49 43.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.197 -175.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 12.4 p -99.54 110.28 22.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.587 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.491 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -81.66 -21.58 38.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.655 -178.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 34.0 p -128.58 143.95 50.31 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 6.2 Cg_exo -77.38 140.28 19.23 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.296 2.664 . . . . 0.0 111.857 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.492 ' HB3' ' H ' ' A' ' 65' ' ' GLU . . . -162.14 -166.63 1.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.974 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.474 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 7.7 m -58.77 132.99 55.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.85 129.74 55.4 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 168.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.6 m -114.32 147.59 38.87 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.09 0.471 . . . . 0.0 111.67 -171.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.501 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 5.0 tt0 -80.5 136.17 36.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -99.6 100.39 11.39 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.084 0.469 . . . . 0.0 110.471 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.453 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 92.0 t80 -100.93 136.95 39.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.621 176.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.489 ' OG1' HG22 ' A' ' 143' ' ' VAL . 16.9 m -106.22 124.84 50.21 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.95 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.616 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.5 m -67.88 126.33 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -75.81 -56.89 4.24 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.289 -167.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.44 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 10.7 t -167.23 -71.05 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.773 0.32 . . . . 0.0 110.373 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.15 45.45 3.51 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.521 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 2.2 m-20 -103.06 143.1 33.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.119 0.485 . . . . 0.0 110.448 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 110' ' ' ILE . 61.6 p -122.11 159.58 26.84 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.827 173.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.55 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 30.9 tp -61.45 -36.88 81.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 118.506 0.593 . . . . 0.0 110.221 -174.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 p -69.79 -33.02 71.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.189 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HB3' ' H ' ' A' ' 106' ' ' THR . . . -73.4 -43.69 59.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.969 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 106' ' ' THR . 1.3 pp -74.82 -25.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.18 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.467 ' HB3' HD12 ' A' ' 124' ' ' ILE . 13.3 p -71.42 -43.06 67.47 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.182 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -65.82 -23.95 66.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 110.393 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.581 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.0 OUTLIER -66.28 -52.85 43.33 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.167 175.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 146' ' ' ILE . 34.1 m -89.99 -40.87 13.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.259 -171.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.414 ' N ' HG23 ' A' ' 114' ' ' VAL . 55.5 m-85 -88.9 -38.49 14.5 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.96 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.56 -8.02 59.91 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -169.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -124.42 125.95 45.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.64 -0.78 . . . . 0.0 109.576 -174.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.33 -8.76 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.308 . . . . 0.0 111.622 -175.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -76.52 -20.27 57.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.352 0.596 . . . . 0.0 109.754 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 50.7 mt -84.25 18.55 2.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.342 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.55 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 34.8 p90 -66.61 -33.75 76.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.349 0.595 . . . . 0.0 109.454 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -68.4 -35.26 77.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.267 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 27.7 mmmt -52.27 -54.52 30.29 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.611 0.72 . . . . 0.0 110.189 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 111' ' ' SER . 52.2 mt -63.2 -36.93 77.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.588 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 134' ' ' SER . 30.8 t80 -61.54 -56.35 20.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.746 0.308 . . . . 0.0 110.734 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 18.3 mt-10 -61.64 -37.31 83.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.159 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.83 -31.26 70.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.928 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.573 ' O ' ' HG3' ' A' ' 131' ' ' MET . 33.7 m-80 -93.18 8.69 39.14 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.366 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 9.1 mtpm? -84.9 153.83 60.68 Favored Pre-proline 0 C--N 1.318 -0.794 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.882 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -91.87 11.81 55.65 Favored 'Cis proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.946 -1.689 . . . . 0.0 112.752 -0.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.573 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -69.28 -24.38 63.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.708 0.289 . . . . 0.0 111.476 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.4 tp -98.48 121.68 40.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -74.68 -54.38 7.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.654 -172.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.494 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 49.5 m -156.44 157.66 31.12 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.722 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.409 ' HA ' HD22 ' A' ' 107' ' ' LEU . 83.2 Cg_exo -47.8 -56.53 3.01 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 124.002 3.135 . . . . 0.0 113.889 -175.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.6 3.9 26.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -91.92 7.82 40.27 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 120.886 0.374 . . . . 0.0 111.414 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.495 HD11 ' HA ' ' A' ' 106' ' ' THR . 19.1 pt -66.59 169.16 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.354 171.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -163.75 148.1 8.6 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.44 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 63.6 Cg_exo -46.13 120.47 3.67 Favored 'Trans proline' 0 CA--C 1.519 -0.267 0 C-N-CA 123.183 2.589 . . . . 0.0 112.621 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 94.21 24.68 18.64 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.297 -176.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.616 ' H ' HG22 ' A' ' 101' ' ' VAL . 7.3 tp60 -97.79 111.56 23.81 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.524 HG21 ' CD2' ' A' ' 6' ' ' PHE . 46.1 t -77.66 135.86 25.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.2 mt -130.9 137.59 49.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.829 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.529 ' HG2' HG21 ' A' ' 72' ' ' VAL . 25.4 mtm180 -69.1 123.31 20.72 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.083 174.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 24.9 mm -103.87 95.02 7.05 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.16 148.13 49.54 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.311 2.008 . . . . 0.0 111.799 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.489 -179.99 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 82' ' ' SER . 42.1 tp . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -105.99 129.18 54.17 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.597 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -99.32 134.8 41.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.548 0.69 . . . . 0.0 112.002 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 33.0 m-85 -121.19 -166.16 1.32 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.672 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 94.6 t -78.09 -83.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.571 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.3 tmtp? 163.53 -77.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.969 0.793 . . . . 0.0 109.167 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.4 -25.49 54.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.711 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.34 125.15 28.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.497 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.43 -172.35 32.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.737 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -69.62 131.07 44.07 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -78.55 66.25 4.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.199 0.999 . . . . 0.0 108.84 173.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.515 HD21 ' O ' ' A' ' 30' ' ' LYS . 16.1 tp . . . . . 0 N--CA 1.44 -0.96 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.902 -172.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.903 0.382 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -58.92 -38.36 78.78 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.884 174.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 48' ' ' ILE . . . -56.99 -45.93 82.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.707 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 60.0 tttp -67.34 -39.47 85.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.515 ' O ' HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -53.08 -47.64 68.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 110.554 175.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.57 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 86.9 t -65.62 -39.57 85.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.825 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.544 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -60.02 -44.2 94.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.274 -0.171 . . . . 0.0 110.558 174.011 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 66.5 mm-40 -54.86 -49.27 71.54 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.193 0.521 . . . . 0.0 110.315 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -55.04 -33.07 62.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.603 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 79.5 mt -81.87 -44.59 16.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.061 0.458 . . . . 0.0 110.989 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -69.14 -35.02 75.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.64 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -77.36 -31.54 54.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.568 0.223 . . . . 0.0 111.467 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -76.63 -39.28 52.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.676 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.92 28.64 4.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.222 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.5 mm -62.61 130.7 93.76 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.1 130.83 23.7 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.234 1.956 . . . . 0.0 112.679 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 62.63 12.08 5.27 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.253 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 35' ' ' LEU . . . -71.64 -17.41 62.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.381 0.61 . . . . 0.0 110.796 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.01 -22.08 39.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.491 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -84.61 -23.65 29.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.168 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.32 177.59 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.61 129.77 25.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.086 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.425 HG13 HG22 ' A' ' 57' ' ' VAL . 3.2 mp -96.57 131.01 44.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -126.12 118.35 25.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.0 110.426 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.7 mm -89.33 132.7 33.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.514 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.11 -81.42 0.61 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.375 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -152.42 101.81 2.7 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.66 13.23 50.53 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 82' ' ' SER . 34.7 mtmm -133.2 124.44 27.43 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 120.844 0.354 . . . . 0.0 111.113 -174.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.38 104.77 14.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.498 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 m -82.58 113.88 20.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.322 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.425 HG22 HG13 ' A' ' 48' ' ' ILE . 62.9 t -100.62 113.46 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-O 121.089 0.471 . . . . 0.0 110.711 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 1.3 m -110.26 158.66 18.16 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.075 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.6 157.65 8.29 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.23 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -137.08 151.47 48.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 86.85 38.55 7.96 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.98 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.2 163.93 18.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 0.0 111.201 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 m -106.01 151.21 24.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.54 173.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 11.2 mm100 -49.15 -48.23 45.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.33 -41.56 80.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.55 -42.31 64.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.259 0.552 . . . . 0.0 109.936 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.474 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 50.1 tttm -55.26 -51.66 65.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.48 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 4.9 mm-40 -67.89 -28.87 67.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.3 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -65.43 -37.25 86.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.148 0.499 . . . . 0.0 109.989 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.6 mt -70.09 -55.52 14.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.14 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 78.5 mt -50.06 -44.18 51.55 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.405 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.17 -34.55 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.964 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.57 -27.14 34.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.658 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.7 m -84.82 -22.5 7.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.223 0.535 . . . . 0.0 110.768 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -79.89 -35.51 27.76 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.32 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -79.91 55.84 2.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.025 0.44 . . . . 0.0 111.187 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.441 ' HB ' HG12 ' A' ' 80' ' ' ILE . 11.2 mm -118.67 138.13 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 t -68.21 92.07 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.241 0.543 . . . . 0.0 109.95 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.1 -19.93 3.05 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 77' ' ' ILE . 48.2 mm -97.16 131.59 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.254 0.55 . . . . 0.0 110.026 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -124.27 -3.37 7.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.755 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -164.78 147.2 8.38 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.225 -179.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.25 122.79 69.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.782 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.51 92.05 7.41 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.28 123.08 20.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.508 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.406 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 81.8 mm-40 -126.49 14.65 7.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.053 177.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 89' ' ' THR . 52.1 t -73.92 118.54 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.12 0.486 . . . . 0.0 109.776 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -89.14 4.94 46.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.267 -170.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.455 ' H ' HG12 ' A' ' 87' ' ' VAL . 32.0 p 44.95 -153.92 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.765 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.571 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -173.29 -41.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -118.16 131.97 23.95 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.564 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.8 144.34 48.21 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.868 2.379 . . . . 0.0 112.434 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 64' ' ' GLN . . . -158.74 -178.46 7.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.222 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.2 m -66.72 126.21 28.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.142 0.496 . . . . 0.0 111.258 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.53 164.47 20.85 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.8 m -121.37 145.13 48.21 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.622 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.447 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.5 tt0 -84.77 140.96 30.86 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -110.19 102.95 11.59 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.027 0.441 . . . . 0.0 110.504 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -106.27 133.52 50.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.011 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.444 ' OG1' HG22 ' A' ' 143' ' ' VAL . 7.8 m -100.02 122.46 42.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.346 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.577 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.7 m -71.21 136.3 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.406 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 40.7 mmtm -84.44 -163.9 0.87 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.451 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 1.6 p -60.33 -64.51 0.93 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.97 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.87 46.67 2.48 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.194 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.544 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 7.4 m-20 -104.79 127.81 52.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.131 0.491 . . . . 0.0 110.92 -177.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.549 ' O ' HG23 ' A' ' 110' ' ' ILE . 40.6 m -114.93 153.06 31.23 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.929 177.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 29.1 tp -51.97 -49.98 62.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.785 0.266 . . . . 0.0 111.63 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.456 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 m -66.66 -27.09 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.214 0.531 . . . . 0.0 111.156 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.572 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -73.33 -40.64 64.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.811 0.339 . . . . 0.0 110.375 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 106' ' ' THR . 1.2 pp -79.71 -25.29 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.106 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.3 p -70.28 -38.67 75.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.032 0.444 . . . . 0.0 109.824 173.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 5.6 tmtm? -58.71 -35.84 73.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.449 173.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 13.6 mm100 -59.72 -65.05 0.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 122.241 1.02 . . . . 0.0 111.267 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -81.97 -37.47 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 113.679 -1.6 . . . . 0.0 112.643 -165.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.478 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 55.5 m-85 -89.58 -45.25 9.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.292 0.568 . . . . 0.0 110.65 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.86 -14.72 26.58 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.475 ' HB3' ' HG ' ' A' ' 120' ' ' LEU . 56.7 t-20 -123.19 121.71 36.61 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.85 62.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.619 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -65.64 -21.63 66.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.07 0.462 . . . . 0.0 110.765 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.598 HD13 ' HE2' ' A' ' 123' ' ' LYS . 42.2 mt -79.78 29.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.703 -176.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 50.1 p90 -72.17 -35.27 68.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.166 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.403 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 24.7 t-20 -71.05 -31.82 68.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.948 -176.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.598 ' HE2' HD13 ' A' ' 120' ' ' LEU . 22.0 mtmt -52.44 -44.78 65.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.365 0.602 . . . . 0.0 110.439 173.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.413 HG22 ' OD1' ' A' ' 128' ' ' ASN . 46.2 mt -70.1 -44.67 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.278 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -52.97 -47.81 67.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.655 0.264 . . . . 0.0 111.043 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 31.7 mt-10 -66.03 -29.98 70.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.402 . . . . 0.0 110.908 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.07 -25.11 40.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.364 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 131' ' ' MET . 7.0 m120 -84.75 -41.87 15.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.106 0.479 . . . . 0.0 109.715 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 18.6 pttp -64.62 155.99 79.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.595 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 92.7 Cg_endo -81.97 17.69 18.8 Favored 'Cis proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.436 -1.485 . . . . 0.0 113.448 2.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.526 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -74.49 -36.27 63.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.874 0.368 . . . . 0.0 110.32 174.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.1 tp -88.95 126.81 35.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.014 0.435 . . . . 0.0 109.867 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -88.09 -38.77 15.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.426 -173.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.414 ' HB2' ' HG2' ' A' ' 137' ' ' LYS . 29.1 m -153.56 153.09 28.58 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.36 -18.41 38.92 Favored 'Trans proline' 0 C--O 1.23 0.089 0 C-N-CA 123.54 2.827 . . . . 0.0 112.312 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -101.95 -5.67 24.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.807 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 25.6 mmmt -86.28 10.19 15.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.469 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.464 HD11 ' HA ' ' A' ' 106' ' ' THR . 9.0 pt -62.88 173.69 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.189 170.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.572 ' CE1' ' HG2' ' A' ' 142' ' ' GLN . 5.9 p90 -166.19 150.85 7.34 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -175.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 84.9 Cg_exo -49.57 102.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.258 2.639 . . . . 0.0 112.656 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.41 ' CA ' HG21 ' A' ' 7' ' ' VAL . . . 113.33 23.53 5.12 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.473 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.577 ' H ' HG22 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -91.33 109.78 21.07 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.444 HG22 ' OG1' ' A' ' 100' ' ' THR . 39.3 t -80.58 122.2 35.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.448 0.642 . . . . 0.0 110.052 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.437 HD22 ' OD1' ' A' ' 128' ' ' ASN . 75.6 mt -117.39 139.91 50.26 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.863 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.454 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 48.4 mtp180 -69.79 119.09 13.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.084 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 31.7 mm -105.32 98.49 16.73 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.478 ' HD2' ' OH ' ' A' ' 115' ' ' TYR . 47.9 Cg_exo -56.64 154.04 32.96 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.827 2.351 . . . . 0.0 111.706 175.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--N 1.32 -0.706 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.21 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.7 tp . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.047 0.451 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -100.73 125.2 47.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.044 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -103.3 140.59 37.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.828 0.346 . . . . 0.0 110.648 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 73.5 m-85 -126.24 -161.14 1.03 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.751 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.95 HG11 ' HB3' ' A' ' 10' ' ' ALA . 7.3 p -79.75 -25.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.643 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 16.9 tptm 79.06 -66.26 0.19 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.488 0.715 . . . . 0.0 112.003 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.97 -36.01 36.73 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.742 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.95 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -79.17 152.17 30.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.498 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.65 -172.24 24.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.112 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -62.89 128.77 37.43 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.54 65.62 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.038 0.923 . . . . 0.0 108.969 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 77' ' ' ILE . 11.2 tp . . . . . 0 N--CA 1.436 -1.129 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.161 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.977 0.418 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.417 ' OE1' HG21 ' A' ' 50' ' ' ILE . 98.9 mt-30 -65.04 -30.22 71.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.055 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.33 89.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.503 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.575 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 87.7 tttt -68.32 -36.84 79.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.177 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' HD21 ' A' ' 14' ' ' LEU . 3.2 mptp? -58.63 -43.07 89.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.423 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 95.3 t -64.2 -44.61 97.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.218 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -52.25 -50.36 62.22 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.693 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 48.6 mt-10 -56.16 -51.66 67.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.181 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -53.72 -42.68 68.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.331 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 93.0 mt -70.13 -41.04 74.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.53 -39.48 67.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.189 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 74.6 mmtt -63.98 -36.86 85.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.152 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 p -78.74 -38.81 37.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.141 0.496 . . . . 0.0 110.868 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.41 31.95 4.43 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.998 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.2 mm -63.2 127.35 90.87 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -59.78 130.56 35.56 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.484 2.123 . . . . 0.0 112.729 -175.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.28 26.5 15.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.198 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.94 -17.15 64.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.192 0.52 . . . . 0.0 110.718 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -84.18 -16.25 44.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.639 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -86.04 -35.09 20.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.998 0.428 . . . . 0.0 110.363 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.2 m -83.73 166.25 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.554 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -134.33 131.05 37.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.542 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 mp -108.23 139.16 31.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.636 0.255 . . . . 0.0 110.652 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -123.89 140.8 52.63 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 172.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.417 HG21 ' OE1' ' A' ' 27' ' ' GLN . 11.1 mm -118.14 133.05 66.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.9 0.381 . . . . 0.0 111.107 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.28 91.86 2.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.894 174.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.4 t70 65.9 -75.82 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.829 0.705 . . . . 0.0 111.215 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.38 6.2 4.6 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -98.68 110.88 23.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.809 0.338 . . . . 0.0 110.235 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.634 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -103.51 106.44 16.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.028 176.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 84' ' ' ASP . 33.5 m -92.72 115.97 28.59 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.638 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.91 120.46 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.083 0.468 . . . . 0.0 110.295 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.22 160.47 21.54 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.09 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.21 178.3 28.48 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 6.3 p-10 -167.51 155.12 8.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.908 0.385 . . . . 0.0 110.513 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.34 15.99 63.27 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.145 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -95.56 -167.69 1.65 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.658 0.742 . . . . 0.0 110.723 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -124.19 152.27 43.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.241 -1.345 . . . . 0.0 108.658 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 51.7 tt0 -58.18 -42.02 85.18 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -166.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG3' ' HB1' ' A' ' 93' ' ' ALA . 45.5 mt-10 -54.54 -48.83 71.53 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.611 0.243 . . . . 0.0 111.374 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.84 75.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.216 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.545 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 49.7 tttp -49.35 -53.43 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.452 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 72' ' ' VAL . 54.1 mt-10 -62.03 -48.01 82.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -59.98 -38.48 82.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 74' ' ' VAL . 57.8 mt -62.02 -56.1 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.085 174.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 91.0 mt -49.16 -42.11 38.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.105 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 68' ' ' GLU . 40.9 t -72.7 -44.63 59.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.902 0.382 . . . . 0.0 110.957 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.12 -35.58 81.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 70' ' ' ILE . 11.3 p -79.15 -26.83 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.328 0.585 . . . . 0.0 110.423 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -77.02 -11.82 85.22 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.535 173.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.532 ' OD1' ' HG3' ' A' ' 142' ' ' GLN . 5.8 m-80 -97.64 39.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.725 -0.238 . . . . 0.0 110.714 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.536 HD12 HD22 ' A' ' 14' ' ' LEU . 10.8 mm -115.44 132.38 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.4 t -65.46 99.25 0.41 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.4 -15.66 3.9 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.025 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.634 HD12 ' HB2' ' A' ' 55' ' ' ALA . 43.2 mm -96.78 121.65 47.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.157 0.503 . . . . 0.0 111.069 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.643 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -96.75 -37.19 10.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.393 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 p -150.87 154.2 36.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.456 0.646 . . . . 0.0 111.612 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 53.0 t -117.71 122.77 70.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.587 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 56' ' ' THR . 7.1 t70 -91.78 93.37 8.83 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -71.78 112.51 7.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.157 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -128.06 14.77 6.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.544 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 p -93.62 129.7 43.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.189 0.519 . . . . 0.0 111.4 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -96.77 158.22 15.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.068 -177.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.5 p -124.58 136.45 53.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.431 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.98 -28.07 16.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.608 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 p -123.07 138.89 30.5 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.852 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.53 160.16 28.63 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.785 2.323 . . . . 0.0 111.664 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 65' ' ' GLU . . . -159.06 -167.31 2.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.938 -177.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 88.4 m -57.95 138.7 55.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.483 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -108.01 125.25 51.31 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.347 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.1 m -110.69 146.49 36.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.424 0.63 . . . . 0.0 111.286 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 15.8 tt0 -87.86 138.82 31.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.772 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -98.13 94.09 6.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.12 0.486 . . . . 0.0 110.699 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -95.74 136.3 36.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.044 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.492 ' OG1' HG22 ' A' ' 143' ' ' VAL . 7.5 m -106.66 122.9 47.27 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.568 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -67.82 128.55 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -82.13 -57.9 3.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.861 -167.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 140' ' ' PRO . 12.0 p -156.98 -87.61 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.112 -176.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.97 49.83 2.93 Favored Glycine 0 C--N 1.329 0.19 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.568 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -97.46 120.05 37.12 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.937 -0.631 . . . . 0.0 110.941 -174.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 110' ' ' ILE . 58.7 p -112.61 163.3 14.68 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -63.07 -40.45 97.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 118.837 0.744 . . . . 0.0 110.573 -174.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.514 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 15.6 m -69.98 -23.07 63.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 110.43 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.461 ' HB3' ' H ' ' A' ' 106' ' ' THR . . . -80.82 -47.42 13.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.236 -0.29 . . . . 0.0 110.759 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.608 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.4 pp -72.46 -23.57 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.141 -177.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 p -73.93 -48.01 33.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.729 0.3 . . . . 0.0 110.237 173.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -61.16 -21.84 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.451 0.643 . . . . 0.0 110.208 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.608 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 6.4 tp60 -71.84 -58.43 3.47 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.161 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.0 m -85.39 -39.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.045 -172.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -88.48 -57.21 3.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.548 0.689 . . . . 0.0 110.43 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.04 -23.81 6.46 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.644 -171.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -105.52 124.09 48.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.079 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -72.12 -21.03 61.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.206 0.526 . . . . 0.0 110.346 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.85 -22.53 65.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.114 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.8 mt -84.29 16.13 3.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.191 -0.458 . . . . 0.0 112.202 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.451 ' HD1' ' O ' ' A' ' 118' ' ' ALA . 40.0 p90 -64.46 -27.27 68.87 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -54.82 -55.04 34.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.24 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -50.27 -51.75 42.19 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.474 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.491 HG22 ' OD1' ' A' ' 128' ' ' ASN . 35.8 mt -62.98 -45.17 99.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.419 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.483 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 62.6 t80 -56.7 -49.48 74.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.985 0.422 . . . . 0.0 110.846 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.528 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 17.4 mt-10 -70.02 -23.62 63.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.981 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.71 -28.88 30.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.262 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.653 ' O ' ' HG3' ' A' ' 131' ' ' MET . 7.0 m120 -81.62 -10.83 59.32 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 28.8 mtpp -76.27 153.38 84.17 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.704 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -91.95 13.43 51.71 Favored 'Cis proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.762 -1.766 . . . . 0.0 112.814 -0.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.653 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -76.25 -13.95 60.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.672 0.273 . . . . 0.0 111.71 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.3 tp -99.07 125.8 44.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 171.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -73.61 -56.62 4.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.966 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.2 m -153.22 155.65 31.99 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.003 0.43 . . . . 0.0 109.988 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.405 ' HA ' HD12 ' A' ' 107' ' ' LEU . 24.2 Cg_exo -65.23 -27.24 56.27 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.906 3.071 . . . . 0.0 113.447 -170.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -99.76 0.87 42.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.99 0.424 . . . . 0.0 110.231 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -96.17 12.45 30.79 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.139 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.431 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 15.5 pt -72.57 168.51 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -158.78 144.06 11.93 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.143 -171.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.458 ' HG3' ' O ' ' A' ' 103' ' ' SER . 87.3 Cg_exo -49.41 110.11 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.605 2.87 . . . . 0.0 112.387 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.35 3.19 10.57 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.185 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.532 ' HG3' ' OD1' ' A' ' 76' ' ' ASN . 46.0 tt0 -93.13 118.21 30.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.518 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.492 HG22 ' OG1' ' A' ' 100' ' ' THR . 50.3 t -80.15 134.18 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.459 170.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 76.5 mt -130.21 147.98 51.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.575 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.405 ' HG2' HG21 ' A' ' 72' ' ' VAL . 25.6 mtm180 -77.41 119.11 20.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.972 175.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 38.9 mm -103.85 102.37 30.77 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.02 143.18 90.4 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.113 1.875 . . . . 0.0 110.746 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.571 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 20.1 tp . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.006 0.431 . . . . 0.0 109.953 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -101.21 123.32 45.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.374 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -78.77 141.54 37.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.539 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.566 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 93.6 m-85 -134.54 175.18 9.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.565 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.522 HG21 ' HA2' ' A' ' 141' ' ' GLY . 22.6 t -78.03 -15.06 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.791 -167.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.668 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 26.6 tptp 74.34 -49.82 0.67 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.946 0.498 . . . . 0.0 112.027 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -91.01 -36.06 14.29 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.73 0.3 . . . . 0.0 111.567 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.07 155.51 20.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.083 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.37 -160.91 24.34 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -76.58 125.46 29.28 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -86.07 65.47 9.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.482 0.658 . . . . 0.0 111.081 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.6 mt . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.549 178.631 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 34.5 t70 . . . . . 0 CA--C 1.521 -0.152 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.478 ' HB2' HG13 ' A' ' 50' ' ' ILE . 22.7 mt-30 -59.03 -41.49 87.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.729 174.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB2' HG12 ' A' ' 50' ' ' ILE . . . -57.71 -43.15 85.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.852 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 61.1 tttp -63.51 -44.81 93.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.373 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 12.9 mptt -57.71 -42.16 83.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.576 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.491 HG11 HG13 ' A' ' 74' ' ' VAL . 95.7 t -68.65 -41.92 82.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.892 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.51 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 2.9 mm-40 -56.45 -48.67 76.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.071 174.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 53.7 mt-10 -60.28 -40.59 90.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.817 0.341 . . . . 0.0 110.441 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -56.52 -38.24 71.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.212 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 88.7 mt -72.96 -43.63 62.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.2 0.524 . . . . 0.0 110.864 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -72.49 -35.7 68.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.48 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -71.9 -27.07 62.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.563 0.22 . . . . 0.0 111.56 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 p -83.85 -39.36 20.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.182 0.515 . . . . 0.0 110.514 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.85 31.14 3.73 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.806 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 30.5 mm -66.44 127.31 93.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -64.28 139.4 65.65 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.055 1.836 . . . . 0.0 112.509 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 57.18 24.8 10.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.103 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -72.17 -17.67 61.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.271 0.558 . . . . 0.0 110.175 176.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.93 -19.92 36.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.026 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -83.0 -24.71 32.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.759 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.11 179.66 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.506 -177.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 27.0 t-20 -144.87 138.38 26.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.46 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.51 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 14.9 mm -108.48 126.56 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 123.26 0.35 . . . . 0.0 110.836 -175.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -132.18 123.21 26.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.115 0.483 . . . . 0.0 110.39 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 27' ' ' GLN . 26.8 mm -98.4 112.4 30.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.396 -173.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.85 86.4 2.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.844 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 67.53 -76.58 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.422 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.45 -2.3 4.08 Favored Glycine 0 N--CA 1.454 -0.138 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.607 ' HG2' ' HB3' ' A' ' 82' ' ' SER . 38.3 mtmm -99.0 118.7 36.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.817 0.341 . . . . 0.0 110.682 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -94.65 106.75 18.74 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.947 176.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.411 ' CG2' HE21 ' A' ' 86' ' ' GLN . 27.9 m -82.99 113.14 20.36 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 120.766 0.317 . . . . 0.0 110.322 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 97.6 t -99.67 109.99 25.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.199 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 m -104.9 164.38 11.83 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.871 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.5 172.65 28.04 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -162.66 148.08 12.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.987 0.422 . . . . 0.0 110.056 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 97.5 6.97 57.23 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.103 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 89' ' ' THR . 6.8 mp -95.81 169.86 9.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.057 0.456 . . . . 0.0 110.856 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -110.66 154.9 23.17 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.658 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 7.5 tp60 -50.36 -47.79 55.93 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -173.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.46 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 43.9 mt-10 -52.17 -40.31 61.27 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -176.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.05 -45.53 13.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 110.338 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.491 ' HE3' ' OD1' ' A' ' 85' ' ' ASP . 75.7 tttt -51.54 -59.52 4.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.133 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 26.1 pt-20 -67.29 -18.07 65.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -72.33 -35.19 68.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.467 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.5 -46.56 92.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 10.1 mp -46.13 -43.62 15.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.652 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.627 HG21 ' HB2' ' A' ' 145' ' ' ARG . 39.9 t -63.13 -58.92 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.379 0.609 . . . . 0.0 111.117 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.3 64.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.347 -173.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.491 HG13 HG11 ' A' ' 31' ' ' VAL . 53.3 t -87.61 -29.19 5.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 0.0 110.712 177.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.566 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -75.98 -34.46 47.43 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.824 177.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -79.92 58.73 2.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.608 0.242 . . . . 0.0 110.849 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.559 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 29.7 mm -124.7 130.42 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.1 m -66.13 102.81 0.87 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.52 -17.86 5.51 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.481 -172.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.559 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 38.9 mm -100.46 126.23 54.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.195 0.522 . . . . 0.0 110.729 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.668 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -105.27 -17.18 14.55 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.297 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.607 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . 16.1 t -166.96 167.23 14.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.204 0.525 . . . . 0.0 110.763 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.23 125.38 47.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.809 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -98.42 90.81 4.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.491 ' OD1' ' HE3' ' A' ' 67' ' ' LYS . 2.9 t70 -66.75 124.2 22.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.153 -177.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.411 HE21 ' CG2' ' A' ' 56' ' ' THR . 31.8 mt-30 -134.67 27.03 3.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.239 175.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -85.96 127.05 40.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.889 0.376 . . . . 0.0 110.267 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -91.95 127.78 37.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.18 0.514 . . . . 0.0 111.005 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.2 p -89.86 124.47 34.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.416 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.466 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -79.77 -38.37 33.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.758 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.8 p -127.13 150.59 72.62 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.892 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.31 141.73 52.64 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.339 2.693 . . . . 0.0 112.063 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -156.47 174.37 15.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.807 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.1 m -67.95 127.87 34.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.265 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.76 127.86 42.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.588 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 146' ' ' ILE . 14.1 m -106.03 171.55 7.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.124 0.488 . . . . 0.0 111.71 -175.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.617 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 13.7 tt0 -89.59 153.7 20.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.322 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -111.78 91.5 3.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -98.79 118.68 36.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.34 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.8 m -85.59 121.03 27.7 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.057 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 142' ' ' GLN . 1.5 m -69.34 136.74 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -105.7 -166.16 1.18 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.985 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.415 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 49.5 m -62.02 116.84 5.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.108 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.39 18.23 64.82 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.658 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 9.3 m-20 -90.93 114.46 26.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.128 0.49 . . . . 0.0 110.833 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 110' ' ' ILE . 21.7 p -110.02 162.0 14.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.084 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 16.1 tp -62.02 -41.46 98.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 118.391 0.541 . . . . 0.0 111.356 -169.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.3 p -69.32 -27.33 65.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.213 0.53 . . . . 0.0 110.972 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.91 -41.78 50.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -78.89 -23.65 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.465 -176.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.3 p -71.11 -41.01 71.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 172.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 4.9 tmmm? -60.19 -29.87 68.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.986 171.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.9 OUTLIER -67.71 -63.52 1.04 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.018 177.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 115' ' ' TYR . 35.3 m -76.22 -46.3 33.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.406 -171.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.455 ' N ' HG23 ' A' ' 114' ' ' VAL . 59.6 m-85 -90.91 -30.94 16.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.193 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 92.47 -2.92 74.72 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -170.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.446 ' HB3' HD12 ' A' ' 120' ' ' LEU . 16.3 t-20 -126.08 110.63 13.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.738 -0.731 . . . . 0.0 109.876 -173.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.44 -31.77 72.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.455 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -69.43 -14.75 63.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.627 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 117' ' ' ASN . 50.5 mt -83.83 17.32 2.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.821 0.343 . . . . 0.0 111.318 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 31.3 p90 -66.58 -27.48 67.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.08 0.467 . . . . 0.0 110.106 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.521 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 25.7 p-10 -66.69 -33.69 76.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -57.25 -52.45 65.27 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.579 0.704 . . . . 0.0 109.495 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.9 mt -66.53 -40.21 85.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.251 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.564 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 20.4 t80 -54.27 -60.01 3.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.538 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.526 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 24.5 mt-10 -61.72 -34.5 75.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.689 -176.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.426 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -68.57 -31.29 70.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.835 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 131' ' ' MET . 36.4 m-80 -91.34 -18.78 23.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 28.4 mtpp -67.08 151.7 96.85 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.434 176.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -87.67 15.35 44.47 Favored 'Cis proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.987 -1.672 . . . . 0.0 113.474 1.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.3 OUTLIER -67.75 -33.18 74.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.024 0.44 . . . . 0.0 110.281 177.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.434 HD11 HG23 ' A' ' 138' ' ' ILE . 0.1 OUTLIER -97.46 131.01 44.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -85.0 -49.56 8.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.598 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.467 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 46.5 p -154.08 161.45 29.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.973 0.416 . . . . 0.0 110.441 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.98 -15.29 48.35 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 123.631 2.887 . . . . 0.0 111.944 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -103.69 -16.34 15.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.206 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -81.74 -6.92 59.48 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 106' ' ' THR . 12.1 pt -65.6 168.53 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 0.0 110.709 172.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -165.06 148.29 7.2 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.476 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.415 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 75.1 Cg_exo -43.78 115.13 0.62 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.51 2.807 . . . . 0.0 112.806 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.522 ' HA2' HG21 ' A' ' 7' ' ' VAL . . . 109.51 6.89 28.67 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.445 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.575 ' O ' HG13 ' A' ' 101' ' ' VAL . 6.5 mm100 -87.7 110.08 20.17 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 41.5 t -77.63 119.63 26.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.403 0.62 . . . . 0.0 109.887 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.8 132.55 53.89 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.183 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.627 ' HB2' HG21 ' A' ' 72' ' ' VAL . 36.1 ttt180 -75.56 110.47 9.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.656 175.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 18.1 mm -94.08 108.63 36.86 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 34.8 Cg_exo -58.31 153.14 48.86 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.591 2.194 . . . . 0.0 111.938 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.602 176.973 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.5 tp . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.519 ' HB2' HG12 ' A' ' 83' ' ' VAL . 74.7 m-85 -99.47 125.29 45.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.362 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.32 144.64 28.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.946 -178.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.591 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 68.3 m-85 -130.07 -162.48 1.21 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.951 0.405 . . . . 0.0 111.658 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.946 HG11 ' HB3' ' A' ' 10' ' ' ALA . 5.9 p -73.32 -25.71 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.996 -176.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.753 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 49.9 tptt 78.17 -56.97 0.48 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.457 0.703 . . . . 0.0 111.575 -176.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.91 -47.99 14.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.946 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -73.71 151.79 40.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.889 0.376 . . . . 0.0 110.907 -176.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.83 173.94 14.29 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.437 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.18 125.49 24.23 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 122.485 0.314 . . . . 0.0 110.179 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 96.1 mttt -90.28 83.35 5.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.957 0.408 . . . . 0.0 110.892 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 34' ' ' HIS . 1.7 mm? . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 121.479 0.657 . . . . 0.0 109.392 175.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 CA--C 1.522 -0.115 0 CA-C-O 120.966 0.412 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' VAL . 28.1 mt-30 -67.3 -17.38 64.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 171.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 48' ' ' ILE . . . -59.92 -42.22 93.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.053 171.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -63.15 -42.36 99.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 3.6 mptp? -54.46 -36.87 64.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.264 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.561 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 96.0 t -69.36 -46.09 77.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.641 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.426 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 16.5 mm-40 -56.9 -42.04 79.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.97 174.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -57.62 -51.13 70.77 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.455 ' HB2' HD11 ' A' ' 14' ' ' LEU . 51.3 t60 -51.19 -42.45 60.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.624 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 86.2 mt -72.63 -41.61 65.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.543 -176.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -80.56 -26.43 37.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.82 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -69.74 -45.78 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.594 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.0 p -68.1 -40.16 82.65 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.836 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.55 31.22 4.06 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.879 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.459 HD13 ' HD2' ' A' ' 130' ' ' PRO . 30.8 mm -65.81 125.0 89.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.68 141.53 50.15 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.0 1.8 . . . . 0.0 112.545 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 55.68 20.27 3.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.538 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 35' ' ' LEU . . . -84.87 -17.26 38.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.988 0.423 . . . . 0.0 111.0 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -83.74 -16.71 43.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.731 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.58 -27.15 61.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.772 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 m -89.8 159.62 2.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.658 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -112.95 136.91 52.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.79 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.426 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 15.8 mm -106.07 143.61 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 123.375 0.422 . . . . 0.0 110.707 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 9.6 tt0 -144.98 126.68 15.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.5 mm -107.44 121.26 60.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.966 0.412 . . . . 0.0 111.553 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.47 76.74 1.07 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.56 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 69.1 -80.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.953 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.01 2.53 7.89 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -104.95 98.62 8.31 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -94.23 118.78 32.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.336 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 12.8 m -90.57 134.14 34.59 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.638 0.256 . . . . 0.0 110.319 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.5 t -120.7 109.77 26.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.087 0.47 . . . . 0.0 109.98 176.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.19 159.87 16.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.223 -177.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.62 172.57 39.14 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -155.98 139.33 15.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.052 0.453 . . . . 0.0 110.666 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 95.16 7.03 59.81 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.822 -0.626 . . . . 0.0 113.131 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 89' ' ' THR . 7.3 mp -92.94 168.6 11.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.023 0.44 . . . . 0.0 110.735 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 m -105.82 151.49 24.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.114 172.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.695 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 41.0 tt0 -56.55 -43.13 79.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.489 -173.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -54.18 -36.57 63.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.808 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.38 -38.97 29.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.355 176.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -55.91 -42.41 76.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.071 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 3.0 mm-40 -64.34 -23.69 67.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.659 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -66.42 -38.83 88.31 Favored 'General case' 0 N--CA 1.461 0.085 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.602 ' O ' HG12 ' A' ' 74' ' ' VAL . 4.0 mp -71.14 -55.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.203 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -48.7 -45.72 39.6 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.34 -30.49 43.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.963 0.411 . . . . 0.0 111.219 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -84.72 -30.64 24.59 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.284 -0.26 . . . . 0.0 111.555 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 70' ' ' ILE . 4.5 p -81.98 -39.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.018 0.437 . . . . 0.0 110.7 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.591 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -67.24 -26.01 73.49 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.656 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -88.39 48.19 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.299 . . . . 0.0 110.814 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 31' ' ' VAL . 96.3 mt -121.21 142.93 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 121.225 0.536 . . . . 0.0 111.442 175.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 13' ' ' LYS . 51.8 p -64.83 105.91 1.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.764 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.51 -11.86 10.35 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.685 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 35.8 mm -90.96 113.37 26.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.544 0.688 . . . . 0.0 111.105 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.753 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -92.82 -26.49 17.65 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.002 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 5.9 p -157.76 155.17 29.37 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.526 -177.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 10.6 p -126.59 127.05 69.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.56 174.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.62 93.32 6.68 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -70.43 112.84 7.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.53 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -121.76 22.74 10.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.202 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.06 118.41 28.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.071 0.462 . . . . 0.0 110.523 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -80.05 123.58 27.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.356 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 5.1 p -92.53 111.38 22.94 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.234 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.478 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -71.58 -33.38 69.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.007 178.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 p -128.72 138.84 34.0 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.861 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.5 142.7 33.36 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.771 2.314 . . . . 0.0 111.724 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.25 174.18 10.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.967 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.8 m -61.65 137.03 58.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.935 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.63 143.2 27.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.646 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.1 m -110.69 137.35 48.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.08 0.467 . . . . 0.0 110.514 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 14.5 tt0 -86.67 147.23 25.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.242 177.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.64 118.86 33.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.985 0.422 . . . . 0.0 111.24 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -119.72 136.61 54.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.098 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.1 m -99.91 124.51 45.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 142' ' ' GLN . 2.4 m -71.4 136.42 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.421 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 34.0 mmtp -93.31 -168.67 1.96 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.065 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.476 ' HA ' ' HB3' ' A' ' 140' ' ' PRO . 27.4 m -56.51 -40.19 74.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.61 37.26 3.44 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.566 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.578 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 73.4 m-20 -99.36 128.57 45.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.411 0.624 . . . . 0.0 110.639 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 110' ' ' ILE . 1.5 p -114.48 153.82 29.29 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.205 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.487 HD22 ' HA ' ' A' ' 135' ' ' PRO . 27.6 tp -54.75 -43.33 72.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.307 0.503 . . . . 0.0 110.931 -172.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -62.39 -44.03 97.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.092 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.71 83.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.41 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.2 pp -73.73 -25.14 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.541 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.9 t -68.03 -46.82 70.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.131 0.491 . . . . 0.0 109.823 171.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.508 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 12.6 tmtt? -60.61 -29.01 68.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.583 0.706 . . . . 0.0 109.194 175.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 6.4 tp60 -67.32 -62.27 1.5 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.43 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 146' ' ' ILE . 34.5 m -79.6 -45.81 23.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.254 -172.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 114' ' ' VAL . 38.8 m-85 -81.42 -51.23 8.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.305 0.574 . . . . 0.0 110.509 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.51 -14.19 13.28 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.679 -174.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.46 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 17.7 t30 -123.34 126.93 47.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.154 -0.523 . . . . 0.0 109.829 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . . . -75.01 -17.06 60.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.82 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -80.46 -13.24 59.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.061 0.458 . . . . 0.0 110.843 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.46 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 39.1 mt -82.47 14.14 3.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.448 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.474 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 53.6 p90 -60.07 -24.82 64.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.27 -178.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.482 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 51.0 m-80 -62.56 -38.9 91.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.09 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -55.57 -50.51 69.86 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.575 0.702 . . . . 0.0 109.805 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.97 -39.41 81.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.48 -177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.446 ' HA ' HD23 ' A' ' 132' ' ' LEU . 85.8 t80 -58.55 -53.95 52.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.512 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 21.5 mt-10 -66.04 -35.74 81.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.061 -176.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.425 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -64.14 -33.43 75.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.513 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.525 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 42.5 m-80 -95.72 -28.63 14.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.849 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 56.8 pttt -64.45 155.76 79.49 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.472 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 2.9 Cg_endo -82.0 10.63 36.33 Favored 'Cis proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.968 -1.263 . . . . 0.0 113.088 1.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.525 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.4 tmm? -66.31 -40.29 89.86 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.448 HD13 HE22 ' A' ' 142' ' ' GLN . 7.6 tp -86.24 113.38 22.2 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 171.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -76.9 -52.46 9.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.612 -170.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.492 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 24.0 m -142.38 155.74 64.23 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.011 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.487 ' HA ' HD22 ' A' ' 107' ' ' LEU . 74.4 Cg_exo -51.72 -54.53 5.17 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.495 2.797 . . . . 0.0 113.258 -172.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.07 9.78 29.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.219 0.533 . . . . 0.0 111.024 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 26.2 mmtp -92.27 13.09 20.28 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.549 HD11 ' HA ' ' A' ' 106' ' ' THR . 18.3 pt -67.19 171.39 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 171.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -148.08 144.69 19.22 Favored Pre-proline 0 C--N 1.315 -0.898 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.64 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.476 ' HB3' ' HA ' ' A' ' 103' ' ' SER . 81.5 Cg_exo -49.33 110.66 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.275 2.65 . . . . 0.0 112.47 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.53 22.79 6.56 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.085 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.578 ' H ' HG22 ' A' ' 101' ' ' VAL . 44.8 tt0 -105.56 118.63 37.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 117.613 0.706 . . . . 0.0 110.708 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 37.3 t -78.46 131.64 34.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.744 174.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.7 mt -121.19 135.64 55.11 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.101 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 145' ' ' ARG . 46.8 mtp180 -65.44 123.36 19.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.39 173.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 114' ' ' VAL . 23.3 mm -106.24 97.86 17.44 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.425 ' HG3' ' HB2' ' A' ' 127' ' ' ALA . 39.5 Cg_endo -70.49 158.8 54.91 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.227 1.951 . . . . 0.0 111.871 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.492 -177.482 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.504 HD13 ' N ' ' A' ' 4' ' ' PHE . 2.6 tm? . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.504 ' N ' HD13 ' A' ' 3' ' ' LEU . 98.4 m-85 -121.55 145.78 47.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.371 178.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.23 128.97 48.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 111.268 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 76.1 m-85 -124.77 -167.22 1.63 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.78 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 10' ' ' ALA . 91.2 t -107.69 118.94 56.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.114 0.483 . . . . 0.0 110.262 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.624 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 22.5 tptm -60.7 -33.74 73.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.906 -172.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -90.23 -33.94 15.98 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -87.34 128.65 35.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.857 0.36 . . . . 0.0 111.426 -172.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.69 179.9 26.84 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.873 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.68 135.92 47.05 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -99.86 94.29 6.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.76 0.314 . . . . 0.0 110.525 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 34' ' ' HIS . 1.8 mm? . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.852 0.358 . . . . 0.0 111.062 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.8 m-20 . . . . . 0 CA--C 1.516 -0.355 0 CA-C-O 120.285 0.088 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.41 ' O ' HG23 ' A' ' 31' ' ' VAL . 97.7 mt-30 -63.05 -46.95 85.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.638 0.256 . . . . 0.0 110.721 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 48' ' ' ILE . . . -57.15 -30.58 64.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.326 0.584 . . . . 0.0 111.197 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 35.6 ttpt -80.03 -50.67 10.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.339 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 72.7 mmtt -51.74 -39.66 58.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.412 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 41.4 t -58.46 -52.06 64.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.694 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.611 ' HB3' HD13 ' A' ' 48' ' ' ILE . 3.0 pt20 -78.28 -21.1 50.26 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.464 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 46.9 mt-10 -64.99 -39.0 92.82 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 172.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.529 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 63.6 t60 -55.97 -37.49 69.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.02 172.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.6 mt -70.53 -45.84 64.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.22 -41.7 94.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.05 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 97.3 mttt -59.48 -54.85 41.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.053 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 p -62.74 -44.18 96.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.085 0.469 . . . . 0.0 111.142 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.54 33.75 1.86 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.899 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.453 HD13 ' HD2' ' A' ' 130' ' ' PRO . 24.3 mm -69.53 129.15 91.75 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.83 143.19 49.74 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.614 2.209 . . . . 0.0 113.207 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 57.15 28.57 15.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.697 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.83 -20.6 62.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.24 0.543 . . . . 0.0 110.349 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -81.32 -15.99 53.75 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.425 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -86.81 -11.28 51.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.816 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.08 177.31 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.113 0.483 . . . . 0.0 111.292 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.63 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 42.0 t30 -141.4 128.51 20.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.065 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 32' ' ' GLN . 3.2 mp -104.53 129.25 57.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 123.39 0.431 . . . . 0.0 110.608 -174.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -128.7 128.03 43.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.273 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.4 mm -98.74 120.59 48.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.001 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.45 88.01 2.86 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.769 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 67.33 -74.88 0.06 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.803 0.69 . . . . 0.0 111.134 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.38 -1.0 4.01 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 84' ' ' ASP . 38.7 ttmt -96.74 115.74 27.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.959 0.409 . . . . 0.0 110.731 -178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.82 100.74 12.26 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.425 ' CG2' HE21 ' A' ' 86' ' ' GLN . 38.1 m -83.35 128.5 34.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.382 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -120.79 117.33 52.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.008 0.432 . . . . 0.0 111.043 177.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.486 HG23 ' HB3' ' A' ' 86' ' ' GLN . 2.2 m -100.52 162.96 12.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.789 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.8 166.68 33.64 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.801 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -156.13 138.07 14.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.875 0.369 . . . . 0.0 110.066 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 91.96 8.21 63.56 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.802 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.504 ' HG ' ' CG1' ' A' ' 87' ' ' VAL . 4.5 mm? -78.68 171.79 14.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.0 112.265 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -128.05 146.41 50.69 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 170.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.614 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 9.8 mt-30 -59.65 -22.48 61.95 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.303 0.377 . . . . 0.0 112.008 -175.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.67 -34.55 72.98 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.259 0.349 . . . . 0.0 111.311 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.42 -36.52 7.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.027 0.441 . . . . 0.0 110.475 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 52.5 tttm -50.91 -46.53 60.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.049 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.415 ' O ' ' HD2' ' A' ' 145' ' ' ARG . 21.7 mt-10 -87.92 20.58 3.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.415 0.626 . . . . 0.0 110.923 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -113.91 -41.7 3.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.059 170.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 54.6 mt -59.22 -59.3 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.245 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 67' ' ' LYS . 9.3 mp -42.86 -41.99 3.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.458 176.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.85 -53.39 30.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.99 -24.06 65.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.39 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.2 t -79.0 -40.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.171 0.51 . . . . 0.0 110.481 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -72.27 -25.94 73.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.506 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.426 ' HB3' ' OH ' ' A' ' 139' ' ' TYR . 90.4 m-20 -86.45 39.95 0.86 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.099 0.476 . . . . 0.0 111.056 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.457 ' CD1' HG13 ' A' ' 31' ' ' VAL . 92.9 mt -114.26 135.31 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.715 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -67.92 123.81 21.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.31 -9.27 38.72 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.252 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.1 mm -105.01 137.81 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.624 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -124.04 -19.47 5.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.721 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 p -152.97 157.04 39.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.065 0.459 . . . . 0.0 111.297 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.3 t -133.04 126.11 52.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.84 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . 15.1 t70 -102.37 110.64 22.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.409 ' CB ' HD21 ' A' ' 71' ' ' LEU . 9.0 p-10 -92.49 100.47 13.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 122.145 0.974 . . . . 0.0 111.77 -174.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.486 ' HB3' HG23 ' A' ' 58' ' ' THR . 43.0 mt-30 -98.98 18.47 17.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.163 172.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.504 ' CG1' ' HG ' ' A' ' 62' ' ' LEU . 43.1 t -80.01 108.08 13.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.437 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -86.59 137.57 32.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.075 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.8 p -102.45 130.42 49.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.058 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.441 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -90.08 -16.18 30.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.6 p -129.27 142.53 45.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.85 124.42 7.44 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.668 2.245 . . . . 0.0 111.842 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.35 168.87 18.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.5 m -65.18 140.77 58.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.434 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.89 154.7 17.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.08 0.467 . . . . 0.0 111.759 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.9 m -118.94 146.96 44.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.981 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.482 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 7.6 tt0 -91.3 150.73 21.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.425 175.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -105.82 100.83 10.37 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.103 0.477 . . . . 0.0 110.85 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.441 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 80.0 t80 -101.66 144.24 30.63 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.917 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 143' ' ' VAL . 17.1 m -110.94 124.15 51.57 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.358 -0.137 . . . . 0.0 110.675 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.675 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.7 m -66.09 129.5 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -80.84 -81.51 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.969 -171.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.3 m -162.26 123.49 2.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.12 28.88 71.01 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.26 130.43 43.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.892 -0.654 . . . . 0.0 109.95 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.561 ' HA ' HD11 ' A' ' 138' ' ' ILE . 7.6 p -115.76 162.61 17.04 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.878 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 22.9 mt -57.83 -42.67 84.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.76 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.4 m -59.63 -38.69 82.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.942 0.401 . . . . 0.0 110.822 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.7 -44.65 69.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.264 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.5 pp -78.22 -22.15 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.483 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.4 p -77.8 -42.67 33.05 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.243 -0.286 . . . . 0.0 110.564 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 61.3 tttp -62.73 -26.27 68.6 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.506 0.67 . . . . 0.0 109.75 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.637 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 4.7 tp60 -64.33 -55.02 24.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.949 175.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 115' ' ' TYR . 34.2 m -86.46 -51.25 13.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.349 -173.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.473 ' N ' HG23 ' A' ' 114' ' ' VAL . 21.6 m-85 -87.67 -31.01 19.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.249 -176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.31 -19.51 39.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.102 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -114.1 120.61 41.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . . . -69.19 -20.13 63.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.872 -175.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -81.77 -0.15 41.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.985 0.421 . . . . 0.0 111.004 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.8 mt -91.28 17.43 8.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 42.3 p90 -60.84 -30.91 70.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.362 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -69.8 -30.54 68.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.522 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -63.11 -44.12 96.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.257 0.551 . . . . 0.0 110.341 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.3 mt -75.46 -36.88 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.163 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -53.26 -60.81 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.801 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.472 ' CD ' ' HZ2' ' A' ' 129' ' ' LYS . 11.6 mm-40 -50.43 -43.62 55.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.943 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.565 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -63.84 -33.08 74.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.32 -174.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.497 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 42.2 m-80 -92.8 5.17 52.17 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.715 0.293 . . . . 0.0 111.506 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.472 ' HZ2' ' CD ' ' A' ' 126' ' ' GLU . 15.3 mtmm -82.63 156.27 68.14 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HD2' HD13 ' A' ' 40' ' ' ILE . 96.6 Cg_endo -86.39 15.37 41.24 Favored 'Cis proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.72 -1.367 . . . . 0.0 113.424 -1.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.497 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.3 OUTLIER -66.12 -41.94 89.84 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.128 0.49 . . . . 0.0 110.069 175.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 tp -95.03 124.41 39.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.441 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -101.6 -33.27 9.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.862 -172.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 69.0 m -155.42 153.64 26.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.57 0.224 . . . . 0.0 111.179 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.523 ' HA ' ' CD1' ' A' ' 107' ' ' LEU . 81.9 Cg_exo -48.67 -56.95 2.67 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.627 2.885 . . . . 0.0 113.382 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.01 -7.78 53.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.864 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 134' ' ' SER . 30.2 mmtp -81.51 -2.72 50.88 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.561 HD11 ' HA ' ' A' ' 106' ' ' THR . 12.3 pt -68.37 167.55 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.972 0.415 . . . . 0.0 110.438 174.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 76' ' ' ASN . 10.5 p90 -141.46 141.67 23.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.428 -174.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.81 111.02 0.5 Allowed 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 123.176 2.584 . . . . 0.0 112.248 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.24 23.47 6.35 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.907 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.675 ' H ' HG22 ' A' ' 101' ' ' VAL . 47.3 tt0 -104.48 121.8 44.2 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.572 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.442 HG22 ' OG1' ' A' ' 100' ' ' THR . 42.7 t -80.93 133.75 28.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.965 174.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.1 mt -126.15 135.67 51.94 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.673 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.583 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 3.1 ptm180 -73.84 123.78 24.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.289 0.566 . . . . 0.0 110.011 176.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.482 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 26.3 mm -103.84 91.29 3.45 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.038 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 37.1 Cg_exo -60.88 144.28 99.53 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.501 2.134 . . . . 0.0 111.318 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 121.18 0.515 . . . . 0.0 110.328 -179.5 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.7 tp . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 82' ' ' SER . 74.1 m-85 -114.16 133.92 55.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.645 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -109.85 134.56 51.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.272 0.558 . . . . 0.0 110.827 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 67.3 m-85 -118.03 -157.96 0.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.644 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.957 HG11 ' HB3' ' A' ' 10' ' ' ALA . 7.7 p -85.17 -24.61 6.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.914 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 28.9 tptp 74.83 -52.43 0.68 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.319 0.647 . . . . 0.0 111.881 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -85.81 -44.07 12.77 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.957 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -78.8 172.33 13.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.761 -177.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.21 -173.72 15.65 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.32 121.29 15.4 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 57.6 mtmt -80.04 74.76 6.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.471 0.653 . . . . 0.0 111.601 -171.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.581 175.882 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.845 0.355 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.407 ' O ' HG23 ' A' ' 31' ' ' VAL . 10.5 mm100 -67.18 -21.85 65.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.579 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.77 82.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.225 176.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.3 tptt -65.28 -45.9 82.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.317 176.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -55.73 -46.86 77.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.793 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 77' ' ' ILE . 72.0 t -60.39 -49.31 84.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.941 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 3.2 mm-40 -53.11 -41.97 65.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.613 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 44.8 mt-10 -56.28 -44.84 80.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.498 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -56.16 -46.87 79.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.728 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.66 -39.21 84.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.826 0.346 . . . . 0.0 111.823 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -77.08 -24.36 51.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.488 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -82.54 -24.33 34.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.562 0.22 . . . . 0.0 111.353 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -83.75 -35.9 24.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.859 0.362 . . . . 0.0 110.955 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.69 24.15 6.23 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.162 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.88 125.56 91.01 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -78.53 149.32 23.96 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.978 1.786 . . . . 0.0 111.955 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.56 8.2 4.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.42 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.81 -13.24 56.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.054 0.454 . . . . 0.0 110.951 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.77 -7.46 56.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.634 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -89.36 -12.32 40.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.403 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.412 HG21 HG21 ' A' ' 70' ' ' ILE . 35.0 m -103.05 157.56 4.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.839 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 18.3 m120 -119.27 132.96 55.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.646 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.468 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 13.4 mm -95.26 140.97 15.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -174.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 52.6 mt-30 -137.53 127.41 25.62 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 34.5 mm -117.91 116.58 52.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.185 0.517 . . . . 0.0 111.711 -172.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.05 70.81 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.915 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 t70 72.87 -66.45 0.31 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.185 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.12 31.49 2.69 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.894 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.569 ' CE ' ' HB2' ' A' ' 84' ' ' ASP . 87.2 tttt -140.25 129.42 23.68 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.503 -0.41 . . . . 0.0 110.718 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 83' ' ' VAL . . . -108.63 107.68 18.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.41 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 84' ' ' ASP . 36.5 m -95.21 114.05 25.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -104.71 127.6 59.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.82 0.343 . . . . 0.0 111.609 -177.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -104.35 158.08 16.71 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.123 177.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.41 156.72 10.11 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.29 137.49 27.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.144 0.497 . . . . 0.0 110.533 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 96.43 0.58 61.05 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.514 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 89' ' ' THR . 4.6 mm? -68.64 178.1 2.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.176 0.512 . . . . 0.0 111.982 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.464 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 53.6 p -127.02 144.34 51.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.564 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.623 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 48.8 tp60 -45.64 -54.86 7.1 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.532 0.52 . . . . 0.0 112.076 -175.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.91 -35.13 72.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.03 -42.6 19.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.936 0.398 . . . . 0.0 110.077 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 79.8 tttt -54.54 -40.45 68.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.27 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 79.0 mt-10 -63.46 -35.47 80.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.44 -43.87 93.05 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.412 HG21 HG21 ' A' ' 46' ' ' VAL . 2.8 mp -62.26 -50.77 78.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.092 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 88.0 mt -53.97 -45.96 71.5 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.409 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 68' ' ' GLU . 46.5 t -72.0 -44.22 66.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.211 0.529 . . . . 0.0 110.83 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -62.9 -34.66 77.89 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.349 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 80' ' ' ILE . 22.5 m -82.18 -31.12 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.638 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -72.36 -32.8 62.06 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.766 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.25 41.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.941 0.4 . . . . 0.0 111.056 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.432 ' CD1' HG13 ' A' ' 31' ' ' VAL . 96.8 mt -115.54 134.75 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 121.061 0.458 . . . . 0.0 110.398 172.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.53 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 14.8 t -62.47 105.99 0.7 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.486 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.91 -15.42 5.65 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.565 -174.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 49.7 mm -100.85 120.57 50.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.128 0.49 . . . . 0.0 111.49 -177.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.914 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -98.96 -38.26 9.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.685 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.4 p -142.7 159.6 41.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.48 0.657 . . . . 0.0 111.85 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 55' ' ' ALA . 69.0 t -131.07 127.53 61.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.628 177.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.569 ' HB2' ' CE ' ' A' ' 54' ' ' LYS . 5.6 t70 -106.39 107.75 18.92 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.76 110.04 15.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.115 0.96 . . . . 0.0 111.032 -173.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 14.6 mm-40 -107.98 17.51 22.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.531 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -92.4 116.24 33.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.843 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -85.59 139.17 31.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.307 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 16.6 p -105.48 131.11 53.29 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.99 0.424 . . . . 0.0 111.202 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.462 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -103.77 -40.02 6.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -176.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 63' ' ' SER . 17.8 p -96.28 141.0 22.5 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.586 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.6 130.49 18.4 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.805 2.337 . . . . 0.0 112.293 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.623 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -148.54 160.86 42.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.9 m -82.36 133.71 35.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.379 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.6 141.42 29.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.677 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.8 m -108.96 170.99 7.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.65 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.513 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.6 tt0 -96.33 147.7 23.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.518 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -104.29 107.08 17.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.976 0.417 . . . . 0.0 110.039 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -108.31 129.96 55.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.353 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.431 ' OG1' HG22 ' A' ' 143' ' ' VAL . 17.7 m -98.07 123.44 42.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.95 175.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -69.03 130.14 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.307 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.47 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 45.5 mmtm -80.18 -73.37 0.36 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.313 -170.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 140' ' ' PRO . 18.4 t -150.39 -68.66 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.765 -176.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.35 36.67 2.58 Favored Glycine 0 C--N 1.329 0.189 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -96.4 115.84 28.08 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.152 -172.2 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 110' ' ' ILE . 27.6 p -110.2 159.2 17.59 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -57.41 -45.12 84.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.178 0.444 . . . . 0.0 110.783 -171.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.505 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 14.3 m -63.04 -40.19 96.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.56 82.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.331 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 106' ' ' THR . 1.3 pp -74.11 -27.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 120.805 0.336 . . . . 0.0 110.503 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -67.19 -43.52 81.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.057 0.456 . . . . 0.0 110.133 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.16 -28.2 69.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.369 0.604 . . . . 0.0 109.964 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.596 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.1 tp-100 -67.42 -54.49 19.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.078 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 115' ' ' TYR . 27.4 m -85.18 -50.49 14.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.207 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.475 ' N ' HG23 ' A' ' 114' ' ' VAL . 68.9 m-85 -85.81 -42.13 14.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.057 0.456 . . . . 0.0 111.146 -177.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.8 -14.88 31.83 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.447 ' HB3' ' HG ' ' A' ' 120' ' ' LEU . 55.3 t-20 -118.75 120.15 36.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.505 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -71.08 -22.24 62.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -174.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.08 -8.18 55.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.039 0.447 . . . . 0.0 111.106 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' ' 117' ' ' ASN . 46.6 mt -86.4 10.8 13.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.648 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 51.0 p90 -59.14 -26.49 64.79 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.925 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -70.3 -31.54 68.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.112 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.434 ' HE2' HD13 ' A' ' 120' ' ' LEU . 33.6 mtmt -62.43 -45.29 93.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.717 0.77 . . . . 0.0 109.68 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.0 mt -66.62 -42.76 90.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.619 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -56.74 -53.78 53.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.367 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -65.45 -26.31 67.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 111.664 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -76.58 -25.83 54.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.708 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 131' ' ' MET . 39.2 m-80 -98.02 -30.59 12.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.272 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 19.4 pttp -66.14 156.91 83.22 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.4 Cg_endo -81.2 10.33 32.71 Favored 'Cis proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.494 -1.461 . . . . 0.0 113.4 2.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.54 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.6 tmm? -64.99 -37.96 89.39 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.534 HD13 HE22 ' A' ' 142' ' ' GLN . 7.8 tp -88.74 114.77 25.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.026 171.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -73.41 -46.65 47.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.684 -171.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 135' ' ' PRO . 16.4 m -152.1 150.54 25.92 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 121.239 0.542 . . . . 0.0 109.928 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 107' ' ' LEU . 28.0 Cg_endo -62.6 -20.78 71.79 Favored 'Trans proline' 0 C--N 1.334 -0.232 0 C-N-CA 123.784 2.99 . . . . 0.0 113.025 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -101.4 -0.45 35.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.564 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -98.35 16.18 22.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.464 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 19.0 pt -74.0 166.44 2.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 171.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -153.27 147.21 18.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.821 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.413 ' HB3' ' HA ' ' A' ' 103' ' ' SER . 92.4 Cg_exo -47.53 113.68 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.573 2.849 . . . . 0.0 112.629 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.57 30.63 4.86 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.315 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.534 HE22 HD13 ' A' ' 132' ' ' LEU . 43.1 tt0 -114.02 124.9 53.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.629 0.714 . . . . 0.0 110.933 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.431 HG22 ' OG1' ' A' ' 100' ' ' THR . 45.1 t -82.69 134.73 26.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.757 173.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.4 mt -126.01 138.84 53.76 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.896 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.557 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 52.9 mtp180 -65.91 118.28 9.5 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.675 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 39.3 mm -105.96 90.16 4.24 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 24.5 Cg_exo -62.37 150.31 87.69 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.685 2.257 . . . . 0.0 111.443 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--N 1.321 -0.657 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.34 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 110.736 -0.098 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.48 -135.4 3.12 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.995 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 4' ' ' PHE . 3.1 tm? -96.2 136.93 36.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.061 0.458 . . . . 0.0 110.283 -175.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' N ' HD13 ' A' ' 3' ' ' LEU . 96.7 m-85 -126.09 136.35 52.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.223 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -108.44 147.25 31.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.447 0.641 . . . . 0.0 112.275 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.506 ' CD2' HG21 ' A' ' 143' ' ' VAL . 53.7 m-85 -130.47 -169.17 2.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.751 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.473 HG21 ' HA2' ' A' ' 141' ' ' GLY . 40.5 t -86.61 -13.38 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.536 0.207 . . . . 0.0 111.115 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 63.7 tttm 73.85 -68.71 0.21 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.083 0.553 . . . . 0.0 111.784 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.02 -26.24 65.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.905 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.503 ' CB ' ' HA3' ' A' ' 141' ' ' GLY . . . -100.28 125.53 46.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.153 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.11 -169.43 40.32 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -60.49 129.89 43.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -74.81 73.39 2.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.029 0.919 . . . . 0.0 109.717 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.541 HD23 ' CZ3' ' A' ' 15' ' ' TRP . 12.1 tp -89.5 -45.25 9.55 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.552 -174.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.541 ' CZ3' HD23 ' A' ' 14' ' ' LEU . 18.0 p90 -143.71 -29.61 0.51 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.087 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 54.76 81.91 0.1 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.795 0.331 . . . . 0.0 110.46 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 67.1 4.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.151 0.501 . . . . 0.0 111.578 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.1 t -88.24 -68.14 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.28 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.7 p -94.62 -20.53 19.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.408 0.623 . . . . 0.0 109.763 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.84 118.59 4.17 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.758 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -125.49 -0.49 7.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.576 0.227 . . . . 0.0 111.061 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -164.67 147.83 8.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.912 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 5.3 t70 -79.9 169.99 17.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.156 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 63.8 mmtt -59.34 -48.66 80.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.878 0.37 . . . . 0.0 111.185 -171.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -67.51 -30.6 70.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -71.3 -36.2 71.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.86 0.362 . . . . 0.0 110.099 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.54 ' O ' HG23 ' A' ' 31' ' ' VAL . 95.8 mt-30 -63.88 -45.99 86.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.586 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.25 -43.1 78.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.184 0.516 . . . . 0.0 110.727 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.09 -45.47 94.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.537 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' O ' HD21 ' A' ' 14' ' ' LEU . 68.5 mmtt -61.11 -35.21 76.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.852 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.559 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 97.4 t -62.74 -48.94 85.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -55.35 -48.56 74.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.569 172.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 66.1 mt-10 -55.71 -50.27 70.76 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -53.23 -43.95 67.7 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.698 0.624 . . . . 0.0 111.505 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 98.5 mt -62.76 -42.95 99.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.502 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -75.1 -25.39 58.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.989 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 13.2 mmmm -65.84 -51.99 54.25 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.222 0.534 . . . . 0.0 110.385 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 130' ' ' PRO . 2.4 p -73.3 -28.97 62.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.375 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.07 30.54 7.81 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.973 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.61 126.05 85.93 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.52 145.71 71.57 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.894 1.729 . . . . 0.0 112.107 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 61.29 21.45 11.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.804 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.11 -22.39 63.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.6 2.99 56.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.684 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -99.26 3.05 46.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.453 . . . . 0.0 110.155 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.12 172.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.025 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -137.3 131.73 32.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.627 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 mm -98.14 141.45 16.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.952 0.406 . . . . 0.0 111.21 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 49.2 tt0 -139.67 119.8 13.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.686 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 31' ' ' VAL . 43.5 mm -96.57 108.16 20.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.289 0.566 . . . . 0.0 110.833 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.56 72.48 2.04 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 68.08 -82.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.867 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.7 1.81 24.64 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.132 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -110.08 110.48 21.39 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.522 -0.399 . . . . 0.0 111.084 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.484 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -84.24 92.14 7.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.792 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 84' ' ' ASP . 43.3 m -75.78 122.62 24.33 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.905 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.4 t -112.01 113.61 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 CA-C-O 121.115 0.483 . . . . 0.0 110.28 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -100.91 162.96 12.53 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.224 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.75 167.05 32.18 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.495 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -155.15 142.27 19.3 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.959 0.409 . . . . 0.0 110.319 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.11 7.83 86.41 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.384 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.44 169.23 18.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.381 0.61 . . . . 0.0 112.165 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.1 m -115.32 147.69 40.15 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 170.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.592 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 39.8 tt0 -51.93 -45.8 64.44 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -173.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.3 -50.35 62.37 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.945 0.403 . . . . 0.0 110.184 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.08 -43.06 96.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.066 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' O ' HD13 ' A' ' 71' ' ' LEU . 27.5 ttpp -59.13 -47.34 85.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 0.0 111.098 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 4.1 mm-40 -66.19 -15.88 63.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.091 0.472 . . . . 0.0 110.736 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -39.04 53.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.701 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.3 mm -65.31 -57.04 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.471 0.653 . . . . 0.0 109.915 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 67' ' ' LYS . 11.0 mp -42.44 -49.68 5.23 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.871 -177.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.662 HG21 ' HG2' ' A' ' 145' ' ' ARG . 57.5 t -69.85 -49.56 56.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.235 0.54 . . . . 0.0 111.199 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HA ' ' SD ' ' A' ' 131' ' ' MET . . . -64.02 -29.68 70.81 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.956 -174.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.2 m -87.6 -29.08 5.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.988 0.423 . . . . 0.0 111.043 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -73.63 -33.46 58.13 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.443 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -80.01 54.26 1.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.773 0.32 . . . . 0.0 111.138 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -122.76 142.48 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 120.927 0.394 . . . . 0.0 110.551 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 t -70.83 103.26 2.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.504 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.61 -18.11 5.46 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.285 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 45.9 mm -94.34 117.17 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.455 0.645 . . . . 0.0 111.045 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.58 -30.47 13.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.881 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.42 ' HB2' HD21 ' A' ' 3' ' ' LEU . 11.7 p -153.17 160.23 42.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.261 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 55' ' ' ALA . 54.9 t -124.94 125.89 70.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.432 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.532 ' HB3' HG23 ' A' ' 56' ' ' THR . 6.4 t70 -97.98 96.84 8.44 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.45 104.98 5.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.117 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -115.94 19.45 15.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.111 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -78.9 114.91 20.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.997 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -83.19 122.33 28.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.1 p -99.43 130.72 45.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.155 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.47 -21.84 35.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.905 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.3 p -140.17 131.69 14.36 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.105 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.53 156.96 36.44 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.499 2.133 . . . . 0.0 111.066 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -150.64 -160.41 1.16 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.512 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.7 m -67.04 131.78 46.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 110.723 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.41 159.53 17.97 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.0 m -138.66 143.26 39.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.101 0.477 . . . . 0.0 110.814 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.474 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 6.5 tt0 -81.33 137.05 35.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.488 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -99.1 80.29 2.44 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.532 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -73.91 144.86 45.16 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.541 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.419 ' OG1' HG22 ' A' ' 143' ' ' VAL . 12.9 m -120.74 117.94 28.76 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 142' ' ' GLN . 0.6 OUTLIER -68.18 131.38 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.406 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 32.5 mmtp -84.0 -61.14 1.89 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.92 -170.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.8 t -163.15 -68.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.19 53.43 4.79 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.544 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.8 m-20 -113.1 112.65 24.19 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.129 0.49 . . . . 0.0 111.05 -172.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.472 ' O ' HG23 ' A' ' 110' ' ' ILE . 25.1 m -108.81 146.59 33.39 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.562 ' O ' HG13 ' A' ' 110' ' ' ILE . 25.4 tp -52.61 -45.89 66.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -168.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.619 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 38.9 m -67.19 -41.56 85.67 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.096 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HA ' ' HG3' ' A' ' 112' ' ' LYS . . . -64.37 -37.77 88.66 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.628 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.4 pp -76.96 -22.36 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 109.992 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -67.98 -49.38 62.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.05 171.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.694 ' HG2' ' HB2' ' A' ' 118' ' ' ALA . 22.2 mttt -55.26 -30.31 59.84 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 121.295 0.569 . . . . 0.0 110.155 172.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.628 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 4.5 tp60 -68.24 -56.82 7.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.617 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.47 HG21 HD12 ' A' ' 146' ' ' ILE . 33.8 m -86.32 -42.91 16.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.158 -172.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.5 ' HB3' HD12 ' A' ' 120' ' ' LEU . 17.6 m-85 -90.82 -26.18 19.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.747 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.14 -9.73 76.86 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.626 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.523 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 26.2 t30 -126.12 129.35 48.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.694 ' HB2' ' HG2' ' A' ' 112' ' ' LYS . . . -72.9 -28.95 62.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.631 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.82 -19.19 65.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.551 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.523 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 54.6 mt -82.99 13.93 3.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.122 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 42.6 p90 -61.2 -32.62 72.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.424 0.63 . . . . 0.0 110.333 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.484 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 11.7 p30 -69.57 -30.04 67.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.458 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -61.94 -46.55 88.84 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.285 0.564 . . . . 0.0 109.656 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.5 mt -64.52 -44.94 96.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.451 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.545 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 26.2 t80 -51.8 -59.44 4.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.207 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 45.4 mt-10 -59.22 -41.37 88.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.361 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -59.51 -31.62 69.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.377 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.494 ' OD1' ' HA ' ' A' ' 144' ' ' LEU . 43.0 m-80 -90.11 -1.63 57.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 132' ' ' LEU . 29.5 mtpp -81.84 155.19 70.63 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.683 0.277 . . . . 0.0 110.362 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' THR . 1.9 Cg_endo -87.58 24.56 18.33 Favored 'Cis proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.819 -1.326 . . . . 0.0 113.461 0.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.467 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.1 OUTLIER -76.35 -37.13 57.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.222 0.534 . . . . 0.0 110.044 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.625 ' O ' ' HG2' ' A' ' 129' ' ' LYS . 13.4 tp -98.0 117.13 31.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.891 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -81.24 -51.29 8.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.783 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.4 m -138.29 154.61 73.94 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.527 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.24 -54.4 5.51 Favored 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 123.415 2.743 . . . . 0.0 112.963 -175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.98 5.76 24.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.541 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -83.82 -0.94 53.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.628 0.251 . . . . 0.0 111.185 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.9 pt -65.76 168.36 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -158.49 153.48 21.43 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.07 112.85 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.043 2.496 . . . . 0.0 112.389 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.503 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 96.77 35.91 5.22 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.615 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.615 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.2 tp60 -108.78 121.43 45.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.988 0.394 . . . . 0.0 110.152 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.506 HG21 ' CD2' ' A' ' 6' ' ' PHE . 41.2 t -83.62 129.46 37.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.237 0.542 . . . . 0.0 110.645 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.494 ' HA ' ' OD1' ' A' ' 128' ' ' ASN . 0.6 OUTLIER -118.98 130.83 55.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.229 -177.14 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.662 ' HG2' HG21 ' A' ' 72' ' ' VAL . 55.3 mtp180 -69.52 119.26 13.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.334 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 27.6 mm -106.93 95.58 12.87 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 35.0 Cg_exo -61.49 149.88 87.71 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.656 2.237 . . . . 0.0 111.737 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -58.55 132.23 53.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.286 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -73.46 67.5 1.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.152 0.501 . . . . 0.0 110.961 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 150' ' ' LEU . 0.4 OUTLIER -88.67 61.52 6.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 172.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -140.38 121.52 14.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.647 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -117.96 152.28 35.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.659 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 60.14 57.11 3.08 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.709 0.631 . . . . 0.0 111.032 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -111.81 122.97 49.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.258 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 5.7 t-80 -60.99 134.93 57.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.167 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.528 ' HB2' ' O ' ' A' ' 155' ' ' HIS . 13.0 m-70 75.15 126.42 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.959 0.787 . . . . 0.0 110.65 -173.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 . . . . . 0 C--O 1.247 0.949 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.117 177.345 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.43 68.73 1.48 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.995 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.1 mt -73.51 134.01 43.76 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.76 0.791 . . . . 0.0 112.225 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.516 ' HB2' HG12 ' A' ' 83' ' ' VAL . 97.7 m-85 -101.44 127.11 48.25 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.358 175.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -87.43 134.08 33.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.704 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 50.7 m-85 -117.76 -158.15 0.7 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 88.5 t -89.36 -79.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.015 173.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.6 tmtp? 165.82 -71.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.017 0.823 . . . . 0.0 109.235 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.03 -25.95 34.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.355 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.79 124.06 23.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.963 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.21 -178.02 28.84 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -71.5 130.0 40.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 117.017 0.408 . . . . 0.0 109.911 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 48.0 mtmt -77.64 92.93 4.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.356 0.598 . . . . 0.0 111.554 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 34' ' ' HIS . 6.9 mp -91.98 -42.54 9.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.556 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.43 ' CB ' ' HG2' ' A' ' 21' ' ' GLN . 38.5 p90 -136.14 23.86 3.27 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.708 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 66.26 -6.46 0.48 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.419 ' HB2' ' C ' ' A' ' 78' ' ' SER . . . 62.22 29.27 17.4 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.815 0.446 . . . . 0.0 111.951 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.0 t -106.24 -71.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.006 0.431 . . . . 0.0 110.461 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 p -121.04 -39.79 2.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.92 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 145.93 -139.78 8.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.731 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.43 ' HG2' ' CB ' ' A' ' 15' ' ' TRP . 15.2 mm-40 -141.13 -91.54 0.15 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.408 0.146 . . . . 0.0 110.645 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -94.38 -35.12 12.51 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.437 ' H ' ' HB3' ' A' ' 26' ' ' ASP . 4.3 t70 -169.15 -175.04 2.16 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -81.18 -39.21 25.84 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.702 0.287 . . . . 0.0 110.405 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -72.07 -21.54 61.5 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 24.2 t70 -64.34 -37.37 87.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.957 173.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.592 ' O ' HG23 ' A' ' 31' ' ' VAL . 20.7 mt-30 -61.55 -38.98 89.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.291 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.2 -42.89 96.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.101 0.477 . . . . 0.0 110.483 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 27.1 ttpp -62.04 -42.84 99.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.041 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 28.0 mmtp -60.44 -40.11 89.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.97 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 27' ' ' GLN . 95.3 t -58.29 -49.06 83.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.359 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -55.16 -46.61 75.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.922 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 46.6 mt-10 -57.28 -44.15 83.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.732 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.439 ' HB2' HD21 ' A' ' 14' ' ' LEU . 65.9 t60 -57.81 -44.74 86.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.979 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 91.3 mt -64.96 -40.79 95.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.964 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -72.5 -34.01 67.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.273 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -72.1 -33.19 67.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.42 -25.35 46.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.109 0.48 . . . . 0.0 110.854 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.35 26.91 12.71 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.082 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.0 mm -65.09 122.15 78.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -75.45 151.21 37.29 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.978 1.785 . . . . 0.0 111.745 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 63.78 6.72 2.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.949 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.24 -22.92 61.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.018 0.437 . . . . 0.0 111.001 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -77.32 -19.67 56.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.383 176.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -77.47 -21.81 52.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.986 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.5 m -101.34 173.49 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.338 0.59 . . . . 0.0 111.88 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -131.19 140.56 49.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.991 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.3 mm -102.99 138.68 26.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.957 0.408 . . . . 0.0 111.118 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -137.29 122.53 19.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.699 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 27' ' ' GLN . 17.4 mm -92.93 122.37 44.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.979 0.419 . . . . 0.0 110.597 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.7 70.41 0.71 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.98 -82.34 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.325 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 -5.86 23.34 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.989 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 106.3 17.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.941 0.401 . . . . 0.0 111.017 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.59 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -83.09 111.18 18.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.479 HG23 ' HB3' ' A' ' 84' ' ' ASP . 32.6 m -93.31 132.49 37.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.858 0.361 . . . . 0.0 111.32 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.99 123.56 65.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.0 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -122.75 158.04 31.02 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.385 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.22 177.7 28.75 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -160.16 145.18 14.89 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.053 0.426 . . . . 0.0 110.433 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 100.26 11.7 41.34 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.942 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 mp -96.12 165.67 12.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.172 0.51 . . . . 0.0 111.574 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.0 m -85.57 143.02 28.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.871 174.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 93' ' ' ALA . 20.1 tm0? -63.92 -28.18 69.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.466 -174.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.46 -29.59 59.67 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.904 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.38 -39.98 31.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.744 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -62.68 -31.97 72.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.679 -176.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.549 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.5 mm-40 -65.29 -42.59 92.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.148 0.499 . . . . 0.0 110.118 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -63.46 -43.9 96.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.668 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 67' ' ' LYS . 46.5 mt -61.52 -53.65 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.583 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 94.9 mt -44.65 -48.35 10.54 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.798 0.686 . . . . 0.0 111.917 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 68' ' ' GLU . 54.8 t -62.91 -52.11 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.141 0.496 . . . . 0.0 111.053 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.9 70.07 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.692 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.467 HG13 HG11 ' A' ' 31' ' ' VAL . 52.7 t -75.04 -43.38 45.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.865 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.704 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -71.8 -28.79 68.33 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.329 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -77.79 45.29 0.5 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.062 0.458 . . . . 0.0 111.919 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.3 mt -117.89 140.33 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.356 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.423 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 11.9 t -65.96 103.28 0.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.529 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.14 -19.71 4.08 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 55' ' ' ALA . 34.8 mm -97.13 133.24 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.301 0.572 . . . . 0.0 110.546 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -113.45 -14.21 12.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.479 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 p -165.26 150.77 9.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.777 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.539 HG12 ' HE1' ' A' ' 6' ' ' PHE . 15.0 p -120.3 134.23 64.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.835 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.479 ' HB3' HG23 ' A' ' 56' ' ' THR . 22.7 t0 -101.71 125.53 48.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -92.0 101.36 13.91 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.847 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -119.11 12.96 12.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.205 0.526 . . . . 0.0 110.217 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.9 p -86.77 128.28 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.432 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -89.18 147.35 24.22 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.841 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.4 p -108.01 142.09 38.68 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.83 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.435 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -95.2 -33.17 12.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.321 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 p -126.87 134.77 26.46 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.087 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.72 119.05 5.29 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.579 2.186 . . . . 0.0 111.102 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.403 ' H ' ' HB3' ' A' ' 64' ' ' GLN . . . -130.48 -160.91 1.08 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.658 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 m -76.47 116.87 17.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.101 0.477 . . . . 0.0 111.764 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.38 162.69 24.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.732 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 m -128.02 150.17 50.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.49 0.662 . . . . 0.0 112.308 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.423 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.6 tt0 -91.16 139.33 30.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.144 172.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -106.35 82.27 1.72 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.95 0.405 . . . . 0.0 110.838 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.523 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 75.6 t80 -84.71 141.32 30.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.062 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.2 m -107.44 118.8 37.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.694 0.283 . . . . 0.0 110.77 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.0 OUTLIER -72.56 134.05 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.478 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 33.4 mmtp -100.99 -166.03 1.27 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.397 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.8 t -72.77 122.64 21.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.948 0.404 . . . . 0.0 109.959 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.67 7.18 69.23 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.91 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 5.8 m-20 -82.6 118.84 23.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.211 0.529 . . . . 0.0 110.518 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.574 ' O ' HG23 ' A' ' 110' ' ' ILE . 7.1 m -100.74 149.43 23.82 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.81 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.548 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 24.4 tp -58.66 -35.21 72.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.571 0.623 . . . . 0.0 110.29 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.461 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 9.1 p -69.22 -40.33 78.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.401 0.62 . . . . 0.0 110.567 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -68.18 -38.92 82.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.152 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.615 ' HA ' ' CG ' ' A' ' 113' ' ' GLN . 1.5 pp -79.34 -23.79 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 124' ' ' ILE . 8.7 p -74.57 -34.96 63.02 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 5.7 tmmm? -58.34 -30.53 66.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.768 170.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.615 ' CG ' ' HA ' ' A' ' 110' ' ' ILE . 11.0 mm100 -68.32 -72.22 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.126 0.965 . . . . 0.0 110.774 175.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 110' ' ' ILE . 29.2 m -73.32 -36.87 50.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 113.65 -1.613 . . . . 0.0 112.631 -166.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 120' ' ' LEU . 22.8 m-85 -97.46 -22.86 16.34 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.482 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.21 11.31 76.08 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.436 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -151.94 124.19 8.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.66 0.267 . . . . 0.0 110.791 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 108' ' ' SER . . . -73.58 -19.54 60.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.951 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -68.15 -24.64 65.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.443 HD12 ' HB3' ' A' ' 115' ' ' TYR . 51.6 mt -85.83 20.46 2.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.757 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.548 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 17.3 p90 -68.95 -28.42 66.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.121 0.486 . . . . 0.0 110.217 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.514 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 27.1 p-10 -70.63 -31.48 68.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.448 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 29.4 mmmt -54.81 -49.19 71.58 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.428 0.632 . . . . 0.0 110.158 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 111' ' ' SER . 47.7 mt -66.72 -47.51 82.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.315 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.539 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 44.7 t80 -49.32 -54.02 19.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.592 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 34.8 mt-10 -61.96 -36.62 81.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.244 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.37 -31.02 65.23 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.459 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 131' ' ' MET . 8.1 m120 -76.09 -27.95 57.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.969 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.592 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 29.5 mtpp -61.24 151.72 75.01 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.087 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -88.73 17.03 41.65 Favored 'Cis proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.672 -1.803 . . . . 0.0 112.779 0.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.463 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -69.37 -37.56 77.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.417 177.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.74 117.01 29.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.66 -37.39 24.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.574 -174.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 137' ' ' LYS . 19.3 m -152.0 144.55 16.85 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.151 0.501 . . . . 0.0 109.879 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.41 -20.37 66.18 Favored 'Trans proline' 0 C--N 1.332 -0.32 0 C-N-CA 123.487 2.791 . . . . 0.0 112.545 -171.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -98.73 -4.65 33.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.909 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.435 ' HG3' ' HB2' ' A' ' 134' ' ' SER . 27.3 mtpp -90.15 9.28 28.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.928 0.394 . . . . 0.0 111.284 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 14.0 pt -58.89 169.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.569 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -157.21 143.87 13.29 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.069 -175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.6 112.73 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.281 2.654 . . . . 0.0 112.559 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 107.56 27.01 5.4 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.894 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.548 ' H ' HG22 ' A' ' 101' ' ' VAL . 48.1 tt0 -103.21 116.61 32.79 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.989 -175.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.661 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 25.7 t -80.63 130.88 35.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.7 mt -118.25 145.58 44.92 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.795 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.534 ' HB2' HG21 ' A' ' 72' ' ' VAL . 37.3 ttt180 -74.93 98.38 3.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.826 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 19.7 mm -87.51 106.55 11.8 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.65 156.04 67.65 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.718 1.612 . . . . 0.0 111.748 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.89 136.08 56.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.805 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -67.73 101.63 1.08 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.092 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 151' ' ' GLU . 44.0 tp -103.58 90.5 3.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 150' ' ' LEU . 34.4 tt0 71.11 147.58 0.08 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.93 0.769 . . . . 0.0 110.035 -172.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -134.78 123.57 23.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.407 0.622 . . . . 0.0 112.484 -175.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -82.45 78.88 9.04 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -78.02 41.34 0.36 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -169.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -136.5 114.47 11.36 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.277 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -113.97 -30.52 6.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.827 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 38.6 t60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.739 -178.197 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.685 0.279 . . . . 0.0 110.397 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.42 167.33 16.21 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.064 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 83' ' ' VAL . 41.3 tp -134.87 125.78 27.46 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.651 ' HB2' HG12 ' A' ' 83' ' ' VAL . 78.1 m-85 -124.72 138.9 54.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.901 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -98.19 140.99 31.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.618 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.639 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 86.7 m-85 -127.27 -171.69 2.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.037 0.446 . . . . 0.0 111.899 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.904 HG11 ' HB3' ' A' ' 10' ' ' ALA . 4.5 p -78.16 -26.44 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.176 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.604 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 25.1 tptp 78.95 -55.05 0.45 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.472 0.709 . . . . 0.0 112.295 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.08 7.23 43.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.904 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -125.21 157.62 36.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 121.243 -0.183 . . . . 0.0 110.561 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.6 -148.29 16.88 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.089 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.472 ' HG2' ' ND1' ' A' ' 34' ' ' HIS . 8.9 tp10 -82.39 129.87 34.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.007 0.404 . . . . 0.0 110.277 177.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -95.84 93.16 6.89 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.775 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 34' ' ' HIS . 1.4 mm? -86.36 -51.32 6.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -105.97 2.34 27.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.218 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 63.09 104.93 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 O-C-N 124.117 0.885 . . . . 0.0 111.214 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' A' ' 78' ' ' SER . . . -73.02 79.97 1.2 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.386 0.612 . . . . 0.0 110.371 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.0 p -170.26 -35.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.514 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 p -103.59 -62.03 1.35 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.323 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.79 73.16 1.08 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -84.74 121.46 27.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.138 -0.531 . . . . 0.0 111.765 -171.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 38.3 m80 65.81 -170.65 0.19 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.134 174.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -67.69 163.98 20.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.459 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -70.31 -30.14 67.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.651 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -67.78 -31.32 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.956 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 24.3 t70 -70.26 -35.88 74.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.734 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 31' ' ' VAL . 90.9 mt-30 -63.17 -36.46 83.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.379 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 50' ' ' ILE . . . -58.93 -41.06 86.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 174.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -63.68 -39.91 95.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.556 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -62.42 -32.94 73.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.157 177.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.554 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 84.6 t -68.48 -44.99 82.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.377 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -52.87 -52.26 58.02 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.311 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -59.32 -41.32 88.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.702 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.472 ' ND1' ' HG2' ' A' ' 12' ' ' GLU . 31.9 t60 -54.52 -48.67 71.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.805 0.336 . . . . 0.0 110.797 174.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 77.4 mt -66.92 -42.8 84.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.985 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -75.99 -27.11 57.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.725 -176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.55 -34.36 47.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.495 0.188 . . . . 0.0 111.159 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.424 ' O ' ' HG2' ' A' ' 130' ' ' PRO . 2.0 p -73.44 -44.55 57.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.675 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.2 32.86 1.58 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.529 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.55 HD13 ' HD2' ' A' ' 130' ' ' PRO . 35.8 mm -73.08 126.69 90.22 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 5.7 Cg_exo -73.54 145.09 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.374 2.049 . . . . 0.0 112.763 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 63.56 15.8 9.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.12 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.36 -23.8 63.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.239 0.542 . . . . 0.0 110.457 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.13 -20.51 62.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.801 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -92.03 -26.24 18.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.952 0.406 . . . . 0.0 110.984 -174.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.6 HG21 HG21 ' A' ' 70' ' ' ILE . 33.6 m -90.26 163.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -128.41 131.61 48.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.705 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.7 mp -105.79 128.89 59.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.08 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -117.15 132.74 56.59 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' A' ' 28' ' ' ALA . 14.2 mm -105.04 108.82 25.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.379 0.609 . . . . 0.0 111.331 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' ASP . . . -99.05 69.26 1.74 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.096 176.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 3.5 m-20 70.2 -80.04 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.132 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.75 -8.21 12.41 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.702 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' CE ' ' HB2' ' A' ' 84' ' ' ASP . 82.4 tttt -102.26 112.97 25.87 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.049 0.452 . . . . 0.0 110.688 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.532 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -94.54 121.39 36.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.139 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.409 ' CG2' HE21 ' A' ' 86' ' ' GLN . 35.0 m -99.93 118.24 35.94 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 74' ' ' VAL . 25.5 t -98.26 122.76 50.27 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.89 155.16 33.24 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.859 -176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.4 174.74 36.75 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 p-10 -153.02 142.31 21.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.975 0.417 . . . . 0.0 110.649 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.89 17.42 61.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.238 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mp -93.34 178.41 5.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.103 0.477 . . . . 0.0 111.201 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.8 m -126.82 149.55 49.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.99 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.516 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 15.7 mm100 -57.53 -26.59 61.6 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.988 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.82 -36.6 72.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.722 0.296 . . . . 0.0 111.785 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.85 -34.45 10.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.498 . . . . 0.0 110.396 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 82.3 tttt -61.0 -41.26 96.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.469 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 145' ' ' ARG . 7.1 mm-40 -78.25 8.92 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.086 0.469 . . . . 0.0 110.822 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -98.72 -46.44 5.68 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.6 HG21 HG21 ' A' ' 46' ' ' VAL . 20.7 mt -67.34 -55.34 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.352 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 tp -65.33 -16.85 64.02 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.099 -170.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 145' ' ' ARG . 63.9 t -90.6 -52.63 10.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.327 175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.32 -18.98 65.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.954 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.523 HG23 HG11 ' A' ' 31' ' ' VAL . 7.6 p -82.05 -42.74 19.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.875 0.369 . . . . 0.0 110.693 175.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.639 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -67.71 -35.92 86.54 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.135 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -85.3 38.23 0.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.546 0.689 . . . . 0.0 111.262 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.2 mt -102.29 144.13 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.116 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.424 ' C ' ' HB2' ' A' ' 17' ' ' ALA . 67.8 m -70.47 99.26 1.58 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.428 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.97 -18.27 3.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.986 -175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 55' ' ' ALA . 41.0 mm -98.53 120.5 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.376 0.608 . . . . 0.0 110.991 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.604 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -98.55 -24.91 14.93 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.738 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.7 m -159.52 160.21 34.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.917 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 4' ' ' PHE . 4.3 p -131.31 138.4 53.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.891 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.422 ' HB2' ' CE ' ' A' ' 54' ' ' LYS . 31.3 t70 -111.36 120.53 42.51 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' A' ' 1' ' ' MET . 7.1 t0 -88.54 121.46 30.95 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.107 0.479 . . . . 0.0 110.942 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.409 HE21 ' CG2' ' A' ' 56' ' ' THR . 40.3 mt-30 -135.26 32.16 3.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.592 172.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.74 110.61 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.087 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 53.5 mttm -74.76 130.09 38.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.966 0.412 . . . . 0.0 110.144 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 p -105.29 124.6 49.82 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.767 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.97 -18.17 44.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.96 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.6 p -109.27 144.88 30.66 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.72 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.36 42.73 1.28 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.985 2.457 . . . . 0.0 111.988 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.85 156.59 32.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.899 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 m -74.07 129.13 37.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.182 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.74 164.17 23.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.397 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.9 m -120.16 148.16 43.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.189 0.518 . . . . 0.0 111.471 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -78.67 148.91 32.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.426 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -116.54 116.22 27.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.875 0.369 . . . . 0.0 110.531 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 143' ' ' VAL . 94.4 t80 -110.57 130.26 55.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.9 m -94.08 118.54 31.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.614 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 2.0 m -72.63 130.3 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 140' ' ' PRO . 73.3 mmtt -98.72 -60.43 1.54 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -169.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.4 t -164.0 122.76 1.92 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.745 0.307 . . . . 0.0 110.189 -174.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.62 11.06 72.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.827 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.614 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 2.0 m-20 -73.16 121.33 20.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.265 0.555 . . . . 0.0 110.431 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 110' ' ' ILE . 46.3 p -114.63 157.7 22.73 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 135' ' ' PRO . 26.0 tp -58.05 -40.55 81.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.583 0.629 . . . . 0.0 111.455 -170.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.459 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 13.3 m -76.54 -20.12 57.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.067 0.46 . . . . 0.0 111.05 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.8 -39.55 26.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.049 -0.407 . . . . 0.0 110.43 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.6 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.1 pp -80.25 -24.5 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.958 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.0 p -70.21 -45.12 67.24 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -61.41 -24.28 66.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.579 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -72.12 -57.75 4.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.977 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 115' ' ' TYR . 32.6 m -84.0 -48.43 17.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.043 -172.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.487 ' N ' HG23 ' A' ' 114' ' ' VAL . 56.2 m-85 -82.23 -41.23 20.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.056 0.455 . . . . 0.0 110.647 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.96 -14.73 34.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.997 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.402 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 27.6 t30 -123.0 123.12 40.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.815 0.341 . . . . 0.0 110.297 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -67.32 -27.59 67.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.675 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -74.58 -3.55 31.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 0.0 111.282 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 115' ' ' TYR . 68.4 mt -91.11 19.49 5.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.232 0.539 . . . . 0.0 110.682 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -63.09 -35.77 81.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.499 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -67.4 -27.64 67.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.723 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -60.08 -43.74 95.28 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.355 0.597 . . . . 0.0 109.921 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.429 HD13 HD11 ' A' ' 110' ' ' ILE . 62.0 mt -72.21 -43.35 65.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.296 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 134' ' ' SER . 61.1 t80 -55.54 -53.01 61.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.249 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 19.2 mt-10 -68.11 -24.01 64.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.349 0.595 . . . . 0.0 111.399 -177.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.437 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -79.38 -25.76 42.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.85 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.49 ' HB3' ' HE2' ' A' ' 131' ' ' MET . 24.1 m-80 -99.13 18.68 16.83 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.028 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.449 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 30.5 mmmt -79.76 140.83 55.0 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.209 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.55 ' HD2' HD13 ' A' ' 40' ' ' ILE . 19.6 Cg_endo -100.22 13.24 23.51 Favored 'Cis proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.84 -0.9 . . . . 0.0 112.078 -6.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.49 ' HE2' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -65.51 -25.93 67.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.712 -178.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 133' ' ' LYS . 9.0 tp -100.63 122.7 43.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 170.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.522 ' H ' ' HD2' ' A' ' 133' ' ' LYS . 9.6 mptt -81.05 -44.71 17.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.738 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.409 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 57.2 p -157.72 163.11 25.79 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.882 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.466 ' HA ' HD22 ' A' ' 107' ' ' LEU . 51.8 Cg_exo -54.5 -28.13 53.32 Favored 'Trans proline' 0 C--N 1.328 -0.526 0 C-N-CA 123.096 2.531 . . . . 0.0 112.316 175.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.11 -20.25 19.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.48 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 133' ' ' LYS . 22.9 mmtp -73.48 -6.93 49.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -173.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.614 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 21.1 pt -65.82 166.56 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.182 0.515 . . . . 0.0 111.086 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 142' ' ' GLN . 12.4 p90 -165.58 148.99 7.02 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.923 -177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 102' ' ' LYS . 50.5 Cg_exo -42.71 118.32 1.13 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.915 3.077 . . . . 0.0 113.313 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 106.66 12.32 24.85 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.799 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.614 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 14.0 mt-30 -99.86 120.77 40.3 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.968 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 23.2 t -86.53 127.73 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.173 170.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.3 mt -117.72 143.28 46.35 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.754 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 68' ' ' GLU . 42.2 ttt180 -70.37 118.93 13.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.691 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.3 mm -111.16 90.19 11.13 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.766 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.437 ' HG3' ' HB2' ' A' ' 127' ' ' ALA . 92.8 Cg_endo -77.54 176.67 9.77 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.32 2.013 . . . . 0.0 111.801 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.8 132.75 49.46 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 149' ' ' GLU . 1.4 pm0 -69.02 73.44 0.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.211 0.529 . . . . 0.0 111.925 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 77.4 mt -66.25 132.37 48.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.732 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.04 94.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.565 0.541 . . . . 0.0 111.597 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -136.72 -16.84 1.49 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.505 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -159.7 75.04 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -94.15 146.21 24.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.302 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -146.85 -60.86 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 0.0 110.918 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -77.02 130.62 37.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 110.372 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 75.1 m80 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.059 179.427 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 121.235 0.54 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.26 124.46 4.73 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.388 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 83' ' ' VAL . 47.9 tp 68.7 134.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.478 0.711 . . . . 0.0 111.981 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -123.61 147.16 47.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.982 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -114.9 138.55 50.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.988 0.423 . . . . 0.0 111.165 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.539 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 37.8 m-85 -130.27 171.03 13.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.339 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 93.7 t -88.67 119.29 35.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.941 0.4 . . . . 0.0 110.009 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 1.069 ' HG2' ' HB2' ' A' ' 81' ' ' ALA . 5.0 tmtp? -52.2 -40.34 61.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.232 -171.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.31 -17.07 35.52 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.277 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . . . -88.07 164.65 15.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.927 0.394 . . . . 0.0 111.535 -174.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.52 -170.92 14.29 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.061 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.97 125.47 26.06 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -77.27 59.94 1.88 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.219 1.009 . . . . 0.0 109.062 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.411 HD21 ' O ' ' A' ' 30' ' ' LYS . 17.3 tp -64.52 -51.57 62.21 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.428 -175.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.571 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 3.3 p90 -117.71 -0.53 11.78 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.168 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 68.2 -36.23 0.3 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.814 0.846 . . . . 0.0 113.102 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.484 ' N ' ' HD1' ' A' ' 15' ' ' TRP . . . 77.18 -30.57 0.17 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.25 1.02 . . . . 0.0 111.455 177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 m -85.13 -15.68 10.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.474 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 t -179.09 105.57 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.484 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.37 -19.26 2.27 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.034 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.571 ' HB2' ' CD1' ' A' ' 15' ' ' TRP . 30.5 tt0 -98.61 141.25 31.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.335 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -132.8 -89.4 0.41 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.713 0.292 . . . . 0.0 111.293 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.582 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 8.1 m-20 -97.22 148.76 22.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.451 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' HD2' ' H ' ' A' ' 52' ' ' ASP . 33.9 mtmm -64.67 -38.38 90.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.069 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -72.57 -22.63 60.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.088 0.47 . . . . 0.0 110.203 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 12.8 t70 -74.95 -41.4 59.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.53 172.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 23' ' ' ASP . 24.8 mt-30 -57.65 -44.17 85.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.159 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.48 -44.87 73.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.966 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 52.5 tttm -66.35 -43.87 84.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.807 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -55.44 -42.61 74.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.339 178.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.692 HG11 HG23 ' A' ' 74' ' ' VAL . 43.2 t -66.16 -44.41 91.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.597 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.507 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 8.6 mm-40 -57.77 -46.58 84.34 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.548 0.213 . . . . 0.0 111.01 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.2 mt-10 -58.44 -46.33 86.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -55.78 -44.01 77.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.351 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 83.8 mt -64.16 -38.45 91.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 110.557 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -78.27 -22.83 47.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.197 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 32.5 mmmt -75.52 -48.07 24.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.903 0.382 . . . . 0.0 110.344 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 p -64.24 -38.71 92.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.505 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.32 32.69 3.63 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.585 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.644 HD13 ' HD2' ' A' ' 130' ' ' PRO . 29.9 mm -72.6 120.36 80.21 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -81.09 150.58 17.92 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 122.099 1.866 . . . . 0.0 111.876 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 65.57 11.9 7.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.259 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.42 -25.64 33.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.189 0.518 . . . . 0.0 110.045 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.03 -12.05 59.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.881 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -76.97 -25.23 52.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.841 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.441 HG21 HG21 ' A' ' 70' ' ' ILE . 27.1 m -109.14 168.11 3.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.397 0.618 . . . . 0.0 111.822 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -121.93 146.62 46.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.415 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.507 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 21.0 mm -105.63 137.07 37.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.878 0.37 . . . . 0.0 110.692 -177.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.432 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 98.6 mt-30 -134.04 145.68 49.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.573 HG21 ' NE2' ' A' ' 27' ' ' GLN . 26.0 mm -126.09 128.12 71.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.114 0.483 . . . . 0.0 111.754 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -119.22 89.2 3.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.046 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.427 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 3.2 m-20 63.85 -92.65 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.735 -174.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.26 10.5 13.18 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.869 -0.682 . . . . 0.0 111.605 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 82' ' ' SER . 21.7 ttmm -104.18 112.84 26.01 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.088 0.471 . . . . 0.0 110.381 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -92.06 121.75 33.92 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.982 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.432 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 23.7 m -100.22 116.7 32.83 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.9 t -92.78 133.9 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.779 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -142.06 160.64 39.81 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.009 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.43 172.29 31.71 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.55 146.08 41.44 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.99 0.395 . . . . 0.0 110.22 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 84.63 10.74 78.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.229 177.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.86 168.7 19.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.122 0.487 . . . . 0.0 111.896 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.3 p -111.18 154.06 24.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.408 ' CA ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -71.87 0.74 8.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.13 -51.46 4.62 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.72 90.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.746 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 19.8 ptmt -58.79 -34.63 71.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.671 0.272 . . . . 0.0 111.544 -174.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.533 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.4 mm-40 -65.96 -29.45 69.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.215 0.531 . . . . 0.0 110.083 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -72.73 -40.8 65.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.599 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.441 HG21 HG21 ' A' ' 46' ' ' VAL . 2.4 mp -63.11 -47.21 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 96.4 mt -53.73 -32.74 53.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.008 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 68' ' ' GLU . 47.0 t -72.15 -58.32 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.393 0.616 . . . . 0.0 110.975 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.38 -28.32 69.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.451 -173.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.692 HG23 HG11 ' A' ' 31' ' ' VAL . 7.2 p -79.98 -26.14 12.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.337 0.589 . . . . 0.0 110.661 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.539 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -83.99 -34.16 18.94 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.543 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.57 60.95 2.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.018 0.437 . . . . 0.0 111.006 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.484 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 7.9 mm -126.22 128.81 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 t -65.11 113.4 3.92 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 119.28 -13.76 11.08 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.397 -171.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.484 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 37.4 mm -100.61 138.86 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.064 0.459 . . . . 0.0 110.133 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.069 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -125.55 -17.04 5.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.5 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 9.2 p -155.87 158.57 38.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.081 0.467 . . . . 0.0 111.321 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 56.0 t -133.23 130.5 57.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.949 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HB3' HG23 ' A' ' 56' ' ' THR . 26.3 t0 -104.05 124.58 49.3 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -95.23 101.41 13.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.302 -174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -119.11 11.84 12.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.121 0.486 . . . . 0.0 110.596 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.43 135.52 26.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.228 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -99.77 141.85 32.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.631 -173.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.5 p -109.17 137.44 47.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.194 0.521 . . . . 0.0 111.445 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.447 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -99.62 -35.79 9.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.393 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 24.2 p -112.43 147.05 36.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.293 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 3.0 Cg_endo -80.43 143.09 15.18 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.417 2.744 . . . . 0.0 111.843 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -161.06 166.68 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.209 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.7 m -73.39 131.43 41.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.502 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.8 173.31 8.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.701 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.7 m -123.8 151.76 42.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.442 0.639 . . . . 0.0 111.297 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.448 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 17.9 tt0 -89.81 143.36 26.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.132 173.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -105.77 102.06 11.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.247 0.546 . . . . 0.0 111.067 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.467 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 93.3 t80 -102.14 135.99 42.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.219 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.401 ' OG1' HG22 ' A' ' 143' ' ' VAL . 3.0 m -105.46 122.29 45.7 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.2 m -67.37 126.74 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 140' ' ' PRO . 34.5 mmtp -87.18 -66.06 0.95 Allowed 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -170.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.2 t -175.12 122.63 0.22 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.88 15.12 81.6 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -172.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.519 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -86.42 118.12 25.64 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.547 -0.827 . . . . 0.0 109.885 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 110' ' ' ILE . 22.7 p -109.03 157.8 18.34 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -55.29 -45.54 76.23 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.579 -174.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.436 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 7.4 m -61.09 -42.45 98.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.709 0.29 . . . . 0.0 110.82 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.99 -40.36 87.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.341 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 106' ' ' THR . 1.2 pp -76.27 -26.52 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.74 0.305 . . . . 0.0 110.442 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.527 ' OG ' ' HA ' ' A' ' 121' ' ' TYR . 42.5 m -68.37 -46.45 70.05 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-O 121.204 0.526 . . . . 0.0 109.793 169.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -56.38 -30.61 62.93 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.326 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -68.52 -63.3 1.09 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.4 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.404 HG21 HD12 ' A' ' 146' ' ' ILE . 23.5 m -80.0 -40.98 20.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.111 -170.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.425 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 15.7 m-85 -91.27 -49.74 6.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.446 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.95 5.74 32.91 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 120' ' ' LEU . 58.6 t-20 -135.17 113.91 11.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -71.52 -15.59 62.31 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -85.48 -2.87 58.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.04 0.448 . . . . 0.0 110.743 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.443 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . 63.4 mt -89.51 18.65 5.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.061 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HA ' ' OG ' ' A' ' 111' ' ' SER . 47.5 p90 -68.94 -26.14 64.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.084 -174.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -68.93 -36.47 78.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.439 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 120' ' ' LEU . 31.6 mtmt -54.26 -52.76 60.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.328 0.585 . . . . 0.0 110.697 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.406 ' HB ' HD11 ' A' ' 107' ' ' LEU . 32.6 mt -68.75 -39.44 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.747 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.752 ' HA ' HD23 ' A' ' 132' ' ' LEU . 5.5 t80 -59.55 -52.91 63.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.745 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HA ' ' HG3' ' A' ' 129' ' ' LYS . 2.2 mm-40 -60.99 -39.66 90.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.131 0.491 . . . . 0.0 111.507 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -63.85 -28.04 69.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.386 -177.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.541 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 38.9 m-80 -98.99 6.69 46.57 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 20.9 mtmm -78.7 156.2 77.89 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 122.101 -0.374 . . . . 0.0 110.709 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.644 ' HD2' HD13 ' A' ' 40' ' ' ILE . 1.3 Cg_endo -87.73 14.62 46.83 Favored 'Cis proline' 0 CA--C 1.531 0.368 0 C-N-CA 123.994 -1.253 . . . . 0.0 112.478 -3.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.541 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.0 tmm? -64.71 -39.23 93.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 125' ' ' PHE . 35.0 tp -97.33 117.83 32.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.409 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 10.6 mptt -87.51 -33.9 18.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.899 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.456 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 15.1 p -161.8 155.0 17.56 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.137 0.494 . . . . 0.0 109.751 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 107' ' ' LEU . 12.2 Cg_endo -60.75 -8.14 8.79 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 123.679 2.919 . . . . 0.0 113.117 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -113.72 -14.8 12.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.238 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -87.47 20.16 3.0 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 106' ' ' THR . 8.3 pt -79.06 172.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.2 p90 -154.12 142.05 13.99 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.428 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 139' ' ' TYR . 80.4 Cg_exo -51.07 114.27 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.261 2.641 . . . . 0.0 112.851 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.34 13.91 11.33 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.892 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.538 ' H ' HG22 ' A' ' 101' ' ' VAL . 41.5 tt0 -98.47 120.58 39.14 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.661 -175.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 100' ' ' THR . 42.4 t -82.65 133.18 29.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.281 0.562 . . . . 0.0 109.999 174.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.1 mt -126.2 136.03 52.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.605 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.475 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 2.2 ptm180 -74.49 123.64 25.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.222 0.534 . . . . 0.0 110.026 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 37.0 mm -100.34 102.9 20.13 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.784 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 46.4 Cg_exo -56.77 145.37 83.45 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.377 2.052 . . . . 0.0 111.253 176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -57.21 119.81 7.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.618 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -66.15 125.7 26.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.979 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 90.4 mt -120.07 13.48 12.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.658 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.55 112.04 2.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.259 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -102.17 -6.76 22.86 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -125.77 86.79 2.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.598 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -75.15 88.03 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.118 0.485 . . . . 0.0 110.798 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -146.75 130.66 17.16 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.404 ' HD2' ' OD1' ' A' ' 117' ' ' ASN . 31.6 m170 -61.76 -36.93 82.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.057 0.456 . . . . 0.0 110.74 -177.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 C--O 1.242 0.691 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.817 176.331 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 120.698 0.285 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.03 -7.98 1.92 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.476 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 23.9 tp -101.11 115.44 30.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.28 0.54 . . . . 0.0 110.82 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 82' ' ' SER . 82.8 m-85 -113.03 139.22 48.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.921 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -99.52 155.87 17.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.579 0.228 . . . . 0.0 110.909 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.695 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 94.2 m-85 -134.29 -158.73 0.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.977 0.418 . . . . 0.0 111.429 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.008 HG11 ' HB3' ' A' ' 10' ' ' ALA . 6.3 p -82.3 -23.14 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.462 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.62 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 18.5 tptm 75.82 -61.39 0.47 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.472 0.709 . . . . 0.0 111.891 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.44 -37.94 35.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 1.008 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -81.53 152.6 27.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.737 0.303 . . . . 0.0 110.622 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.25 -178.26 19.4 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.055 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.63 134.52 47.64 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -83.72 89.97 7.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.62 0.724 . . . . 0.0 112.287 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.581 HD22 HD12 ' A' ' 77' ' ' ILE . 6.4 mp -89.88 -39.15 13.23 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.672 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -136.33 151.51 49.68 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -65.33 -21.67 66.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.988 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 66.6 -1.25 1.34 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.101 0.56 . . . . 0.0 112.472 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 m -67.88 -41.05 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 120.976 0.417 . . . . 0.0 110.41 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.3 p -107.08 -3.87 19.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.486 174.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.47 -21.82 12.5 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.138 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 56.45 24.6 8.69 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.172 0.51 . . . . 0.0 110.796 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -75.25 -17.56 60.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.351 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -69.37 -12.92 62.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.94 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -101.62 145.0 29.66 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.698 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -92.44 -10.86 36.43 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.653 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 2.9 m-20 -73.26 -10.77 60.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.848 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -62.42 -31.83 72.58 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.929 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.77 -35.0 74.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.313 0.578 . . . . 0.0 110.086 174.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -69.28 -38.99 78.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.642 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 75.3 mmtt -53.06 -43.4 66.67 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.556 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 51.7 t -69.73 -36.14 68.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.78 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -59.61 -43.52 93.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.0 mt-10 -57.7 -51.14 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.05 -47.11 53.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.347 177.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 91.6 mt -66.83 -41.95 86.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.192 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -72.13 -32.07 66.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.121 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 14.3 mmmm -72.34 -38.6 68.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.813 0.339 . . . . 0.0 111.225 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' HG12 ' A' ' 40' ' ' ILE . 2.9 p -74.49 -31.42 62.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.156 0.503 . . . . 0.0 110.91 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.1 30.1 8.07 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.6 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.544 HD13 ' HD2' ' A' ' 130' ' ' PRO . 46.0 mm -59.3 129.01 86.34 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 122.264 0.226 . . . . 0.0 110.504 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -61.46 129.02 26.55 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.541 2.161 . . . . 0.0 112.637 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.16 22.75 10.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.53 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -70.59 -20.04 62.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.207 0.527 . . . . 0.0 110.69 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -78.02 -15.78 58.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.244 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -87.53 -24.58 24.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.9 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 70' ' ' ILE . 28.9 m -98.16 162.94 2.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.276 0.56 . . . . 0.0 111.73 -174.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -126.92 150.49 49.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.328 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 56' ' ' THR . 60.6 mt -128.43 142.66 43.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.799 0.333 . . . . 0.0 111.549 -173.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -130.4 128.67 41.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.454 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 55' ' ' ALA . 40.0 mm -106.1 119.66 55.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.028 0.442 . . . . 0.0 111.45 -175.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.75 79.27 1.2 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.182 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 69.38 -74.49 0.08 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.34 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.65 42.99 1.3 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.49 ' HE2' ' HB2' ' A' ' 84' ' ' ASP . 49.4 tttm -141.98 114.25 8.24 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.505 ' HA ' HD13 ' A' ' 50' ' ' ILE . . . -99.4 96.81 7.96 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.118 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.527 HG23 ' HB3' ' A' ' 84' ' ' ASP . 21.1 m -84.83 112.83 20.89 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.414 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -101.2 131.15 49.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.273 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -130.71 160.57 33.91 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.389 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.59 142.24 3.65 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -122.98 150.72 42.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.947 0.403 . . . . 0.0 110.397 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.28 12.28 54.74 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.051 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.23 175.55 10.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.403 . . . . 0.0 111.768 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.7 p -127.05 144.98 50.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 172.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -46.74 -45.31 19.58 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 9.6 tp10 -61.14 -47.5 85.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.466 -174.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.33 -39.3 65.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.408 0.623 . . . . 0.0 110.315 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -52.34 -47.75 65.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.872 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -76.89 -20.2 56.53 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.548 -174.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 35.3 mmtm -62.26 -38.82 90.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.456 HG21 HG21 ' A' ' 46' ' ' VAL . 28.4 mt -70.7 -58.51 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.421 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 mp -43.67 -48.25 7.8 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.35 -28.86 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.928 0.394 . . . . 0.0 111.439 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.86 -26.22 22.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 m -82.43 -23.71 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 110.835 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.695 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -81.4 -29.81 39.04 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.929 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -81.1 53.8 2.09 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.163 0.506 . . . . 0.0 111.232 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.581 HD12 HD22 ' A' ' 14' ' ' LEU . 26.1 mm -117.77 134.76 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -68.73 99.5 1.03 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.96 -14.71 5.7 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.299 -172.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 21.9 mm -98.4 122.67 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.314 0.578 . . . . 0.0 111.315 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -102.62 -14.73 16.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.705 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 25.8 p -160.26 158.31 29.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.294 0.569 . . . . 0.0 112.413 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.524 HG12 ' CE2' ' A' ' 6' ' ' PHE . 7.5 p -126.74 133.02 69.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.231 173.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.7 t70 -107.6 95.48 5.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.39 107.57 5.76 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.375 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -115.13 22.21 13.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.218 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -83.26 131.32 34.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.962 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -105.29 129.01 53.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.405 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 p -97.45 136.44 37.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.485 0.66 . . . . 0.0 112.153 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.65 -44.16 10.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.937 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.7 p -114.43 137.73 22.75 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.588 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.59 152.91 29.99 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.61 2.207 . . . . 0.0 111.719 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.404 ' HB3' ' H ' ' A' ' 65' ' ' GLU . . . -157.14 -174.1 4.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.419 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.0 m -64.3 132.55 50.53 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.368 0.418 . . . . 0.0 111.109 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.22 169.19 8.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.648 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.5 p -143.65 155.34 44.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.543 0.687 . . . . 0.0 112.105 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.494 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.4 tt0 -86.23 141.58 29.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.48 173.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -101.59 101.73 12.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.963 0.411 . . . . 0.0 110.853 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 113' ' ' GLN . 93.6 t80 -107.07 141.16 38.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.547 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 4.6 m -104.19 122.41 45.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.183 177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.494 HG22 ' H ' ' A' ' 142' ' ' GLN . 2.8 m -67.22 140.03 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.46 -162.19 0.93 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.112 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.2 t -56.62 -31.4 64.27 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 123.123 0.264 . . . . 0.0 111.219 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.28 49.23 2.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.155 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -64.92 109.24 2.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.44 1.114 . . . . 0.0 112.117 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 110' ' ' ILE . 86.4 m -151.39 129.24 11.66 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.616 170.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 15.2 mt -51.03 -48.74 61.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.878 0.763 . . . . 0.0 111.333 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.9 p -58.48 -37.61 75.88 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.297 0.373 . . . . 0.0 111.152 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.68 -50.63 49.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -74.17 -23.81 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.575 -176.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.6 t -69.78 -46.29 66.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 61.7 tttm -60.88 -28.04 68.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.619 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.598 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 2.6 tp-100 -66.2 -64.18 0.91 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.21 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.8 m -78.23 -44.67 27.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.558 -170.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.435 ' N ' HG23 ' A' ' 114' ' ' VAL . 63.8 m-85 -81.61 -46.37 14.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.67 0.747 . . . . 0.0 110.343 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.94 -6.28 32.68 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.567 -170.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -127.98 131.34 49.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.221 -0.489 . . . . 0.0 110.161 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . . . -84.77 0.97 48.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.991 0.424 . . . . 0.0 110.717 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -93.68 0.09 56.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.739 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.76 21.18 17.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.377 0.608 . . . . 0.0 110.875 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 44.0 p90 -61.51 -32.33 72.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.479 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -79.27 -22.37 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.824 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -60.48 -48.75 80.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.373 0.606 . . . . 0.0 110.13 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.43 HD13 HD11 ' A' ' 110' ' ' ILE . 50.1 mt -63.83 -49.9 79.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.094 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -46.3 -53.34 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.806 0.691 . . . . 0.0 111.083 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.565 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 7.7 mm-40 -65.24 -29.36 70.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.621 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.443 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -77.2 -19.1 57.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.043 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.498 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 5.3 m120 -95.05 -2.1 50.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.511 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.565 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 6.5 mmmm -68.6 145.88 97.34 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.544 ' HD2' HD13 ' A' ' 40' ' ' ILE . 66.6 Cg_endo -96.36 22.97 25.96 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 C-N-CA 124.059 -1.226 . . . . 0.0 112.027 -7.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.498 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 1.7 tmm? -70.81 -35.81 72.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.529 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.9 tp -90.33 119.31 30.53 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -77.96 -45.65 23.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.616 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -154.66 157.32 32.09 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.39 -51.89 9.84 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 C-N-CA 123.29 2.66 . . . . 0.0 112.83 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.06 6.49 18.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.407 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -98.93 15.22 26.32 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.639 0.257 . . . . 0.0 111.332 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.511 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 9.6 pt -78.0 175.55 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 171.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -159.63 144.25 11.17 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -52.3 112.31 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.277 2.651 . . . . 0.0 112.312 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 117.61 0.16 18.03 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.167 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.511 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 39.5 tt0 -88.28 122.78 32.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.965 0.412 . . . . 0.0 110.354 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 37.6 t -83.33 133.6 28.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.999 173.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 70.2 mt -124.02 151.04 44.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.284 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.473 ' H ' ' ND2' ' A' ' 128' ' ' ASN . 58.0 mtp180 -80.07 122.82 27.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.229 177.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 25.4 mm -109.23 97.29 25.12 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.228 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.02 148.77 35.64 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.084 1.856 . . . . 0.0 111.312 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.33 133.8 50.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.532 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.77 25.65 0.43 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.97 31.36 4.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.197 0.522 . . . . 0.0 110.435 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -64.05 -77.96 0.05 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.702 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -168.73 -48.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.386 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -78.68 99.4 6.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.359 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -80.06 34.19 0.29 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.084 0.468 . . . . 0.0 111.513 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -82.88 81.45 8.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.09 0.471 . . . . 0.0 109.963 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -109.43 10.72 25.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.766 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.4 m170 . . . . . 0 C--O 1.243 0.738 0 CA-C-O 118.575 -0.726 . . . . 0.0 109.312 172.558 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.3 -122.71 3.73 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.072 -177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.7 tp -101.96 118.25 36.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.081 0.467 . . . . 0.0 110.733 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.46 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 86.7 m-85 -105.52 118.02 35.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.803 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -89.83 150.0 22.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.071 0.463 . . . . 0.0 111.351 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.66 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 74.8 m-85 -132.08 -156.72 0.77 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.928 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.054 HG11 ' HB3' ' A' ' 10' ' ' ALA . 5.7 p -88.6 -22.01 6.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.038 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.81 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 23.8 tptm 75.99 -57.84 0.56 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.549 0.739 . . . . 0.0 111.513 -175.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.58 -53.49 11.76 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.029 0.442 . . . . 0.0 111.726 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 1.054 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -73.31 146.24 45.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.126 -175.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.75 -167.73 29.29 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -72.03 124.79 25.69 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -73.01 83.13 1.25 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.456 HD21 ' O ' ' A' ' 30' ' ' LYS . 20.1 tp -94.33 -43.2 8.52 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.87 -170.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -127.66 14.53 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.361 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.588 ' HB3' HG12 ' A' ' 18' ' ' VAL . 10.1 m-20 61.41 99.19 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.865 0.728 . . . . 0.0 110.694 -175.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.41 -3.2 10.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.546 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 16' ' ' ASP . 14.5 p -64.48 -25.63 38.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.888 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.0 m -150.64 -61.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.727 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 141.75 -152.31 23.39 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -146.24 66.33 1.19 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.269 0.557 . . . . 0.0 110.643 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.3 m80 69.89 -73.89 0.09 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.274 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -116.15 142.15 47.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.856 0.36 . . . . 0.0 110.796 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.423 ' HA ' ' OE1' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -67.22 -19.76 65.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.75 175.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.1 -35.43 64.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.536 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -77.16 -27.08 53.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.163 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.592 ' O ' HG23 ' A' ' 31' ' ' VAL . 54.9 mt-30 -64.74 -32.87 74.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.301 173.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.01 85.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.119 0.485 . . . . 0.0 110.416 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -64.18 -44.09 93.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.52 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -52.93 -44.74 67.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.689 175.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 27' ' ' GLN . 82.1 t -58.59 -48.92 84.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.303 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.405 ' HG2' HD13 ' A' ' 48' ' ' ILE . 26.6 mt-30 -63.92 -40.79 97.28 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.282 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 40.7 mt-10 -58.86 -46.29 88.09 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 65.7 t60 -52.7 -44.9 66.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.866 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 99.0 mt -66.08 -39.75 90.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.248 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -74.17 -39.35 63.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.228 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 62.2 mtpt -64.43 -44.54 90.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.016 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.7 p -66.05 -51.05 61.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.166 0.508 . . . . 0.0 110.037 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.71 30.54 1.98 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.928 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.473 HD11 ' HB2' ' A' ' 131' ' ' MET . 27.4 mm -67.19 120.69 74.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.57 142.64 84.99 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.369 2.046 . . . . 0.0 112.961 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 58.54 25.47 13.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.473 -1.239 . . . . 0.0 112.645 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.51 -15.9 63.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.406 0.622 . . . . 0.0 110.14 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -86.61 -8.0 57.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.684 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -97.41 -8.81 28.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.738 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.84 172.1 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.317 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.69 131.19 25.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.458 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 56' ' ' THR . 4.1 mp -108.04 141.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.793 0.33 . . . . 0.0 110.794 -176.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -134.54 123.91 24.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.756 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mm -87.16 120.79 37.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.442 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -127.73 81.5 2.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.756 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 49.75 64.59 1.7 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.776 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.26 -26.53 14.88 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.54 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.449 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 30.8 mttp -90.06 114.16 26.01 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.152 0.501 . . . . 0.0 111.468 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 83' ' ' VAL . . . -89.49 94.68 9.97 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.221 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 48' ' ' ILE . 21.1 m -77.55 125.9 30.05 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG22 HG13 ' A' ' 48' ' ' ILE . 42.8 t -119.01 109.68 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.127 0.489 . . . . 0.0 111.18 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.7 m -102.67 166.63 10.4 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.911 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 88' ' ' LYS . . . 168.44 170.5 33.21 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.475 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -155.89 138.71 15.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.065 0.46 . . . . 0.0 110.151 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 93.53 3.55 64.62 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.91 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.59 -177.14 2.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.333 0.587 . . . . 0.0 111.994 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.7 p -132.04 157.8 43.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.105 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -47.91 -41.77 25.44 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 123.165 0.291 . . . . 0.0 111.05 176.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.461 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 49.9 mm-40 -55.92 -64.87 0.72 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.515 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.78 95.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.169 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.664 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 49.1 tttm -50.09 -63.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.891 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 72' ' ' VAL . 5.6 mm-40 -64.67 -35.01 79.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.158 0.504 . . . . 0.0 110.489 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -62.24 -45.35 93.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.81 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.404 ' O ' HG13 ' A' ' 74' ' ' VAL . 53.8 mt -62.2 -51.91 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.997 175.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 78.6 mt -47.44 -42.23 21.95 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.889 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 68' ' ' GLU . 62.0 t -67.25 -51.85 48.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.401 0.62 . . . . 0.0 110.739 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.22 72.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.222 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 70' ' ' ILE . 15.3 m -81.37 -32.68 12.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.875 0.369 . . . . 0.0 110.788 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.66 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -70.66 -26.2 74.46 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.676 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -85.14 47.21 1.37 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.766 0.317 . . . . 0.0 111.341 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.8 mt -120.45 141.19 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 120.846 0.355 . . . . 0.0 110.478 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -66.26 105.3 1.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.216 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.89 -2.75 9.96 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.774 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.1 mm -106.24 117.79 52.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.579 0.704 . . . . 0.0 111.126 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.81 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -91.98 -27.51 17.8 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.229 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.449 ' OG ' ' HG2' ' A' ' 54' ' ' LYS . 5.5 p -164.48 161.06 21.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.184 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 55' ' ' ALA . 4.3 p -119.77 124.1 72.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.611 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -94.68 103.08 15.0 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -76.24 119.06 19.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.866 -174.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -127.22 28.64 5.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.854 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.48 123.81 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.209 0.528 . . . . 0.0 111.351 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 59' ' ' GLY . 13.9 tptm -90.23 124.66 35.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.265 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.0 p -100.02 135.06 42.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.199 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.433 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -106.12 -23.93 12.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.58 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.447 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 67.4 p -123.58 138.75 30.77 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.52 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 2.1 Cg_endo -80.96 158.88 20.92 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.181 2.588 . . . . 0.0 112.788 -176.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -161.84 -176.84 5.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.168 177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.3 m -82.42 125.02 30.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HA ' ' CD ' ' A' ' 64' ' ' GLN . . . -73.24 145.48 46.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -123.96 172.09 9.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.388 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -106.66 153.88 21.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.784 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -111.63 116.98 31.69 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.407 ' CZ ' ' HG2' ' A' ' 113' ' ' GLN . 88.3 t80 -123.52 142.43 51.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.588 0.232 . . . . 0.0 110.4 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 2.5 m -104.1 124.28 48.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.361 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 142' ' ' GLN . 2.8 m -68.09 134.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -98.36 -177.19 3.62 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.143 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 p -61.9 116.21 4.68 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.15 25.75 5.99 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -169.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.562 ' OD2' HG13 ' A' ' 138' ' ' ILE . 10.4 p-10 -53.94 118.91 4.37 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.218 1.009 . . . . 0.0 111.768 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 110' ' ' ILE . 92.6 m -144.35 127.37 16.49 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.57 HD21 ' HB2' ' A' ' 125' ' ' PHE . 22.9 tp -63.15 -31.09 72.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.255 -170.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 p -75.71 -26.95 57.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.371 0.605 . . . . 0.0 110.152 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.431 ' CB ' ' HB ' ' A' ' 106' ' ' THR . . . -75.77 -44.22 42.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.851 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.609 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.3 pp -78.35 -24.28 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.394 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.2 p -72.7 -45.33 59.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.95 0.405 . . . . 0.0 109.993 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -64.26 -18.48 64.6 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.277 0.561 . . . . 0.0 110.231 174.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.609 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 5.4 tp-100 -72.66 -60.98 1.97 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.859 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 115' ' ' TYR . 30.8 m -78.01 -48.52 23.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.072 -172.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.496 ' HB3' HD12 ' A' ' 120' ' ' LEU . 83.4 m-85 -84.12 -36.21 23.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.327 0.584 . . . . 0.0 110.822 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 -2.54 56.74 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.096 -173.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.435 HD21 ' HB3' ' A' ' 119' ' ' ASN . 33.0 t30 -134.67 125.27 26.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.577 -0.311 . . . . 0.0 110.399 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.427 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -74.66 -22.78 58.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.56 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.435 ' HB3' HD21 ' A' ' 117' ' ' ASN . 7.9 t30 -63.78 -21.42 66.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.898 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 115' ' ' TYR . 63.3 mt -85.83 15.8 4.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.498 -177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.459 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 35.2 p90 -62.0 -35.84 79.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.284 0.564 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.401 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 8.4 t30 -65.72 -33.07 75.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.676 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -57.0 -49.26 76.32 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.442 0.639 . . . . 0.0 109.67 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.506 HG22 ' OD1' ' A' ' 128' ' ' ASN . 27.7 mt -67.73 -43.98 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.896 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.594 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 43.2 t80 -53.54 -56.33 18.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.854 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 19.2 mt-10 -65.42 -25.81 67.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.559 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.39 -34.9 31.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.061 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 124' ' ' ILE . 7.8 m120 -74.6 -30.54 61.71 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 7.2 mtpm? -57.25 148.41 52.73 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.559 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -87.78 8.74 64.56 Favored 'Cis proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.291 -1.545 . . . . 0.0 113.256 1.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.477 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -62.97 -39.98 96.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.108 0.48 . . . . 0.0 109.826 175.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.14 125.99 37.04 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -95.98 -36.64 10.98 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.447 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 19.7 m -150.79 153.2 33.31 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.063 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.442 ' HA ' HD22 ' A' ' 107' ' ' LEU . 74.1 Cg_exo -50.5 -54.12 5.99 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 C-N-CA 123.318 2.679 . . . . 0.0 113.054 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -84.52 7.36 20.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.55 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.447 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 37.1 mmtm -92.13 4.59 52.84 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.751 0.31 . . . . 0.0 111.802 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.562 HG13 ' OD2' ' A' ' 105' ' ' ASP . 11.6 pt -67.71 173.72 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.517 171.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 6.6 p90 -158.59 141.93 10.87 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.604 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 139' ' ' TYR . 71.9 Cg_exo -50.75 117.11 3.02 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.374 2.716 . . . . 0.0 112.858 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.12 4.03 24.23 Favored Glycine 0 N--CA 1.437 -1.286 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.03 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.475 ' H ' HG22 ' A' ' 101' ' ' VAL . 34.3 tt0 -93.0 116.38 29.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.348 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 37.1 t -79.71 134.66 27.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.7 mt -123.51 143.43 50.19 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.091 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.551 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 34.8 ttt180 -74.64 109.79 8.4 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.96 105.61 14.3 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.701 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 32.0 Cg_exo -59.12 164.44 10.33 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.722 2.281 . . . . 0.0 111.907 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -83.71 139.81 32.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.96 72.73 6.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.351 0.596 . . . . 0.0 111.126 -176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 83.9 mt -94.6 4.83 53.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.445 0.64 . . . . 0.0 109.835 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -96.46 138.57 33.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.187 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -81.54 43.71 0.76 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.277 0.56 . . . . 0.0 111.721 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -118.56 36.03 4.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 155' ' ' HIS . 2.3 t-80 -82.81 159.87 22.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.947 -176.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 25.2 m-70 72.94 149.71 0.1 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.081 0.552 . . . . 0.0 110.683 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -120.51 12.81 11.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.033 0.444 . . . . 0.0 110.585 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.752 -0.642 . . . . 0.0 109.822 -178.422 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmt? . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.933 0.396 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.47 114.33 0.6 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.621 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.6 tp -126.04 114.6 18.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.356 0.598 . . . . 0.0 110.32 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.65 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 56.5 m-85 -106.76 131.56 53.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.608 -176.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.33 136.77 41.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.453 0.644 . . . . 0.0 112.252 -171.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.621 ' HE1' HG12 ' A' ' 83' ' ' VAL . 31.4 m-85 -123.03 -166.0 1.39 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.48 176.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 57.2 t -81.25 -81.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.98 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtt? 160.68 -74.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.91 -30.56 69.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.098 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.17 126.24 30.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.885 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.93 -178.26 31.73 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.02 125.83 25.32 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -74.67 69.24 1.75 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.975 0.893 . . . . 0.0 109.16 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD21 ' O ' ' A' ' 30' ' ' LYS . 19.4 tp -70.69 -50.18 39.24 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.214 -174.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.423 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 13.2 p90 -120.24 27.64 8.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.826 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 15' ' ' TRP . 9.0 m-20 73.3 -52.96 0.7 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.923 -175.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 68.19 14.86 9.33 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.581 0.752 . . . . 0.0 112.001 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 t -88.5 -70.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.818 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -145.4 46.15 1.31 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.62 136.34 6.86 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.706 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.642 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . 2.0 mp0 68.41 108.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.383 0.611 . . . . 0.0 110.842 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -78.42 151.9 32.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.458 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.537 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 1.2 m-20 -68.21 72.36 0.19 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.556 0.535 . . . . 0.0 111.974 -175.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -131.94 -159.95 1.01 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.35 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -60.65 -25.17 66.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.985 0.421 . . . . 0.0 110.753 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.531 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 2.1 m-20 -58.29 -35.78 72.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.216 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.642 ' OE1' ' HB3' ' A' ' 21' ' ' GLN . 6.6 mm100 -75.88 -41.22 52.77 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -176.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.11 62.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.76 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 24.7 ttmm -67.1 -49.13 66.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.14 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 14.0 mptt -58.28 -41.51 84.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.673 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 27' ' ' GLN . 93.9 t -60.71 -43.46 95.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.731 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -58.13 -47.04 84.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.699 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 39.8 mt-10 -58.22 -47.17 84.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.065 176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -51.67 -49.9 61.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.094 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 98.2 mt -63.58 -38.72 92.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.333 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -79.85 -33.14 40.38 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.549 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -71.65 -30.56 65.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.662 0.268 . . . . 0.0 110.908 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 p -80.18 -40.42 27.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.039 0.447 . . . . 0.0 110.547 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.07 26.81 5.35 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.248 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.459 HD13 ' HD2' ' A' ' 130' ' ' PRO . 35.9 mm -61.71 132.25 93.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 110.467 -0.198 . . . . 0.0 110.467 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 11.9 Cg_exo -65.31 130.97 26.79 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.429 2.086 . . . . 0.0 112.819 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 59.44 29.56 19.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.819 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.87 -26.52 68.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.777 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -75.32 -26.06 58.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.733 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -74.07 -22.03 59.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.684 -174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.404 HG21 HG21 ' A' ' 70' ' ' ILE . 23.5 m -100.76 162.39 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.563 0.697 . . . . 0.0 111.816 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -128.83 129.76 46.03 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.878 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.74 133.73 46.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.963 0.411 . . . . 0.0 110.914 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -119.69 122.06 40.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.52 173.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.607 HG13 ' HB2' ' A' ' 27' ' ' GLN . 30.5 mm -97.59 108.36 21.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.212 0.529 . . . . 0.0 110.868 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.21 66.2 0.65 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.798 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 55.94 77.82 0.22 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.653 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.07 -18.24 32.84 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.219 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 82' ' ' SER . 28.0 ttpp -108.37 116.5 32.08 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.153 -0.616 . . . . 0.0 110.702 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.27 101.34 13.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.933 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 84' ' ' ASP . 14.4 m -85.18 124.95 32.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.237 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.95 110.77 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 120.982 0.42 . . . . 0.0 111.436 -175.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.444 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -97.92 157.49 16.07 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.889 177.121 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 87' ' ' VAL . . . 163.1 165.98 21.13 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.432 176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -148.37 143.01 26.54 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.916 0.389 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 83.68 37.75 11.49 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.964 176.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.62 165.51 12.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.802 0.334 . . . . 0.0 110.961 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -93.57 160.65 14.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.998 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.575 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 7.6 tp60 -53.54 -58.0 8.71 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.222 0.326 . . . . 0.0 111.76 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.413 ' HG2' HH12 ' A' ' 145' ' ' ARG . 27.1 mt-10 -58.24 -46.78 85.32 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.23 76.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.113 0.482 . . . . 0.0 110.09 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 68.3 tttt -57.4 -46.33 83.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.528 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 72' ' ' VAL . 75.5 mt-10 -60.71 -47.53 85.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.653 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -55.8 -40.05 72.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.755 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.404 HG21 HG21 ' A' ' 46' ' ' VAL . 58.6 mt -63.03 -57.84 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.339 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 98.6 mt -48.03 -45.53 32.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.099 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 68' ' ' GLU . 30.9 t -68.64 -49.17 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.156 0.503 . . . . 0.0 110.593 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.41 74.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.486 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.14 -33.48 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.842 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.586 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -70.88 -35.4 65.55 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.247 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.05 38.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.801 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.5 mt -110.42 139.99 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.7 t -65.6 120.21 12.52 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.54 -22.93 11.49 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.506 HG21 ' HA2' ' A' ' 75' ' ' GLY . 45.8 mm -97.37 136.95 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.398 0.618 . . . . 0.0 110.196 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -126.45 -9.51 6.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.739 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 1.8 p -160.06 150.56 18.71 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.65 ' CG1' ' HB2' ' A' ' 4' ' ' PHE . 7.2 p -122.97 132.74 70.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.416 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.9 t0 -111.29 110.99 21.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -78.24 123.21 26.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.993 -173.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 77.7 mm-40 -131.25 8.32 4.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.846 174.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 1.7 p -96.11 126.58 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.265 0.555 . . . . 0.0 111.17 -176.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -85.51 149.26 25.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.932 -176.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.2 p -104.37 121.29 43.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.926 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.481 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -84.99 -41.87 15.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.027 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 p -117.19 127.36 26.75 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.799 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.82 153.08 13.12 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.77 2.313 . . . . 0.0 112.822 -175.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -148.68 -161.14 1.28 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.506 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.4 m -76.04 127.81 33.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.929 0.395 . . . . 0.0 110.305 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.85 128.11 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.898 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.9 m -103.65 153.32 20.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.348 0.594 . . . . 0.0 111.84 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 8.6 tt0 -87.05 155.66 20.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.324 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -116.2 98.69 6.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.242 0.544 . . . . 0.0 110.517 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 78.8 t80 -101.49 136.33 41.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.553 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.432 ' OG1' HG22 ' A' ' 143' ' ' VAL . 5.4 m -102.09 126.93 49.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.557 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 142' ' ' GLN . 3.3 m -73.56 141.52 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -91.83 -165.56 1.38 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.931 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.3 m -62.38 -31.46 72.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.814 0.34 . . . . 0.0 111.091 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -96.37 44.8 1.95 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.651 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' OD2' HG13 ' A' ' 138' ' ' ILE . 7.8 p-10 -56.37 120.81 8.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 122.007 0.908 . . . . 0.0 112.137 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 110' ' ' ILE . 53.4 m -143.71 126.11 15.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 168.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.487 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 40.6 tp -61.1 -28.1 68.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.714 0.293 . . . . 0.0 110.765 -174.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.481 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 9.6 m -76.24 -29.87 57.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.302 0.572 . . . . 0.0 110.274 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.406 ' CB ' ' HB ' ' A' ' 106' ' ' THR . . . -75.0 -44.86 45.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.802 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.1 pp -76.5 -21.58 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.976 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.2 p -77.05 -43.92 32.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.89 -23.28 63.33 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.317 0.58 . . . . 0.0 110.156 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.6 tp-100 -70.02 -61.93 1.58 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.142 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.6 m -82.86 -39.51 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.376 -169.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.416 ' HB3' HD12 ' A' ' 120' ' ' LEU . 40.9 m-85 -91.38 -36.17 13.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.129 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.62 -3.91 53.62 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.264 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -131.76 129.21 40.28 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -81.46 -13.7 57.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.495 -176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.27 -18.14 55.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.381 0.61 . . . . 0.0 110.183 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 115' ' ' TYR . 64.8 mt -84.39 21.06 1.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.211 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.487 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 41.9 p90 -65.74 -33.41 75.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.566 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 7.9 p30 -68.11 -28.47 67.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.946 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' A' ' 123' ' ' LYS . 29.5 mmmt -59.74 -49.69 76.76 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.337 0.589 . . . . 0.0 110.163 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.1 mt -65.82 -44.82 92.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.868 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.465 ' HB2' HD21 ' A' ' 107' ' ' LEU . 50.8 t80 -48.98 -56.73 8.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.171 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.576 ' HA ' ' HG2' ' A' ' 129' ' ' LYS . 29.5 mt-10 -68.43 -21.19 64.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.944 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -81.88 -23.39 36.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.063 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.494 ' OD1' HD22 ' A' ' 144' ' ' LEU . 7.6 m120 -88.3 -3.26 58.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.936 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.576 ' HG2' ' HA ' ' A' ' 126' ' ' GLU . 28.0 mmmt -72.07 148.52 91.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HD2' HD13 ' A' ' 40' ' ' ILE . 72.1 Cg_endo -95.98 31.9 11.79 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.636 -1.401 . . . . 0.0 112.409 -2.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.47 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -84.87 -33.84 22.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.072 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.01 120.98 33.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.451 0.643 . . . . 0.0 110.578 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -67.24 -62.5 1.39 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.066 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.446 ' H ' ' HB2' ' A' ' 137' ' ' LYS . 26.5 m -145.66 161.05 42.35 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.345 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 134' ' ' SER . 78.3 Cg_exo -52.24 -41.49 65.56 Favored 'Trans proline' 0 C--N 1.332 -0.303 0 C-N-CA 123.216 2.611 . . . . 0.0 112.426 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.7 19.91 7.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.446 ' HB2' ' H ' ' A' ' 134' ' ' SER . 3.0 mmpt? -107.03 11.73 29.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.874 0.368 . . . . 0.0 111.335 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.441 HG13 ' OD2' ' A' ' 105' ' ' ASP . 15.0 pt -73.88 172.95 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.11 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -166.46 149.62 6.42 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -175.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.44 110.91 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.092 2.528 . . . . 0.0 112.515 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.88 4.68 26.01 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.522 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.488 ' H ' HG22 ' A' ' 101' ' ' VAL . 7.4 tp60 -82.37 112.27 19.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.713 0.292 . . . . 0.0 110.377 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.462 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 26.8 t -82.97 134.15 27.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.494 HD22 ' OD1' ' A' ' 128' ' ' ASN . 77.7 mt -121.29 144.0 48.86 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.068 0.461 . . . . 0.0 111.112 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 27.4 ttp85 -75.01 108.03 7.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.266 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 30.9 mm -99.02 103.04 17.38 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.57 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 20.9 Cg_exo -63.78 146.99 92.55 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.126 1.884 . . . . 0.0 111.382 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.1 131.89 47.74 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -63.05 100.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.956 0.408 . . . . 0.0 110.961 -175.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 74.5 mt -90.82 4.3 52.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.478 0.656 . . . . 0.0 109.722 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -76.98 -70.41 0.46 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.742 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.9 t60 66.57 -73.56 0.07 Allowed 'General case' 0 CA--C 1.529 0.149 0 O-C-N 124.083 0.865 . . . . 0.0 110.469 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -93.5 143.72 26.03 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 58.11 47.81 13.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.445 0.641 . . . . 0.0 109.754 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -91.75 29.05 1.62 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.621 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 69.62 176.02 0.28 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.157 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.7 p80 . . . . . 0 C--O 1.245 0.848 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.568 -178.027 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.52 -32.84 0.15 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.041 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.53 129.21 54.99 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.627 0.727 . . . . 0.0 111.121 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.581 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 87.0 m-85 -111.97 125.58 54.22 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.447 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -93.12 136.44 33.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.433 0.635 . . . . 0.0 111.839 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.564 ' HE1' HG12 ' A' ' 83' ' ' VAL . 32.7 m-85 -126.1 -167.47 1.71 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.858 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.5 t -116.0 113.81 44.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.815 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 19.2 ptmt -59.85 -29.03 68.01 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -171.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.97 -10.09 58.96 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.04 -178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.13 122.18 46.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.124 0.488 . . . . 0.0 111.222 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 157.76 179.18 32.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.972 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.17 132.91 48.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -86.53 80.36 8.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.188 0.518 . . . . 0.0 111.801 -173.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 34' ' ' HIS . 7.1 mp -72.33 -46.76 54.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.244 172.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.403 ' HE1' ' HA3' ' A' ' 79' ' ' GLY . 43.8 p90 -127.72 169.87 13.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.491 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.71 16.94 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.02 20.93 10.04 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.117 0.567 . . . . 0.0 111.865 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 t -93.05 65.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.9 p 66.46 -47.79 0.44 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.003 1.321 . . . . 0.0 112.464 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.546 ' HA2' ' NE2' ' A' ' 27' ' ' GLN . . . -155.05 162.57 30.98 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.549 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 6.2 tp-100 -69.55 -66.76 0.54 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -123.47 -50.43 1.88 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.402 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -133.01 -72.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.081 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -176.04 -55.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.091 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -63.26 -30.77 71.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.541 0.686 . . . . 0.0 110.398 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.549 ' OD2' ' HB3' ' A' ' 21' ' ' GLN . 1.2 p-10 -61.72 -36.78 81.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.076 176.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 31' ' ' VAL . 53.2 mt-30 -61.95 -45.77 92.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.348 177.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.62 71.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.805 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -70.52 -36.21 73.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.185 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 30.1 mmmt -62.7 -43.28 99.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.338 174.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 27' ' ' GLN . 72.6 t -62.59 -39.5 84.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.815 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -57.31 -43.9 83.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.592 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.35 -48.94 78.96 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.9 0.381 . . . . 0.0 110.579 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.502 ' HB2' HD21 ' A' ' 14' ' ' LEU . 58.5 t60 -52.51 -43.17 64.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.369 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.21 -39.71 65.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.471 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -82.19 -31.26 30.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.777 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -75.05 -23.45 58.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.608 0.242 . . . . 0.0 111.376 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 p -86.06 -39.08 17.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.232 0.539 . . . . 0.0 110.439 174.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.61 33.81 3.75 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.96 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.28 124.72 88.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.99 144.87 65.76 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.845 1.696 . . . . 0.0 112.379 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.557 ' HB3' HD22 ' A' ' 62' ' ' LEU . 12.0 m-20 65.9 3.41 2.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.419 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.55 -16.23 61.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.401 0.62 . . . . 0.0 110.518 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.66 -18.31 59.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.018 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -103.25 -0.6 30.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.531 -172.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 70' ' ' ILE . 30.7 m -103.02 171.13 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.181 0.515 . . . . 0.0 111.593 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -134.73 125.11 26.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.866 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.0 135.73 37.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.278 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.478 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 48.2 tt0 -127.7 125.33 39.83 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 27' ' ' GLN . 21.5 mm -97.26 134.86 33.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.893 0.378 . . . . 0.0 110.595 -177.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.39 50.96 2.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.375 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 63.1 93.23 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.788 0.68 . . . . 0.0 111.483 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 78.41 -23.47 2.84 Favored Glycine 0 CA--C 1.517 0.176 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.585 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HE3' ' OG1' ' A' ' 56' ' ' THR . 0.8 OUTLIER -109.68 115.14 29.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -101.48 120.17 39.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.315 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.528 ' OG1' ' HE3' ' A' ' 54' ' ' LYS . 49.2 m -90.72 132.86 35.56 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.309 -0.244 . . . . 0.0 110.528 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.99 119.96 61.82 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.347 0.594 . . . . 0.0 110.396 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -117.62 162.24 18.34 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.226 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.85 156.87 8.21 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -138.54 144.83 40.08 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.912 0.387 . . . . 0.0 110.509 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 88.36 22.69 39.82 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.48 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.557 HD22 ' HB3' ' A' ' 42' ' ' ASP . 8.6 mt -100.08 -166.85 1.38 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.238 0.542 . . . . 0.0 109.952 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.4 p -125.73 168.26 14.03 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.923 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.675 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -63.22 -43.34 98.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.843 0.354 . . . . 0.0 110.522 -178.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.489 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 42.7 tt0 -64.46 -42.82 95.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.622 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.42 -46.95 83.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.454 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 12.9 ptmm? -59.62 -37.34 78.35 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.915 -175.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 72' ' ' VAL . 85.9 mt-10 -64.75 -48.17 75.55 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.719 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 28.6 mtpp -54.22 -41.01 68.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.676 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.618 HD13 HG11 ' A' ' 46' ' ' VAL . 29.7 mt -71.38 -53.93 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.691 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 96.3 mt -48.95 -47.31 43.97 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.656 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 68' ' ' GLU . 70.0 t -65.37 -45.78 92.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.389 0.614 . . . . 0.0 110.647 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.471 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -61.72 -39.24 90.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.358 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.6 m -78.18 -31.21 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.718 0.294 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' HA2' HG21 ' A' ' 80' ' ' ILE . . . -69.6 -36.79 76.81 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.301 175.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -80.24 50.02 1.2 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.321 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.473 HD13 HD22 ' A' ' 14' ' ' LEU . 96.8 mt -119.04 143.34 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 120.946 0.403 . . . . 0.0 110.387 173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -67.66 115.11 6.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.461 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 111.29 -13.17 28.42 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.131 -172.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 50.6 mm -105.96 132.89 51.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.896 0.379 . . . . 0.0 110.684 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.815 ' HB2' ' HB3' ' A' ' 8' ' ' LYS . . . -131.29 -5.49 3.82 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.421 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 2.7 p -156.2 154.34 30.63 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.193 0.52 . . . . 0.0 111.317 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.6 p -134.4 134.6 54.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.034 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.71 113.68 27.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -83.09 111.06 18.54 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.474 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -123.47 29.02 6.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.483 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.483 ' CG1' HD12 ' A' ' 62' ' ' LEU . 77.4 t -82.45 139.9 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.508 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -105.14 137.71 42.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.047 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.4 p -108.89 130.27 55.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.419 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.455 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -97.31 -29.46 13.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.104 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.7 p -127.27 140.29 37.51 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.707 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.04 153.47 25.08 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.754 2.303 . . . . 0.0 111.774 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.489 ' HB3' ' H ' ' A' ' 65' ' ' GLU . . . -159.58 -172.77 3.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.99 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.2 m -61.78 149.2 40.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.348 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.89 138.53 51.08 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.732 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.5 m -120.18 149.41 42.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.217 0.532 . . . . 0.0 111.709 -175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 8.8 tt0 -84.16 153.01 23.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.019 173.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -110.67 96.17 6.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.156 0.503 . . . . 0.0 111.167 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -95.3 136.07 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.861 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.435 ' OG1' HG22 ' A' ' 143' ' ' VAL . 18.4 m -106.83 124.0 48.97 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 142' ' ' GLN . 0.8 OUTLIER -67.45 134.05 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 72.0 mmtt -86.67 -72.39 0.51 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.376 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 t -175.08 115.5 0.16 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -175.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.01 -3.81 85.71 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -171.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 1.0 OUTLIER -63.71 113.94 3.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.2 -1.0 . . . . 0.0 110.829 178.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 110' ' ' ILE . 40.0 p -104.97 158.28 16.65 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.664 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -57.37 -45.91 83.94 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.356 -172.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.575 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 17.2 m -65.47 -35.16 80.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.75 0.309 . . . . 0.0 110.588 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.98 77.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.106 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.584 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.5 pp -75.6 -29.68 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 120.833 0.349 . . . . 0.0 110.495 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.2 t -65.16 -45.69 83.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.232 0.539 . . . . 0.0 109.627 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -62.88 -30.33 71.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.455 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.5 OUTLIER -64.41 -62.86 1.34 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.229 176.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 115' ' ' TYR . 34.2 m -77.21 -46.23 28.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.262 -170.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.699 ' CE2' ' HD2' ' A' ' 123' ' ' LYS . 15.8 m-85 -88.14 -50.46 6.36 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 120.5 -19.88 9.02 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -173.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -111.23 128.32 55.89 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.575 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -81.56 -8.59 59.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.981 0.42 . . . . 0.0 110.247 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -80.25 -12.3 59.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.395 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.483 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 55.7 mt -87.16 11.53 13.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.459 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 51.0 p90 -58.05 -30.78 66.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.196 0.522 . . . . 0.0 110.51 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.455 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 26.9 p-10 -76.27 -32.71 58.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.171 -176.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.699 ' HD2' ' CE2' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -71.81 -24.31 61.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -177.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mt -83.99 -41.97 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.65 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.567 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 40.9 t80 -53.66 -59.76 4.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.359 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 30.2 mt-10 -60.6 -36.11 77.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.152 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.73 -32.34 73.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.045 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.523 ' O ' ' HB3' ' A' ' 131' ' ' MET . 40.8 m-80 -90.01 -8.15 52.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 120.939 0.399 . . . . 0.0 110.866 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 132' ' ' LEU . 30.4 mtpp -74.11 156.67 87.56 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.531 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -84.28 14.82 35.48 Favored 'Cis proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.383 -1.507 . . . . 0.0 113.365 -0.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.523 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 4.2 tmm? -67.31 -38.5 85.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.175 0.512 . . . . 0.0 109.75 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.637 ' O ' ' HG2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -90.9 111.69 23.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -74.29 -60.34 2.31 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.335 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 16.3 m -137.96 155.62 74.55 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 134' ' ' SER . 25.8 Cg_exo -63.09 -23.64 73.45 Favored 'Trans proline' 0 CA--C 1.522 -0.097 0 C-N-CA 123.655 2.903 . . . . 0.0 113.134 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -99.67 4.87 45.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.952 0.406 . . . . 0.0 110.668 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 134' ' ' SER . 27.3 mmmt -90.62 -0.77 57.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.756 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.407 HD11 ' HA ' ' A' ' 106' ' ' THR . 21.4 pt -64.56 166.13 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.046 0.451 . . . . 0.0 110.833 174.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -155.24 144.65 15.25 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.917 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -54.29 116.39 3.03 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.332 2.688 . . . . 0.0 112.71 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.46 14.52 14.22 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.202 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.57 ' O ' HG13 ' A' ' 101' ' ' VAL . 65.0 tt0 -99.78 130.83 46.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.899 0.381 . . . . 0.0 110.322 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 6' ' ' PHE . 42.5 t -85.63 130.57 36.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.269 0.557 . . . . 0.0 109.957 174.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.0 mt -118.81 134.76 54.93 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.733 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.521 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 51.8 mtp180 -65.87 120.34 12.88 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.325 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 35.2 mm -111.46 82.65 3.74 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 31.9 Cg_exo -62.79 170.17 7.62 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 122.825 2.35 . . . . 0.0 112.215 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -51.66 133.21 31.05 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.64 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -78.69 77.6 5.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.3 tp -80.01 73.59 6.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.27 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.425 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . 38.1 tt0 62.41 -91.29 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.802 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.9 m80 55.85 54.33 8.27 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.677 0.391 . . . . 0.0 112.052 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 66.8 m80 60.45 87.0 0.09 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.075 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.425 ' CE1' ' HA ' ' A' ' 151' ' ' GLU . 18.7 m170 -81.42 -176.58 6.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.163 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 35.0 t60 60.36 77.72 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.315 0.579 . . . . 0.0 109.746 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -64.84 146.49 54.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.56 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 21.9 p80 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.032 177.688 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.954 0.406 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.63 65.23 0.93 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.896 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 39.1 tp -113.84 122.43 47.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -121.39 133.62 55.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.329 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.71 146.88 24.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.756 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CD2' HG21 ' A' ' 143' ' ' VAL . 77.2 m-85 -128.23 -157.95 0.85 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.073 -176.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.667 HG21 ' HB3' ' A' ' 10' ' ' ALA . 22.8 m -83.73 -26.76 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 24.4 tptp 72.51 -53.37 0.7 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.248 0.619 . . . . 0.0 111.479 -174.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.39 -49.34 8.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.857 0.36 . . . . 0.0 111.831 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.667 ' HB3' HG21 ' A' ' 7' ' ' VAL . . . -76.21 -169.18 1.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.45 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.36 -160.02 19.2 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -76.82 127.1 32.12 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -74.64 63.42 1.12 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.017 0.913 . . . . 0.0 109.019 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 77' ' ' ILE . 11.8 tp -65.49 -50.72 64.25 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 113.793 -1.548 . . . . 0.0 110.491 -174.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 21' ' ' GLN . 6.8 p90 -125.57 -35.8 2.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.725 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t70 51.1 -90.47 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.839 0.712 . . . . 0.0 110.474 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -160.76 26.51 0.15 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 p -142.15 126.9 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.263 -171.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.1 p 47.79 37.22 6.8 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.363 0.602 . . . . 0.0 111.369 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -172.45 169.81 42.9 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 15' ' ' TRP . 6.1 tt0 63.3 56.24 1.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.374 0.607 . . . . 0.0 109.487 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -82.91 -16.2 48.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.978 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' H ' ' HB3' ' A' ' 26' ' ' ASP . 5.2 t70 -166.14 178.85 6.06 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -70.93 -47.08 61.03 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -75.92 -15.58 60.16 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.328 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.526 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 20.4 t70 -71.12 -35.92 71.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.065 0.46 . . . . 0.0 109.872 175.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -61.57 -45.12 95.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.973 174.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.71 84.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.603 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 51.6 tttp -60.67 -43.42 97.68 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.48 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 43.5 mmtt -62.66 -38.77 91.64 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.373 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.615 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 73.5 t -66.09 -42.92 92.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.267 176.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -55.44 -51.54 66.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 38.6 mt-10 -56.85 -46.92 81.42 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.255 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -52.59 -48.15 66.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.044 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 88.6 mt -65.81 -41.9 91.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.927 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -69.03 -41.77 77.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.347 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 99.3 mttt -65.17 -42.81 93.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.512 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 p -72.43 -40.64 66.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 111.141 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.01 32.67 2.99 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.234 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.445 HD13 ' HD2' ' A' ' 130' ' ' PRO . 26.2 mm -71.71 126.09 91.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.67 148.35 77.65 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.089 1.86 . . . . 0.0 112.604 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 61.78 16.44 7.9 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.737 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.32 70.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.125 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.49 -23.39 63.62 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.338 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -88.91 -27.92 20.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.322 -171.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 70' ' ' ILE . 24.4 m -88.01 164.11 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.222 0.534 . . . . 0.0 111.833 -177.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -128.32 135.06 49.08 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.973 173.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.79 131.01 60.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.815 0.34 . . . . 0.0 110.287 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -118.75 124.84 48.27 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.078 0.466 . . . . 0.0 110.539 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.0 mm -105.19 136.75 37.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.782 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.06 54.88 1.56 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.205 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.7 88.57 0.09 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.98 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.4 -34.93 2.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.978 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -84.1 119.95 25.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.983 0.421 . . . . 0.0 110.388 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.61 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -121.6 105.89 10.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.233 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.0 m -93.6 122.01 35.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.204 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -98.67 130.72 47.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.165 0.507 . . . . 0.0 109.989 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.55 136.78 54.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.135 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.78 168.22 40.77 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.6 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.477 ' HB3' ' HE3' ' A' ' 88' ' ' LYS . 3.5 p30 -157.17 142.57 17.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.991 0.424 . . . . 0.0 110.453 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.56 24.92 64.11 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.091 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.538 HD12 HG11 ' A' ' 87' ' ' VAL . 11.5 mt -99.41 -162.43 0.95 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.339 0.59 . . . . 0.0 109.916 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.2 p -120.73 155.59 33.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.968 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.423 ' NE2' ' HA ' ' A' ' 95' ' ' ALA . 59.8 tt0 -60.77 -35.29 76.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.893 0.378 . . . . 0.0 110.14 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -60.81 -44.27 97.09 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.538 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.55 -41.85 59.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -54.8 -57.07 13.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.753 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 72' ' ' VAL . 5.9 mm-40 -67.11 -15.77 63.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.043 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -75.9 -48.32 21.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.269 0.557 . . . . 0.0 109.524 176.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.568 ' O ' HG12 ' A' ' 74' ' ' VAL . 47.6 mt -65.05 -52.35 54.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.817 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 85' ' ' ASP . 7.6 mp -40.78 -46.49 2.69 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.83 0.706 . . . . 0.0 112.653 175.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.493 HG21 ' HG3' ' A' ' 145' ' ' ARG . 98.9 t -71.81 -48.52 50.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.196 0.522 . . . . 0.0 110.872 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HA ' ' SD ' ' A' ' 131' ' ' MET . . . -60.6 -32.11 71.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.182 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 70' ' ' ILE . 11.9 p -88.59 -28.28 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.276 0.56 . . . . 0.0 110.851 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.503 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -70.37 -35.25 69.02 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.02 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -83.42 58.86 4.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.795 0.331 . . . . 0.0 110.807 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.636 HD12 HD22 ' A' ' 14' ' ' LEU . 41.8 mm -123.78 132.75 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -63.81 95.42 0.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.53 -17.73 3.96 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.9 -173.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.61 HD12 ' HB2' ' A' ' 55' ' ' ALA . 35.3 mm -102.61 127.81 55.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.194 0.521 . . . . 0.0 111.471 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -111.48 -30.89 7.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.562 -174.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 p -150.69 150.6 31.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.313 0.577 . . . . 0.0 111.448 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 85.4 t -124.25 126.52 72.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.878 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -103.24 112.58 25.51 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.412 ' HB2' HD21 ' A' ' 71' ' ' LEU . 6.3 t0 -84.35 110.63 18.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.344 0.592 . . . . 0.0 111.427 -176.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -119.22 33.04 5.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.461 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 62' ' ' LEU . 77.6 t -95.73 123.64 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.22 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -89.71 123.18 33.5 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 174.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.4 p -102.82 126.46 49.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.82 0.343 . . . . 0.0 111.259 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.0 -27.81 23.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.424 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.8 p -121.04 129.46 25.28 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.998 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.53 164.5 16.46 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.815 2.343 . . . . 0.0 112.418 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.59 -155.04 0.58 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.7 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.6 m -86.62 122.77 31.0 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.423 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -62.92 142.66 58.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.607 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.9 m -127.57 143.27 51.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.116 0.484 . . . . 0.0 111.803 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.578 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 5.8 tt0 -91.85 153.4 19.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 171.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.455 ' N ' ' HG2' ' A' ' 97' ' ' GLN . 31.1 m-85 -107.17 86.84 2.38 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.028 0.442 . . . . 0.0 110.264 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -84.63 131.77 34.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.707 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.449 ' OG1' HG22 ' A' ' 143' ' ' VAL . 20.0 m -103.31 120.43 40.75 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.973 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 142' ' ' GLN . 0.9 OUTLIER -68.44 129.86 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.433 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 72.3 mmtt -78.62 -64.1 1.25 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.302 -169.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.9 t -159.18 -72.91 0.08 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.674 0.273 . . . . 0.0 110.505 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.35 51.6 4.58 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.539 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.1 m-20 -108.72 111.96 24.01 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.039 -0.58 . . . . 0.0 110.983 -171.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 110' ' ' ILE . 8.1 m -104.03 150.37 24.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 21.3 tp -57.87 -43.1 85.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.623 0.647 . . . . 0.0 110.944 -173.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.2 p -61.03 -39.98 91.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.22 0.533 . . . . 0.0 111.095 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.24 -40.87 74.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.354 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.7 pp -79.02 -23.84 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.2 p -71.22 -39.16 71.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.971 0.415 . . . . 0.0 110.03 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 8.3 tmtm? -64.03 -29.93 71.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -65.16 -52.75 53.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.318 177.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.441 HG21 HD12 ' A' ' 146' ' ' ILE . 34.7 m -87.78 -44.0 15.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.175 -171.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.425 ' HB3' HD12 ' A' ' 120' ' ' LEU . 64.8 m-85 -89.56 -53.07 4.69 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.891 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.48 -22.86 7.71 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.061 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -116.51 124.33 49.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.356 -0.422 . . . . 0.0 109.903 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.91 -19.28 60.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.555 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -67.68 -11.39 58.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.187 0.517 . . . . 0.0 110.485 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 115' ' ' TYR . 39.1 mt -89.11 14.43 10.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.176 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.435 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 27.9 p90 -64.74 -28.91 69.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.049 0.452 . . . . 0.0 109.814 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.596 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 32.1 p30 -69.46 -29.6 67.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.878 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -58.69 -49.62 76.92 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.51 0.671 . . . . 0.0 110.078 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.78 -39.82 78.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.295 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.443 ' CE2' ' HD2' ' A' ' 129' ' ' LYS . 45.5 t80 -54.58 -55.76 26.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.758 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 35.1 mt-10 -63.51 -40.13 96.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.942 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.504 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -60.06 -28.47 67.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.115 -177.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.467 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 47.1 m-80 -99.93 0.01 40.36 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 120.619 0.247 . . . . 0.0 110.871 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.547 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 25.8 mtpp -79.36 150.75 74.27 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-O 120.644 0.259 . . . . 0.0 110.779 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.445 ' HD2' HD13 ' A' ' 40' ' ' ILE . 9.5 Cg_endo -90.5 25.1 21.4 Favored 'Cis proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.662 -1.391 . . . . 0.0 112.843 -0.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.467 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 1.0 OUTLIER -74.95 -34.7 62.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.88 0.372 . . . . 0.0 110.276 176.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.486 HD21 HE21 ' A' ' 142' ' ' GLN . 0.1 OUTLIER -93.03 117.76 30.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.98 -43.37 24.6 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.892 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.3 m -151.45 149.85 25.34 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.255 0.55 . . . . 0.0 110.762 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.97 -18.08 61.19 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 123.713 2.942 . . . . 0.0 112.875 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.12 -16.31 22.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.498 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -78.62 -1.2 33.05 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 15.8 pt -65.7 168.14 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.912 0.387 . . . . 0.0 110.063 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -163.9 154.96 13.86 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.343 -172.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -45.2 113.31 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.164 2.576 . . . . 0.0 112.662 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.29 34.65 5.77 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.339 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.572 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.2 tp60 -107.08 116.6 32.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.835 0.318 . . . . 0.0 110.164 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.526 HG21 ' CD2' ' A' ' 6' ' ' PHE . 46.7 t -80.5 132.08 32.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.066 0.46 . . . . 0.0 110.004 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -125.63 134.42 51.9 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.073 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.504 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 47.2 mtp180 -62.68 118.76 8.09 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.064 171.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 39.7 mm -106.24 93.27 7.79 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 173.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 38.5 Cg_exo -59.85 139.14 86.78 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.222 1.948 . . . . 0.0 111.184 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -53.24 127.3 24.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.014 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.52 ' CD ' ' HB3' ' A' ' 152' ' ' HIS . 27.8 tt0 -60.82 99.99 0.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.678 -176.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.0 mt -98.48 98.5 9.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.845 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 66.35 101.99 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.478 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.52 ' HB3' ' CD ' ' A' ' 149' ' ' GLU . 10.1 p80 -93.88 148.0 22.55 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -111.99 106.28 14.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -72.96 -5.22 37.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.996 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -96.46 11.08 36.23 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.129 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 60.46 -174.04 0.12 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.704 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.5 p80 . . . . . 0 C--O 1.244 0.765 0 CA-C-O 118.908 -0.567 . . . . 0.0 110.23 176.734 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.0 ttm . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.93 -17.93 71.2 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.8 tp -93.18 105.8 17.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.268 0.556 . . . . 0.0 110.108 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -93.6 138.81 31.47 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.26 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.417 HD22 ' N ' ' A' ' 5' ' ' ASN . 0.9 OUTLIER -97.57 138.31 35.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.018 0.437 . . . . 0.0 111.01 -177.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.414 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 59.5 m-85 -127.25 -179.12 4.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.496 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.95 HG21 ' HB3' ' A' ' 10' ' ' ALA . 23.7 m -81.26 -9.94 12.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -171.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.644 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 53.4 tptt 74.35 -54.95 0.67 Allowed 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.528 0.518 . . . . 0.0 112.141 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.62 -46.53 15.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.097 0.475 . . . . 0.0 111.963 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.95 ' HB3' HG21 ' A' ' 7' ' ' VAL . . . -81.29 126.93 32.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.183 -173.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.96 -173.1 36.59 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.371 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.04 129.59 41.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.35 54.98 1.8 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.992 0.901 . . . . 0.0 108.88 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 30' ' ' LYS . 14.7 tp -59.25 -45.98 89.73 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 113.8 -1.545 . . . . 0.0 111.312 -172.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -117.88 27.05 9.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.555 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.616 ' HB3' HG12 ' A' ' 18' ' ' VAL . 17.8 t70 62.49 6.14 1.88 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.664 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.71 23.4 13.28 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.159 0.583 . . . . 0.0 111.519 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.616 HG12 ' HB3' ' A' ' 16' ' ' ASP . 3.5 p -108.75 98.37 6.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.305 0.574 . . . . 0.0 110.99 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.8 m 72.06 -57.92 0.6 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.785 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 21' ' ' GLN . . . 156.22 -28.22 0.57 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.259 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 20' ' ' GLY . 32.1 mm-40 75.24 122.45 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.29 0.636 . . . . 0.0 111.128 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 31.0 m80 65.01 -85.9 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.484 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -146.04 -177.16 5.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HA ' ' OE1' ' A' ' 27' ' ' GLN . 41.1 ttmt -74.99 -41.89 58.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.024 0.44 . . . . 0.0 110.55 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.12 -23.27 64.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.093 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 19.0 t70 -72.22 -36.1 69.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.709 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 31' ' ' VAL . 51.5 mt-30 -59.92 -48.35 82.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.375 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.43 -34.7 72.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.765 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 38.6 ttpt -68.11 -39.99 82.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.985 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 74.6 mmtt -56.96 -44.96 83.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.063 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.611 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 47.5 t -59.96 -45.16 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.49 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -55.56 -47.64 76.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.868 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 38.2 mt-10 -58.91 -48.88 79.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.359 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -53.04 -39.37 63.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.456 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 85.7 mt -70.76 -40.91 72.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.013 0.435 . . . . 0.0 111.201 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -78.07 -31.01 50.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.175 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -67.92 -38.2 82.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.943 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.8 p -75.66 -36.42 60.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 110.789 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.92 35.29 4.32 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.167 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.8 mm -77.11 124.69 87.26 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.69 146.46 66.87 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.229 1.953 . . . . 0.0 112.396 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 64.34 -0.9 0.81 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.907 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 35' ' ' LEU . . . -80.77 -9.89 59.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.341 0.591 . . . . 0.0 110.432 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -87.7 -9.53 53.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.276 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -91.72 -35.54 14.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.089 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.8 m -69.68 166.12 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.373 -175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -130.23 128.99 42.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.802 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 48' ' ' ILE . 3.6 mp -103.87 140.91 20.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.8 0.333 . . . . 0.0 110.869 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 38.5 tt0 -123.14 135.78 54.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 173.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.3 mm -104.35 111.72 35.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.079 0.466 . . . . 0.0 110.306 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -112.25 93.89 4.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.473 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.6 t70 64.18 -83.62 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.368 -171.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.77 13.96 4.73 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.656 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 38.0 mtmm -95.82 117.23 30.16 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.662 0.267 . . . . 0.0 110.475 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -92.1 80.59 5.09 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.823 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 89.3 m -66.68 119.65 12.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.959 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 57' ' ' VAL . 7.3 p -106.89 109.97 30.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.441 0.638 . . . . 0.0 111.193 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.9 OUTLIER -100.68 154.41 18.62 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.028 178.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.93 160.23 17.72 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -151.75 146.08 25.47 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.241 0.543 . . . . 0.0 110.721 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.94 31.13 58.34 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.529 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.45 HD12 ' CG1' ' A' ' 87' ' ' VAL . 18.3 mt -98.83 -169.99 1.86 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.837 0.827 . . . . 0.0 110.851 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 m -108.96 128.78 55.24 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.718 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.51 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 9.4 tt0 -61.49 -31.51 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.946 -172.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HG3' ' NH2' ' A' ' 145' ' ' ARG . 42.2 tt0 -65.63 -39.53 91.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.069 0.461 . . . . 0.0 110.151 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.549 ' O ' HG13 ' A' ' 70' ' ' ILE . . . -72.92 -39.34 66.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.918 174.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.638 ' HA ' HD12 ' A' ' 70' ' ' ILE . 73.3 tttt -52.12 -53.68 39.77 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.593 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 72' ' ' VAL . 7.7 mm-40 -52.95 -35.25 58.51 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 127' ' ' ALA . 28.7 ttpt -79.25 -32.55 43.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.505 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 67' ' ' LYS . 45.3 mt -61.89 -52.17 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 67' ' ' LYS . 9.8 mp -45.01 -43.84 9.53 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.646 173.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 68' ' ' GLU . 66.5 t -67.3 -51.47 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.465 0.65 . . . . 0.0 110.885 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.89 79.95 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.6 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.41 HG23 HG21 ' A' ' 83' ' ' VAL . 22.5 m -80.63 -25.94 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.029 0.442 . . . . 0.0 111.087 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -77.86 -28.87 55.95 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.832 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -83.39 42.61 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 111.404 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.2 mt -114.53 138.26 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-O 121.14 0.495 . . . . 0.0 110.488 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 t -71.49 111.91 7.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.182 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.09 -14.61 8.35 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -172.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.6 mm -98.74 121.83 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 110.902 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.644 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -104.14 -20.51 13.79 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.73 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.656 ' OG ' ' HG2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -158.83 153.85 25.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.465 -177.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 55' ' ' ALA . 68.1 t -127.84 124.27 62.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.789 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.8 105.85 18.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.494 ' OD1' ' HE3' ' A' ' 67' ' ' LYS . 3.3 t70 -72.84 116.54 13.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.224 0.535 . . . . 0.0 111.54 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 75.9 mt-30 -121.32 25.74 9.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.119 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.45 ' CG1' HD12 ' A' ' 62' ' ' LEU . 88.0 t -89.55 125.57 42.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.655 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -95.53 142.89 27.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.269 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.0 p -115.72 143.55 45.21 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.942 0.401 . . . . 0.0 111.548 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.91 -8.34 31.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.581 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.5 p -135.32 133.68 20.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.234 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.35 69.15 6.64 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.97 2.446 . . . . 0.0 111.283 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.44 -168.06 1.85 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.731 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.0 m -56.51 129.38 40.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.35 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.16 138.95 31.1 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.6 m -126.5 157.3 39.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.369 0.605 . . . . 0.0 112.02 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 3.9 tt0 -96.38 149.15 22.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.577 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -109.78 93.99 4.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.942 0.401 . . . . 0.0 110.603 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -98.2 139.18 34.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.272 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.6 m -104.54 123.44 47.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.345 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.9 m -70.92 134.87 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.4 mmtp -98.92 -165.61 1.26 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.481 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.427 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 13.9 m -65.1 122.87 18.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.633 0.254 . . . . 0.0 110.481 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.09 8.85 83.3 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.312 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.589 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 13.1 m-20 -88.31 105.18 17.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.367 0.603 . . . . 0.0 111.009 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 110' ' ' ILE . 5.8 m -102.69 161.09 14.01 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.488 ' N ' HD11 ' A' ' 138' ' ' ILE . 19.7 tp -56.39 -41.66 76.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.412 0.551 . . . . 0.0 111.699 -170.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.496 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 9.8 m -63.14 -41.57 99.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.955 0.407 . . . . 0.0 110.571 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.88 81.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.004 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.625 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -75.11 -24.52 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 120.917 0.389 . . . . 0.0 110.481 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.7 t -67.44 -44.14 79.41 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 170.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -61.79 -24.27 66.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.431 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 2.1 tp-100 -71.87 -59.87 2.53 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.924 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.8 m -82.83 -35.82 12.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.236 -170.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.507 ' HB3' HD12 ' A' ' 120' ' ' LEU . 19.0 m-30 -103.68 -23.89 13.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.05 -175.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.44 -6.31 82.34 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.909 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.472 HD21 ' HB3' ' A' ' 119' ' ' ASN . 41.0 t30 -133.94 124.0 25.62 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -76.18 -15.2 60.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.712 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 117' ' ' ASN . 22.9 t-20 -68.68 -23.43 64.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.139 0.495 . . . . 0.0 110.596 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 115' ' ' TYR . 67.1 mt -85.06 14.22 5.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.572 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.46 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 24.2 p90 -62.3 -31.61 72.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.189 0.519 . . . . 0.0 110.257 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.582 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 26.3 p-10 -68.89 -29.64 67.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.507 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -58.17 -47.47 83.29 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.543 0.687 . . . . 0.0 109.772 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.9 mt -71.8 -41.02 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.304 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.465 ' HB2' HD21 ' A' ' 107' ' ' LEU . 83.5 t80 -53.72 -51.76 62.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 40.2 mt-10 -62.74 -23.22 67.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.941 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.558 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -86.87 -31.87 20.53 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.632 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.574 ' O ' ' HB3' ' A' ' 131' ' ' MET . 10.5 m120 -76.67 -42.07 43.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 58.5 pttt -64.47 153.72 85.97 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.949 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.1 Cg_endo -86.27 21.55 22.36 Favored 'Cis proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.225 -1.573 . . . . 0.0 112.892 0.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.574 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.2 tmm? -73.23 -26.73 61.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.465 HD12 ' H ' ' A' ' 133' ' ' LYS . 18.8 tp -111.72 133.75 53.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.078 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.465 ' H ' HD12 ' A' ' 132' ' ' LEU . 29.7 mtpp -81.67 -45.18 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.063 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.499 ' OG ' ' HG2' ' A' ' 137' ' ' LYS . 79.0 p -154.02 160.94 30.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.79 -17.75 52.05 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 123.528 2.819 . . . . 0.0 111.929 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -100.43 -12.98 18.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.511 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HG2' ' OG ' ' A' ' 134' ' ' SER . 56.4 mmtt -81.49 -8.03 59.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.655 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 9.3 pt -68.43 168.9 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.098 0.475 . . . . 0.0 110.978 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.492 ' CE1' ' HG3' ' A' ' 142' ' ' GLN . 15.4 p90 -155.98 147.79 17.18 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.177 -174.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.427 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 88.7 Cg_exo -48.48 103.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.597 2.865 . . . . 0.0 113.037 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.406 ' HA2' HG11 ' A' ' 7' ' ' VAL . . . 124.19 8.81 5.86 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.601 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.655 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 1.7 mt-30 -94.37 121.97 36.45 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 117.341 0.571 . . . . 0.0 111.224 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 41.9 t -80.61 135.31 25.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.303 172.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.2 mt -126.36 145.31 50.5 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.063 0.459 . . . . 0.0 110.748 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HB2' HG21 ' A' ' 72' ' ' VAL . 28.5 ttt180 -72.48 110.37 6.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.906 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 41.5 mm -94.7 112.38 57.72 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.558 ' HG3' ' HB2' ' A' ' 127' ' ' ALA . 32.4 Cg_exo -59.69 166.68 7.81 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.985 2.457 . . . . 0.0 113.109 177.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -84.24 121.13 27.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.922 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.95 25.56 3.62 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -175.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 63.5 mt -80.7 56.38 2.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.247 0.546 . . . . 0.0 110.822 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -92.72 -7.21 47.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.869 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 48.0 m80 75.35 132.7 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.621 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 63.16 85.11 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.43 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -59.77 121.27 11.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.511 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -77.46 -63.16 1.44 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.752 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -95.1 85.89 4.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.461 177.787 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.499 ' HB2' ' HG2' ' A' ' 86' ' ' GLN . 85.6 mtp . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.688 0.28 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.94 78.7 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.51 HD13 ' N ' ' A' ' 4' ' ' PHE . 1.7 tm? -90.01 139.11 30.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.291 0.567 . . . . 0.0 111.31 -172.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.51 ' N ' HD13 ' A' ' 3' ' ' LEU . 86.5 m-85 -125.52 132.22 52.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.194 175.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -97.61 140.9 31.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.006 0.431 . . . . 0.0 110.997 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -127.75 -164.4 1.36 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.151 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -96.3 -10.81 8.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.794 0.331 . . . . 0.0 111.128 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 84.8 tttt 72.67 -67.19 0.27 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 176.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.31 -24.78 63.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.289 0.566 . . . . 0.0 110.504 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.26 119.98 31.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.711 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.01 -173.55 41.58 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.842 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -77.31 136.18 38.46 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 19.3 mtpt -77.97 86.05 4.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.45 0.643 . . . . 0.0 111.781 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.625 HD22 HD12 ' A' ' 77' ' ' ILE . 8.9 mp -84.3 -40.81 17.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.005 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.471 ' CZ3' ' HB3' ' A' ' 27' ' ' GLN . 22.7 p90 -152.17 155.6 38.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.702 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 18' ' ' VAL . 23.7 m-20 -95.2 -6.39 41.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.592 171.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 65.27 -80.52 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.277 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 16' ' ' ASP . 6.9 m -47.02 -51.39 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 124.061 0.944 . . . . 0.0 112.731 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.468 ' H ' HG23 ' A' ' 18' ' ' VAL . 4.2 p -121.64 28.22 7.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.646 0.736 . . . . 0.0 109.908 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.29 -33.18 0.74 Allowed Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.379 -0.828 . . . . 0.0 113.23 -173.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.596 ' NE2' ' HG2' ' A' ' 27' ' ' GLN . 2.9 tt0 -161.46 118.54 2.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.986 0.393 . . . . 0.0 110.453 -174.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -73.3 -42.43 62.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.582 -174.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.492 ' HB3' ' OD1' ' A' ' 25' ' ' ASP . 28.7 m-20 -107.21 138.01 44.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.089 0.471 . . . . 0.0 110.678 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.412 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 63.4 mttp -79.35 -17.2 54.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.875 -177.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.492 ' OD1' ' HB3' ' A' ' 23' ' ' ASP . 5.0 p-10 -73.41 -24.39 60.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.346 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -74.92 -25.91 59.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.138 0.494 . . . . 0.0 110.018 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.596 ' HG2' ' NE2' ' A' ' 21' ' ' GLN . 86.1 mt-30 -66.56 -33.78 76.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.154 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.23 72.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.763 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 17.4 tppt? -65.18 -43.29 92.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.589 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -66.87 -32.06 73.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.046 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.612 HG11 HG23 ' A' ' 74' ' ' VAL . 75.3 t -63.59 -46.18 95.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.311 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.424 ' NE2' HD12 ' A' ' 35' ' ' LEU . 16.5 mm-40 -57.85 -41.42 82.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.516 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 54.6 mt-10 -56.95 -48.47 78.26 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.011 0.434 . . . . 0.0 110.765 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.499 ' HB2' HD11 ' A' ' 14' ' ' LEU . 57.7 t60 -57.97 -37.02 73.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.428 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 64.4 mt -73.18 -40.65 64.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.008 0.433 . . . . 0.0 110.429 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -65.05 -48.0 75.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.419 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -58.03 -49.88 75.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.754 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.405 ' OG1' HG12 ' A' ' 40' ' ' ILE . 16.7 p -68.28 -44.38 75.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.37 35.49 3.85 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.792 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.405 HG12 ' OG1' ' A' ' 38' ' ' THR . 35.6 mm -66.67 124.04 87.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -66.38 138.65 51.48 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.989 1.793 . . . . 0.0 112.333 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 63.33 9.33 3.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.351 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -75.94 -14.38 60.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.27 0.557 . . . . 0.0 110.367 177.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -81.36 -16.32 52.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.13 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -75.19 -44.1 48.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.614 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.5 m -77.34 163.63 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.595 -172.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -118.8 139.28 51.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.877 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.9 mm -102.39 139.78 22.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.026 0.441 . . . . 0.0 111.316 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 49.9 tt0 -138.97 128.7 24.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.327 172.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mm -108.91 116.57 52.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.672 0.272 . . . . 0.0 110.912 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.48 100.06 7.6 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.832 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 t70 66.11 -80.96 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.8 0.688 . . . . 0.0 110.757 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.06 18.51 2.53 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 82' ' ' SER . 38.9 ttmt -107.78 114.74 28.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.294 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.68 111.87 23.62 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.155 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 18.5 m -86.65 130.64 34.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.917 177.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 57' ' ' VAL . 5.3 p -114.74 106.93 21.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.337 0.589 . . . . 0.0 110.897 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 m -104.55 155.88 18.44 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.996 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.22 179.72 39.25 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.325 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.13 150.52 13.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 0.0 110.6 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.54 23.97 48.46 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.504 -0.771 . . . . 0.0 113.163 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.46 175.35 5.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.76 0.314 . . . . 0.0 110.667 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 91' ' ' THR . 14.3 m -104.75 157.95 16.85 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 7.8 tp60 -53.85 -41.91 67.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.891 0.377 . . . . 0.0 110.227 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.689 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 61.1 mm-40 -49.84 -62.39 1.59 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.061 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.02 -37.69 84.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.685 0.279 . . . . 0.0 110.966 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -55.55 -51.77 65.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.625 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.558 ' O ' HG23 ' A' ' 72' ' ' VAL . 56.1 mt-10 -65.09 -33.56 76.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.106 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 29.8 mtpp -60.01 -42.73 94.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.867 0.365 . . . . 0.0 110.095 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.512 ' O ' HG12 ' A' ' 74' ' ' VAL . 52.6 mt -62.45 -57.38 12.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.322 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mp -41.9 -43.25 3.0 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.828 0.705 . . . . 0.0 112.406 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 68' ' ' GLU . 86.2 t -69.08 -53.19 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.33 0.586 . . . . 0.0 111.017 177.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.419 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -64.07 -31.09 72.16 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.588 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.612 HG23 HG11 ' A' ' 31' ' ' VAL . 11.7 p -84.62 -23.35 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.492 0.663 . . . . 0.0 110.532 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.23 -35.37 34.1 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.196 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -82.07 60.29 4.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.64 0.257 . . . . 0.0 111.145 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.625 HD12 HD22 ' A' ' 14' ' ' LEU . 32.7 mm -118.13 142.24 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.495 ' OG ' ' HA ' ' A' ' 13' ' ' LYS . 72.3 p -65.91 91.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.966 0.412 . . . . 0.0 110.492 176.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.98 -17.72 5.67 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.914 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 28.1 mm -86.51 113.06 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.667 0.746 . . . . 0.0 110.868 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.99 -24.61 15.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.03 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 5.4 p -150.05 156.83 42.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.293 0.568 . . . . 0.0 111.514 -178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.412 HG21 HG13 ' A' ' 74' ' ' VAL . 61.7 t -132.5 130.23 59.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.737 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -104.95 106.71 17.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -72.65 117.27 14.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.539 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 1' ' ' MET . 79.9 mt-30 -133.92 28.39 3.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.138 175.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.25 116.29 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.617 0.723 . . . . 0.0 110.712 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -82.37 144.46 30.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.766 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.9 p -112.17 127.43 55.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.19 0.519 . . . . 0.0 111.222 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.57 -27.75 23.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.23 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 16.3 p -119.93 132.24 24.13 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.332 176.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 50.4 Cg_endo -91.3 168.09 3.46 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.793 2.329 . . . . 0.0 113.205 -175.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -158.51 -156.63 0.56 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.554 174.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.11 154.5 19.32 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.21 129.09 35.85 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.6 m -97.39 156.48 16.44 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.281 0.563 . . . . 0.0 111.006 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.427 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.9 tt0 -87.87 142.19 28.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.323 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -106.76 90.55 3.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.442 . . . . 0.0 110.235 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 90.5 t80 -90.89 146.48 23.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.96 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.478 ' OG1' HG22 ' A' ' 143' ' ' VAL . 5.9 m -117.96 123.01 44.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.042 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.623 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.5 m -67.85 128.85 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -106.87 115.7 30.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.5 t 55.58 -90.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.822 173.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.5 19.32 53.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.427 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.578 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 2.2 m-20 -66.93 134.58 52.29 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.49 0.662 . . . . 0.0 111.253 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.629 ' O ' HG23 ' A' ' 110' ' ' ILE . 36.0 p -119.4 156.44 30.12 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.284 175.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 110' ' ' ILE . 20.9 tp -56.38 -40.86 75.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 118.185 0.448 . . . . 0.0 111.132 -171.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 4.6 m -63.77 -40.25 96.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.155 0.502 . . . . 0.0 110.378 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -73.83 -27.52 61.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.73 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 106' ' ' THR . 1.4 pp -85.34 -24.28 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.809 0.338 . . . . 0.0 110.958 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.494 ' HB3' HD12 ' A' ' 124' ' ' ILE . 11.3 p -76.3 -29.67 57.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 170.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 52.5 tptt -60.43 -26.33 66.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.842 170.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 16.2 mm-40 -75.69 -72.42 0.31 Allowed 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 122.282 1.039 . . . . 0.0 110.715 175.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.479 HG23 ' CD2' ' A' ' 115' ' ' TYR . 28.8 m -70.41 -40.1 77.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 113.251 -1.795 . . . . 0.0 112.659 -167.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.489 ' HB3' HD12 ' A' ' 120' ' ' LEU . 56.5 m-85 -96.97 -20.11 18.32 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.602 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 80.89 5.5 90.05 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.544 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.484 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 35.8 t30 -140.81 116.05 9.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.806 0.336 . . . . 0.0 110.318 -176.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.43 ' O ' ' HD2' ' A' ' 121' ' ' TYR . . . -70.31 -11.11 60.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.553 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -81.76 -10.96 59.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.489 HD12 ' HB3' ' A' ' 115' ' ' TYR . 74.8 mt -96.11 22.68 7.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.76 -178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.452 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 50.8 p90 -68.35 -29.13 67.79 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.041 -175.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.411 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 9.0 t30 -69.93 -30.51 67.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.084 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -53.83 -47.76 70.6 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.808 0.813 . . . . 0.0 109.484 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.548 HG22 ' OD1' ' A' ' 128' ' ' ASN . 55.7 mt -68.49 -46.71 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.491 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -53.96 -46.64 71.69 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.103 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.434 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 15.0 mt-10 -69.63 -24.67 63.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.96 0.41 . . . . 0.0 111.598 -176.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.49 29.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.951 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.548 ' OD1' HG22 ' A' ' 124' ' ' ILE . 8.3 m120 -74.82 -46.84 33.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.925 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 62.3 pttt -58.5 154.06 36.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.84 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.463 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.9 Cg_endo -80.86 15.18 20.15 Favored 'Cis proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.241 -1.566 . . . . 0.0 113.674 0.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.477 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.6 tmm? -70.03 -36.86 75.37 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.7 tp -94.45 115.88 28.14 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -73.81 -42.6 60.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.316 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 52.8 m -157.89 154.03 23.71 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 134' ' ' SER . 33.2 Cg_exo -61.72 -23.19 75.92 Favored 'Trans proline' 0 C--O 1.23 0.077 0 C-N-CA 123.76 2.974 . . . . 0.0 112.975 -173.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -105.38 7.16 33.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 110.689 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.416 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 30.9 mmtp -100.82 14.79 30.57 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.458 0.647 . . . . 0.0 110.692 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 106' ' ' THR . 17.6 pt -67.54 171.61 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.605 172.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 12.0 p90 -153.81 143.77 15.41 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.705 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 139' ' ' TYR . 58.0 Cg_exo -51.64 115.49 2.14 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.285 2.657 . . . . 0.0 112.898 -178.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.01 26.0 7.68 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.357 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.623 ' H ' HG22 ' A' ' 101' ' ' VAL . 65.4 tt0 -100.21 121.62 41.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.871 0.367 . . . . 0.0 110.782 -175.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.478 HG22 ' OG1' ' A' ' 100' ' ' THR . 55.4 t -82.12 138.4 19.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.691 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.0 mt -132.52 146.38 51.88 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.441 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.689 ' NH2' ' HA ' ' A' ' 65' ' ' GLU . 32.7 ttt180 -75.65 113.4 13.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.746 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 36.4 mm -99.93 103.09 20.0 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.106 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 27.2 Cg_exo -61.96 160.55 29.22 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.33 2.02 . . . . 0.0 111.805 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -80.73 129.9 34.78 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -62.75 96.29 0.08 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.453 0.471 . . . . 0.0 110.757 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.9 tp -101.59 84.79 2.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.166 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.93 157.54 37.9 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -174.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -73.67 -8.21 55.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.952 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -99.28 151.17 21.34 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -151.33 20.71 0.74 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.28 0.562 . . . . 0.0 110.462 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -105.97 107.4 18.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.678 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.405 ' HB2' ' C ' ' A' ' 116' ' ' GLY . 15.0 p-80 -84.48 170.83 13.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.295 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.2 p80 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.066 -178.581 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.653 0.263 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.89 23.25 0.97 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.353 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.0 tp -110.13 129.53 55.69 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.913 0.387 . . . . 0.0 110.405 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 82' ' ' SER . 81.3 m-85 -120.85 133.63 55.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.902 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -102.64 151.08 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.971 0.415 . . . . 0.0 110.813 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.747 ' HE1' HG12 ' A' ' 83' ' ' VAL . 90.8 m-85 -131.68 -179.88 5.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.945 -175.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.23 -17.81 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.867 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 81.2 tttt 72.93 -69.46 0.19 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.403 0.681 . . . . 0.0 111.7 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.26 -25.11 65.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.823 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.76 124.57 42.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.714 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.39 -163.26 36.78 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.71 134.4 38.11 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -78.06 90.49 4.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.327 0.584 . . . . 0.0 111.359 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.406 HD22 HD13 ' A' ' 77' ' ' ILE . 8.0 mp -97.69 -48.31 5.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.59 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -142.46 149.28 39.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.034 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.31 -1.07 35.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.301 0.572 . . . . 0.0 111.017 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 57.92 38.12 26.92 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.523 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.8 t -64.32 -73.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.993 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.8 p -130.03 23.94 5.28 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.28 -139.81 15.85 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.547 -171.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -156.01 93.81 1.47 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 34.5 m80 67.26 -72.14 0.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -168.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -122.67 -164.97 1.23 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.001 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -94.73 -42.93 8.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.077 0.465 . . . . 0.0 109.794 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.77 -10.47 59.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.954 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 18.9 t70 -72.05 -21.79 61.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.277 0.56 . . . . 0.0 109.734 177.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.434 ' HB2' HG13 ' A' ' 50' ' ' ILE . 17.6 mt-30 -69.09 -31.33 69.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.787 176.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 50' ' ' ILE . . . -62.89 -27.45 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.232 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.589 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 60.5 tttp -65.19 -42.76 93.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -64.04 -37.99 89.43 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.176 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.565 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 62.1 t -59.15 -51.68 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.893 176.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -54.58 -43.43 72.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.445 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 43.3 mt-10 -57.36 -56.74 17.93 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.105 0.478 . . . . 0.0 110.034 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -51.74 -42.76 62.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.283 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 99.2 mt -68.04 -42.76 80.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.645 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.51 -26.81 51.46 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.124 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -74.13 -32.43 63.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.688 0.28 . . . . 0.0 111.346 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.416 ' OG1' HG12 ' A' ' 40' ' ' ILE . 2.1 p -80.4 -30.64 37.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.905 0.383 . . . . 0.0 110.984 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.28 27.51 8.66 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.843 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.548 HD13 ' HD2' ' A' ' 130' ' ' PRO . 43.8 mm -58.41 129.75 84.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 122.402 0.281 . . . . 0.0 110.582 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -66.56 134.62 36.15 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.047 1.831 . . . . 0.0 111.981 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.484 ' HB3' HD22 ' A' ' 62' ' ' LEU . 7.5 m-20 62.96 21.69 13.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.804 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.493 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -70.34 -20.53 62.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.089 0.471 . . . . 0.0 111.093 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -91.54 -9.59 43.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.322 0.582 . . . . 0.0 109.991 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.77 -14.31 30.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.203 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.569 HG11 HD13 ' A' ' 70' ' ' ILE . 18.4 m -97.87 177.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.616 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -142.09 133.16 26.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.063 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.04 132.98 58.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.003 0.43 . . . . 0.0 110.751 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.424 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 95.3 mt-30 -115.71 147.9 40.36 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.46 HG22 ' H ' ' A' ' 52' ' ' ASP . 23.0 mm -120.48 128.86 76.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.19 35.24 4.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.194 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' H ' HG22 ' A' ' 50' ' ' ILE . 25.8 t70 66.88 98.26 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.671 0.607 . . . . 0.0 110.992 177.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 75.49 7.26 82.67 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.835 -176.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -146.5 138.69 24.95 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -120.11 148.26 43.84 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.693 175.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 61.2 m -117.65 119.79 36.05 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.1 t -99.54 111.76 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.459 0.647 . . . . 0.0 110.522 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -113.12 160.5 18.14 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.977 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.78 161.93 15.93 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -139.87 150.66 44.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 117.127 0.464 . . . . 0.0 111.008 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.92 35.45 84.57 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.93 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 42' ' ' ASP . 15.2 mt -107.67 -166.25 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.677 0.751 . . . . 0.0 111.305 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 79.5 p -141.59 159.06 43.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.2 -1.363 . . . . 0.0 107.862 174.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 13.4 mt-30 -68.26 -18.92 64.67 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.413 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.42 -44.9 96.33 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.86 -38.33 15.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.964 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -58.76 -41.26 86.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 -178.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.16 35.04 0.63 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.319 1.057 . . . . 0.0 110.304 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -123.75 -50.06 1.85 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.597 -1.638 . . . . 0.0 107.152 167.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.569 HD13 HG11 ' A' ' 46' ' ' VAL . 16.5 mt -61.99 -51.94 66.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.775 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp -67.43 -19.26 65.35 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.829 0.824 . . . . 0.0 110.419 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.4 t -86.14 -56.25 5.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.15 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.67 -23.23 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.151 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.412 HG23 HG11 ' A' ' 31' ' ' VAL . 14.5 p -76.28 -39.13 34.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.866 0.365 . . . . 0.0 110.662 176.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.639 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -71.24 -27.89 70.98 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.865 175.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -83.06 44.69 0.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 111.064 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.406 HD13 HD22 ' A' ' 14' ' ' LEU . 96.4 mt -119.71 141.28 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.424 174.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.3 m -68.27 103.19 1.53 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.548 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 130.62 -20.14 4.94 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.458 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.656 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 50.1 mm -94.73 116.85 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.439 . . . . 0.0 110.93 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 8' ' ' LYS . . . -107.78 -10.11 15.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.249 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 5.4 p -162.32 156.93 22.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.983 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.747 HG12 ' HE1' ' A' ' 6' ' ' PHE . 11.5 p -140.93 136.58 34.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.586 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.82 114.46 28.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.542 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.7 112.39 18.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.088 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -129.64 35.91 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.385 0.612 . . . . 0.0 110.503 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.481 HG11 HD12 ' A' ' 62' ' ' LEU . 93.4 t -89.09 131.98 35.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.392 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -94.99 97.6 10.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.748 175.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.7 p -81.74 121.52 26.5 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -86.88 -32.69 20.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.57 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 63' ' ' SER . 17.5 p -106.67 130.22 23.25 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.593 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.21 148.81 34.99 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.93 2.42 . . . . 0.0 112.795 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 64' ' ' GLN . . . -157.12 166.75 32.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.818 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.0 m -74.76 127.24 32.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.871 0.367 . . . . 0.0 110.943 -177.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.421 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -75.75 136.04 40.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.902 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 44.9 m -112.96 172.84 6.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.195 0.521 . . . . 0.0 111.694 -174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.0 tt0 -96.79 143.25 27.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.232 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -103.6 87.53 2.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.154 0.502 . . . . 0.0 110.456 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -88.11 136.71 32.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.115 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.437 ' OG1' HG22 ' A' ' 143' ' ' VAL . 6.6 m -105.7 123.64 48.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.338 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.559 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.2 m -72.16 135.06 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.277 0.561 . . . . 0.0 109.633 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.492 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 75.2 mmtt -86.92 -165.29 1.25 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.154 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.3 m -55.45 -55.21 34.37 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.862 -173.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.13 26.53 20.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.818 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 102' ' ' LYS . 7.9 m-20 -82.11 111.51 18.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.149 0.499 . . . . 0.0 111.111 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.604 ' HA ' HD11 ' A' ' 138' ' ' ILE . 22.7 p -101.06 164.42 11.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.217 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 125' ' ' PHE . 18.2 tp -63.37 -36.49 83.88 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.165 -174.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -67.16 -35.83 80.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.958 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.85 -41.73 67.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.037 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -78.34 -24.3 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.622 -176.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 p -73.28 -40.63 64.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -61.86 -21.92 65.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.292 0.568 . . . . 0.0 110.145 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.637 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.1 tp-100 -75.44 -63.86 1.19 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.8 176.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -76.76 -43.0 33.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.192 -170.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.497 ' CD1' ' HB2' ' A' ' 149' ' ' GLU . 19.7 m-85 -92.96 -32.36 14.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.933 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.1 -4.62 58.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.192 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.522 ' OD1' ' HG ' ' A' ' 120' ' ' LEU . 24.1 t-20 -126.59 121.99 33.78 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.494 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -77.12 -18.42 57.93 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -174.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -78.67 -14.45 59.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.146 0.498 . . . . 0.0 110.339 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.522 ' HG ' ' OD1' ' A' ' 117' ' ' ASN . 78.4 mt -84.62 14.99 4.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.582 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.494 ' HD1' ' O ' ' A' ' 118' ' ' ALA . 38.8 p90 -63.08 -30.69 71.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.864 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.52 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 15.9 m120 -64.9 -32.76 74.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -61.12 -48.4 81.84 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.391 0.615 . . . . 0.0 110.187 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.06 -36.28 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.368 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.481 ' HB2' HD21 ' A' ' 107' ' ' LEU . 83.3 t80 -56.23 -53.82 52.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.406 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 26.6 mt-10 -70.72 -17.03 62.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.281 -175.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -84.86 -10.0 57.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.032 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -115.1 25.65 10.73 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.203 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 126' ' ' GLU . 11.1 mmmm -86.31 150.21 51.31 Favored Pre-proline 0 C--N 1.326 -0.424 0 O-C-N 122.158 -0.339 . . . . 0.0 110.402 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.548 ' HD2' HD13 ' A' ' 40' ' ' ILE . 10.0 Cg_endo -95.87 15.99 37.75 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.441 -1.066 . . . . 0.0 111.969 -6.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -14.71 62.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.222 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.424 HD21 HE21 ' A' ' 142' ' ' GLN . 0.9 OUTLIER -107.67 124.21 49.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 168.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -99.43 -42.09 7.11 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.757 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.453 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 14.7 m -149.56 147.96 24.55 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.19 0.519 . . . . 0.0 109.786 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.63 -19.91 65.08 Favored 'Trans proline' 0 C--N 1.336 -0.129 0 C-N-CA 123.714 2.943 . . . . 0.0 112.851 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -96.88 -8.24 31.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.371 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.453 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 36.7 mmtm -91.44 9.13 33.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.604 HD11 ' HA ' ' A' ' 106' ' ' THR . 10.3 pt -69.51 174.97 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.016 169.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -162.2 148.12 10.49 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.69 116.92 2.36 Favored 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.226 2.617 . . . . 0.0 112.136 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.99 14.32 23.11 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.1 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.559 ' H ' HG22 ' A' ' 101' ' ' VAL . 1.7 mm100 -86.5 108.71 18.66 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.16 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.437 HG22 ' OG1' ' A' ' 100' ' ' THR . 41.7 t -79.8 125.06 38.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 172.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.2 mt -118.96 140.17 50.45 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.81 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.534 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 35.6 ttt180 -74.74 111.54 10.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.544 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 33.3 mm -97.67 102.93 14.47 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.006 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 25.5 Cg_exo -63.13 145.76 93.9 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.55 2.167 . . . . 0.0 111.67 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.9 117.71 4.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.492 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.497 ' HB2' ' CD1' ' A' ' 115' ' ' TYR . 8.5 tp10 -70.7 113.89 8.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.344 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.0 tp -154.42 29.69 0.44 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -112.95 78.84 1.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 53.93 57.54 5.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.413 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -88.75 -1.9 58.32 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.654 -174.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -89.27 0.94 56.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 171.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 11.4 t-80 -118.91 145.07 46.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 173.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 155' ' ' HIS . 67.7 m-70 66.26 88.08 0.11 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.177 0.513 . . . . 0.0 109.973 -171.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.347 -177.371 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.82 0.343 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.16 44.61 1.44 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 83' ' ' VAL . 19.4 tp -87.39 111.3 20.97 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.491 0.662 . . . . 0.0 111.612 -171.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -93.88 140.71 29.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.039 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -92.19 124.89 36.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.846 0.355 . . . . 0.0 110.81 -176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.628 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 57.1 m-85 -110.41 -164.16 0.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.784 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.857 HG11 ' HB3' ' A' ' 10' ' ' ALA . 7.3 p -82.8 -28.26 8.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -173.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.796 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 22.2 tptm 76.44 -60.4 0.48 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.218 0.607 . . . . 0.0 111.33 -175.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.26 -42.62 36.38 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.857 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -84.22 179.05 7.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.034 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.2 -168.89 12.69 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.553 ' HG2' HD13 ' A' ' 14' ' ' LEU . 4.8 tp10 -60.19 122.87 15.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -77.68 64.75 3.03 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.257 1.027 . . . . 0.0 109.216 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.553 HD13 ' HG2' ' A' ' 12' ' ' GLU . 11.7 tp -75.47 -32.15 60.49 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 113.571 -1.65 . . . . 0.0 110.383 -174.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -151.27 176.8 10.88 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.016 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.47 113.02 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.023 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.8 47.76 1.13 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.74 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -119.53 97.28 5.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.485 0.66 . . . . 0.0 110.123 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.6 p 51.7 42.0 29.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.636 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.39 168.53 44.3 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.029 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -91.69 -57.59 2.7 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -179.97 -53.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.702 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -123.07 128.68 50.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.389 0.614 . . . . 0.0 110.936 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -69.76 -40.11 76.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.202 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.73 -27.32 66.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.924 0.392 . . . . 0.0 110.12 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.43 -45.35 60.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.198 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' VAL . 82.9 mt-30 -57.89 -45.49 86.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.379 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.78 78.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.115 0.483 . . . . 0.0 110.734 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -70.93 -45.21 64.6 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.562 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' C ' HD21 ' A' ' 14' ' ' LEU . 30.1 mmtp -58.77 -39.38 80.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.397 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 98.1 t -64.81 -36.28 77.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.735 0.302 . . . . 0.0 110.372 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.425 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 25.6 mm-40 -64.4 -46.98 80.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.906 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.71 -38.71 78.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.246 0.546 . . . . 0.0 109.922 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -60.32 -40.47 90.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.381 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 95.9 mt -71.13 -38.79 72.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.244 0.545 . . . . 0.0 110.888 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -76.72 -32.41 57.8 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.487 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -75.33 -23.82 57.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.082 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -83.77 -32.72 25.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.288 0.566 . . . . 0.0 110.541 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.07 35.69 4.71 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.753 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.5 mm -74.75 126.19 88.74 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -71.59 144.89 45.7 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.079 1.853 . . . . 0.0 112.596 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 59.37 23.84 12.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.418 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.89 -42.6 73.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 -177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.64 -0.52 34.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.924 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -88.92 -11.23 45.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.014 0.435 . . . . 0.0 110.242 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.26 157.26 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.288 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -106.44 130.33 54.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.854 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.437 HG21 ' HB ' ' A' ' 31' ' ' VAL . 34.4 mm -90.54 135.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.337 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 27.0 mt-30 -132.86 140.34 47.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.956 175.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mm -118.35 120.65 65.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.48 60.46 1.01 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.068 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 53.68 76.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.039 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 79' ' ' GLY . . . 86.59 20.72 53.55 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.641 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 82' ' ' SER . 3.1 ttmp? -146.69 124.21 11.73 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 122.682 -0.305 . . . . 0.0 110.479 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 83' ' ' VAL . . . -104.79 91.53 3.88 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.783 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.545 HG23 ' HB3' ' A' ' 84' ' ' ASP . 58.7 m -80.41 109.42 14.89 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.151 0.501 . . . . 0.0 109.899 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 12.2 p -93.83 136.87 24.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.124 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 86' ' ' GLN . 1.4 m -132.01 157.17 44.82 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.0 171.62 29.48 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -155.15 144.52 21.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.873 0.368 . . . . 0.0 110.803 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.25 18.19 31.97 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.165 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.36 178.24 4.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.993 0.425 . . . . 0.0 111.265 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -111.68 170.28 8.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.959 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 47.8 tp60 -57.47 -53.57 56.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' HG3' ' NH1' ' A' ' 145' ' ' ARG . 39.5 tt0 -57.33 -49.37 76.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.175 -174.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.01 -49.12 77.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.688 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.508 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 41.6 tttp -45.94 -52.81 10.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.45 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.597 ' O ' HG23 ' A' ' 72' ' ' VAL . 53.7 mt-10 -74.79 -28.55 60.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.937 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 65' ' ' GLU . 13.4 tptm -63.32 -42.74 99.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.407 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.06 -49.65 80.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 77.3 mt -48.41 -47.42 37.84 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.164 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 68' ' ' GLU . 39.7 t -66.2 -52.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.308 0.575 . . . . 0.0 111.1 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.31 -30.35 70.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.565 -172.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 m -83.43 -23.15 8.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.061 0.457 . . . . 0.0 111.234 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.628 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -78.01 -33.06 42.28 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.821 176.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -80.15 61.28 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.716 0.293 . . . . 0.0 110.812 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.571 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 23.3 mm -122.51 132.71 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 t -65.22 101.81 0.59 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 173.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.427 ' O ' ' HA2' ' A' ' 53' ' ' GLY . . . 126.8 -17.37 6.4 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.645 -172.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.571 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 39.2 mm -102.14 121.11 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.292 0.568 . . . . 0.0 110.822 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.796 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -98.86 -33.97 10.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.704 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 25.4 m -147.24 160.34 42.6 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.49 HG22 ' HB3' ' A' ' 55' ' ' ALA . 55.7 t -132.34 121.72 46.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.671 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.545 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.5 t70 -97.58 106.53 18.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.267 0.556 . . . . 0.0 109.597 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.98 115.64 9.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.034 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 26.7 mt-30 -125.86 35.05 4.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.305 171.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.02 118.86 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.959 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -86.4 131.88 34.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.824 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.6 p -104.39 120.81 42.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.056 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.88 -25.14 43.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.73 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -127.94 127.37 23.9 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.884 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.25 155.92 10.99 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.078 2.519 . . . . 0.0 112.25 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -160.27 -157.97 0.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.463 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -71.81 121.09 18.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.875 0.369 . . . . 0.0 111.231 -175.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.35 146.46 27.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.697 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.8 m -123.22 157.97 31.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.66 0.743 . . . . 0.0 112.258 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -96.46 155.38 16.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.278 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -113.52 96.08 5.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.873 0.368 . . . . 0.0 110.776 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 90.3 t80 -96.23 142.63 28.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.453 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.8 m -109.13 120.86 43.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.517 176.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.3 m -72.21 139.89 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 33.7 mmtp -109.76 -165.9 1.05 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.002 0.429 . . . . 0.0 111.257 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 m -67.55 114.69 6.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.63 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.85 13.13 57.08 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.973 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 11.5 m-20 -94.48 123.53 37.96 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.346 0.593 . . . . 0.0 110.837 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 110' ' ' ILE . 24.7 p -111.39 155.85 22.51 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.346 174.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.532 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 2.3 pt? -55.52 -36.59 66.89 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.409 -176.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 m -66.32 -44.78 82.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.683 0.278 . . . . 0.0 110.804 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.32 -42.33 96.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.039 0.447 . . . . 0.0 110.831 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 99' ' ' TYR . 1.4 pp -76.17 -25.11 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.3 t -66.0 -45.06 82.94 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -58.95 -33.77 71.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.345 0.593 . . . . 0.0 109.678 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.1 tp-100 -65.75 -56.82 10.0 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.53 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -86.3 -47.85 16.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.442 -171.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.454 ' HB3' HD12 ' A' ' 120' ' ' LEU . 54.2 m-85 -82.48 -37.99 24.55 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.183 0.516 . . . . 0.0 110.695 -178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 106.92 -14.06 41.15 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -129.33 128.36 42.97 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.516 ' O ' ' HD1' ' A' ' 121' ' ' TYR . . . -72.39 -24.9 61.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.747 -175.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -74.07 -0.19 15.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 0.0 111.92 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 115' ' ' TYR . 72.3 mt -96.13 15.68 20.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.149 0.499 . . . . 0.0 110.764 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' A' ' 108' ' ' SER . 53.6 p90 -62.83 -27.46 69.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.137 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.551 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 4.6 p30 -67.0 -35.2 79.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.869 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -60.07 -31.67 70.23 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.425 0.631 . . . . 0.0 110.059 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.586 HG22 ' OD1' ' A' ' 128' ' ' ASN . 39.3 mt -79.17 -52.09 15.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.448 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.433 ' CE2' ' HD3' ' A' ' 129' ' ' LYS . 76.6 t80 -49.76 -48.83 50.05 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.085 0.469 . . . . 0.0 111.355 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 42.6 mt-10 -63.63 -25.9 68.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -94.77 -10.22 32.22 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.761 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.761 ' O ' ' HG3' ' A' ' 131' ' ' MET . 8.9 m120 -94.54 -43.97 8.08 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.444 ' HA ' ' H ' ' A' ' 132' ' ' LEU . 40.6 pttt -60.03 147.36 80.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.416 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -90.56 11.5 58.48 Favored 'Cis proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.554 -1.436 . . . . 0.0 114.574 6.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.761 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -81.05 -7.57 59.59 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.481 0.658 . . . . 0.0 110.297 174.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.47 ' HB3' ' CB ' ' A' ' 128' ' ' ASN . 12.9 tp -132.84 112.06 11.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.827 166.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -90.07 -26.5 20.23 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -168.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 25.5 m -151.49 153.82 32.69 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.353 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -53.17 -48.55 21.46 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 C-N-CA 123.197 2.598 . . . . 0.0 112.397 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -82.27 6.91 15.3 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.893 -175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 134' ' ' SER . 37.8 mmtm -89.79 -4.62 57.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.577 0.227 . . . . 0.0 111.441 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.634 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 15.8 pt -63.02 171.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.062 174.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -163.11 147.94 9.25 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.099 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -51.11 104.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.213 2.609 . . . . 0.0 112.251 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 112.08 35.19 1.85 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.218 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.634 ' OE1' ' HA ' ' A' ' 138' ' ' ILE . 45.8 tt0 -117.13 121.96 42.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.881 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 99' ' ' TYR . 48.6 t -80.16 136.05 24.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.963 174.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.0 mt -124.31 145.18 49.57 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.067 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.558 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 37.3 ttt180 -73.51 117.06 14.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.593 176.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.8 mm -107.7 88.66 4.5 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.961 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 24.7 Cg_exo -63.83 166.47 15.98 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.361 2.041 . . . . 0.0 111.927 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.99 131.55 46.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.465 ' OE2' ' HA ' ' A' ' 152' ' ' HIS . 0.4 OUTLIER -57.76 107.48 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.569 0.543 . . . . 0.0 110.3 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 96.5 mt -98.87 133.23 43.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.112 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 154' ' ' HIS . 43.1 mm-40 68.04 72.03 0.31 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 123.868 0.73 . . . . 0.0 110.622 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.465 ' HA ' ' OE2' ' A' ' 149' ' ' GLU . 39.0 m-70 -66.64 110.38 3.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.084 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 62.24 51.87 3.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.201 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 151' ' ' GLU . 4.1 t-160 -84.56 -54.55 4.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.593 176.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -148.63 32.16 0.79 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.138 0.495 . . . . 0.0 110.449 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -138.88 142.25 38.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.209 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.8 t60 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.717 177.935 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 85' ' ' ASP . 16.3 mmt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.591 0.234 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.5 163.29 27.53 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.957 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 83' ' ' VAL . 58.8 tp -116.09 118.12 31.98 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -103.7 134.49 46.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.592 -176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -96.06 132.57 41.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.732 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.524 ' CD2' HG21 ' A' ' 143' ' ' VAL . 50.2 m-85 -124.6 179.91 4.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.188 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.8 t -97.3 107.5 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 59.1 tttm -56.5 -51.74 67.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.337 -170.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.54 -12.81 61.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.026 0.441 . . . . 0.0 111.037 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.565 ' CB ' ' HA3' ' A' ' 141' ' ' GLY . . . -92.82 -164.06 1.13 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.528 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.94 -173.05 44.61 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.923 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.51 125.27 25.62 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -73.52 66.95 1.04 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.201 1.001 . . . . 0.0 109.541 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.435 HD21 ' O ' ' A' ' 30' ' ' LYS . 11.7 tp -69.4 -50.94 41.27 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.765 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 21' ' ' GLN . 7.8 p90 -126.17 16.65 7.82 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.785 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.417 ' HB3' HG12 ' A' ' 18' ' ' VAL . 2.1 m-20 71.86 -43.85 0.57 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.534 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 69.1 23.38 6.5 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.414 0.686 . . . . 0.0 111.251 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' A' ' 16' ' ' ASP . 2.5 p -137.82 97.68 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.364 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 m 56.86 36.2 27.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.811 0.815 . . . . 0.0 110.49 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.0 -115.03 2.3 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.498 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.48 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . 2.6 mp0 -80.14 125.34 29.7 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -123.11 -17.6 6.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.713 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.665 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 39.6 m-20 -74.34 107.51 6.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.854 0.359 . . . . 0.0 110.664 -174.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.562 ' O ' ' HB ' ' A' ' 50' ' ' ILE . 21.4 pttp -55.99 -37.31 68.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -170.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.79 -30.07 65.13 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.612 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 33.5 t70 -77.94 -30.59 50.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.873 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 7.0 mm100 -60.37 -41.75 94.4 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.62 -43.2 65.25 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.926 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.3 tttm -64.2 -44.11 92.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.064 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 73.2 mmtt -61.85 -40.92 97.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.112 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.62 HG11 HG23 ' A' ' 74' ' ' VAL . 92.2 t -62.52 -45.1 99.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.355 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.558 ' HG2' HG13 ' A' ' 48' ' ' ILE . 7.8 mm-40 -55.96 -46.41 78.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.615 173.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 50.4 mt-10 -55.74 -47.39 77.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.349 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -54.78 -45.84 74.35 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.326 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 80.3 mt -68.0 -35.52 78.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.968 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -73.43 -34.49 65.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.897 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 98.7 mttt -69.11 -46.12 68.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.131 178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.8 p -64.29 -34.14 77.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.099 0.476 . . . . 0.0 110.764 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.53 34.39 4.45 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.503 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.421 ' HB ' ' CB ' ' A' ' 43' ' ' ALA . 7.8 mm -80.31 116.34 61.02 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.25 -49.08 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.958 2.439 . . . . 0.0 113.346 -171.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.44 -5.99 54.03 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.428 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.484 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -72.72 -17.89 61.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.326 0.584 . . . . 0.0 110.149 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.09 -14.62 59.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.891 176.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.52 -0.76 37.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.21 -172.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 m -117.3 162.57 15.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.148 0.499 . . . . 0.0 111.216 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.33 138.2 42.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.043 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.558 HG13 ' HG2' ' A' ' 32' ' ' GLN . 31.2 mm -100.37 130.26 49.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.631 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.503 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 98.4 mt-30 -129.98 136.27 49.24 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 172.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' A' ' 24' ' ' LYS . 26.8 mm -120.25 119.37 59.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.022 0.439 . . . . 0.0 111.167 -174.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 54' ' ' LYS . . . -100.46 59.53 0.98 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 172.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 70.15 -65.56 0.31 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.712 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 -17.62 6.49 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.246 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 40.7 ttmt -97.85 121.51 39.84 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.078 0.466 . . . . 0.0 110.718 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -100.38 114.62 28.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.078 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 47.3 m -92.9 123.81 36.43 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.836 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.02 125.16 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.813 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -131.59 143.34 50.27 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.479 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.9 174.56 36.93 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 2.7 p-10 -146.56 149.64 33.98 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.874 0.337 . . . . 0.0 110.325 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 84.4 22.69 53.49 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.263 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 89' ' ' THR . 7.0 mp -99.07 176.18 5.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.847 0.356 . . . . 0.0 110.42 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.6 p -113.24 154.21 27.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.162 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.657 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 2.3 mm100 -51.27 -47.61 62.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.492 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 7.4 tp10 -53.19 -48.6 67.94 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 111.051 -177.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.19 -43.14 71.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.667 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.44 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 28.0 tttm -54.07 -45.22 71.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.735 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 6.1 mm-40 -60.72 -36.65 79.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.35 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -63.6 -40.09 96.06 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 67' ' ' LYS . 3.6 mm -60.34 -54.6 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 88.8 mt -52.6 -39.47 61.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.824 -1.535 . . . . 0.0 112.224 -174.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.529 HG21 ' HG2' ' A' ' 145' ' ' ARG . 42.9 t -76.74 -51.92 18.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.038 0.447 . . . . 0.0 110.878 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.53 72.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.716 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.62 HG23 HG11 ' A' ' 31' ' ' VAL . 9.1 p -80.47 -30.03 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.069 0.462 . . . . 0.0 110.849 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.33 -32.8 27.38 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.148 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.08 60.88 3.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 111.493 -178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.43 139.64 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.427 173.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 10' ' ' ALA . 23.5 m -66.06 112.47 3.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.723 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.5 -28.09 5.59 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -173.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 46.0 mm -89.12 126.2 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 121.254 0.55 . . . . 0.0 110.475 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.94 -28.49 9.56 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.485 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.409 ' HA ' ' HD1' ' A' ' 6' ' ' PHE . 41.8 m -156.54 160.72 39.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.474 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 55.0 t -127.99 129.52 69.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.61 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -98.09 103.85 15.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.711 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.9 t70 -78.13 114.17 16.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.291 -176.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -132.26 18.9 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.615 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.56 115.15 27.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.451 0.643 . . . . 0.0 110.825 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 57.1 mttm -73.68 133.49 43.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.197 -175.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 12.4 p -99.54 110.28 22.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.587 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.491 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -81.66 -21.58 38.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.655 -178.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 34.0 p -128.58 143.95 50.31 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 91' ' ' THR . 6.2 Cg_exo -77.38 140.28 19.23 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.296 2.664 . . . . 0.0 111.857 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.492 ' HB3' ' H ' ' A' ' 65' ' ' GLU . . . -162.14 -166.63 1.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.974 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.474 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 7.7 m -58.77 132.99 55.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -176.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.85 129.74 55.4 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 168.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.6 m -114.32 147.59 38.87 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.09 0.471 . . . . 0.0 111.67 -171.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.501 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 5.0 tt0 -80.5 136.17 36.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -99.6 100.39 11.39 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.084 0.469 . . . . 0.0 110.471 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.453 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 92.0 t80 -100.93 136.95 39.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.621 176.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.489 ' OG1' HG22 ' A' ' 143' ' ' VAL . 16.9 m -106.22 124.84 50.21 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.95 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.616 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.5 m -67.88 126.33 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -75.81 -56.89 4.24 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.289 -167.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.44 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 10.7 t -167.23 -71.05 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.773 0.32 . . . . 0.0 110.373 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.15 45.45 3.51 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.521 ' HB2' ' HB ' ' A' ' 101' ' ' VAL . 2.2 m-20 -103.06 143.1 33.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.119 0.485 . . . . 0.0 110.448 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 110' ' ' ILE . 61.6 p -122.11 159.58 26.84 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.827 173.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.55 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 30.9 tp -61.45 -36.88 81.63 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 118.506 0.593 . . . . 0.0 110.221 -174.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 p -69.79 -33.02 71.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.189 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HB3' ' H ' ' A' ' 106' ' ' THR . . . -73.4 -43.69 59.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.969 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 106' ' ' THR . 1.3 pp -74.82 -25.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.18 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.467 ' HB3' HD12 ' A' ' 124' ' ' ILE . 13.3 p -71.42 -43.06 67.47 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.182 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -65.82 -23.95 66.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 110.393 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.581 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.0 OUTLIER -66.28 -52.85 43.33 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.167 175.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 146' ' ' ILE . 34.1 m -89.99 -40.87 13.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.259 -171.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.414 ' N ' HG23 ' A' ' 114' ' ' VAL . 55.5 m-85 -88.9 -38.49 14.5 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.96 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.56 -8.02 59.91 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -169.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -124.42 125.95 45.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.64 -0.78 . . . . 0.0 109.576 -174.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.33 -8.76 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.308 . . . . 0.0 111.622 -175.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -76.52 -20.27 57.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.352 0.596 . . . . 0.0 109.754 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 50.7 mt -84.25 18.55 2.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.342 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.55 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 34.8 p90 -66.61 -33.75 76.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.349 0.595 . . . . 0.0 109.454 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -68.4 -35.26 77.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.267 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 27.7 mmmt -52.27 -54.52 30.29 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.611 0.72 . . . . 0.0 110.189 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 111' ' ' SER . 52.2 mt -63.2 -36.93 77.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.588 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 134' ' ' SER . 30.8 t80 -61.54 -56.35 20.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.746 0.308 . . . . 0.0 110.734 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 18.3 mt-10 -61.64 -37.31 83.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.159 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.83 -31.26 70.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.928 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.573 ' O ' ' HG3' ' A' ' 131' ' ' MET . 33.7 m-80 -93.18 8.69 39.14 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.366 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 9.1 mtpm? -84.9 153.83 60.68 Favored Pre-proline 0 C--N 1.318 -0.794 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.882 177.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -91.87 11.81 55.65 Favored 'Cis proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.946 -1.689 . . . . 0.0 112.752 -0.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.573 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -69.28 -24.38 63.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.708 0.289 . . . . 0.0 111.476 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.4 tp -98.48 121.68 40.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -74.68 -54.38 7.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.654 -172.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.494 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 49.5 m -156.44 157.66 31.12 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.722 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.409 ' HA ' HD22 ' A' ' 107' ' ' LEU . 83.2 Cg_exo -47.8 -56.53 3.01 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 124.002 3.135 . . . . 0.0 113.889 -175.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.6 3.9 26.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -91.92 7.82 40.27 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 120.886 0.374 . . . . 0.0 111.414 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.495 HD11 ' HA ' ' A' ' 106' ' ' THR . 19.1 pt -66.59 169.16 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.354 171.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -163.75 148.1 8.6 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.44 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 63.6 Cg_exo -46.13 120.47 3.67 Favored 'Trans proline' 0 CA--C 1.519 -0.267 0 C-N-CA 123.183 2.589 . . . . 0.0 112.621 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 10' ' ' ALA . . . 94.21 24.68 18.64 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.297 -176.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.616 ' H ' HG22 ' A' ' 101' ' ' VAL . 7.3 tp60 -97.79 111.56 23.81 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.524 HG21 ' CD2' ' A' ' 6' ' ' PHE . 46.1 t -77.66 135.86 25.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.2 mt -130.9 137.59 49.4 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.829 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.529 ' HG2' HG21 ' A' ' 72' ' ' VAL . 25.4 mtm180 -69.1 123.31 20.72 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.083 174.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 24.9 mm -103.87 95.02 7.05 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -72.16 148.13 49.54 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.311 2.008 . . . . 0.0 111.799 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -65.5 114.48 4.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.489 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.32 86.22 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.577 175.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.1 tp -90.07 46.15 1.33 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.467 0.651 . . . . 0.0 110.243 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.93 128.38 34.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.381 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -93.69 -10.66 33.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.764 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -97.11 168.32 10.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.119 176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -118.9 42.18 2.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.883 0.849 . . . . 0.0 109.309 175.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -81.41 -26.87 35.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.341 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -90.48 151.09 21.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.326 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.906 175.728 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.544 0.211 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.23 -152.28 9.5 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.313 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 82' ' ' SER . 42.1 tp -93.84 130.43 39.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.08 0.467 . . . . 0.0 110.69 -177.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -105.99 129.18 54.17 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.597 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -99.32 134.8 41.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.548 0.69 . . . . 0.0 112.002 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 33.0 m-85 -121.19 -166.16 1.32 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.672 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 94.6 t -78.09 -83.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.571 178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 2.3 tmtp? 163.53 -77.23 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.969 0.793 . . . . 0.0 109.167 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.4 -25.49 54.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.711 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.34 125.15 28.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.497 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.43 -172.35 32.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.737 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -69.62 131.07 44.07 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -78.55 66.25 4.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.199 0.999 . . . . 0.0 108.84 173.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.515 HD21 ' O ' ' A' ' 30' ' ' LYS . 16.1 tp -72.59 -46.04 56.17 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.902 -172.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.455 ' HD1' ' H ' ' A' ' 17' ' ' ALA . 1.2 p90 -100.49 -162.73 0.97 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.574 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -57.21 -33.05 67.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.799 0.333 . . . . 0.0 111.611 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' H ' ' HD1' ' A' ' 15' ' ' TRP . . . 67.6 21.94 9.27 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.987 171.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 p -126.11 109.96 22.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.723 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.4 m 74.27 -44.79 0.57 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.144 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.75 141.36 4.12 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -72.92 135.06 45.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -81.93 -27.31 33.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.23 -173.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 75.2 m-20 -77.87 80.41 4.32 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.523 ' HA ' ' OE1' ' A' ' 27' ' ' GLN . 38.0 ttpt -59.95 -42.37 93.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.249 -173.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -74.3 -20.14 60.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.472 . . . . 0.0 110.396 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . 36.2 t70 -83.96 -28.49 27.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.007 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.523 ' OE1' ' HA ' ' A' ' 24' ' ' LYS . 56.1 mt-30 -58.92 -38.36 78.78 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.884 174.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 48' ' ' ILE . . . -56.99 -45.93 82.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.707 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 60.0 tttp -67.34 -39.47 85.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.515 ' O ' HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -53.08 -47.64 68.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 110.554 175.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.57 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 86.9 t -65.62 -39.57 85.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.825 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.544 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -60.02 -44.2 94.76 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.274 -0.171 . . . . 0.0 110.558 174.011 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 66.5 mm-40 -54.86 -49.27 71.54 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.193 0.521 . . . . 0.0 110.315 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -55.04 -33.07 62.36 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.603 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 79.5 mt -81.87 -44.59 16.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.061 0.458 . . . . 0.0 110.989 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -69.14 -35.02 75.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.64 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -77.36 -31.54 54.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.568 0.223 . . . . 0.0 111.467 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -76.63 -39.28 52.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.869 0.366 . . . . 0.0 110.676 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.92 28.64 4.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.222 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.5 mm -62.61 130.7 93.76 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.1 130.83 23.7 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.234 1.956 . . . . 0.0 112.679 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 62.63 12.08 5.27 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.253 176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 35' ' ' LEU . . . -71.64 -17.41 62.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.381 0.61 . . . . 0.0 110.796 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.01 -22.08 39.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.491 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -84.61 -23.65 29.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.168 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.32 177.59 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.804 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.61 129.77 25.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.086 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.425 HG13 HG22 ' A' ' 57' ' ' VAL . 3.2 mp -96.57 131.01 44.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -126.12 118.35 25.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.639 0.733 . . . . 0.0 110.426 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.7 mm -89.33 132.7 33.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.514 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -116.11 -81.42 0.61 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.375 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -152.42 101.81 2.7 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.66 13.23 50.53 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 82' ' ' SER . 34.7 mtmm -133.2 124.44 27.43 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 120.844 0.354 . . . . 0.0 111.113 -174.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.38 104.77 14.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.498 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 m -82.58 113.88 20.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.322 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.425 HG22 HG13 ' A' ' 48' ' ' ILE . 62.9 t -100.62 113.46 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-O 121.089 0.471 . . . . 0.0 110.711 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 1.3 m -110.26 158.66 18.16 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.075 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.6 157.65 8.29 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.23 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -137.08 151.47 48.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 86.85 38.55 7.96 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.98 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.2 163.93 18.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 0.0 111.201 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 m -106.01 151.21 24.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.54 173.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 11.2 mm100 -49.15 -48.23 45.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.33 -41.56 80.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.55 -42.31 64.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.259 0.552 . . . . 0.0 109.936 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 50.1 tttm -55.26 -51.66 65.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.48 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 4.9 mm-40 -67.89 -28.87 67.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.3 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -65.43 -37.25 86.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.148 0.499 . . . . 0.0 109.989 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 43.6 mt -70.09 -55.52 14.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.14 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 78.5 mt -50.06 -44.18 51.55 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.405 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.17 -34.55 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.929 0.395 . . . . 0.0 110.964 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.57 -27.14 34.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.658 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.7 m -84.82 -22.5 7.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.223 0.535 . . . . 0.0 110.768 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -79.89 -35.51 27.76 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.32 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -79.91 55.84 2.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.025 0.44 . . . . 0.0 111.187 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.441 ' HB ' HG12 ' A' ' 80' ' ' ILE . 11.2 mm -118.67 138.13 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 t -68.21 92.07 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.241 0.543 . . . . 0.0 109.95 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.1 -19.93 3.05 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 77' ' ' ILE . 48.2 mm -97.16 131.59 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.254 0.55 . . . . 0.0 110.026 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . . . -124.27 -3.37 7.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.755 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.656 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -164.78 147.2 8.38 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.225 -179.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.25 122.79 69.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.782 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.51 92.05 7.41 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.28 123.08 20.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.508 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.406 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 81.8 mm-40 -126.49 14.65 7.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.053 177.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 89' ' ' THR . 52.1 t -73.92 118.54 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.12 0.486 . . . . 0.0 109.776 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -89.14 4.94 46.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.267 -170.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.455 ' H ' HG12 ' A' ' 87' ' ' VAL . 32.0 p 44.95 -153.92 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.765 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.571 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -173.29 -41.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -118.16 131.97 23.95 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.564 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.8 144.34 48.21 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.868 2.379 . . . . 0.0 112.434 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 64' ' ' GLN . . . -158.74 -178.46 7.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.222 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.2 m -66.72 126.21 28.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.142 0.496 . . . . 0.0 111.258 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.53 164.47 20.85 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.8 m -121.37 145.13 48.21 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.622 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.447 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.5 tt0 -84.77 140.96 30.86 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -110.19 102.95 11.59 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.027 0.441 . . . . 0.0 110.504 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -106.27 133.52 50.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.011 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.444 ' OG1' HG22 ' A' ' 143' ' ' VAL . 7.8 m -100.02 122.46 42.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.346 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.577 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.7 m -71.21 136.3 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.406 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 40.7 mmtm -84.44 -163.9 0.87 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.451 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 1.6 p -60.33 -64.51 0.93 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.97 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.87 46.67 2.48 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.194 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.544 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 7.4 m-20 -104.79 127.81 52.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.131 0.491 . . . . 0.0 110.92 -177.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.549 ' O ' HG23 ' A' ' 110' ' ' ILE . 40.6 m -114.93 153.06 31.23 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.929 177.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 29.1 tp -51.97 -49.98 62.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.785 0.266 . . . . 0.0 111.63 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.456 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 m -66.66 -27.09 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.214 0.531 . . . . 0.0 111.156 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.572 ' O ' ' HG2' ' A' ' 113' ' ' GLN . . . -73.33 -40.64 64.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.811 0.339 . . . . 0.0 110.375 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 106' ' ' THR . 1.2 pp -79.71 -25.29 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.106 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.3 p -70.28 -38.67 75.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.032 0.444 . . . . 0.0 109.824 173.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 5.6 tmtm? -58.71 -35.84 73.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.449 173.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 109' ' ' ALA . 13.6 mm100 -59.72 -65.05 0.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 122.241 1.02 . . . . 0.0 111.267 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 110' ' ' ILE . 34.4 m -81.97 -37.47 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 113.679 -1.6 . . . . 0.0 112.643 -165.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.478 ' OH ' ' HD2' ' A' ' 147' ' ' PRO . 55.5 m-85 -89.58 -45.25 9.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.292 0.568 . . . . 0.0 110.65 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.86 -14.72 26.58 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.475 ' HB3' ' HG ' ' A' ' 120' ' ' LEU . 56.7 t-20 -123.19 121.71 36.61 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.48 -24.85 62.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.619 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -65.64 -21.63 66.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.07 0.462 . . . . 0.0 110.765 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.598 HD13 ' HE2' ' A' ' 123' ' ' LYS . 42.2 mt -79.78 29.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.703 -176.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 50.1 p90 -72.17 -35.27 68.97 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.166 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.403 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 24.7 t-20 -71.05 -31.82 68.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.948 -176.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.598 ' HE2' HD13 ' A' ' 120' ' ' LEU . 22.0 mtmt -52.44 -44.78 65.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.365 0.602 . . . . 0.0 110.439 173.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.413 HG22 ' OD1' ' A' ' 128' ' ' ASN . 46.2 mt -70.1 -44.67 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.278 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -52.97 -47.81 67.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.655 0.264 . . . . 0.0 111.043 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 31.7 mt-10 -66.03 -29.98 70.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.402 . . . . 0.0 110.908 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.07 -25.11 40.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.364 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 131' ' ' MET . 7.0 m120 -84.75 -41.87 15.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.106 0.479 . . . . 0.0 109.715 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 18.6 pttp -64.62 155.99 79.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.595 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 92.7 Cg_endo -81.97 17.69 18.8 Favored 'Cis proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.436 -1.485 . . . . 0.0 113.448 2.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.526 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.4 OUTLIER -74.49 -36.27 63.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.874 0.368 . . . . 0.0 110.32 174.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.1 tp -88.95 126.81 35.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.014 0.435 . . . . 0.0 109.867 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -88.09 -38.77 15.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.426 -173.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.414 ' HB2' ' HG2' ' A' ' 137' ' ' LYS . 29.1 m -153.56 153.09 28.58 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.36 -18.41 38.92 Favored 'Trans proline' 0 C--O 1.23 0.089 0 C-N-CA 123.54 2.827 . . . . 0.0 112.312 -173.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -101.95 -5.67 24.4 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.807 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 25.6 mmmt -86.28 10.19 15.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.469 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.464 HD11 ' HA ' ' A' ' 106' ' ' THR . 9.0 pt -62.88 173.69 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.189 170.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.572 ' CE1' ' HG2' ' A' ' 142' ' ' GLN . 5.9 p90 -166.19 150.85 7.34 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -175.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 84.9 Cg_exo -49.57 102.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.258 2.639 . . . . 0.0 112.656 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.41 ' CA ' HG21 ' A' ' 7' ' ' VAL . . . 113.33 23.53 5.12 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.473 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.577 ' H ' HG22 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -91.33 109.78 21.07 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.444 HG22 ' OG1' ' A' ' 100' ' ' THR . 39.3 t -80.58 122.2 35.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.448 0.642 . . . . 0.0 110.052 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.437 HD22 ' OD1' ' A' ' 128' ' ' ASN . 75.6 mt -117.39 139.91 50.26 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.863 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.454 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 48.4 mtp180 -69.79 119.09 13.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.084 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 31.7 mm -105.32 98.49 16.73 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.478 ' HD2' ' OH ' ' A' ' 115' ' ' TYR . 47.9 Cg_exo -56.64 154.04 32.96 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.827 2.351 . . . . 0.0 111.706 175.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 35.2 tt0 -67.86 126.3 29.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -51.26 101.71 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.209 0.943 . . . . 0.0 112.206 -177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 148' ' ' GLU . 92.3 mt -111.34 3.39 18.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.23 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 155' ' ' HIS . 13.0 mp0 -113.62 47.02 1.21 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.048 0.927 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -78.33 -11.47 59.94 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.49 -171.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -80.73 27.92 0.36 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.593 0.235 . . . . 0.0 111.062 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 58.48 38.65 25.53 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.195 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 151' ' ' GLU . 54.8 t-80 -73.79 95.98 2.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.518 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -110.4 146.1 36.44 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.697 -174.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.0 t60 . . . . . 0 C--O 1.248 0.999 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.885 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.612 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 87.0 mtp . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.684 0.278 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.53 177.52 44.65 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.7 tp -105.83 116.49 32.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.047 0.451 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -100.73 125.2 47.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.044 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -103.3 140.59 37.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.828 0.346 . . . . 0.0 110.648 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.458 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 73.5 m-85 -126.24 -161.14 1.03 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.751 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.95 HG11 ' HB3' ' A' ' 10' ' ' ALA . 7.3 p -79.75 -25.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.643 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 16.9 tptm 79.06 -66.26 0.19 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.488 0.715 . . . . 0.0 112.003 -176.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -79.97 -36.01 36.73 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.742 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.95 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -79.17 152.17 30.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.498 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.65 -172.24 24.05 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.112 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -62.89 128.77 37.43 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.54 65.62 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.038 0.923 . . . . 0.0 108.969 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 77' ' ' ILE . 11.2 tp -75.82 -49.61 17.55 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.161 -175.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.472 ' CH2' HG21 ' A' ' 77' ' ' ILE . 9.0 p90 -124.51 -10.94 7.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.982 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.454 ' HB3' HG23 ' A' ' 18' ' ' VAL . 11.4 m-20 70.64 124.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 O-C-N 124.258 0.974 . . . . 0.0 111.961 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.72 49.39 1.72 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.722 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 16' ' ' ASP . 22.1 t -67.52 -75.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.441 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.98 29.63 6.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.39 66.86 2.02 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.207 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 22' ' ' HIS . 47.8 mt-30 -70.81 161.62 30.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.494 -0.188 . . . . 0.0 110.494 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 21' ' ' GLN . 19.0 m-70 74.71 178.87 0.2 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.65 0.594 . . . . 0.0 111.151 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 15.2 m-20 -104.97 29.43 6.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.253 -171.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 21.1 pttp 61.28 -51.3 0.12 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.538 1.535 . . . . 0.0 113.897 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.91 -26.35 63.17 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.747 -0.596 . . . . 0.0 111.115 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' OD1' ' HB3' ' A' ' 22' ' ' HIS . 1.8 p-10 -81.27 -18.27 46.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.977 0.418 . . . . 0.0 110.017 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 24' ' ' LYS . 98.9 mt-30 -65.04 -30.22 71.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.055 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.33 89.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.503 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.575 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 87.7 tttt -68.32 -36.84 79.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.177 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' HD21 ' A' ' 14' ' ' LEU . 3.2 mptp? -58.63 -43.07 89.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.423 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 95.3 t -64.2 -44.61 97.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.218 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -52.25 -50.36 62.22 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.693 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 48.6 mt-10 -56.16 -51.66 67.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.181 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -53.72 -42.68 68.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.331 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 93.0 mt -70.13 -41.04 74.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.53 -39.48 67.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.189 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 74.6 mmtt -63.98 -36.86 85.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.152 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 p -78.74 -38.81 37.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.141 0.496 . . . . 0.0 110.868 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.41 31.95 4.43 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.998 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.2 mm -63.2 127.35 90.87 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -59.78 130.56 35.56 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.484 2.123 . . . . 0.0 112.729 -175.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.28 26.5 15.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.198 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.94 -17.15 64.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.192 0.52 . . . . 0.0 110.718 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -84.18 -16.25 44.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.639 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -86.04 -35.09 20.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.998 0.428 . . . . 0.0 110.363 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.2 m -83.73 166.25 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.554 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -134.33 131.05 37.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.542 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 mp -108.23 139.16 31.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.636 0.255 . . . . 0.0 110.652 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -123.89 140.8 52.63 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 172.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' A' ' 24' ' ' LYS . 11.1 mm -118.14 133.05 66.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.9 0.381 . . . . 0.0 111.107 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.28 91.86 2.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.894 174.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.4 t70 65.9 -75.82 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.829 0.705 . . . . 0.0 111.215 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.38 6.2 4.6 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -98.68 110.88 23.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.809 0.338 . . . . 0.0 110.235 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.634 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -103.51 106.44 16.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.028 176.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 84' ' ' ASP . 33.5 m -92.72 115.97 28.59 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.638 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.91 120.46 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 121.083 0.468 . . . . 0.0 110.295 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.22 160.47 21.54 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.09 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.21 178.3 28.48 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 6.3 p-10 -167.51 155.12 8.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.908 0.385 . . . . 0.0 110.513 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.34 15.99 63.27 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.145 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -95.56 -167.69 1.65 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.658 0.742 . . . . 0.0 110.723 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -124.19 152.27 43.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.241 -1.345 . . . . 0.0 108.658 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 51.7 tt0 -58.18 -42.02 85.18 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -166.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG3' ' HB1' ' A' ' 93' ' ' ALA . 45.5 mt-10 -54.54 -48.83 71.53 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.611 0.243 . . . . 0.0 111.374 -176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.86 -49.84 75.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.216 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.545 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 49.7 tttp -49.35 -53.43 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.452 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 72' ' ' VAL . 54.1 mt-10 -62.03 -48.01 82.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -59.98 -38.48 82.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 74' ' ' VAL . 57.8 mt -62.02 -56.1 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.085 174.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 91.0 mt -49.16 -42.11 38.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.105 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 68' ' ' GLU . 40.9 t -72.7 -44.63 59.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.902 0.382 . . . . 0.0 110.957 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.12 -35.58 81.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.943 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 70' ' ' ILE . 11.3 p -79.15 -26.83 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.328 0.585 . . . . 0.0 110.423 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -77.02 -11.82 85.22 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.535 173.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.532 ' OD1' ' HG3' ' A' ' 142' ' ' GLN . 5.8 m-80 -97.64 39.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.725 -0.238 . . . . 0.0 110.714 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.536 HD12 HD22 ' A' ' 14' ' ' LEU . 10.8 mm -115.44 132.38 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.4 t -65.46 99.25 0.41 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.4 -15.66 3.9 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.025 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.634 HD12 ' HB2' ' A' ' 55' ' ' ALA . 43.2 mm -96.78 121.65 47.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.157 0.503 . . . . 0.0 111.069 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.643 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -96.75 -37.19 10.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.393 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 p -150.87 154.2 36.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.456 0.646 . . . . 0.0 111.612 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 53.0 t -117.71 122.77 70.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.587 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 56' ' ' THR . 7.1 t70 -91.78 93.37 8.83 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.612 ' OD2' ' HA ' ' A' ' 1' ' ' MET . 17.7 t70 -71.78 112.51 7.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.157 -175.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -128.06 14.77 6.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.544 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 p -93.62 129.7 43.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.189 0.519 . . . . 0.0 111.4 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -96.77 158.22 15.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.068 -177.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.5 p -124.58 136.45 53.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.431 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.98 -28.07 16.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.608 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 p -123.07 138.89 30.5 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.852 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.53 160.16 28.63 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.785 2.323 . . . . 0.0 111.664 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 65' ' ' GLU . . . -159.06 -167.31 2.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.938 -177.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 88.4 m -57.95 138.7 55.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.483 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . . . -108.01 125.25 51.31 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.347 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.1 m -110.69 146.49 36.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.424 0.63 . . . . 0.0 111.286 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 15.8 tt0 -87.86 138.82 31.12 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.772 175.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -98.13 94.09 6.63 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.12 0.486 . . . . 0.0 110.699 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -95.74 136.3 36.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.044 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.492 ' OG1' HG22 ' A' ' 143' ' ' VAL . 7.5 m -106.66 122.9 47.27 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.568 ' HB ' ' CB ' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -67.82 128.55 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -82.13 -57.9 3.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.861 -167.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 140' ' ' PRO . 12.0 p -156.98 -87.61 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.112 -176.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -76.97 49.83 2.93 Favored Glycine 0 C--N 1.329 0.19 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.568 ' CB ' ' HB ' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -97.46 120.05 37.12 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.937 -0.631 . . . . 0.0 110.941 -174.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 110' ' ' ILE . 58.7 p -112.61 163.3 14.68 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 173.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -63.07 -40.45 97.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 118.837 0.744 . . . . 0.0 110.573 -174.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.514 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 15.6 m -69.98 -23.07 63.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 110.43 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.461 ' HB3' ' H ' ' A' ' 106' ' ' THR . . . -80.82 -47.42 13.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.236 -0.29 . . . . 0.0 110.759 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.608 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.4 pp -72.46 -23.57 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.141 -177.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 p -73.93 -48.01 33.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.729 0.3 . . . . 0.0 110.237 173.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -61.16 -21.84 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.451 0.643 . . . . 0.0 110.208 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.608 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 6.4 tp60 -71.84 -58.43 3.47 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.161 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.0 m -85.39 -39.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.045 -172.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -88.48 -57.21 3.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.548 0.689 . . . . 0.0 110.43 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.04 -23.81 6.46 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.644 -171.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -105.52 124.09 48.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.288 -0.456 . . . . 0.0 110.079 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -72.12 -21.03 61.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.206 0.526 . . . . 0.0 110.346 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -66.85 -22.53 65.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.114 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.8 mt -84.29 16.13 3.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.191 -0.458 . . . . 0.0 112.202 -175.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.451 ' HD1' ' O ' ' A' ' 118' ' ' ALA . 40.0 p90 -64.46 -27.27 68.87 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -54.82 -55.04 34.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.24 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -50.27 -51.75 42.19 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.474 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.491 HG22 ' OD1' ' A' ' 128' ' ' ASN . 35.8 mt -62.98 -45.17 99.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.419 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.483 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 62.6 t80 -56.7 -49.48 74.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.985 0.422 . . . . 0.0 110.846 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.528 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 17.4 mt-10 -70.02 -23.62 63.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.981 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -82.71 -28.88 30.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.262 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.653 ' O ' ' HG3' ' A' ' 131' ' ' MET . 7.0 m120 -81.62 -10.83 59.32 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' A' ' 126' ' ' GLU . 28.8 mtpp -76.27 153.38 84.17 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.704 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -91.95 13.43 51.71 Favored 'Cis proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.762 -1.766 . . . . 0.0 112.814 -0.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.653 ' HG3' ' O ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -76.25 -13.95 60.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.672 0.273 . . . . 0.0 111.71 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.3 tp -99.07 125.8 44.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 171.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -73.61 -56.62 4.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.966 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.2 m -153.22 155.65 31.99 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.003 0.43 . . . . 0.0 109.988 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.405 ' HA ' HD12 ' A' ' 107' ' ' LEU . 24.2 Cg_exo -65.23 -27.24 56.27 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.906 3.071 . . . . 0.0 113.447 -170.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -99.76 0.87 42.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.99 0.424 . . . . 0.0 110.231 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -96.17 12.45 30.79 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.139 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.431 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 15.5 pt -72.57 168.51 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -158.78 144.06 11.93 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.143 -171.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.458 ' HG3' ' O ' ' A' ' 103' ' ' SER . 87.3 Cg_exo -49.41 110.11 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.605 2.87 . . . . 0.0 112.387 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.35 3.19 10.57 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.185 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.532 ' HG3' ' OD1' ' A' ' 76' ' ' ASN . 46.0 tt0 -93.13 118.21 30.96 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.518 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.492 HG22 ' OG1' ' A' ' 100' ' ' THR . 50.3 t -80.15 134.18 28.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.459 170.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 76.5 mt -130.21 147.98 51.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.575 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.405 ' HG2' HG21 ' A' ' 72' ' ' VAL . 25.6 mtm180 -77.41 119.11 20.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.972 175.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 38.9 mm -103.85 102.37 30.77 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.02 143.18 90.4 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.113 1.875 . . . . 0.0 110.746 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.39 132.01 52.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.457 ' CD ' ' HB2' ' A' ' 152' ' ' HIS . 33.7 tt0 -50.9 116.77 2.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.981 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 25.3 tp -107.8 102.93 12.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.007 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 64.52 86.22 0.13 Allowed 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.535 0.522 . . . . 0.0 111.328 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.457 ' HB2' ' CD ' ' A' ' 149' ' ' GLU . 22.2 t-80 -73.43 142.27 46.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.135 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -136.97 159.0 43.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.436 173.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -101.25 115.96 31.7 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -115.09 -24.11 8.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.846 -175.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -150.67 135.53 17.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.788 0.328 . . . . 0.0 110.146 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 . . . . . 0 C--N 1.321 -0.665 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.48 177.707 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.663 ' HA ' ' O ' ' A' ' 85' ' ' ASP . 27.9 ttt . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.12 163.79 32.17 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.73 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HG ' ' OG ' ' A' ' 82' ' ' SER . 20.1 tp -102.94 115.43 30.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.006 0.431 . . . . 0.0 109.953 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -101.21 123.32 45.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.374 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -78.77 141.54 37.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.539 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.566 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 93.6 m-85 -134.54 175.18 9.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.565 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.522 HG21 ' HA2' ' A' ' 141' ' ' GLY . 22.6 t -78.03 -15.06 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.791 -167.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.668 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 26.6 tptp 74.34 -49.82 0.67 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.946 0.498 . . . . 0.0 112.027 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -91.01 -36.06 14.29 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.73 0.3 . . . . 0.0 111.567 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.07 155.51 20.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.083 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.37 -160.91 24.34 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -76.58 125.46 29.28 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -86.07 65.47 9.11 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.482 0.658 . . . . 0.0 111.081 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.54 -55.5 30.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.549 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.442 ' O ' HG22 ' A' ' 18' ' ' VAL . 41.2 p90 -113.07 21.09 15.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.36 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.0 t70 55.99 23.07 6.34 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.492 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 55.57 37.66 29.17 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.922 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 21' ' ' GLN . 35.6 m -74.18 -172.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.343 174.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.4 p -78.71 53.72 1.39 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.95 -2.71 69.55 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.918 173.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.448 ' H ' HG23 ' A' ' 18' ' ' VAL . 5.9 tp-100 70.04 -70.09 0.16 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.069 0.547 . . . . 0.0 111.632 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -155.79 -35.14 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.711 0.291 . . . . 0.0 110.613 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 23.3 t70 -168.94 154.2 6.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -66.69 -34.78 78.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.073 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -73.22 -22.4 60.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.272 0.558 . . . . 0.0 109.9 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 30' ' ' LYS . 34.5 t70 -74.58 -40.93 61.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.771 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.478 ' HB2' HG13 ' A' ' 50' ' ' ILE . 22.7 mt-30 -59.03 -41.49 87.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.729 174.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB2' HG12 ' A' ' 50' ' ' ILE . . . -57.71 -43.15 85.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.852 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 61.1 tttp -63.51 -44.81 93.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.373 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 26' ' ' ASP . 12.9 mptt -57.71 -42.16 83.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.576 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.491 HG11 HG13 ' A' ' 74' ' ' VAL . 95.7 t -68.65 -41.92 82.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.892 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.51 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 2.9 mm-40 -56.45 -48.67 76.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.071 174.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 53.7 mt-10 -60.28 -40.59 90.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.817 0.341 . . . . 0.0 110.441 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -56.52 -38.24 71.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.212 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 88.7 mt -72.96 -43.63 62.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.2 0.524 . . . . 0.0 110.864 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -72.49 -35.7 68.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.48 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -71.9 -27.07 62.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.563 0.22 . . . . 0.0 111.56 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 p -83.85 -39.36 20.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.182 0.515 . . . . 0.0 110.514 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.85 31.14 3.73 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.806 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 30.5 mm -66.44 127.31 93.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -64.28 139.4 65.65 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.055 1.836 . . . . 0.0 112.509 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 57.18 24.8 10.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.103 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -72.17 -17.67 61.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.271 0.558 . . . . 0.0 110.175 176.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -82.93 -19.92 36.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.026 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -83.0 -24.71 32.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.759 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.11 179.66 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.506 -177.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 27.0 t-20 -144.87 138.38 26.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.46 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.51 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 14.9 mm -108.48 126.56 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 123.26 0.35 . . . . 0.0 110.836 -175.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -132.18 123.21 26.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.115 0.483 . . . . 0.0 110.39 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 27' ' ' GLN . 26.8 mm -98.4 112.4 30.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.396 -173.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.85 86.4 2.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.844 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 67.53 -76.58 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.422 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.45 -2.3 4.08 Favored Glycine 0 N--CA 1.454 -0.138 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.607 ' HG2' ' HB3' ' A' ' 82' ' ' SER . 38.3 mtmm -99.0 118.7 36.37 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.817 0.341 . . . . 0.0 110.682 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' A' ' 80' ' ' ILE . . . -94.65 106.75 18.74 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.947 176.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.411 ' CG2' HE21 ' A' ' 86' ' ' GLN . 27.9 m -82.99 113.14 20.36 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 120.766 0.317 . . . . 0.0 110.322 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 97.6 t -99.67 109.99 25.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.199 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.5 m -104.9 164.38 11.83 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.871 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.5 172.65 28.04 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -162.66 148.08 12.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.987 0.422 . . . . 0.0 110.056 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 97.5 6.97 57.23 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.103 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 89' ' ' THR . 6.8 mp -95.81 169.86 9.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.057 0.456 . . . . 0.0 110.856 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -110.66 154.9 23.17 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.658 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 7.5 tp60 -50.36 -47.79 55.93 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -173.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.46 ' HA ' ' NH2' ' A' ' 145' ' ' ARG . 43.9 mt-10 -52.17 -40.31 61.27 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -176.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.05 -45.53 13.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 110.338 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.491 ' HE3' ' OD1' ' A' ' 85' ' ' ASP . 75.7 tttt -51.54 -59.52 4.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.133 -177.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.658 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 26.1 pt-20 -67.29 -18.07 65.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -72.33 -35.19 68.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.467 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.5 -46.56 92.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 68' ' ' GLU . 10.1 mp -46.13 -43.62 15.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.652 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.627 HG21 ' HB2' ' A' ' 145' ' ' ARG . 39.9 t -63.13 -58.92 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.379 0.609 . . . . 0.0 111.117 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.05 -22.3 64.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.347 -173.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.491 HG13 HG11 ' A' ' 31' ' ' VAL . 53.3 t -87.61 -29.19 5.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 0.0 110.712 177.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.566 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -75.98 -34.46 47.43 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.824 177.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -79.92 58.73 2.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.608 0.242 . . . . 0.0 110.849 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.559 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 29.7 mm -124.7 130.42 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.1 m -66.13 102.81 0.87 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.52 -17.86 5.51 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.481 -172.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.559 ' CG1' ' HB ' ' A' ' 77' ' ' ILE . 38.9 mm -100.46 126.23 54.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.195 0.522 . . . . 0.0 110.729 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.668 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -105.27 -17.18 14.55 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.297 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.607 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . 16.1 t -166.96 167.23 14.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.204 0.525 . . . . 0.0 110.763 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.7 t -134.23 125.38 47.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.809 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -98.42 90.81 4.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.663 ' O ' ' HA ' ' A' ' 1' ' ' MET . 2.9 t70 -66.75 124.2 22.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.153 -177.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.411 HE21 ' CG2' ' A' ' 56' ' ' THR . 31.8 mt-30 -134.67 27.03 3.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.239 175.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -85.96 127.05 40.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.889 0.376 . . . . 0.0 110.267 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -91.95 127.78 37.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.18 0.514 . . . . 0.0 111.005 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.2 p -89.86 124.47 34.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.416 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.466 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -79.77 -38.37 33.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.758 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.8 p -127.13 150.59 72.62 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.892 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.31 141.73 52.64 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.339 2.693 . . . . 0.0 112.063 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -156.47 174.37 15.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.807 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.1 m -67.95 127.87 34.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.265 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.76 127.86 42.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.588 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 146' ' ' ILE . 14.1 m -106.03 171.55 7.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.124 0.488 . . . . 0.0 111.71 -175.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.617 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 13.7 tt0 -89.59 153.7 20.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.322 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -111.78 91.5 3.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -98.79 118.68 36.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.34 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.8 m -85.59 121.03 27.7 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.057 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 142' ' ' GLN . 1.5 m -69.34 136.74 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -105.7 -166.16 1.18 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.985 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.415 ' HA ' ' HG3' ' A' ' 140' ' ' PRO . 49.5 m -62.02 116.84 5.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.108 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.39 18.23 64.82 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.658 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 9.3 m-20 -90.93 114.46 26.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.128 0.49 . . . . 0.0 110.833 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 110' ' ' ILE . 21.7 p -110.02 162.0 14.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.084 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 121' ' ' TYR . 16.1 tp -62.02 -41.46 98.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 118.391 0.541 . . . . 0.0 111.356 -169.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.3 p -69.32 -27.33 65.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.213 0.53 . . . . 0.0 110.972 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.91 -41.78 50.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.467 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.6 pp -78.89 -23.65 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.465 -176.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.3 p -71.11 -41.01 71.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 172.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 4.9 tmmm? -60.19 -29.87 68.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.986 171.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 0.9 OUTLIER -67.71 -63.52 1.04 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.018 177.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 115' ' ' TYR . 35.3 m -76.22 -46.3 33.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.406 -171.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.455 ' N ' HG23 ' A' ' 114' ' ' VAL . 59.6 m-85 -90.91 -30.94 16.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.193 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 112' ' ' LYS . . . 92.47 -2.92 74.72 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -170.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.446 ' HB3' HD12 ' A' ' 120' ' ' LEU . 16.3 t-20 -126.08 110.63 13.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.738 -0.731 . . . . 0.0 109.876 -173.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.44 -31.77 72.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.455 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -69.43 -14.75 63.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.627 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 117' ' ' ASN . 50.5 mt -83.83 17.32 2.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.821 0.343 . . . . 0.0 111.318 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 31.3 p90 -66.58 -27.48 67.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.08 0.467 . . . . 0.0 110.106 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.521 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 25.7 p-10 -66.69 -33.69 76.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -57.25 -52.45 65.27 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.579 0.704 . . . . 0.0 109.495 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.9 mt -66.53 -40.21 85.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.251 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.564 ' O ' ' HG3' ' A' ' 129' ' ' LYS . 20.4 t80 -54.27 -60.01 3.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.538 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.526 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 24.5 mt-10 -61.72 -34.5 75.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.689 -176.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.426 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -68.57 -31.29 70.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.835 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 131' ' ' MET . 36.4 m-80 -91.34 -18.78 23.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' A' ' 125' ' ' PHE . 28.4 mtpp -67.08 151.7 96.85 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.434 176.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -87.67 15.35 44.47 Favored 'Cis proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.987 -1.672 . . . . 0.0 113.474 1.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 0.3 OUTLIER -67.75 -33.18 74.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.024 0.44 . . . . 0.0 110.281 177.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.434 HD11 HG23 ' A' ' 138' ' ' ILE . 0.1 OUTLIER -97.46 131.01 44.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -85.0 -49.56 8.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.598 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.467 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 46.5 p -154.08 161.45 29.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.973 0.416 . . . . 0.0 110.441 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.98 -15.29 48.35 Favored 'Trans proline' 0 N--CA 1.466 -0.131 0 C-N-CA 123.631 2.887 . . . . 0.0 111.944 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -103.69 -16.34 15.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.206 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -81.74 -6.92 59.48 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 106' ' ' THR . 12.1 pt -65.6 168.53 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 0.0 110.709 172.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -165.06 148.29 7.2 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.476 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.415 ' HG3' ' HA ' ' A' ' 103' ' ' SER . 75.1 Cg_exo -43.78 115.13 0.62 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.51 2.807 . . . . 0.0 112.806 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.522 ' HA2' HG21 ' A' ' 7' ' ' VAL . . . 109.51 6.89 28.67 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.445 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.575 ' O ' HG13 ' A' ' 101' ' ' VAL . 6.5 mm100 -87.7 110.08 20.17 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 41.5 t -77.63 119.63 26.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.403 0.62 . . . . 0.0 109.887 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.8 132.55 53.89 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.183 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.627 ' HB2' HG21 ' A' ' 72' ' ' VAL . 36.1 ttt180 -75.56 110.47 9.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.656 175.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 18.1 mm -94.08 108.63 36.86 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 34.8 Cg_exo -58.31 153.14 48.86 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.591 2.194 . . . . 0.0 111.938 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.85 124.37 23.5 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.602 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -67.38 115.6 7.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.21 -171.04 2.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.594 176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 69.13 -77.04 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.732 0.645 . . . . 0.0 110.033 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.53 -74.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -178.57 143.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.288 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.2 t60 55.61 43.92 27.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.387 0.613 . . . . 0.0 110.096 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -99.39 -27.59 13.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -90.07 160.22 16.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.128 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.692 -176.309 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 121.075 0.464 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.21 166.13 35.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.869 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.5 tp -99.36 121.82 41.64 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.519 ' HB2' HG12 ' A' ' 83' ' ' VAL . 74.7 m-85 -99.47 125.29 45.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.362 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.32 144.64 28.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.946 -178.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.591 ' CZ ' ' HA3' ' A' ' 75' ' ' GLY . 68.3 m-85 -130.07 -162.48 1.21 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.951 0.405 . . . . 0.0 111.658 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.946 HG11 ' HB3' ' A' ' 10' ' ' ALA . 5.9 p -73.32 -25.71 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.996 -176.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.753 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 49.9 tptt 78.17 -56.97 0.48 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.457 0.703 . . . . 0.0 111.575 -176.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.91 -47.99 14.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.946 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -73.71 151.79 40.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.889 0.376 . . . . 0.0 110.907 -176.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.83 173.94 14.29 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.437 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.18 125.49 24.23 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 122.485 0.314 . . . . 0.0 110.179 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 96.1 mttt -90.28 83.35 5.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.957 0.408 . . . . 0.0 110.892 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 34' ' ' HIS . 1.7 mm? -72.37 -44.21 62.88 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.479 0.657 . . . . 0.0 109.392 175.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.44 ' HD1' ' H ' ' A' ' 17' ' ' ALA . 20.0 p90 -101.66 -173.34 2.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.042 178.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.28 -43.66 74.93 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.434 0.459 . . . . 0.0 111.598 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' H ' ' HD1' ' A' ' 15' ' ' TRP . . . 63.22 54.34 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 110.575 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.61 -43.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.533 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.5 p -135.8 -61.27 0.72 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.302 0.573 . . . . 0.0 110.192 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.33 169.45 35.76 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -124.05 66.38 1.05 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.259 0.552 . . . . 0.0 109.849 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 4.0 t60 73.64 -58.04 0.61 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.766 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.552 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 41.7 m-20 -138.68 144.67 39.7 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.412 ' NZ ' ' HB2' ' A' ' 24' ' ' LYS . 9.3 mtmp? -85.72 -18.54 32.79 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.411 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -74.46 -30.84 62.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.855 -175.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' A' ' 23' ' ' ASP . 4.0 p30 -90.49 -0.55 57.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.618 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' VAL . 28.1 mt-30 -67.3 -17.38 64.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 171.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 48' ' ' ILE . . . -59.92 -42.22 93.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.053 171.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -63.15 -42.36 99.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 3.6 mptp? -54.46 -36.87 64.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.264 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.561 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 96.0 t -69.36 -46.09 77.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.641 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.426 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 16.5 mm-40 -56.9 -42.04 79.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.97 174.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -57.62 -51.13 70.77 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.455 ' HB2' HD11 ' A' ' 14' ' ' LEU . 51.3 t60 -51.19 -42.45 60.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.624 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 86.2 mt -72.63 -41.61 65.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.543 -176.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -80.56 -26.43 37.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.82 -176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -69.74 -45.78 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.594 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.0 p -68.1 -40.16 82.65 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.836 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.55 31.22 4.06 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.879 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.459 HD13 ' HD2' ' A' ' 130' ' ' PRO . 30.8 mm -65.81 125.0 89.05 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.68 141.53 50.15 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.0 1.8 . . . . 0.0 112.545 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 55.68 20.27 3.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.538 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 35' ' ' LEU . . . -84.87 -17.26 38.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.988 0.423 . . . . 0.0 111.0 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -83.74 -16.71 43.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.731 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -73.58 -27.15 61.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.772 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.9 m -89.8 159.62 2.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.658 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -112.95 136.91 52.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.79 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.426 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 15.8 mm -106.07 143.61 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 123.375 0.422 . . . . 0.0 110.707 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 9.6 tt0 -144.98 126.68 15.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.5 mm -107.44 121.26 60.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.966 0.412 . . . . 0.0 111.553 -174.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.47 76.74 1.07 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.56 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 69.1 -80.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.953 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.01 2.53 7.89 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -104.95 98.62 8.31 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -94.23 118.78 32.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.336 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 49' ' ' GLN . 12.8 m -90.57 134.14 34.59 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.638 0.256 . . . . 0.0 110.319 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.5 t -120.7 109.77 26.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.087 0.47 . . . . 0.0 109.98 176.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.19 159.87 16.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.223 -177.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.62 172.57 39.14 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -155.98 139.33 15.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.052 0.453 . . . . 0.0 110.666 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 95.16 7.03 59.81 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.822 -0.626 . . . . 0.0 113.131 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 89' ' ' THR . 7.3 mp -92.94 168.6 11.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.023 0.44 . . . . 0.0 110.735 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 m -105.82 151.49 24.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.114 172.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.695 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 41.0 tt0 -56.55 -43.13 79.61 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.489 -173.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -54.18 -36.57 63.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.808 -176.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.38 -38.97 29.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.355 176.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -55.91 -42.41 76.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.071 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 3.0 mm-40 -64.34 -23.69 67.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.659 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -66.42 -38.83 88.31 Favored 'General case' 0 N--CA 1.461 0.085 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.602 ' O ' HG12 ' A' ' 74' ' ' VAL . 4.0 mp -71.14 -55.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.203 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -48.7 -45.72 39.6 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.34 -30.49 43.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.963 0.411 . . . . 0.0 111.219 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -84.72 -30.64 24.59 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.284 -0.26 . . . . 0.0 111.555 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 70' ' ' ILE . 4.5 p -81.98 -39.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.018 0.437 . . . . 0.0 110.7 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.591 ' HA3' ' CZ ' ' A' ' 6' ' ' PHE . . . -67.24 -26.01 73.49 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.656 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -88.39 48.19 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.299 . . . . 0.0 110.814 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 31' ' ' VAL . 96.3 mt -121.21 142.93 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 121.225 0.536 . . . . 0.0 111.442 175.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 13' ' ' LYS . 51.8 p -64.83 105.91 1.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.764 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.51 -11.86 10.35 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.685 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 35.8 mm -90.96 113.37 26.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.544 0.688 . . . . 0.0 111.105 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.753 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -92.82 -26.49 17.65 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.002 177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 5.9 p -157.76 155.17 29.37 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.526 -177.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 10.6 p -126.59 127.05 69.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.56 174.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.62 93.32 6.68 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -70.43 112.84 7.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.53 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -121.76 22.74 10.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.202 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.06 118.41 28.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.071 0.462 . . . . 0.0 110.523 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -80.05 123.58 27.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.356 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 5.1 p -92.53 111.38 22.94 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.234 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.478 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -71.58 -33.38 69.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.007 178.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 p -128.72 138.84 34.0 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.861 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.5 142.7 33.36 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.771 2.314 . . . . 0.0 111.724 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.25 174.18 10.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.967 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.8 m -61.65 137.03 58.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.935 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.63 143.2 27.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.646 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.1 m -110.69 137.35 48.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.08 0.467 . . . . 0.0 110.514 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 14.5 tt0 -86.67 147.23 25.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.242 177.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.64 118.86 33.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.985 0.422 . . . . 0.0 111.24 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -119.72 136.61 54.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.098 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 143' ' ' VAL . 3.1 m -99.91 124.51 45.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 177.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 142' ' ' GLN . 2.4 m -71.4 136.42 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.421 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 34.0 mmtp -93.31 -168.67 1.96 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.065 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.476 ' HA ' ' HB3' ' A' ' 140' ' ' PRO . 27.4 m -56.51 -40.19 74.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -174.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.61 37.26 3.44 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.566 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.578 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 73.4 m-20 -99.36 128.57 45.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.411 0.624 . . . . 0.0 110.639 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 110' ' ' ILE . 1.5 p -114.48 153.82 29.29 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.205 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.487 HD22 ' HA ' ' A' ' 135' ' ' PRO . 27.6 tp -54.75 -43.33 72.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.307 0.503 . . . . 0.0 110.931 -172.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 p -62.39 -44.03 97.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.092 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.71 83.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.41 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.2 pp -73.73 -25.14 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.541 -178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.9 t -68.03 -46.82 70.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.131 0.491 . . . . 0.0 109.823 171.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.508 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 12.6 tmtt? -60.61 -29.01 68.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.583 0.706 . . . . 0.0 109.194 175.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 6.4 tp60 -67.32 -62.27 1.5 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.43 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 146' ' ' ILE . 34.5 m -79.6 -45.81 23.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.254 -172.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 114' ' ' VAL . 38.8 m-85 -81.42 -51.23 8.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.305 0.574 . . . . 0.0 110.509 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.51 -14.19 13.28 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.679 -174.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.46 ' ND2' ' HG ' ' A' ' 120' ' ' LEU . 17.7 t30 -123.34 126.93 47.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.154 -0.523 . . . . 0.0 109.829 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . . . -75.01 -17.06 60.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.82 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -80.46 -13.24 59.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.061 0.458 . . . . 0.0 110.843 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.46 ' HG ' ' ND2' ' A' ' 117' ' ' ASN . 39.1 mt -82.47 14.14 3.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.448 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.474 ' HB2' ' HG ' ' A' ' 107' ' ' LEU . 53.6 p90 -60.07 -24.82 64.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.27 -178.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.482 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 51.0 m-80 -62.56 -38.9 91.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.09 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -55.57 -50.51 69.86 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.575 0.702 . . . . 0.0 109.805 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.97 -39.41 81.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.48 -177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.446 ' HA ' HD23 ' A' ' 132' ' ' LEU . 85.8 t80 -58.55 -53.95 52.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.512 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 122' ' ' ASN . 21.5 mt-10 -66.04 -35.74 81.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.061 -176.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.425 ' HB2' ' HG3' ' A' ' 147' ' ' PRO . . . -64.14 -33.43 75.77 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.513 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.525 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 42.5 m-80 -95.72 -28.63 14.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.849 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 56.8 pttt -64.45 155.76 79.49 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.472 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 2.9 Cg_endo -82.0 10.63 36.33 Favored 'Cis proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.968 -1.263 . . . . 0.0 113.088 1.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.525 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 3.4 tmm? -66.31 -40.29 89.86 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.448 HD13 HE22 ' A' ' 142' ' ' GLN . 7.6 tp -86.24 113.38 22.2 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 171.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -76.9 -52.46 9.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.612 -170.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.492 ' HB2' ' CG ' ' A' ' 137' ' ' LYS . 24.0 m -142.38 155.74 64.23 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.011 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.487 ' HA ' HD22 ' A' ' 107' ' ' LEU . 74.4 Cg_exo -51.72 -54.53 5.17 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.495 2.797 . . . . 0.0 113.258 -172.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -91.07 9.78 29.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.219 0.533 . . . . 0.0 111.024 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 134' ' ' SER . 26.2 mmtp -92.27 13.09 20.28 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.549 HD11 ' HA ' ' A' ' 106' ' ' THR . 18.3 pt -67.19 171.39 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 171.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -148.08 144.69 19.22 Favored Pre-proline 0 C--N 1.315 -0.898 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.64 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.476 ' HB3' ' HA ' ' A' ' 103' ' ' SER . 81.5 Cg_exo -49.33 110.66 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.275 2.65 . . . . 0.0 112.47 -178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.53 22.79 6.56 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.085 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.578 ' H ' HG22 ' A' ' 101' ' ' VAL . 44.8 tt0 -105.56 118.63 37.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 117.613 0.706 . . . . 0.0 110.708 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 37.3 t -78.46 131.64 34.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.744 174.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.7 mt -121.19 135.64 55.11 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.101 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 145' ' ' ARG . 46.8 mtp180 -65.44 123.36 19.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.39 173.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 114' ' ' VAL . 23.3 mm -106.24 97.86 17.44 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.425 ' HG3' ' HB2' ' A' ' 127' ' ' ALA . 39.5 Cg_endo -70.49 158.8 54.91 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.227 1.951 . . . . 0.0 111.871 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.28 104.64 14.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.492 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -78.05 134.23 37.8 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.145 0.498 . . . . 0.0 109.995 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 151' ' ' GLU . 0.8 OUTLIER -140.51 100.28 3.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 150' ' ' LEU . 25.3 tt0 71.41 106.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.038 0.836 . . . . 0.0 110.976 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -128.41 138.41 52.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -69.53 145.82 52.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.993 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -77.58 79.48 4.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.825 0.821 . . . . 0.0 111.648 -174.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -85.27 -47.47 10.03 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.772 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -179.62 107.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.428 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.47 178.358 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 ttm . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.507 0.67 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.14 -89.94 0.18 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.504 HD13 ' N ' ' A' ' 4' ' ' PHE . 2.6 tm? -139.46 140.74 37.36 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.504 ' N ' HD13 ' A' ' 3' ' ' LEU . 98.4 m-85 -121.55 145.78 47.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.371 178.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -102.23 128.97 48.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 111.268 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 76.1 m-85 -124.77 -167.22 1.63 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.78 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 10' ' ' ALA . 91.2 t -107.69 118.94 56.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.114 0.483 . . . . 0.0 110.262 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.624 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 22.5 tptm -60.7 -33.74 73.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.906 -172.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -90.23 -33.94 15.98 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' H ' HG12 ' A' ' 7' ' ' VAL . . . -87.34 128.65 35.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.857 0.36 . . . . 0.0 111.426 -172.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.69 179.9 26.84 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.873 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.68 135.92 47.05 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -99.86 94.29 6.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.76 0.314 . . . . 0.0 110.525 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 34' ' ' HIS . 1.8 mm? -81.78 -32.17 31.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.852 0.358 . . . . 0.0 111.062 -177.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -118.66 22.08 12.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.336 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 56.97 83.47 0.1 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.639 -172.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.89 47.42 0.52 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.315 0.579 . . . . 0.0 111.868 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 p -98.78 -38.91 7.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.749 175.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -133.52 -30.3 1.29 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.92 -146.87 18.79 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.781 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.601 ' HA ' HE21 ' A' ' 21' ' ' GLN . 0.0 OUTLIER -129.18 -75.89 0.55 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 173.27 -53.13 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -113.88 133.58 55.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.672 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -64.98 -23.56 67.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.69 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -60.41 -39.97 89.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.821 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.8 m-20 -66.9 -34.76 78.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.41 ' O ' HG23 ' A' ' 31' ' ' VAL . 97.7 mt-30 -63.05 -46.95 85.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.638 0.256 . . . . 0.0 110.721 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 48' ' ' ILE . . . -57.15 -30.58 64.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.326 0.584 . . . . 0.0 111.197 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 35.6 ttpt -80.03 -50.67 10.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.339 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 26' ' ' ASP . 72.7 mmtt -51.74 -39.66 58.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.412 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 41.4 t -58.46 -52.06 64.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.694 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.611 ' HB3' HD13 ' A' ' 48' ' ' ILE . 3.0 pt20 -78.28 -21.1 50.26 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.464 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 46.9 mt-10 -64.99 -39.0 92.82 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 172.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.529 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 63.6 t60 -55.97 -37.49 69.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.02 172.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.6 mt -70.53 -45.84 64.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.22 -41.7 94.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.05 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 97.3 mttt -59.48 -54.85 41.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.053 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 p -62.74 -44.18 96.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.085 0.469 . . . . 0.0 111.142 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.54 33.75 1.86 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.899 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.453 HD13 ' HD2' ' A' ' 130' ' ' PRO . 24.3 mm -69.53 129.15 91.75 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.83 143.19 49.74 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.614 2.209 . . . . 0.0 113.207 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 57.15 28.57 15.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.697 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.83 -20.6 62.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.24 0.543 . . . . 0.0 110.349 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -81.32 -15.99 53.75 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.425 177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -86.81 -11.28 51.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.816 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.08 177.31 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.113 0.483 . . . . 0.0 111.292 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.63 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 42.0 t30 -141.4 128.51 20.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.065 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 32' ' ' GLN . 3.2 mp -104.53 129.25 57.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 123.39 0.431 . . . . 0.0 110.608 -174.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -128.7 128.03 43.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.273 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.4 mm -98.74 120.59 48.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.001 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.45 88.01 2.86 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.769 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 67.33 -74.88 0.06 Allowed 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.803 0.69 . . . . 0.0 111.134 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.38 -1.0 4.01 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 84' ' ' ASP . 38.7 ttmt -96.74 115.74 27.95 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.959 0.409 . . . . 0.0 110.731 -178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.82 100.74 12.26 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.425 ' CG2' HE21 ' A' ' 86' ' ' GLN . 38.1 m -83.35 128.5 34.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.382 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -120.79 117.33 52.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.008 0.432 . . . . 0.0 111.043 177.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.486 HG23 ' HB3' ' A' ' 86' ' ' GLN . 2.2 m -100.52 162.96 12.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.789 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.8 166.68 33.64 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.801 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -156.13 138.07 14.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.875 0.369 . . . . 0.0 110.066 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 91.96 8.21 63.56 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.802 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.504 ' HG ' ' CG1' ' A' ' 87' ' ' VAL . 4.5 mm? -78.68 171.79 14.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.0 112.265 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -128.05 146.41 50.69 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 170.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.614 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 9.8 mt-30 -59.65 -22.48 61.95 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.303 0.377 . . . . 0.0 112.008 -175.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.67 -34.55 72.98 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.259 0.349 . . . . 0.0 111.311 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.42 -36.52 7.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.027 0.441 . . . . 0.0 110.475 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 64' ' ' GLN . 52.5 tttm -50.91 -46.53 60.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.049 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.415 ' O ' ' HD2' ' A' ' 145' ' ' ARG . 21.7 mt-10 -87.92 20.58 3.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.415 0.626 . . . . 0.0 110.923 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -113.91 -41.7 3.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.059 170.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 54.6 mt -59.22 -59.3 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.245 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 67' ' ' LYS . 9.3 mp -42.86 -41.99 3.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.458 176.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.85 -53.39 30.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.99 -24.06 65.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.39 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.2 t -79.0 -40.68 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.171 0.51 . . . . 0.0 110.481 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -72.27 -25.94 73.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.506 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.426 ' HB3' ' OH ' ' A' ' 139' ' ' TYR . 90.4 m-20 -86.45 39.95 0.86 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.099 0.476 . . . . 0.0 111.056 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.457 ' CD1' HG13 ' A' ' 31' ' ' VAL . 92.9 mt -114.26 135.31 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.715 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -67.92 123.81 21.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.31 -9.27 38.72 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.252 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 42.1 mm -105.01 137.81 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.624 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -124.04 -19.47 5.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.721 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 p -152.97 157.04 39.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.065 0.459 . . . . 0.0 111.297 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.3 t -133.04 126.11 52.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.84 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . 15.1 t70 -102.37 110.64 22.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.409 ' CB ' HD21 ' A' ' 71' ' ' LEU . 9.0 p-10 -92.49 100.47 13.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 122.145 0.974 . . . . 0.0 111.77 -174.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.486 ' HB3' HG23 ' A' ' 58' ' ' THR . 43.0 mt-30 -98.98 18.47 17.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.163 172.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.504 ' CG1' ' HG ' ' A' ' 62' ' ' LEU . 43.1 t -80.01 108.08 13.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.437 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -86.59 137.57 32.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.075 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.8 p -102.45 130.42 49.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.058 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.441 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -90.08 -16.18 30.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.6 p -129.27 142.53 45.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.85 124.42 7.44 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.668 2.245 . . . . 0.0 111.842 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.35 168.87 18.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.5 m -65.18 140.77 58.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.434 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.89 154.7 17.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.08 0.467 . . . . 0.0 111.759 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.9 m -118.94 146.96 44.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.981 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.482 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 7.6 tt0 -91.3 150.73 21.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.425 175.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -105.82 100.83 10.37 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.103 0.477 . . . . 0.0 110.85 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.441 ' CE2' ' HB ' ' A' ' 110' ' ' ILE . 80.0 t80 -101.66 144.24 30.63 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.917 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 143' ' ' VAL . 17.1 m -110.94 124.15 51.57 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.358 -0.137 . . . . 0.0 110.675 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.675 HG22 ' H ' ' A' ' 142' ' ' GLN . 1.7 m -66.09 129.5 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -80.84 -81.51 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.969 -171.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.3 m -162.26 123.49 2.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.12 28.88 71.01 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.26 130.43 43.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.892 -0.654 . . . . 0.0 109.95 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.561 ' HA ' HD11 ' A' ' 138' ' ' ILE . 7.6 p -115.76 162.61 17.04 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.878 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 22.9 mt -57.83 -42.67 84.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.76 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.4 m -59.63 -38.69 82.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.942 0.401 . . . . 0.0 110.822 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.7 -44.65 69.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.264 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 113' ' ' GLN . 1.5 pp -78.22 -22.15 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.483 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.4 p -77.8 -42.67 33.05 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.243 -0.286 . . . . 0.0 110.564 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 61.3 tttp -62.73 -26.27 68.6 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.506 0.67 . . . . 0.0 109.75 171.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.637 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 4.7 tp60 -64.33 -55.02 24.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.949 175.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 115' ' ' TYR . 34.2 m -86.46 -51.25 13.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.349 -173.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.538 ' CE1' ' HB2' ' A' ' 149' ' ' GLU . 21.6 m-85 -87.67 -31.01 19.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.249 -176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.31 -19.51 39.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.102 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -114.1 120.61 41.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' A' ' 112' ' ' LYS . . . -69.19 -20.13 63.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.872 -175.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -81.77 -0.15 41.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.985 0.421 . . . . 0.0 111.004 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.8 mt -91.28 17.43 8.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 42.3 p90 -60.84 -30.91 70.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.362 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -69.8 -30.54 68.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.522 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -63.11 -44.12 96.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.257 0.551 . . . . 0.0 110.341 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.3 mt -75.46 -36.88 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.163 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -53.26 -60.81 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.801 177.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.472 ' CD ' ' HZ2' ' A' ' 129' ' ' LYS . 11.6 mm-40 -50.43 -43.62 55.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.943 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.565 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -63.84 -33.08 74.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.32 -174.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.497 ' HB3' ' CE ' ' A' ' 131' ' ' MET . 42.2 m-80 -92.8 5.17 52.17 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.715 0.293 . . . . 0.0 111.506 -175.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.472 ' HZ2' ' CD ' ' A' ' 126' ' ' GLU . 15.3 mtmm -82.63 156.27 68.14 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HD2' HD13 ' A' ' 40' ' ' ILE . 96.6 Cg_endo -86.39 15.37 41.24 Favored 'Cis proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.72 -1.367 . . . . 0.0 113.424 -1.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.497 ' CE ' ' HB3' ' A' ' 128' ' ' ASN . 0.3 OUTLIER -66.12 -41.94 89.84 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.128 0.49 . . . . 0.0 110.069 175.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 tp -95.03 124.41 39.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.441 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -101.6 -33.27 9.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.862 -172.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 69.0 m -155.42 153.64 26.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.57 0.224 . . . . 0.0 111.179 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.523 ' HA ' ' CD1' ' A' ' 107' ' ' LEU . 81.9 Cg_exo -48.67 -56.95 2.67 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.627 2.885 . . . . 0.0 113.382 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.01 -7.78 53.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.864 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 134' ' ' SER . 30.2 mmtp -81.51 -2.72 50.88 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.561 HD11 ' HA ' ' A' ' 106' ' ' THR . 12.3 pt -68.37 167.55 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.972 0.415 . . . . 0.0 110.438 174.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 76' ' ' ASN . 10.5 p90 -141.46 141.67 23.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.428 -174.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.81 111.02 0.5 Allowed 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 123.176 2.584 . . . . 0.0 112.248 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.24 23.47 6.35 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.907 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.675 ' H ' HG22 ' A' ' 101' ' ' VAL . 47.3 tt0 -104.48 121.8 44.2 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.572 -178.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.442 HG22 ' OG1' ' A' ' 100' ' ' THR . 42.7 t -80.93 133.75 28.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.965 174.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.1 mt -126.15 135.67 51.94 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.673 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.583 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 3.1 ptm180 -73.84 123.78 24.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.289 0.566 . . . . 0.0 110.011 176.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.482 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 26.3 mm -103.84 91.29 3.45 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.038 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 37.1 Cg_exo -60.88 144.28 99.53 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.501 2.134 . . . . 0.0 111.318 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.72 116.3 3.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.18 0.515 . . . . 0.0 110.328 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.538 ' HB2' ' CE1' ' A' ' 115' ' ' TYR . 41.0 tt0 -76.28 126.86 31.75 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.01 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.22 5.19 42.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.321 0.581 . . . . 0.0 109.743 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 149' ' ' GLU . 51.5 tt0 -88.0 98.53 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.525 177.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -101.3 -16.85 16.8 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.998 0.428 . . . . 0.0 110.654 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -91.58 81.34 5.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.126 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -89.46 -74.25 0.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.444 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 38.7 m80 53.55 52.28 13.6 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.987 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -134.57 -178.43 5.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.133 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.067 -177.995 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 27.1 ptm . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.43 -68.62 0.22 Allowed Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.7 tp -146.0 132.13 19.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.473 ' CZ ' ' HA ' ' A' ' 1' ' ' MET . 74.1 m-85 -114.16 133.92 55.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.645 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -109.85 134.56 51.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.272 0.558 . . . . 0.0 110.827 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' A' ' 75' ' ' GLY . 67.3 m-85 -118.03 -157.96 0.69 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.644 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.957 HG11 ' HB3' ' A' ' 10' ' ' ALA . 7.7 p -85.17 -24.61 6.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.914 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 28.9 tptp 74.83 -52.43 0.68 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.319 0.647 . . . . 0.0 111.881 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -85.81 -44.07 12.77 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.957 ' HB3' HG11 ' A' ' 7' ' ' VAL . . . -78.8 172.33 13.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.761 -177.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.21 -173.72 15.65 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.32 121.29 15.4 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 57.6 mtmt -80.04 74.76 6.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.471 0.653 . . . . 0.0 111.601 -171.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp -67.15 -48.53 67.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.581 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -133.62 18.76 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 56.61 20.78 5.21 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.587 176.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.43 22.44 9.53 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -75.53 83.82 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.692 0.282 . . . . 0.0 110.879 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.9 p 46.51 39.45 6.75 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.15 6.61 74.89 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.123 -0.561 . . . . 0.0 113.126 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 55.41 41.64 30.82 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.972 0.509 . . . . 0.0 110.629 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 35.6 m80 68.06 -74.11 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.746 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 19.6 m-20 -79.45 87.92 5.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.653 -177.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.563 ' O ' ' HB ' ' A' ' 50' ' ' ILE . 17.9 ptpt -67.07 -31.38 71.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.444 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -71.29 -33.77 70.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.99 0.424 . . . . 0.0 111.022 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.11 -16.21 60.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.824 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 23' ' ' ASP . 10.5 mm100 -67.18 -21.85 65.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.579 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.77 82.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.225 176.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 33' ' ' GLU . 57.3 tptt -65.28 -45.9 82.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.317 176.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -55.73 -46.86 77.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.793 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 77' ' ' ILE . 72.0 t -60.39 -49.31 84.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.941 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HG2' ' CG1' ' A' ' 48' ' ' ILE . 3.2 mm-40 -53.11 -41.97 65.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.613 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 44.8 mt-10 -56.28 -44.84 80.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.498 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -56.16 -46.87 79.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.728 -178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.66 -39.21 84.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.826 0.346 . . . . 0.0 111.823 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -77.08 -24.36 51.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.488 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -82.54 -24.33 34.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.562 0.22 . . . . 0.0 111.353 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -83.75 -35.9 24.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.859 0.362 . . . . 0.0 110.955 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.69 24.15 6.23 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.162 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.88 125.56 91.01 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -78.53 149.32 23.96 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.978 1.786 . . . . 0.0 111.955 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.56 8.2 4.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.42 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.81 -13.24 56.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.054 0.454 . . . . 0.0 110.951 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.77 -7.46 56.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.634 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -89.36 -12.32 40.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.403 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.412 HG21 HG21 ' A' ' 70' ' ' ILE . 35.0 m -103.05 157.56 4.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.839 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 18.3 m120 -119.27 132.96 55.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.646 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.468 ' CG1' ' HG2' ' A' ' 32' ' ' GLN . 13.4 mm -95.26 140.97 15.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -174.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 52.6 mt-30 -137.53 127.41 25.62 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 24' ' ' LYS . 34.5 mm -117.91 116.58 52.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.185 0.517 . . . . 0.0 111.711 -172.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.05 70.81 0.78 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.915 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 t70 72.87 -66.45 0.31 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.185 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.12 31.49 2.69 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.894 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.569 ' CE ' ' HB2' ' A' ' 84' ' ' ASP . 87.2 tttt -140.25 129.42 23.68 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.503 -0.41 . . . . 0.0 110.718 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 83' ' ' VAL . . . -108.63 107.68 18.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.41 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 84' ' ' ASP . 36.5 m -95.21 114.05 25.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -104.71 127.6 59.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.82 0.343 . . . . 0.0 111.609 -177.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 86' ' ' GLN . 0.2 OUTLIER -104.35 158.08 16.71 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.123 177.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.41 156.72 10.11 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.29 137.49 27.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.144 0.497 . . . . 0.0 110.533 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 90' ' ' ALA . . . 96.43 0.58 61.05 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.514 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 89' ' ' THR . 4.6 mm? -68.64 178.1 2.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.176 0.512 . . . . 0.0 111.982 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.464 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 53.6 p -127.02 144.34 51.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.564 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.623 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 48.8 tp60 -45.64 -54.86 7.1 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.532 0.52 . . . . 0.0 112.076 -175.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.91 -35.13 72.54 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.03 -42.6 19.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.936 0.398 . . . . 0.0 110.077 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 79.8 tttt -54.54 -40.45 68.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.27 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 64' ' ' GLN . 79.0 mt-10 -63.46 -35.47 80.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.44 -43.87 93.05 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.412 HG21 HG21 ' A' ' 46' ' ' VAL . 2.8 mp -62.26 -50.77 78.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.092 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 67' ' ' LYS . 88.0 mt -53.97 -45.96 71.5 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.409 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 68' ' ' GLU . 46.5 t -72.0 -44.22 66.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.211 0.529 . . . . 0.0 110.83 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' A' ' 131' ' ' MET . . . -62.9 -34.66 77.89 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.349 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 80' ' ' ILE . 22.5 m -82.18 -31.12 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.638 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 6' ' ' PHE . . . -72.36 -32.8 62.06 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.766 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.25 41.03 0.8 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.941 0.4 . . . . 0.0 111.056 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.432 ' CD1' HG13 ' A' ' 31' ' ' VAL . 96.8 mt -115.54 134.75 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 121.061 0.458 . . . . 0.0 110.398 172.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.53 ' HB3' ' HA ' ' A' ' 13' ' ' LYS . 14.8 t -62.47 105.99 0.7 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.486 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.91 -15.42 5.65 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.565 -174.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 8' ' ' LYS . 49.7 mm -100.85 120.57 50.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.128 0.49 . . . . 0.0 111.49 -177.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.914 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . . . -98.96 -38.26 9.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.685 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.4 p -142.7 159.6 41.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.48 0.657 . . . . 0.0 111.85 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 55' ' ' ALA . 69.0 t -131.07 127.53 61.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.628 177.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.569 ' HB2' ' CE ' ' A' ' 54' ' ' LYS . 5.6 t70 -106.39 107.75 18.92 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.76 110.04 15.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.115 0.96 . . . . 0.0 111.032 -173.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 58' ' ' THR . 14.6 mm-40 -107.98 17.51 22.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.531 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -92.4 116.24 33.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.843 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -85.59 139.17 31.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.307 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 16.6 p -105.48 131.11 53.29 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.99 0.424 . . . . 0.0 111.202 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.462 ' HB2' ' HA2' ' A' ' 61' ' ' GLY . . . -103.77 -40.02 6.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.238 -176.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 63' ' ' SER . 17.8 p -96.28 141.0 22.5 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.586 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.6 130.49 18.4 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.805 2.337 . . . . 0.0 112.293 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.623 ' HB3' ' HB3' ' A' ' 64' ' ' GLN . . . -148.54 160.86 42.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.9 m -82.36 133.71 35.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.379 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.6 141.42 29.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.677 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.8 m -108.96 170.99 7.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.65 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.513 ' HB3' ' HB ' ' A' ' 146' ' ' ILE . 4.6 tt0 -96.33 147.7 23.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.518 174.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -104.29 107.08 17.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.976 0.417 . . . . 0.0 110.039 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -108.31 129.96 55.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.353 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.431 ' OG1' HG22 ' A' ' 143' ' ' VAL . 17.7 m -98.07 123.44 42.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.95 175.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -69.03 130.14 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.307 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.47 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 45.5 mmtm -80.18 -73.37 0.36 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.313 -170.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 140' ' ' PRO . 18.4 t -150.39 -68.66 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.765 -176.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.35 36.67 2.58 Favored Glycine 0 C--N 1.329 0.189 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -96.4 115.84 28.08 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.152 -172.2 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 110' ' ' ILE . 27.6 p -110.2 159.2 17.59 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -57.41 -45.12 84.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.178 0.444 . . . . 0.0 110.783 -171.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.505 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . 14.3 m -63.04 -40.19 96.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.56 82.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.331 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 106' ' ' THR . 1.3 pp -74.11 -27.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 120.805 0.336 . . . . 0.0 110.503 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -67.19 -43.52 81.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.057 0.456 . . . . 0.0 110.133 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.16 -28.2 69.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.369 0.604 . . . . 0.0 109.964 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.596 ' HB3' ' O ' ' A' ' 110' ' ' ILE . 1.1 tp-100 -67.42 -54.49 19.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.078 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 115' ' ' TYR . 27.4 m -85.18 -50.49 14.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.207 -172.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.475 ' N ' HG23 ' A' ' 114' ' ' VAL . 68.9 m-85 -85.81 -42.13 14.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.057 0.456 . . . . 0.0 111.146 -177.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.8 -14.88 31.83 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.447 ' HB3' ' HG ' ' A' ' 120' ' ' LEU . 55.3 t-20 -118.75 120.15 36.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.505 ' HB1' ' HB3' ' A' ' 108' ' ' SER . . . -71.08 -22.24 62.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -174.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.08 -8.18 55.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.039 0.447 . . . . 0.0 111.106 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' ' 117' ' ' ASN . 46.6 mt -86.4 10.8 13.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.648 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 107' ' ' LEU . 51.0 p90 -59.14 -26.49 64.79 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.925 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -70.3 -31.54 68.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.112 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.434 ' HE2' HD13 ' A' ' 120' ' ' LEU . 33.6 mtmt -62.43 -45.29 93.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.717 0.77 . . . . 0.0 109.68 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.0 mt -66.62 -42.76 90.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.619 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -56.74 -53.78 53.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.367 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -65.45 -26.31 67.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.884 0.373 . . . . 0.0 111.664 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 145' ' ' ARG . . . -76.58 -25.83 54.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.708 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 131' ' ' MET . 39.2 m-80 -98.02 -30.59 12.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.272 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 130' ' ' PRO . 19.4 pttp -66.14 156.91 83.22 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 129' ' ' LYS . 95.4 Cg_endo -81.2 10.33 32.71 Favored 'Cis proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.494 -1.461 . . . . 0.0 113.4 2.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.54 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 3.6 tmm? -64.99 -37.96 89.39 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.534 HD13 HE22 ' A' ' 142' ' ' GLN . 7.8 tp -88.74 114.77 25.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.026 171.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -73.41 -46.65 47.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.684 -171.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 135' ' ' PRO . 16.4 m -152.1 150.54 25.92 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 121.239 0.542 . . . . 0.0 109.928 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 107' ' ' LEU . 28.0 Cg_endo -62.6 -20.78 71.79 Favored 'Trans proline' 0 C--N 1.334 -0.232 0 C-N-CA 123.784 2.99 . . . . 0.0 113.025 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -101.4 -0.45 35.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.564 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -98.35 16.18 22.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.464 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 19.0 pt -74.0 166.44 2.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 171.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -153.27 147.21 18.56 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.821 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.413 ' HB3' ' HA ' ' A' ' 103' ' ' SER . 92.4 Cg_exo -47.53 113.68 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.573 2.849 . . . . 0.0 112.629 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.57 30.63 4.86 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.315 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.534 HE22 HD13 ' A' ' 132' ' ' LEU . 43.1 tt0 -114.02 124.9 53.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.629 0.714 . . . . 0.0 110.933 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.431 HG22 ' OG1' ' A' ' 100' ' ' THR . 45.1 t -82.69 134.73 26.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.757 173.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.4 mt -126.01 138.84 53.76 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.896 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.557 ' O ' ' HD3' ' A' ' 147' ' ' PRO . 52.9 mtp180 -65.91 118.28 9.5 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.675 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 97' ' ' GLN . 39.3 mm -105.96 90.16 4.24 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 145' ' ' ARG . 24.5 Cg_exo -62.37 150.31 87.69 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.685 2.257 . . . . 0.0 111.443 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.431 ' O ' HD22 ' A' ' 150' ' ' LEU . 30.6 tt0 -64.96 126.67 28.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -74.34 116.22 14.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.801 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 148' ' ' GLU . 2.9 mm? -89.16 72.08 8.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.751 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 57.38 -127.76 1.73 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.106 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 69.9 m80 62.82 48.67 3.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.14 0.495 . . . . 0.0 110.645 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -143.87 121.2 11.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.857 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -108.04 -64.59 1.2 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.418 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -162.14 130.31 4.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.501 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -150.67 124.89 9.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.015 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 44.8 t60 . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.612 175.461 . . . . . . . . 0 0 . 1 stop_ save_